data_2kyt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kyt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--O 1.236 0.424 0 CA-C-O 121.688 0.62 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -134.72 146.76 60.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.162 1.385 . . . . 0.0 107.636 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.17 133.55 15.17 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.538 2.159 . . . . 0.0 110.327 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.93 -8.76 50.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.239 1.399 . . . . 0.0 112.397 -169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.01 147.92 24.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.064 1.932 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.07 139.52 42.86 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.3 mm -118.12 146.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.32 153.09 35.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -129.17 103.15 8.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -168.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.575 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.33 169.38 7.52 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.819 1.648 . . . . 0.0 107.533 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.16 -28.18 50.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.947 2.432 . . . . 0.0 115.843 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -142.05 4.4 1.65 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.703 0.801 . . . . 0.0 112.92 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.4 -155.89 0.49 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.912 1.285 . . . . 0.0 108.465 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.66 170.02 19.66 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.51 1.05 . . . . 0.0 110.746 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -144.32 172.46 12.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.333 1.853 . . . . 0.0 109.352 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -137.42 146.92 44.97 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.73 173.72 15.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.401 1.48 . . . . 0.0 108.892 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.2 133.86 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -77.09 132.05 38.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.07 -3.81 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.9 177.22 42.27 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.14 53.39 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.525 1.13 . . . . 0.0 111.484 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.87 -13.17 0.39 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.225 -1.32 . . . . 0.0 114.083 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -119.21 155.49 31.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.121 1.961 . . . . 0.0 111.834 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -134.39 156.01 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.85 1.26 . . . . 0.0 110.874 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.46 142.71 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.53 171.27 16.07 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.326 0.651 . . . . 0.0 110.284 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.37 148.62 28.16 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.44 158.99 65.03 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 125.426 1.49 . . . . 0.0 108.571 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.65 156.58 22.09 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.006 1.804 . . . . 0.0 110.419 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 CA--C 1.542 0.889 0 C-N-CA 122.882 2.388 . . . . 0.0 110.958 169.81 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.21 177.23 10.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.506 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 mt -134.83 147.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 t -88.58 125.94 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -135.17 165.57 25.09 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.246 1.018 . . . . 0.0 109.701 -168.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -125.69 139.11 53.82 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -151.95 160.85 43.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.859 1.264 . . . . 0.0 108.598 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.39 132.89 50.13 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -53.31 -43.91 67.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.531 0.732 . . . . 0.0 110.748 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -67.06 -19.19 65.63 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.6 -46.21 33.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.141 0.882 . . . . 0.0 109.906 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.95 -39.21 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.489 0.715 . . . . 0.0 110.197 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.76 -20.15 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.315 1.446 . . . . 0.0 112.861 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.5 -11.92 37.2 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.176 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -51.46 -57.94 7.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.531 1.132 . . . . 0.0 111.009 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -165.79 -50.8 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.968 1.707 . . . . 0.0 110.132 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -159.41 173.0 16.9 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.022 1.729 . . . . 0.0 107.977 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -157.96 164.1 37.16 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.475 -0.766 . . . . 0.0 109.75 173.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -147.83 160.19 43.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.403 1.481 . . . . 0.0 108.367 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.67 135.22 26.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -154.09 75.06 1.0 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.65 0.659 . . . . 0.0 110.779 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.45 94.89 0.42 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -57.53 -23.29 49.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 82' ' ' ASP . 61.5 m-70 -136.95 21.97 3.05 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.738 1.154 . . . . 0.0 112.251 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.62 -4.72 1.0 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.481 1.491 . . . . 0.0 112.08 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.7 t70 -87.28 -9.89 53.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.669 1.187 . . . . 0.0 110.729 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -132.3 -41.14 0.99 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.011 1.324 . . . . 0.0 111.213 -169.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -153.05 162.19 41.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.179 . . . . 0.0 111.898 -169.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -178.78 72.16 0.2 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 129.286 3.035 . . . . 0.0 105.275 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -13.64 40.45 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.535 2.823 . . . . 0.0 113.986 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.86 138.64 24.14 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 108.641 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.39 159.14 50.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.313 2.008 . . . . 0.0 109.823 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.24 -42.46 61.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.757 0.823 . . . . 0.0 111.502 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -53.66 -56.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.624 0.77 . . . . 0.0 111.194 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.7 -38.38 90.2 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.354 1.061 . . . . 0.0 111.718 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.84 -49.31 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.431 1.014 . . . . 0.0 108.692 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.29 -46.09 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.91 89.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.877 -0.582 . . . . 0.0 109.957 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -63.3 -48.0 79.92 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.925 0.784 . . . . 0.0 109.851 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.26 60.2 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.321 0.509 . . . . 0.0 110.005 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.68 -19.93 58.79 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.78 -26.51 61.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.864 1.266 . . . . 0.0 109.048 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.76 -10.65 19.75 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.88 -169.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.47 144.52 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.399 0.999 . . . . 0.0 109.784 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.14 60.77 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.66 1.124 . . . . 0.0 112.979 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -86.46 158.42 19.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.798 1.299 . . . . 0.0 109.536 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -100.68 154.04 18.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.53 147.06 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.968 1.307 . . . . 0.0 107.89 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.33 42.09 1.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.788 1.28 . . . . 0.0 110.16 -168.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -139.87 147.79 41.16 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.692 1.597 . . . . 0.0 108.406 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.33 150.5 34.85 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.116 0.967 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 108' ' ' LEU . 1.2 pt? -77.23 56.28 1.29 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.177 1.391 . . . . 0.0 112.282 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -64.58 159.07 22.62 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.076 -1.015 . . . . 0.0 109.26 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.3 t -50.07 -45.03 52.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.42 -43.57 97.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.211 0.604 . . . . 0.0 111.476 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -71.71 -37.0 70.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.112 0.869 . . . . 0.0 111.142 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.3 m -67.87 -42.85 80.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.257 0.48 . . . . 0.0 110.159 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.45 -46.73 83.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.071 0.948 . . . . 0.0 109.643 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -58.06 -55.27 37.15 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.722 1.209 . . . . 0.0 109.771 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.39 -49.6 76.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.643 0.202 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.55 -30.59 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.819 -169.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -67.34 -33.28 74.91 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.472 -0.768 . . . . 0.0 110.398 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -55.99 -29.86 60.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.541 0.736 . . . . 0.0 112.194 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.15 -50.17 9.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.534 0.606 . . . . 0.0 110.354 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -71.17 -33.34 69.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.558 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.25 6.72 6.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.669 0.668 . . . . 0.0 112.601 -170.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.56 7.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.113 0.869 . . . . 0.0 112.691 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.48 141.4 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.406 1.882 . . . . 0.0 107.914 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.793 168.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.457 -0.666 0 CA-C-O 121.667 0.611 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.35 148.43 67.91 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.32 1.448 . . . . 0.0 107.594 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -47.51 129.15 16.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.582 2.188 . . . . 0.0 110.088 170.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.64 -6.16 35.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.933 1.254 . . . . 0.0 112.297 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.35 150.8 22.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.385 2.092 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.66 142.53 38.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.13 146.08 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -129.05 146.78 50.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 167.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.83 93.78 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.8 135.04 51.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -128.21 172.41 6.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.055 1.342 . . . . 0.0 110.074 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.33 -34.88 26.21 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.454 2.77 . . . . 0.0 116.733 -169.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -139.75 7.98 2.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.699 0.8 . . . . 0.0 112.721 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.58 -169.0 1.97 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 109.121 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.17 156.82 45.88 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.166 -0.959 . . . . 0.0 109.216 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -119.76 169.08 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.471 1.508 . . . . 0.0 107.609 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -132.87 146.0 51.43 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.491 1.041 . . . . 0.0 111.146 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.89 174.88 12.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.647 1.979 . . . . 0.0 108.383 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 tt -135.72 135.51 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.35 131.52 37.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.82 -3.77 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.45 174.57 41.93 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.93 53.75 0.96 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.205 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.2 -13.08 0.29 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.289 -1.284 . . . . 0.0 113.781 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -120.3 155.76 32.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.095 1.948 . . . . 0.0 111.934 -171.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 m -133.98 160.33 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.971 1.308 . . . . 0.0 110.957 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -114.53 140.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 167.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.75 173.51 15.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.898 0.479 . . . . 0.0 110.937 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.32 141.22 34.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.94 160.93 58.63 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.425 1.89 . . . . 0.0 108.142 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -61.58 150.69 84.35 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.548 1.498 . . . . 0.0 109.727 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 123.395 2.73 . . . . 0.0 114.296 -179.336 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.56 12.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 112.058 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.42 148.5 25.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 125.761 1.624 . . . . 0.0 107.132 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.69 128.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -137.72 161.0 37.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.685 1.194 . . . . 0.0 109.145 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -121.67 134.08 54.97 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.62 160.9 43.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.755 1.222 . . . . 0.0 109.002 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.08 128.18 35.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.887 0.875 . . . . 0.0 108.877 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.33 -45.11 68.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.83 0.852 . . . . 0.0 110.626 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -64.3 -24.42 67.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.919 -172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.59 -43.22 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.706 0.685 . . . . 0.0 110.481 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.93 -46.8 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.452 0.701 . . . . 0.0 109.744 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.25 65.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.845 1.258 . . . . 0.0 112.117 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 -12.16 15.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.723 1.154 . . . . 0.0 113.363 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.9 m -52.42 -50.55 62.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.959 1.38 . . . . 0.0 111.133 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -165.04 -56.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.041 1.336 . . . . 0.0 110.631 171.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.95 -176.93 5.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.078 1.351 . . . . 0.0 109.855 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.79 169.53 24.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.894 0.878 . . . . 0.0 110.218 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -152.88 156.53 39.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.521 1.129 . . . . 0.0 110.065 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.64 138.43 20.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 169.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -150.63 67.96 0.95 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.171 0.51 . . . . 0.0 109.714 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.36 114.7 3.34 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -56.75 -42.33 79.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.458 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -163.11 43.47 0.12 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.331 0.652 . . . . 0.0 110.729 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.09 -14.25 6.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.818 . . . . 0.0 111.812 168.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.99 -16.74 37.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.0 1.32 . . . . 0.0 110.908 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -116.56 -27.11 6.82 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.454 1.102 . . . . 0.0 110.928 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -144.97 146.51 31.97 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.316 0.647 . . . . 0.0 111.643 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 p -164.82 66.28 1.23 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.541 1.536 . . . . 0.0 108.96 169.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.46 -13.82 41.49 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.452 2.101 . . . . 0.0 113.025 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.58 119.39 21.59 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.239 1.416 . . . . 0.0 108.764 -171.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.44 153.67 22.11 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.734 2.289 . . . . 0.0 110.146 167.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.1 m -52.71 -43.46 65.66 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.713 0.405 . . . . 0.0 111.87 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -56.71 -41.17 76.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.689 0.795 . . . . 0.0 112.269 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -64.94 -31.89 73.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.573 0.749 . . . . 0.0 111.133 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -64.74 -46.07 93.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.58 -48.81 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -55.64 -46.19 77.48 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.744 1.218 . . . . 0.0 110.724 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -61.03 -51.41 69.31 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.49 67.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.395 0.278 . . . . 0.0 110.712 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.76 -20.55 61.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.93 -27.49 61.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 119.254 0.934 . . . . 0.0 108.877 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.68 -16.19 15.54 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.711 -1.137 . . . . 0.0 113.529 -168.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.0 t -53.2 134.78 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.622 1.556 . . . . 0.0 108.578 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.78 -7.17 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.524 1.059 . . . . 0.0 113.335 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 159.36 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.184 1.492 . . . . 0.0 108.918 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -127.51 142.87 51.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.71 146.79 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.876 0.87 . . . . 0.0 109.01 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.36 -1.21 48.2 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.757 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -80.14 149.68 30.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.813 0.733 . . . . 0.0 109.209 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -74.65 154.45 38.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.498 1.919 . . . . 0.0 109.443 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.91 121.81 16.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.7 p -140.92 158.26 44.2 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 m -51.97 -42.38 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.852 0.461 . . . . 0.0 110.184 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.46 -48.33 70.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 110.841 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.67 -38.04 83.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.57 0.623 . . . . 0.0 110.853 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.2 m -67.91 -44.62 76.51 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.932 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -58.01 -44.69 87.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.489 0.715 . . . . 0.0 110.209 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -56.86 -52.41 65.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.163 1.385 . . . . 0.0 109.414 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -62.33 -49.97 73.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.757 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.0 -33.17 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.693 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.16 -34.7 78.62 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 121.639 -0.663 . . . . 0.0 110.682 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.55 -34.44 71.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.354 0.662 . . . . 0.0 112.203 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -76.88 -45.5 27.95 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.53 -0.731 . . . . 0.0 110.253 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -34.87 61.31 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.301 0.64 . . . . 0.0 111.265 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.08 8.35 6.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 111.999 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.77 -21.04 12.03 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.057 -1.027 . . . . 0.0 112.906 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.26 143.57 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.605 1.562 . . . . 0.0 106.891 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.483 0.713 . . . . 0.0 111.256 172.81 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 N-CA-C 111.824 -0.106 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -125.35 141.52 39.02 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.98 134.84 18.2 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.772 2.315 . . . . 0.0 110.504 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.65 -10.0 58.96 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.154 1.359 . . . . 0.0 112.402 -169.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -78.04 140.5 39.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.119 1.959 . . . . 0.0 111.033 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.57 136.28 52.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.89 140.87 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.31 145.63 45.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 110.95 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -75.76 134.48 40.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -132.86 168.89 15.65 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.053 0.941 . . . . 0.0 110.687 -170.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.53 -30.41 35.61 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.37 2.713 . . . . 0.0 116.588 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 4.93 1.5 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.474 0.71 . . . . 0.0 112.763 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.68 -165.86 1.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.699 1.2 . . . . 0.0 109.029 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.09 149.46 44.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -120.69 171.77 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.746 1.618 . . . . 0.0 108.362 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -138.18 146.13 42.33 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.471 0.709 . . . . 0.0 111.012 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 174.43 12.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.459 1.904 . . . . 0.0 108.065 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.94 131.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.34 134.42 41.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.86 -3.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.58 175.18 42.63 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.88 55.38 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.163 0.985 . . . . 0.0 111.394 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.12 -15.3 0.33 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.956 1.265 . . . . 0.0 113.694 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -119.6 154.06 34.54 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.714 1.757 . . . . 0.0 111.738 -169.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.16 159.61 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.655 1.182 . . . . 0.0 110.673 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -111.47 138.68 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 167.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.67 168.03 27.95 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 111.009 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.39 139.95 33.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 165.34 21.07 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.534 1.533 . . . . 0.0 109.184 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.42 150.51 41.62 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.736 2.291 . . . . 0.0 112.458 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 C-N-CA 122.324 2.016 . . . . 0.0 109.938 174.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.22 176.83 10.83 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.222 1.009 . . . . 0.0 110.481 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -138.03 148.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.73 126.58 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -130.64 166.14 21.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.348 1.059 . . . . 0.0 109.772 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.06 127.46 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -151.8 163.16 39.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.462 1.105 . . . . 0.0 108.84 -169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.64 131.07 45.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.69 -45.64 70.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.693 0.797 . . . . 0.0 110.576 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -66.37 -19.81 65.9 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.94 -45.27 16.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.851 0.751 . . . . 0.0 110.065 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.6 t -59.43 -40.79 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.796 0.838 . . . . 0.0 110.638 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.02 -2.0 54.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 0.0 113.115 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.29 -15.88 46.88 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.917 0.77 . . . . 0.0 113.14 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 p -55.95 -47.13 78.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.139 1.376 . . . . 0.0 111.976 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -162.76 -67.9 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.707 1.203 . . . . 0.0 111.706 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -155.54 172.57 18.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.167 0.987 . . . . 0.0 109.926 -167.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.33 165.56 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.848 0.859 . . . . 0.0 110.75 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.56 163.08 40.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.07 0.948 . . . . 0.0 110.414 167.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.1 139.38 20.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 168.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -147.3 55.42 1.09 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.39 0.614 . . . . 0.0 110.39 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -54.61 113.03 1.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -61.84 -33.3 73.92 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.484 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.9 m-70 -138.06 23.22 2.81 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.68 0.792 . . . . 0.0 112.13 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.4 -2.71 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.348 0.976 . . . . 0.0 112.491 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 80' ' ' HIS . 5.1 p-10 -74.69 -26.33 59.77 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.169 -0.957 . . . . 0.0 110.945 172.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -143.2 -25.02 0.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -128.92 164.81 22.32 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.494 1.518 . . . . 0.0 112.233 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 m 165.64 72.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 131.52 3.928 . . . . 0.0 106.077 168.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.33 -13.86 36.48 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.287 2.658 . . . . 0.0 113.512 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.6 120.06 34.99 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 108.218 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.23 158.33 12.26 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 111.884 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -48.56 -44.46 36.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 111.786 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.2 p -56.02 -51.91 66.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.575 0.75 . . . . 0.0 110.926 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -65.46 -37.02 85.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.7 0.8 . . . . 0.0 111.373 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.87 -48.7 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.79 -39.36 83.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -55.74 -45.68 77.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.485 0.714 . . . . 0.0 110.213 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -60.85 -53.93 51.26 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 119.008 -0.52 . . . . 0.0 109.678 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.99 -48.84 61.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.283 0.492 . . . . 0.0 111.21 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -66.31 -34.22 77.5 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.681 1.592 . . . . 0.0 112.244 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -72.88 -24.09 60.81 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.232 1.013 . . . . 0.0 109.979 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.17 -12.02 17.64 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.965 . . . . 0.0 112.669 -168.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.87 142.19 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.375 1.443 . . . . 0.0 109.598 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.02 -8.39 79.91 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.807 1.194 . . . . 0.0 113.172 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -81.68 153.62 26.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.0 1.4 . . . . 0.0 109.186 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -101.52 154.16 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.321 1.048 . . . . 0.0 109.238 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.57 147.99 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 107.797 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.18 34.92 2.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.17 0.985 . . . . 0.0 110.665 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -125.54 146.77 49.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 108.393 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -73.38 164.12 27.12 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 127.099 2.16 . . . . 0.0 110.383 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.36 126.71 30.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.5 p -145.01 159.0 43.64 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -44.43 64.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.035 0.534 . . . . 0.0 109.623 174.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.11 -43.5 70.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.798 0.839 . . . . 0.0 111.447 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -66.68 -41.85 87.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.102 0.865 . . . . 0.0 110.369 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.23 -43.97 80.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.878 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.48 -45.22 89.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.4 0.68 . . . . 0.0 110.311 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -57.13 -52.02 66.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.041 0.936 . . . . 0.0 109.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -61.54 -49.42 76.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.019 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.21 -32.45 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.603 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -67.9 -31.75 71.75 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.219 -0.925 . . . . 0.0 111.151 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.2 -19.76 55.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.651 1.18 . . . . 0.0 112.414 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.5 -43.87 6.37 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.783 0.833 . . . . 0.0 110.339 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.65 -43.23 76.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.577 1.08 . . . . 0.0 111.438 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.4 2.41 13.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.45 -30.62 5.18 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.346 -0.846 . . . . 0.0 112.138 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -156.1 141.36 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 169.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 118.282 0.492 . . . . 0.0 110.64 170.006 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 CA--C 1.536 0.617 0 CA-C-O 120.853 0.272 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -138.48 151.42 69.08 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.148 0.979 . . . . 0.0 110.036 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -46.33 135.33 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.879 2.386 . . . . 0.0 110.837 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -14.59 54.49 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.254 1.407 . . . . 0.0 111.797 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -83.77 151.03 25.42 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.098 1.949 . . . . 0.0 111.43 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.9 139.54 41.69 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.42 125.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -96.86 152.08 19.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.4 mm -126.35 109.84 22.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.91 132.51 46.83 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.41 166.43 17.33 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.32 -35.88 28.65 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.47 2.78 . . . . 0.0 116.235 -168.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.97 13.05 2.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.285 1.034 . . . . 0.0 111.801 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.09 -164.78 1.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.058 0.943 . . . . 0.0 109.954 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 156.66 47.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 172.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -124.16 170.71 10.44 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.748 2.019 . . . . 0.0 106.292 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -136.8 148.3 47.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.715 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 173.71 12.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 107.962 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.7 tt -136.58 134.21 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.22 131.73 37.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.286 1.035 . . . . 0.0 108.309 -171.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.41 -5.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.45 -178.88 38.23 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.35 41.77 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.255 1.022 . . . . 0.0 111.671 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.41 -29.75 0.28 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.905 1.24 . . . . 0.0 112.627 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -88.77 149.65 23.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.784 1.292 . . . . 0.0 111.445 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -131.59 155.48 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.561 1.545 . . . . 0.0 109.112 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -102.42 143.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 166.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.2 165.07 35.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.571 -0.705 . . . . 0.0 111.131 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 136.91 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.27 34.53 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.804 0.842 . . . . 0.0 110.71 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.7 164.25 36.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.416 2.077 . . . . 0.0 110.112 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 C--N 1.348 0.54 0 C-N-CA 122.058 1.839 . . . . 0.0 110.675 173.047 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.28 -172.69 4.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 109.728 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 mt -141.8 156.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.867 1.267 . . . . 0.0 109.252 -170.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -98.82 127.88 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -129.92 168.7 16.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.456 1.102 . . . . 0.0 110.411 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -125.72 134.34 51.81 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -150.69 160.83 43.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.74 1.216 . . . . 0.0 108.686 -175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.44 138.01 56.31 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 167.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.85 -33.4 68.62 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.687 0.795 . . . . 0.0 110.623 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -36.97 74.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.954 0.797 . . . . 0.0 110.954 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.07 -46.04 65.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.831 0.287 . . . . 0.0 110.471 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.67 -41.24 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.091 0.557 . . . . 0.0 110.397 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.22 40.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.383 1.473 . . . . 0.0 113.45 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.48 -16.0 34.44 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.044 0.831 . . . . 0.0 113.689 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 p -61.64 -44.1 97.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.553 1.176 . . . . 0.0 112.014 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -162.26 -59.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.861 0.865 . . . . 0.0 112.377 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -164.32 -170.73 2.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.673 1.589 . . . . 0.0 108.986 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -148.1 166.88 26.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.889 0.875 . . . . 0.0 109.956 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -145.44 153.21 40.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.197 1.399 . . . . 0.0 107.482 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -83.77 137.31 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.37 70.78 0.87 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.228 0.537 . . . . 0.0 109.92 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.51 112.9 2.66 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -65.69 -11.43 45.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.869 . . . . 0.0 113.184 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.8 m-70 -129.85 26.24 5.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.639 1.175 . . . . 0.0 111.591 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.11 23.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.895 -1.128 . . . . 0.0 112.605 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.8 t70 -132.91 -3.38 3.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 111.607 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -132.82 -31.59 1.31 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.26 1.424 . . . . 0.0 111.579 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 67.81 136.11 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 128.569 2.748 . . . . 0.0 116.211 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -63.93 139.97 97.76 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.382 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -16.75 32.37 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.894 2.396 . . . . 0.0 112.211 168.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.04 128.39 26.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.669 1.588 . . . . 0.0 108.802 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.93 155.03 24.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.165 2.577 . . . . 0.0 111.832 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.0 p -54.3 -40.45 67.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.86 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -56.52 -53.56 56.12 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.595 0.758 . . . . 0.0 110.569 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -62.92 -36.89 84.89 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.298 0.639 . . . . 0.0 111.472 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.03 -51.55 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.158 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -56.03 -49.1 74.64 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.188 0.995 . . . . 0.0 110.036 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -65.16 -45.65 84.08 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.729 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.95 -52.07 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.632 0.651 . . . . 0.0 110.793 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.93 -23.18 60.66 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -72.73 -27.5 62.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.66 -4.58 30.58 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.703 0.801 . . . . 0.0 113.051 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.28 150.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 109.828 169.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.5 23.53 56.15 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.439 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -126.85 161.98 26.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.703 1.201 . . . . 0.0 107.927 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.08 156.86 16.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.941 1.296 . . . . 0.0 109.754 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.8 m -130.56 148.84 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.827 2.051 . . . . 0.0 106.664 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.44 19.78 11.6 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.62 -0.675 . . . . 0.0 112.223 -169.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -121.41 155.92 33.79 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.293 1.437 . . . . 0.0 109.179 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -88.44 169.93 11.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.431 1.093 . . . . 0.0 112.542 -170.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.19 121.45 14.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 p -147.05 152.86 39.24 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 165.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -53.57 -40.84 65.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.102 0.41 . . . . 0.0 110.571 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.79 -44.74 84.81 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.376 0.67 . . . . 0.0 111.047 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -67.94 -38.57 83.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 0.786 . . . . 0.0 110.534 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.62 -44.62 81.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.646 0.657 . . . . 0.0 110.039 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -60.11 -45.3 93.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.101 0.56 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -57.82 -54.48 46.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.251 1.02 . . . . 0.0 109.587 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.49 -48.62 80.18 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.919 0.488 . . . . 0.0 111.729 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.47 -31.25 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.165 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -72.38 -27.61 62.49 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.897 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -61.61 -39.61 91.86 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.811 1.187 . . . . 0.0 109.644 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.42 -47.32 50.04 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.288 -0.883 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -17.35 59.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.284 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -142.76 7.39 1.66 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.81 1.186 . . . . 0.0 113.585 -169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.97 -48.55 3.68 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 120.806 -1.184 . . . . 0.0 110.637 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.66 141.23 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.582 1.953 . . . . 0.0 106.931 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.938 168.362 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 N--CA 1.46 -0.452 0 CA-C-O 121.179 0.408 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -135.81 151.79 74.74 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.726 1.211 . . . . 0.0 108.95 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.01 143.53 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.889 2.393 . . . . 0.0 111.495 169.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.56 73.99 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.038 1.304 . . . . 0.0 112.227 -170.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -76.76 147.81 37.07 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.509 1.654 . . . . 0.0 111.056 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.87 140.86 46.0 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.098 0.959 . . . . 0.0 108.829 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -125.21 138.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.39 148.9 41.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -121.87 106.37 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 -169.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -75.42 133.01 41.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -129.3 167.85 18.42 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 0.0 110.531 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.12 -25.54 29.65 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.252 2.635 . . . . 0.0 116.433 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -141.48 0.25 1.46 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.02 -165.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.67 1.188 . . . . 0.0 109.271 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.435 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -134.01 152.22 51.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -126.78 171.95 10.77 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.144 1.777 . . . . 0.0 107.998 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.435 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 66.6 m95 -139.2 150.0 45.05 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.073 0.851 . . . . 0.0 110.869 -172.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.33 173.24 16.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.421 1.488 . . . . 0.0 108.667 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.77 128.94 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.39 130.14 42.21 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.68 1.592 . . . . 0.0 109.433 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.53 168.6 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.075 1.35 . . . . 0.0 109.416 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.84 -135.31 49.23 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -120.71 8.99 10.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.397 1.079 . . . . 0.0 111.392 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.11 16.67 0.02 OUTLIER Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.437 -0.789 . . . . 0.0 113.686 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -107.6 169.2 8.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.847 1.324 . . . . 0.0 109.013 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.85 151.98 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.936 0.494 . . . . 0.0 110.649 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.28 141.37 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 166.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.84 171.54 17.59 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.92 143.2 30.88 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.6 159.33 71.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.286 1.834 . . . . 0.0 108.561 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.49 159.55 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.156 1.904 . . . . 0.0 110.921 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.538 0.676 0 C-N-CA 122.509 2.139 . . . . 0.0 113.008 -177.283 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.55 173.9 13.57 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.397 . . . . 0.0 108.21 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -142.13 154.52 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.65 138.52 19.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -142.92 168.59 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.953 1.301 . . . . 0.0 108.814 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -128.54 140.79 51.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -151.24 161.14 43.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.41 1.484 . . . . 0.0 107.929 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.82 137.25 57.09 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.61 -44.74 73.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.714 0.688 . . . . 0.0 110.82 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.04 -19.79 65.74 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.92 -47.58 28.99 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.129 0.877 . . . . 0.0 109.737 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.4 t -62.19 -43.35 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.563 0.745 . . . . 0.0 110.243 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.43 -7.97 56.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.992 1.317 . . . . 0.0 113.182 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.32 -20.41 58.56 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.714 0.673 . . . . 0.0 113.22 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 -47.49 84.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.77 1.228 . . . . 0.0 111.976 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -159.08 -61.42 0.07 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.733 0.813 . . . . 0.0 112.884 172.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -155.73 171.34 20.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -158.94 163.25 36.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.71 0.804 . . . . 0.0 110.111 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -151.15 154.14 36.33 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.605 0.762 . . . . 0.0 110.78 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.81 137.56 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.74 68.55 0.46 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.528 0.68 . . . . 0.0 110.587 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.91 101.58 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -68.14 129.53 40.2 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 44.67 44.89 7.78 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.866 1.667 . . . . 0.0 112.1 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.78 -12.43 4.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.623 0.769 . . . . 0.0 112.967 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.95 -20.24 33.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.657 1.583 . . . . 0.0 111.029 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 -14.25 8.94 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.987 1.315 . . . . 0.0 111.026 -173.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -136.37 -156.09 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.973 1.709 . . . . 0.0 109.452 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m 57.79 59.93 6.57 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.361 1.864 . . . . 0.0 112.359 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -61.8 -14.74 38.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.363 2.042 . . . . 0.0 114.197 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.46 141.69 23.04 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.683 0.793 . . . . 0.0 110.51 -167.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 159.48 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.202 . . . . 0.0 110.137 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.7 m -48.05 -47.63 33.59 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.464 1.106 . . . . 0.0 111.57 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.68 -49.99 69.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.538 0.735 . . . . 0.0 111.683 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.38 -35.25 77.42 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.774 -0.579 . . . . 0.0 111.433 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.8 -49.01 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.69 -45.05 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.181 0.993 . . . . 0.0 109.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.07 -52.27 52.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.052 0.941 . . . . 0.0 108.963 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -66.86 -45.99 76.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.305 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.27 -47.88 62.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.617 0.644 . . . . 0.0 111.434 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.6 -10.72 57.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.351 0.661 . . . . 0.0 112.594 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.68 -22.49 40.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.38 0.991 . . . . 0.0 110.185 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.5 mt -111.7 -4.64 14.63 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.602 0.761 . . . . 0.0 112.372 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.25 142.79 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 118.869 0.759 . . . . 0.0 110.066 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.64 -3.2 80.04 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.297 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -74.07 152.74 39.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.321 1.561 . . . . 0.0 109.268 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.46 149.97 22.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.13 176.63 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.585 1.154 . . . . 0.0 107.944 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.42 6.12 6.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.564 -0.71 . . . . 0.0 112.519 -169.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -99.0 146.43 26.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.123 0.969 . . . . 0.0 109.062 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -61.83 153.46 28.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.323 1.449 . . . . 0.0 111.149 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.65 127.08 31.02 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.4 p -141.86 159.51 42.07 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 m -49.31 -42.09 40.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.21 0.604 . . . . 0.0 111.127 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.2 -23.75 18.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.318 -168.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -68.16 -39.93 82.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.633 1.106 . . . . 0.0 109.442 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.2 m -69.79 -40.6 75.91 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.079 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -53.64 -49.09 68.64 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.446 0.698 . . . . 0.0 109.883 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -60.2 -46.2 90.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.181 0.992 . . . . 0.0 110.11 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.31 -53.19 59.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.373 0.533 . . . . 0.0 111.77 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.86 -33.71 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 119.881 -0.727 . . . . 0.0 111.216 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -68.75 -32.12 71.65 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.596 -0.69 . . . . 0.0 111.148 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.17 -41.7 98.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.207 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.59 -44.79 81.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.865 1.212 . . . . 0.0 111.017 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -66.07 -42.43 89.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.343 0.657 . . . . 0.0 111.463 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -95.33 -43.98 7.78 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.001 0.364 . . . . 0.0 111.909 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.33 -53.52 0.69 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.53 138.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.127 -0.463 . . . . 0.0 109.82 -179.293 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 CA--C 1.536 0.576 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.05 151.02 69.7 Favored Pre-proline 0 C--O 1.236 0.351 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.86 131.53 38.62 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.018 1.812 . . . . 0.0 109.3 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.9 -1.48 65.49 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.749 1.166 . . . . 0.0 113.015 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -73.61 147.71 43.55 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.963 1.881 . . . . 0.0 111.06 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.08 136.11 44.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.89 124.31 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.96 150.29 20.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -125.89 113.56 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 131.74 44.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -119.49 169.0 8.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.528 1.531 . . . . 0.0 107.888 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.26 96.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.733 2.288 . . . . 0.0 112.625 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 57.88 28.02 15.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.407 2.283 . . . . 0.0 113.508 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -149.21 -164.57 2.06 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.938 0.895 . . . . 0.0 109.436 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.9 158.84 43.43 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.065 -1.022 . . . . 0.0 109.591 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -127.77 168.53 15.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -135.62 150.65 49.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.864 0.757 . . . . 0.0 111.345 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.69 173.07 14.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.092 1.757 . . . . 0.0 108.181 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.77 132.97 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -70.93 134.83 47.54 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.624 1.17 . . . . 0.0 109.856 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.46 165.94 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.39 1.076 . . . . 0.0 109.879 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.54 -123.17 31.86 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -142.95 37.48 1.42 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.317 1.047 . . . . 0.0 109.021 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.2 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.382 -0.824 . . . . 0.0 115.016 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.39 171.03 7.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.938 1.369 . . . . 0.0 109.168 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.57 159.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.794 0.838 . . . . 0.0 110.194 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.8 137.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.73 173.3 14.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.545 0.738 . . . . 0.0 110.781 -172.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.26 143.37 30.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 161.9 46.7 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.862 1.665 . . . . 0.0 109.791 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 154.96 27.32 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.235 2.624 . . . . 0.0 112.533 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 CA--C 1.54 0.787 0 C-N-CA 122.85 2.367 . . . . 0.0 112.373 175.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.18 175.0 14.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.003 1.321 . . . . 0.0 108.467 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.78 157.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.0 139.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -142.74 169.65 17.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.572 1.549 . . . . 0.0 108.739 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.55 142.65 51.47 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -151.28 159.38 44.37 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.728 1.211 . . . . 0.0 108.443 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.9 135.6 52.73 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.87 -44.12 70.14 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.485 0.584 . . . . 0.0 111.679 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -66.51 -22.25 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.21 -44.4 59.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.789 0.722 . . . . 0.0 109.935 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.72 -41.49 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.414 0.686 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -3.78 22.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.657 1.183 . . . . 0.0 113.526 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.87 42.92 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.853 1.216 . . . . 0.0 114.831 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -58.88 -44.3 91.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.73 1.265 . . . . 0.0 112.365 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.2 -67.45 0.06 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 123.605 0.762 . . . . 0.0 112.439 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -157.76 177.03 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.638 1.175 . . . . 0.0 108.726 -166.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -151.93 169.59 21.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.05 1.34 . . . . 0.0 108.527 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.68 152.67 25.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.809 0.844 . . . . 0.0 110.296 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.69 133.24 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -149.68 70.86 1.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.729 0.776 . . . . 0.0 109.163 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.02 119.13 10.82 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -62.74 -28.27 69.85 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.326 -0.234 . . . . 0.0 110.761 169.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.543 ' C ' ' H ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -97.16 17.52 16.99 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.041 -168.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.73 21.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.776 1.626 . . . . 0.0 113.048 176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.9 t70 -136.3 2.19 2.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 111.469 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -138.08 -30.44 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.737 1.615 . . . . 0.0 111.866 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 67.54 149.6 0.06 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 128.986 2.914 . . . . 0.0 115.968 169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -50.73 113.41 3.67 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.17 1.388 . . . . 0.0 111.261 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.82 -18.85 16.69 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.941 2.427 . . . . 0.0 111.793 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.49 136.42 20.83 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 126.029 1.731 . . . . 0.0 107.273 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.61 145.78 57.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.083 1.855 . . . . 0.0 109.284 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.1 m -54.42 -42.34 70.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.45 0.3 . . . . 0.0 111.433 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -56.66 -42.51 79.11 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.703 0.801 . . . . 0.0 112.055 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -66.42 -33.19 75.15 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 117.764 -1.112 . . . . 0.0 111.441 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.4 mt -58.22 -49.04 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.135 1.334 . . . . 0.0 108.045 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.2 mm -61.89 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.862 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -45.2 91.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.23 -51.98 65.57 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.47 49.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.839 0.856 . . . . 0.0 110.721 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -76.76 -18.01 58.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.958 -0.544 . . . . 0.0 112.324 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.86 -27.16 62.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.684 1.129 . . . . 0.0 110.265 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.86 -27.69 16.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 110.644 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.12 125.62 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.581 1.082 . . . . 0.0 108.956 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.93 82.6 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.098 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -82.22 153.82 25.74 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.851 1.826 . . . . 0.0 108.885 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.85 151.42 23.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.228 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.52 172.24 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.668 1.187 . . . . 0.0 108.429 169.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.25 14.27 10.46 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.474 -0.766 . . . . 0.0 111.667 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -112.04 149.48 31.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 109.288 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -68.19 161.3 27.39 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 112.359 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.19 124.16 20.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.5 p -144.57 157.53 44.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.5 m -53.26 -45.41 68.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.653 0.381 . . . . 0.0 110.144 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.48 -37.98 80.61 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.086 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -69.24 -37.82 78.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.329 0.968 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.2 m -65.3 -47.37 76.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.12 -44.31 87.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.236 1.014 . . . . 0.0 110.144 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -58.04 -56.26 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 109.309 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.81 -47.37 85.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.722 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.6 -32.64 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.611 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -70.96 -40.96 71.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 110.528 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.6 -43.77 68.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.452 1.101 . . . . 0.0 110.618 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -72.08 -44.72 62.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.356 1.062 . . . . 0.0 112.007 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -74.43 -35.11 63.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.415 1.007 . . . . 0.0 112.658 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -120.96 -2.41 9.73 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -167.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.06 -26.24 24.29 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.831 -1.168 . . . . 0.0 111.983 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.65 139.91 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.049 -0.501 . . . . 0.0 111.128 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 121.131 0.388 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -128.91 147.13 63.37 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.497 0.719 . . . . 0.0 109.863 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -47.96 139.06 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.55 -3.1 68.16 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.662 1.125 . . . . 0.0 112.438 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -80.52 139.26 36.44 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.056 1.428 . . . . 0.0 109.661 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mt -67.73 135.33 52.55 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.69 126.9 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -97.49 148.6 23.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 mm -126.18 123.03 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -75.0 112.39 11.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -84.64 171.27 11.4 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.88 -34.19 74.9 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.549 2.166 . . . . 0.0 114.904 -171.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -141.21 13.06 2.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.437 1.095 . . . . 0.0 111.967 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -157.68 -157.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.759 1.224 . . . . 0.0 109.272 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.24 155.07 45.23 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.085 -1.009 . . . . 0.0 109.809 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.61 168.49 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.009 1.724 . . . . 0.0 106.565 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -136.4 147.12 47.13 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.782 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.68 11.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.214 1.805 . . . . 0.0 107.48 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 tt -134.07 132.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.88 129.08 38.41 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.228 1.411 . . . . 0.0 108.879 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.2 m -136.38 169.14 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.07 0.948 . . . . 0.0 109.326 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.12 -117.32 8.76 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -141.7 25.33 1.99 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.26 1.024 . . . . 0.0 110.685 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.79 -17.29 0.14 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.159 -0.963 . . . . 0.0 113.853 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -70.79 163.65 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.012 0.906 . . . . 0.0 109.723 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.76 154.65 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.17 137.44 33.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.76 168.9 25.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 111.501 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.81 133.14 34.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.119 1.368 . . . . 0.0 107.441 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.84 153.89 58.15 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.275 1.03 . . . . 0.0 111.171 -171.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 152.53 44.02 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.329 2.686 . . . . 0.0 112.934 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 C--N 1.35 0.625 0 C-N-CA 122.876 2.384 . . . . 0.0 112.94 179.151 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 -170.84 3.69 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.235 1.414 . . . . 0.0 109.734 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -149.76 173.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.73 141.11 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.83 166.96 21.78 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.785 1.234 . . . . 0.0 110.048 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -126.59 125.92 42.75 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.19 161.69 40.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.629 1.172 . . . . 0.0 108.415 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 132.12 44.94 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -49.11 -48.35 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.47 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.46 -25.99 68.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.049 0.386 . . . . 0.0 111.914 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.59 -43.59 31.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.482 0.583 . . . . 0.0 110.367 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.79 -35.87 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 110.224 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.18 10.59 31.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.762 1.225 . . . . 0.0 113.508 -176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.62 -22.17 38.46 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.817 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -57.5 -50.12 74.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 1.271 . . . . 0.0 113.254 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.86 -69.07 0.06 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -157.74 172.0 19.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.497 1.119 . . . . 0.0 109.294 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -163.99 157.55 18.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.402 1.081 . . . . 0.0 109.328 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.48 166.14 34.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.404 0.681 . . . . 0.0 110.115 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.76 139.98 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -150.58 71.54 1.05 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -66.98 93.53 0.28 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -60.99 122.13 14.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 48.56 44.44 20.88 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 113.017 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.12 -19.05 2.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.134 0.974 . . . . 0.0 113.307 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.17 -22.68 30.89 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.228 1.011 . . . . 0.0 110.892 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -112.49 -26.47 8.67 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.986 0.914 . . . . 0.0 111.279 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.92 159.99 42.03 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m 128.69 76.75 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 1 C-N-CA 131.801 4.041 . . . . 0.0 108.708 174.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.38 -19.48 43.44 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.804 2.336 . . . . 0.0 114.017 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.42 132.9 29.25 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.534 0.734 . . . . 0.0 109.818 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.46 162.83 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.11 1.873 . . . . 0.0 109.115 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.2 m -50.94 -43.12 60.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.82 0.848 . . . . 0.0 112.587 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 p -55.59 -47.68 76.09 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.847 0.859 . . . . 0.0 111.996 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -32.07 73.48 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.54 0.736 . . . . 0.0 111.228 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.8 mt -65.13 -47.56 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.05 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 118.603 0.638 . . . . 0.0 109.915 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -54.86 -49.74 70.38 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.865 0.866 . . . . 0.0 109.793 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.05 -52.29 66.02 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.088 0.555 . . . . 0.0 110.144 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.8 -15.71 55.69 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.229 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.89 -32.05 68.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.784 1.174 . . . . 0.0 109.165 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.0 -18.12 22.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.055 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -50.34 130.67 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.93 1.241 . . . . 0.0 109.445 171.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.3 -2.61 81.14 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.277 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.34 162.81 19.91 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.472 1.636 . . . . 0.0 109.193 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -103.77 153.19 20.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.887 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.2 146.6 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 109.682 171.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -97.56 23.11 8.07 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.003 -1.061 . . . . 0.0 112.336 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -125.04 151.42 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.048 1.339 . . . . 0.0 110.508 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -65.85 162.6 18.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.44 2.296 . . . . 0.0 112.167 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.53 125.89 28.07 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.0 p -146.69 156.54 43.25 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -53.76 -42.52 68.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.64 0.776 . . . . 0.0 110.408 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.24 -39.92 82.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.05 0.94 . . . . 0.0 110.987 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -68.26 -34.45 76.23 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.36 0.982 . . . . 0.0 110.93 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.58 -45.3 83.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.406 1.003 . . . . 0.0 110.145 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -60.61 -45.33 94.42 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.256 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -57.87 -55.39 35.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.136 1.374 . . . . 0.0 109.021 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -55.09 -50.5 69.01 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.893 0.477 . . . . 0.0 111.52 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.45 -31.28 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.701 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -70.62 -27.88 64.42 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 121.52 -0.738 . . . . 0.0 111.656 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -60.23 -30.33 69.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.416 1.007 . . . . 0.0 110.643 170.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 mt -81.94 -47.6 12.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.657 0.662 . . . . 0.0 110.018 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -26.43 67.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.311 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -119.84 -33.63 3.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.764 0.711 . . . . 0.0 112.776 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.09 -40.09 2.08 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 p -157.27 140.41 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 118.649 0.659 . . . . 0.0 110.606 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 110.229 -0.719 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.29 139.82 29.0 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.47 137.54 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.171 2.581 . . . . 0.0 111.931 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.84 -16.64 60.85 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.02 -1.434 . . . . 0.0 112.44 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -71.12 153.99 42.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.505 2.153 . . . . 0.0 109.803 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.29 138.79 39.58 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.36 145.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -123.54 151.18 43.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 166.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -126.58 108.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.7 140.71 48.02 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.989 171.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -115.2 169.39 6.8 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.626 1.57 . . . . 0.0 107.45 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.63 -24.74 55.81 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.784 2.323 . . . . 0.0 115.316 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -141.71 3.99 1.69 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.108 0.963 . . . . 0.0 113.323 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -157.92 -160.89 0.96 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.633 1.173 . . . . 0.0 109.076 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -150.2 154.09 37.39 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -140.22 169.13 18.26 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.335 1.854 . . . . 0.0 107.283 -173.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -135.85 149.86 49.18 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.712 0.687 . . . . 0.0 110.42 -173.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.83 173.3 13.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.667 1.987 . . . . 0.0 108.11 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.57 133.69 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.6 136.98 38.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.57 0.57 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.87 -175.09 39.23 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.88 42.83 0.32 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 111.377 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 -33.27 0.25 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.87 -0.961 . . . . 0.0 113.109 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -89.57 153.26 20.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.464 1.632 . . . . 0.0 111.713 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.55 155.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.31 1.444 . . . . 0.0 109.665 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.46 136.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.29 173.05 16.26 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.724 -0.61 . . . . 0.0 110.645 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.23 147.21 28.14 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.97 165.86 22.14 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.491 1.917 . . . . 0.0 108.202 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.45 154.13 12.25 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.628 2.219 . . . . 0.0 112.174 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.538 0.697 0 C-N-CA 122.296 1.998 . . . . 0.0 110.923 174.772 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.025 0.44 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 172.85 14.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.983 0.913 . . . . 0.0 110.109 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.42 149.09 28.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 125.401 1.481 . . . . 0.0 107.101 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.17 129.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -128.22 167.98 16.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.564 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -124.72 129.61 50.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.87 160.52 43.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.46 130.37 40.52 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.25 -40.69 64.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.202 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -36.02 67.92 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.443 0.565 . . . . 0.0 111.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.67 -42.82 67.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.113 0.415 . . . . 0.0 110.038 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 t -66.13 -45.73 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.569 0.748 . . . . 0.0 109.522 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.92 -22.79 65.89 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.411 1.084 . . . . 0.0 112.015 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.67 -11.63 8.2 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.23 1.395 . . . . 0.0 113.483 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -49.36 -51.44 34.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.658 1.229 . . . . 0.0 110.722 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.79 -52.34 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.918 1.687 . . . . 0.0 110.184 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -159.69 173.76 15.57 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.458 1.903 . . . . 0.0 107.973 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -153.21 167.74 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.347 -0.846 . . . . 0.0 110.787 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.3 165.71 27.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.919 1.687 . . . . 0.0 108.327 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.84 128.8 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -158.1 63.94 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -55.94 128.55 35.74 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -69.19 -56.08 8.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.62 -166.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.49 45.59 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.645 1.178 . . . . 0.0 109.812 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.89 -10.55 4.11 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.294 -0.879 . . . . 0.0 112.89 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -86.61 -21.71 26.64 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.223 1.009 . . . . 0.0 111.037 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -113.15 -25.91 8.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.295 1.038 . . . . 0.0 111.162 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -143.03 -165.16 2.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.178 1.791 . . . . 0.0 109.435 -169.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m 57.64 62.69 5.21 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.408 1.483 . . . . 0.0 113.569 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -11.66 31.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.354 2.036 . . . . 0.0 113.934 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.99 132.64 94.68 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.954 1.301 . . . . 0.0 110.429 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.6 151.67 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.632 2.221 . . . . 0.0 110.978 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.39 -41.11 65.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.302 0.641 . . . . 0.0 111.102 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -52.31 -50.51 62.06 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 111.335 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -68.33 -38.52 81.6 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.29 0.636 . . . . 0.0 110.7 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.64 -49.58 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.47 -41.4 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.874 0.87 . . . . 0.0 109.375 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -55.32 -51.23 67.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.764 0.826 . . . . 0.0 109.185 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -62.31 -43.1 99.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.271 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.88 83.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.265 0.939 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.57 -15.27 55.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.178 0.591 . . . . 0.0 112.308 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -79.99 -21.31 43.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.106 0.962 . . . . 0.0 110.737 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -115.65 -5.08 12.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.492 0.717 . . . . 0.0 112.813 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.75 146.0 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.054 0.843 . . . . 0.0 109.835 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 -6.34 79.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.621 1.105 . . . . 0.0 112.967 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -79.26 155.23 28.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.114 1.457 . . . . 0.0 109.519 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.97 151.71 24.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.638 1.175 . . . . 0.0 108.966 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.59 147.04 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.141 1.376 . . . . 0.0 107.996 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.53 33.73 3.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.543 1.163 . . . . 0.0 110.492 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -130.91 158.17 40.95 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.514 1.926 . . . . 0.0 108.182 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.36 156.22 39.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.36 48.54 0.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.475 1.51 . . . . 0.0 111.454 168.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 p -65.71 158.86 26.38 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.831 -1.168 . . . . 0.0 108.597 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.2 m -51.48 -41.31 60.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.117 0.967 . . . . 0.0 111.095 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.32 -41.62 80.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.663 0.785 . . . . 0.0 111.374 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -72.08 -34.91 69.04 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.168 0.894 . . . . 0.0 111.102 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 68.9 m -66.82 -45.46 78.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.74 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.1 -44.12 87.51 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.125 0.57 . . . . 0.0 110.013 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -56.66 -55.13 37.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.788 1.235 . . . . 0.0 108.898 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.82 -48.19 82.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.07 -32.5 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.233 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -69.71 -32.49 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.138 -0.976 . . . . 0.0 110.37 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.98 -8.42 1.01 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 113.026 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.13 -48.47 3.04 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.237 1.415 . . . . 0.0 110.261 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -58.2 -36.07 72.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.386 0.674 . . . . 0.0 111.265 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -121.23 -7.47 9.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.354 1.062 . . . . 0.0 111.53 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.84 -10.03 63.9 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.821 -1.174 . . . . 0.0 112.243 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.27 139.44 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.155 175.006 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 CA--C 1.537 0.629 0 N-CA-C 111.613 -0.187 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -153.1 147.11 18.55 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.024 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.76 139.35 19.1 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.497 2.131 . . . . 0.0 111.284 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.98 60.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.915 1.245 . . . . 0.0 112.287 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.64 153.85 20.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.425 1.612 . . . . 0.0 110.987 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.77 143.43 36.12 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.92 124.82 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.72 152.96 18.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.82 116.03 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -171.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 111.71 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 -89.62 170.51 10.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.333 1.053 . . . . 0.0 108.244 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.22 -31.32 55.12 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.02 2.48 . . . . 0.0 115.841 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.79 16.15 1.24 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.291 1.037 . . . . 0.0 111.814 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -154.48 -158.78 0.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 108.999 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.29 157.35 44.92 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.99 -1.069 . . . . 0.0 109.879 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -128.82 169.08 14.99 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.964 1.705 . . . . 0.0 106.749 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -135.37 146.0 47.93 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.569 0.622 . . . . 0.0 111.7 -173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.54 171.97 15.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.168 1.787 . . . . 0.0 108.422 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.36 134.72 63.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.08 130.04 35.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.77 -14.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.81 168.64 34.99 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 -32.17 8.15 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -168.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.6 12.89 4.85 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.159 -1.356 . . . . 0.0 113.671 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -124.05 149.71 45.78 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.103 1.952 . . . . 0.0 112.175 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.86 159.46 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.181 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.43 140.33 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 167.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.25 171.92 18.97 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.771 0.429 . . . . 0.0 111.281 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.05 143.91 33.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 169.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 161.68 51.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.224 1.81 . . . . 0.0 109.149 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.01 148.39 58.36 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.661 2.24 . . . . 0.0 111.768 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.541 0.846 0 C-N-CA 122.965 2.443 . . . . 0.0 111.678 176.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.8 mttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.92 13.32 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.628 1.171 . . . . 0.0 108.758 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.0 159.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.26 134.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.43 166.9 22.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.377 1.071 . . . . 0.0 109.622 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -118.29 132.7 56.28 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -150.44 160.99 43.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.448 1.099 . . . . 0.0 108.617 -173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.09 126.8 30.33 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.62 -46.13 66.89 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.428 1.091 . . . . 0.0 110.632 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -65.2 -21.73 66.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.12 -41.6 20.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.686 0.676 . . . . 0.0 110.375 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.34 -41.17 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.367 0.667 . . . . 0.0 110.061 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.14 1.83 12.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.304 1.441 . . . . 0.0 113.756 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.01 -25.44 31.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.024 1.297 . . . . 0.0 115.175 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -57.72 -45.88 85.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.855 1.327 . . . . 0.0 112.338 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -164.04 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.669 0.788 . . . . 0.0 112.4 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -156.76 176.96 12.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.635 1.174 . . . . 0.0 109.292 -165.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -152.62 168.26 26.21 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.943 1.297 . . . . 0.0 108.417 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.41 157.8 37.61 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.254 0.622 . . . . 0.0 110.056 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.0 135.26 28.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -149.44 62.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -63.31 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.529 1.131 . . . . 0.0 110.655 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.41 114.06 0.63 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.001 1.721 . . . . 0.0 110.17 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m80 52.82 40.19 30.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.469 1.508 . . . . 0.0 113.255 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.88 -15.3 1.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 167.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -82.9 -20.19 35.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.206 1.802 . . . . 0.0 111.468 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -131.27 -18.78 2.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.047 0.939 . . . . 0.0 112.448 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -140.99 -167.92 2.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.418 1.487 . . . . 0.0 109.7 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m 57.3 68.82 1.85 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.228 1.411 . . . . 0.0 112.31 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.77 -16.47 37.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.429 2.086 . . . . 0.0 113.386 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -73.67 142.32 80.45 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.619 1.168 . . . . 0.0 110.005 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.93 154.07 53.04 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.29 1.993 . . . . 0.0 109.641 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.0 m -55.62 -34.85 65.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.846 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 p -52.91 -60.3 3.45 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.081 0.952 . . . . 0.0 110.82 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -61.32 -38.43 86.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.611 1.164 . . . . 0.0 111.503 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.06 -51.67 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.28 -44.22 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 109.231 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -42.8 89.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.051 0.541 . . . . 0.0 110.131 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -68.09 -45.79 72.78 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.569 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.3 -50.38 59.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.447 0.567 . . . . 0.0 110.855 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.16 -19.94 59.61 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -71.68 -28.35 63.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.984 1.266 . . . . 0.0 108.904 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 mt -88.54 -16.38 32.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.06 0.944 . . . . 0.0 111.869 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.92 129.43 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 119.65 1.114 . . . . 0.0 108.895 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.15 -3.37 86.85 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -84.2 164.1 19.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.604 1.702 . . . . 0.0 109.344 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -123.92 148.48 46.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.781 -168.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.56 161.13 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.234 1.014 . . . . 0.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.05 32.28 5.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.437 1.113 . . . . 0.0 111.561 -168.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -132.86 147.23 52.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.218 1.407 . . . . 0.0 109.265 170.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -67.92 166.02 16.51 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.787 2.035 . . . . 0.0 111.587 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 mt -69.51 127.55 33.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 167.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 73.1 p -144.22 151.58 39.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 166.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -36.33 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 122.168 -0.332 . . . . 0.0 110.915 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -71.76 -40.18 69.49 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.728 0.411 . . . . 0.0 110.567 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.6 -40.73 92.97 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.865 0.757 . . . . 0.0 110.239 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.4 m -64.82 -45.27 86.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.099 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.69 -45.02 93.36 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.182 0.447 . . . . 0.0 110.143 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -59.39 -50.21 74.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.586 1.154 . . . . 0.0 109.718 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -59.69 -52.41 65.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.102 0.41 . . . . 0.0 111.392 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -64.65 -32.5 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.895 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.24 -36.37 81.51 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.698 -0.626 . . . . 0.0 111.077 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.19 -46.5 62.17 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.242 1.017 . . . . 0.0 109.661 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.26 -46.26 70.93 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.158 0.583 . . . . 0.0 111.346 -177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -76.98 -33.85 57.59 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.89 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -94.13 -48.26 6.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.028 0.376 . . . . 0.0 110.881 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.86 -51.41 0.6 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.17 128.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 CA--C 1.537 0.672 0 N-CA-C 111.259 -0.324 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -133.49 155.76 80.33 Favored Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 124.979 1.312 . . . . 0.0 108.973 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.31 131.74 18.62 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.363 2.708 . . . . 0.0 112.529 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.68 84.09 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.899 1.238 . . . . 0.0 113.036 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.37 143.74 48.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 120.288 2.044 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -71.84 131.27 42.79 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -114.96 145.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.91 143.7 49.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 117.04 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.07 138.27 43.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -117.19 167.21 11.28 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.379 1.472 . . . . 0.0 107.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.92 -24.9 33.47 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.018 2.479 . . . . 0.0 115.754 -174.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -141.4 4.85 1.81 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.191 0.996 . . . . 0.0 113.209 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -158.22 -158.25 0.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.976 0.91 . . . . 0.0 110.199 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -153.09 141.27 20.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -127.46 165.31 20.06 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.416 1.486 . . . . 0.0 107.607 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -128.95 145.94 51.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.352 0.524 . . . . 0.0 110.008 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 169.86 22.23 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.951 1.7 . . . . 0.0 108.531 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt -140.46 126.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 121.368 -0.832 . . . . 0.0 109.534 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -72.24 132.11 43.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.062 1.345 . . . . 0.0 110.015 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.55 166.55 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.24 1.416 . . . . 0.0 108.873 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.04 21.5 38.63 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.531 -0.731 . . . . 0.0 114.255 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t0 39.26 50.66 1.97 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.869 2.068 . . . . 0.0 113.514 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.1 -11.55 0.1 OUTLIER Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.925 -0.484 . . . . 0.0 113.546 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.17 170.62 7.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.696 1.198 . . . . 0.0 108.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.84 148.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.402 0.681 . . . . 0.0 109.639 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.56 136.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 171.67 18.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.413 0.551 . . . . 0.0 111.019 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 151.12 36.76 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 158.1 64.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.501 2.32 . . . . 0.0 107.676 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.47 153.95 71.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 110.938 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.539 0.752 0 C-N-CA 122.906 2.404 . . . . 0.0 111.703 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.79 13.1 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.823 0.849 . . . . 0.0 109.35 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -134.01 158.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.29 132.22 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -136.67 169.05 18.36 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.059 0.944 . . . . 0.0 109.79 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.59 133.02 54.56 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -148.55 161.19 42.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.209 1.403 . . . . 0.0 107.753 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.15 133.26 47.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.13 -43.83 74.49 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.684 0.674 . . . . 0.0 110.678 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -65.07 -21.58 66.84 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.81 -46.06 19.55 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.897 0.771 . . . . 0.0 110.238 171.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.03 -40.11 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 110.294 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.1 -20.73 59.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.964 1.305 . . . . 0.0 112.512 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.35 -12.5 25.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.59 1.091 . . . . 0.0 113.226 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.7 m -50.34 -48.93 55.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.119 . . . . 0.0 110.915 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -167.84 -61.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.264 1.826 . . . . 0.0 109.239 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -160.92 171.31 18.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.149 2.179 . . . . 0.0 107.126 -167.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -153.36 164.01 38.9 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.571 -0.706 . . . . 0.0 110.607 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -138.77 158.01 45.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.881 1.672 . . . . 0.0 109.851 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 130.93 40.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -148.8 70.86 1.12 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -69.12 88.3 0.42 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -64.93 119.84 11.45 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.21 53.06 9.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.794 1.638 . . . . 0.0 111.786 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -51.86 -20.66 2.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.987 1.315 . . . . 0.0 113.248 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.71 -27.12 31.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -100.64 -20.32 15.7 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.024 0.929 . . . . 0.0 111.339 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -129.93 -174.09 3.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.765 0.793 . . . . 0.0 112.7 -168.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 52.51 62.71 9.9 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.531 1.932 . . . . 0.0 113.919 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 -12.14 28.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.462 2.108 . . . . 0.0 113.732 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.97 142.74 97.56 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.424 1.089 . . . . 0.0 110.594 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.92 142.48 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.165 1.91 . . . . 0.0 108.944 167.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -54.21 -43.2 70.57 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.443 0.297 . . . . 0.0 111.401 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.71 -44.73 73.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.138 0.975 . . . . 0.0 112.1 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -63.32 -34.37 77.55 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 124.203 1.001 . . . . 0.0 111.591 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.5 -48.36 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.69 -47.22 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -44.61 81.87 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.412 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -60.71 -52.98 62.79 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.294 0.952 . . . . 0.0 109.367 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.36 60.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.664 0.386 . . . . 0.0 111.189 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.82 -16.69 50.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.6 -29.02 56.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 119.904 1.229 . . . . 0.0 109.073 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.57 -11.71 44.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.972 0.909 . . . . 0.0 111.852 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -56.13 129.88 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.592 1.087 . . . . 0.0 108.925 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.29 -0.04 89.89 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.403 -1.221 . . . . 0.0 112.984 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -86.57 166.01 15.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.292 1.546 . . . . 0.0 109.4 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -120.55 149.51 42.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.319 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.17 147.16 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.706 1.202 . . . . 0.0 108.221 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.72 39.8 1.62 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.731 1.253 . . . . 0.0 111.153 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -141.08 149.72 41.99 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.469 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -60.28 148.54 36.37 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.947 1.299 . . . . 0.0 110.187 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 54.24 0.28 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.758 1.623 . . . . 0.0 113.266 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.8 p -64.26 161.69 16.12 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.655 -1.278 . . . . 0.0 109.206 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.56 -44.67 62.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.128 0.971 . . . . 0.0 110.309 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.67 -41.33 75.63 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.84 0.856 . . . . 0.0 110.893 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.42 -29.02 65.51 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.143 0.883 . . . . 0.0 111.294 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.7 m -69.87 -42.52 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.223 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.16 -43.98 95.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.346 0.521 . . . . 0.0 110.021 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -57.15 -58.23 9.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.032 1.733 . . . . 0.0 109.493 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.39 -54.88 30.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.754 0.421 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.02 -27.37 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.405 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -70.24 -29.4 66.19 Favored 'General case' 0 C--N 1.338 0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 111.144 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.0 -23.47 63.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.445 1.02 . . . . 0.0 112.094 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.88 -47.78 7.66 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.62 1.1 . . . . 0.0 110.115 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -86.54 -45.59 10.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.451 0.568 . . . . 0.0 112.221 -172.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -83.46 -48.32 10.44 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.54 -25.14 3.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.033 0.825 . . . . 0.0 111.634 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.42 149.91 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.38 169.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo . . . . . 0 CA--C 1.533 0.475 0 N-CA-C 111.259 -0.324 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.29 146.88 34.89 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.98 140.12 24.53 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.693 2.262 . . . . 0.0 110.983 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.36 -10.83 71.04 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.1 1.333 . . . . 0.0 112.313 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.89 156.09 23.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.31 2.055 . . . . 0.0 110.652 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.1 139.02 41.15 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.06 141.85 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.53 151.54 39.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -122.79 110.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.86 100.69 2.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -80.33 166.47 39.8 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.273 1.029 . . . . 0.0 108.919 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -51.01 -30.81 32.32 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.478 2.785 . . . . 0.0 116.379 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -145.55 14.71 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.094 0.957 . . . . 0.0 112.213 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -155.81 -159.2 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.892 1.277 . . . . 0.0 108.717 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.4 159.5 43.62 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.773 -1.204 . . . . 0.0 109.938 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -132.37 168.0 18.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.929 1.291 . . . . 0.0 107.612 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -137.37 147.27 45.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.804 0.729 . . . . 0.0 110.694 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.37 174.83 14.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.988 1.715 . . . . 0.0 108.569 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.18 131.64 58.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.66 130.09 41.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.098 1.359 . . . . 0.0 108.795 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.84 165.3 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 109.065 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.51 -158.36 18.25 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.91 -29.53 55.74 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.942 -0.74 . . . . 0.0 112.221 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.99 26.97 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.896 0.76 . . . . 0.0 113.359 -173.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -100.58 170.55 8.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.141 0.97 . . . . 0.0 109.394 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.72 153.28 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.229 0.612 . . . . 0.0 109.635 168.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.88 137.72 29.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.12 169.03 25.12 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.983 -0.448 . . . . 0.0 110.932 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.57 138.7 34.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.13 160.07 56.45 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 125.076 1.351 . . . . 0.0 109.536 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.88 145.16 24.98 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.328 2.685 . . . . 0.0 111.757 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 121.857 1.705 . . . . 0.0 111.554 -176.188 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 C--O 1.235 0.326 0 CA-C-O 121.199 0.523 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.41 169.09 18.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.185 1.394 . . . . 0.0 108.128 166.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.78 146.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 t -85.51 122.25 38.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -127.25 165.82 18.93 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.309 1.044 . . . . 0.0 109.715 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -125.69 131.29 52.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -148.38 163.57 36.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.014 1.326 . . . . 0.0 107.787 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.69 140.18 58.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.14 -42.7 73.4 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -60.46 -29.77 69.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.964 0.906 . . . . 0.0 112.062 -173.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.43 -40.07 27.02 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.21 0.459 . . . . 0.0 110.838 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.68 -37.59 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.335 0.654 . . . . 0.0 109.826 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.54 30.7 0.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.026 1.731 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.81 -23.58 30.5 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.072 0.844 . . . . 0.0 112.918 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 -4.54 5.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.887 1.675 . . . . 0.0 113.654 171.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.4 t70 61.49 16.46 7.59 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 114.576 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -149.46 124.62 10.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.888 1.675 . . . . 0.0 108.739 -169.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -164.8 164.31 21.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -155.77 161.56 40.65 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.599 0.76 . . . . 0.0 110.865 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.61 138.17 22.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -145.85 66.18 1.21 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.31 0.576 . . . . 0.0 109.935 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.38 131.78 38.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 122.896 0.478 . . . . 0.0 110.469 169.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -103.77 3.02 33.61 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 82' ' ' ASP . 75.7 m-70 -132.2 23.5 4.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.847 0.859 . . . . 0.0 112.088 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.07 21.31 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.044 -1.035 . . . . 0.0 112.593 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 80' ' ' HIS . 37.9 t70 -127.36 -9.33 5.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 111.611 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -127.6 -31.85 2.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.084 1.354 . . . . 0.0 111.609 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 66.21 134.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 128.605 2.762 . . . . 0.0 115.728 173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -61.0 136.76 93.79 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.914 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.43 -16.76 34.78 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.599 2.199 . . . . 0.0 111.862 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.08 125.38 35.4 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 108.235 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.17 154.63 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.812 2.341 . . . . 0.0 111.374 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.26 -38.86 69.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.327 0.651 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -54.96 -53.15 59.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.905 0.882 . . . . 0.0 110.498 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.81 -34.78 78.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.161 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.8 -50.83 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.061 0.846 . . . . 0.0 108.889 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.29 -45.6 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 123.536 0.734 . . . . 0.0 109.112 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -64.37 -46.56 82.84 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.85 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.29 -51.92 55.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.692 0.678 . . . . 0.0 110.405 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.82 -21.72 59.13 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.7 mt -99.14 -4.13 32.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 112.476 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.75 150.71 8.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.341 1.056 . . . . 0.0 109.344 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.67 53.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.313 -0.715 . . . . 0.0 112.269 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -124.06 159.98 28.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.585 1.154 . . . . 0.0 108.071 171.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -109.6 153.45 24.17 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.312 1.445 . . . . 0.0 109.53 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.07 152.29 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.374 1.47 . . . . 0.0 107.353 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.58 8.22 44.62 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.835 0.454 . . . . 0.0 112.224 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -95.42 147.11 23.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -74.12 162.87 28.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.446 1.098 . . . . 0.0 111.799 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.08 125.33 23.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.6 p -145.75 154.53 42.15 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 167.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.1 m -55.94 -34.37 65.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.817 0.447 . . . . 0.0 111.206 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.97 -38.61 44.72 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.451 0.701 . . . . 0.0 111.174 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -68.24 -35.77 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.528 1.058 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -66.34 -47.7 72.64 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -56.27 -44.63 79.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.319 1.048 . . . . 0.0 110.377 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -57.73 -56.79 17.43 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.018 1.327 . . . . 0.0 109.135 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.68 -48.1 82.24 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.1 -29.35 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.543 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -73.36 -30.53 63.37 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.712 0.687 . . . . 0.0 111.64 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.88 -37.9 80.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.305 0.957 . . . . 0.0 110.09 170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.16 -50.14 24.27 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.683 0.674 . . . . 0.0 110.243 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -64.8 -26.37 68.31 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.066 0.946 . . . . 0.0 112.349 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.77 3.28 1.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -168.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.38 -32.52 5.44 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.853 -1.154 . . . . 0.0 111.876 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -155.39 146.63 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.023 1.329 . . . . 0.0 107.576 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.277 0.631 . . . . 0.0 110.727 172.306 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 CA--C 1.537 0.665 0 N-CA-C 113.421 0.508 . . . . 0.0 113.421 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.04 55.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 109.026 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.62 135.74 27.24 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.769 2.313 . . . . 0.0 111.646 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.18 -13.61 57.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.321 1.439 . . . . 0.0 111.714 -169.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.21 142.86 32.78 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.144 1.472 . . . . 0.0 111.312 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.18 140.55 45.2 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.31 129.19 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.08 147.65 25.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.49 103.68 12.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -168.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.45 141.64 57.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.06 168.61 13.01 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.503 1.521 . . . . 0.0 107.935 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.86 -27.96 17.06 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.512 2.808 . . . . 0.0 117.059 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -145.8 13.78 1.34 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.609 0.764 . . . . 0.0 112.021 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.32 -163.86 1.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.511 1.124 . . . . 0.0 109.475 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.413 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -144.11 159.72 42.15 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.214 -0.929 . . . . 0.0 109.931 173.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -131.2 170.69 14.23 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.613 2.365 . . . . 0.0 107.046 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.413 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 77.9 m95 -136.49 146.27 46.09 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.935 0.789 . . . . 0.0 111.448 -174.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.19 172.42 14.35 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.127 2.171 . . . . 0.0 108.046 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.8 tt -137.4 133.36 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.65 127.71 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.16 -3.96 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.03 -175.19 34.67 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.09 -28.09 66.18 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.87 0.835 . . . . 0.0 113.072 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.9 13.22 1.13 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.216 -1.324 . . . . 0.0 114.136 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -117.31 153.19 33.4 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.963 1.881 . . . . 0.0 111.516 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 m -132.16 155.05 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.061 1.345 . . . . 0.0 110.073 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.1 142.3 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 167.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.4 173.62 14.66 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.276 0.631 . . . . 0.0 110.73 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.6 141.72 33.45 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.62 157.95 66.85 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.54 1.936 . . . . 0.0 107.427 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 151.49 69.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.181 1.457 . . . . 0.0 110.51 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--N 1.349 0.553 0 C-N-CA 122.211 1.941 . . . . 0.0 111.367 175.133 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.9 168.91 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.594 0.712 . . . . 0.0 111.304 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 pt -147.11 154.97 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.918 1.687 . . . . 0.0 106.692 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.42 129.7 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -135.44 159.0 42.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.279 1.432 . . . . 0.0 107.954 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -127.38 131.25 50.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -151.54 163.36 39.21 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.784 1.233 . . . . 0.0 108.893 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.21 131.78 45.99 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.61 -40.87 66.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 110.963 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -61.92 -27.92 69.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.873 0.469 . . . . 0.0 111.638 -171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.71 -45.15 46.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.469 0.577 . . . . 0.0 110.402 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 t -64.17 -39.48 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.615 0.766 . . . . 0.0 109.757 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.64 -11.77 19.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.267 1.427 . . . . 0.0 113.169 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.16 -10.43 65.54 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.655 1.116 . . . . 0.0 113.071 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 -54.22 47.77 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.646 1.223 . . . . 0.0 112.339 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.23 -49.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.661 1.584 . . . . 0.0 110.145 169.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -166.73 -176.12 3.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.863 2.065 . . . . 0.0 107.673 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -152.02 165.45 34.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.54 1.064 . . . . 0.0 110.282 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -148.38 147.32 29.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.243 1.417 . . . . 0.0 109.089 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.03 132.01 33.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -149.83 73.04 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.5 101.96 1.07 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -59.23 124.52 20.24 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 m80 46.31 42.26 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 113.206 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -59.4 -10.82 3.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.562 0.745 . . . . 0.0 112.499 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.17 -17.87 26.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.971 2.109 . . . . 0.0 111.427 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -131.09 -16.83 3.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.074 0.95 . . . . 0.0 112.357 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.35 -161.07 1.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.186 1.794 . . . . 0.0 108.372 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 66.39 2.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.859 1.664 . . . . 0.0 112.953 -170.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.55 -22.18 58.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.571 2.181 . . . . 0.0 114.441 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.14 141.17 39.98 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 111.264 -168.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.15 161.85 39.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.64 2.227 . . . . 0.0 109.762 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 65.1 m -52.4 -40.96 62.74 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.634 0.774 . . . . 0.0 111.682 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.44 -54.23 43.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.293 0.637 . . . . 0.0 111.103 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.37 -37.98 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.337 1.055 . . . . 0.0 111.695 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.29 -49.26 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.39 -46.21 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.683 0.793 . . . . 0.0 108.861 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -43.89 86.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.085 0.554 . . . . 0.0 110.113 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.95 -50.73 69.66 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.23 67.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.562 0.345 . . . . 0.0 111.107 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.94 -20.84 55.65 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.213 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -69.0 -35.5 76.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.74 1.155 . . . . 0.0 109.486 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.38 -10.15 52.86 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.4 133.73 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.516 1.053 . . . . 0.0 109.063 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.0 -8.07 76.3 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.484 -1.176 . . . . 0.0 112.88 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -71.89 157.58 37.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.453 1.626 . . . . 0.0 109.264 171.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -126.58 144.23 50.96 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.44 146.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.055 0.942 . . . . 0.0 110.35 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.46 -9.87 42.97 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.228 -0.92 . . . . 0.0 112.924 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -75.67 154.61 36.41 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.556 0.616 . . . . 0.0 110.498 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -81.37 158.38 24.69 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.871 1.668 . . . . 0.0 110.022 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.72 121.35 11.43 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.5 p -143.68 159.02 43.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -52.49 -45.33 66.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.799 0.44 . . . . 0.0 109.904 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.79 -46.34 79.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.939 0.896 . . . . 0.0 110.827 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -67.33 -41.41 85.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.65 0.659 . . . . 0.0 110.722 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.17 -41.62 81.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.265 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -61.1 -40.6 94.38 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.199 0.6 . . . . 0.0 110.394 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -63.82 -55.76 20.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 110.138 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -57.59 -48.41 79.46 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.327 0.512 . . . . 0.0 110.883 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.4 -30.95 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.48 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -72.45 -25.55 61.49 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.422 -0.799 . . . . 0.0 111.817 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.35 -38.92 69.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.184 0.902 . . . . 0.0 110.319 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.4 mt -74.39 -43.42 56.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.355 0.662 . . . . 0.0 110.2 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 tpt85 -72.58 -31.98 65.65 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.527 -172.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -104.02 -36.46 7.73 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.037 0.535 . . . . 0.0 112.125 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.73 -37.17 3.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.972 1.273 . . . . 0.0 110.599 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.18 135.28 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 123.078 0.551 . . . . 0.0 110.71 -179.698 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 CA--C 1.534 0.483 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -83.91 144.09 44.24 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.07 129.33 24.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 109.745 169.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.83 3.86 67.93 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.308 0.956 . . . . 0.0 113.205 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.1 136.19 48.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.663 1.732 . . . . 0.0 110.216 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.48 138.04 54.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.92 133.5 66.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -104.65 146.37 29.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -127.48 115.35 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 -169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.35 140.21 46.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -128.66 167.72 18.31 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.982 0.913 . . . . 0.0 109.718 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.33 -26.79 36.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.19 2.593 . . . . 0.0 116.576 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -143.24 6.73 1.53 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.293 1.037 . . . . 0.0 112.942 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -160.97 -168.66 2.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.949 -169.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.43 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 7.1 ppt_? -136.24 161.03 36.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 121.65 -0.656 . . . . 0.0 109.44 169.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -137.09 169.09 18.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.343 1.857 . . . . 0.0 107.986 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.43 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 67.2 m95 -138.7 148.35 43.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.624 0.769 . . . . 0.0 110.591 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 174.97 11.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.321 1.848 . . . . 0.0 107.934 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.13 134.0 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.43 133.23 48.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.075 1.35 . . . . 0.0 109.009 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 m -139.0 165.8 23.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.123 0.969 . . . . 0.0 109.967 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.44 -121.07 18.72 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.354 -2.299 . . . . 0.0 107.354 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -146.06 51.24 1.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.52 -12.16 0.11 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.164 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.77 171.68 8.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.531 1.166 . . . . 0.0 109.101 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.23 157.35 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.194 0.998 . . . . 0.0 110.052 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.98 138.19 48.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 168.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 169.47 22.79 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.082 0.953 . . . . 0.0 110.396 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.85 140.46 32.89 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.52 163.66 23.31 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.672 1.189 . . . . 0.0 109.326 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.28 156.31 30.94 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.567 2.178 . . . . 0.0 112.134 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 123.034 2.489 . . . . 0.0 110.247 170.665 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.11 172.96 13.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.752 1.221 . . . . 0.0 109.108 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.12 150.26 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -83.21 132.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -137.23 164.9 27.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.291 1.436 . . . . 0.0 109.525 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -125.62 141.31 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -149.92 156.46 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.779 1.232 . . . . 0.0 107.923 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.57 137.47 52.4 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -52.06 -37.74 54.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -36.27 61.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.217 0.607 . . . . 0.0 112.147 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.92 -35.26 80.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.689 0.396 . . . . 0.0 111.315 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -86.67 -41.58 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.878 0.871 . . . . 0.0 109.017 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.42 -21.83 65.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.359 1.064 . . . . 0.0 112.725 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.14 -11.12 24.56 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.545 -1.142 . . . . 0.0 113.728 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.9 m -56.05 -55.49 32.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.956 1.378 . . . . 0.0 111.787 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -166.57 -60.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.323 1.449 . . . . 0.0 110.398 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -159.36 173.74 15.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.275 1.43 . . . . 0.0 108.765 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -162.63 160.53 25.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -154.56 162.58 41.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.622 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.62 138.75 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -152.39 73.75 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.436 0.694 . . . . 0.0 109.587 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.24 92.32 0.41 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.96 131.97 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 49.28 34.93 6.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.842 1.657 . . . . 0.0 113.336 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.98 -9.29 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.081 0.952 . . . . 0.0 112.773 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.98 -27.82 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.483 1.113 . . . . 0.0 110.628 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -127.87 -21.78 3.64 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -108.47 -160.07 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.504 1.522 . . . . 0.0 110.023 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 59.35 59.61 4.94 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.22 1.808 . . . . 0.0 112.517 -169.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.29 -13.2 38.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.0 1.8 . . . . 0.0 113.528 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.2 130.54 33.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.169 0.988 . . . . 0.0 110.673 -169.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 156.91 17.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.119 2.546 . . . . 0.0 111.302 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.06 -48.55 52.95 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.154 0.982 . . . . 0.0 111.28 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -57.34 -45.65 84.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.335 1.054 . . . . 0.0 111.966 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.5 -33.31 75.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.314 0.646 . . . . 0.0 111.313 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.79 -44.22 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.17 -45.19 99.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.644 0.656 . . . . 0.0 109.702 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -54.67 -44.39 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.517 0.727 . . . . 0.0 110.372 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -61.9 -52.01 65.82 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.095 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.98 78.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.654 0.661 . . . . 0.0 111.442 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -71.83 -25.64 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.907 1.283 . . . . 0.0 112.255 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.94 -20.2 42.54 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.436 1.095 . . . . 0.0 109.948 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.9 -13.98 12.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -167.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.37 146.11 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 120.089 1.313 . . . . 0.0 110.27 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 -4.17 84.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.964 1.269 . . . . 0.0 113.605 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.67 154.05 38.63 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.172 1.486 . . . . 0.0 108.779 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.43 147.59 27.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.62 151.49 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.764 1.225 . . . . 0.0 109.586 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.25 32.66 4.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.989 0.899 . . . . 0.0 111.462 -168.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -123.09 146.71 47.48 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.152 1.381 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -62.59 159.17 16.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.37 1.868 . . . . 0.0 112.316 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.9 121.85 16.01 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 165.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.7 p -142.62 156.34 45.06 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.5 m -51.37 -41.82 60.93 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.681 0.793 . . . . 0.0 110.814 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -72.46 -41.79 65.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.443 1.097 . . . . 0.0 111.368 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -40.3 85.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.2 0.909 . . . . 0.0 110.343 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.53 -45.52 79.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.016 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -56.75 -46.6 81.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.629 0.772 . . . . 0.0 110.111 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -59.14 -53.73 54.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.82 0.848 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.17 -48.62 80.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -64.35 -30.61 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.469 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -70.75 -29.12 65.27 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.663 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 72.3 mt-10 -61.33 -34.6 75.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.829 1.195 . . . . 0.0 110.489 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.5 mt -75.5 -46.64 31.14 Favored 'General case' 0 C--O 1.228 -0.036 0 CA-C-N 118.693 0.679 . . . . 0.0 110.23 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -64.33 -40.63 96.27 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 122.981 0.512 . . . . 0.0 110.96 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.22 -33.06 10.58 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.55 -42.12 1.92 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -168.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.93 135.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.428 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.21 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.458 -0.583 0 CA-C-O 121.804 0.668 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.43 144.78 50.6 Favored Pre-proline 0 N--CA 1.464 0.235 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.67 131.47 19.93 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.513 2.142 . . . . 0.0 110.718 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.04 27.43 7.82 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.678 1.132 . . . . 0.0 111.28 -168.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -123.19 148.0 46.26 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.701 1.751 . . . . 0.0 110.387 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.29 137.1 35.81 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.15 131.11 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.88 151.12 22.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mm -126.65 106.43 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.57 138.5 48.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.14 166.89 20.95 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.873 0.869 . . . . 0.0 109.169 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.51 -35.65 29.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.401 2.734 . . . . 0.0 116.174 -169.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -140.29 12.59 2.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.448 1.099 . . . . 0.0 112.065 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -160.18 -168.82 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.249 1.02 . . . . 0.0 110.179 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.417 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -138.07 153.91 49.29 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.156 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -135.28 170.55 15.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.4 1.88 . . . . 0.0 107.461 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.417 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 81.8 m95 -137.64 148.62 45.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.451 0.7 . . . . 0.0 111.515 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.28 171.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.142 1.777 . . . . 0.0 108.42 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.4 127.59 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -76.13 127.42 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.3 1.84 . . . . 0.0 108.306 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -139.08 1.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 -172.29 22.18 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.94 -29.01 70.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.243 1.022 . . . . 0.0 112.479 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.14 11.2 1.03 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.555 1.074 . . . . 0.0 113.268 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.92 153.11 23.01 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.037 1.419 . . . . 0.0 110.733 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.53 154.34 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 109.831 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.31 141.78 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 167.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.38 169.78 22.39 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.866 -0.521 . . . . 0.0 110.724 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.52 138.51 34.28 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.95 164.84 31.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 108.104 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.58 155.7 51.7 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.781 1.654 . . . . 0.0 110.824 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 N--CA 1.454 -0.832 0 C-N-CA 122.27 1.98 . . . . 0.0 110.806 -178.361 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 pttt . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.75 169.18 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.17 1.388 . . . . 0.0 109.123 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mt -135.82 144.12 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.94 121.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 163.03 19.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.467 1.507 . . . . 0.0 108.109 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.43 128.73 44.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -149.89 160.09 43.86 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.408 1.083 . . . . 0.0 108.642 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.56 133.9 49.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -54.69 -40.91 69.61 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.58 0.752 . . . . 0.0 111.902 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -61.03 -29.9 70.0 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.663 0.385 . . . . 0.0 111.898 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.55 -46.02 41.71 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.209 0.459 . . . . 0.0 110.277 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.14 -42.33 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.753 0.821 . . . . 0.0 109.908 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 -6.56 52.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.236 1.415 . . . . 0.0 113.28 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.27 -10.46 52.76 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.414 -0.659 . . . . 0.0 113.395 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 p -60.94 -43.75 98.21 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.76 1.224 . . . . 0.0 112.181 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -159.3 -58.56 0.07 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.296 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -166.05 -174.42 2.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.578 1.551 . . . . 0.0 108.853 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -154.64 167.87 28.68 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.201 1.001 . . . . 0.0 109.383 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -155.54 156.8 35.79 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.805 0.842 . . . . 0.0 109.958 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.04 138.77 21.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -148.22 71.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -68.58 81.7 0.27 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.22 1.008 . . . . 0.0 108.547 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -56.81 125.65 23.38 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 47.04 44.88 15.46 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.675 1.59 . . . . 0.0 112.528 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.76 -13.96 1.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 170.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.59 -15.61 25.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.159 1.383 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -123.6 -19.92 5.68 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.194 0.998 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -140.48 -167.65 2.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.111 1.364 . . . . 0.0 109.643 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m 52.15 60.38 13.51 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.91 1.284 . . . . 0.0 112.247 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.9 -12.54 34.7 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.395 2.064 . . . . 0.0 113.9 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.07 133.57 83.68 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 124.175 0.99 . . . . 0.0 110.72 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.55 145.46 69.36 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.201 1.934 . . . . 0.0 108.881 166.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.4 m -55.0 -39.38 69.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -170.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 p -54.88 -44.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.502 1.121 . . . . 0.0 112.14 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -63.5 -32.09 73.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.646 0.778 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.53 -46.09 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.0 -49.03 84.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -55.66 -43.24 76.12 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.866 0.867 . . . . 0.0 110.857 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -60.17 -55.65 31.2 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.83 -41.38 67.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -74.29 -24.89 59.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.369 1.068 . . . . 0.0 112.027 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -81.13 -23.05 38.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.704 0.683 . . . . 0.0 110.505 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.16 -22.79 13.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.43 -167.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.16 144.6 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.998 1.272 . . . . 0.0 109.066 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.63 34.86 62.79 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -132.06 160.54 35.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.84 150.94 42.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.071 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.88 142.01 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 108.304 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.2 mt -99.78 52.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.022 1.391 . . . . 0.0 110.446 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.71 150.96 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.256 -1.793 . . . . 0.0 108.347 169.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -70.18 164.12 24.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.032 0.933 . . . . 0.0 112.057 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.16 119.45 11.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.2 p -140.44 154.41 46.64 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 m -54.71 -40.22 69.0 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.944 0.498 . . . . 0.0 110.402 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.95 -41.78 77.56 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.749 0.82 . . . . 0.0 111.229 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.99 -39.15 87.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.082 0.856 . . . . 0.0 110.237 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.3 m -68.9 -44.23 73.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.907 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.45 -47.11 79.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.986 0.914 . . . . 0.0 109.91 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -58.38 -53.08 62.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.973 0.909 . . . . 0.0 109.363 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.23 -49.83 75.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.18 0.446 . . . . 0.0 111.678 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 -34.2 65.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.392 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -66.64 -38.47 86.98 Favored 'General case' 0 C--O 1.225 -0.209 0 O-C-N 121.889 -0.507 . . . . 0.0 110.361 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -56.24 -35.86 67.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.375 1.07 . . . . 0.0 111.86 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.15 -45.72 32.17 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.968 0.803 . . . . 0.0 110.922 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -78.09 -43.28 29.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.823 0.738 . . . . 0.0 111.937 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -75.77 -40.75 54.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.911 0.484 . . . . 0.0 110.838 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 116.02 -37.42 3.43 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 128.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 105.049 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.893 174.577 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.46 -0.479 0 CA-C-O 121.181 0.409 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -76.6 146.19 76.46 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.45 130.66 21.98 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.722 2.282 . . . . 0.0 110.163 168.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.99 -14.99 63.31 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 117.743 -1.587 . . . . 0.0 113.875 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -69.04 152.98 44.54 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.899 2.349 . . . . 0.0 111.82 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.07 139.28 38.15 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -119.92 145.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.87 149.93 41.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 mm -126.42 97.26 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 -168.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.4 143.43 57.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 174.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.48 168.25 18.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.356 1.062 . . . . 0.0 108.911 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.25 -32.88 52.57 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 115.904 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.64 3.34 2.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.94 -161.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.14 1.376 . . . . 0.0 108.504 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 147.79 36.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -117.68 167.47 11.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.466 1.906 . . . . 0.0 108.399 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.17 148.05 49.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.556 0.742 . . . . 0.0 110.304 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.54 172.94 14.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.237 1.415 . . . . 0.0 109.221 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 tt -132.62 128.61 57.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.14 133.07 45.93 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 109.278 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.01 165.68 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.637 1.175 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.66 -126.88 41.02 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -169.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -144.87 53.28 1.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 -8.53 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.783 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -103.72 168.06 9.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.694 1.247 . . . . 0.0 109.278 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.45 151.93 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.063 0.945 . . . . 0.0 109.546 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.86 141.38 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 168.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -163.6 171.59 15.53 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.271 0.629 . . . . 0.0 111.123 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.91 150.06 36.0 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.98 159.21 40.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.76 1.624 . . . . 0.0 108.408 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.0 159.78 40.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 121.474 1.449 . . . . 0.0 109.921 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 C-N-CA 123.549 2.833 . . . . 0.0 113.605 -178.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.5 178.84 9.14 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 108.879 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 pt -145.88 166.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.143 1.777 . . . . 0.0 107.167 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.67 139.79 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -133.69 172.41 12.8 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.566 1.546 . . . . 0.0 109.378 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.38 142.1 50.53 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 125.204 1.402 . . . . 0.0 107.415 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -151.04 159.61 44.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.292 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.86 137.74 55.52 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.86 -41.64 67.7 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.217 0.917 . . . . 0.0 111.669 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -64.86 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.88 -25.84 61.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.858 0.753 . . . . 0.0 111.437 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.66 -36.48 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.873 1.269 . . . . 0.0 109.918 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.5 62.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.536 1.534 . . . . 0.0 113.28 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.42 37.42 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.762 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -53.04 -48.09 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.696 1.248 . . . . 0.0 111.799 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -166.33 -54.29 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 125.881 1.672 . . . . 0.0 109.27 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -166.92 178.79 5.6 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.498 1.919 . . . . 0.0 107.732 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -154.14 165.86 34.9 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.386 -0.821 . . . . 0.0 109.314 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -155.67 158.63 38.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.919 0.888 . . . . 0.0 110.377 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.17 136.65 25.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -149.68 66.94 1.0 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.186 0.517 . . . . 0.0 110.498 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.64 119.14 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -67.8 -11.68 59.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 82' ' ' ASP . 92.5 m-70 -129.27 29.14 5.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 111.621 -169.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.54 21.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.887 -1.133 . . . . 0.0 112.685 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 80' ' ' HIS . 34.8 t70 -130.49 -5.81 4.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.948 2.099 . . . . 0.0 111.351 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.88 -31.2 1.32 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.965 1.306 . . . . 0.0 111.905 -169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 66.65 150.68 0.06 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 128.292 2.637 . . . . 0.0 117.848 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -40.11 109.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.876 2.87 . . . . 0.0 113.94 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 -15.9 18.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.505 2.803 . . . . 0.0 111.812 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.22 138.24 24.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 126.671 1.988 . . . . 0.0 106.698 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 157.28 62.21 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.527 1.485 . . . . 0.0 109.391 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.76 -39.93 62.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.323 0.649 . . . . 0.0 111.557 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 m -54.07 -48.43 70.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 111.393 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.7 -35.89 77.76 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.563 -0.71 . . . . 0.0 111.526 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.29 -49.08 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.186 0.903 . . . . 0.0 108.618 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.09 -38.62 78.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.124 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -55.83 -45.11 78.42 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.387 0.675 . . . . 0.0 110.067 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.3 -48.81 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.477 0.581 . . . . 0.0 109.859 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.31 -42.15 66.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.705 0.684 . . . . 0.0 111.813 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -78.52 -19.17 53.55 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.312 -175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.96 -29.79 26.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.193 0.906 . . . . 0.0 110.021 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.5 mt -96.68 -24.26 16.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.312 -168.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.45 132.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.785 1.175 . . . . 0.0 109.637 171.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.09 -4.87 82.07 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.55 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.45 159.79 25.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.779 1.789 . . . . 0.0 109.3 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -104.1 154.33 19.85 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.488 0.715 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.97 -175.98 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.993 1.317 . . . . 0.0 108.31 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.09 11.04 6.46 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.712 0.805 . . . . 0.0 112.842 -169.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.8 153.16 45.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 109.538 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -71.75 161.21 31.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 111.863 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.27 131.28 46.87 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.5 p -145.81 159.06 43.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 m -55.34 -39.3 69.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.126 0.421 . . . . 0.0 110.213 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.7 -47.48 66.32 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.126 0.571 . . . . 0.0 111.184 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.86 -40.39 87.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.679 0.672 . . . . 0.0 110.82 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.05 -42.46 76.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.774 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -58.97 -44.34 91.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.695 0.679 . . . . 0.0 110.395 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -56.6 -53.72 54.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.879 1.271 . . . . 0.0 109.06 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -60.18 -54.04 50.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.185 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -62.34 -28.22 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.921 0.782 . . . . 0.0 111.081 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -70.28 -32.77 70.72 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.411 -0.806 . . . . 0.0 111.718 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.3 -25.16 63.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.814 0.734 . . . . 0.0 111.321 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.22 -52.95 4.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -60.1 -37.56 80.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.556 1.142 . . . . 0.0 112.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -136.88 9.95 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.231 0.957 . . . . 0.0 111.676 -167.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.0 -29.92 5.72 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.772 -1.205 . . . . 0.0 112.55 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.0 145.58 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.01 1.724 . . . . 0.0 108.336 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.014 0.926 . . . . 0.0 111.064 169.041 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 CA--C 1.536 0.579 0 N-CA-C 111.245 -0.329 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -131.7 145.93 59.64 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.15 0.98 . . . . 0.0 108.424 168.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.23 128.19 19.38 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.465 2.11 . . . . 0.0 111.037 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.99 -10.26 27.24 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.976 1.75 . . . . 0.0 112.141 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.9 135.86 34.32 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.006 1.403 . . . . 0.0 111.408 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.13 137.46 54.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -121.8 121.23 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.13 151.49 21.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.28 112.46 29.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 127.02 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.45 168.96 6.84 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 108.336 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -47.56 -33.19 17.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.052 3.168 . . . . 0.0 116.541 -170.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -146.87 17.35 1.25 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.897 0.879 . . . . 0.0 111.433 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -158.43 -160.64 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.408 1.083 . . . . 0.0 109.586 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 155.43 45.66 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -116.36 168.51 10.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -132.39 147.21 52.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.596 0.635 . . . . 0.0 111.159 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.29 174.7 11.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.237 1.815 . . . . 0.0 107.719 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.18 129.95 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -73.86 125.92 29.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 m -136.31 -10.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.59 167.11 28.67 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -55.37 -22.2 18.54 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -168.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -140.8 16.56 2.83 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.239 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -120.48 154.36 35.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.569 1.684 . . . . 0.0 111.976 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.47 158.17 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.553 1.141 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.87 143.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.0 174.45 13.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.154 0.982 . . . . 0.0 109.932 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.42 143.9 29.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 170.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.93 160.46 62.76 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.779 1.231 . . . . 0.0 108.994 171.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.42 156.86 20.11 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.274 1.982 . . . . 0.0 110.975 168.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 112.379 173.508 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.34 -179.82 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.09 153.73 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.33 139.08 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -139.87 159.64 41.73 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.221 1.409 . . . . 0.0 107.997 -169.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.03 136.52 49.48 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -152.5 159.91 43.28 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 108.63 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.38 132.88 49.31 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.8 -46.61 71.13 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.385 0.674 . . . . 0.0 111.261 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -67.26 -24.46 65.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.86 0.464 . . . . 0.0 111.33 -170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.32 -37.39 60.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.363 0.528 . . . . 0.0 111.011 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.53 -45.33 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.095 0.558 . . . . 0.0 109.56 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.97 64.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.073 0.549 . . . . 0.0 110.381 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.09 -128.83 31.09 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 m -72.26 -8.45 54.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.57 1.148 . . . . 0.0 113.874 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.21 -170.6 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.524 1.056 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -140.12 158.48 43.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.499 2.32 . . . . 0.0 106.084 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -156.61 163.26 39.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.845 -0.534 . . . . 0.0 110.31 -168.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.85 158.92 40.11 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.661 0.784 . . . . 0.0 110.432 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.37 134.31 30.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -149.74 66.57 0.99 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -61.42 118.88 7.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -55.26 -43.99 75.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.94 36.41 1.4 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.396 0.678 . . . . 0.0 111.337 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -58.79 -9.86 2.04 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.355 0.98 . . . . 0.0 112.686 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.61 -20.62 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.918 0.887 . . . . 0.0 110.336 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -114.15 -44.77 3.1 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.022 1.329 . . . . 0.0 110.23 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -155.48 159.0 39.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.719 0.808 . . . . 0.0 112.82 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -171.2 76.87 0.53 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 128.482 2.713 . . . . 0.0 105.096 167.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.55 -16.21 52.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.686 2.924 . . . . 0.0 113.885 -171.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.85 120.82 47.85 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 157.52 61.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.842 1.695 . . . . 0.0 108.904 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.9 m -47.48 -47.83 27.2 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.889 0.876 . . . . 0.0 112.505 -169.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -54.84 -43.94 73.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.637 0.775 . . . . 0.0 112.445 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.48 -33.61 76.07 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.596 -0.69 . . . . 0.0 111.187 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.2 mt -60.84 -48.95 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.29 -50.62 79.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -52.79 -47.05 67.84 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.424 1.089 . . . . 0.0 110.534 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -66.35 -49.72 65.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.57 -45.07 73.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.494 0.588 . . . . 0.0 110.805 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.76 -30.57 71.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.467 1.507 . . . . 0.0 112.188 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -72.45 -28.83 63.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.598 0.759 . . . . 0.0 109.052 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.4 mt -91.95 -16.99 25.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.906 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 t -54.74 128.92 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.363 1.438 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.11 87.66 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.261 -1.3 . . . . 0.0 113.229 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -76.88 143.99 39.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.72 1.76 . . . . 0.0 108.491 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.01 151.4 23.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.756 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.22 146.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 109.18 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.08 1.92 52.87 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.588 -0.695 . . . . 0.0 112.769 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -92.76 155.03 17.94 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.592 0.757 . . . . 0.0 109.261 169.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -70.22 142.58 52.37 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -69.11 131.88 45.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.1 p -145.17 165.3 28.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.096 1.758 . . . . 0.0 106.38 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 m -50.53 -46.94 57.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.795 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.45 -40.22 73.86 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.133 -0.461 . . . . 0.0 111.618 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -71.55 -31.01 66.53 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.231 0.923 . . . . 0.0 110.959 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.1 m -69.87 -43.6 71.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.124 0.874 . . . . 0.0 109.926 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -59.91 -41.12 91.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.637 0.775 . . . . 0.0 110.149 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -59.84 -58.89 6.6 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 110.286 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.64 -49.84 73.8 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.09 -31.05 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 121.096 -0.241 . . . . 0.0 110.557 -170.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -70.14 -28.12 65.1 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.177 -0.952 . . . . 0.0 111.527 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -53.98 -31.5 51.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.764 0.711 . . . . 0.0 111.368 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.1 mt -80.78 -45.8 16.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.239 0.616 . . . . 0.0 110.408 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -74.79 -29.38 61.09 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.203 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -130.22 -5.18 4.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.04 -14.7 62.79 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.81 -1.181 . . . . 0.0 112.737 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -154.8 151.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.644 1.577 . . . . 0.0 106.984 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.198 170.593 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo . . . . . 0 CA--C 1.534 0.509 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -113.64 138.38 22.6 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.32 132.36 23.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.29 -21.16 35.97 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.138 1.352 . . . . 0.0 112.014 -170.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -67.44 144.26 55.83 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.448 1.624 . . . . 0.0 111.674 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.11 139.92 43.08 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.61 128.21 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.51 150.83 22.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 165.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.05 114.1 40.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 102.355 -3.202 . . . . 0.0 102.355 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.45 131.08 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -108.87 167.26 9.42 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -50.39 -28.58 21.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 115.901 -173.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.62 14.5 1.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.819 0.848 . . . . 0.0 112.102 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -156.78 -155.81 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.488 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 157.87 44.13 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.865 1.211 . . . . 0.0 109.331 174.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -127.75 168.84 14.54 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.236 1.814 . . . . 0.0 106.113 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -135.09 147.45 49.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.848 0.749 . . . . 0.0 111.673 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.67 173.0 14.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.37 1.868 . . . . 0.0 108.879 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.78 133.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -80.48 135.23 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.56 -2.68 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -170.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.37 -175.41 38.56 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -77.04 44.28 0.39 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.195 0.998 . . . . 0.0 111.743 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.35 -32.31 0.35 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.861 1.22 . . . . 0.0 112.532 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.9 152.94 23.19 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.793 1.296 . . . . 0.0 111.651 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.82 156.31 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.33 1.452 . . . . 0.0 109.273 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 140.05 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.47 170.77 21.0 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.044 0.538 . . . . 0.0 110.798 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.02 138.43 33.74 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.04 8.59 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.671 . . . . 0.0 108.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.0 152.6 36.01 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.537 2.158 . . . . 0.0 112.425 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 121.965 1.777 . . . . 0.0 111.213 170.348 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.735 0.302 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 174.02 12.39 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.318 1.447 . . . . 0.0 109.765 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.35 146.13 29.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.0 t -82.57 130.95 34.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 163.94 28.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.176 1.39 . . . . 0.0 108.019 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -131.09 130.32 43.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.25 160.8 43.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 108.895 -173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -73.01 130.46 40.38 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.94 -40.23 63.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.11 0.964 . . . . 0.0 112.627 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -35.98 67.81 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.832 0.453 . . . . 0.0 111.832 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.35 -38.14 71.63 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.299 0.5 . . . . 0.0 110.605 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.09 -46.86 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.819 0.848 . . . . 0.0 108.834 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -24.6 66.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.536 1.135 . . . . 0.0 112.102 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.69 -14.3 3.66 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.503 1.525 . . . . 0.0 113.835 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.5 m -48.81 -48.2 41.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.595 1.197 . . . . 0.0 111.51 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -168.58 -55.92 0.02 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.927 1.691 . . . . 0.0 109.636 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.18 -174.95 3.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.947 2.099 . . . . 0.0 107.695 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -149.06 168.14 23.95 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.43 -0.794 . . . . 0.0 109.563 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -146.11 153.69 40.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.116 0.967 . . . . 0.0 108.88 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -78.14 135.09 26.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 166.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -147.19 69.66 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -63.47 104.72 0.66 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -54.0 -51.13 64.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.726 1.211 . . . . 0.0 113.848 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -148.2 38.95 0.9 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.383 1.073 . . . . 0.0 111.264 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.32 -14.26 1.14 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.09 1.356 . . . . 0.0 113.214 169.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.97 -28.27 27.89 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.476 -0.765 . . . . 0.0 110.596 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -97.44 -34.26 11.08 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.583 -177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -148.51 156.85 42.99 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.305 0.642 . . . . 0.0 111.756 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -178.4 72.86 0.21 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 128.475 2.71 . . . . 0.0 107.491 168.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.9 -14.45 41.36 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.643 2.229 . . . . 0.0 113.372 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.66 121.08 30.13 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 124.911 1.284 . . . . 0.0 108.491 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.62 159.67 10.74 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.294 2.662 . . . . 0.0 111.492 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -50.09 -46.57 53.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.655 0.782 . . . . 0.0 111.269 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.62 -44.7 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.32 0.648 . . . . 0.0 111.754 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.42 -35.72 68.42 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.293 0.637 . . . . 0.0 111.237 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.81 -49.87 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.5 -46.08 96.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -43.29 69.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.369 0.668 . . . . 0.0 110.338 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -51.05 64.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.79 -45.11 67.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.38 0.536 . . . . 0.0 111.213 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.01 -29.82 68.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.234 1.413 . . . . 0.0 112.127 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.38 -28.51 62.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.154 0.982 . . . . 0.0 109.192 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.78 -14.7 27.49 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.857 -1.068 . . . . 0.0 112.8 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.66 126.52 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 109.137 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.82 -1.22 88.04 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.453 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.21 159.93 21.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.629 1.715 . . . . 0.0 109.34 174.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -110.63 154.37 23.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.76 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.98 145.27 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.79 1.236 . . . . 0.0 107.755 169.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 tp -87.86 14.3 9.07 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.749 -0.595 . . . . 0.0 112.18 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -121.84 159.67 26.28 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.128 1.371 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -87.42 172.97 9.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.989 1.715 . . . . 0.0 113.501 -167.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.21 43.25 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.888 2.075 . . . . 0.0 112.477 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 p -70.18 148.19 48.95 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -55.21 -37.72 67.49 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.09 -0.381 . . . . 0.0 110.252 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -65.83 -40.44 91.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.445 1.098 . . . . 0.0 111.473 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -68.67 -36.98 79.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.054 1.297 . . . . 0.0 110.55 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.42 -45.43 79.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.2 -46.08 86.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.087 0.955 . . . . 0.0 110.086 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -56.47 -54.68 42.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.501 1.121 . . . . 0.0 109.052 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.59 -51.03 71.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.336 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.93 -33.47 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.22 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -68.45 -36.6 79.26 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.001 0.819 . . . . 0.0 110.713 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.72 -36.11 69.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.262 1.025 . . . . 0.0 111.421 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.0 mp -79.12 -45.05 20.78 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.066 0.848 . . . . 0.0 110.587 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.4 tpt85 -65.93 -33.61 76.23 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.915 0.886 . . . . 0.0 112.083 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.51 5.51 4.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.871 0.868 . . . . 0.0 113.125 -170.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.18 4.0 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 120.793 -1.192 . . . . 0.0 112.124 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.32 138.49 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.122 0.569 . . . . 0.0 111.648 175.045 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 C--O 1.237 0.466 0 CA-C-O 120.664 0.193 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -138.22 148.28 59.13 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 109.941 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.18 131.9 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.904 2.403 . . . . 0.0 110.352 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.51 -20.82 31.66 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.011 1.767 . . . . 0.0 111.708 -172.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.45 145.51 52.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.687 1.743 . . . . 0.0 111.394 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.19 138.62 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.35 145.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -123.6 149.43 45.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 mm -125.57 124.15 66.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -168.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -73.76 134.53 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -132.16 163.99 46.37 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.437 0.695 . . . . 0.0 109.681 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.3 -21.19 61.79 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.696 1.597 . . . . 0.0 115.214 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -135.37 1.14 2.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.038 0.836 . . . . 0.0 113.01 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -166.49 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.525 1.53 . . . . 0.0 108.769 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.73 152.37 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -131.31 168.77 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 109.279 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -137.98 144.8 41.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.165 0.986 . . . . 0.0 110.279 -169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.7 14.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.791 1.636 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.23 131.54 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.15 131.39 39.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.085 1.354 . . . . 0.0 108.152 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.26 -20.65 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.52 43.97 0.94 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 119.265 0.938 . . . . 0.0 112.07 -168.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.68 38.21 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.16 1.784 . . . . 0.0 112.744 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.05 0.94 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.997 1.284 . . . . 0.0 110.536 -172.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -91.72 152.48 20.17 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.62 1.21 . . . . 0.0 110.766 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.19 160.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 126.1 1.76 . . . . 0.0 109.836 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.71 140.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.29 169.41 22.18 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.865 -0.522 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 143.02 31.32 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.52 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 108.122 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.99 155.3 65.23 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 N-CA-C 109.334 -1.064 . . . . 0.0 109.334 168.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo . . . . . 0 C--N 1.349 0.59 0 C-N-CA 123.175 2.583 . . . . 0.0 113.76 -178.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 173.4 11.87 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.414 1.486 . . . . 0.0 109.333 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -135.88 147.68 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.65 125.97 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -122.59 166.4 14.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.324 1.05 . . . . 0.0 109.282 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.2 124.48 39.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -150.32 163.83 37.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 108.938 -169.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -69.77 128.88 37.97 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.69 -45.34 70.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.344 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.66 -18.19 64.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -88.13 -43.88 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.746 0.703 . . . . 0.0 110.5 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.78 -40.43 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.066 0.946 . . . . 0.0 110.824 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.72 -2.08 57.1 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.255 1.422 . . . . 0.0 113.088 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.45 -18.49 37.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.934 0.778 . . . . 0.0 113.125 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -53.7 -43.47 68.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.473 1.509 . . . . 0.0 112.424 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -161.12 -69.03 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.058 0.943 . . . . 0.0 111.411 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -167.28 -176.39 3.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.374 1.87 . . . . 0.0 108.811 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -156.18 168.47 27.19 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.795 0.838 . . . . 0.0 110.684 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -151.52 159.82 43.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.941 0.896 . . . . 0.0 110.284 168.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.7 t -70.76 139.26 20.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -148.05 67.4 1.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.321 0.582 . . . . 0.0 109.582 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -57.78 117.33 4.14 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.3 -38.47 71.76 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.415 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.447 ' C ' ' H ' ' A' ' 82' ' ' ASP . 76.6 m-70 -144.9 25.62 1.42 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 112.23 -171.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.27 -1.55 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.872 1.215 . . . . 0.0 112.055 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.7 t70 -99.99 -6.78 25.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.392 1.477 . . . . 0.0 110.868 177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -128.81 -32.08 2.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.749 1.22 . . . . 0.0 111.343 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -146.47 149.13 33.07 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.492 1.117 . . . . 0.0 110.97 -170.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.9 p -162.56 65.8 1.72 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.061 1.344 . . . . 0.0 109.255 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.93 -14.78 46.15 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.362 2.042 . . . . 0.0 113.02 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.4 125.66 22.59 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.992 1.317 . . . . 0.0 108.376 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.31 167.17 27.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.444 2.096 . . . . 0.0 109.951 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -47.05 -49.14 21.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.486 1.114 . . . . 0.0 111.904 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -54.08 -54.21 42.56 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.812 1.245 . . . . 0.0 111.811 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.55 -35.02 79.11 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.229 1.012 . . . . 0.0 111.608 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.2 mt -61.99 -44.98 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.721 1.146 . . . . 0.0 108.618 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -63.41 -49.07 84.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.02 -40.37 73.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.088 0.555 . . . . 0.0 110.427 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -63.48 -54.44 36.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.401 0.68 . . . . 0.0 109.447 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.48 -43.8 55.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.736 0.414 . . . . 0.0 111.262 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.16 -32.11 72.14 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.201 1.401 . . . . 0.0 111.768 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.94 -25.57 62.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.13 0.572 . . . . 0.0 110.806 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.21 -10.74 17.69 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.895 -1.05 . . . . 0.0 113.315 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 t -59.0 139.88 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 121.026 1.739 . . . . 0.0 109.509 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.25 -5.88 84.33 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.377 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -80.94 154.46 26.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.25 1.525 . . . . 0.0 109.087 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.491 1.116 . . . . 0.0 109.104 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.19 146.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.139 1.376 . . . . 0.0 107.898 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.29 49.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 123.089 1.423 . . . . 0.0 109.812 -171.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -135.24 148.23 49.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.671 168.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -70.03 165.2 22.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.61 118.95 11.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -140.28 155.48 46.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 m -54.61 -40.25 68.71 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.721 0.408 . . . . 0.0 110.315 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.47 -42.85 74.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.466 0.706 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -67.42 -39.37 85.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.824 0.738 . . . . 0.0 110.385 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.8 m -69.93 -44.04 70.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.35 -46.65 79.87 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.498 0.719 . . . . 0.0 109.887 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -57.69 -54.49 46.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.872 0.869 . . . . 0.0 109.196 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -57.81 -52.3 66.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.374 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.94 -31.42 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.487 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.12 -28.26 67.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.624 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.26 -42.88 96.28 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 119.465 1.03 . . . . 0.0 109.728 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.93 -40.31 75.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.014 0.825 . . . . 0.0 110.405 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -76.66 -40.64 48.39 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.199 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -122.7 15.48 10.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.06 -52.51 3.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.4 142.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.144 -0.455 . . . . 0.0 110.502 172.811 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 N-CA-C 111.417 -0.263 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -138.84 142.15 32.83 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 124.401 1.08 . . . . 0.0 109.093 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.97 133.15 14.48 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.183 2.589 . . . . 0.0 111.5 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.48 -25.34 12.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.051 1.786 . . . . 0.0 110.622 -169.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.75 136.64 56.5 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.183 0.991 . . . . 0.0 111.046 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.26 140.95 52.47 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.36 129.88 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.23 151.43 23.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.88 98.96 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 102.758 -3.053 . . . . 0.0 102.758 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.38 136.2 56.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -133.84 169.44 13.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.673 . . . . 0.0 110.526 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.95 -30.68 24.83 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.428 2.752 . . . . 0.0 117.134 -169.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -145.76 10.49 1.21 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.691 0.796 . . . . 0.0 112.635 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -163.78 -169.55 1.92 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.27 1.428 . . . . 0.0 108.618 -172.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 158.05 45.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -127.01 169.49 13.29 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -138.83 145.43 40.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.592 0.633 . . . . 0.0 110.681 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.13 174.46 12.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.924 2.09 . . . . 0.0 107.782 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.08 136.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -75.96 128.86 35.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.31 -15.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.19 168.5 33.06 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -50.21 -29.77 10.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -167.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.93 13.06 4.45 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.449 -1.195 . . . . 0.0 113.622 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -123.05 152.38 41.05 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.77 1.785 . . . . 0.0 111.928 -170.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -133.36 159.67 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.947 1.299 . . . . 0.0 110.594 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.52 136.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.23 168.71 26.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.351 0.661 . . . . 0.0 110.47 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.85 141.06 32.55 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 165.12 28.34 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 125.223 1.409 . . . . 0.0 108.812 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.4 151.76 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.977 2.451 . . . . 0.0 112.205 170.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 122.195 1.93 . . . . 0.0 110.364 179.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.44 172.19 13.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.582 1.553 . . . . 0.0 109.121 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.1 147.27 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.81 128.02 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 160.6 31.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.236 1.415 . . . . 0.0 108.481 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.55 124.67 41.78 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.6 165.03 35.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.389 1.076 . . . . 0.0 108.982 -169.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.16 132.86 49.45 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.763 0.825 . . . . 0.0 109.208 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.89 -45.38 71.08 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.609 0.764 . . . . 0.0 110.899 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -66.45 -19.6 65.83 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.032 -0.509 . . . . 0.0 112.25 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.84 -42.26 27.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.005 0.82 . . . . 0.0 110.167 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.38 -44.83 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.267 0.627 . . . . 0.0 110.099 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.47 18.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.359 1.064 . . . . 0.0 112.454 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.22 51.97 3.31 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.689 1.614 . . . . 0.0 110.649 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 p -140.51 -55.03 0.52 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.132 1.773 . . . . 0.0 107.692 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.41 -67.6 0.2 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 123.954 0.902 . . . . 0.0 111.486 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -155.25 176.12 12.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.195 0.598 . . . . 0.0 110.158 -168.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.65 164.68 37.88 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.724 0.81 . . . . 0.0 111.04 171.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -156.89 162.13 39.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.63 1.172 . . . . 0.0 110.227 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -71.17 142.52 15.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -153.58 76.61 1.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.173 0.589 . . . . 0.0 109.599 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -70.8 81.34 0.63 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -56.12 129.23 39.16 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.939 -0.475 . . . . 0.0 110.34 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' ' 82' ' ' ASP . 22.2 m80 62.45 19.46 11.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.878 2.071 . . . . 0.0 115.213 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.58 -6.2 1.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.997 0.817 . . . . 0.0 111.848 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 80' ' ' HIS . 33.0 t70 -77.95 -25.25 48.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.249 1.02 . . . . 0.0 110.703 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.18 -27.56 1.8 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -140.87 141.94 34.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.816 0.735 . . . . 0.0 112.101 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -162.03 69.03 2.22 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.251 2.621 . . . . 0.0 107.554 171.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.22 -14.44 40.53 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.665 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.9 mt -122.58 126.08 26.25 Favored Pre-proline 0 C--O 1.235 0.307 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.12 162.3 42.78 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.3 2.0 . . . . 0.0 109.307 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.2 p -49.02 -45.99 43.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.892 0.877 . . . . 0.0 112.573 -171.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -53.11 -45.79 68.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.031 0.932 . . . . 0.0 112.352 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -66.51 -31.75 72.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.622 0.769 . . . . 0.0 111.549 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -64.49 -46.93 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.096 0.862 . . . . 0.0 108.815 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.36 -47.68 87.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -56.09 -43.16 77.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.802 0.841 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.7 -47.93 81.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.046 0.384 . . . . 0.0 110.168 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.23 92.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.841 -0.537 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -70.38 -20.59 62.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.264 1.425 . . . . 0.0 112.351 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.26 -28.95 38.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.34 1.056 . . . . 0.0 109.052 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.49 -20.98 13.31 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.611 -169.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 p -52.24 133.18 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 120.498 1.499 . . . . 0.0 109.779 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.78 -5.22 84.42 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.271 -1.294 . . . . 0.0 113.446 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -84.28 164.56 18.95 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.762 1.781 . . . . 0.0 109.593 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -117.49 150.85 38.25 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.238 1.015 . . . . 0.0 109.208 -172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.3 144.32 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.185 0.994 . . . . 0.0 108.37 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.45 53.0 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 123.303 1.525 . . . . 0.0 109.479 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.92 147.9 37.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.434 -2.166 . . . . 0.0 107.908 168.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -65.06 166.15 9.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.109 1.364 . . . . 0.0 113.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.32 125.4 25.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p -145.18 159.03 43.63 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -51.68 -44.63 63.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.675 0.39 . . . . 0.0 110.658 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.11 -48.74 69.9 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.558 0.743 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -64.97 -39.86 94.12 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.267 0.94 . . . . 0.0 110.955 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.57 -43.31 73.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.402 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.32 -44.85 92.54 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.545 0.611 . . . . 0.0 110.105 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.42 -47.55 85.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.517 1.127 . . . . 0.0 109.684 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -58.41 -50.55 73.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.557 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.04 -30.76 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.923 0.783 . . . . 0.0 111.148 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -68.17 -30.88 70.1 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.244 -0.91 . . . . 0.0 111.237 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.2 -11.35 2.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.353 1.061 . . . . 0.0 113.267 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.05 -41.61 5.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.597 1.159 . . . . 0.0 110.174 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.806 0.73 . . . . 0.0 111.893 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.25 -11.45 10.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.013 0.925 . . . . 0.0 111.248 -173.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.09 -9.96 76.28 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.326 -0.859 . . . . 0.0 112.742 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -145.08 143.73 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.555 169.425 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 CA--C 1.537 0.646 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -115.31 153.83 47.49 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.22 1.408 . . . . 0.0 107.905 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.44 134.07 20.55 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.548 2.165 . . . . 0.0 110.484 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.22 7.32 88.57 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.789 -1.562 . . . . 0.0 113.055 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -81.19 149.38 29.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.339 2.57 . . . . 0.0 110.368 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.94 136.55 46.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -120.15 135.94 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.62 153.67 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -128.05 98.64 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 133.46 52.71 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.707 -0.62 . . . . 0.0 109.875 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.26 167.51 10.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.461 1.105 . . . . 0.0 109.11 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.28 -26.79 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.87 2.38 . . . . 0.0 115.175 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -140.59 2.8 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.345 1.058 . . . . 0.0 112.999 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -157.42 -152.43 0.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.445 1.098 . . . . 0.0 109.031 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 164.63 37.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -126.24 168.41 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -136.66 147.88 47.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.828 0.74 . . . . 0.0 111.479 -172.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.82 174.84 13.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.185 1.794 . . . . 0.0 108.726 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.41 132.06 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -74.67 134.54 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.206 1.002 . . . . 0.0 110.107 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.99 166.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.032 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.18 26.54 43.31 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.54 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.66 37.51 9.59 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.83 1.652 . . . . 0.0 113.28 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.63 -14.72 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 O-C-N 121.336 -0.852 . . . . 0.0 114.637 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.7 172.18 8.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.269 1.034 . . . . 0.0 109.016 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.29 161.54 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.399 0.68 . . . . 0.0 110.093 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -114.31 135.56 53.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.33 168.98 25.04 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.165 0.586 . . . . 0.0 110.902 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.55 139.27 33.95 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.26 46.09 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.697 1.599 . . . . 0.0 109.233 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.87 158.92 40.26 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.078 1.852 . . . . 0.0 111.279 172.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 C-N-CA 123.143 2.562 . . . . 0.0 113.109 -177.408 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.32 173.09 12.57 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.996 1.718 . . . . 0.0 109.13 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -143.47 158.45 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -87.49 132.77 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.88 164.51 22.93 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 109.481 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -125.23 126.34 45.03 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.01 1.324 . . . . 0.0 108.301 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -68.38 135.56 51.97 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.593 -0.692 . . . . 0.0 109.275 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -43.67 75.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.872 0.76 . . . . 0.0 111.01 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -66.07 -19.37 65.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 -44.12 13.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.844 0.747 . . . . 0.0 110.228 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.32 -29.67 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.072 0.949 . . . . 0.0 111.281 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.97 -29.39 60.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.213 -0.899 . . . . 0.0 112.255 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.77 -109.49 0.64 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.86 1.219 . . . . 0.0 111.97 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -61.88 -0.49 0.48 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.645 1.978 . . . . 0.0 114.635 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t0 67.54 160.05 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 129.37 3.068 . . . . 0.0 114.152 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 96.98 129.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 131.63 3.972 . . . . 0.0 109.063 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -165.29 161.48 19.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.062 1.345 . . . . 0.0 108.959 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.1 156.75 42.97 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.332 1.453 . . . . 0.0 108.381 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.31 134.65 28.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -153.61 75.4 1.04 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.727 -0.608 . . . . 0.0 110.24 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.93 85.58 0.23 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.767 0.827 . . . . 0.0 108.883 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -62.25 125.09 22.67 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -171.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.49 44.37 13.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 126.474 1.91 . . . . 0.0 112.525 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.12 -18.87 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.18 -30.56 25.7 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.253 1.021 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -91.19 -34.42 15.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.781 0.832 . . . . 0.0 110.559 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -80.48 175.7 10.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.965 0.888 . . . . 0.0 112.723 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -56.27 160.08 5.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.85 2.86 . . . . 0.0 113.786 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.77 -0.6 3.22 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.815 3.01 . . . . 0.0 115.68 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 mt -36.61 119.58 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.391 2.276 . . . . 0.0 112.638 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.94 151.01 35.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.057 2.504 . . . . 0.0 111.841 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.5 m -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.633 0.773 . . . . 0.0 111.104 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -51.34 66.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.854 1.261 . . . . 0.0 111.677 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.68 -34.95 76.64 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.979 0.912 . . . . 0.0 110.992 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.3 mt -65.13 -43.35 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.573 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.6 -48.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 120.017 1.28 . . . . 0.0 108.946 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -53.18 -47.39 68.89 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.627 1.171 . . . . 0.0 110.066 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -62.18 -50.56 71.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.945 0.498 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.44 78.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.834 0.454 . . . . 0.0 111.359 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -82.55 -11.18 58.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.24 0.616 . . . . 0.0 112.343 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.53 -21.89 35.23 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 109.783 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.08 -11.7 13.78 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.19 147.61 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.181 0.9 . . . . 0.0 109.832 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.01 -2.63 80.19 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.081 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -71.15 154.91 41.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.991 1.396 . . . . 0.0 109.174 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.92 148.9 29.02 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.01 178.27 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.397 1.079 . . . . 0.0 108.62 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.35 21.77 5.64 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.27 1.028 . . . . 0.0 111.167 -170.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -123.05 160.41 26.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.553 1.541 . . . . 0.0 109.735 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -75.2 169.01 18.88 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.54 43.59 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.343 1.857 . . . . 0.0 110.282 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 p -70.46 152.71 43.74 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.542 -1.349 . . . . 0.0 107.558 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -51.76 11.6 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 109.926 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.26 -37.59 83.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.712 1.605 . . . . 0.0 112.401 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -68.69 -39.13 80.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.346 1.43 . . . . 0.0 110.543 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.1 m -67.21 -44.81 78.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.73 -44.24 90.4 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.773 1.229 . . . . 0.0 110.573 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -58.79 -53.62 56.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.099 0.96 . . . . 0.0 109.486 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -46.96 87.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.06 -33.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.315 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.8 -33.52 74.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.184 0.902 . . . . 0.0 110.968 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -58.71 -33.74 70.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.202 1.001 . . . . 0.0 111.695 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.82 -52.98 7.57 Favored 'General case' 0 N--CA 1.458 -0.072 0 O-C-N 121.292 -0.88 . . . . 0.0 110.529 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -30.81 70.94 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.522 0.729 . . . . 0.0 111.395 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -135.03 9.2 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.66 -43.42 2.75 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.886 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.87 139.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.433 171.056 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -61.93 149.45 40.52 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.715 -0.615 . . . . 0.0 109.976 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.87 156.78 30.97 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 126.096 1.758 . . . . 0.0 108.221 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.87 175.34 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.381 2.054 . . . . 0.0 110.683 171.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.15 76.88 67.74 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.78 -23.89 5.34 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.719 2.946 . . . . 0.0 113.058 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.88 -53.91 10.92 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.432 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.15 160.93 28.36 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.801 2.334 . . . . 0.0 112.978 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -134.72 146.76 60.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.162 1.385 . . . . 0.0 107.636 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.17 133.55 15.17 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.538 2.159 . . . . 0.0 110.327 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.93 -8.76 50.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.239 1.399 . . . . 0.0 112.397 -169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.01 147.92 24.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.064 1.932 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.07 139.52 42.86 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.3 mm -118.12 146.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.32 153.09 35.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -129.17 103.15 8.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -168.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.575 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.33 169.38 7.52 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.819 1.648 . . . . 0.0 107.533 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.16 -28.18 50.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.947 2.432 . . . . 0.0 115.843 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -142.05 4.4 1.65 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.703 0.801 . . . . 0.0 112.92 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.4 -155.89 0.49 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.912 1.285 . . . . 0.0 108.465 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.66 170.02 19.66 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.51 1.05 . . . . 0.0 110.746 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -144.32 172.46 12.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.333 1.853 . . . . 0.0 109.352 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -137.42 146.92 44.97 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.73 173.72 15.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.401 1.48 . . . . 0.0 108.892 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 tt -139.2 133.86 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -77.09 132.05 38.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.07 -3.81 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.9 177.22 42.27 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.14 53.39 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.525 1.13 . . . . 0.0 111.484 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.87 -13.17 0.39 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.225 -1.32 . . . . 0.0 114.083 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -119.21 155.49 31.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.121 1.961 . . . . 0.0 111.834 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -134.39 156.01 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.85 1.26 . . . . 0.0 110.874 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.46 142.71 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.53 171.27 16.07 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.326 0.651 . . . . 0.0 110.284 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.37 148.62 28.16 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.44 158.99 65.03 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 125.426 1.49 . . . . 0.0 108.571 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.65 156.58 22.09 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.006 1.804 . . . . 0.0 110.419 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.67 103.83 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.882 2.388 . . . . 0.0 110.958 169.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -135.21 3.32 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.784 0.834 . . . . 0.0 112.907 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -131.7 27.57 4.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.608 1.163 . . . . 0.0 109.871 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.62 -21.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 112.915 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.18 147.15 28.1 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.63 41.07 2.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.358 0.98 . . . . 0.0 111.834 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 49.68 27.78 2.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.548 1.939 . . . . 0.0 113.436 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.67 23.33 0.41 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.228 0.918 . . . . 0.0 112.658 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.68 17.36 2.0 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.528 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.71 169.03 23.74 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.976 1.711 . . . . 0.0 107.632 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 -8.71 2.37 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.922 1.289 . . . . 0.0 113.412 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.17 -30.53 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.524 -0.735 . . . . 0.0 110.73 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.4 ttt -62.45 -38.23 88.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.231 1.012 . . . . 0.0 110.443 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -79.35 -1.34 36.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.418 1.487 . . . . 0.0 112.136 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.2 36.36 6.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.412 1.885 . . . . 0.0 112.475 -170.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.7 tp -147.52 101.05 3.32 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -145.3 163.02 35.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -131.85 46.66 2.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.643 1.211 . . . . 0.0 108.79 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.47 163.17 29.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.677 1.591 . . . . 0.0 109.22 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.21 177.23 10.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.506 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 mt -134.83 147.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 t -88.58 125.94 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -135.17 165.57 25.09 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.246 1.018 . . . . 0.0 109.701 -168.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -125.69 139.11 53.82 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -151.95 160.85 43.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.859 1.264 . . . . 0.0 108.598 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.39 132.89 50.13 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -53.31 -43.91 67.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.531 0.732 . . . . 0.0 110.748 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -67.06 -19.19 65.63 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.6 -46.21 33.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.141 0.882 . . . . 0.0 109.906 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.95 -39.21 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.489 0.715 . . . . 0.0 110.197 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.76 -20.15 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.315 1.446 . . . . 0.0 112.861 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.5 -11.92 37.2 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.176 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -51.46 -57.94 7.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.531 1.132 . . . . 0.0 111.009 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -165.79 -50.8 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.968 1.707 . . . . 0.0 110.132 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -159.41 173.0 16.9 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.022 1.729 . . . . 0.0 107.977 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -157.96 164.1 37.16 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.475 -0.766 . . . . 0.0 109.75 173.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -147.83 160.19 43.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.403 1.481 . . . . 0.0 108.367 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.67 135.22 26.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -154.09 75.06 1.0 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.65 0.659 . . . . 0.0 110.779 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.45 94.89 0.42 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -57.53 -23.29 49.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 82' ' ' ASP . 61.5 m-70 -136.95 21.97 3.05 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.738 1.154 . . . . 0.0 112.251 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.62 -4.72 1.0 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.481 1.491 . . . . 0.0 112.08 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.7 t70 -87.28 -9.89 53.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.669 1.187 . . . . 0.0 110.729 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -132.3 -41.14 0.99 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.011 1.324 . . . . 0.0 111.213 -169.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -153.05 162.19 41.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.179 . . . . 0.0 111.898 -169.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -178.78 72.16 0.2 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 129.286 3.035 . . . . 0.0 105.275 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -13.64 40.45 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.535 2.823 . . . . 0.0 113.986 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.86 138.64 24.14 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 108.641 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.39 159.14 50.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.313 2.008 . . . . 0.0 109.823 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.24 -42.46 61.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.757 0.823 . . . . 0.0 111.502 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -53.66 -56.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.624 0.77 . . . . 0.0 111.194 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.7 -38.38 90.2 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.354 1.061 . . . . 0.0 111.718 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.84 -49.31 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.431 1.014 . . . . 0.0 108.692 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.29 -46.09 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.91 89.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.877 -0.582 . . . . 0.0 109.957 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -63.3 -48.0 79.92 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.925 0.784 . . . . 0.0 109.851 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.26 60.2 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.321 0.509 . . . . 0.0 110.005 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.68 -19.93 58.79 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.78 -26.51 61.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.864 1.266 . . . . 0.0 109.048 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.76 -10.65 19.75 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.88 -169.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.47 144.52 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.399 0.999 . . . . 0.0 109.784 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.14 60.77 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.66 1.124 . . . . 0.0 112.979 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -86.46 158.42 19.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.798 1.299 . . . . 0.0 109.536 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -100.68 154.04 18.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.53 147.06 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.968 1.307 . . . . 0.0 107.89 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.33 42.09 1.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.788 1.28 . . . . 0.0 110.16 -168.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -139.87 147.79 41.16 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.692 1.597 . . . . 0.0 108.406 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.33 150.5 34.85 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.116 0.967 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 108' ' ' LEU . 1.2 pt? -77.23 56.28 1.29 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.177 1.391 . . . . 0.0 112.282 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -64.58 159.07 22.62 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.076 -1.015 . . . . 0.0 109.26 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.3 t -50.07 -45.03 52.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.42 -43.57 97.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.211 0.604 . . . . 0.0 111.476 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -71.71 -37.0 70.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.112 0.869 . . . . 0.0 111.142 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.3 m -67.87 -42.85 80.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.257 0.48 . . . . 0.0 110.159 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.45 -46.73 83.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.071 0.948 . . . . 0.0 109.643 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -58.06 -55.27 37.15 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.722 1.209 . . . . 0.0 109.771 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.39 -49.6 76.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.643 0.202 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.55 -30.59 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.819 -169.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -67.34 -33.28 74.91 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.472 -0.768 . . . . 0.0 110.398 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -55.99 -29.86 60.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.541 0.736 . . . . 0.0 112.194 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.15 -50.17 9.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.534 0.606 . . . . 0.0 110.354 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -71.17 -33.34 69.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.558 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.25 6.72 6.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.669 0.668 . . . . 0.0 112.601 -170.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.56 7.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.113 0.869 . . . . 0.0 112.691 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.48 141.4 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.406 1.882 . . . . 0.0 107.914 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.793 168.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -66.99 -41.99 85.81 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.611 -0.68 . . . . 0.0 111.13 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.36 143.07 97.86 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.347 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.06 -20.49 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.3 2.0 . . . . 0.0 113.177 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.1 pt 37.02 55.63 3.37 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.395 1.878 . . . . 0.0 111.808 -172.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -80.44 175.62 10.0 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 123.725 2.95 . . . . 0.0 109.747 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.05 67.94 73.98 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.43 159.03 46.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.077 2.518 . . . . 0.0 112.182 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.35 148.43 67.91 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.32 1.448 . . . . 0.0 107.594 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -47.51 129.15 16.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.582 2.188 . . . . 0.0 110.088 170.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.64 -6.16 35.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.933 1.254 . . . . 0.0 112.297 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.35 150.8 22.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.385 2.092 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.66 142.53 38.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.13 146.08 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -129.05 146.78 50.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 167.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.83 93.78 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.8 135.04 51.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -128.21 172.41 6.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.055 1.342 . . . . 0.0 110.074 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.33 -34.88 26.21 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.454 2.77 . . . . 0.0 116.733 -169.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -139.75 7.98 2.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.699 0.8 . . . . 0.0 112.721 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.58 -169.0 1.97 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 109.121 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.17 156.82 45.88 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.166 -0.959 . . . . 0.0 109.216 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -119.76 169.08 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.471 1.508 . . . . 0.0 107.609 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -132.87 146.0 51.43 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.491 1.041 . . . . 0.0 111.146 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.89 174.88 12.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.647 1.979 . . . . 0.0 108.383 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 tt -135.72 135.51 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.35 131.52 37.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.82 -3.77 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.45 174.57 41.93 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.93 53.75 0.96 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.205 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.2 -13.08 0.29 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.289 -1.284 . . . . 0.0 113.781 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -120.3 155.76 32.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.095 1.948 . . . . 0.0 111.934 -171.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 m -133.98 160.33 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.971 1.308 . . . . 0.0 110.957 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -114.53 140.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 167.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.75 173.51 15.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.898 0.479 . . . . 0.0 110.937 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.32 141.22 34.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.94 160.93 58.63 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.425 1.89 . . . . 0.0 108.142 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -61.58 150.69 84.35 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.548 1.498 . . . . 0.0 109.727 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.83 148.62 21.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.395 2.73 . . . . 0.0 114.296 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -56.12 151.2 12.66 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.867 1.267 . . . . 0.0 111.426 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.86 73.56 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 168.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.287 26.2 m 42.39 -130.13 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.602 1.961 . . . . 0.0 110.931 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.79 -6.52 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.291 1.437 . . . . 0.0 114.01 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -19.71 64.44 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 112.139 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.98 17.9 3.63 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.577 1.951 . . . . 0.0 114.248 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.6 175.64 37.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.41 -178.41 6.97 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.579 1.152 . . . . 0.0 109.484 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.01 166.7 23.8 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.723 1.609 . . . . 0.0 108.177 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 m -64.7 -16.14 62.45 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.834 0.853 . . . . 0.0 112.946 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -52.81 107.79 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.669 1.588 . . . . 0.0 109.95 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.3 tpp 49.69 22.07 0.74 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.563 1.945 . . . . 0.0 113.557 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 m -146.2 13.44 1.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.456 1.103 . . . . 0.0 111.945 -169.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.02 -18.0 55.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.218 1.007 . . . . 0.0 113.621 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.0 tp -147.23 142.98 27.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.198 1.799 . . . . 0.0 106.712 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 p -144.8 152.49 40.4 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.349 1.459 . . . . 0.0 107.164 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.6 8.36 8.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -146.22 163.81 34.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.802 3.241 . . . . 0.0 106.912 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.56 12.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 112.058 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.42 148.5 25.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 125.761 1.624 . . . . 0.0 107.132 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.69 128.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -137.72 161.0 37.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.685 1.194 . . . . 0.0 109.145 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -121.67 134.08 54.97 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.62 160.9 43.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.755 1.222 . . . . 0.0 109.002 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.08 128.18 35.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.887 0.875 . . . . 0.0 108.877 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.33 -45.11 68.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.83 0.852 . . . . 0.0 110.626 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -64.3 -24.42 67.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.919 -172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.59 -43.22 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.706 0.685 . . . . 0.0 110.481 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.93 -46.8 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.452 0.701 . . . . 0.0 109.744 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.25 65.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.845 1.258 . . . . 0.0 112.117 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 -12.16 15.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.723 1.154 . . . . 0.0 113.363 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.9 m -52.42 -50.55 62.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.959 1.38 . . . . 0.0 111.133 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -165.04 -56.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.041 1.336 . . . . 0.0 110.631 171.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.95 -176.93 5.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.078 1.351 . . . . 0.0 109.855 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.79 169.53 24.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.894 0.878 . . . . 0.0 110.218 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -152.88 156.53 39.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.521 1.129 . . . . 0.0 110.065 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.64 138.43 20.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 169.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -150.63 67.96 0.95 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.171 0.51 . . . . 0.0 109.714 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.36 114.7 3.34 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -56.75 -42.33 79.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.458 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -163.11 43.47 0.12 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.331 0.652 . . . . 0.0 110.729 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.09 -14.25 6.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.818 . . . . 0.0 111.812 168.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.99 -16.74 37.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.0 1.32 . . . . 0.0 110.908 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -116.56 -27.11 6.82 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.454 1.102 . . . . 0.0 110.928 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -144.97 146.51 31.97 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.316 0.647 . . . . 0.0 111.643 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 p -164.82 66.28 1.23 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.541 1.536 . . . . 0.0 108.96 169.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.46 -13.82 41.49 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.452 2.101 . . . . 0.0 113.025 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.58 119.39 21.59 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.239 1.416 . . . . 0.0 108.764 -171.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.44 153.67 22.11 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.734 2.289 . . . . 0.0 110.146 167.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.1 m -52.71 -43.46 65.66 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.713 0.405 . . . . 0.0 111.87 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -56.71 -41.17 76.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.689 0.795 . . . . 0.0 112.269 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -64.94 -31.89 73.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.573 0.749 . . . . 0.0 111.133 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -64.74 -46.07 93.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.58 -48.81 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -55.64 -46.19 77.48 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.744 1.218 . . . . 0.0 110.724 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -61.03 -51.41 69.31 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.49 67.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.395 0.278 . . . . 0.0 110.712 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.76 -20.55 61.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.93 -27.49 61.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 119.254 0.934 . . . . 0.0 108.877 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.68 -16.19 15.54 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.711 -1.137 . . . . 0.0 113.529 -168.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.0 t -53.2 134.78 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.622 1.556 . . . . 0.0 108.578 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.78 -7.17 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.524 1.059 . . . . 0.0 113.335 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 159.36 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.184 1.492 . . . . 0.0 108.918 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -127.51 142.87 51.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.71 146.79 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.876 0.87 . . . . 0.0 109.01 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.36 -1.21 48.2 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.757 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -80.14 149.68 30.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.813 0.733 . . . . 0.0 109.209 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -74.65 154.45 38.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.498 1.919 . . . . 0.0 109.443 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.91 121.81 16.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.7 p -140.92 158.26 44.2 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 m -51.97 -42.38 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.852 0.461 . . . . 0.0 110.184 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.46 -48.33 70.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 110.841 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.67 -38.04 83.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.57 0.623 . . . . 0.0 110.853 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.2 m -67.91 -44.62 76.51 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.932 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -58.01 -44.69 87.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.489 0.715 . . . . 0.0 110.209 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -56.86 -52.41 65.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.163 1.385 . . . . 0.0 109.414 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -62.33 -49.97 73.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.757 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.0 -33.17 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.693 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.16 -34.7 78.62 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 121.639 -0.663 . . . . 0.0 110.682 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.55 -34.44 71.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.354 0.662 . . . . 0.0 112.203 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -76.88 -45.5 27.95 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.53 -0.731 . . . . 0.0 110.253 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -34.87 61.31 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.301 0.64 . . . . 0.0 111.265 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.08 8.35 6.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 111.999 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.77 -21.04 12.03 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.057 -1.027 . . . . 0.0 112.906 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.26 143.57 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.605 1.562 . . . . 0.0 106.891 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.483 0.713 . . . . 0.0 111.256 172.81 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -70.03 -33.15 71.61 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.4 -0.812 . . . . 0.0 111.755 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.44 47.26 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.944 1.698 . . . . 0.0 107.877 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.12 -166.81 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.209 2.606 . . . . 0.0 110.977 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -115.09 54.8 0.87 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.496 1.118 . . . . 0.0 112.231 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.58 -38.9 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.739 1.626 . . . . 0.0 110.335 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.27 64.21 7.18 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.462 1.905 . . . . 0.0 110.234 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.85 151.91 10.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.423 2.082 . . . . 0.0 111.824 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -125.35 141.52 39.02 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.98 134.84 18.2 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.772 2.315 . . . . 0.0 110.504 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.65 -10.0 58.96 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.154 1.359 . . . . 0.0 112.402 -169.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -78.04 140.5 39.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.119 1.959 . . . . 0.0 111.033 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.57 136.28 52.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.89 140.87 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.31 145.63 45.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 110.95 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -75.76 134.48 40.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -132.86 168.89 15.65 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.053 0.941 . . . . 0.0 110.687 -170.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.53 -30.41 35.61 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.37 2.713 . . . . 0.0 116.588 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 4.93 1.5 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.474 0.71 . . . . 0.0 112.763 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.68 -165.86 1.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.699 1.2 . . . . 0.0 109.029 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.09 149.46 44.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -120.69 171.77 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.746 1.618 . . . . 0.0 108.362 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -138.18 146.13 42.33 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.471 0.709 . . . . 0.0 111.012 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 174.43 12.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.459 1.904 . . . . 0.0 108.065 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.94 131.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.34 134.42 41.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.86 -3.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.58 175.18 42.63 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.88 55.38 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.163 0.985 . . . . 0.0 111.394 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.12 -15.3 0.33 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.956 1.265 . . . . 0.0 113.694 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -119.6 154.06 34.54 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.714 1.757 . . . . 0.0 111.738 -169.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.16 159.61 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.655 1.182 . . . . 0.0 110.673 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -111.47 138.68 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 167.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.67 168.03 27.95 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 111.009 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.39 139.95 33.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 165.34 21.07 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.534 1.533 . . . . 0.0 109.184 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.42 150.51 41.62 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.736 2.291 . . . . 0.0 112.458 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.11 145.92 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.324 2.016 . . . . 0.0 109.938 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -68.52 168.53 12.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.051 0.94 . . . . 0.0 110.949 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.27 61.76 2.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.036 1.335 . . . . 0.0 110.011 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.37 171.48 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.697 1.199 . . . . 0.0 111.268 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.53 142.98 25.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 111.092 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.27 32.6 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.005 0.812 . . . . 0.0 111.682 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.94 -14.23 59.44 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.114 0.966 . . . . 0.0 113.505 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.33 35.22 2.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.343 1.449 . . . . 0.0 110.901 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.76 163.24 32.7 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.182 1.393 . . . . 0.0 109.622 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.44 169.07 24.62 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.74 1.616 . . . . 0.0 108.692 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 m -132.97 10.67 4.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.039 0.936 . . . . 0.0 112.209 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 t 69.46 -39.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.707 2.403 . . . . 0.0 112.387 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.6 mtp -141.52 142.37 33.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.186 1.795 . . . . 0.0 106.707 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 m -60.6 -33.72 73.15 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.29 60.99 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.422 0.689 . . . . 0.0 112.554 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.82 122.91 19.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -151.98 150.08 29.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -144.11 20.28 1.76 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.687 1.232 . . . . 0.0 112.036 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.17 168.69 19.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.48 2.312 . . . . 0.0 108.727 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.22 176.83 10.83 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.222 1.009 . . . . 0.0 110.481 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -138.03 148.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.73 126.58 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -130.64 166.14 21.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.348 1.059 . . . . 0.0 109.772 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.06 127.46 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -151.8 163.16 39.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.462 1.105 . . . . 0.0 108.84 -169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.64 131.07 45.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.69 -45.64 70.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.693 0.797 . . . . 0.0 110.576 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -66.37 -19.81 65.9 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.94 -45.27 16.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.851 0.751 . . . . 0.0 110.065 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.6 t -59.43 -40.79 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.796 0.838 . . . . 0.0 110.638 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.02 -2.0 54.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 0.0 113.115 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.29 -15.88 46.88 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.917 0.77 . . . . 0.0 113.14 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 p -55.95 -47.13 78.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.139 1.376 . . . . 0.0 111.976 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -162.76 -67.9 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.707 1.203 . . . . 0.0 111.706 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -155.54 172.57 18.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.167 0.987 . . . . 0.0 109.926 -167.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.33 165.56 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.848 0.859 . . . . 0.0 110.75 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.56 163.08 40.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.07 0.948 . . . . 0.0 110.414 167.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.1 139.38 20.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 168.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -147.3 55.42 1.09 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.39 0.614 . . . . 0.0 110.39 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -54.61 113.03 1.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -61.84 -33.3 73.92 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.484 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.9 m-70 -138.06 23.22 2.81 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.68 0.792 . . . . 0.0 112.13 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.4 -2.71 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.348 0.976 . . . . 0.0 112.491 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 80' ' ' HIS . 5.1 p-10 -74.69 -26.33 59.77 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.169 -0.957 . . . . 0.0 110.945 172.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -143.2 -25.02 0.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -128.92 164.81 22.32 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.494 1.518 . . . . 0.0 112.233 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 m 165.64 72.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 131.52 3.928 . . . . 0.0 106.077 168.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.33 -13.86 36.48 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.287 2.658 . . . . 0.0 113.512 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.6 120.06 34.99 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 108.218 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.23 158.33 12.26 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 111.884 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -48.56 -44.46 36.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 111.786 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.2 p -56.02 -51.91 66.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.575 0.75 . . . . 0.0 110.926 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -65.46 -37.02 85.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.7 0.8 . . . . 0.0 111.373 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.87 -48.7 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.79 -39.36 83.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -55.74 -45.68 77.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.485 0.714 . . . . 0.0 110.213 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -60.85 -53.93 51.26 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 119.008 -0.52 . . . . 0.0 109.678 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.99 -48.84 61.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.283 0.492 . . . . 0.0 111.21 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -66.31 -34.22 77.5 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.681 1.592 . . . . 0.0 112.244 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -72.88 -24.09 60.81 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.232 1.013 . . . . 0.0 109.979 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.17 -12.02 17.64 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.965 . . . . 0.0 112.669 -168.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.87 142.19 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.375 1.443 . . . . 0.0 109.598 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.02 -8.39 79.91 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.807 1.194 . . . . 0.0 113.172 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -81.68 153.62 26.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.0 1.4 . . . . 0.0 109.186 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -101.52 154.16 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.321 1.048 . . . . 0.0 109.238 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.57 147.99 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 107.797 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.18 34.92 2.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.17 0.985 . . . . 0.0 110.665 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -125.54 146.77 49.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 108.393 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -73.38 164.12 27.12 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 127.099 2.16 . . . . 0.0 110.383 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.36 126.71 30.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.5 p -145.01 159.0 43.64 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -44.43 64.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.035 0.534 . . . . 0.0 109.623 174.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.11 -43.5 70.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.798 0.839 . . . . 0.0 111.447 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -66.68 -41.85 87.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.102 0.865 . . . . 0.0 110.369 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.23 -43.97 80.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.878 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.48 -45.22 89.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.4 0.68 . . . . 0.0 110.311 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -57.13 -52.02 66.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.041 0.936 . . . . 0.0 109.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -61.54 -49.42 76.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.019 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.21 -32.45 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.603 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -67.9 -31.75 71.75 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.219 -0.925 . . . . 0.0 111.151 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.2 -19.76 55.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.651 1.18 . . . . 0.0 112.414 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.5 -43.87 6.37 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.783 0.833 . . . . 0.0 110.339 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.65 -43.23 76.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.577 1.08 . . . . 0.0 111.438 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.4 2.41 13.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.45 -30.62 5.18 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.346 -0.846 . . . . 0.0 112.138 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -156.1 141.36 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 169.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 118.282 0.492 . . . . 0.0 110.64 170.006 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mmm . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.55 -32.15 71.88 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.594 -0.691 . . . . 0.0 110.059 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.6 121.05 8.14 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.18 -179.88 3.43 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.278 1.986 . . . . 0.0 110.638 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 pt -124.46 59.73 21.43 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.229 1.412 . . . . 0.0 108.936 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.6 -40.62 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.185 1.924 . . . . 0.0 112.506 -168.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -146.54 30.7 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.845 1.258 . . . . 0.0 113.85 -170.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -61.85 158.13 39.61 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.657 1.985 . . . . 0.0 112.037 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -138.48 151.42 69.08 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.148 0.979 . . . . 0.0 110.036 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -46.33 135.33 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.879 2.386 . . . . 0.0 110.837 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -14.59 54.49 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.254 1.407 . . . . 0.0 111.797 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -83.77 151.03 25.42 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.098 1.949 . . . . 0.0 111.43 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.9 139.54 41.69 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.42 125.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -96.86 152.08 19.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.4 mm -126.35 109.84 22.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.91 132.51 46.83 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.41 166.43 17.33 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.32 -35.88 28.65 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.47 2.78 . . . . 0.0 116.235 -168.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.97 13.05 2.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.285 1.034 . . . . 0.0 111.801 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.09 -164.78 1.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.058 0.943 . . . . 0.0 109.954 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 156.66 47.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 172.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -124.16 170.71 10.44 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.748 2.019 . . . . 0.0 106.292 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -136.8 148.3 47.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.715 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 173.71 12.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 107.962 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.7 tt -136.58 134.21 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.22 131.73 37.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.286 1.035 . . . . 0.0 108.309 -171.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.41 -5.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.45 -178.88 38.23 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.35 41.77 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.255 1.022 . . . . 0.0 111.671 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.41 -29.75 0.28 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.905 1.24 . . . . 0.0 112.627 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -88.77 149.65 23.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.784 1.292 . . . . 0.0 111.445 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -131.59 155.48 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.561 1.545 . . . . 0.0 109.112 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -102.42 143.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 166.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.2 165.07 35.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.571 -0.705 . . . . 0.0 111.131 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 136.91 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.27 34.53 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.804 0.842 . . . . 0.0 110.71 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.7 164.25 36.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.416 2.077 . . . . 0.0 110.112 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.05 -41.46 52.26 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.058 1.839 . . . . 0.0 110.675 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -160.93 145.98 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.939 1.696 . . . . 0.0 106.852 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -93.51 10.7 31.37 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.565 1.174 . . . . 0.0 111.698 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -147.23 156.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 128.798 2.839 . . . . 0.0 105.854 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.99 39.75 1.92 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.684 1.194 . . . . 0.0 111.89 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.7 -121.62 0.6 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -168.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.87 61.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.515 0.726 . . . . 0.0 112.845 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.74 -169.38 11.08 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.557 1.075 . . . . 0.0 112.905 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.15 -17.94 13.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.019 1.328 . . . . 0.0 114.228 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.21 -29.18 21.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.765 0.826 . . . . 0.0 112.199 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m 54.76 34.24 21.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.837 1.255 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -76.99 -170.92 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.725 0.81 . . . . 0.0 109.846 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -49.52 -35.58 20.54 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.331 1.452 . . . . 0.0 113.218 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -60.82 -38.26 84.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.729 0.812 . . . . 0.0 112.388 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -27.84 37.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.42 0.94 17.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.043 1.337 . . . . 0.0 111.892 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -134.18 176.83 8.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.873 1.669 . . . . 0.0 107.112 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.85 30.09 4.36 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.686 0.795 . . . . 0.0 111.901 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -92.5 172.94 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.103 1.361 . . . . 0.0 110.453 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.28 -172.69 4.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 109.728 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 mt -141.8 156.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.867 1.267 . . . . 0.0 109.252 -170.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -98.82 127.88 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -129.92 168.7 16.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.456 1.102 . . . . 0.0 110.411 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -125.72 134.34 51.81 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -150.69 160.83 43.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.74 1.216 . . . . 0.0 108.686 -175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.44 138.01 56.31 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 167.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.85 -33.4 68.62 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.687 0.795 . . . . 0.0 110.623 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -36.97 74.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.954 0.797 . . . . 0.0 110.954 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.07 -46.04 65.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.831 0.287 . . . . 0.0 110.471 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.67 -41.24 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.091 0.557 . . . . 0.0 110.397 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.22 40.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.383 1.473 . . . . 0.0 113.45 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.48 -16.0 34.44 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.044 0.831 . . . . 0.0 113.689 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 p -61.64 -44.1 97.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.553 1.176 . . . . 0.0 112.014 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -162.26 -59.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.861 0.865 . . . . 0.0 112.377 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -164.32 -170.73 2.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.673 1.589 . . . . 0.0 108.986 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -148.1 166.88 26.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.889 0.875 . . . . 0.0 109.956 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -145.44 153.21 40.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.197 1.399 . . . . 0.0 107.482 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -83.77 137.31 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.37 70.78 0.87 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.228 0.537 . . . . 0.0 109.92 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.51 112.9 2.66 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -65.69 -11.43 45.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.869 . . . . 0.0 113.184 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.527 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.8 m-70 -129.85 26.24 5.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.639 1.175 . . . . 0.0 111.591 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.11 23.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.895 -1.128 . . . . 0.0 112.605 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.8 t70 -132.91 -3.38 3.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 111.607 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -132.82 -31.59 1.31 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.26 1.424 . . . . 0.0 111.579 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 67.81 136.11 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 128.569 2.748 . . . . 0.0 116.211 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -63.93 139.97 97.76 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.382 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -16.75 32.37 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.894 2.396 . . . . 0.0 112.211 168.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.04 128.39 26.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.669 1.588 . . . . 0.0 108.802 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.93 155.03 24.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.165 2.577 . . . . 0.0 111.832 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.0 p -54.3 -40.45 67.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.86 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -56.52 -53.56 56.12 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.595 0.758 . . . . 0.0 110.569 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -62.92 -36.89 84.89 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.298 0.639 . . . . 0.0 111.472 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.03 -51.55 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.158 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -56.03 -49.1 74.64 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.188 0.995 . . . . 0.0 110.036 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -65.16 -45.65 84.08 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.729 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.95 -52.07 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.632 0.651 . . . . 0.0 110.793 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.93 -23.18 60.66 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -72.73 -27.5 62.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.66 -4.58 30.58 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.703 0.801 . . . . 0.0 113.051 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.28 150.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 109.828 169.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.5 23.53 56.15 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.439 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -126.85 161.98 26.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.703 1.201 . . . . 0.0 107.927 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.08 156.86 16.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.941 1.296 . . . . 0.0 109.754 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.8 m -130.56 148.84 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.827 2.051 . . . . 0.0 106.664 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.44 19.78 11.6 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.62 -0.675 . . . . 0.0 112.223 -169.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -121.41 155.92 33.79 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.293 1.437 . . . . 0.0 109.179 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -88.44 169.93 11.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.431 1.093 . . . . 0.0 112.542 -170.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.19 121.45 14.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 p -147.05 152.86 39.24 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 165.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -53.57 -40.84 65.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.102 0.41 . . . . 0.0 110.571 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.79 -44.74 84.81 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.376 0.67 . . . . 0.0 111.047 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -67.94 -38.57 83.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 0.786 . . . . 0.0 110.534 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.62 -44.62 81.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.646 0.657 . . . . 0.0 110.039 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -60.11 -45.3 93.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.101 0.56 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -57.82 -54.48 46.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.251 1.02 . . . . 0.0 109.587 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.49 -48.62 80.18 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.919 0.488 . . . . 0.0 111.729 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.47 -31.25 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.165 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -72.38 -27.61 62.49 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.897 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -61.61 -39.61 91.86 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.811 1.187 . . . . 0.0 109.644 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.42 -47.32 50.04 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.288 -0.883 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -17.35 59.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.284 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -142.76 7.39 1.66 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.81 1.186 . . . . 0.0 113.585 -169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.97 -48.55 3.68 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 120.806 -1.184 . . . . 0.0 110.637 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.66 141.23 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.582 1.953 . . . . 0.0 106.931 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.938 168.362 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? 65.51 -39.15 0.28 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.494 2.318 . . . . 0.0 113.336 -169.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.76 147.69 20.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.662 1.585 . . . . 0.0 107.504 169.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.19 177.52 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.554 2.169 . . . . 0.0 111.045 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.8 pt -128.49 63.6 64.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.39 1.476 . . . . 0.0 107.61 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.32 -45.3 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.785 2.324 . . . . 0.0 113.436 -166.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.46 52.07 0.42 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.336 1.454 . . . . 0.0 110.914 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -66.37 160.24 46.38 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.213 1.942 . . . . 0.0 111.799 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -135.81 151.79 74.74 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.726 1.211 . . . . 0.0 108.95 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.01 143.53 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.889 2.393 . . . . 0.0 111.495 169.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.56 73.99 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.038 1.304 . . . . 0.0 112.227 -170.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -76.76 147.81 37.07 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.509 1.654 . . . . 0.0 111.056 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.87 140.86 46.0 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.098 0.959 . . . . 0.0 108.829 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -125.21 138.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.39 148.9 41.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -121.87 106.37 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 -169.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -75.42 133.01 41.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -129.3 167.85 18.42 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 0.0 110.531 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.12 -25.54 29.65 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.252 2.635 . . . . 0.0 116.433 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -141.48 0.25 1.46 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.02 -165.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.67 1.188 . . . . 0.0 109.271 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.435 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -134.01 152.22 51.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -126.78 171.95 10.77 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.144 1.777 . . . . 0.0 107.998 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.435 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 66.6 m95 -139.2 150.0 45.05 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.073 0.851 . . . . 0.0 110.869 -172.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.33 173.24 16.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.421 1.488 . . . . 0.0 108.667 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.77 128.94 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.39 130.14 42.21 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.68 1.592 . . . . 0.0 109.433 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.53 168.6 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.075 1.35 . . . . 0.0 109.416 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.84 -135.31 49.23 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -120.71 8.99 10.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.397 1.079 . . . . 0.0 111.392 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.11 16.67 0.02 OUTLIER Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.437 -0.789 . . . . 0.0 113.686 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -107.6 169.2 8.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.847 1.324 . . . . 0.0 109.013 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.85 151.98 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.936 0.494 . . . . 0.0 110.649 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.28 141.37 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 166.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.84 171.54 17.59 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.92 143.2 30.88 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.6 159.33 71.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.286 1.834 . . . . 0.0 108.561 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.49 159.55 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.156 1.904 . . . . 0.0 110.921 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.02 -24.69 32.78 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.509 2.139 . . . . 0.0 113.008 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m 53.13 -164.21 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.247 1.419 . . . . 0.0 112.151 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -137.95 33.33 2.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.481 1.113 . . . . 0.0 109.368 -174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t 69.77 -41.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.287 2.635 . . . . 0.0 112.357 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.82 168.82 23.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.853 1.661 . . . . 0.0 109.519 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.95 177.45 47.54 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 -21.13 64.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.333 0.653 . . . . 0.0 112.5 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.04 -27.68 0.34 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.625 1.107 . . . . 0.0 111.733 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.36 173.08 12.94 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.935 1.694 . . . . 0.0 108.703 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.86 176.36 10.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.782 1.633 . . . . 0.0 108.301 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.0 m -58.28 -11.77 3.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.374 1.07 . . . . 0.0 113.331 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.4 -34.66 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.211 -0.93 . . . . 0.0 110.856 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -69.33 -33.21 72.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.492 0.717 . . . . 0.0 109.975 173.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -72.69 5.58 3.04 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.981 1.312 . . . . 0.0 112.402 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 57.21 28.78 15.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.671 1.989 . . . . 0.0 113.161 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.16 -16.11 62.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.495 0.718 . . . . 0.0 111.993 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 152.74 19.9 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -120.39 22.94 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.937 0.875 . . . . 0.0 112.724 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -130.82 -179.12 5.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.108 2.163 . . . . 0.0 109.862 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.55 173.9 13.57 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.397 . . . . 0.0 108.21 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -142.13 154.52 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.65 138.52 19.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -142.92 168.59 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.953 1.301 . . . . 0.0 108.814 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -128.54 140.79 51.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -151.24 161.14 43.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.41 1.484 . . . . 0.0 107.929 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.82 137.25 57.09 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.61 -44.74 73.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.714 0.688 . . . . 0.0 110.82 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.04 -19.79 65.74 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.92 -47.58 28.99 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.129 0.877 . . . . 0.0 109.737 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.4 t -62.19 -43.35 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.563 0.745 . . . . 0.0 110.243 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.43 -7.97 56.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.992 1.317 . . . . 0.0 113.182 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.32 -20.41 58.56 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.714 0.673 . . . . 0.0 113.22 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 -47.49 84.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.77 1.228 . . . . 0.0 111.976 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -159.08 -61.42 0.07 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.733 0.813 . . . . 0.0 112.884 172.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -155.73 171.34 20.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -158.94 163.25 36.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.71 0.804 . . . . 0.0 110.111 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -151.15 154.14 36.33 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.605 0.762 . . . . 0.0 110.78 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.81 137.56 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.74 68.55 0.46 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.528 0.68 . . . . 0.0 110.587 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.91 101.58 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -68.14 129.53 40.2 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 44.67 44.89 7.78 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.866 1.667 . . . . 0.0 112.1 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.78 -12.43 4.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.623 0.769 . . . . 0.0 112.967 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.95 -20.24 33.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.657 1.583 . . . . 0.0 111.029 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 -14.25 8.94 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.987 1.315 . . . . 0.0 111.026 -173.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -136.37 -156.09 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.973 1.709 . . . . 0.0 109.452 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m 57.79 59.93 6.57 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.361 1.864 . . . . 0.0 112.359 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -61.8 -14.74 38.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.363 2.042 . . . . 0.0 114.197 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.46 141.69 23.04 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.683 0.793 . . . . 0.0 110.51 -167.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 159.48 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.202 . . . . 0.0 110.137 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.7 m -48.05 -47.63 33.59 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.464 1.106 . . . . 0.0 111.57 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.68 -49.99 69.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.538 0.735 . . . . 0.0 111.683 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.38 -35.25 77.42 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.774 -0.579 . . . . 0.0 111.433 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.8 -49.01 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.69 -45.05 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.181 0.993 . . . . 0.0 109.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.07 -52.27 52.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.052 0.941 . . . . 0.0 108.963 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -66.86 -45.99 76.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.305 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.27 -47.88 62.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.617 0.644 . . . . 0.0 111.434 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.6 -10.72 57.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.351 0.661 . . . . 0.0 112.594 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.68 -22.49 40.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.38 0.991 . . . . 0.0 110.185 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.5 mt -111.7 -4.64 14.63 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.602 0.761 . . . . 0.0 112.372 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.25 142.79 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 118.869 0.759 . . . . 0.0 110.066 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.64 -3.2 80.04 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.297 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -74.07 152.74 39.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.321 1.561 . . . . 0.0 109.268 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.46 149.97 22.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.13 176.63 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.585 1.154 . . . . 0.0 107.944 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.42 6.12 6.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.564 -0.71 . . . . 0.0 112.519 -169.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -99.0 146.43 26.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.123 0.969 . . . . 0.0 109.062 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -61.83 153.46 28.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.323 1.449 . . . . 0.0 111.149 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.65 127.08 31.02 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.4 p -141.86 159.51 42.07 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 m -49.31 -42.09 40.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.21 0.604 . . . . 0.0 111.127 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.2 -23.75 18.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.318 -168.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -68.16 -39.93 82.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.633 1.106 . . . . 0.0 109.442 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.2 m -69.79 -40.6 75.91 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.079 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -53.64 -49.09 68.64 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.446 0.698 . . . . 0.0 109.883 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -60.2 -46.2 90.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.181 0.992 . . . . 0.0 110.11 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.31 -53.19 59.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.373 0.533 . . . . 0.0 111.77 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.86 -33.71 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 119.881 -0.727 . . . . 0.0 111.216 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -68.75 -32.12 71.65 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.596 -0.69 . . . . 0.0 111.148 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.17 -41.7 98.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.207 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.59 -44.79 81.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.865 1.212 . . . . 0.0 111.017 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -66.07 -42.43 89.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.343 0.657 . . . . 0.0 111.463 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -95.33 -43.98 7.78 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.001 0.364 . . . . 0.0 111.909 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.33 -53.52 0.69 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.53 138.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.127 -0.463 . . . . 0.0 109.82 -179.293 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -143.7 168.09 20.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.127 1.371 . . . . 0.0 108.869 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.1 79.62 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -72.2 -21.89 22.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.367 2.044 . . . . 0.0 113.815 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.1 mt 44.34 60.29 12.34 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.568 1.547 . . . . 0.0 109.64 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.18 -50.86 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.237 1.958 . . . . 0.0 112.133 -167.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -168.87 75.14 0.77 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.061 1.744 . . . . 0.0 108.863 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.44 129.43 26.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.492 2.128 . . . . 0.0 110.716 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.05 151.02 69.7 Favored Pre-proline 0 C--O 1.236 0.351 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.86 131.53 38.62 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.018 1.812 . . . . 0.0 109.3 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.9 -1.48 65.49 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.749 1.166 . . . . 0.0 113.015 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -73.61 147.71 43.55 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.963 1.881 . . . . 0.0 111.06 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.08 136.11 44.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.89 124.31 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.96 150.29 20.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -125.89 113.56 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 131.74 44.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -119.49 169.0 8.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.528 1.531 . . . . 0.0 107.888 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.26 96.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.733 2.288 . . . . 0.0 112.625 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 57.88 28.02 15.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.407 2.283 . . . . 0.0 113.508 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -149.21 -164.57 2.06 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.938 0.895 . . . . 0.0 109.436 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.9 158.84 43.43 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.065 -1.022 . . . . 0.0 109.591 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -127.77 168.53 15.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -135.62 150.65 49.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.864 0.757 . . . . 0.0 111.345 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.69 173.07 14.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.092 1.757 . . . . 0.0 108.181 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.77 132.97 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -70.93 134.83 47.54 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.624 1.17 . . . . 0.0 109.856 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.46 165.94 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.39 1.076 . . . . 0.0 109.879 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.54 -123.17 31.86 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -142.95 37.48 1.42 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.317 1.047 . . . . 0.0 109.021 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.2 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.382 -0.824 . . . . 0.0 115.016 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.39 171.03 7.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.938 1.369 . . . . 0.0 109.168 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.57 159.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.794 0.838 . . . . 0.0 110.194 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.8 137.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.73 173.3 14.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.545 0.738 . . . . 0.0 110.781 -172.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.26 143.37 30.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 161.9 46.7 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.862 1.665 . . . . 0.0 109.791 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 154.96 27.32 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.235 2.624 . . . . 0.0 112.533 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -68.66 -24.25 35.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.85 2.367 . . . . 0.0 112.373 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 42' ' ' VAL . 25.1 m -141.62 62.93 1.44 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.667 1.587 . . . . 0.0 107.502 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.01 20.6 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.272 1.429 . . . . 0.0 112.7 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' SER . 3.4 m -146.61 160.36 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.882 2.073 . . . . 0.0 108.027 174.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.14 119.44 3.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.603 1.161 . . . . 0.0 110.245 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.21 -13.04 0.04 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.948 -0.918 . . . . 0.0 114.159 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.06 19.31 2.99 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.746 1.273 . . . . 0.0 111.064 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.4 176.89 48.26 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.696 1.617 . . . . 0.0 109.367 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.74 55.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.13 165.96 31.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.739 1.615 . . . . 0.0 108.206 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -57.44 -39.15 75.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.094 0.558 . . . . 0.0 111.194 169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -65.88 -38.81 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.691 0.678 . . . . 0.0 111.516 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.2 ttm -71.77 -38.04 70.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.03 -0.419 . . . . 0.0 109.943 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -64.98 -41.21 95.63 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.381 0.672 . . . . 0.0 110.975 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.59 68.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.553 0.741 . . . . 0.0 111.792 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.3 103.15 0.6 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.038 0.935 . . . . 0.0 108.559 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 p -150.46 -177.95 6.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.454 1.901 . . . . 0.0 107.356 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -115.57 18.33 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.384 1.074 . . . . 0.0 112.589 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.05 -179.93 5.93 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 110.438 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.18 175.0 14.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.003 1.321 . . . . 0.0 108.467 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.78 157.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.0 139.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -142.74 169.65 17.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.572 1.549 . . . . 0.0 108.739 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.55 142.65 51.47 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -151.28 159.38 44.37 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.728 1.211 . . . . 0.0 108.443 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.9 135.6 52.73 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.87 -44.12 70.14 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.485 0.584 . . . . 0.0 111.679 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -66.51 -22.25 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.21 -44.4 59.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.789 0.722 . . . . 0.0 109.935 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.72 -41.49 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.414 0.686 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -3.78 22.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.657 1.183 . . . . 0.0 113.526 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.87 42.92 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.853 1.216 . . . . 0.0 114.831 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -58.88 -44.3 91.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.73 1.265 . . . . 0.0 112.365 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.2 -67.45 0.06 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 123.605 0.762 . . . . 0.0 112.439 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -157.76 177.03 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.638 1.175 . . . . 0.0 108.726 -166.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -151.93 169.59 21.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.05 1.34 . . . . 0.0 108.527 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.68 152.67 25.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.809 0.844 . . . . 0.0 110.296 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.69 133.24 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -149.68 70.86 1.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.729 0.776 . . . . 0.0 109.163 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.02 119.13 10.82 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -62.74 -28.27 69.85 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.326 -0.234 . . . . 0.0 110.761 169.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.543 ' C ' ' H ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -97.16 17.52 16.99 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.041 -168.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.73 21.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.776 1.626 . . . . 0.0 113.048 176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.9 t70 -136.3 2.19 2.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 111.469 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -138.08 -30.44 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.737 1.615 . . . . 0.0 111.866 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 67.54 149.6 0.06 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 128.986 2.914 . . . . 0.0 115.968 169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -50.73 113.41 3.67 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.17 1.388 . . . . 0.0 111.261 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.82 -18.85 16.69 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.941 2.427 . . . . 0.0 111.793 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.49 136.42 20.83 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 126.029 1.731 . . . . 0.0 107.273 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.61 145.78 57.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.083 1.855 . . . . 0.0 109.284 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.1 m -54.42 -42.34 70.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.45 0.3 . . . . 0.0 111.433 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -56.66 -42.51 79.11 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.703 0.801 . . . . 0.0 112.055 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -66.42 -33.19 75.15 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 117.764 -1.112 . . . . 0.0 111.441 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.4 mt -58.22 -49.04 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.135 1.334 . . . . 0.0 108.045 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.2 mm -61.89 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.862 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -45.2 91.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.23 -51.98 65.57 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.47 49.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.839 0.856 . . . . 0.0 110.721 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -76.76 -18.01 58.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.958 -0.544 . . . . 0.0 112.324 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.86 -27.16 62.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.684 1.129 . . . . 0.0 110.265 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.86 -27.69 16.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 110.644 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.12 125.62 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.581 1.082 . . . . 0.0 108.956 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.93 82.6 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.098 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -82.22 153.82 25.74 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.851 1.826 . . . . 0.0 108.885 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.85 151.42 23.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.228 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.52 172.24 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.668 1.187 . . . . 0.0 108.429 169.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.25 14.27 10.46 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.474 -0.766 . . . . 0.0 111.667 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -112.04 149.48 31.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 109.288 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -68.19 161.3 27.39 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 112.359 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.19 124.16 20.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.5 p -144.57 157.53 44.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.5 m -53.26 -45.41 68.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.653 0.381 . . . . 0.0 110.144 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.48 -37.98 80.61 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.086 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -69.24 -37.82 78.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.329 0.968 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.2 m -65.3 -47.37 76.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.12 -44.31 87.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.236 1.014 . . . . 0.0 110.144 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -58.04 -56.26 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 109.309 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.81 -47.37 85.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.722 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.6 -32.64 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.611 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -70.96 -40.96 71.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 110.528 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.6 -43.77 68.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.452 1.101 . . . . 0.0 110.618 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -72.08 -44.72 62.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.356 1.062 . . . . 0.0 112.007 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -74.43 -35.11 63.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.415 1.007 . . . . 0.0 112.658 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -120.96 -2.41 9.73 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -167.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.06 -26.24 24.29 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.831 -1.168 . . . . 0.0 111.983 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.65 139.91 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.049 -0.501 . . . . 0.0 111.128 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.287 0.089 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -127.21 -20.36 4.13 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.48 113.7 3.51 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -72.3 -7.08 20.31 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.63 2.22 . . . . 0.0 113.763 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.279 44.7 pt 44.46 56.61 13.93 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 127.131 2.172 . . . . 0.0 113.331 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.2 -33.1 2.11 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.826 2.35 . . . . 0.0 113.126 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.15 -42.59 2.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.063 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -50.79 163.66 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.195 3.263 . . . . 0.0 113.046 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -128.91 147.13 63.37 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.497 0.719 . . . . 0.0 109.863 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -47.96 139.06 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.55 -3.1 68.16 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.662 1.125 . . . . 0.0 112.438 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -80.52 139.26 36.44 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.056 1.428 . . . . 0.0 109.661 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mt -67.73 135.33 52.55 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.69 126.9 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -97.49 148.6 23.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 mm -126.18 123.03 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -75.0 112.39 11.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -84.64 171.27 11.4 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.88 -34.19 74.9 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.549 2.166 . . . . 0.0 114.904 -171.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -141.21 13.06 2.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.437 1.095 . . . . 0.0 111.967 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -157.68 -157.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.759 1.224 . . . . 0.0 109.272 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.24 155.07 45.23 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.085 -1.009 . . . . 0.0 109.809 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.61 168.49 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.009 1.724 . . . . 0.0 106.565 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -136.4 147.12 47.13 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.782 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.68 11.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.214 1.805 . . . . 0.0 107.48 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 tt -134.07 132.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.88 129.08 38.41 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.228 1.411 . . . . 0.0 108.879 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.2 m -136.38 169.14 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.07 0.948 . . . . 0.0 109.326 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.12 -117.32 8.76 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -141.7 25.33 1.99 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.26 1.024 . . . . 0.0 110.685 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.79 -17.29 0.14 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.159 -0.963 . . . . 0.0 113.853 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -70.79 163.65 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.012 0.906 . . . . 0.0 109.723 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.76 154.65 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.17 137.44 33.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.76 168.9 25.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 111.501 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.81 133.14 34.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.119 1.368 . . . . 0.0 107.441 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.84 153.89 58.15 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.275 1.03 . . . . 0.0 111.171 -171.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 152.53 44.02 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.329 2.686 . . . . 0.0 112.934 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.65 -40.62 83.15 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.876 2.384 . . . . 0.0 112.94 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -85.26 11.22 10.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.049 0.939 . . . . 0.0 112.498 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.85 69.39 1.85 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.228 0.922 . . . . 0.0 109.409 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.07 -20.48 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.202 1.401 . . . . 0.0 112.421 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 19.35 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.97 0.508 . . . . 0.0 111.814 -168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.65 -145.71 35.69 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.07 -14.52 24.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.47 76.52 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.9 -0.944 . . . . 0.0 112.704 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.66 108.35 2.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.943 1.372 . . . . 0.0 108.795 173.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 38.79 -106.35 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.617 1.967 . . . . 0.0 111.98 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -124.86 27.29 6.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.28 1.432 . . . . 0.0 110.648 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.327 4.2 p 55.43 -47.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 1 C-N-CA 132.027 4.131 . . . . 0.0 116.11 -177.953 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -60.18 -25.22 65.39 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.321 0.964 . . . . 0.0 110.52 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -52.31 -26.68 12.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.625 1.97 . . . . 0.0 113.365 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -19.52 65.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.525 0.73 . . . . 0.0 112.42 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.05 114.28 3.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -147.38 153.89 40.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.96 11.12 2.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.545 1.164 . . . . 0.0 113.679 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -134.93 161.39 35.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.386 2.674 . . . . 0.0 107.994 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 -170.84 3.69 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.235 1.414 . . . . 0.0 109.734 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -149.76 173.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.73 141.11 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.83 166.96 21.78 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.785 1.234 . . . . 0.0 110.048 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -126.59 125.92 42.75 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.19 161.69 40.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.629 1.172 . . . . 0.0 108.415 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 132.12 44.94 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -49.11 -48.35 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.47 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.46 -25.99 68.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.049 0.386 . . . . 0.0 111.914 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.59 -43.59 31.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.482 0.583 . . . . 0.0 110.367 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.79 -35.87 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 110.224 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.18 10.59 31.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.762 1.225 . . . . 0.0 113.508 -176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.62 -22.17 38.46 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.817 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -57.5 -50.12 74.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 1.271 . . . . 0.0 113.254 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.86 -69.07 0.06 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -157.74 172.0 19.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.497 1.119 . . . . 0.0 109.294 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -163.99 157.55 18.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.402 1.081 . . . . 0.0 109.328 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.48 166.14 34.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.404 0.681 . . . . 0.0 110.115 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.76 139.98 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -150.58 71.54 1.05 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -66.98 93.53 0.28 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -60.99 122.13 14.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 48.56 44.44 20.88 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 113.017 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.12 -19.05 2.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.134 0.974 . . . . 0.0 113.307 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.17 -22.68 30.89 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.228 1.011 . . . . 0.0 110.892 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -112.49 -26.47 8.67 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.986 0.914 . . . . 0.0 111.279 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.92 159.99 42.03 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m 128.69 76.75 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 1 C-N-CA 131.801 4.041 . . . . 0.0 108.708 174.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.38 -19.48 43.44 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.804 2.336 . . . . 0.0 114.017 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.42 132.9 29.25 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.534 0.734 . . . . 0.0 109.818 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.46 162.83 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.11 1.873 . . . . 0.0 109.115 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.2 m -50.94 -43.12 60.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.82 0.848 . . . . 0.0 112.587 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 p -55.59 -47.68 76.09 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.847 0.859 . . . . 0.0 111.996 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -32.07 73.48 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.54 0.736 . . . . 0.0 111.228 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.8 mt -65.13 -47.56 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.05 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 118.603 0.638 . . . . 0.0 109.915 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -54.86 -49.74 70.38 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.865 0.866 . . . . 0.0 109.793 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.05 -52.29 66.02 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.088 0.555 . . . . 0.0 110.144 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.8 -15.71 55.69 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.229 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.89 -32.05 68.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.784 1.174 . . . . 0.0 109.165 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.0 -18.12 22.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.055 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -50.34 130.67 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.93 1.241 . . . . 0.0 109.445 171.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.3 -2.61 81.14 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.277 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.34 162.81 19.91 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.472 1.636 . . . . 0.0 109.193 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -103.77 153.19 20.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.887 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.2 146.6 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 109.682 171.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -97.56 23.11 8.07 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.003 -1.061 . . . . 0.0 112.336 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -125.04 151.42 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.048 1.339 . . . . 0.0 110.508 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -65.85 162.6 18.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.44 2.296 . . . . 0.0 112.167 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.53 125.89 28.07 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.0 p -146.69 156.54 43.25 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -53.76 -42.52 68.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.64 0.776 . . . . 0.0 110.408 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.24 -39.92 82.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.05 0.94 . . . . 0.0 110.987 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -68.26 -34.45 76.23 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.36 0.982 . . . . 0.0 110.93 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.58 -45.3 83.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.406 1.003 . . . . 0.0 110.145 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -60.61 -45.33 94.42 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.256 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -57.87 -55.39 35.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.136 1.374 . . . . 0.0 109.021 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -55.09 -50.5 69.01 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.893 0.477 . . . . 0.0 111.52 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.45 -31.28 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.701 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -70.62 -27.88 64.42 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 121.52 -0.738 . . . . 0.0 111.656 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -60.23 -30.33 69.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.416 1.007 . . . . 0.0 110.643 170.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 mt -81.94 -47.6 12.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.657 0.662 . . . . 0.0 110.018 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -26.43 67.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.311 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -119.84 -33.63 3.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.764 0.711 . . . . 0.0 112.776 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.09 -40.09 2.08 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 p -157.27 140.41 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 118.649 0.659 . . . . 0.0 110.606 179.223 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.596 0.236 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.8 mmt-85 -146.53 164.62 31.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 107.198 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.09 150.47 78.67 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.24 178.21 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.247 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 pt -127.54 61.32 49.19 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.865 1.666 . . . . 0.0 107.464 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.22 -41.59 1.81 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 -167.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -159.91 67.62 2.85 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.846 1.258 . . . . 0.0 110.981 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -51.35 139.74 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.074 1.85 . . . . 0.0 110.229 168.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.29 139.82 29.0 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.47 137.54 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.171 2.581 . . . . 0.0 111.931 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.84 -16.64 60.85 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.02 -1.434 . . . . 0.0 112.44 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -71.12 153.99 42.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.505 2.153 . . . . 0.0 109.803 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.29 138.79 39.58 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.36 145.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -123.54 151.18 43.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 166.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -126.58 108.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.7 140.71 48.02 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.989 171.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -115.2 169.39 6.8 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.626 1.57 . . . . 0.0 107.45 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.63 -24.74 55.81 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.784 2.323 . . . . 0.0 115.316 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -141.71 3.99 1.69 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.108 0.963 . . . . 0.0 113.323 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -157.92 -160.89 0.96 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.633 1.173 . . . . 0.0 109.076 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -150.2 154.09 37.39 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -140.22 169.13 18.26 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.335 1.854 . . . . 0.0 107.283 -173.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -135.85 149.86 49.18 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.712 0.687 . . . . 0.0 110.42 -173.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.83 173.3 13.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.667 1.987 . . . . 0.0 108.11 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.57 133.69 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.6 136.98 38.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.57 0.57 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.87 -175.09 39.23 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.88 42.83 0.32 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 111.377 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 -33.27 0.25 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.87 -0.961 . . . . 0.0 113.109 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -89.57 153.26 20.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.464 1.632 . . . . 0.0 111.713 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.55 155.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.31 1.444 . . . . 0.0 109.665 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.46 136.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.29 173.05 16.26 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.724 -0.61 . . . . 0.0 110.645 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.23 147.21 28.14 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.97 165.86 22.14 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.491 1.917 . . . . 0.0 108.202 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.45 154.13 12.25 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.628 2.219 . . . . 0.0 112.174 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 163.88 32.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.296 1.998 . . . . 0.0 110.923 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m 53.51 -159.11 0.15 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.891 0.877 . . . . 0.0 109.192 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -153.49 150.82 29.14 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.373 -1.455 . . . . 0.0 110.462 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.42 177.15 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 129.192 2.997 . . . . 0.0 105.841 172.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.12 17.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.93 1.292 . . . . 0.0 114.174 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.59 11.41 35.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.242 0.925 . . . . 0.0 113.722 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.73 62.2 3.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.026 1.413 . . . . 0.0 109.487 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.86 -136.6 2.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.47 31.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.39 -18.43 62.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.388 -0.815 . . . . 0.0 113.104 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.4 m 42.23 48.18 4.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.751 1.62 . . . . 0.0 112.087 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.31 152.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.281 0.633 . . . . 0.0 111.414 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -63.79 -21.67 66.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.614 1.165 . . . . 0.0 112.802 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -56.49 119.88 6.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.135 0.974 . . . . 0.0 110.1 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.93 14.91 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.309 1.843 . . . . 0.0 114.859 -173.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.41 119.08 8.42 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 p -150.39 -176.51 5.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.582 1.953 . . . . 0.0 105.82 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.14 28.91 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.938 -1.101 . . . . 0.0 113.346 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -130.6 165.76 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.008 2.123 . . . . 0.0 110.002 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 172.85 14.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.983 0.913 . . . . 0.0 110.109 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.42 149.09 28.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 125.401 1.481 . . . . 0.0 107.101 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.17 129.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -128.22 167.98 16.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.564 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -124.72 129.61 50.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.87 160.52 43.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.46 130.37 40.52 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.25 -40.69 64.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.202 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -36.02 67.92 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.443 0.565 . . . . 0.0 111.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.67 -42.82 67.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.113 0.415 . . . . 0.0 110.038 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 t -66.13 -45.73 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.569 0.748 . . . . 0.0 109.522 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.92 -22.79 65.89 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.411 1.084 . . . . 0.0 112.015 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.67 -11.63 8.2 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.23 1.395 . . . . 0.0 113.483 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -49.36 -51.44 34.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.658 1.229 . . . . 0.0 110.722 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.79 -52.34 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.918 1.687 . . . . 0.0 110.184 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -159.69 173.76 15.57 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.458 1.903 . . . . 0.0 107.973 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -153.21 167.74 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.347 -0.846 . . . . 0.0 110.787 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.3 165.71 27.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.919 1.687 . . . . 0.0 108.327 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.84 128.8 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -158.1 63.94 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -55.94 128.55 35.74 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -69.19 -56.08 8.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.62 -166.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.49 45.59 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.645 1.178 . . . . 0.0 109.812 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.89 -10.55 4.11 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.294 -0.879 . . . . 0.0 112.89 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -86.61 -21.71 26.64 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.223 1.009 . . . . 0.0 111.037 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -113.15 -25.91 8.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.295 1.038 . . . . 0.0 111.162 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -143.03 -165.16 2.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.178 1.791 . . . . 0.0 109.435 -169.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m 57.64 62.69 5.21 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.408 1.483 . . . . 0.0 113.569 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -11.66 31.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.354 2.036 . . . . 0.0 113.934 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.99 132.64 94.68 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.954 1.301 . . . . 0.0 110.429 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.6 151.67 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.632 2.221 . . . . 0.0 110.978 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.39 -41.11 65.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.302 0.641 . . . . 0.0 111.102 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -52.31 -50.51 62.06 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 111.335 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -68.33 -38.52 81.6 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.29 0.636 . . . . 0.0 110.7 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.64 -49.58 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.47 -41.4 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.874 0.87 . . . . 0.0 109.375 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -55.32 -51.23 67.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.764 0.826 . . . . 0.0 109.185 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -62.31 -43.1 99.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.271 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.88 83.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.265 0.939 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.57 -15.27 55.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.178 0.591 . . . . 0.0 112.308 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -79.99 -21.31 43.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.106 0.962 . . . . 0.0 110.737 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -115.65 -5.08 12.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.492 0.717 . . . . 0.0 112.813 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.75 146.0 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.054 0.843 . . . . 0.0 109.835 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 -6.34 79.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.621 1.105 . . . . 0.0 112.967 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -79.26 155.23 28.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.114 1.457 . . . . 0.0 109.519 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.97 151.71 24.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.638 1.175 . . . . 0.0 108.966 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.59 147.04 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.141 1.376 . . . . 0.0 107.996 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.53 33.73 3.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.543 1.163 . . . . 0.0 110.492 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -130.91 158.17 40.95 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.514 1.926 . . . . 0.0 108.182 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.36 156.22 39.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.36 48.54 0.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.475 1.51 . . . . 0.0 111.454 168.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 p -65.71 158.86 26.38 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.831 -1.168 . . . . 0.0 108.597 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.2 m -51.48 -41.31 60.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.117 0.967 . . . . 0.0 111.095 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.32 -41.62 80.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.663 0.785 . . . . 0.0 111.374 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -72.08 -34.91 69.04 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.168 0.894 . . . . 0.0 111.102 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 68.9 m -66.82 -45.46 78.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.74 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.1 -44.12 87.51 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.125 0.57 . . . . 0.0 110.013 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -56.66 -55.13 37.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.788 1.235 . . . . 0.0 108.898 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.82 -48.19 82.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.07 -32.5 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.233 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -69.71 -32.49 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.138 -0.976 . . . . 0.0 110.37 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.98 -8.42 1.01 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 113.026 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.13 -48.47 3.04 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.237 1.415 . . . . 0.0 110.261 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -58.2 -36.07 72.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.386 0.674 . . . . 0.0 111.265 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -121.23 -7.47 9.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.354 1.062 . . . . 0.0 111.53 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.84 -10.03 63.9 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.821 -1.174 . . . . 0.0 112.243 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.27 139.44 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.155 175.006 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -148.93 164.42 34.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 108.069 172.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.63 -53.62 42.94 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.083 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.73 177.34 8.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.989 1.793 . . . . 0.0 111.453 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.8 mt -127.92 70.13 77.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.66 -21.83 5.84 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.697 2.265 . . . . 0.0 113.257 -169.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 16.9 pt-20 -139.53 -25.85 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 51.7 Cg_exo -56.72 146.47 77.06 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 122.909 2.075 . . . . 0.0 111.613 170.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -153.1 147.11 18.55 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.024 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.76 139.35 19.1 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.497 2.131 . . . . 0.0 111.284 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.98 60.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.915 1.245 . . . . 0.0 112.287 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.64 153.85 20.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.425 1.612 . . . . 0.0 110.987 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.77 143.43 36.12 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.92 124.82 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.72 152.96 18.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.82 116.03 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -171.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 111.71 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 -89.62 170.51 10.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.333 1.053 . . . . 0.0 108.244 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.22 -31.32 55.12 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.02 2.48 . . . . 0.0 115.841 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.79 16.15 1.24 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.291 1.037 . . . . 0.0 111.814 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -154.48 -158.78 0.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 108.999 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.29 157.35 44.92 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.99 -1.069 . . . . 0.0 109.879 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -128.82 169.08 14.99 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.964 1.705 . . . . 0.0 106.749 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -135.37 146.0 47.93 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.569 0.622 . . . . 0.0 111.7 -173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.54 171.97 15.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.168 1.787 . . . . 0.0 108.422 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.36 134.72 63.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.08 130.04 35.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.77 -14.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.81 168.64 34.99 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 -32.17 8.15 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -168.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.6 12.89 4.85 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.159 -1.356 . . . . 0.0 113.671 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -124.05 149.71 45.78 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.103 1.952 . . . . 0.0 112.175 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.86 159.46 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.181 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.43 140.33 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 167.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.25 171.92 18.97 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.771 0.429 . . . . 0.0 111.281 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.05 143.91 33.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 169.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 161.68 51.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.224 1.81 . . . . 0.0 109.149 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.01 148.39 58.36 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.661 2.24 . . . . 0.0 111.768 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.07 -15.28 25.96 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.965 2.443 . . . . 0.0 111.678 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -58.67 159.58 6.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.815 2.446 . . . . 0.0 112.508 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.72 24.08 3.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 111.276 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -70.66 170.22 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.383 1.073 . . . . 0.0 110.681 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.51 77.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.172 0.989 . . . . 0.0 111.799 170.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.6 -174.35 42.66 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.7 69.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.216 0.607 . . . . 0.0 112.027 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.6 -157.68 33.4 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.594 0.616 . . . . 0.0 111.994 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -14.69 38.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.26 1.024 . . . . 0.0 113.703 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.25 68.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.937 0.789 . . . . 0.0 111.78 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m 54.79 22.91 4.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.934 1.294 . . . . 0.0 112.768 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.03 152.26 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 125.285 1.434 . . . . 0.0 107.248 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.3 tpp -78.84 73.2 5.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.643 0.777 . . . . 0.0 108.95 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.1 m -56.43 -27.08 55.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.851 0.86 . . . . 0.0 113.247 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.07 -8.98 57.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.129 0.972 . . . . 0.0 113.18 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.23 146.3 44.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.963 0.887 . . . . 0.0 109.603 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -141.01 173.92 11.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.646 2.779 . . . . 0.0 104.276 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -74.21 48.55 0.32 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.54 1.518 . . . . 0.0 112.476 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -134.64 163.51 29.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.252 2.621 . . . . 0.0 107.721 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.92 13.32 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.628 1.171 . . . . 0.0 108.758 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.0 159.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.26 134.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.43 166.9 22.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.377 1.071 . . . . 0.0 109.622 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -118.29 132.7 56.28 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -150.44 160.99 43.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.448 1.099 . . . . 0.0 108.617 -173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.09 126.8 30.33 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.62 -46.13 66.89 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.428 1.091 . . . . 0.0 110.632 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -65.2 -21.73 66.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.12 -41.6 20.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.686 0.676 . . . . 0.0 110.375 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.34 -41.17 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.367 0.667 . . . . 0.0 110.061 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.14 1.83 12.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.304 1.441 . . . . 0.0 113.756 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.01 -25.44 31.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.024 1.297 . . . . 0.0 115.175 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -57.72 -45.88 85.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.855 1.327 . . . . 0.0 112.338 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -164.04 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.669 0.788 . . . . 0.0 112.4 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -156.76 176.96 12.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.635 1.174 . . . . 0.0 109.292 -165.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -152.62 168.26 26.21 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.943 1.297 . . . . 0.0 108.417 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.41 157.8 37.61 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.254 0.622 . . . . 0.0 110.056 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.0 135.26 28.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -149.44 62.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -63.31 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.529 1.131 . . . . 0.0 110.655 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.41 114.06 0.63 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.001 1.721 . . . . 0.0 110.17 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m80 52.82 40.19 30.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.469 1.508 . . . . 0.0 113.255 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.88 -15.3 1.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 167.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -82.9 -20.19 35.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.206 1.802 . . . . 0.0 111.468 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -131.27 -18.78 2.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.047 0.939 . . . . 0.0 112.448 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -140.99 -167.92 2.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.418 1.487 . . . . 0.0 109.7 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m 57.3 68.82 1.85 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.228 1.411 . . . . 0.0 112.31 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.77 -16.47 37.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.429 2.086 . . . . 0.0 113.386 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -73.67 142.32 80.45 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.619 1.168 . . . . 0.0 110.005 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.93 154.07 53.04 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.29 1.993 . . . . 0.0 109.641 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.0 m -55.62 -34.85 65.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.846 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 p -52.91 -60.3 3.45 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.081 0.952 . . . . 0.0 110.82 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -61.32 -38.43 86.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.611 1.164 . . . . 0.0 111.503 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.06 -51.67 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.28 -44.22 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 109.231 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -42.8 89.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.051 0.541 . . . . 0.0 110.131 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -68.09 -45.79 72.78 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.569 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.3 -50.38 59.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.447 0.567 . . . . 0.0 110.855 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.16 -19.94 59.61 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -71.68 -28.35 63.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.984 1.266 . . . . 0.0 108.904 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 mt -88.54 -16.38 32.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.06 0.944 . . . . 0.0 111.869 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.92 129.43 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 119.65 1.114 . . . . 0.0 108.895 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.15 -3.37 86.85 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -84.2 164.1 19.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.604 1.702 . . . . 0.0 109.344 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -123.92 148.48 46.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.781 -168.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.56 161.13 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.234 1.014 . . . . 0.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.05 32.28 5.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.437 1.113 . . . . 0.0 111.561 -168.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -132.86 147.23 52.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.218 1.407 . . . . 0.0 109.265 170.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -67.92 166.02 16.51 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.787 2.035 . . . . 0.0 111.587 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 mt -69.51 127.55 33.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 167.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 73.1 p -144.22 151.58 39.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 166.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -36.33 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 122.168 -0.332 . . . . 0.0 110.915 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -71.76 -40.18 69.49 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.728 0.411 . . . . 0.0 110.567 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.6 -40.73 92.97 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.865 0.757 . . . . 0.0 110.239 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.4 m -64.82 -45.27 86.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.099 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.69 -45.02 93.36 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.182 0.447 . . . . 0.0 110.143 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -59.39 -50.21 74.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.586 1.154 . . . . 0.0 109.718 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -59.69 -52.41 65.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.102 0.41 . . . . 0.0 111.392 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -64.65 -32.5 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.895 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.24 -36.37 81.51 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.698 -0.626 . . . . 0.0 111.077 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.19 -46.5 62.17 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.242 1.017 . . . . 0.0 109.661 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.26 -46.26 70.93 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.158 0.583 . . . . 0.0 111.346 -177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -76.98 -33.85 57.59 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.89 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -94.13 -48.26 6.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.028 0.376 . . . . 0.0 110.881 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.86 -51.41 0.6 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.17 128.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -147.25 160.19 42.78 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.747 1.219 . . . . 0.0 108.364 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.31 150.68 84.19 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 122.688 0.395 . . . . 0.0 110.678 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.36 -175.5 2.45 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.022 2.481 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 pt -130.95 59.49 46.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.407 1.883 . . . . 0.0 108.312 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.66 -49.32 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.415 2.076 . . . . 0.0 112.605 -167.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -166.17 71.26 1.2 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.637 1.575 . . . . 0.0 109.842 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.89 143.5 59.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.338 2.025 . . . . 0.0 111.259 170.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -133.49 155.76 80.33 Favored Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 124.979 1.312 . . . . 0.0 108.973 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.31 131.74 18.62 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.363 2.708 . . . . 0.0 112.529 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.68 84.09 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.899 1.238 . . . . 0.0 113.036 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.37 143.74 48.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 120.288 2.044 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -71.84 131.27 42.79 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -114.96 145.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.91 143.7 49.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 117.04 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.07 138.27 43.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -117.19 167.21 11.28 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.379 1.472 . . . . 0.0 107.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.92 -24.9 33.47 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.018 2.479 . . . . 0.0 115.754 -174.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -141.4 4.85 1.81 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.191 0.996 . . . . 0.0 113.209 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -158.22 -158.25 0.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.976 0.91 . . . . 0.0 110.199 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -153.09 141.27 20.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -127.46 165.31 20.06 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.416 1.486 . . . . 0.0 107.607 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -128.95 145.94 51.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.352 0.524 . . . . 0.0 110.008 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 169.86 22.23 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.951 1.7 . . . . 0.0 108.531 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt -140.46 126.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 121.368 -0.832 . . . . 0.0 109.534 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -72.24 132.11 43.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.062 1.345 . . . . 0.0 110.015 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.55 166.55 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.24 1.416 . . . . 0.0 108.873 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.04 21.5 38.63 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.531 -0.731 . . . . 0.0 114.255 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t0 39.26 50.66 1.97 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.869 2.068 . . . . 0.0 113.514 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.1 -11.55 0.1 OUTLIER Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.925 -0.484 . . . . 0.0 113.546 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.17 170.62 7.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.696 1.198 . . . . 0.0 108.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.84 148.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.402 0.681 . . . . 0.0 109.639 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.56 136.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 171.67 18.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.413 0.551 . . . . 0.0 111.019 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 151.12 36.76 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 158.1 64.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.501 2.32 . . . . 0.0 107.676 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.47 153.95 71.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 110.938 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.69 -21.81 18.64 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.906 2.404 . . . . 0.0 111.703 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.08 164.54 15.22 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.998 2.119 . . . . 0.0 112.768 -172.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -150.87 162.88 39.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 t -50.56 -29.65 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.266 1.426 . . . . 0.0 112.646 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.39 162.01 41.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.649 1.18 . . . . 0.0 108.975 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.96 -71.16 1.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.088 1.328 . . . . 0.0 111.876 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.67 -5.87 56.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.804 0.842 . . . . 0.0 112.259 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.8 -161.69 28.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.42 7.13 8.98 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 111.17 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 152.71 19.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.304 2.241 . . . . 0.0 106.057 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 m -82.3 33.25 0.4 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 111.637 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.25 172.29 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.441 1.496 . . . . 0.0 109.387 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.3 mmt -66.57 16.07 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -58.96 -36.68 75.23 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.433 -1.417 . . . . 0.0 109.55 167.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.97 51.17 1.98 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.795 1.238 . . . . 0.0 109.725 169.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.8 tp -48.34 118.29 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.495 1.518 . . . . 0.0 110.59 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -147.79 153.42 39.18 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.31 55.98 3.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.582 1.182 . . . . 0.0 109.528 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.39 164.49 29.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.171 1.788 . . . . 0.0 108.724 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.79 13.1 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.823 0.849 . . . . 0.0 109.35 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -134.01 158.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.29 132.22 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -136.67 169.05 18.36 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.059 0.944 . . . . 0.0 109.79 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.59 133.02 54.56 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -148.55 161.19 42.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.209 1.403 . . . . 0.0 107.753 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.15 133.26 47.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.13 -43.83 74.49 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.684 0.674 . . . . 0.0 110.678 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -65.07 -21.58 66.84 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.81 -46.06 19.55 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.897 0.771 . . . . 0.0 110.238 171.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.03 -40.11 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 110.294 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.1 -20.73 59.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.964 1.305 . . . . 0.0 112.512 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.35 -12.5 25.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.59 1.091 . . . . 0.0 113.226 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.7 m -50.34 -48.93 55.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.119 . . . . 0.0 110.915 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -167.84 -61.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.264 1.826 . . . . 0.0 109.239 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -160.92 171.31 18.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.149 2.179 . . . . 0.0 107.126 -167.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -153.36 164.01 38.9 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.571 -0.706 . . . . 0.0 110.607 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -138.77 158.01 45.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.881 1.672 . . . . 0.0 109.851 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 130.93 40.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -148.8 70.86 1.12 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -69.12 88.3 0.42 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -64.93 119.84 11.45 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.21 53.06 9.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.794 1.638 . . . . 0.0 111.786 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -51.86 -20.66 2.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.987 1.315 . . . . 0.0 113.248 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.71 -27.12 31.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -100.64 -20.32 15.7 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.024 0.929 . . . . 0.0 111.339 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -129.93 -174.09 3.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.765 0.793 . . . . 0.0 112.7 -168.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 52.51 62.71 9.9 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.531 1.932 . . . . 0.0 113.919 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 -12.14 28.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.462 2.108 . . . . 0.0 113.732 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.97 142.74 97.56 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.424 1.089 . . . . 0.0 110.594 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.92 142.48 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.165 1.91 . . . . 0.0 108.944 167.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -54.21 -43.2 70.57 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.443 0.297 . . . . 0.0 111.401 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.71 -44.73 73.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.138 0.975 . . . . 0.0 112.1 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -63.32 -34.37 77.55 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 124.203 1.001 . . . . 0.0 111.591 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.5 -48.36 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.69 -47.22 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -44.61 81.87 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.412 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -60.71 -52.98 62.79 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.294 0.952 . . . . 0.0 109.367 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.36 60.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.664 0.386 . . . . 0.0 111.189 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.82 -16.69 50.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.6 -29.02 56.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 119.904 1.229 . . . . 0.0 109.073 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.57 -11.71 44.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.972 0.909 . . . . 0.0 111.852 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -56.13 129.88 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.592 1.087 . . . . 0.0 108.925 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.29 -0.04 89.89 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.403 -1.221 . . . . 0.0 112.984 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -86.57 166.01 15.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.292 1.546 . . . . 0.0 109.4 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -120.55 149.51 42.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.319 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.17 147.16 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.706 1.202 . . . . 0.0 108.221 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.72 39.8 1.62 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.731 1.253 . . . . 0.0 111.153 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -141.08 149.72 41.99 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.469 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -60.28 148.54 36.37 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.947 1.299 . . . . 0.0 110.187 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 54.24 0.28 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.758 1.623 . . . . 0.0 113.266 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.8 p -64.26 161.69 16.12 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.655 -1.278 . . . . 0.0 109.206 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.56 -44.67 62.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.128 0.971 . . . . 0.0 110.309 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.67 -41.33 75.63 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.84 0.856 . . . . 0.0 110.893 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.42 -29.02 65.51 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.143 0.883 . . . . 0.0 111.294 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.7 m -69.87 -42.52 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.223 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.16 -43.98 95.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.346 0.521 . . . . 0.0 110.021 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -57.15 -58.23 9.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.032 1.733 . . . . 0.0 109.493 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.39 -54.88 30.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.754 0.421 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.02 -27.37 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.405 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -70.24 -29.4 66.19 Favored 'General case' 0 C--N 1.338 0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 111.144 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.0 -23.47 63.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.445 1.02 . . . . 0.0 112.094 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.88 -47.78 7.66 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.62 1.1 . . . . 0.0 110.115 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -86.54 -45.59 10.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.451 0.568 . . . . 0.0 112.221 -172.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -83.46 -48.32 10.44 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.54 -25.14 3.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.033 0.825 . . . . 0.0 111.634 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.42 149.91 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.38 169.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 40.67 45.24 1.99 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.455 1.902 . . . . 0.0 113.804 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.52 147.5 76.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 0.0 110.334 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.75 177.47 6.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.433 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 pt -121.67 74.19 33.83 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.343 1.457 . . . . 0.0 107.725 170.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -21.13 26.83 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.735 2.29 . . . . 0.0 112.63 -171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 44.8 mt-10 -131.57 -39.74 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.184 -1.389 . . . . 0.0 113.303 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.435 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 39.9 Cg_exo -57.43 137.35 81.11 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.396 2.064 . . . . 0.0 111.259 172.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.29 146.88 34.89 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.98 140.12 24.53 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.693 2.262 . . . . 0.0 110.983 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.36 -10.83 71.04 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.1 1.333 . . . . 0.0 112.313 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.89 156.09 23.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.31 2.055 . . . . 0.0 110.652 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.1 139.02 41.15 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.06 141.85 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.53 151.54 39.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -122.79 110.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.86 100.69 2.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -80.33 166.47 39.8 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.273 1.029 . . . . 0.0 108.919 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -51.01 -30.81 32.32 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.478 2.785 . . . . 0.0 116.379 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -145.55 14.71 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.094 0.957 . . . . 0.0 112.213 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -155.81 -159.2 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.892 1.277 . . . . 0.0 108.717 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.4 159.5 43.62 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.773 -1.204 . . . . 0.0 109.938 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -132.37 168.0 18.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.929 1.291 . . . . 0.0 107.612 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -137.37 147.27 45.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.804 0.729 . . . . 0.0 110.694 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.37 174.83 14.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.988 1.715 . . . . 0.0 108.569 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.18 131.64 58.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.66 130.09 41.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.098 1.359 . . . . 0.0 108.795 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.84 165.3 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 109.065 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.51 -158.36 18.25 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.91 -29.53 55.74 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.942 -0.74 . . . . 0.0 112.221 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.99 26.97 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.896 0.76 . . . . 0.0 113.359 -173.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -100.58 170.55 8.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.141 0.97 . . . . 0.0 109.394 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.72 153.28 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.229 0.612 . . . . 0.0 109.635 168.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.88 137.72 29.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.12 169.03 25.12 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.983 -0.448 . . . . 0.0 110.932 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.57 138.7 34.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.13 160.07 56.45 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 125.076 1.351 . . . . 0.0 109.536 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.88 145.16 24.98 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.328 2.685 . . . . 0.0 111.757 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.47 -46.46 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.857 1.705 . . . . 0.0 111.554 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -139.5 25.96 2.38 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.225 1.01 . . . . 0.0 111.084 -170.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 51.71 40.84 28.34 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.481 1.512 . . . . 0.0 111.584 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -49.76 -19.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 128.239 2.616 . . . . 0.0 115.664 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.94 27.53 2.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.265 1.026 . . . . 0.0 110.361 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.07 -27.5 0.06 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.112 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.99 -25.5 67.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.01 1.405 . . . . 0.0 112.561 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.46 -36.98 1.24 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.538 1.542 . . . . 0.0 109.311 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.02 164.01 11.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.179 0.991 . . . . 0.0 110.194 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.21 165.78 35.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.923 1.289 . . . . 0.0 108.556 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.1 m -62.88 3.77 0.21 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.73 1.612 . . . . 0.0 114.111 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -62.21 -19.89 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.842 0.857 . . . . 0.0 111.131 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.43 -168.66 2.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.014 1.726 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -52.78 -12.52 0.31 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.459 2.304 . . . . 0.0 116.662 -169.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.38 60.14 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.616 1.098 . . . . 0.0 111.948 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 tp -49.05 116.26 1.6 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.043 1.337 . . . . 0.0 108.818 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -148.26 162.8 38.76 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.037 1.735 . . . . 0.0 106.709 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -133.35 21.41 4.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.751 0.82 . . . . 0.0 112.405 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -97.13 173.8 7.06 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.907 1.683 . . . . 0.0 110.71 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.41 169.09 18.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.185 1.394 . . . . 0.0 108.128 166.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.78 146.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 t -85.51 122.25 38.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -127.25 165.82 18.93 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.309 1.044 . . . . 0.0 109.715 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -125.69 131.29 52.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -148.38 163.57 36.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.014 1.326 . . . . 0.0 107.787 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.69 140.18 58.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.14 -42.7 73.4 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -60.46 -29.77 69.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.964 0.906 . . . . 0.0 112.062 -173.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.43 -40.07 27.02 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.21 0.459 . . . . 0.0 110.838 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.68 -37.59 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.335 0.654 . . . . 0.0 109.826 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.54 30.7 0.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.026 1.731 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.81 -23.58 30.5 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.072 0.844 . . . . 0.0 112.918 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 -4.54 5.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.887 1.675 . . . . 0.0 113.654 171.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.4 t70 61.49 16.46 7.59 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 114.576 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -149.46 124.62 10.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.888 1.675 . . . . 0.0 108.739 -169.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -164.8 164.31 21.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -155.77 161.56 40.65 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.599 0.76 . . . . 0.0 110.865 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.61 138.17 22.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -145.85 66.18 1.21 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.31 0.576 . . . . 0.0 109.935 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.38 131.78 38.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 122.896 0.478 . . . . 0.0 110.469 169.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -103.77 3.02 33.61 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.519 ' C ' ' H ' ' A' ' 82' ' ' ASP . 75.7 m-70 -132.2 23.5 4.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.847 0.859 . . . . 0.0 112.088 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.07 21.31 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.044 -1.035 . . . . 0.0 112.593 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 80' ' ' HIS . 37.9 t70 -127.36 -9.33 5.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 111.611 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -127.6 -31.85 2.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.084 1.354 . . . . 0.0 111.609 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 66.21 134.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 128.605 2.762 . . . . 0.0 115.728 173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -61.0 136.76 93.79 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.914 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.43 -16.76 34.78 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.599 2.199 . . . . 0.0 111.862 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.08 125.38 35.4 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 108.235 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.17 154.63 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.812 2.341 . . . . 0.0 111.374 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.26 -38.86 69.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.327 0.651 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -54.96 -53.15 59.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.905 0.882 . . . . 0.0 110.498 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.81 -34.78 78.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.161 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.8 -50.83 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.061 0.846 . . . . 0.0 108.889 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.29 -45.6 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 123.536 0.734 . . . . 0.0 109.112 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -64.37 -46.56 82.84 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.85 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.29 -51.92 55.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.692 0.678 . . . . 0.0 110.405 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.82 -21.72 59.13 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.7 mt -99.14 -4.13 32.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 112.476 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.75 150.71 8.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.341 1.056 . . . . 0.0 109.344 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.67 53.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.313 -0.715 . . . . 0.0 112.269 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -124.06 159.98 28.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.585 1.154 . . . . 0.0 108.071 171.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -109.6 153.45 24.17 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.312 1.445 . . . . 0.0 109.53 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.07 152.29 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.374 1.47 . . . . 0.0 107.353 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.58 8.22 44.62 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.835 0.454 . . . . 0.0 112.224 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -95.42 147.11 23.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -74.12 162.87 28.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.446 1.098 . . . . 0.0 111.799 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.08 125.33 23.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.6 p -145.75 154.53 42.15 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 167.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.1 m -55.94 -34.37 65.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.817 0.447 . . . . 0.0 111.206 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.97 -38.61 44.72 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.451 0.701 . . . . 0.0 111.174 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -68.24 -35.77 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.528 1.058 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -66.34 -47.7 72.64 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -56.27 -44.63 79.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.319 1.048 . . . . 0.0 110.377 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -57.73 -56.79 17.43 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.018 1.327 . . . . 0.0 109.135 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.68 -48.1 82.24 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.1 -29.35 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.543 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -73.36 -30.53 63.37 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.712 0.687 . . . . 0.0 111.64 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.88 -37.9 80.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.305 0.957 . . . . 0.0 110.09 170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.16 -50.14 24.27 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.683 0.674 . . . . 0.0 110.243 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -64.8 -26.37 68.31 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.066 0.946 . . . . 0.0 112.349 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.77 3.28 1.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -168.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.38 -32.52 5.44 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.853 -1.154 . . . . 0.0 111.876 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -155.39 146.63 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.023 1.329 . . . . 0.0 107.576 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.277 0.631 . . . . 0.0 110.727 172.306 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 64.23 -38.41 0.21 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.199 2.6 . . . . 0.0 115.355 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.73 72.51 77.35 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 109.54 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.12 -12.38 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.08 2.52 . . . . 0.0 113.943 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mm 57.05 68.58 2.01 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.769 1.628 . . . . 0.0 109.197 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.73 -23.96 16.19 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.312 2.008 . . . . 0.0 112.584 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 44.1 mt-10 -142.3 -36.8 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.824 -171.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 27.9 Cg_exo -59.49 155.39 41.95 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.135 1.89 . . . . 0.0 113.421 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.04 55.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 109.026 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.62 135.74 27.24 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.769 2.313 . . . . 0.0 111.646 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.18 -13.61 57.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.321 1.439 . . . . 0.0 111.714 -169.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.21 142.86 32.78 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.144 1.472 . . . . 0.0 111.312 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.18 140.55 45.2 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.31 129.19 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.08 147.65 25.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.49 103.68 12.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -168.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.45 141.64 57.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.06 168.61 13.01 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.503 1.521 . . . . 0.0 107.935 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.86 -27.96 17.06 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.512 2.808 . . . . 0.0 117.059 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -145.8 13.78 1.34 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.609 0.764 . . . . 0.0 112.021 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.32 -163.86 1.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.511 1.124 . . . . 0.0 109.475 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.413 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -144.11 159.72 42.15 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.214 -0.929 . . . . 0.0 109.931 173.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -131.2 170.69 14.23 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.613 2.365 . . . . 0.0 107.046 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.413 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 77.9 m95 -136.49 146.27 46.09 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.935 0.789 . . . . 0.0 111.448 -174.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.19 172.42 14.35 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.127 2.171 . . . . 0.0 108.046 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.8 tt -137.4 133.36 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.65 127.71 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.16 -3.96 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.03 -175.19 34.67 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.09 -28.09 66.18 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.87 0.835 . . . . 0.0 113.072 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.9 13.22 1.13 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.216 -1.324 . . . . 0.0 114.136 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -117.31 153.19 33.4 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.963 1.881 . . . . 0.0 111.516 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 m -132.16 155.05 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.061 1.345 . . . . 0.0 110.073 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.1 142.3 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 167.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.4 173.62 14.66 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.276 0.631 . . . . 0.0 110.73 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.6 141.72 33.45 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.62 157.95 66.85 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.54 1.936 . . . . 0.0 107.427 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 151.49 69.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.181 1.457 . . . . 0.0 110.51 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.68 -25.97 68.8 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.211 1.941 . . . . 0.0 111.367 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -52.25 -24.2 6.94 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.282 2.233 . . . . 0.0 113.859 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -82.93 2.71 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 t -141.84 -54.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.587 1.155 . . . . 0.0 111.205 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.38 16.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.56 0.744 . . . . 0.0 111.836 -168.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.94 171.09 43.69 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.62 -22.95 66.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.004 0.521 . . . . 0.0 112.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 -173.85 46.47 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 126.273 1.892 . . . . 0.0 108.545 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.13 111.81 2.37 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 153.24 42.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.289 0.636 . . . . 0.0 110.38 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -62.43 -45.75 91.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.051 0.94 . . . . 0.0 110.119 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -144.38 152.6 15.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.289 2.236 . . . . 0.0 106.169 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -57.86 -25.66 61.01 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 m -56.16 -30.48 62.25 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.433 1.093 . . . . 0.0 112.504 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.07 -6.72 47.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 112.806 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.1 tp -128.62 -18.55 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.907 1.283 . . . . 0.0 111.605 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 m -105.74 5.49 31.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.777 1.275 . . . . 0.0 110.08 -172.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.8 19.37 4.8 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.858 2.063 . . . . 0.0 111.561 169.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -136.31 171.24 14.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 129.336 3.054 . . . . 0.0 107.871 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.9 168.91 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.594 0.712 . . . . 0.0 111.304 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 pt -147.11 154.97 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.918 1.687 . . . . 0.0 106.692 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.42 129.7 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -135.44 159.0 42.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.279 1.432 . . . . 0.0 107.954 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -127.38 131.25 50.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -151.54 163.36 39.21 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.784 1.233 . . . . 0.0 108.893 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.21 131.78 45.99 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.61 -40.87 66.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 110.963 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -61.92 -27.92 69.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.873 0.469 . . . . 0.0 111.638 -171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.71 -45.15 46.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.469 0.577 . . . . 0.0 110.402 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 t -64.17 -39.48 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.615 0.766 . . . . 0.0 109.757 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.64 -11.77 19.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.267 1.427 . . . . 0.0 113.169 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.16 -10.43 65.54 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.655 1.116 . . . . 0.0 113.071 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 -54.22 47.77 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.646 1.223 . . . . 0.0 112.339 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.23 -49.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.661 1.584 . . . . 0.0 110.145 169.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -166.73 -176.12 3.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.863 2.065 . . . . 0.0 107.673 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -152.02 165.45 34.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.54 1.064 . . . . 0.0 110.282 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -148.38 147.32 29.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.243 1.417 . . . . 0.0 109.089 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.03 132.01 33.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -149.83 73.04 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.5 101.96 1.07 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -59.23 124.52 20.24 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 m80 46.31 42.26 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 113.206 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -59.4 -10.82 3.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.562 0.745 . . . . 0.0 112.499 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.17 -17.87 26.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.971 2.109 . . . . 0.0 111.427 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -131.09 -16.83 3.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.074 0.95 . . . . 0.0 112.357 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.35 -161.07 1.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.186 1.794 . . . . 0.0 108.372 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 66.39 2.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.859 1.664 . . . . 0.0 112.953 -170.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.55 -22.18 58.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.571 2.181 . . . . 0.0 114.441 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.14 141.17 39.98 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 111.264 -168.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.15 161.85 39.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.64 2.227 . . . . 0.0 109.762 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 65.1 m -52.4 -40.96 62.74 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.634 0.774 . . . . 0.0 111.682 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.44 -54.23 43.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.293 0.637 . . . . 0.0 111.103 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.37 -37.98 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.337 1.055 . . . . 0.0 111.695 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.29 -49.26 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.39 -46.21 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.683 0.793 . . . . 0.0 108.861 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -43.89 86.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.085 0.554 . . . . 0.0 110.113 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.95 -50.73 69.66 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.23 67.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.562 0.345 . . . . 0.0 111.107 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.94 -20.84 55.65 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.213 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -69.0 -35.5 76.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.74 1.155 . . . . 0.0 109.486 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.38 -10.15 52.86 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.4 133.73 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.516 1.053 . . . . 0.0 109.063 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.0 -8.07 76.3 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.484 -1.176 . . . . 0.0 112.88 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -71.89 157.58 37.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.453 1.626 . . . . 0.0 109.264 171.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -126.58 144.23 50.96 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.44 146.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.055 0.942 . . . . 0.0 110.35 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.46 -9.87 42.97 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.228 -0.92 . . . . 0.0 112.924 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -75.67 154.61 36.41 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.556 0.616 . . . . 0.0 110.498 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -81.37 158.38 24.69 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.871 1.668 . . . . 0.0 110.022 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.72 121.35 11.43 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.5 p -143.68 159.02 43.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -52.49 -45.33 66.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.799 0.44 . . . . 0.0 109.904 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.79 -46.34 79.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.939 0.896 . . . . 0.0 110.827 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -67.33 -41.41 85.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.65 0.659 . . . . 0.0 110.722 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.17 -41.62 81.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.265 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -61.1 -40.6 94.38 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.199 0.6 . . . . 0.0 110.394 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -63.82 -55.76 20.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 110.138 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -57.59 -48.41 79.46 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.327 0.512 . . . . 0.0 110.883 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.4 -30.95 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.48 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -72.45 -25.55 61.49 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.422 -0.799 . . . . 0.0 111.817 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.35 -38.92 69.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.184 0.902 . . . . 0.0 110.319 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.4 mt -74.39 -43.42 56.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.355 0.662 . . . . 0.0 110.2 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 tpt85 -72.58 -31.98 65.65 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.527 -172.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -104.02 -36.46 7.73 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.037 0.535 . . . . 0.0 112.125 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.73 -37.17 3.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.972 1.273 . . . . 0.0 110.599 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.18 135.28 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 123.078 0.551 . . . . 0.0 110.71 -179.698 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -149.92 171.4 16.86 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.673 1.189 . . . . 0.0 109.343 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.68 140.27 80.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.412 0.685 . . . . 0.0 111.764 -170.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.97 -179.67 5.42 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.626 2.884 . . . . 0.0 111.746 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.31 73.64 72.9 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.804 1.642 . . . . 0.0 107.653 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.08 -40.1 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.361 2.041 . . . . 0.0 112.366 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.06 45.22 0.19 Allowed Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.513 1.125 . . . . 0.0 113.084 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -59.97 130.49 34.88 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.385 1.53 . . . . 0.0 109.823 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -83.91 144.09 44.24 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.07 129.33 24.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 109.745 169.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.83 3.86 67.93 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.308 0.956 . . . . 0.0 113.205 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.1 136.19 48.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.663 1.732 . . . . 0.0 110.216 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.48 138.04 54.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.92 133.5 66.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -104.65 146.37 29.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -127.48 115.35 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 -169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.35 140.21 46.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -128.66 167.72 18.31 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.982 0.913 . . . . 0.0 109.718 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.33 -26.79 36.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.19 2.593 . . . . 0.0 116.576 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -143.24 6.73 1.53 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.293 1.037 . . . . 0.0 112.942 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -160.97 -168.66 2.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.949 -169.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.43 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 7.1 ppt_? -136.24 161.03 36.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 121.65 -0.656 . . . . 0.0 109.44 169.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -137.09 169.09 18.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.343 1.857 . . . . 0.0 107.986 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.43 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 67.2 m95 -138.7 148.35 43.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.624 0.769 . . . . 0.0 110.591 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 174.97 11.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.321 1.848 . . . . 0.0 107.934 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.13 134.0 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.43 133.23 48.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.075 1.35 . . . . 0.0 109.009 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 m -139.0 165.8 23.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.123 0.969 . . . . 0.0 109.967 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.44 -121.07 18.72 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.354 -2.299 . . . . 0.0 107.354 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -146.06 51.24 1.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.52 -12.16 0.11 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.164 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.77 171.68 8.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.531 1.166 . . . . 0.0 109.101 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.23 157.35 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.194 0.998 . . . . 0.0 110.052 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.98 138.19 48.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 168.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 169.47 22.79 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.082 0.953 . . . . 0.0 110.396 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.85 140.46 32.89 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.52 163.66 23.31 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.672 1.189 . . . . 0.0 109.326 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.28 156.31 30.94 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.567 2.178 . . . . 0.0 112.134 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -55.25 132.89 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.034 2.489 . . . . 0.0 110.247 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -64.2 -19.27 65.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.53 12.63 10.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.612 0.765 . . . . 0.0 111.756 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.257 15.4 m 47.24 -39.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.61 1 C-N-CA 131.765 4.026 . . . . 0.0 118.633 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 166.68 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.592 1.542 . . . . 0.0 110.21 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.23 21.48 0.15 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.044 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.78 158.33 39.32 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.17 1.388 . . . . 0.0 108.615 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.32 -13.78 58.65 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.077 0.846 . . . . 0.0 113.425 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -8.69 23.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.576 1.151 . . . . 0.0 113.078 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.19 166.58 23.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.085 1.354 . . . . 0.0 109.746 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.3 m -138.18 40.86 2.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.866 1.267 . . . . 0.0 110.286 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.265 28.6 m 51.05 18.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 127.439 2.296 . . . . 0.0 114.79 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -10.73 59.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.882 1.273 . . . . 0.0 112.515 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.07 17.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.735 2.014 . . . . 0.0 115.964 -168.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.26 -27.88 64.42 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.093 -1.005 . . . . 0.0 109.877 168.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 tp -149.52 131.0 14.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.31 172.16 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -174.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.33 26.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -136.7 161.9 34.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.878 2.471 . . . . 0.0 108.628 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.11 172.96 13.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.752 1.221 . . . . 0.0 109.108 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.12 150.26 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -83.21 132.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -137.23 164.9 27.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.291 1.436 . . . . 0.0 109.525 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -125.62 141.31 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -149.92 156.46 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.779 1.232 . . . . 0.0 107.923 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.57 137.47 52.4 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -52.06 -37.74 54.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -36.27 61.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.217 0.607 . . . . 0.0 112.147 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.92 -35.26 80.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.689 0.396 . . . . 0.0 111.315 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -86.67 -41.58 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.878 0.871 . . . . 0.0 109.017 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.42 -21.83 65.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.359 1.064 . . . . 0.0 112.725 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.14 -11.12 24.56 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.545 -1.142 . . . . 0.0 113.728 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.9 m -56.05 -55.49 32.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.956 1.378 . . . . 0.0 111.787 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -166.57 -60.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.323 1.449 . . . . 0.0 110.398 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -159.36 173.74 15.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.275 1.43 . . . . 0.0 108.765 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -162.63 160.53 25.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -154.56 162.58 41.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.622 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.62 138.75 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -152.39 73.75 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.436 0.694 . . . . 0.0 109.587 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.24 92.32 0.41 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.96 131.97 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 49.28 34.93 6.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.842 1.657 . . . . 0.0 113.336 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.98 -9.29 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.081 0.952 . . . . 0.0 112.773 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.98 -27.82 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.483 1.113 . . . . 0.0 110.628 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -127.87 -21.78 3.64 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -108.47 -160.07 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.504 1.522 . . . . 0.0 110.023 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 59.35 59.61 4.94 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.22 1.808 . . . . 0.0 112.517 -169.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.29 -13.2 38.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.0 1.8 . . . . 0.0 113.528 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.2 130.54 33.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.169 0.988 . . . . 0.0 110.673 -169.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 156.91 17.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.119 2.546 . . . . 0.0 111.302 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.06 -48.55 52.95 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.154 0.982 . . . . 0.0 111.28 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -57.34 -45.65 84.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.335 1.054 . . . . 0.0 111.966 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.5 -33.31 75.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.314 0.646 . . . . 0.0 111.313 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.79 -44.22 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.17 -45.19 99.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.644 0.656 . . . . 0.0 109.702 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -54.67 -44.39 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.517 0.727 . . . . 0.0 110.372 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -61.9 -52.01 65.82 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.095 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.98 78.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.654 0.661 . . . . 0.0 111.442 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -71.83 -25.64 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.907 1.283 . . . . 0.0 112.255 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.94 -20.2 42.54 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.436 1.095 . . . . 0.0 109.948 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.9 -13.98 12.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -167.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.37 146.11 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 120.089 1.313 . . . . 0.0 110.27 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 -4.17 84.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.964 1.269 . . . . 0.0 113.605 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.67 154.05 38.63 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.172 1.486 . . . . 0.0 108.779 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.43 147.59 27.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.62 151.49 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.764 1.225 . . . . 0.0 109.586 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.25 32.66 4.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.989 0.899 . . . . 0.0 111.462 -168.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -123.09 146.71 47.48 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.152 1.381 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -62.59 159.17 16.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.37 1.868 . . . . 0.0 112.316 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.9 121.85 16.01 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 165.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.7 p -142.62 156.34 45.06 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.5 m -51.37 -41.82 60.93 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.681 0.793 . . . . 0.0 110.814 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -72.46 -41.79 65.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.443 1.097 . . . . 0.0 111.368 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -40.3 85.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.2 0.909 . . . . 0.0 110.343 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.53 -45.52 79.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.016 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -56.75 -46.6 81.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.629 0.772 . . . . 0.0 110.111 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -59.14 -53.73 54.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.82 0.848 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.17 -48.62 80.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -64.35 -30.61 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.469 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -70.75 -29.12 65.27 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.663 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 72.3 mt-10 -61.33 -34.6 75.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.829 1.195 . . . . 0.0 110.489 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.5 mt -75.5 -46.64 31.14 Favored 'General case' 0 C--O 1.228 -0.036 0 CA-C-N 118.693 0.679 . . . . 0.0 110.23 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -64.33 -40.63 96.27 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 122.981 0.512 . . . . 0.0 110.96 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.22 -33.06 10.58 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.55 -42.12 1.92 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -168.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.93 135.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.21 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -151.07 168.26 25.17 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.719 1.207 . . . . 0.0 108.009 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.89 150.15 61.46 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.5 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -67.69 176.37 5.17 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.971 2.447 . . . . 0.0 110.248 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mm -81.19 116.69 64.31 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.01 -38.39 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.769 1.646 . . . . 0.0 114.481 -166.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.12 -48.27 3.45 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.72 173.22 13.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.655 2.236 . . . . 0.0 111.898 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.43 144.78 50.6 Favored Pre-proline 0 N--CA 1.464 0.235 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.67 131.47 19.93 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.513 2.142 . . . . 0.0 110.718 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.04 27.43 7.82 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.678 1.132 . . . . 0.0 111.28 -168.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -123.19 148.0 46.26 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.701 1.751 . . . . 0.0 110.387 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.29 137.1 35.81 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.15 131.11 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.88 151.12 22.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mm -126.65 106.43 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.57 138.5 48.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.14 166.89 20.95 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.873 0.869 . . . . 0.0 109.169 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.51 -35.65 29.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.401 2.734 . . . . 0.0 116.174 -169.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -140.29 12.59 2.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.448 1.099 . . . . 0.0 112.065 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -160.18 -168.82 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.249 1.02 . . . . 0.0 110.179 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.417 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -138.07 153.91 49.29 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.156 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -135.28 170.55 15.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.4 1.88 . . . . 0.0 107.461 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.417 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 81.8 m95 -137.64 148.62 45.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.451 0.7 . . . . 0.0 111.515 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.28 171.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.142 1.777 . . . . 0.0 108.42 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.4 127.59 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -76.13 127.42 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.3 1.84 . . . . 0.0 108.306 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -139.08 1.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 -172.29 22.18 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.94 -29.01 70.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.243 1.022 . . . . 0.0 112.479 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.14 11.2 1.03 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.555 1.074 . . . . 0.0 113.268 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.92 153.11 23.01 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.037 1.419 . . . . 0.0 110.733 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.53 154.34 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 109.831 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.31 141.78 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 167.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.38 169.78 22.39 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.866 -0.521 . . . . 0.0 110.724 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.52 138.51 34.28 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.95 164.84 31.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 108.104 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.58 155.7 51.7 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.781 1.654 . . . . 0.0 110.824 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.46 139.07 62.97 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.27 1.98 . . . . 0.0 110.806 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -73.43 -14.49 61.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.854 0.861 . . . . 0.0 112.424 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.06 134.98 57.56 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.43 1.092 . . . . 0.0 110.049 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.26 169.12 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 110.371 174.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.78 -38.96 36.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.077 1.351 . . . . 0.0 112.042 175.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.78 -16.69 18.23 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.274 0.94 . . . . 0.0 114.45 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.0 18.38 3.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.198 1.399 . . . . 0.0 111.476 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.24 26.95 0.07 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.671 -171.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 155.4 20.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.85 1.325 . . . . 0.0 111.041 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.24 -24.26 63.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.49 0.716 . . . . 0.0 112.594 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m 59.32 13.99 3.44 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.428 1.491 . . . . 0.0 113.55 -170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -143.21 169.63 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.574 1.949 . . . . 0.0 107.588 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -66.32 -36.55 83.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.878 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.5 m -64.59 158.48 24.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.768 1.227 . . . . 0.0 111.091 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.21 36.29 0.15 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.695 1.198 . . . . 0.0 111.961 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.1 tp -58.91 121.07 10.26 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.847 1.259 . . . . 0.0 109.546 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -144.53 152.89 41.23 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -147.12 25.6 1.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.864 0.84 . . . . 0.0 112.721 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -136.19 160.24 39.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.799 1.24 . . . . 0.0 109.052 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.75 169.18 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.17 1.388 . . . . 0.0 109.123 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mt -135.82 144.12 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.94 121.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 163.03 19.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.467 1.507 . . . . 0.0 108.109 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.43 128.73 44.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -149.89 160.09 43.86 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.408 1.083 . . . . 0.0 108.642 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.56 133.9 49.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -54.69 -40.91 69.61 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.58 0.752 . . . . 0.0 111.902 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -61.03 -29.9 70.0 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.663 0.385 . . . . 0.0 111.898 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.55 -46.02 41.71 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.209 0.459 . . . . 0.0 110.277 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.14 -42.33 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.753 0.821 . . . . 0.0 109.908 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 -6.56 52.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.236 1.415 . . . . 0.0 113.28 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.27 -10.46 52.76 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.414 -0.659 . . . . 0.0 113.395 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 p -60.94 -43.75 98.21 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.76 1.224 . . . . 0.0 112.181 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -159.3 -58.56 0.07 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.296 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -166.05 -174.42 2.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.578 1.551 . . . . 0.0 108.853 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -154.64 167.87 28.68 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.201 1.001 . . . . 0.0 109.383 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -155.54 156.8 35.79 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.805 0.842 . . . . 0.0 109.958 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.04 138.77 21.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -148.22 71.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -68.58 81.7 0.27 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.22 1.008 . . . . 0.0 108.547 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -56.81 125.65 23.38 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 47.04 44.88 15.46 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.675 1.59 . . . . 0.0 112.528 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.76 -13.96 1.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 170.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.59 -15.61 25.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.159 1.383 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -123.6 -19.92 5.68 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.194 0.998 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -140.48 -167.65 2.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.111 1.364 . . . . 0.0 109.643 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m 52.15 60.38 13.51 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.91 1.284 . . . . 0.0 112.247 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.9 -12.54 34.7 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.395 2.064 . . . . 0.0 113.9 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.07 133.57 83.68 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 124.175 0.99 . . . . 0.0 110.72 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.55 145.46 69.36 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.201 1.934 . . . . 0.0 108.881 166.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.4 m -55.0 -39.38 69.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -170.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 p -54.88 -44.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.502 1.121 . . . . 0.0 112.14 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -63.5 -32.09 73.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.646 0.778 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.53 -46.09 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.0 -49.03 84.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -55.66 -43.24 76.12 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.866 0.867 . . . . 0.0 110.857 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -60.17 -55.65 31.2 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.83 -41.38 67.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -74.29 -24.89 59.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.369 1.068 . . . . 0.0 112.027 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -81.13 -23.05 38.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.704 0.683 . . . . 0.0 110.505 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.16 -22.79 13.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.43 -167.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.16 144.6 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.998 1.272 . . . . 0.0 109.066 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.63 34.86 62.79 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -132.06 160.54 35.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.84 150.94 42.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.071 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.88 142.01 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 108.304 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.2 mt -99.78 52.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.022 1.391 . . . . 0.0 110.446 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.71 150.96 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.256 -1.793 . . . . 0.0 108.347 169.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -70.18 164.12 24.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.032 0.933 . . . . 0.0 112.057 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.16 119.45 11.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.2 p -140.44 154.41 46.64 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 m -54.71 -40.22 69.0 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.944 0.498 . . . . 0.0 110.402 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.95 -41.78 77.56 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.749 0.82 . . . . 0.0 111.229 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.99 -39.15 87.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.082 0.856 . . . . 0.0 110.237 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.3 m -68.9 -44.23 73.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.907 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.45 -47.11 79.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.986 0.914 . . . . 0.0 109.91 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -58.38 -53.08 62.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.973 0.909 . . . . 0.0 109.363 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.23 -49.83 75.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.18 0.446 . . . . 0.0 111.678 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 -34.2 65.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.392 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -66.64 -38.47 86.98 Favored 'General case' 0 C--O 1.225 -0.209 0 O-C-N 121.889 -0.507 . . . . 0.0 110.361 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -56.24 -35.86 67.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.375 1.07 . . . . 0.0 111.86 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.15 -45.72 32.17 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.968 0.803 . . . . 0.0 110.922 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -78.09 -43.28 29.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.823 0.738 . . . . 0.0 111.937 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -75.77 -40.75 54.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.911 0.484 . . . . 0.0 110.838 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 116.02 -37.42 3.43 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 128.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 105.049 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.893 174.577 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -60.57 149.63 34.17 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.727 -0.608 . . . . 0.0 109.597 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 42.96 62.88 8.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.321 1.449 . . . . 0.0 112.026 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.97 -13.82 39.4 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.733 2.289 . . . . 0.0 114.094 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.272 44.0 pt 41.89 59.28 9.68 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.435 1.894 . . . . 0.0 111.735 -173.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.46 178.57 6.89 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.766 2.977 . . . . 0.0 109.096 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.09 67.36 77.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 150.22 83.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.599 2.866 . . . . 0.0 111.212 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -76.6 146.19 76.46 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.45 130.66 21.98 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.722 2.282 . . . . 0.0 110.163 168.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.99 -14.99 63.31 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 117.743 -1.587 . . . . 0.0 113.875 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -69.04 152.98 44.54 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.899 2.349 . . . . 0.0 111.82 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.07 139.28 38.15 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -119.92 145.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.87 149.93 41.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 mm -126.42 97.26 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 -168.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.4 143.43 57.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 174.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.48 168.25 18.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.356 1.062 . . . . 0.0 108.911 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.25 -32.88 52.57 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 115.904 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.64 3.34 2.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.94 -161.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.14 1.376 . . . . 0.0 108.504 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 147.79 36.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -117.68 167.47 11.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.466 1.906 . . . . 0.0 108.399 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.17 148.05 49.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.556 0.742 . . . . 0.0 110.304 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.54 172.94 14.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.237 1.415 . . . . 0.0 109.221 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 tt -132.62 128.61 57.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.14 133.07 45.93 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 109.278 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.01 165.68 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.637 1.175 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.66 -126.88 41.02 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -169.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -144.87 53.28 1.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 -8.53 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.783 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -103.72 168.06 9.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.694 1.247 . . . . 0.0 109.278 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.45 151.93 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.063 0.945 . . . . 0.0 109.546 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.86 141.38 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 168.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -163.6 171.59 15.53 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.271 0.629 . . . . 0.0 111.123 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.91 150.06 36.0 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.98 159.21 40.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.76 1.624 . . . . 0.0 108.408 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.0 159.78 40.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 121.474 1.449 . . . . 0.0 109.921 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.18 -0.72 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.549 2.833 . . . . 0.0 113.605 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -49.4 136.53 15.97 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 111.501 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -146.75 34.06 0.93 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.617 1.167 . . . . 0.0 108.796 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.26 165.57 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 126.005 1.722 . . . . 0.0 108.91 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.56 19.18 4.02 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.38 1.872 . . . . 0.0 114.621 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.4 -163.55 35.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.08 0.848 . . . . 0.0 113.063 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.18 171.06 17.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.095 1.758 . . . . 0.0 108.257 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.3 -176.96 44.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.9 -5.42 2.86 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.176 1.39 . . . . 0.0 114.584 -173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.37 -25.81 67.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.142 0.883 . . . . 0.0 111.057 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 m 55.69 22.65 5.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.795 1.638 . . . . 0.0 113.264 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.05 146.38 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.2 1.0 . . . . 0.0 110.14 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.0 mtt -142.17 71.05 1.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.412 1.485 . . . . 0.0 107.574 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -55.83 150.41 13.09 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.736 1.214 . . . . 0.0 111.577 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.03 61.63 2.02 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 110.394 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.4 -32.27 66.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.255 1.022 . . . . 0.0 111.362 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 p -148.89 174.75 11.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.791 2.036 . . . . 0.0 107.33 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.37 18.09 18.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.943 0.897 . . . . 0.0 112.723 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -119.99 179.12 4.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.534 1.933 . . . . 0.0 109.928 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.5 178.84 9.14 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 108.879 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 pt -145.88 166.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.143 1.777 . . . . 0.0 107.167 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.67 139.79 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -133.69 172.41 12.8 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.566 1.546 . . . . 0.0 109.378 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.38 142.1 50.53 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 125.204 1.402 . . . . 0.0 107.415 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -151.04 159.61 44.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.292 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.86 137.74 55.52 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.86 -41.64 67.7 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.217 0.917 . . . . 0.0 111.669 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -64.86 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.88 -25.84 61.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.858 0.753 . . . . 0.0 111.437 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.66 -36.48 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.873 1.269 . . . . 0.0 109.918 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.5 62.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.536 1.534 . . . . 0.0 113.28 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.42 37.42 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.762 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -53.04 -48.09 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.696 1.248 . . . . 0.0 111.799 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -166.33 -54.29 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 125.881 1.672 . . . . 0.0 109.27 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -166.92 178.79 5.6 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.498 1.919 . . . . 0.0 107.732 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -154.14 165.86 34.9 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.386 -0.821 . . . . 0.0 109.314 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -155.67 158.63 38.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.919 0.888 . . . . 0.0 110.377 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.17 136.65 25.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -149.68 66.94 1.0 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.186 0.517 . . . . 0.0 110.498 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.64 119.14 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -67.8 -11.68 59.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.533 ' C ' ' H ' ' A' ' 82' ' ' ASP . 92.5 m-70 -129.27 29.14 5.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 111.621 -169.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.54 21.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.887 -1.133 . . . . 0.0 112.685 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 80' ' ' HIS . 34.8 t70 -130.49 -5.81 4.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.948 2.099 . . . . 0.0 111.351 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.88 -31.2 1.32 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.965 1.306 . . . . 0.0 111.905 -169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 66.65 150.68 0.06 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 128.292 2.637 . . . . 0.0 117.848 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -40.11 109.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.876 2.87 . . . . 0.0 113.94 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 -15.9 18.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.505 2.803 . . . . 0.0 111.812 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.22 138.24 24.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 126.671 1.988 . . . . 0.0 106.698 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 157.28 62.21 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.527 1.485 . . . . 0.0 109.391 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.76 -39.93 62.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.323 0.649 . . . . 0.0 111.557 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 m -54.07 -48.43 70.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 111.393 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.7 -35.89 77.76 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.563 -0.71 . . . . 0.0 111.526 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.29 -49.08 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.186 0.903 . . . . 0.0 108.618 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.09 -38.62 78.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.124 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -55.83 -45.11 78.42 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.387 0.675 . . . . 0.0 110.067 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.3 -48.81 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.477 0.581 . . . . 0.0 109.859 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.31 -42.15 66.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.705 0.684 . . . . 0.0 111.813 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -78.52 -19.17 53.55 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.312 -175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.96 -29.79 26.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.193 0.906 . . . . 0.0 110.021 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.5 mt -96.68 -24.26 16.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.312 -168.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.45 132.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.785 1.175 . . . . 0.0 109.637 171.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.09 -4.87 82.07 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.55 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.45 159.79 25.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.779 1.789 . . . . 0.0 109.3 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -104.1 154.33 19.85 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.488 0.715 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.97 -175.98 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.993 1.317 . . . . 0.0 108.31 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.09 11.04 6.46 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.712 0.805 . . . . 0.0 112.842 -169.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.8 153.16 45.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 109.538 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -71.75 161.21 31.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 111.863 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.27 131.28 46.87 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.5 p -145.81 159.06 43.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 m -55.34 -39.3 69.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.126 0.421 . . . . 0.0 110.213 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.7 -47.48 66.32 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.126 0.571 . . . . 0.0 111.184 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.86 -40.39 87.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.679 0.672 . . . . 0.0 110.82 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.05 -42.46 76.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.774 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -58.97 -44.34 91.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.695 0.679 . . . . 0.0 110.395 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -56.6 -53.72 54.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.879 1.271 . . . . 0.0 109.06 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -60.18 -54.04 50.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.185 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -62.34 -28.22 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.921 0.782 . . . . 0.0 111.081 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -70.28 -32.77 70.72 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.411 -0.806 . . . . 0.0 111.718 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.3 -25.16 63.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.814 0.734 . . . . 0.0 111.321 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.22 -52.95 4.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -60.1 -37.56 80.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.556 1.142 . . . . 0.0 112.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -136.88 9.95 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.231 0.957 . . . . 0.0 111.676 -167.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.0 -29.92 5.72 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.772 -1.205 . . . . 0.0 112.55 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.0 145.58 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.01 1.724 . . . . 0.0 108.336 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.014 0.926 . . . . 0.0 111.064 169.041 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -151.15 167.52 27.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.446 1.098 . . . . 0.0 109.708 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.92 154.73 80.54 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.69 174.31 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.266 1.978 . . . . 0.0 111.151 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 pt -125.45 68.94 60.78 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.682 1.593 . . . . 0.0 106.791 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.17 -23.18 21.51 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 114.384 -167.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 13.1 pt-20 -145.95 -21.78 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 92.0 Cg_endo -74.65 158.38 43.54 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 123.697 2.356 . . . . 0.0 111.245 -174.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -131.7 145.93 59.64 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.15 0.98 . . . . 0.0 108.424 168.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.23 128.19 19.38 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.465 2.11 . . . . 0.0 111.037 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.99 -10.26 27.24 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.976 1.75 . . . . 0.0 112.141 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.9 135.86 34.32 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.006 1.403 . . . . 0.0 111.408 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.13 137.46 54.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -121.8 121.23 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.13 151.49 21.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.28 112.46 29.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 127.02 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.45 168.96 6.84 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 108.336 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -47.56 -33.19 17.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.052 3.168 . . . . 0.0 116.541 -170.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -146.87 17.35 1.25 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.897 0.879 . . . . 0.0 111.433 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -158.43 -160.64 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.408 1.083 . . . . 0.0 109.586 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 155.43 45.66 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -116.36 168.51 10.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -132.39 147.21 52.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.596 0.635 . . . . 0.0 111.159 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.29 174.7 11.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.237 1.815 . . . . 0.0 107.719 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.18 129.95 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -73.86 125.92 29.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 m -136.31 -10.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.59 167.11 28.67 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -55.37 -22.2 18.54 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -168.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -140.8 16.56 2.83 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.239 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -120.48 154.36 35.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.569 1.684 . . . . 0.0 111.976 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.47 158.17 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.553 1.141 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.87 143.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.0 174.45 13.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.154 0.982 . . . . 0.0 109.932 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.42 143.9 29.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 170.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.93 160.46 62.76 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.779 1.231 . . . . 0.0 108.994 171.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.42 156.86 20.11 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.274 1.982 . . . . 0.0 110.975 168.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.08 144.84 27.32 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 112.379 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 m -59.75 155.03 16.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.874 0.87 . . . . 0.0 111.505 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.56 166.31 31.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.12 -44.15 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.351 1.061 . . . . 0.0 108.888 174.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.87 159.2 39.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.971 1.709 . . . . 0.0 108.204 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.13 170.52 35.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.31 -31.6 70.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.795 0.438 . . . . 0.0 111.736 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.84 -169.4 34.61 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.206 1.384 . . . . 0.0 109.971 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.86 167.67 5.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.392 0.677 . . . . 0.0 110.453 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.8 22.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.995 0.518 . . . . 0.0 111.345 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -37.79 83.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.085 0.954 . . . . 0.0 110.841 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -67.5 157.65 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.355 0.662 . . . . 0.0 110.82 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.3 -17.85 55.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 112.91 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 m -57.5 -23.8 52.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.865 1.266 . . . . 0.0 112.68 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.48 35.4 1.33 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.531 1.933 . . . . 0.0 114.046 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.8 tp 55.35 11.26 0.55 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.437 1.895 . . . . 0.0 114.197 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -134.18 12.27 3.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.569 1.176 . . . . 0.0 112.119 -169.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -0.39 13.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 169.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -134.43 166.98 21.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.333 3.053 . . . . 0.0 106.891 171.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.34 -179.82 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.09 153.73 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.33 139.08 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -139.87 159.64 41.73 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.221 1.409 . . . . 0.0 107.997 -169.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.03 136.52 49.48 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -152.5 159.91 43.28 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 108.63 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.38 132.88 49.31 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.8 -46.61 71.13 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.385 0.674 . . . . 0.0 111.261 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -67.26 -24.46 65.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.86 0.464 . . . . 0.0 111.33 -170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.32 -37.39 60.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.363 0.528 . . . . 0.0 111.011 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.53 -45.33 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.095 0.558 . . . . 0.0 109.56 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.97 64.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.073 0.549 . . . . 0.0 110.381 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.09 -128.83 31.09 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 m -72.26 -8.45 54.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.57 1.148 . . . . 0.0 113.874 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.21 -170.6 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.524 1.056 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -140.12 158.48 43.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.499 2.32 . . . . 0.0 106.084 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -156.61 163.26 39.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.845 -0.534 . . . . 0.0 110.31 -168.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.85 158.92 40.11 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.661 0.784 . . . . 0.0 110.432 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.37 134.31 30.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -149.74 66.57 0.99 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -61.42 118.88 7.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -55.26 -43.99 75.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.94 36.41 1.4 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.396 0.678 . . . . 0.0 111.337 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -58.79 -9.86 2.04 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.355 0.98 . . . . 0.0 112.686 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.61 -20.62 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.918 0.887 . . . . 0.0 110.336 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -114.15 -44.77 3.1 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.022 1.329 . . . . 0.0 110.23 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -155.48 159.0 39.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.719 0.808 . . . . 0.0 112.82 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -171.2 76.87 0.53 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 128.482 2.713 . . . . 0.0 105.096 167.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.55 -16.21 52.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.686 2.924 . . . . 0.0 113.885 -171.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.85 120.82 47.85 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 157.52 61.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.842 1.695 . . . . 0.0 108.904 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.9 m -47.48 -47.83 27.2 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.889 0.876 . . . . 0.0 112.505 -169.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -54.84 -43.94 73.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.637 0.775 . . . . 0.0 112.445 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.48 -33.61 76.07 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.596 -0.69 . . . . 0.0 111.187 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.2 mt -60.84 -48.95 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.29 -50.62 79.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -52.79 -47.05 67.84 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.424 1.089 . . . . 0.0 110.534 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -66.35 -49.72 65.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.57 -45.07 73.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.494 0.588 . . . . 0.0 110.805 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.76 -30.57 71.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.467 1.507 . . . . 0.0 112.188 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -72.45 -28.83 63.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.598 0.759 . . . . 0.0 109.052 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.4 mt -91.95 -16.99 25.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.906 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 t -54.74 128.92 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.363 1.438 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.11 87.66 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.261 -1.3 . . . . 0.0 113.229 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -76.88 143.99 39.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.72 1.76 . . . . 0.0 108.491 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.01 151.4 23.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.756 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.22 146.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 109.18 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.08 1.92 52.87 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.588 -0.695 . . . . 0.0 112.769 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -92.76 155.03 17.94 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.592 0.757 . . . . 0.0 109.261 169.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -70.22 142.58 52.37 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -69.11 131.88 45.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.1 p -145.17 165.3 28.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.096 1.758 . . . . 0.0 106.38 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 m -50.53 -46.94 57.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.795 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.45 -40.22 73.86 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.133 -0.461 . . . . 0.0 111.618 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -71.55 -31.01 66.53 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.231 0.923 . . . . 0.0 110.959 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.1 m -69.87 -43.6 71.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.124 0.874 . . . . 0.0 109.926 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -59.91 -41.12 91.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.637 0.775 . . . . 0.0 110.149 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -59.84 -58.89 6.6 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 110.286 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.64 -49.84 73.8 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.09 -31.05 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 121.096 -0.241 . . . . 0.0 110.557 -170.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -70.14 -28.12 65.1 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.177 -0.952 . . . . 0.0 111.527 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -53.98 -31.5 51.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.764 0.711 . . . . 0.0 111.368 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.1 mt -80.78 -45.8 16.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.239 0.616 . . . . 0.0 110.408 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -74.79 -29.38 61.09 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.203 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -130.22 -5.18 4.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.04 -14.7 62.79 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.81 -1.181 . . . . 0.0 112.737 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -154.8 151.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.644 1.577 . . . . 0.0 106.984 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.198 170.593 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -143.97 151.14 39.35 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 33.89 58.91 1.93 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.918 2.087 . . . . 0.0 114.418 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.42 174.9 10.84 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.996 2.464 . . . . 0.0 111.145 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.5 73.6 80.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.25 176.29 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.41 2.74 . . . . 0.0 109.279 -174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.49 75.89 56.73 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 169.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -53.49 149.99 28.83 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.275 2.65 . . . . 0.0 112.536 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -113.64 138.38 22.6 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.32 132.36 23.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.29 -21.16 35.97 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.138 1.352 . . . . 0.0 112.014 -170.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -67.44 144.26 55.83 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.448 1.624 . . . . 0.0 111.674 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.11 139.92 43.08 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.61 128.21 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.51 150.83 22.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 165.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.05 114.1 40.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 102.355 -3.202 . . . . 0.0 102.355 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.45 131.08 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -108.87 167.26 9.42 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -50.39 -28.58 21.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 115.901 -173.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.62 14.5 1.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.819 0.848 . . . . 0.0 112.102 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -156.78 -155.81 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.488 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 157.87 44.13 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.865 1.211 . . . . 0.0 109.331 174.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -127.75 168.84 14.54 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.236 1.814 . . . . 0.0 106.113 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -135.09 147.45 49.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.848 0.749 . . . . 0.0 111.673 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.67 173.0 14.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.37 1.868 . . . . 0.0 108.879 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.78 133.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -80.48 135.23 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.56 -2.68 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -170.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.37 -175.41 38.56 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -77.04 44.28 0.39 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.195 0.998 . . . . 0.0 111.743 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.35 -32.31 0.35 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.861 1.22 . . . . 0.0 112.532 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.9 152.94 23.19 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.793 1.296 . . . . 0.0 111.651 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.82 156.31 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.33 1.452 . . . . 0.0 109.273 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 140.05 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.47 170.77 21.0 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.044 0.538 . . . . 0.0 110.798 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.02 138.43 33.74 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.04 8.59 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.671 . . . . 0.0 108.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.0 152.6 36.01 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.537 2.158 . . . . 0.0 112.425 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -69.94 -28.89 23.81 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.965 1.777 . . . . 0.0 111.213 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -68.53 165.12 19.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.381 1.873 . . . . 0.0 111.481 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -144.17 154.26 42.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.249 1.419 . . . . 0.0 107.337 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.11 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.704 0.801 . . . . 0.0 110.868 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.3 114.19 0.82 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.017 1.327 . . . . 0.0 109.908 172.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.18 -38.3 1.79 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.83 1.205 . . . . 0.0 110.355 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.81 -0.7 1.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.564 1.146 . . . . 0.0 112.437 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.94 -144.84 4.22 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.3 -0.09 0.88 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.23 145.62 16.63 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.495 1.498 . . . . 0.0 110.751 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -61.84 -32.95 73.33 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 112.263 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 m -147.09 153.93 12.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.7 1.6 . . . . 0.0 108.373 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 161.07 27.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.863 0.865 . . . . 0.0 109.467 168.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -76.61 45.48 0.4 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.75 1.62 . . . . 0.0 111.943 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 51.04 29.05 4.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.426 1.891 . . . . 0.0 112.527 -169.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.65 -27.96 69.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.231 1.012 . . . . 0.0 111.356 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 p -143.89 173.37 11.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.544 1.938 . . . . 0.0 106.934 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -133.07 29.69 4.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.698 1.199 . . . . 0.0 110.97 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.49 176.66 7.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.588 1.555 . . . . 0.0 110.564 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 174.02 12.39 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.318 1.447 . . . . 0.0 109.765 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.35 146.13 29.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.0 t -82.57 130.95 34.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 163.94 28.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.176 1.39 . . . . 0.0 108.019 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -131.09 130.32 43.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.25 160.8 43.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 108.895 -173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -73.01 130.46 40.38 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.94 -40.23 63.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.11 0.964 . . . . 0.0 112.627 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -35.98 67.81 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.832 0.453 . . . . 0.0 111.832 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.35 -38.14 71.63 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.299 0.5 . . . . 0.0 110.605 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.09 -46.86 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.819 0.848 . . . . 0.0 108.834 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -24.6 66.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.536 1.135 . . . . 0.0 112.102 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.69 -14.3 3.66 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.503 1.525 . . . . 0.0 113.835 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.5 m -48.81 -48.2 41.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.595 1.197 . . . . 0.0 111.51 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -168.58 -55.92 0.02 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.927 1.691 . . . . 0.0 109.636 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.18 -174.95 3.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.947 2.099 . . . . 0.0 107.695 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -149.06 168.14 23.95 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.43 -0.794 . . . . 0.0 109.563 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -146.11 153.69 40.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.116 0.967 . . . . 0.0 108.88 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -78.14 135.09 26.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 166.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -147.19 69.66 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -63.47 104.72 0.66 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -54.0 -51.13 64.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.726 1.211 . . . . 0.0 113.848 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -148.2 38.95 0.9 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.383 1.073 . . . . 0.0 111.264 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.32 -14.26 1.14 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.09 1.356 . . . . 0.0 113.214 169.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.97 -28.27 27.89 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.476 -0.765 . . . . 0.0 110.596 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -97.44 -34.26 11.08 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.583 -177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -148.51 156.85 42.99 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.305 0.642 . . . . 0.0 111.756 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -178.4 72.86 0.21 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 128.475 2.71 . . . . 0.0 107.491 168.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.9 -14.45 41.36 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.643 2.229 . . . . 0.0 113.372 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.66 121.08 30.13 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 124.911 1.284 . . . . 0.0 108.491 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.62 159.67 10.74 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.294 2.662 . . . . 0.0 111.492 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -50.09 -46.57 53.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.655 0.782 . . . . 0.0 111.269 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.62 -44.7 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.32 0.648 . . . . 0.0 111.754 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.42 -35.72 68.42 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.293 0.637 . . . . 0.0 111.237 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.81 -49.87 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.5 -46.08 96.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -43.29 69.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.369 0.668 . . . . 0.0 110.338 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -51.05 64.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.79 -45.11 67.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.38 0.536 . . . . 0.0 111.213 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.01 -29.82 68.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.234 1.413 . . . . 0.0 112.127 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.38 -28.51 62.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.154 0.982 . . . . 0.0 109.192 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.78 -14.7 27.49 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.857 -1.068 . . . . 0.0 112.8 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.66 126.52 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 109.137 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.82 -1.22 88.04 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.453 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.21 159.93 21.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.629 1.715 . . . . 0.0 109.34 174.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -110.63 154.37 23.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.76 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.98 145.27 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.79 1.236 . . . . 0.0 107.755 169.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 tp -87.86 14.3 9.07 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.749 -0.595 . . . . 0.0 112.18 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -121.84 159.67 26.28 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.128 1.371 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -87.42 172.97 9.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.989 1.715 . . . . 0.0 113.501 -167.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.21 43.25 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.888 2.075 . . . . 0.0 112.477 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 p -70.18 148.19 48.95 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -55.21 -37.72 67.49 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.09 -0.381 . . . . 0.0 110.252 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -65.83 -40.44 91.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.445 1.098 . . . . 0.0 111.473 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -68.67 -36.98 79.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.054 1.297 . . . . 0.0 110.55 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.42 -45.43 79.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.2 -46.08 86.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.087 0.955 . . . . 0.0 110.086 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -56.47 -54.68 42.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.501 1.121 . . . . 0.0 109.052 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.59 -51.03 71.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.336 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.93 -33.47 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.22 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -68.45 -36.6 79.26 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.001 0.819 . . . . 0.0 110.713 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.72 -36.11 69.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.262 1.025 . . . . 0.0 111.421 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.0 mp -79.12 -45.05 20.78 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.066 0.848 . . . . 0.0 110.587 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.4 tpt85 -65.93 -33.61 76.23 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.915 0.886 . . . . 0.0 112.083 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.51 5.51 4.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.871 0.868 . . . . 0.0 113.125 -170.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.18 4.0 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 120.793 -1.192 . . . . 0.0 112.124 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.32 138.49 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.122 0.569 . . . . 0.0 111.648 175.045 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -71.12 -37.64 72.33 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 0.0 111.098 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.01 147.29 86.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.027 0.531 . . . . 0.0 110.443 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.21 174.41 11.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.698 2.265 . . . . 0.0 111.194 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 pt -125.41 72.28 66.34 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 106.824 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.08 -19.87 15.3 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.113 2.542 . . . . 0.0 114.221 -168.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.93 -18.74 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 -169.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -56.51 155.22 26.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.598 2.199 . . . . 0.0 112.427 169.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -138.22 148.28 59.13 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 109.941 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.18 131.9 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.904 2.403 . . . . 0.0 110.352 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.51 -20.82 31.66 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.011 1.767 . . . . 0.0 111.708 -172.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.45 145.51 52.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.687 1.743 . . . . 0.0 111.394 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.19 138.62 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.35 145.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -123.6 149.43 45.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 mm -125.57 124.15 66.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -168.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -73.76 134.53 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -132.16 163.99 46.37 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.437 0.695 . . . . 0.0 109.681 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.3 -21.19 61.79 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.696 1.597 . . . . 0.0 115.214 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -135.37 1.14 2.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.038 0.836 . . . . 0.0 113.01 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -166.49 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.525 1.53 . . . . 0.0 108.769 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.73 152.37 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -131.31 168.77 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 109.279 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -137.98 144.8 41.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.165 0.986 . . . . 0.0 110.279 -169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.7 14.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.791 1.636 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.23 131.54 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.15 131.39 39.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.085 1.354 . . . . 0.0 108.152 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.26 -20.65 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.52 43.97 0.94 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 119.265 0.938 . . . . 0.0 112.07 -168.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.68 38.21 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.16 1.784 . . . . 0.0 112.744 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.05 0.94 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.997 1.284 . . . . 0.0 110.536 -172.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -91.72 152.48 20.17 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.62 1.21 . . . . 0.0 110.766 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.19 160.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 126.1 1.76 . . . . 0.0 109.836 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.71 140.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.29 169.41 22.18 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.865 -0.522 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 143.02 31.32 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.52 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 108.122 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.99 155.3 65.23 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 N-CA-C 109.334 -1.064 . . . . 0.0 109.334 168.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.08 -37.54 57.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.175 2.583 . . . . 0.0 113.76 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 m -138.57 168.51 19.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.524 1.93 . . . . 0.0 106.956 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.11 34.14 0.07 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.546 1.538 . . . . 0.0 114.623 -172.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -49.59 -30.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.592 1.957 . . . . 0.0 114.396 -174.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.86 12.68 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.227 1.011 . . . . 0.0 111.138 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.69 156.56 6.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.545 1.545 . . . . 0.0 110.021 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.3 100.62 0.83 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.52 34.49 76.02 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -173.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 169.74 20.84 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.77 0.785 . . . . 0.0 111.478 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.22 176.14 9.75 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.213 1.805 . . . . 0.0 107.827 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m -131.46 27.53 4.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 110.813 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.38 38.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -152.65 43.31 0.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.013 1.725 . . . . 0.0 108.005 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -59.42 162.54 4.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 0.0 111.795 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.82 43.2 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.671 1.589 . . . . 0.0 112.722 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.9 tp 47.04 76.63 0.1 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.156 2.182 . . . . 0.0 110.725 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -143.48 158.07 43.95 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.58 1.952 . . . . 0.0 106.618 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -142.15 30.57 1.59 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.954 0.883 . . . . 0.0 112.039 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -137.85 164.6 28.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.365 1.466 . . . . 0.0 109.819 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 173.4 11.87 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.414 1.486 . . . . 0.0 109.333 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -135.88 147.68 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.65 125.97 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -122.59 166.4 14.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.324 1.05 . . . . 0.0 109.282 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.2 124.48 39.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -150.32 163.83 37.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 108.938 -169.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -69.77 128.88 37.97 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.69 -45.34 70.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.344 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.66 -18.19 64.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -88.13 -43.88 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.746 0.703 . . . . 0.0 110.5 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.78 -40.43 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.066 0.946 . . . . 0.0 110.824 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.72 -2.08 57.1 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.255 1.422 . . . . 0.0 113.088 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.45 -18.49 37.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.934 0.778 . . . . 0.0 113.125 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -53.7 -43.47 68.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.473 1.509 . . . . 0.0 112.424 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -161.12 -69.03 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.058 0.943 . . . . 0.0 111.411 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -167.28 -176.39 3.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.374 1.87 . . . . 0.0 108.811 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -156.18 168.47 27.19 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.795 0.838 . . . . 0.0 110.684 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -151.52 159.82 43.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.941 0.896 . . . . 0.0 110.284 168.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.7 t -70.76 139.26 20.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -148.05 67.4 1.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.321 0.582 . . . . 0.0 109.582 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -57.78 117.33 4.14 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.3 -38.47 71.76 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.415 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.447 ' C ' ' H ' ' A' ' 82' ' ' ASP . 76.6 m-70 -144.9 25.62 1.42 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 112.23 -171.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.27 -1.55 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.872 1.215 . . . . 0.0 112.055 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.7 t70 -99.99 -6.78 25.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.392 1.477 . . . . 0.0 110.868 177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -128.81 -32.08 2.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.749 1.22 . . . . 0.0 111.343 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -146.47 149.13 33.07 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.492 1.117 . . . . 0.0 110.97 -170.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.9 p -162.56 65.8 1.72 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.061 1.344 . . . . 0.0 109.255 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.93 -14.78 46.15 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.362 2.042 . . . . 0.0 113.02 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.4 125.66 22.59 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.992 1.317 . . . . 0.0 108.376 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.31 167.17 27.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.444 2.096 . . . . 0.0 109.951 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -47.05 -49.14 21.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.486 1.114 . . . . 0.0 111.904 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -54.08 -54.21 42.56 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.812 1.245 . . . . 0.0 111.811 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.55 -35.02 79.11 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.229 1.012 . . . . 0.0 111.608 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.2 mt -61.99 -44.98 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.721 1.146 . . . . 0.0 108.618 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -63.41 -49.07 84.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.02 -40.37 73.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.088 0.555 . . . . 0.0 110.427 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -63.48 -54.44 36.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.401 0.68 . . . . 0.0 109.447 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.48 -43.8 55.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.736 0.414 . . . . 0.0 111.262 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.16 -32.11 72.14 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.201 1.401 . . . . 0.0 111.768 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.94 -25.57 62.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.13 0.572 . . . . 0.0 110.806 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.21 -10.74 17.69 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.895 -1.05 . . . . 0.0 113.315 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 t -59.0 139.88 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 121.026 1.739 . . . . 0.0 109.509 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.25 -5.88 84.33 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.377 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -80.94 154.46 26.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.25 1.525 . . . . 0.0 109.087 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.491 1.116 . . . . 0.0 109.104 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.19 146.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.139 1.376 . . . . 0.0 107.898 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.29 49.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 123.089 1.423 . . . . 0.0 109.812 -171.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -135.24 148.23 49.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.671 168.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -70.03 165.2 22.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.61 118.95 11.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -140.28 155.48 46.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 m -54.61 -40.25 68.71 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.721 0.408 . . . . 0.0 110.315 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.47 -42.85 74.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.466 0.706 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -67.42 -39.37 85.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.824 0.738 . . . . 0.0 110.385 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.8 m -69.93 -44.04 70.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.35 -46.65 79.87 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.498 0.719 . . . . 0.0 109.887 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -57.69 -54.49 46.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.872 0.869 . . . . 0.0 109.196 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -57.81 -52.3 66.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.374 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.94 -31.42 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.487 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.12 -28.26 67.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.624 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.26 -42.88 96.28 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 119.465 1.03 . . . . 0.0 109.728 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.93 -40.31 75.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.014 0.825 . . . . 0.0 110.405 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -76.66 -40.64 48.39 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.199 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -122.7 15.48 10.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.06 -52.51 3.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.4 142.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.144 -0.455 . . . . 0.0 110.502 172.811 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 121.051 0.453 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -144.44 -177.28 5.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.134 1.773 . . . . 0.0 106.813 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.64 89.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.15 -161.45 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.393 2.062 . . . . 0.0 110.772 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 pt -118.57 64.97 6.19 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.742 1.217 . . . . 0.0 110.832 -174.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.54 -21.55 16.86 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.518 2.146 . . . . 0.0 113.365 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.36 -16.48 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 118.062 2.616 . . . . 0.0 118.062 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.43 162.75 39.4 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 123.933 2.44 . . . . 0.0 111.417 -174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -138.84 142.15 32.83 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 124.401 1.08 . . . . 0.0 109.093 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.97 133.15 14.48 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.183 2.589 . . . . 0.0 111.5 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.48 -25.34 12.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.051 1.786 . . . . 0.0 110.622 -169.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.75 136.64 56.5 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.183 0.991 . . . . 0.0 111.046 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.26 140.95 52.47 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.36 129.88 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.23 151.43 23.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.88 98.96 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 102.758 -3.053 . . . . 0.0 102.758 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.38 136.2 56.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -133.84 169.44 13.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.673 . . . . 0.0 110.526 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.95 -30.68 24.83 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.428 2.752 . . . . 0.0 117.134 -169.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -145.76 10.49 1.21 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.691 0.796 . . . . 0.0 112.635 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -163.78 -169.55 1.92 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.27 1.428 . . . . 0.0 108.618 -172.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 158.05 45.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -127.01 169.49 13.29 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -138.83 145.43 40.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.592 0.633 . . . . 0.0 110.681 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.13 174.46 12.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.924 2.09 . . . . 0.0 107.782 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.08 136.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -75.96 128.86 35.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.31 -15.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.19 168.5 33.06 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -50.21 -29.77 10.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -167.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.93 13.06 4.45 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.449 -1.195 . . . . 0.0 113.622 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -123.05 152.38 41.05 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.77 1.785 . . . . 0.0 111.928 -170.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -133.36 159.67 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.947 1.299 . . . . 0.0 110.594 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.52 136.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.23 168.71 26.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.351 0.661 . . . . 0.0 110.47 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.85 141.06 32.55 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 165.12 28.34 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 125.223 1.409 . . . . 0.0 108.812 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.4 151.76 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.977 2.451 . . . . 0.0 112.205 170.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.32 132.3 31.05 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.195 1.93 . . . . 0.0 110.364 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -68.9 -38.83 79.87 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.635 0.374 . . . . 0.0 110.686 173.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.93 144.24 49.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.514 0.725 . . . . 0.0 109.567 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.09 169.7 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 111.227 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.07 -38.04 64.86 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.489 1.515 . . . . 0.0 112.718 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.12 -143.56 29.67 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.08 -7.21 50.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.576 0.75 . . . . 0.0 112.934 174.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.63 -31.06 0.68 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.48 1.038 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 46.02 35.41 2.45 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.675 1.99 . . . . 0.0 113.793 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.14 7.43 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.998 1.719 . . . . 0.0 108.452 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -58.63 -35.42 72.48 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.023 0.929 . . . . 0.0 111.346 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.3 143.55 17.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -58.14 -21.48 46.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -57.93 -24.38 57.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.363 1.065 . . . . 0.0 113.122 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.54 -11.69 60.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.65 0.659 . . . . 0.0 112.362 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 127.62 32.16 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m 86.03 4.15 0.5 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.352 2.261 . . . . 0.0 111.299 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.33 41.89 2.22 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.268 2.227 . . . . 0.0 109.986 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -136.72 163.59 30.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.065 1.346 . . . . 0.0 109.882 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.44 172.19 13.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.582 1.553 . . . . 0.0 109.121 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.1 147.27 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.81 128.02 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 160.6 31.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.236 1.415 . . . . 0.0 108.481 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.55 124.67 41.78 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.6 165.03 35.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.389 1.076 . . . . 0.0 108.982 -169.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.16 132.86 49.45 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.763 0.825 . . . . 0.0 109.208 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.89 -45.38 71.08 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.609 0.764 . . . . 0.0 110.899 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -66.45 -19.6 65.83 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.032 -0.509 . . . . 0.0 112.25 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.84 -42.26 27.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.005 0.82 . . . . 0.0 110.167 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.38 -44.83 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.267 0.627 . . . . 0.0 110.099 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.47 18.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.359 1.064 . . . . 0.0 112.454 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.22 51.97 3.31 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.689 1.614 . . . . 0.0 110.649 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 p -140.51 -55.03 0.52 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.132 1.773 . . . . 0.0 107.692 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.41 -67.6 0.2 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 123.954 0.902 . . . . 0.0 111.486 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -155.25 176.12 12.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.195 0.598 . . . . 0.0 110.158 -168.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.65 164.68 37.88 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.724 0.81 . . . . 0.0 111.04 171.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -156.89 162.13 39.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.63 1.172 . . . . 0.0 110.227 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -71.17 142.52 15.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -153.58 76.61 1.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.173 0.589 . . . . 0.0 109.599 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -70.8 81.34 0.63 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -56.12 129.23 39.16 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.939 -0.475 . . . . 0.0 110.34 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' ' 82' ' ' ASP . 22.2 m80 62.45 19.46 11.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.878 2.071 . . . . 0.0 115.213 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.58 -6.2 1.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.997 0.817 . . . . 0.0 111.848 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 80' ' ' HIS . 33.0 t70 -77.95 -25.25 48.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.249 1.02 . . . . 0.0 110.703 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.18 -27.56 1.8 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -140.87 141.94 34.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.816 0.735 . . . . 0.0 112.101 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -162.03 69.03 2.22 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.251 2.621 . . . . 0.0 107.554 171.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.22 -14.44 40.53 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.665 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.9 mt -122.58 126.08 26.25 Favored Pre-proline 0 C--O 1.235 0.307 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.12 162.3 42.78 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.3 2.0 . . . . 0.0 109.307 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.2 p -49.02 -45.99 43.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.892 0.877 . . . . 0.0 112.573 -171.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -53.11 -45.79 68.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.031 0.932 . . . . 0.0 112.352 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -66.51 -31.75 72.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.622 0.769 . . . . 0.0 111.549 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -64.49 -46.93 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.096 0.862 . . . . 0.0 108.815 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.36 -47.68 87.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -56.09 -43.16 77.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.802 0.841 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.7 -47.93 81.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.046 0.384 . . . . 0.0 110.168 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.23 92.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.841 -0.537 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -70.38 -20.59 62.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.264 1.425 . . . . 0.0 112.351 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.26 -28.95 38.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.34 1.056 . . . . 0.0 109.052 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.49 -20.98 13.31 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.611 -169.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 p -52.24 133.18 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 120.498 1.499 . . . . 0.0 109.779 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.78 -5.22 84.42 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.271 -1.294 . . . . 0.0 113.446 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -84.28 164.56 18.95 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.762 1.781 . . . . 0.0 109.593 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -117.49 150.85 38.25 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.238 1.015 . . . . 0.0 109.208 -172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.3 144.32 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.185 0.994 . . . . 0.0 108.37 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.45 53.0 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 123.303 1.525 . . . . 0.0 109.479 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.92 147.9 37.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.434 -2.166 . . . . 0.0 107.908 168.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -65.06 166.15 9.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.109 1.364 . . . . 0.0 113.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.32 125.4 25.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p -145.18 159.03 43.63 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -51.68 -44.63 63.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.675 0.39 . . . . 0.0 110.658 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.11 -48.74 69.9 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.558 0.743 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -64.97 -39.86 94.12 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.267 0.94 . . . . 0.0 110.955 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.57 -43.31 73.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.402 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.32 -44.85 92.54 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.545 0.611 . . . . 0.0 110.105 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.42 -47.55 85.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.517 1.127 . . . . 0.0 109.684 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -58.41 -50.55 73.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.557 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.04 -30.76 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.923 0.783 . . . . 0.0 111.148 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -68.17 -30.88 70.1 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.244 -0.91 . . . . 0.0 111.237 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.2 -11.35 2.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.353 1.061 . . . . 0.0 113.267 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.05 -41.61 5.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.597 1.159 . . . . 0.0 110.174 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.806 0.73 . . . . 0.0 111.893 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.25 -11.45 10.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.013 0.925 . . . . 0.0 111.248 -173.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.09 -9.96 76.28 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.326 -0.859 . . . . 0.0 112.742 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -145.08 143.73 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.555 169.425 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -156.17 151.27 26.43 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.707 1.203 . . . . 0.0 107.963 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.02 161.45 34.59 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.694 1.998 . . . . 0.0 106.297 168.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.4 -107.07 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.883 2.389 . . . . 0.0 108.522 169.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.0 pt -139.34 57.49 10.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.374 1.47 . . . . 0.0 109.167 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.64 -36.91 5.89 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.986 1.791 . . . . 0.0 112.2 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -159.88 60.24 1.44 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.862 1.265 . . . . 0.0 111.88 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -53.49 127.68 26.28 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.796 1.32 . . . . 0.0 110.376 169.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -115.31 153.83 47.49 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.22 1.408 . . . . 0.0 107.905 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.44 134.07 20.55 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.548 2.165 . . . . 0.0 110.484 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.22 7.32 88.57 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.789 -1.562 . . . . 0.0 113.055 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -81.19 149.38 29.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.339 2.57 . . . . 0.0 110.368 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.94 136.55 46.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -120.15 135.94 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.62 153.67 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -128.05 98.64 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 133.46 52.71 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.707 -0.62 . . . . 0.0 109.875 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.26 167.51 10.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.461 1.105 . . . . 0.0 109.11 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.28 -26.79 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.87 2.38 . . . . 0.0 115.175 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -140.59 2.8 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.345 1.058 . . . . 0.0 112.999 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -157.42 -152.43 0.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.445 1.098 . . . . 0.0 109.031 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 164.63 37.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -126.24 168.41 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -136.66 147.88 47.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.828 0.74 . . . . 0.0 111.479 -172.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.82 174.84 13.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.185 1.794 . . . . 0.0 108.726 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.41 132.06 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -74.67 134.54 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.206 1.002 . . . . 0.0 110.107 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.99 166.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.032 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.18 26.54 43.31 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.54 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.66 37.51 9.59 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.83 1.652 . . . . 0.0 113.28 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.63 -14.72 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 O-C-N 121.336 -0.852 . . . . 0.0 114.637 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.7 172.18 8.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.269 1.034 . . . . 0.0 109.016 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.29 161.54 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.399 0.68 . . . . 0.0 110.093 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -114.31 135.56 53.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.33 168.98 25.04 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.165 0.586 . . . . 0.0 110.902 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.55 139.27 33.95 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.26 46.09 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.697 1.599 . . . . 0.0 109.233 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.87 158.92 40.26 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.078 1.852 . . . . 0.0 111.279 172.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.69 -23.46 36.13 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.143 2.562 . . . . 0.0 113.109 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m 55.06 34.59 22.84 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.667 1.187 . . . . 0.0 112.389 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -139.29 31.48 2.14 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.895 1.278 . . . . 0.0 109.21 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.98 -27.07 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 113.832 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.96 2.98 2.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -169.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.59 172.55 28.02 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.301 1.429 . . . . 0.0 109.701 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -25.19 67.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 112.818 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.81 35.78 0.5 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.978 1.275 . . . . 0.0 110.557 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 163.82 16.95 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.592 0.757 . . . . 0.0 110.722 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.38 -26.23 52.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 112.719 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 m 50.58 50.22 19.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.938 1.295 . . . . 0.0 111.534 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.16 -37.09 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 123.345 0.658 . . . . 0.0 109.362 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.0 tpp -63.07 141.71 58.66 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 m -52.82 137.48 31.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.537 1.135 . . . . 0.0 110.823 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.26 -19.13 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.36 142.93 46.76 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.313 . . . . 0.0 110.003 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 p -145.84 -174.25 4.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 127.147 2.179 . . . . 0.0 107.517 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -95.18 12.23 29.54 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.79 0.805 . . . . 0.0 112.874 169.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.8 168.75 16.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.529 2.332 . . . . 0.0 109.433 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.32 173.09 12.57 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.996 1.718 . . . . 0.0 109.13 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -143.47 158.45 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -87.49 132.77 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.88 164.51 22.93 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 109.481 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -125.23 126.34 45.03 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.01 1.324 . . . . 0.0 108.301 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -68.38 135.56 51.97 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.593 -0.692 . . . . 0.0 109.275 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -43.67 75.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.872 0.76 . . . . 0.0 111.01 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -66.07 -19.37 65.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 -44.12 13.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.844 0.747 . . . . 0.0 110.228 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.32 -29.67 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.072 0.949 . . . . 0.0 111.281 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.97 -29.39 60.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.213 -0.899 . . . . 0.0 112.255 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.77 -109.49 0.64 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.86 1.219 . . . . 0.0 111.97 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -61.88 -0.49 0.48 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.645 1.978 . . . . 0.0 114.635 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t0 67.54 160.05 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 129.37 3.068 . . . . 0.0 114.152 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 96.98 129.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 131.63 3.972 . . . . 0.0 109.063 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -165.29 161.48 19.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.062 1.345 . . . . 0.0 108.959 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.1 156.75 42.97 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.332 1.453 . . . . 0.0 108.381 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.31 134.65 28.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -153.61 75.4 1.04 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.727 -0.608 . . . . 0.0 110.24 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.93 85.58 0.23 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.767 0.827 . . . . 0.0 108.883 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -62.25 125.09 22.67 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -171.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.49 44.37 13.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 126.474 1.91 . . . . 0.0 112.525 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.12 -18.87 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.18 -30.56 25.7 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.253 1.021 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -91.19 -34.42 15.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.781 0.832 . . . . 0.0 110.559 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -80.48 175.7 10.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.965 0.888 . . . . 0.0 112.723 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -56.27 160.08 5.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.85 2.86 . . . . 0.0 113.786 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.77 -0.6 3.22 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.815 3.01 . . . . 0.0 115.68 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 mt -36.61 119.58 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.391 2.276 . . . . 0.0 112.638 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.94 151.01 35.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.057 2.504 . . . . 0.0 111.841 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.5 m -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.633 0.773 . . . . 0.0 111.104 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -51.34 66.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.854 1.261 . . . . 0.0 111.677 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.68 -34.95 76.64 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.979 0.912 . . . . 0.0 110.992 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.3 mt -65.13 -43.35 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.573 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.6 -48.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 120.017 1.28 . . . . 0.0 108.946 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -53.18 -47.39 68.89 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.627 1.171 . . . . 0.0 110.066 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -62.18 -50.56 71.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.945 0.498 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.44 78.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.834 0.454 . . . . 0.0 111.359 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -82.55 -11.18 58.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.24 0.616 . . . . 0.0 112.343 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.53 -21.89 35.23 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 109.783 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.08 -11.7 13.78 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.19 147.61 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.181 0.9 . . . . 0.0 109.832 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.01 -2.63 80.19 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.081 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -71.15 154.91 41.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.991 1.396 . . . . 0.0 109.174 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.92 148.9 29.02 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.01 178.27 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.397 1.079 . . . . 0.0 108.62 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.35 21.77 5.64 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.27 1.028 . . . . 0.0 111.167 -170.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -123.05 160.41 26.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.553 1.541 . . . . 0.0 109.735 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -75.2 169.01 18.88 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.54 43.59 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.343 1.857 . . . . 0.0 110.282 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 p -70.46 152.71 43.74 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.542 -1.349 . . . . 0.0 107.558 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -51.76 11.6 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 109.926 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.26 -37.59 83.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.712 1.605 . . . . 0.0 112.401 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -68.69 -39.13 80.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.346 1.43 . . . . 0.0 110.543 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.1 m -67.21 -44.81 78.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.73 -44.24 90.4 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.773 1.229 . . . . 0.0 110.573 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -58.79 -53.62 56.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.099 0.96 . . . . 0.0 109.486 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -46.96 87.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.06 -33.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.315 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.8 -33.52 74.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.184 0.902 . . . . 0.0 110.968 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -58.71 -33.74 70.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.202 1.001 . . . . 0.0 111.695 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.82 -52.98 7.57 Favored 'General case' 0 N--CA 1.458 -0.072 0 O-C-N 121.292 -0.88 . . . . 0.0 110.529 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -30.81 70.94 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.522 0.729 . . . . 0.0 111.395 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -135.03 9.2 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.66 -43.42 2.75 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.886 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.87 139.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.433 171.056 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--O 1.236 0.424 0 CA-C-O 121.688 0.62 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -134.72 146.76 60.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.162 1.385 . . . . 0.0 107.636 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.17 133.55 15.17 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.538 2.159 . . . . 0.0 110.327 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.93 -8.76 50.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.239 1.399 . . . . 0.0 112.397 -169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.01 147.92 24.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.064 1.932 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.07 139.52 42.86 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.3 mm -118.12 146.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.32 153.09 35.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -129.17 103.15 8.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -168.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.575 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.33 169.38 7.52 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.819 1.648 . . . . 0.0 107.533 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.16 -28.18 50.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.947 2.432 . . . . 0.0 115.843 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -142.05 4.4 1.65 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.703 0.801 . . . . 0.0 112.92 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.4 -155.89 0.49 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.912 1.285 . . . . 0.0 108.465 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.66 170.02 19.66 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.51 1.05 . . . . 0.0 110.746 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -144.32 172.46 12.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.333 1.853 . . . . 0.0 109.352 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -137.42 146.92 44.97 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.73 173.72 15.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.401 1.48 . . . . 0.0 108.892 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 117' ' ' VAL . 17.7 tt -139.2 133.86 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -77.09 132.05 38.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.07 -3.81 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.9 177.22 42.27 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.14 53.39 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.525 1.13 . . . . 0.0 111.484 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.87 -13.17 0.39 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.225 -1.32 . . . . 0.0 114.083 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -119.21 155.49 31.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.121 1.961 . . . . 0.0 111.834 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -134.39 156.01 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.85 1.26 . . . . 0.0 110.874 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.46 142.71 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.53 171.27 16.07 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.326 0.651 . . . . 0.0 110.284 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.37 148.62 28.16 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.44 158.99 65.03 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 125.426 1.49 . . . . 0.0 108.571 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.65 156.58 22.09 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.006 1.804 . . . . 0.0 110.419 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 CA--C 1.542 0.889 0 C-N-CA 122.882 2.388 . . . . 0.0 110.958 169.81 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.21 177.23 10.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.506 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 mt -134.83 147.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 t -88.58 125.94 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -135.17 165.57 25.09 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.246 1.018 . . . . 0.0 109.701 -168.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -125.69 139.11 53.82 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -151.95 160.85 43.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.859 1.264 . . . . 0.0 108.598 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.39 132.89 50.13 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -53.31 -43.91 67.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.531 0.732 . . . . 0.0 110.748 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -67.06 -19.19 65.63 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.6 -46.21 33.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.141 0.882 . . . . 0.0 109.906 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.95 -39.21 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.489 0.715 . . . . 0.0 110.197 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.76 -20.15 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.315 1.446 . . . . 0.0 112.861 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.5 -11.92 37.2 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.176 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -51.46 -57.94 7.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.531 1.132 . . . . 0.0 111.009 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -165.79 -50.8 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.968 1.707 . . . . 0.0 110.132 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -159.41 173.0 16.9 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.022 1.729 . . . . 0.0 107.977 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -157.96 164.1 37.16 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.475 -0.766 . . . . 0.0 109.75 173.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -147.83 160.19 43.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.403 1.481 . . . . 0.0 108.367 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.67 135.22 26.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -154.09 75.06 1.0 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.65 0.659 . . . . 0.0 110.779 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.45 94.89 0.42 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -57.53 -23.29 49.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -136.95 21.97 3.05 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.738 1.154 . . . . 0.0 112.251 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.62 -4.72 1.0 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.481 1.491 . . . . 0.0 112.08 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.28 -9.89 53.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.669 1.187 . . . . 0.0 110.729 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -132.3 -41.14 0.99 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.011 1.324 . . . . 0.0 111.213 -169.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -153.05 162.19 41.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.179 . . . . 0.0 111.898 -169.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -178.78 72.16 0.2 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 129.286 3.035 . . . . 0.0 105.275 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -13.64 40.45 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.535 2.823 . . . . 0.0 113.986 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.86 138.64 24.14 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 108.641 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.39 159.14 50.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.313 2.008 . . . . 0.0 109.823 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.24 -42.46 61.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.757 0.823 . . . . 0.0 111.502 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -53.66 -56.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.624 0.77 . . . . 0.0 111.194 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.7 -38.38 90.2 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.354 1.061 . . . . 0.0 111.718 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.84 -49.31 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.431 1.014 . . . . 0.0 108.692 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.29 -46.09 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.91 89.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.877 -0.582 . . . . 0.0 109.957 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -63.3 -48.0 79.92 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.925 0.784 . . . . 0.0 109.851 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.26 60.2 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.321 0.509 . . . . 0.0 110.005 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.68 -19.93 58.79 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.78 -26.51 61.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.864 1.266 . . . . 0.0 109.048 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.76 -10.65 19.75 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.88 -169.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.47 144.52 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.399 0.999 . . . . 0.0 109.784 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.14 60.77 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.66 1.124 . . . . 0.0 112.979 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -86.46 158.42 19.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.798 1.299 . . . . 0.0 109.536 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -100.68 154.04 18.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.53 147.06 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.968 1.307 . . . . 0.0 107.89 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.33 42.09 1.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.788 1.28 . . . . 0.0 110.16 -168.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -139.87 147.79 41.16 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.692 1.597 . . . . 0.0 108.406 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.33 150.5 34.85 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.116 0.967 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -77.23 56.28 1.29 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.177 1.391 . . . . 0.0 112.282 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -64.58 159.07 22.62 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.076 -1.015 . . . . 0.0 109.26 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.3 t -50.07 -45.03 52.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.42 -43.57 97.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.211 0.604 . . . . 0.0 111.476 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -71.71 -37.0 70.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.112 0.869 . . . . 0.0 111.142 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.3 m -67.87 -42.85 80.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.257 0.48 . . . . 0.0 110.159 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.45 -46.73 83.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.071 0.948 . . . . 0.0 109.643 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -58.06 -55.27 37.15 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.722 1.209 . . . . 0.0 109.771 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.39 -49.6 76.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.643 0.202 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 1.4 p -70.55 -30.59 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.819 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -67.34 -33.28 74.91 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.472 -0.768 . . . . 0.0 110.398 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -55.99 -29.86 60.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.541 0.736 . . . . 0.0 112.194 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.15 -50.17 9.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.534 0.606 . . . . 0.0 110.354 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -71.17 -33.34 69.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.558 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.25 6.72 6.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.669 0.668 . . . . 0.0 112.601 -170.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.56 7.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.113 0.869 . . . . 0.0 112.691 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.48 141.4 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.406 1.882 . . . . 0.0 107.914 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.793 168.871 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.457 -0.666 0 CA-C-O 121.667 0.611 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.35 148.43 67.91 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.32 1.448 . . . . 0.0 107.594 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -47.51 129.15 16.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.582 2.188 . . . . 0.0 110.088 170.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.64 -6.16 35.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.933 1.254 . . . . 0.0 112.297 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.35 150.8 22.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.385 2.092 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.66 142.53 38.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.13 146.08 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -129.05 146.78 50.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 167.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.83 93.78 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.8 135.04 51.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -128.21 172.41 6.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.055 1.342 . . . . 0.0 110.074 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.33 -34.88 26.21 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.454 2.77 . . . . 0.0 116.733 -169.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -139.75 7.98 2.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.699 0.8 . . . . 0.0 112.721 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.58 -169.0 1.97 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 109.121 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.17 156.82 45.88 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.166 -0.959 . . . . 0.0 109.216 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -119.76 169.08 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.471 1.508 . . . . 0.0 107.609 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -132.87 146.0 51.43 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.491 1.041 . . . . 0.0 111.146 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.89 174.88 12.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.647 1.979 . . . . 0.0 108.383 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 tt -135.72 135.51 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.35 131.52 37.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.82 -3.77 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.45 174.57 41.93 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.93 53.75 0.96 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.205 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.2 -13.08 0.29 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.289 -1.284 . . . . 0.0 113.781 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -120.3 155.76 32.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.095 1.948 . . . . 0.0 111.934 -171.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 m -133.98 160.33 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.971 1.308 . . . . 0.0 110.957 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -114.53 140.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 167.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.75 173.51 15.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.898 0.479 . . . . 0.0 110.937 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.32 141.22 34.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.94 160.93 58.63 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.425 1.89 . . . . 0.0 108.142 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -61.58 150.69 84.35 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.548 1.498 . . . . 0.0 109.727 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 123.395 2.73 . . . . 0.0 114.296 -179.336 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.56 12.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 112.058 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.42 148.5 25.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 125.761 1.624 . . . . 0.0 107.132 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.69 128.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -137.72 161.0 37.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.685 1.194 . . . . 0.0 109.145 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -121.67 134.08 54.97 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.62 160.9 43.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.755 1.222 . . . . 0.0 109.002 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.08 128.18 35.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.887 0.875 . . . . 0.0 108.877 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.33 -45.11 68.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.83 0.852 . . . . 0.0 110.626 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -64.3 -24.42 67.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.919 -172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.59 -43.22 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.706 0.685 . . . . 0.0 110.481 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.93 -46.8 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.452 0.701 . . . . 0.0 109.744 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.25 65.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.845 1.258 . . . . 0.0 112.117 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 -12.16 15.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.723 1.154 . . . . 0.0 113.363 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.9 m -52.42 -50.55 62.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.959 1.38 . . . . 0.0 111.133 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -165.04 -56.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.041 1.336 . . . . 0.0 110.631 171.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.95 -176.93 5.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.078 1.351 . . . . 0.0 109.855 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.79 169.53 24.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.894 0.878 . . . . 0.0 110.218 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -152.88 156.53 39.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.521 1.129 . . . . 0.0 110.065 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.64 138.43 20.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 169.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -150.63 67.96 0.95 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.171 0.51 . . . . 0.0 109.714 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.36 114.7 3.34 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -56.75 -42.33 79.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.458 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -163.11 43.47 0.12 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.331 0.652 . . . . 0.0 110.729 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.09 -14.25 6.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.818 . . . . 0.0 111.812 168.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.99 -16.74 37.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.0 1.32 . . . . 0.0 110.908 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -116.56 -27.11 6.82 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.454 1.102 . . . . 0.0 110.928 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -144.97 146.51 31.97 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.316 0.647 . . . . 0.0 111.643 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 p -164.82 66.28 1.23 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.541 1.536 . . . . 0.0 108.96 169.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.46 -13.82 41.49 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.452 2.101 . . . . 0.0 113.025 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.58 119.39 21.59 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.239 1.416 . . . . 0.0 108.764 -171.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.44 153.67 22.11 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.734 2.289 . . . . 0.0 110.146 167.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.1 m -52.71 -43.46 65.66 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.713 0.405 . . . . 0.0 111.87 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -56.71 -41.17 76.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.689 0.795 . . . . 0.0 112.269 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -64.94 -31.89 73.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.573 0.749 . . . . 0.0 111.133 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -64.74 -46.07 93.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.58 -48.81 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -55.64 -46.19 77.48 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.744 1.218 . . . . 0.0 110.724 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -61.03 -51.41 69.31 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.49 67.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.395 0.278 . . . . 0.0 110.712 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.76 -20.55 61.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.93 -27.49 61.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 119.254 0.934 . . . . 0.0 108.877 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.68 -16.19 15.54 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.711 -1.137 . . . . 0.0 113.529 -168.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.0 t -53.2 134.78 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.622 1.556 . . . . 0.0 108.578 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.78 -7.17 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.524 1.059 . . . . 0.0 113.335 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 159.36 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.184 1.492 . . . . 0.0 108.918 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -127.51 142.87 51.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.71 146.79 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.876 0.87 . . . . 0.0 109.01 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.36 -1.21 48.2 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.757 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -80.14 149.68 30.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.813 0.733 . . . . 0.0 109.209 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -74.65 154.45 38.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.498 1.919 . . . . 0.0 109.443 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.91 121.81 16.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.7 p -140.92 158.26 44.2 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 m -51.97 -42.38 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.852 0.461 . . . . 0.0 110.184 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.46 -48.33 70.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 110.841 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.67 -38.04 83.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.57 0.623 . . . . 0.0 110.853 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.2 m -67.91 -44.62 76.51 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.932 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -58.01 -44.69 87.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.489 0.715 . . . . 0.0 110.209 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -56.86 -52.41 65.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.163 1.385 . . . . 0.0 109.414 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -62.33 -49.97 73.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.757 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.0 -33.17 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.693 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.16 -34.7 78.62 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 121.639 -0.663 . . . . 0.0 110.682 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.55 -34.44 71.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.354 0.662 . . . . 0.0 112.203 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -76.88 -45.5 27.95 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.53 -0.731 . . . . 0.0 110.253 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -34.87 61.31 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.301 0.64 . . . . 0.0 111.265 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.08 8.35 6.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 111.999 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.77 -21.04 12.03 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.057 -1.027 . . . . 0.0 112.906 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.26 143.57 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.605 1.562 . . . . 0.0 106.891 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.483 0.713 . . . . 0.0 111.256 172.81 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 N-CA-C 111.824 -0.106 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -125.35 141.52 39.02 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.98 134.84 18.2 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.772 2.315 . . . . 0.0 110.504 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.65 -10.0 58.96 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.154 1.359 . . . . 0.0 112.402 -169.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -78.04 140.5 39.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.119 1.959 . . . . 0.0 111.033 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.57 136.28 52.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.89 140.87 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.31 145.63 45.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 110.95 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -75.76 134.48 40.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -132.86 168.89 15.65 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.053 0.941 . . . . 0.0 110.687 -170.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.53 -30.41 35.61 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.37 2.713 . . . . 0.0 116.588 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 4.93 1.5 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.474 0.71 . . . . 0.0 112.763 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.68 -165.86 1.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.699 1.2 . . . . 0.0 109.029 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.09 149.46 44.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -120.69 171.77 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.746 1.618 . . . . 0.0 108.362 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -138.18 146.13 42.33 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.471 0.709 . . . . 0.0 111.012 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 174.43 12.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.459 1.904 . . . . 0.0 108.065 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.94 131.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.34 134.42 41.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.86 -3.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.58 175.18 42.63 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.88 55.38 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.163 0.985 . . . . 0.0 111.394 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.12 -15.3 0.33 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.956 1.265 . . . . 0.0 113.694 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -119.6 154.06 34.54 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.714 1.757 . . . . 0.0 111.738 -169.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.16 159.61 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.655 1.182 . . . . 0.0 110.673 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -111.47 138.68 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 167.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.67 168.03 27.95 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 111.009 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.39 139.95 33.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 165.34 21.07 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.534 1.533 . . . . 0.0 109.184 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.42 150.51 41.62 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.736 2.291 . . . . 0.0 112.458 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 C-N-CA 122.324 2.016 . . . . 0.0 109.938 174.691 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.22 176.83 10.83 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.222 1.009 . . . . 0.0 110.481 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -138.03 148.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.73 126.58 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -130.64 166.14 21.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.348 1.059 . . . . 0.0 109.772 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.06 127.46 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -151.8 163.16 39.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.462 1.105 . . . . 0.0 108.84 -169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.64 131.07 45.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.69 -45.64 70.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.693 0.797 . . . . 0.0 110.576 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -66.37 -19.81 65.9 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.94 -45.27 16.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.851 0.751 . . . . 0.0 110.065 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.6 t -59.43 -40.79 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.796 0.838 . . . . 0.0 110.638 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.02 -2.0 54.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 0.0 113.115 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.29 -15.88 46.88 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.917 0.77 . . . . 0.0 113.14 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 p -55.95 -47.13 78.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.139 1.376 . . . . 0.0 111.976 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -162.76 -67.9 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.707 1.203 . . . . 0.0 111.706 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -155.54 172.57 18.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.167 0.987 . . . . 0.0 109.926 -167.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.33 165.56 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.848 0.859 . . . . 0.0 110.75 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.56 163.08 40.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.07 0.948 . . . . 0.0 110.414 167.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.1 139.38 20.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 168.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -147.3 55.42 1.09 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.39 0.614 . . . . 0.0 110.39 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -54.61 113.03 1.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -61.84 -33.3 73.92 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -138.06 23.22 2.81 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.68 0.792 . . . . 0.0 112.13 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.4 -2.71 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.348 0.976 . . . . 0.0 112.491 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.69 -26.33 59.77 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.169 -0.957 . . . . 0.0 110.945 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -143.2 -25.02 0.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -128.92 164.81 22.32 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.494 1.518 . . . . 0.0 112.233 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 m 165.64 72.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 131.52 3.928 . . . . 0.0 106.077 168.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.33 -13.86 36.48 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.287 2.658 . . . . 0.0 113.512 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.6 120.06 34.99 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 108.218 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.23 158.33 12.26 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 111.884 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -48.56 -44.46 36.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 111.786 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.2 p -56.02 -51.91 66.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.575 0.75 . . . . 0.0 110.926 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -65.46 -37.02 85.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.7 0.8 . . . . 0.0 111.373 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.87 -48.7 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.79 -39.36 83.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -55.74 -45.68 77.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.485 0.714 . . . . 0.0 110.213 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -60.85 -53.93 51.26 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 119.008 -0.52 . . . . 0.0 109.678 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.99 -48.84 61.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.283 0.492 . . . . 0.0 111.21 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -66.31 -34.22 77.5 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.681 1.592 . . . . 0.0 112.244 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -72.88 -24.09 60.81 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.232 1.013 . . . . 0.0 109.979 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.17 -12.02 17.64 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.965 . . . . 0.0 112.669 -168.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.87 142.19 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.375 1.443 . . . . 0.0 109.598 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.02 -8.39 79.91 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.807 1.194 . . . . 0.0 113.172 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -81.68 153.62 26.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.0 1.4 . . . . 0.0 109.186 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -101.52 154.16 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.321 1.048 . . . . 0.0 109.238 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.57 147.99 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 107.797 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.18 34.92 2.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.17 0.985 . . . . 0.0 110.665 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -125.54 146.77 49.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 108.393 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -73.38 164.12 27.12 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 127.099 2.16 . . . . 0.0 110.383 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.36 126.71 30.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.5 p -145.01 159.0 43.64 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -44.43 64.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.035 0.534 . . . . 0.0 109.623 174.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.11 -43.5 70.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.798 0.839 . . . . 0.0 111.447 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -66.68 -41.85 87.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.102 0.865 . . . . 0.0 110.369 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.23 -43.97 80.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.878 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.48 -45.22 89.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.4 0.68 . . . . 0.0 110.311 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -57.13 -52.02 66.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.041 0.936 . . . . 0.0 109.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -61.54 -49.42 76.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.019 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.21 -32.45 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.603 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -67.9 -31.75 71.75 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.219 -0.925 . . . . 0.0 111.151 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.2 -19.76 55.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.651 1.18 . . . . 0.0 112.414 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.5 -43.87 6.37 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.783 0.833 . . . . 0.0 110.339 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.65 -43.23 76.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.577 1.08 . . . . 0.0 111.438 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.4 2.41 13.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.45 -30.62 5.18 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.346 -0.846 . . . . 0.0 112.138 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -156.1 141.36 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 169.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 118.282 0.492 . . . . 0.0 110.64 170.006 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 CA--C 1.536 0.617 0 CA-C-O 120.853 0.272 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -138.48 151.42 69.08 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.148 0.979 . . . . 0.0 110.036 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -46.33 135.33 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.879 2.386 . . . . 0.0 110.837 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -14.59 54.49 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.254 1.407 . . . . 0.0 111.797 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -83.77 151.03 25.42 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.098 1.949 . . . . 0.0 111.43 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.9 139.54 41.69 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.42 125.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -96.86 152.08 19.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.4 mm -126.35 109.84 22.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.91 132.51 46.83 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.41 166.43 17.33 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.32 -35.88 28.65 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.47 2.78 . . . . 0.0 116.235 -168.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.97 13.05 2.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.285 1.034 . . . . 0.0 111.801 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.09 -164.78 1.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.058 0.943 . . . . 0.0 109.954 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 156.66 47.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 172.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -124.16 170.71 10.44 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.748 2.019 . . . . 0.0 106.292 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -136.8 148.3 47.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.715 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 173.71 12.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 107.962 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.7 tt -136.58 134.21 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.22 131.73 37.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.286 1.035 . . . . 0.0 108.309 -171.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.41 -5.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.45 -178.88 38.23 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.35 41.77 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.255 1.022 . . . . 0.0 111.671 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.41 -29.75 0.28 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.905 1.24 . . . . 0.0 112.627 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -88.77 149.65 23.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.784 1.292 . . . . 0.0 111.445 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -131.59 155.48 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.561 1.545 . . . . 0.0 109.112 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -102.42 143.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 166.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.2 165.07 35.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.571 -0.705 . . . . 0.0 111.131 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 136.91 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.27 34.53 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.804 0.842 . . . . 0.0 110.71 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.7 164.25 36.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.416 2.077 . . . . 0.0 110.112 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 C--N 1.348 0.54 0 C-N-CA 122.058 1.839 . . . . 0.0 110.675 173.047 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.28 -172.69 4.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 109.728 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 mt -141.8 156.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.867 1.267 . . . . 0.0 109.252 -170.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -98.82 127.88 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -129.92 168.7 16.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.456 1.102 . . . . 0.0 110.411 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -125.72 134.34 51.81 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -150.69 160.83 43.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.74 1.216 . . . . 0.0 108.686 -175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.44 138.01 56.31 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 167.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.85 -33.4 68.62 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.687 0.795 . . . . 0.0 110.623 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -36.97 74.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.954 0.797 . . . . 0.0 110.954 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.07 -46.04 65.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.831 0.287 . . . . 0.0 110.471 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.67 -41.24 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.091 0.557 . . . . 0.0 110.397 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.22 40.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.383 1.473 . . . . 0.0 113.45 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.48 -16.0 34.44 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.044 0.831 . . . . 0.0 113.689 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 p -61.64 -44.1 97.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.553 1.176 . . . . 0.0 112.014 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -162.26 -59.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.861 0.865 . . . . 0.0 112.377 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -164.32 -170.73 2.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.673 1.589 . . . . 0.0 108.986 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -148.1 166.88 26.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.889 0.875 . . . . 0.0 109.956 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -145.44 153.21 40.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.197 1.399 . . . . 0.0 107.482 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -83.77 137.31 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.37 70.78 0.87 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.228 0.537 . . . . 0.0 109.92 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.51 112.9 2.66 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -65.69 -11.43 45.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.869 . . . . 0.0 113.184 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.8 m-70 -129.85 26.24 5.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.639 1.175 . . . . 0.0 111.591 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.11 23.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.895 -1.128 . . . . 0.0 112.605 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.8 t70 -132.91 -3.38 3.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 111.607 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -132.82 -31.59 1.31 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.26 1.424 . . . . 0.0 111.579 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 67.81 136.11 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 128.569 2.748 . . . . 0.0 116.211 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -63.93 139.97 97.76 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.382 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -16.75 32.37 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.894 2.396 . . . . 0.0 112.211 168.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.04 128.39 26.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.669 1.588 . . . . 0.0 108.802 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.93 155.03 24.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.165 2.577 . . . . 0.0 111.832 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.0 p -54.3 -40.45 67.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.86 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -56.52 -53.56 56.12 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.595 0.758 . . . . 0.0 110.569 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -62.92 -36.89 84.89 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.298 0.639 . . . . 0.0 111.472 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.03 -51.55 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.158 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -56.03 -49.1 74.64 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.188 0.995 . . . . 0.0 110.036 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -65.16 -45.65 84.08 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.729 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.95 -52.07 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.632 0.651 . . . . 0.0 110.793 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.93 -23.18 60.66 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -72.73 -27.5 62.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.66 -4.58 30.58 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.703 0.801 . . . . 0.0 113.051 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.28 150.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 109.828 169.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.5 23.53 56.15 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.439 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -126.85 161.98 26.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.703 1.201 . . . . 0.0 107.927 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.08 156.86 16.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.941 1.296 . . . . 0.0 109.754 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.8 m -130.56 148.84 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.827 2.051 . . . . 0.0 106.664 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.44 19.78 11.6 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.62 -0.675 . . . . 0.0 112.223 -169.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -121.41 155.92 33.79 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.293 1.437 . . . . 0.0 109.179 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -88.44 169.93 11.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.431 1.093 . . . . 0.0 112.542 -170.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.19 121.45 14.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 p -147.05 152.86 39.24 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 165.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -53.57 -40.84 65.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.102 0.41 . . . . 0.0 110.571 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.79 -44.74 84.81 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.376 0.67 . . . . 0.0 111.047 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -67.94 -38.57 83.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 0.786 . . . . 0.0 110.534 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.62 -44.62 81.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.646 0.657 . . . . 0.0 110.039 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -60.11 -45.3 93.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.101 0.56 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -57.82 -54.48 46.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.251 1.02 . . . . 0.0 109.587 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.49 -48.62 80.18 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.919 0.488 . . . . 0.0 111.729 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.47 -31.25 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.165 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -72.38 -27.61 62.49 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.897 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -61.61 -39.61 91.86 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.811 1.187 . . . . 0.0 109.644 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.42 -47.32 50.04 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.288 -0.883 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -17.35 59.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.284 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -142.76 7.39 1.66 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.81 1.186 . . . . 0.0 113.585 -169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.97 -48.55 3.68 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 120.806 -1.184 . . . . 0.0 110.637 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.66 141.23 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.582 1.953 . . . . 0.0 106.931 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.938 168.362 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.5 Cg_endo . . . . . 0 N--CA 1.46 -0.452 0 CA-C-O 121.179 0.408 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -135.81 151.79 74.74 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.726 1.211 . . . . 0.0 108.95 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HB2' HD11 ' A' ' 93' ' ' ILE . 94.8 Cg_exo -47.01 143.53 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.889 2.393 . . . . 0.0 111.495 169.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.56 73.99 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.038 1.304 . . . . 0.0 112.227 -170.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -76.76 147.81 37.07 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.509 1.654 . . . . 0.0 111.056 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.87 140.86 46.0 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.098 0.959 . . . . 0.0 108.829 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -125.21 138.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.39 148.9 41.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -121.87 106.37 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 -169.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -75.42 133.01 41.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -129.3 167.85 18.42 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 0.0 110.531 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.12 -25.54 29.65 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.252 2.635 . . . . 0.0 116.433 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -141.48 0.25 1.46 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.02 -165.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.67 1.188 . . . . 0.0 109.271 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -134.01 152.22 51.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -126.78 171.95 10.77 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.144 1.777 . . . . 0.0 107.998 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 66.6 m95 -139.2 150.0 45.05 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.073 0.851 . . . . 0.0 110.869 -172.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.33 173.24 16.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.421 1.488 . . . . 0.0 108.667 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.77 128.94 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.39 130.14 42.21 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.68 1.592 . . . . 0.0 109.433 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.53 168.6 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.075 1.35 . . . . 0.0 109.416 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.84 -135.31 49.23 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -120.71 8.99 10.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.397 1.079 . . . . 0.0 111.392 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.11 16.67 0.02 OUTLIER Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.437 -0.789 . . . . 0.0 113.686 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -107.6 169.2 8.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.847 1.324 . . . . 0.0 109.013 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.85 151.98 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.936 0.494 . . . . 0.0 110.649 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.28 141.37 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 166.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.84 171.54 17.59 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.92 143.2 30.88 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.6 159.33 71.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.286 1.834 . . . . 0.0 108.561 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.49 159.55 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.156 1.904 . . . . 0.0 110.921 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.538 0.676 0 C-N-CA 122.509 2.139 . . . . 0.0 113.008 -177.283 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.55 173.9 13.57 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.397 . . . . 0.0 108.21 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -142.13 154.52 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.65 138.52 19.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -142.92 168.59 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.953 1.301 . . . . 0.0 108.814 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -128.54 140.79 51.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -151.24 161.14 43.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.41 1.484 . . . . 0.0 107.929 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.82 137.25 57.09 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.61 -44.74 73.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.714 0.688 . . . . 0.0 110.82 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.04 -19.79 65.74 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.92 -47.58 28.99 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.129 0.877 . . . . 0.0 109.737 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.4 t -62.19 -43.35 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.563 0.745 . . . . 0.0 110.243 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.43 -7.97 56.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.992 1.317 . . . . 0.0 113.182 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.32 -20.41 58.56 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.714 0.673 . . . . 0.0 113.22 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 -47.49 84.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.77 1.228 . . . . 0.0 111.976 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -159.08 -61.42 0.07 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.733 0.813 . . . . 0.0 112.884 172.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -155.73 171.34 20.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -158.94 163.25 36.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.71 0.804 . . . . 0.0 110.111 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -151.15 154.14 36.33 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.605 0.762 . . . . 0.0 110.78 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 8' ' ' PRO . 92.2 t -79.81 137.56 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.74 68.55 0.46 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.528 0.68 . . . . 0.0 110.587 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.91 101.58 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -68.14 129.53 40.2 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 44.67 44.89 7.78 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.866 1.667 . . . . 0.0 112.1 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.78 -12.43 4.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.623 0.769 . . . . 0.0 112.967 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.95 -20.24 33.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.657 1.583 . . . . 0.0 111.029 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 -14.25 8.94 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.987 1.315 . . . . 0.0 111.026 -173.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -136.37 -156.09 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.973 1.709 . . . . 0.0 109.452 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m 57.79 59.93 6.57 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.361 1.864 . . . . 0.0 112.359 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -61.8 -14.74 38.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.363 2.042 . . . . 0.0 114.197 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.46 141.69 23.04 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.683 0.793 . . . . 0.0 110.51 -167.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 159.48 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.202 . . . . 0.0 110.137 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.7 m -48.05 -47.63 33.59 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.464 1.106 . . . . 0.0 111.57 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.68 -49.99 69.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.538 0.735 . . . . 0.0 111.683 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.38 -35.25 77.42 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.774 -0.579 . . . . 0.0 111.433 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.8 -49.01 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 10' ' ' PRO . 54.7 mt -63.69 -45.05 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.181 0.993 . . . . 0.0 109.166 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.07 -52.27 52.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.052 0.941 . . . . 0.0 108.963 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -66.86 -45.99 76.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.305 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.27 -47.88 62.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.617 0.644 . . . . 0.0 111.434 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.6 -10.72 57.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.351 0.661 . . . . 0.0 112.594 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.68 -22.49 40.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.38 0.991 . . . . 0.0 110.185 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.5 mt -111.7 -4.64 14.63 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.602 0.761 . . . . 0.0 112.372 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.25 142.79 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 118.869 0.759 . . . . 0.0 110.066 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.64 -3.2 80.04 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.297 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -74.07 152.74 39.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.321 1.561 . . . . 0.0 109.268 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.46 149.97 22.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.13 176.63 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.585 1.154 . . . . 0.0 107.944 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.42 6.12 6.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.564 -0.71 . . . . 0.0 112.519 -169.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -99.0 146.43 26.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.123 0.969 . . . . 0.0 109.062 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -61.83 153.46 28.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.323 1.449 . . . . 0.0 111.149 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.65 127.08 31.02 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.4 p -141.86 159.51 42.07 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 m -49.31 -42.09 40.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.21 0.604 . . . . 0.0 111.127 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.2 -23.75 18.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.318 -168.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -68.16 -39.93 82.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.633 1.106 . . . . 0.0 109.442 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.2 m -69.79 -40.6 75.91 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.079 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -53.64 -49.09 68.64 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.446 0.698 . . . . 0.0 109.883 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -60.2 -46.2 90.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.181 0.992 . . . . 0.0 110.11 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.31 -53.19 59.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.373 0.533 . . . . 0.0 111.77 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.86 -33.71 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 119.881 -0.727 . . . . 0.0 111.216 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -68.75 -32.12 71.65 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.596 -0.69 . . . . 0.0 111.148 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.17 -41.7 98.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.207 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.59 -44.79 81.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.865 1.212 . . . . 0.0 111.017 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -66.07 -42.43 89.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.343 0.657 . . . . 0.0 111.463 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -95.33 -43.98 7.78 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.001 0.364 . . . . 0.0 111.909 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.33 -53.52 0.69 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.53 138.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.127 -0.463 . . . . 0.0 109.82 -179.293 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 CA--C 1.536 0.576 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.05 151.02 69.7 Favored Pre-proline 0 C--O 1.236 0.351 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.86 131.53 38.62 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.018 1.812 . . . . 0.0 109.3 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.9 -1.48 65.49 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.749 1.166 . . . . 0.0 113.015 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -73.61 147.71 43.55 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.963 1.881 . . . . 0.0 111.06 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.08 136.11 44.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.89 124.31 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.96 150.29 20.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -125.89 113.56 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -171.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 131.74 44.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -119.49 169.0 8.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.528 1.531 . . . . 0.0 107.888 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.26 96.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.733 2.288 . . . . 0.0 112.625 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 57.88 28.02 15.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.407 2.283 . . . . 0.0 113.508 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -149.21 -164.57 2.06 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.938 0.895 . . . . 0.0 109.436 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.9 158.84 43.43 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.065 -1.022 . . . . 0.0 109.591 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -127.77 168.53 15.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -135.62 150.65 49.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.864 0.757 . . . . 0.0 111.345 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.69 173.07 14.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.092 1.757 . . . . 0.0 108.181 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.77 132.97 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -70.93 134.83 47.54 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.624 1.17 . . . . 0.0 109.856 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.46 165.94 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.39 1.076 . . . . 0.0 109.879 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.54 -123.17 31.86 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -142.95 37.48 1.42 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.317 1.047 . . . . 0.0 109.021 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.2 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.382 -0.824 . . . . 0.0 115.016 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.39 171.03 7.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.938 1.369 . . . . 0.0 109.168 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.57 159.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.794 0.838 . . . . 0.0 110.194 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.8 137.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.73 173.3 14.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.545 0.738 . . . . 0.0 110.781 -172.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.26 143.37 30.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 161.9 46.7 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.862 1.665 . . . . 0.0 109.791 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 154.96 27.32 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.235 2.624 . . . . 0.0 112.533 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 CA--C 1.54 0.787 0 C-N-CA 122.85 2.367 . . . . 0.0 112.373 175.903 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.18 175.0 14.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.003 1.321 . . . . 0.0 108.467 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.78 157.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.0 139.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -142.74 169.65 17.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.572 1.549 . . . . 0.0 108.739 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.55 142.65 51.47 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -151.28 159.38 44.37 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.728 1.211 . . . . 0.0 108.443 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.9 135.6 52.73 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.87 -44.12 70.14 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.485 0.584 . . . . 0.0 111.679 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -66.51 -22.25 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.21 -44.4 59.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.789 0.722 . . . . 0.0 109.935 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.72 -41.49 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.414 0.686 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -3.78 22.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.657 1.183 . . . . 0.0 113.526 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.87 42.92 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.853 1.216 . . . . 0.0 114.831 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -58.88 -44.3 91.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.73 1.265 . . . . 0.0 112.365 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.2 -67.45 0.06 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 123.605 0.762 . . . . 0.0 112.439 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -157.76 177.03 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.638 1.175 . . . . 0.0 108.726 -166.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -151.93 169.59 21.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.05 1.34 . . . . 0.0 108.527 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.68 152.67 25.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.809 0.844 . . . . 0.0 110.296 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.69 133.24 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -149.68 70.86 1.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.729 0.776 . . . . 0.0 109.163 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.02 119.13 10.82 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -62.74 -28.27 69.85 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.326 -0.234 . . . . 0.0 110.761 169.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -97.16 17.52 16.99 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.041 -168.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.73 21.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.776 1.626 . . . . 0.0 113.048 176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.9 t70 -136.3 2.19 2.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 111.469 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -138.08 -30.44 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.737 1.615 . . . . 0.0 111.866 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 67.54 149.6 0.06 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 128.986 2.914 . . . . 0.0 115.968 169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -50.73 113.41 3.67 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.17 1.388 . . . . 0.0 111.261 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.82 -18.85 16.69 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.941 2.427 . . . . 0.0 111.793 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.49 136.42 20.83 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 126.029 1.731 . . . . 0.0 107.273 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.61 145.78 57.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.083 1.855 . . . . 0.0 109.284 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.1 m -54.42 -42.34 70.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.45 0.3 . . . . 0.0 111.433 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -56.66 -42.51 79.11 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.703 0.801 . . . . 0.0 112.055 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -66.42 -33.19 75.15 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 117.764 -1.112 . . . . 0.0 111.441 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.4 mt -58.22 -49.04 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.135 1.334 . . . . 0.0 108.045 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.2 mm -61.89 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.862 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -45.2 91.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.23 -51.98 65.57 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.47 49.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.839 0.856 . . . . 0.0 110.721 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -76.76 -18.01 58.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.958 -0.544 . . . . 0.0 112.324 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.86 -27.16 62.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.684 1.129 . . . . 0.0 110.265 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.86 -27.69 16.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 110.644 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.12 125.62 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.581 1.082 . . . . 0.0 108.956 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.93 82.6 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.098 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -82.22 153.82 25.74 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.851 1.826 . . . . 0.0 108.885 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.85 151.42 23.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.228 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.52 172.24 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.668 1.187 . . . . 0.0 108.429 169.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.25 14.27 10.46 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.474 -0.766 . . . . 0.0 111.667 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -112.04 149.48 31.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 109.288 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -68.19 161.3 27.39 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 112.359 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.19 124.16 20.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.5 p -144.57 157.53 44.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.5 m -53.26 -45.41 68.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.653 0.381 . . . . 0.0 110.144 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.48 -37.98 80.61 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.086 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -69.24 -37.82 78.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.329 0.968 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.2 m -65.3 -47.37 76.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.12 -44.31 87.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.236 1.014 . . . . 0.0 110.144 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -58.04 -56.26 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 109.309 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.81 -47.37 85.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.722 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.6 -32.64 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.611 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -70.96 -40.96 71.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 110.528 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.6 -43.77 68.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.452 1.101 . . . . 0.0 110.618 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -72.08 -44.72 62.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.356 1.062 . . . . 0.0 112.007 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -74.43 -35.11 63.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.415 1.007 . . . . 0.0 112.658 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -120.96 -2.41 9.73 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -167.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.06 -26.24 24.29 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.831 -1.168 . . . . 0.0 111.983 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.65 139.91 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.049 -0.501 . . . . 0.0 111.128 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 121.131 0.388 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -128.91 147.13 63.37 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.497 0.719 . . . . 0.0 109.863 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -47.96 139.06 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.55 -3.1 68.16 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.662 1.125 . . . . 0.0 112.438 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -80.52 139.26 36.44 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.056 1.428 . . . . 0.0 109.661 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mt -67.73 135.33 52.55 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.69 126.9 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -97.49 148.6 23.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 mm -126.18 123.03 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -75.0 112.39 11.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -84.64 171.27 11.4 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.88 -34.19 74.9 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.549 2.166 . . . . 0.0 114.904 -171.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -141.21 13.06 2.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.437 1.095 . . . . 0.0 111.967 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -157.68 -157.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.759 1.224 . . . . 0.0 109.272 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.24 155.07 45.23 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.085 -1.009 . . . . 0.0 109.809 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.61 168.49 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.009 1.724 . . . . 0.0 106.565 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -136.4 147.12 47.13 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.782 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.68 11.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.214 1.805 . . . . 0.0 107.48 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 tt -134.07 132.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.88 129.08 38.41 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.228 1.411 . . . . 0.0 108.879 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.2 m -136.38 169.14 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.07 0.948 . . . . 0.0 109.326 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.12 -117.32 8.76 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -141.7 25.33 1.99 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.26 1.024 . . . . 0.0 110.685 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.79 -17.29 0.14 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.159 -0.963 . . . . 0.0 113.853 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -70.79 163.65 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.012 0.906 . . . . 0.0 109.723 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.76 154.65 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.17 137.44 33.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.76 168.9 25.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 111.501 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -89.81 133.14 34.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.119 1.368 . . . . 0.0 107.441 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.84 153.89 58.15 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.275 1.03 . . . . 0.0 111.171 -171.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 152.53 44.02 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.329 2.686 . . . . 0.0 112.934 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 C--N 1.35 0.625 0 C-N-CA 122.876 2.384 . . . . 0.0 112.94 179.151 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 -170.84 3.69 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.235 1.414 . . . . 0.0 109.734 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -149.76 173.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.73 141.11 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.83 166.96 21.78 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.785 1.234 . . . . 0.0 110.048 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -126.59 125.92 42.75 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.19 161.69 40.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.629 1.172 . . . . 0.0 108.415 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 132.12 44.94 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -49.11 -48.35 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.47 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.46 -25.99 68.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.049 0.386 . . . . 0.0 111.914 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.59 -43.59 31.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.482 0.583 . . . . 0.0 110.367 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.79 -35.87 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 110.224 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.18 10.59 31.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.762 1.225 . . . . 0.0 113.508 -176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.62 -22.17 38.46 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.817 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -57.5 -50.12 74.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 1.271 . . . . 0.0 113.254 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.86 -69.07 0.06 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -157.74 172.0 19.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.497 1.119 . . . . 0.0 109.294 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -163.99 157.55 18.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.402 1.081 . . . . 0.0 109.328 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.48 166.14 34.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.404 0.681 . . . . 0.0 110.115 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.76 139.98 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -150.58 71.54 1.05 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -66.98 93.53 0.28 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -60.99 122.13 14.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 48.56 44.44 20.88 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 113.017 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.12 -19.05 2.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.134 0.974 . . . . 0.0 113.307 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.17 -22.68 30.89 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.228 1.011 . . . . 0.0 110.892 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -112.49 -26.47 8.67 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.986 0.914 . . . . 0.0 111.279 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.92 159.99 42.03 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m 128.69 76.75 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 1 C-N-CA 131.801 4.041 . . . . 0.0 108.708 174.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.38 -19.48 43.44 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.804 2.336 . . . . 0.0 114.017 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.42 132.9 29.25 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.534 0.734 . . . . 0.0 109.818 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.46 162.83 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.11 1.873 . . . . 0.0 109.115 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.2 m -50.94 -43.12 60.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.82 0.848 . . . . 0.0 112.587 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 p -55.59 -47.68 76.09 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.847 0.859 . . . . 0.0 111.996 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -32.07 73.48 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.54 0.736 . . . . 0.0 111.228 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.8 mt -65.13 -47.56 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.05 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 118.603 0.638 . . . . 0.0 109.915 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -54.86 -49.74 70.38 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.865 0.866 . . . . 0.0 109.793 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.05 -52.29 66.02 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.088 0.555 . . . . 0.0 110.144 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.8 -15.71 55.69 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.229 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.89 -32.05 68.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.784 1.174 . . . . 0.0 109.165 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.0 -18.12 22.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.055 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -50.34 130.67 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.93 1.241 . . . . 0.0 109.445 171.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.3 -2.61 81.14 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.277 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.34 162.81 19.91 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.472 1.636 . . . . 0.0 109.193 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -103.77 153.19 20.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.887 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG21 HD21 ' A' ' 36' ' ' LEU . 16.1 m -129.2 146.6 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 109.682 171.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -97.56 23.11 8.07 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.003 -1.061 . . . . 0.0 112.336 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -125.04 151.42 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.048 1.339 . . . . 0.0 110.508 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -65.85 162.6 18.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.44 2.296 . . . . 0.0 112.167 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.53 125.89 28.07 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.0 p -146.69 156.54 43.25 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -53.76 -42.52 68.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.64 0.776 . . . . 0.0 110.408 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.24 -39.92 82.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.05 0.94 . . . . 0.0 110.987 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -68.26 -34.45 76.23 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.36 0.982 . . . . 0.0 110.93 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.58 -45.3 83.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.406 1.003 . . . . 0.0 110.145 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -60.61 -45.33 94.42 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.256 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -57.87 -55.39 35.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.136 1.374 . . . . 0.0 109.021 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -55.09 -50.5 69.01 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.893 0.477 . . . . 0.0 111.52 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.45 -31.28 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.701 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -70.62 -27.88 64.42 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 121.52 -0.738 . . . . 0.0 111.656 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 59.9 mt-10 -60.23 -30.33 69.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.416 1.007 . . . . 0.0 110.643 170.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 mt -81.94 -47.6 12.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.657 0.662 . . . . 0.0 110.018 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -26.43 67.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.311 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -119.84 -33.63 3.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.764 0.711 . . . . 0.0 112.776 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.09 -40.09 2.08 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 p -157.27 140.41 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 118.649 0.659 . . . . 0.0 110.606 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 110.229 -0.719 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.29 139.82 29.0 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.47 137.54 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.171 2.581 . . . . 0.0 111.931 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.84 -16.64 60.85 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.02 -1.434 . . . . 0.0 112.44 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -71.12 153.99 42.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.505 2.153 . . . . 0.0 109.803 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.29 138.79 39.58 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.36 145.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -123.54 151.18 43.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 166.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -126.58 108.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.7 140.71 48.02 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.989 171.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -115.2 169.39 6.8 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.626 1.57 . . . . 0.0 107.45 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.63 -24.74 55.81 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.784 2.323 . . . . 0.0 115.316 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -141.71 3.99 1.69 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.108 0.963 . . . . 0.0 113.323 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -157.92 -160.89 0.96 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.633 1.173 . . . . 0.0 109.076 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -150.2 154.09 37.39 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -140.22 169.13 18.26 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.335 1.854 . . . . 0.0 107.283 -173.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -135.85 149.86 49.18 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.712 0.687 . . . . 0.0 110.42 -173.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.83 173.3 13.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.667 1.987 . . . . 0.0 108.11 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.57 133.69 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.6 136.98 38.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.57 0.57 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.87 -175.09 39.23 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.88 42.83 0.32 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 111.377 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 -33.27 0.25 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.87 -0.961 . . . . 0.0 113.109 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -89.57 153.26 20.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.464 1.632 . . . . 0.0 111.713 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.55 155.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.31 1.444 . . . . 0.0 109.665 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.46 136.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.29 173.05 16.26 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.724 -0.61 . . . . 0.0 110.645 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.23 147.21 28.14 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.97 165.86 22.14 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.491 1.917 . . . . 0.0 108.202 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.45 154.13 12.25 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.628 2.219 . . . . 0.0 112.174 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.538 0.697 0 C-N-CA 122.296 1.998 . . . . 0.0 110.923 174.772 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.025 0.44 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 172.85 14.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.983 0.913 . . . . 0.0 110.109 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.42 149.09 28.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 125.401 1.481 . . . . 0.0 107.101 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.17 129.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -128.22 167.98 16.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.564 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -124.72 129.61 50.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.87 160.52 43.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.46 130.37 40.52 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.25 -40.69 64.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.202 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -36.02 67.92 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.443 0.565 . . . . 0.0 111.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.67 -42.82 67.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.113 0.415 . . . . 0.0 110.038 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 t -66.13 -45.73 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.569 0.748 . . . . 0.0 109.522 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.92 -22.79 65.89 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.411 1.084 . . . . 0.0 112.015 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.67 -11.63 8.2 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.23 1.395 . . . . 0.0 113.483 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -49.36 -51.44 34.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.658 1.229 . . . . 0.0 110.722 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.79 -52.34 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.918 1.687 . . . . 0.0 110.184 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -159.69 173.76 15.57 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.458 1.903 . . . . 0.0 107.973 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -153.21 167.74 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.347 -0.846 . . . . 0.0 110.787 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.3 165.71 27.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.919 1.687 . . . . 0.0 108.327 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.84 128.8 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -158.1 63.94 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -55.94 128.55 35.74 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -69.19 -56.08 8.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.62 -166.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.49 45.59 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.645 1.178 . . . . 0.0 109.812 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.89 -10.55 4.11 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.294 -0.879 . . . . 0.0 112.89 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -86.61 -21.71 26.64 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.223 1.009 . . . . 0.0 111.037 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -113.15 -25.91 8.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.295 1.038 . . . . 0.0 111.162 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -143.03 -165.16 2.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.178 1.791 . . . . 0.0 109.435 -169.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m 57.64 62.69 5.21 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.408 1.483 . . . . 0.0 113.569 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -11.66 31.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.354 2.036 . . . . 0.0 113.934 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.99 132.64 94.68 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.954 1.301 . . . . 0.0 110.429 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.6 151.67 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.632 2.221 . . . . 0.0 110.978 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.39 -41.11 65.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.302 0.641 . . . . 0.0 111.102 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -52.31 -50.51 62.06 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 111.335 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -68.33 -38.52 81.6 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.29 0.636 . . . . 0.0 110.7 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.64 -49.58 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.47 -41.4 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.874 0.87 . . . . 0.0 109.375 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -55.32 -51.23 67.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.764 0.826 . . . . 0.0 109.185 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -62.31 -43.1 99.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.271 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.88 83.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.265 0.939 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.57 -15.27 55.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.178 0.591 . . . . 0.0 112.308 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -79.99 -21.31 43.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.106 0.962 . . . . 0.0 110.737 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -115.65 -5.08 12.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.492 0.717 . . . . 0.0 112.813 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.75 146.0 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.054 0.843 . . . . 0.0 109.835 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 -6.34 79.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.621 1.105 . . . . 0.0 112.967 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -79.26 155.23 28.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.114 1.457 . . . . 0.0 109.519 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.97 151.71 24.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.638 1.175 . . . . 0.0 108.966 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.59 147.04 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.141 1.376 . . . . 0.0 107.996 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.53 33.73 3.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.543 1.163 . . . . 0.0 110.492 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -130.91 158.17 40.95 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.514 1.926 . . . . 0.0 108.182 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.36 156.22 39.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.36 48.54 0.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.475 1.51 . . . . 0.0 111.454 168.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 p -65.71 158.86 26.38 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.831 -1.168 . . . . 0.0 108.597 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.2 m -51.48 -41.31 60.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.117 0.967 . . . . 0.0 111.095 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.32 -41.62 80.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.663 0.785 . . . . 0.0 111.374 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -72.08 -34.91 69.04 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.168 0.894 . . . . 0.0 111.102 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 68.9 m -66.82 -45.46 78.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.74 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.1 -44.12 87.51 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.125 0.57 . . . . 0.0 110.013 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -56.66 -55.13 37.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.788 1.235 . . . . 0.0 108.898 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.82 -48.19 82.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.07 -32.5 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.233 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -69.71 -32.49 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.138 -0.976 . . . . 0.0 110.37 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.98 -8.42 1.01 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 113.026 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.13 -48.47 3.04 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.237 1.415 . . . . 0.0 110.261 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -58.2 -36.07 72.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.386 0.674 . . . . 0.0 111.265 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -121.23 -7.47 9.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.354 1.062 . . . . 0.0 111.53 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.84 -10.03 63.9 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.821 -1.174 . . . . 0.0 112.243 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.27 139.44 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.155 175.006 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 CA--C 1.537 0.629 0 N-CA-C 111.613 -0.187 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -153.1 147.11 18.55 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.024 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.76 139.35 19.1 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.497 2.131 . . . . 0.0 111.284 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.98 60.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.915 1.245 . . . . 0.0 112.287 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.64 153.85 20.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.425 1.612 . . . . 0.0 110.987 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.77 143.43 36.12 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.92 124.82 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.72 152.96 18.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.82 116.03 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -171.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 111.71 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 -89.62 170.51 10.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.333 1.053 . . . . 0.0 108.244 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.22 -31.32 55.12 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.02 2.48 . . . . 0.0 115.841 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.79 16.15 1.24 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.291 1.037 . . . . 0.0 111.814 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -154.48 -158.78 0.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 108.999 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.29 157.35 44.92 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.99 -1.069 . . . . 0.0 109.879 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -128.82 169.08 14.99 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.964 1.705 . . . . 0.0 106.749 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -135.37 146.0 47.93 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.569 0.622 . . . . 0.0 111.7 -173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.54 171.97 15.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.168 1.787 . . . . 0.0 108.422 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.36 134.72 63.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.08 130.04 35.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.77 -14.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.81 168.64 34.99 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 -32.17 8.15 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -168.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.6 12.89 4.85 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.159 -1.356 . . . . 0.0 113.671 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -124.05 149.71 45.78 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.103 1.952 . . . . 0.0 112.175 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.86 159.46 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.181 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.43 140.33 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 167.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.25 171.92 18.97 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.771 0.429 . . . . 0.0 111.281 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.05 143.91 33.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 169.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 161.68 51.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.224 1.81 . . . . 0.0 109.149 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.01 148.39 58.36 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.661 2.24 . . . . 0.0 111.768 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.541 0.846 0 C-N-CA 122.965 2.443 . . . . 0.0 111.678 176.834 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.8 mttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.92 13.32 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.628 1.171 . . . . 0.0 108.758 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.0 159.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.26 134.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.43 166.9 22.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.377 1.071 . . . . 0.0 109.622 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -118.29 132.7 56.28 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -150.44 160.99 43.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.448 1.099 . . . . 0.0 108.617 -173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.09 126.8 30.33 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.62 -46.13 66.89 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.428 1.091 . . . . 0.0 110.632 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -65.2 -21.73 66.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.12 -41.6 20.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.686 0.676 . . . . 0.0 110.375 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.34 -41.17 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.367 0.667 . . . . 0.0 110.061 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.14 1.83 12.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.304 1.441 . . . . 0.0 113.756 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.01 -25.44 31.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.024 1.297 . . . . 0.0 115.175 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -57.72 -45.88 85.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.855 1.327 . . . . 0.0 112.338 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -164.04 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.669 0.788 . . . . 0.0 112.4 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -156.76 176.96 12.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.635 1.174 . . . . 0.0 109.292 -165.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -152.62 168.26 26.21 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.943 1.297 . . . . 0.0 108.417 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.41 157.8 37.61 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.254 0.622 . . . . 0.0 110.056 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.0 135.26 28.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -149.44 62.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -63.31 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.529 1.131 . . . . 0.0 110.655 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.41 114.06 0.63 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.001 1.721 . . . . 0.0 110.17 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m80 52.82 40.19 30.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.469 1.508 . . . . 0.0 113.255 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.88 -15.3 1.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 167.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -82.9 -20.19 35.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.206 1.802 . . . . 0.0 111.468 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -131.27 -18.78 2.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.047 0.939 . . . . 0.0 112.448 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -140.99 -167.92 2.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.418 1.487 . . . . 0.0 109.7 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m 57.3 68.82 1.85 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.228 1.411 . . . . 0.0 112.31 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.77 -16.47 37.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.429 2.086 . . . . 0.0 113.386 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -73.67 142.32 80.45 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.619 1.168 . . . . 0.0 110.005 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.93 154.07 53.04 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.29 1.993 . . . . 0.0 109.641 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.0 m -55.62 -34.85 65.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.846 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 p -52.91 -60.3 3.45 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.081 0.952 . . . . 0.0 110.82 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -61.32 -38.43 86.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.611 1.164 . . . . 0.0 111.503 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.06 -51.67 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.28 -44.22 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 109.231 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -42.8 89.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.051 0.541 . . . . 0.0 110.131 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -68.09 -45.79 72.78 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.569 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.3 -50.38 59.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.447 0.567 . . . . 0.0 110.855 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.16 -19.94 59.61 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -71.68 -28.35 63.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.984 1.266 . . . . 0.0 108.904 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 mt -88.54 -16.38 32.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.06 0.944 . . . . 0.0 111.869 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.92 129.43 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 119.65 1.114 . . . . 0.0 108.895 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.15 -3.37 86.85 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -84.2 164.1 19.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.604 1.702 . . . . 0.0 109.344 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -123.92 148.48 46.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.781 -168.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.56 161.13 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.234 1.014 . . . . 0.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.05 32.28 5.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.437 1.113 . . . . 0.0 111.561 -168.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -132.86 147.23 52.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.218 1.407 . . . . 0.0 109.265 170.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -67.92 166.02 16.51 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.787 2.035 . . . . 0.0 111.587 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 mt -69.51 127.55 33.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 167.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 73.1 p -144.22 151.58 39.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 166.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -36.33 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 122.168 -0.332 . . . . 0.0 110.915 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -71.76 -40.18 69.49 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.728 0.411 . . . . 0.0 110.567 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.6 -40.73 92.97 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.865 0.757 . . . . 0.0 110.239 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.4 m -64.82 -45.27 86.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.099 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.69 -45.02 93.36 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.182 0.447 . . . . 0.0 110.143 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -59.39 -50.21 74.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.586 1.154 . . . . 0.0 109.718 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -59.69 -52.41 65.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.102 0.41 . . . . 0.0 111.392 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -64.65 -32.5 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.895 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.24 -36.37 81.51 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.698 -0.626 . . . . 0.0 111.077 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.19 -46.5 62.17 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.242 1.017 . . . . 0.0 109.661 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.26 -46.26 70.93 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.158 0.583 . . . . 0.0 111.346 -177.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -76.98 -33.85 57.59 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.89 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -94.13 -48.26 6.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.028 0.376 . . . . 0.0 110.881 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.86 -51.41 0.6 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.17 128.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 CA--C 1.537 0.672 0 N-CA-C 111.259 -0.324 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -133.49 155.76 80.33 Favored Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 124.979 1.312 . . . . 0.0 108.973 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.31 131.74 18.62 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.363 2.708 . . . . 0.0 112.529 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.68 84.09 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.899 1.238 . . . . 0.0 113.036 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.37 143.74 48.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 120.288 2.044 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -71.84 131.27 42.79 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -114.96 145.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.91 143.7 49.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 117.04 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.07 138.27 43.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -117.19 167.21 11.28 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.379 1.472 . . . . 0.0 107.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.92 -24.9 33.47 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.018 2.479 . . . . 0.0 115.754 -174.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -141.4 4.85 1.81 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.191 0.996 . . . . 0.0 113.209 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -158.22 -158.25 0.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.976 0.91 . . . . 0.0 110.199 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -153.09 141.27 20.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -127.46 165.31 20.06 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.416 1.486 . . . . 0.0 107.607 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -128.95 145.94 51.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.352 0.524 . . . . 0.0 110.008 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 169.86 22.23 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.951 1.7 . . . . 0.0 108.531 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt -140.46 126.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 121.368 -0.832 . . . . 0.0 109.534 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -72.24 132.11 43.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.062 1.345 . . . . 0.0 110.015 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.55 166.55 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.24 1.416 . . . . 0.0 108.873 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.04 21.5 38.63 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.531 -0.731 . . . . 0.0 114.255 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t0 39.26 50.66 1.97 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.869 2.068 . . . . 0.0 113.514 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.1 -11.55 0.1 OUTLIER Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.925 -0.484 . . . . 0.0 113.546 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.17 170.62 7.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.696 1.198 . . . . 0.0 108.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.84 148.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.402 0.681 . . . . 0.0 109.639 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.56 136.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 171.67 18.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.413 0.551 . . . . 0.0 111.019 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 151.12 36.76 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 158.1 64.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.501 2.32 . . . . 0.0 107.676 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.47 153.95 71.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 110.938 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.539 0.752 0 C-N-CA 122.906 2.404 . . . . 0.0 111.703 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.79 13.1 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.823 0.849 . . . . 0.0 109.35 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -134.01 158.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.29 132.22 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -136.67 169.05 18.36 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.059 0.944 . . . . 0.0 109.79 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.59 133.02 54.56 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -148.55 161.19 42.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.209 1.403 . . . . 0.0 107.753 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.15 133.26 47.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.13 -43.83 74.49 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.684 0.674 . . . . 0.0 110.678 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -65.07 -21.58 66.84 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.81 -46.06 19.55 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.897 0.771 . . . . 0.0 110.238 171.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.03 -40.11 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 110.294 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.1 -20.73 59.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.964 1.305 . . . . 0.0 112.512 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.35 -12.5 25.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.59 1.091 . . . . 0.0 113.226 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.7 m -50.34 -48.93 55.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.119 . . . . 0.0 110.915 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -167.84 -61.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.264 1.826 . . . . 0.0 109.239 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -160.92 171.31 18.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.149 2.179 . . . . 0.0 107.126 -167.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -153.36 164.01 38.9 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.571 -0.706 . . . . 0.0 110.607 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -138.77 158.01 45.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.881 1.672 . . . . 0.0 109.851 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 130.93 40.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -148.8 70.86 1.12 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -69.12 88.3 0.42 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -64.93 119.84 11.45 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.21 53.06 9.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.794 1.638 . . . . 0.0 111.786 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -51.86 -20.66 2.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.987 1.315 . . . . 0.0 113.248 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.71 -27.12 31.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -100.64 -20.32 15.7 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.024 0.929 . . . . 0.0 111.339 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -129.93 -174.09 3.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.765 0.793 . . . . 0.0 112.7 -168.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 52.51 62.71 9.9 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.531 1.932 . . . . 0.0 113.919 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 -12.14 28.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.462 2.108 . . . . 0.0 113.732 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.97 142.74 97.56 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.424 1.089 . . . . 0.0 110.594 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.92 142.48 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.165 1.91 . . . . 0.0 108.944 167.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -54.21 -43.2 70.57 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.443 0.297 . . . . 0.0 111.401 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.71 -44.73 73.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.138 0.975 . . . . 0.0 112.1 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -63.32 -34.37 77.55 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 124.203 1.001 . . . . 0.0 111.591 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.5 -48.36 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.69 -47.22 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -44.61 81.87 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.412 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -60.71 -52.98 62.79 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.294 0.952 . . . . 0.0 109.367 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.36 60.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.664 0.386 . . . . 0.0 111.189 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.82 -16.69 50.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.6 -29.02 56.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 119.904 1.229 . . . . 0.0 109.073 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.57 -11.71 44.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.972 0.909 . . . . 0.0 111.852 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -56.13 129.88 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.592 1.087 . . . . 0.0 108.925 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.29 -0.04 89.89 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.403 -1.221 . . . . 0.0 112.984 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -86.57 166.01 15.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.292 1.546 . . . . 0.0 109.4 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -120.55 149.51 42.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.319 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.17 147.16 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.706 1.202 . . . . 0.0 108.221 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.72 39.8 1.62 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.731 1.253 . . . . 0.0 111.153 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -141.08 149.72 41.99 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.469 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -60.28 148.54 36.37 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.947 1.299 . . . . 0.0 110.187 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 54.24 0.28 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.758 1.623 . . . . 0.0 113.266 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.8 p -64.26 161.69 16.12 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.655 -1.278 . . . . 0.0 109.206 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.56 -44.67 62.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.128 0.971 . . . . 0.0 110.309 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.67 -41.33 75.63 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.84 0.856 . . . . 0.0 110.893 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.42 -29.02 65.51 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.143 0.883 . . . . 0.0 111.294 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.7 m -69.87 -42.52 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.223 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.16 -43.98 95.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.346 0.521 . . . . 0.0 110.021 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -57.15 -58.23 9.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.032 1.733 . . . . 0.0 109.493 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.39 -54.88 30.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.754 0.421 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.02 -27.37 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.405 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -70.24 -29.4 66.19 Favored 'General case' 0 C--N 1.338 0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 111.144 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.0 -23.47 63.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.445 1.02 . . . . 0.0 112.094 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.88 -47.78 7.66 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.62 1.1 . . . . 0.0 110.115 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -86.54 -45.59 10.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.451 0.568 . . . . 0.0 112.221 -172.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -83.46 -48.32 10.44 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.54 -25.14 3.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.033 0.825 . . . . 0.0 111.634 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.42 149.91 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.38 169.937 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo . . . . . 0 CA--C 1.533 0.475 0 N-CA-C 111.259 -0.324 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.29 146.88 34.89 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.98 140.12 24.53 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.693 2.262 . . . . 0.0 110.983 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.36 -10.83 71.04 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.1 1.333 . . . . 0.0 112.313 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.89 156.09 23.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.31 2.055 . . . . 0.0 110.652 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.1 139.02 41.15 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.06 141.85 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.53 151.54 39.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -122.79 110.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.86 100.69 2.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -80.33 166.47 39.8 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.273 1.029 . . . . 0.0 108.919 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -51.01 -30.81 32.32 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.478 2.785 . . . . 0.0 116.379 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -145.55 14.71 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.094 0.957 . . . . 0.0 112.213 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -155.81 -159.2 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.892 1.277 . . . . 0.0 108.717 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.4 159.5 43.62 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.773 -1.204 . . . . 0.0 109.938 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -132.37 168.0 18.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.929 1.291 . . . . 0.0 107.612 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -137.37 147.27 45.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.804 0.729 . . . . 0.0 110.694 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.37 174.83 14.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.988 1.715 . . . . 0.0 108.569 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.18 131.64 58.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.66 130.09 41.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.098 1.359 . . . . 0.0 108.795 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.84 165.3 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 109.065 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.51 -158.36 18.25 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.91 -29.53 55.74 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.942 -0.74 . . . . 0.0 112.221 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.99 26.97 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.896 0.76 . . . . 0.0 113.359 -173.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -100.58 170.55 8.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.141 0.97 . . . . 0.0 109.394 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.72 153.28 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.229 0.612 . . . . 0.0 109.635 168.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.88 137.72 29.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.12 169.03 25.12 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.983 -0.448 . . . . 0.0 110.932 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.57 138.7 34.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.13 160.07 56.45 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 125.076 1.351 . . . . 0.0 109.536 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.88 145.16 24.98 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.328 2.685 . . . . 0.0 111.757 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 121.857 1.705 . . . . 0.0 111.554 -176.188 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 C--O 1.235 0.326 0 CA-C-O 121.199 0.523 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.41 169.09 18.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.185 1.394 . . . . 0.0 108.128 166.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.78 146.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 t -85.51 122.25 38.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -127.25 165.82 18.93 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.309 1.044 . . . . 0.0 109.715 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -125.69 131.29 52.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -148.38 163.57 36.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.014 1.326 . . . . 0.0 107.787 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.69 140.18 58.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.14 -42.7 73.4 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -60.46 -29.77 69.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.964 0.906 . . . . 0.0 112.062 -173.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.43 -40.07 27.02 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.21 0.459 . . . . 0.0 110.838 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.68 -37.59 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.335 0.654 . . . . 0.0 109.826 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.54 30.7 0.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.026 1.731 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.81 -23.58 30.5 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.072 0.844 . . . . 0.0 112.918 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 -4.54 5.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.887 1.675 . . . . 0.0 113.654 171.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.4 t70 61.49 16.46 7.59 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 114.576 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -149.46 124.62 10.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.888 1.675 . . . . 0.0 108.739 -169.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -164.8 164.31 21.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -155.77 161.56 40.65 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.599 0.76 . . . . 0.0 110.865 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.61 138.17 22.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -145.85 66.18 1.21 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.31 0.576 . . . . 0.0 109.935 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.38 131.78 38.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 122.896 0.478 . . . . 0.0 110.469 169.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -103.77 3.02 33.61 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' ASP . 75.7 m-70 -132.2 23.5 4.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.847 0.859 . . . . 0.0 112.088 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.07 21.31 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.044 -1.035 . . . . 0.0 112.593 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' HIS . 37.9 t70 -127.36 -9.33 5.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 111.611 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -127.6 -31.85 2.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.084 1.354 . . . . 0.0 111.609 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 66.21 134.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 128.605 2.762 . . . . 0.0 115.728 173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -61.0 136.76 93.79 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.914 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.43 -16.76 34.78 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.599 2.199 . . . . 0.0 111.862 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.08 125.38 35.4 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 108.235 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.17 154.63 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.812 2.341 . . . . 0.0 111.374 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.26 -38.86 69.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.327 0.651 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -54.96 -53.15 59.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.905 0.882 . . . . 0.0 110.498 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.81 -34.78 78.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.161 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.8 -50.83 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.061 0.846 . . . . 0.0 108.889 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.29 -45.6 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 123.536 0.734 . . . . 0.0 109.112 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -64.37 -46.56 82.84 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.85 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.29 -51.92 55.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.692 0.678 . . . . 0.0 110.405 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.82 -21.72 59.13 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.7 mt -99.14 -4.13 32.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 112.476 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.75 150.71 8.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.341 1.056 . . . . 0.0 109.344 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.67 53.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.313 -0.715 . . . . 0.0 112.269 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -124.06 159.98 28.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.585 1.154 . . . . 0.0 108.071 171.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -109.6 153.45 24.17 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.312 1.445 . . . . 0.0 109.53 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.07 152.29 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.374 1.47 . . . . 0.0 107.353 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.58 8.22 44.62 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.835 0.454 . . . . 0.0 112.224 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -95.42 147.11 23.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -74.12 162.87 28.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.446 1.098 . . . . 0.0 111.799 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.08 125.33 23.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.6 p -145.75 154.53 42.15 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 167.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.1 m -55.94 -34.37 65.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.817 0.447 . . . . 0.0 111.206 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.97 -38.61 44.72 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.451 0.701 . . . . 0.0 111.174 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -68.24 -35.77 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.528 1.058 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -66.34 -47.7 72.64 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -56.27 -44.63 79.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.319 1.048 . . . . 0.0 110.377 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -57.73 -56.79 17.43 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.018 1.327 . . . . 0.0 109.135 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.416 ' CE2' HD11 ' A' ' 120' ' ' LEU . 24.2 t80 -58.68 -48.1 82.24 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.1 -29.35 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.543 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -73.36 -30.53 63.37 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.712 0.687 . . . . 0.0 111.64 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.88 -37.9 80.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.305 0.957 . . . . 0.0 110.09 170.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 116' ' ' PHE . 73.0 mt -73.16 -50.14 24.27 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.683 0.674 . . . . 0.0 110.243 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -64.8 -26.37 68.31 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.066 0.946 . . . . 0.0 112.349 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.77 3.28 1.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -168.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.38 -32.52 5.44 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.853 -1.154 . . . . 0.0 111.876 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -155.39 146.63 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.023 1.329 . . . . 0.0 107.576 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.277 0.631 . . . . 0.0 110.727 172.306 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 CA--C 1.537 0.665 0 N-CA-C 113.421 0.508 . . . . 0.0 113.421 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.04 55.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 109.026 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.62 135.74 27.24 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.769 2.313 . . . . 0.0 111.646 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.18 -13.61 57.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.321 1.439 . . . . 0.0 111.714 -169.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.21 142.86 32.78 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.144 1.472 . . . . 0.0 111.312 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.18 140.55 45.2 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.31 129.19 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.08 147.65 25.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.49 103.68 12.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -168.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.45 141.64 57.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.06 168.61 13.01 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.503 1.521 . . . . 0.0 107.935 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.86 -27.96 17.06 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.512 2.808 . . . . 0.0 117.059 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -145.8 13.78 1.34 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.609 0.764 . . . . 0.0 112.021 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.32 -163.86 1.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.511 1.124 . . . . 0.0 109.475 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -144.11 159.72 42.15 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.214 -0.929 . . . . 0.0 109.931 173.241 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -131.2 170.69 14.23 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.613 2.365 . . . . 0.0 107.046 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.42 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 77.9 m95 -136.49 146.27 46.09 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.935 0.789 . . . . 0.0 111.448 -174.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.19 172.42 14.35 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.127 2.171 . . . . 0.0 108.046 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.8 tt -137.4 133.36 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.65 127.71 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.16 -3.96 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.03 -175.19 34.67 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.09 -28.09 66.18 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.87 0.835 . . . . 0.0 113.072 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.9 13.22 1.13 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.216 -1.324 . . . . 0.0 114.136 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -117.31 153.19 33.4 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.963 1.881 . . . . 0.0 111.516 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 m -132.16 155.05 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.061 1.345 . . . . 0.0 110.073 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.1 142.3 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 167.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.4 173.62 14.66 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.276 0.631 . . . . 0.0 110.73 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.6 141.72 33.45 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.62 157.95 66.85 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.54 1.936 . . . . 0.0 107.427 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 151.49 69.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.181 1.457 . . . . 0.0 110.51 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--N 1.349 0.553 0 C-N-CA 122.211 1.941 . . . . 0.0 111.367 175.133 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.9 168.91 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.594 0.712 . . . . 0.0 111.304 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 pt -147.11 154.97 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.918 1.687 . . . . 0.0 106.692 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.42 129.7 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -135.44 159.0 42.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.279 1.432 . . . . 0.0 107.954 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -127.38 131.25 50.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -151.54 163.36 39.21 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.784 1.233 . . . . 0.0 108.893 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.21 131.78 45.99 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.61 -40.87 66.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 110.963 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -61.92 -27.92 69.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.873 0.469 . . . . 0.0 111.638 -171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.71 -45.15 46.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.469 0.577 . . . . 0.0 110.402 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 t -64.17 -39.48 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.615 0.766 . . . . 0.0 109.757 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.64 -11.77 19.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.267 1.427 . . . . 0.0 113.169 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.16 -10.43 65.54 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.655 1.116 . . . . 0.0 113.071 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 -54.22 47.77 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.646 1.223 . . . . 0.0 112.339 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.23 -49.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.661 1.584 . . . . 0.0 110.145 169.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -166.73 -176.12 3.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.863 2.065 . . . . 0.0 107.673 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -152.02 165.45 34.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.54 1.064 . . . . 0.0 110.282 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -148.38 147.32 29.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.243 1.417 . . . . 0.0 109.089 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.03 132.01 33.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -149.83 73.04 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.5 101.96 1.07 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -59.23 124.52 20.24 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 m80 46.31 42.26 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 113.206 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -59.4 -10.82 3.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.562 0.745 . . . . 0.0 112.499 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.17 -17.87 26.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.971 2.109 . . . . 0.0 111.427 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -131.09 -16.83 3.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.074 0.95 . . . . 0.0 112.357 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.35 -161.07 1.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.186 1.794 . . . . 0.0 108.372 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 66.39 2.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.859 1.664 . . . . 0.0 112.953 -170.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.55 -22.18 58.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.571 2.181 . . . . 0.0 114.441 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.14 141.17 39.98 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 111.264 -168.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.15 161.85 39.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.64 2.227 . . . . 0.0 109.762 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 65.1 m -52.4 -40.96 62.74 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.634 0.774 . . . . 0.0 111.682 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.44 -54.23 43.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.293 0.637 . . . . 0.0 111.103 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.37 -37.98 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.337 1.055 . . . . 0.0 111.695 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.29 -49.26 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.39 -46.21 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.683 0.793 . . . . 0.0 108.861 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -43.89 86.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.085 0.554 . . . . 0.0 110.113 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.95 -50.73 69.66 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.23 67.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.562 0.345 . . . . 0.0 111.107 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.94 -20.84 55.65 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.213 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -69.0 -35.5 76.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.74 1.155 . . . . 0.0 109.486 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.38 -10.15 52.86 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.4 133.73 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.516 1.053 . . . . 0.0 109.063 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.0 -8.07 76.3 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.484 -1.176 . . . . 0.0 112.88 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -71.89 157.58 37.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.453 1.626 . . . . 0.0 109.264 171.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -126.58 144.23 50.96 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.44 146.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.055 0.942 . . . . 0.0 110.35 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.46 -9.87 42.97 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.228 -0.92 . . . . 0.0 112.924 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -75.67 154.61 36.41 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.556 0.616 . . . . 0.0 110.498 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -81.37 158.38 24.69 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.871 1.668 . . . . 0.0 110.022 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 108' ' ' LEU . 3.0 mm? -59.72 121.35 11.43 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.5 p -143.68 159.02 43.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -52.49 -45.33 66.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.799 0.44 . . . . 0.0 109.904 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.79 -46.34 79.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.939 0.896 . . . . 0.0 110.827 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -67.33 -41.41 85.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.65 0.659 . . . . 0.0 110.722 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.17 -41.62 81.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.265 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -61.1 -40.6 94.38 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.199 0.6 . . . . 0.0 110.394 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -63.82 -55.76 20.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 110.138 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 120' ' ' LEU . 7.0 t80 -57.59 -48.41 79.46 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.327 0.512 . . . . 0.0 110.883 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.4 -30.95 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.48 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -72.45 -25.55 61.49 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.422 -0.799 . . . . 0.0 111.817 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.35 -38.92 69.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.184 0.902 . . . . 0.0 110.319 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.403 HD11 ' CE2' ' A' ' 116' ' ' PHE . 11.4 mt -74.39 -43.42 56.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.355 0.662 . . . . 0.0 110.2 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 tpt85 -72.58 -31.98 65.65 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.527 -172.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -104.02 -36.46 7.73 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.037 0.535 . . . . 0.0 112.125 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.73 -37.17 3.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.972 1.273 . . . . 0.0 110.599 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.18 135.28 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 123.078 0.551 . . . . 0.0 110.71 -179.698 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 CA--C 1.534 0.483 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -83.91 144.09 44.24 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.07 129.33 24.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 109.745 169.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.83 3.86 67.93 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.308 0.956 . . . . 0.0 113.205 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.1 136.19 48.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.663 1.732 . . . . 0.0 110.216 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.48 138.04 54.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.92 133.5 66.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -104.65 146.37 29.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -127.48 115.35 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 -169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.35 140.21 46.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -128.66 167.72 18.31 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.982 0.913 . . . . 0.0 109.718 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.33 -26.79 36.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.19 2.593 . . . . 0.0 116.576 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -143.24 6.73 1.53 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.293 1.037 . . . . 0.0 112.942 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -160.97 -168.66 2.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.949 -169.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 7.1 ppt_? -136.24 161.03 36.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 121.65 -0.656 . . . . 0.0 109.44 169.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -137.09 169.09 18.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.343 1.857 . . . . 0.0 107.986 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.402 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 67.2 m95 -138.7 148.35 43.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.624 0.769 . . . . 0.0 110.591 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 174.97 11.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.321 1.848 . . . . 0.0 107.934 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.13 134.0 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.43 133.23 48.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.075 1.35 . . . . 0.0 109.009 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 m -139.0 165.8 23.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.123 0.969 . . . . 0.0 109.967 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.44 -121.07 18.72 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.354 -2.299 . . . . 0.0 107.354 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -146.06 51.24 1.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.52 -12.16 0.11 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.164 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.77 171.68 8.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.531 1.166 . . . . 0.0 109.101 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.23 157.35 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.194 0.998 . . . . 0.0 110.052 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.98 138.19 48.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 168.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 169.47 22.79 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.082 0.953 . . . . 0.0 110.396 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.85 140.46 32.89 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.52 163.66 23.31 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.672 1.189 . . . . 0.0 109.326 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.28 156.31 30.94 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.567 2.178 . . . . 0.0 112.134 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 123.034 2.489 . . . . 0.0 110.247 170.665 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.11 172.96 13.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.752 1.221 . . . . 0.0 109.108 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.12 150.26 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -83.21 132.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -137.23 164.9 27.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.291 1.436 . . . . 0.0 109.525 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -125.62 141.31 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -149.92 156.46 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.779 1.232 . . . . 0.0 107.923 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.57 137.47 52.4 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -52.06 -37.74 54.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -36.27 61.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.217 0.607 . . . . 0.0 112.147 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.92 -35.26 80.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.689 0.396 . . . . 0.0 111.315 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -86.67 -41.58 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.878 0.871 . . . . 0.0 109.017 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.42 -21.83 65.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.359 1.064 . . . . 0.0 112.725 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.14 -11.12 24.56 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.545 -1.142 . . . . 0.0 113.728 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.9 m -56.05 -55.49 32.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.956 1.378 . . . . 0.0 111.787 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -166.57 -60.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.323 1.449 . . . . 0.0 110.398 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -159.36 173.74 15.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.275 1.43 . . . . 0.0 108.765 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -162.63 160.53 25.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -154.56 162.58 41.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.622 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.62 138.75 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -152.39 73.75 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.436 0.694 . . . . 0.0 109.587 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.24 92.32 0.41 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.96 131.97 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 49.28 34.93 6.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.842 1.657 . . . . 0.0 113.336 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.98 -9.29 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.081 0.952 . . . . 0.0 112.773 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.98 -27.82 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.483 1.113 . . . . 0.0 110.628 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -127.87 -21.78 3.64 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -108.47 -160.07 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.504 1.522 . . . . 0.0 110.023 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 59.35 59.61 4.94 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.22 1.808 . . . . 0.0 112.517 -169.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.29 -13.2 38.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.0 1.8 . . . . 0.0 113.528 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.2 130.54 33.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.169 0.988 . . . . 0.0 110.673 -169.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 156.91 17.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.119 2.546 . . . . 0.0 111.302 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.06 -48.55 52.95 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.154 0.982 . . . . 0.0 111.28 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -57.34 -45.65 84.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.335 1.054 . . . . 0.0 111.966 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.5 -33.31 75.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.314 0.646 . . . . 0.0 111.313 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.79 -44.22 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.17 -45.19 99.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.644 0.656 . . . . 0.0 109.702 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -54.67 -44.39 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.517 0.727 . . . . 0.0 110.372 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -61.9 -52.01 65.82 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.095 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.98 78.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.654 0.661 . . . . 0.0 111.442 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -71.83 -25.64 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.907 1.283 . . . . 0.0 112.255 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.94 -20.2 42.54 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.436 1.095 . . . . 0.0 109.948 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.9 -13.98 12.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -167.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.37 146.11 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 120.089 1.313 . . . . 0.0 110.27 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 -4.17 84.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.964 1.269 . . . . 0.0 113.605 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.67 154.05 38.63 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.172 1.486 . . . . 0.0 108.779 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.43 147.59 27.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.62 151.49 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.764 1.225 . . . . 0.0 109.586 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.25 32.66 4.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.989 0.899 . . . . 0.0 111.462 -168.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -123.09 146.71 47.48 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.152 1.381 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -62.59 159.17 16.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.37 1.868 . . . . 0.0 112.316 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.9 121.85 16.01 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 165.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.7 p -142.62 156.34 45.06 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.5 m -51.37 -41.82 60.93 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.681 0.793 . . . . 0.0 110.814 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -72.46 -41.79 65.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.443 1.097 . . . . 0.0 111.368 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -40.3 85.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.2 0.909 . . . . 0.0 110.343 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.53 -45.52 79.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.016 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -56.75 -46.6 81.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.629 0.772 . . . . 0.0 110.111 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -59.14 -53.73 54.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.82 0.848 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.17 -48.62 80.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -64.35 -30.61 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.469 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -70.75 -29.12 65.27 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.663 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 72.3 mt-10 -61.33 -34.6 75.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.829 1.195 . . . . 0.0 110.489 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.5 mt -75.5 -46.64 31.14 Favored 'General case' 0 C--O 1.228 -0.036 0 CA-C-N 118.693 0.679 . . . . 0.0 110.23 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -64.33 -40.63 96.27 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 122.981 0.512 . . . . 0.0 110.96 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.22 -33.06 10.58 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.55 -42.12 1.92 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -168.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.93 135.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.21 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.458 -0.583 0 CA-C-O 121.804 0.668 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.43 144.78 50.6 Favored Pre-proline 0 N--CA 1.464 0.235 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.67 131.47 19.93 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.513 2.142 . . . . 0.0 110.718 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.04 27.43 7.82 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.678 1.132 . . . . 0.0 111.28 -168.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -123.19 148.0 46.26 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.701 1.751 . . . . 0.0 110.387 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.29 137.1 35.81 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.15 131.11 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.88 151.12 22.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mm -126.65 106.43 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.57 138.5 48.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.14 166.89 20.95 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.873 0.869 . . . . 0.0 109.169 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.51 -35.65 29.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.401 2.734 . . . . 0.0 116.174 -169.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -140.29 12.59 2.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.448 1.099 . . . . 0.0 112.065 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -160.18 -168.82 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.249 1.02 . . . . 0.0 110.179 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -138.07 153.91 49.29 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.156 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -135.28 170.55 15.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.4 1.88 . . . . 0.0 107.461 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.437 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 81.8 m95 -137.64 148.62 45.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.451 0.7 . . . . 0.0 111.515 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.28 171.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.142 1.777 . . . . 0.0 108.42 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.4 127.59 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -76.13 127.42 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.3 1.84 . . . . 0.0 108.306 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 34' ' ' VAL . 21.2 m -139.08 1.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 -172.29 22.18 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.94 -29.01 70.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.243 1.022 . . . . 0.0 112.479 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.14 11.2 1.03 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.555 1.074 . . . . 0.0 113.268 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.92 153.11 23.01 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.037 1.419 . . . . 0.0 110.733 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.53 154.34 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 109.831 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 28' ' ' VAL . 4.9 t -105.31 141.78 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 167.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.38 169.78 22.39 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.866 -0.521 . . . . 0.0 110.724 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.52 138.51 34.28 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.95 164.84 31.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 108.104 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.58 155.7 51.7 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.781 1.654 . . . . 0.0 110.824 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 N--CA 1.454 -0.832 0 C-N-CA 122.27 1.98 . . . . 0.0 110.806 -178.361 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 pttt . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.75 169.18 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.17 1.388 . . . . 0.0 109.123 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mt -135.82 144.12 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.94 121.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 163.03 19.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.467 1.507 . . . . 0.0 108.109 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.43 128.73 44.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -149.89 160.09 43.86 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.408 1.083 . . . . 0.0 108.642 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.56 133.9 49.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -54.69 -40.91 69.61 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.58 0.752 . . . . 0.0 111.902 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -61.03 -29.9 70.0 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.663 0.385 . . . . 0.0 111.898 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.55 -46.02 41.71 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.209 0.459 . . . . 0.0 110.277 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.14 -42.33 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.753 0.821 . . . . 0.0 109.908 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 -6.56 52.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.236 1.415 . . . . 0.0 113.28 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.27 -10.46 52.76 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.414 -0.659 . . . . 0.0 113.395 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 p -60.94 -43.75 98.21 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.76 1.224 . . . . 0.0 112.181 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -159.3 -58.56 0.07 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.296 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -166.05 -174.42 2.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.578 1.551 . . . . 0.0 108.853 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -154.64 167.87 28.68 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.201 1.001 . . . . 0.0 109.383 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -155.54 156.8 35.79 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.805 0.842 . . . . 0.0 109.958 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.04 138.77 21.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -148.22 71.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -68.58 81.7 0.27 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.22 1.008 . . . . 0.0 108.547 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -56.81 125.65 23.38 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 47.04 44.88 15.46 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.675 1.59 . . . . 0.0 112.528 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.76 -13.96 1.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 170.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.59 -15.61 25.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.159 1.383 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -123.6 -19.92 5.68 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.194 0.998 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -140.48 -167.65 2.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.111 1.364 . . . . 0.0 109.643 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m 52.15 60.38 13.51 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.91 1.284 . . . . 0.0 112.247 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.9 -12.54 34.7 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.395 2.064 . . . . 0.0 113.9 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.07 133.57 83.68 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 124.175 0.99 . . . . 0.0 110.72 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.55 145.46 69.36 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.201 1.934 . . . . 0.0 108.881 166.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.4 m -55.0 -39.38 69.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -170.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 p -54.88 -44.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.502 1.121 . . . . 0.0 112.14 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -63.5 -32.09 73.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.646 0.778 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.53 -46.09 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.0 -49.03 84.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -55.66 -43.24 76.12 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.866 0.867 . . . . 0.0 110.857 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -60.17 -55.65 31.2 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.83 -41.38 67.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -74.29 -24.89 59.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.369 1.068 . . . . 0.0 112.027 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -81.13 -23.05 38.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.704 0.683 . . . . 0.0 110.505 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.16 -22.79 13.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.43 -167.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.16 144.6 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.998 1.272 . . . . 0.0 109.066 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.63 34.86 62.79 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -132.06 160.54 35.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.84 150.94 42.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.071 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.88 142.01 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 108.304 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.2 mt -99.78 52.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.022 1.391 . . . . 0.0 110.446 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.71 150.96 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.256 -1.793 . . . . 0.0 108.347 169.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -70.18 164.12 24.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.032 0.933 . . . . 0.0 112.057 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.16 119.45 11.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.2 p -140.44 154.41 46.64 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 m -54.71 -40.22 69.0 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.944 0.498 . . . . 0.0 110.402 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.95 -41.78 77.56 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.749 0.82 . . . . 0.0 111.229 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.99 -39.15 87.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.082 0.856 . . . . 0.0 110.237 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.3 m -68.9 -44.23 73.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.907 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.45 -47.11 79.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.986 0.914 . . . . 0.0 109.91 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -58.38 -53.08 62.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.973 0.909 . . . . 0.0 109.363 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.23 -49.83 75.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.18 0.446 . . . . 0.0 111.678 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 -34.2 65.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.392 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -66.64 -38.47 86.98 Favored 'General case' 0 C--O 1.225 -0.209 0 O-C-N 121.889 -0.507 . . . . 0.0 110.361 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -56.24 -35.86 67.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.375 1.07 . . . . 0.0 111.86 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.15 -45.72 32.17 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.968 0.803 . . . . 0.0 110.922 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -78.09 -43.28 29.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.823 0.738 . . . . 0.0 111.937 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -75.77 -40.75 54.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.911 0.484 . . . . 0.0 110.838 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 116.02 -37.42 3.43 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 128.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 105.049 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.893 174.577 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.46 -0.479 0 CA-C-O 121.181 0.409 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -76.6 146.19 76.46 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.45 130.66 21.98 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.722 2.282 . . . . 0.0 110.163 168.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.99 -14.99 63.31 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 117.743 -1.587 . . . . 0.0 113.875 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -69.04 152.98 44.54 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.899 2.349 . . . . 0.0 111.82 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.07 139.28 38.15 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -119.92 145.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.87 149.93 41.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 mm -126.42 97.26 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 -168.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.4 143.43 57.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 174.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.48 168.25 18.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.356 1.062 . . . . 0.0 108.911 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.25 -32.88 52.57 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 115.904 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.64 3.34 2.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.94 -161.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.14 1.376 . . . . 0.0 108.504 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 147.79 36.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -117.68 167.47 11.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.466 1.906 . . . . 0.0 108.399 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.17 148.05 49.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.556 0.742 . . . . 0.0 110.304 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.54 172.94 14.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.237 1.415 . . . . 0.0 109.221 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 tt -132.62 128.61 57.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.14 133.07 45.93 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 109.278 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.01 165.68 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.637 1.175 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.66 -126.88 41.02 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -169.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -144.87 53.28 1.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 -8.53 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.783 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -103.72 168.06 9.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.694 1.247 . . . . 0.0 109.278 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.45 151.93 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.063 0.945 . . . . 0.0 109.546 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.86 141.38 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 168.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -163.6 171.59 15.53 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.271 0.629 . . . . 0.0 111.123 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.91 150.06 36.0 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.98 159.21 40.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.76 1.624 . . . . 0.0 108.408 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.0 159.78 40.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 121.474 1.449 . . . . 0.0 109.921 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 C-N-CA 123.549 2.833 . . . . 0.0 113.605 -178.506 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.5 178.84 9.14 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 108.879 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 pt -145.88 166.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.143 1.777 . . . . 0.0 107.167 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.67 139.79 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -133.69 172.41 12.8 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.566 1.546 . . . . 0.0 109.378 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.38 142.1 50.53 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 125.204 1.402 . . . . 0.0 107.415 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -151.04 159.61 44.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.292 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.86 137.74 55.52 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.86 -41.64 67.7 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.217 0.917 . . . . 0.0 111.669 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -64.86 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.88 -25.84 61.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.858 0.753 . . . . 0.0 111.437 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.66 -36.48 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.873 1.269 . . . . 0.0 109.918 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.5 62.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.536 1.534 . . . . 0.0 113.28 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.42 37.42 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.762 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -53.04 -48.09 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.696 1.248 . . . . 0.0 111.799 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -166.33 -54.29 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 125.881 1.672 . . . . 0.0 109.27 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -166.92 178.79 5.6 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.498 1.919 . . . . 0.0 107.732 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -154.14 165.86 34.9 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.386 -0.821 . . . . 0.0 109.314 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -155.67 158.63 38.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.919 0.888 . . . . 0.0 110.377 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.17 136.65 25.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -149.68 66.94 1.0 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.186 0.517 . . . . 0.0 110.498 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.64 119.14 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -67.8 -11.68 59.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' ASP . 92.5 m-70 -129.27 29.14 5.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 111.621 -169.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.54 21.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.887 -1.133 . . . . 0.0 112.685 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' HIS . 34.8 t70 -130.49 -5.81 4.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.948 2.099 . . . . 0.0 111.351 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.88 -31.2 1.32 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.965 1.306 . . . . 0.0 111.905 -169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 66.65 150.68 0.06 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 128.292 2.637 . . . . 0.0 117.848 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -40.11 109.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.876 2.87 . . . . 0.0 113.94 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 -15.9 18.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.505 2.803 . . . . 0.0 111.812 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.22 138.24 24.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 126.671 1.988 . . . . 0.0 106.698 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 157.28 62.21 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.527 1.485 . . . . 0.0 109.391 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.76 -39.93 62.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.323 0.649 . . . . 0.0 111.557 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 m -54.07 -48.43 70.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 111.393 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.7 -35.89 77.76 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.563 -0.71 . . . . 0.0 111.526 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.29 -49.08 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.186 0.903 . . . . 0.0 108.618 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.09 -38.62 78.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.124 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -55.83 -45.11 78.42 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.387 0.675 . . . . 0.0 110.067 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.3 -48.81 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.477 0.581 . . . . 0.0 109.859 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.31 -42.15 66.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.705 0.684 . . . . 0.0 111.813 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -78.52 -19.17 53.55 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.312 -175.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.96 -29.79 26.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.193 0.906 . . . . 0.0 110.021 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.5 mt -96.68 -24.26 16.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.312 -168.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.45 132.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.785 1.175 . . . . 0.0 109.637 171.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.09 -4.87 82.07 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.55 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.45 159.79 25.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.779 1.789 . . . . 0.0 109.3 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -104.1 154.33 19.85 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.488 0.715 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.97 -175.98 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.993 1.317 . . . . 0.0 108.31 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.09 11.04 6.46 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.712 0.805 . . . . 0.0 112.842 -169.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.8 153.16 45.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 109.538 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -71.75 161.21 31.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 111.863 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.27 131.28 46.87 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.5 p -145.81 159.06 43.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 m -55.34 -39.3 69.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.126 0.421 . . . . 0.0 110.213 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.7 -47.48 66.32 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.126 0.571 . . . . 0.0 111.184 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.86 -40.39 87.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.679 0.672 . . . . 0.0 110.82 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.05 -42.46 76.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.774 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -58.97 -44.34 91.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.695 0.679 . . . . 0.0 110.395 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -56.6 -53.72 54.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.879 1.271 . . . . 0.0 109.06 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -60.18 -54.04 50.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.185 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -62.34 -28.22 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.921 0.782 . . . . 0.0 111.081 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -70.28 -32.77 70.72 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.411 -0.806 . . . . 0.0 111.718 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.3 -25.16 63.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.814 0.734 . . . . 0.0 111.321 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.22 -52.95 4.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -60.1 -37.56 80.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.556 1.142 . . . . 0.0 112.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -136.88 9.95 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.231 0.957 . . . . 0.0 111.676 -167.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.0 -29.92 5.72 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.772 -1.205 . . . . 0.0 112.55 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.0 145.58 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.01 1.724 . . . . 0.0 108.336 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.014 0.926 . . . . 0.0 111.064 169.041 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 CA--C 1.536 0.579 0 N-CA-C 111.245 -0.329 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -131.7 145.93 59.64 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.15 0.98 . . . . 0.0 108.424 168.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.23 128.19 19.38 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.465 2.11 . . . . 0.0 111.037 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.99 -10.26 27.24 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.976 1.75 . . . . 0.0 112.141 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.9 135.86 34.32 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.006 1.403 . . . . 0.0 111.408 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.13 137.46 54.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -121.8 121.23 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.13 151.49 21.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.28 112.46 29.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 127.02 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.45 168.96 6.84 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 108.336 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -47.56 -33.19 17.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.052 3.168 . . . . 0.0 116.541 -170.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -146.87 17.35 1.25 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.897 0.879 . . . . 0.0 111.433 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -158.43 -160.64 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.408 1.083 . . . . 0.0 109.586 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 155.43 45.66 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -116.36 168.51 10.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -132.39 147.21 52.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.596 0.635 . . . . 0.0 111.159 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.29 174.7 11.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.237 1.815 . . . . 0.0 107.719 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.18 129.95 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -73.86 125.92 29.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 m -136.31 -10.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.59 167.11 28.67 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -55.37 -22.2 18.54 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -168.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -140.8 16.56 2.83 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.239 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -120.48 154.36 35.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.569 1.684 . . . . 0.0 111.976 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.47 158.17 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.553 1.141 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.87 143.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.0 174.45 13.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.154 0.982 . . . . 0.0 109.932 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.42 143.9 29.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 170.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.93 160.46 62.76 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.779 1.231 . . . . 0.0 108.994 171.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.42 156.86 20.11 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.274 1.982 . . . . 0.0 110.975 168.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 112.379 173.508 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.34 -179.82 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.09 153.73 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.33 139.08 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -139.87 159.64 41.73 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.221 1.409 . . . . 0.0 107.997 -169.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.03 136.52 49.48 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -152.5 159.91 43.28 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 108.63 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.38 132.88 49.31 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.8 -46.61 71.13 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.385 0.674 . . . . 0.0 111.261 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -67.26 -24.46 65.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.86 0.464 . . . . 0.0 111.33 -170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.32 -37.39 60.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.363 0.528 . . . . 0.0 111.011 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.53 -45.33 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.095 0.558 . . . . 0.0 109.56 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.97 64.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.073 0.549 . . . . 0.0 110.381 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.09 -128.83 31.09 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 m -72.26 -8.45 54.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.57 1.148 . . . . 0.0 113.874 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.21 -170.6 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.524 1.056 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -140.12 158.48 43.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.499 2.32 . . . . 0.0 106.084 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -156.61 163.26 39.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.845 -0.534 . . . . 0.0 110.31 -168.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.85 158.92 40.11 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.661 0.784 . . . . 0.0 110.432 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.37 134.31 30.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -149.74 66.57 0.99 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -61.42 118.88 7.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -55.26 -43.99 75.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.94 36.41 1.4 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.396 0.678 . . . . 0.0 111.337 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -58.79 -9.86 2.04 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.355 0.98 . . . . 0.0 112.686 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.61 -20.62 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.918 0.887 . . . . 0.0 110.336 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -114.15 -44.77 3.1 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.022 1.329 . . . . 0.0 110.23 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -155.48 159.0 39.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.719 0.808 . . . . 0.0 112.82 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -171.2 76.87 0.53 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 128.482 2.713 . . . . 0.0 105.096 167.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.55 -16.21 52.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.686 2.924 . . . . 0.0 113.885 -171.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.85 120.82 47.85 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 157.52 61.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.842 1.695 . . . . 0.0 108.904 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.9 m -47.48 -47.83 27.2 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.889 0.876 . . . . 0.0 112.505 -169.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -54.84 -43.94 73.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.637 0.775 . . . . 0.0 112.445 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.48 -33.61 76.07 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.596 -0.69 . . . . 0.0 111.187 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.2 mt -60.84 -48.95 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.29 -50.62 79.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -52.79 -47.05 67.84 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.424 1.089 . . . . 0.0 110.534 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -66.35 -49.72 65.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.57 -45.07 73.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.494 0.588 . . . . 0.0 110.805 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.76 -30.57 71.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.467 1.507 . . . . 0.0 112.188 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -72.45 -28.83 63.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.598 0.759 . . . . 0.0 109.052 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.4 mt -91.95 -16.99 25.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.906 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 t -54.74 128.92 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.363 1.438 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.11 87.66 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.261 -1.3 . . . . 0.0 113.229 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -76.88 143.99 39.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.72 1.76 . . . . 0.0 108.491 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.01 151.4 23.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.756 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.22 146.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 109.18 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.08 1.92 52.87 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.588 -0.695 . . . . 0.0 112.769 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -92.76 155.03 17.94 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.592 0.757 . . . . 0.0 109.261 169.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -70.22 142.58 52.37 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -69.11 131.88 45.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.1 p -145.17 165.3 28.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.096 1.758 . . . . 0.0 106.38 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 m -50.53 -46.94 57.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.795 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.45 -40.22 73.86 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.133 -0.461 . . . . 0.0 111.618 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -71.55 -31.01 66.53 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.231 0.923 . . . . 0.0 110.959 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.1 m -69.87 -43.6 71.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.124 0.874 . . . . 0.0 109.926 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -59.91 -41.12 91.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.637 0.775 . . . . 0.0 110.149 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -59.84 -58.89 6.6 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 110.286 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.64 -49.84 73.8 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.09 -31.05 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 121.096 -0.241 . . . . 0.0 110.557 -170.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -70.14 -28.12 65.1 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.177 -0.952 . . . . 0.0 111.527 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -53.98 -31.5 51.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.764 0.711 . . . . 0.0 111.368 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.1 mt -80.78 -45.8 16.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.239 0.616 . . . . 0.0 110.408 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -74.79 -29.38 61.09 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.203 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -130.22 -5.18 4.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.04 -14.7 62.79 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.81 -1.181 . . . . 0.0 112.737 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -154.8 151.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.644 1.577 . . . . 0.0 106.984 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.198 170.593 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo . . . . . 0 CA--C 1.534 0.509 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -113.64 138.38 22.6 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.32 132.36 23.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.29 -21.16 35.97 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.138 1.352 . . . . 0.0 112.014 -170.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -67.44 144.26 55.83 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.448 1.624 . . . . 0.0 111.674 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.11 139.92 43.08 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.61 128.21 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.51 150.83 22.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 165.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.05 114.1 40.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 102.355 -3.202 . . . . 0.0 102.355 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.45 131.08 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -108.87 167.26 9.42 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -50.39 -28.58 21.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 115.901 -173.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.62 14.5 1.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.819 0.848 . . . . 0.0 112.102 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -156.78 -155.81 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.488 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 157.87 44.13 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.865 1.211 . . . . 0.0 109.331 174.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -127.75 168.84 14.54 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.236 1.814 . . . . 0.0 106.113 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -135.09 147.45 49.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.848 0.749 . . . . 0.0 111.673 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.67 173.0 14.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.37 1.868 . . . . 0.0 108.879 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.78 133.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -80.48 135.23 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.56 -2.68 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -170.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.37 -175.41 38.56 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -77.04 44.28 0.39 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.195 0.998 . . . . 0.0 111.743 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.35 -32.31 0.35 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.861 1.22 . . . . 0.0 112.532 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.9 152.94 23.19 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.793 1.296 . . . . 0.0 111.651 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.82 156.31 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.33 1.452 . . . . 0.0 109.273 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 140.05 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.47 170.77 21.0 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.044 0.538 . . . . 0.0 110.798 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.02 138.43 33.74 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.04 8.59 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.671 . . . . 0.0 108.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.0 152.6 36.01 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.537 2.158 . . . . 0.0 112.425 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 121.965 1.777 . . . . 0.0 111.213 170.348 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.735 0.302 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 174.02 12.39 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.318 1.447 . . . . 0.0 109.765 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.35 146.13 29.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.0 t -82.57 130.95 34.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 163.94 28.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.176 1.39 . . . . 0.0 108.019 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -131.09 130.32 43.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.25 160.8 43.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 108.895 -173.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -73.01 130.46 40.38 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.94 -40.23 63.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.11 0.964 . . . . 0.0 112.627 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -35.98 67.81 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.832 0.453 . . . . 0.0 111.832 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.35 -38.14 71.63 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.299 0.5 . . . . 0.0 110.605 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.09 -46.86 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.819 0.848 . . . . 0.0 108.834 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -24.6 66.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.536 1.135 . . . . 0.0 112.102 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.69 -14.3 3.66 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.503 1.525 . . . . 0.0 113.835 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.5 m -48.81 -48.2 41.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.595 1.197 . . . . 0.0 111.51 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -168.58 -55.92 0.02 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.927 1.691 . . . . 0.0 109.636 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.18 -174.95 3.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.947 2.099 . . . . 0.0 107.695 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -149.06 168.14 23.95 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.43 -0.794 . . . . 0.0 109.563 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -146.11 153.69 40.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.116 0.967 . . . . 0.0 108.88 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -78.14 135.09 26.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 166.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -147.19 69.66 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -63.47 104.72 0.66 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -54.0 -51.13 64.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.726 1.211 . . . . 0.0 113.848 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -148.2 38.95 0.9 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.383 1.073 . . . . 0.0 111.264 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.32 -14.26 1.14 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.09 1.356 . . . . 0.0 113.214 169.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.97 -28.27 27.89 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.476 -0.765 . . . . 0.0 110.596 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -97.44 -34.26 11.08 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.583 -177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -148.51 156.85 42.99 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.305 0.642 . . . . 0.0 111.756 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -178.4 72.86 0.21 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 128.475 2.71 . . . . 0.0 107.491 168.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.9 -14.45 41.36 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.643 2.229 . . . . 0.0 113.372 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.66 121.08 30.13 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 124.911 1.284 . . . . 0.0 108.491 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.62 159.67 10.74 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.294 2.662 . . . . 0.0 111.492 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -50.09 -46.57 53.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.655 0.782 . . . . 0.0 111.269 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.62 -44.7 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.32 0.648 . . . . 0.0 111.754 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.42 -35.72 68.42 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.293 0.637 . . . . 0.0 111.237 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.418 HD13 ' HD2' ' A' ' 121' ' ' ARG . 55.6 mt -59.81 -49.87 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.5 -46.08 96.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -53.99 -43.29 69.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.369 0.668 . . . . 0.0 110.338 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -51.05 64.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.79 -45.11 67.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.38 0.536 . . . . 0.0 111.213 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.01 -29.82 68.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.234 1.413 . . . . 0.0 112.127 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.38 -28.51 62.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.154 0.982 . . . . 0.0 109.192 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.78 -14.7 27.49 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.857 -1.068 . . . . 0.0 112.8 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.66 126.52 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 109.137 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.82 -1.22 88.04 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.453 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.21 159.93 21.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.629 1.715 . . . . 0.0 109.34 174.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -110.63 154.37 23.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.76 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.98 145.27 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.79 1.236 . . . . 0.0 107.755 169.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 tp -87.86 14.3 9.07 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.749 -0.595 . . . . 0.0 112.18 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -121.84 159.67 26.28 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.128 1.371 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -87.42 172.97 9.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.989 1.715 . . . . 0.0 113.501 -167.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.21 43.25 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.888 2.075 . . . . 0.0 112.477 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 p -70.18 148.19 48.95 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -55.21 -37.72 67.49 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.09 -0.381 . . . . 0.0 110.252 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -65.83 -40.44 91.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.445 1.098 . . . . 0.0 111.473 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -68.67 -36.98 79.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.054 1.297 . . . . 0.0 110.55 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.42 -45.43 79.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.2 -46.08 86.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.087 0.955 . . . . 0.0 110.086 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -56.47 -54.68 42.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.501 1.121 . . . . 0.0 109.052 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.59 -51.03 71.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.336 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.93 -33.47 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.22 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -68.45 -36.6 79.26 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.001 0.819 . . . . 0.0 110.713 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.72 -36.11 69.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.262 1.025 . . . . 0.0 111.421 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.0 mp -79.12 -45.05 20.78 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.066 0.848 . . . . 0.0 110.587 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.418 ' HD2' HD13 ' A' ' 92' ' ' ILE . 45.4 tpt85 -65.93 -33.61 76.23 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.915 0.886 . . . . 0.0 112.083 -175.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.51 5.51 4.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.871 0.868 . . . . 0.0 113.125 -170.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.18 4.0 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 120.793 -1.192 . . . . 0.0 112.124 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.32 138.49 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.122 0.569 . . . . 0.0 111.648 175.045 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 C--O 1.237 0.466 0 CA-C-O 120.664 0.193 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -138.22 148.28 59.13 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 109.941 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.18 131.9 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.904 2.403 . . . . 0.0 110.352 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.51 -20.82 31.66 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.011 1.767 . . . . 0.0 111.708 -172.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.45 145.51 52.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.687 1.743 . . . . 0.0 111.394 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.19 138.62 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.35 145.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -123.6 149.43 45.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 mm -125.57 124.15 66.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -168.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -73.76 134.53 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -132.16 163.99 46.37 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.437 0.695 . . . . 0.0 109.681 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.3 -21.19 61.79 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.696 1.597 . . . . 0.0 115.214 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -135.37 1.14 2.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.038 0.836 . . . . 0.0 113.01 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -166.49 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.525 1.53 . . . . 0.0 108.769 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.73 152.37 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -131.31 168.77 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 109.279 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -137.98 144.8 41.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.165 0.986 . . . . 0.0 110.279 -169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.7 14.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.791 1.636 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.23 131.54 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.15 131.39 39.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.085 1.354 . . . . 0.0 108.152 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.26 -20.65 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.52 43.97 0.94 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 119.265 0.938 . . . . 0.0 112.07 -168.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.68 38.21 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.16 1.784 . . . . 0.0 112.744 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.05 0.94 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.997 1.284 . . . . 0.0 110.536 -172.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -91.72 152.48 20.17 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.62 1.21 . . . . 0.0 110.766 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.19 160.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 126.1 1.76 . . . . 0.0 109.836 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.71 140.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.29 169.41 22.18 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.865 -0.522 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 143.02 31.32 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.52 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 108.122 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.99 155.3 65.23 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 N-CA-C 109.334 -1.064 . . . . 0.0 109.334 168.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo . . . . . 0 C--N 1.349 0.59 0 C-N-CA 123.175 2.583 . . . . 0.0 113.76 -178.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 173.4 11.87 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.414 1.486 . . . . 0.0 109.333 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -135.88 147.68 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.65 125.97 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -122.59 166.4 14.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.324 1.05 . . . . 0.0 109.282 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.2 124.48 39.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -150.32 163.83 37.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 108.938 -169.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -69.77 128.88 37.97 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.69 -45.34 70.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.344 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.66 -18.19 64.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -88.13 -43.88 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.746 0.703 . . . . 0.0 110.5 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.78 -40.43 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.066 0.946 . . . . 0.0 110.824 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.72 -2.08 57.1 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.255 1.422 . . . . 0.0 113.088 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.45 -18.49 37.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.934 0.778 . . . . 0.0 113.125 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -53.7 -43.47 68.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.473 1.509 . . . . 0.0 112.424 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -161.12 -69.03 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.058 0.943 . . . . 0.0 111.411 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -167.28 -176.39 3.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.374 1.87 . . . . 0.0 108.811 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -156.18 168.47 27.19 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.795 0.838 . . . . 0.0 110.684 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -151.52 159.82 43.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.941 0.896 . . . . 0.0 110.284 168.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.7 t -70.76 139.26 20.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -148.05 67.4 1.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.321 0.582 . . . . 0.0 109.582 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -57.78 117.33 4.14 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.3 -38.47 71.76 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.415 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -144.9 25.62 1.42 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 112.23 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.27 -1.55 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.872 1.215 . . . . 0.0 112.055 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -99.99 -6.78 25.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.392 1.477 . . . . 0.0 110.868 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -128.81 -32.08 2.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.749 1.22 . . . . 0.0 111.343 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -146.47 149.13 33.07 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.492 1.117 . . . . 0.0 110.97 -170.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.9 p -162.56 65.8 1.72 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.061 1.344 . . . . 0.0 109.255 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.93 -14.78 46.15 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.362 2.042 . . . . 0.0 113.02 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.4 125.66 22.59 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.992 1.317 . . . . 0.0 108.376 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.31 167.17 27.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.444 2.096 . . . . 0.0 109.951 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -47.05 -49.14 21.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.486 1.114 . . . . 0.0 111.904 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -54.08 -54.21 42.56 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.812 1.245 . . . . 0.0 111.811 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.55 -35.02 79.11 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.229 1.012 . . . . 0.0 111.608 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.2 mt -61.99 -44.98 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.721 1.146 . . . . 0.0 108.618 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -63.41 -49.07 84.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.02 -40.37 73.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.088 0.555 . . . . 0.0 110.427 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -63.48 -54.44 36.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.401 0.68 . . . . 0.0 109.447 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.48 -43.8 55.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.736 0.414 . . . . 0.0 111.262 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.16 -32.11 72.14 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.201 1.401 . . . . 0.0 111.768 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.94 -25.57 62.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.13 0.572 . . . . 0.0 110.806 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.21 -10.74 17.69 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.895 -1.05 . . . . 0.0 113.315 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 t -59.0 139.88 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 121.026 1.739 . . . . 0.0 109.509 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.25 -5.88 84.33 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.377 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -80.94 154.46 26.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.25 1.525 . . . . 0.0 109.087 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.491 1.116 . . . . 0.0 109.104 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.19 146.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.139 1.376 . . . . 0.0 107.898 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.29 49.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 123.089 1.423 . . . . 0.0 109.812 -171.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -135.24 148.23 49.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.671 168.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -70.03 165.2 22.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.61 118.95 11.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -140.28 155.48 46.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 m -54.61 -40.25 68.71 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.721 0.408 . . . . 0.0 110.315 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.47 -42.85 74.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.466 0.706 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -67.42 -39.37 85.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.824 0.738 . . . . 0.0 110.385 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.8 m -69.93 -44.04 70.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.35 -46.65 79.87 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.498 0.719 . . . . 0.0 109.887 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -57.69 -54.49 46.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.872 0.869 . . . . 0.0 109.196 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -57.81 -52.3 66.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.374 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.94 -31.42 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.487 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.12 -28.26 67.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.624 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.26 -42.88 96.28 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 119.465 1.03 . . . . 0.0 109.728 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.93 -40.31 75.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.014 0.825 . . . . 0.0 110.405 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -76.66 -40.64 48.39 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.199 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -122.7 15.48 10.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.06 -52.51 3.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.4 142.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.144 -0.455 . . . . 0.0 110.502 172.811 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 N-CA-C 111.417 -0.263 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -138.84 142.15 32.83 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 124.401 1.08 . . . . 0.0 109.093 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.97 133.15 14.48 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.183 2.589 . . . . 0.0 111.5 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.48 -25.34 12.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.051 1.786 . . . . 0.0 110.622 -169.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.75 136.64 56.5 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.183 0.991 . . . . 0.0 111.046 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.26 140.95 52.47 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.36 129.88 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.23 151.43 23.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.88 98.96 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 102.758 -3.053 . . . . 0.0 102.758 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.38 136.2 56.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -133.84 169.44 13.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.673 . . . . 0.0 110.526 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.95 -30.68 24.83 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.428 2.752 . . . . 0.0 117.134 -169.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -145.76 10.49 1.21 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.691 0.796 . . . . 0.0 112.635 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -163.78 -169.55 1.92 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.27 1.428 . . . . 0.0 108.618 -172.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 158.05 45.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -127.01 169.49 13.29 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -138.83 145.43 40.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.592 0.633 . . . . 0.0 110.681 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.13 174.46 12.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.924 2.09 . . . . 0.0 107.782 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.08 136.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -75.96 128.86 35.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.31 -15.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.19 168.5 33.06 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -50.21 -29.77 10.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -167.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.93 13.06 4.45 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.449 -1.195 . . . . 0.0 113.622 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -123.05 152.38 41.05 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.77 1.785 . . . . 0.0 111.928 -170.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -133.36 159.67 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.947 1.299 . . . . 0.0 110.594 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.52 136.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.23 168.71 26.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.351 0.661 . . . . 0.0 110.47 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.85 141.06 32.55 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 165.12 28.34 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 125.223 1.409 . . . . 0.0 108.812 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.4 151.76 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.977 2.451 . . . . 0.0 112.205 170.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 122.195 1.93 . . . . 0.0 110.364 179.81 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.44 172.19 13.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.582 1.553 . . . . 0.0 109.121 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.1 147.27 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.81 128.02 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 160.6 31.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.236 1.415 . . . . 0.0 108.481 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.55 124.67 41.78 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.6 165.03 35.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.389 1.076 . . . . 0.0 108.982 -169.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.16 132.86 49.45 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.763 0.825 . . . . 0.0 109.208 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.89 -45.38 71.08 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.609 0.764 . . . . 0.0 110.899 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -66.45 -19.6 65.83 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.032 -0.509 . . . . 0.0 112.25 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.84 -42.26 27.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.005 0.82 . . . . 0.0 110.167 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.38 -44.83 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.267 0.627 . . . . 0.0 110.099 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.47 18.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.359 1.064 . . . . 0.0 112.454 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.22 51.97 3.31 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.689 1.614 . . . . 0.0 110.649 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 p -140.51 -55.03 0.52 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.132 1.773 . . . . 0.0 107.692 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.41 -67.6 0.2 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 123.954 0.902 . . . . 0.0 111.486 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -155.25 176.12 12.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.195 0.598 . . . . 0.0 110.158 -168.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.65 164.68 37.88 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.724 0.81 . . . . 0.0 111.04 171.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -156.89 162.13 39.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.63 1.172 . . . . 0.0 110.227 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -71.17 142.52 15.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -153.58 76.61 1.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.173 0.589 . . . . 0.0 109.599 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -70.8 81.34 0.63 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -56.12 129.23 39.16 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.939 -0.475 . . . . 0.0 110.34 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 m80 62.45 19.46 11.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.878 2.071 . . . . 0.0 115.213 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.58 -6.2 1.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.997 0.817 . . . . 0.0 111.848 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.95 -25.25 48.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.249 1.02 . . . . 0.0 110.703 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.18 -27.56 1.8 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -140.87 141.94 34.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.816 0.735 . . . . 0.0 112.101 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -162.03 69.03 2.22 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.251 2.621 . . . . 0.0 107.554 171.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.22 -14.44 40.53 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.665 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.9 mt -122.58 126.08 26.25 Favored Pre-proline 0 C--O 1.235 0.307 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.12 162.3 42.78 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.3 2.0 . . . . 0.0 109.307 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.2 p -49.02 -45.99 43.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.892 0.877 . . . . 0.0 112.573 -171.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -53.11 -45.79 68.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.031 0.932 . . . . 0.0 112.352 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -66.51 -31.75 72.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.622 0.769 . . . . 0.0 111.549 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -64.49 -46.93 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.096 0.862 . . . . 0.0 108.815 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.36 -47.68 87.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -56.09 -43.16 77.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.802 0.841 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.7 -47.93 81.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.046 0.384 . . . . 0.0 110.168 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.23 92.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.841 -0.537 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -70.38 -20.59 62.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.264 1.425 . . . . 0.0 112.351 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.26 -28.95 38.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.34 1.056 . . . . 0.0 109.052 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.49 -20.98 13.31 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.611 -169.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 p -52.24 133.18 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 120.498 1.499 . . . . 0.0 109.779 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.78 -5.22 84.42 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.271 -1.294 . . . . 0.0 113.446 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -84.28 164.56 18.95 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.762 1.781 . . . . 0.0 109.593 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -117.49 150.85 38.25 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.238 1.015 . . . . 0.0 109.208 -172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.3 144.32 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.185 0.994 . . . . 0.0 108.37 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.45 53.0 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 123.303 1.525 . . . . 0.0 109.479 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.92 147.9 37.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.434 -2.166 . . . . 0.0 107.908 168.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -65.06 166.15 9.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.109 1.364 . . . . 0.0 113.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.32 125.4 25.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p -145.18 159.03 43.63 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -51.68 -44.63 63.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.675 0.39 . . . . 0.0 110.658 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.11 -48.74 69.9 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.558 0.743 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -64.97 -39.86 94.12 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.267 0.94 . . . . 0.0 110.955 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.57 -43.31 73.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.402 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.32 -44.85 92.54 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.545 0.611 . . . . 0.0 110.105 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.42 -47.55 85.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.517 1.127 . . . . 0.0 109.684 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -58.41 -50.55 73.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.557 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.04 -30.76 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.923 0.783 . . . . 0.0 111.148 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -68.17 -30.88 70.1 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.244 -0.91 . . . . 0.0 111.237 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.2 -11.35 2.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.353 1.061 . . . . 0.0 113.267 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.05 -41.61 5.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.597 1.159 . . . . 0.0 110.174 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.806 0.73 . . . . 0.0 111.893 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.25 -11.45 10.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.013 0.925 . . . . 0.0 111.248 -173.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.09 -9.96 76.28 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.326 -0.859 . . . . 0.0 112.742 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -145.08 143.73 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.555 169.425 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 CA--C 1.537 0.646 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -115.31 153.83 47.49 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.22 1.408 . . . . 0.0 107.905 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.44 134.07 20.55 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.548 2.165 . . . . 0.0 110.484 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.22 7.32 88.57 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.789 -1.562 . . . . 0.0 113.055 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -81.19 149.38 29.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.339 2.57 . . . . 0.0 110.368 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.94 136.55 46.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -120.15 135.94 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.62 153.67 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -128.05 98.64 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 133.46 52.71 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.707 -0.62 . . . . 0.0 109.875 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.26 167.51 10.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.461 1.105 . . . . 0.0 109.11 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.28 -26.79 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.87 2.38 . . . . 0.0 115.175 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -140.59 2.8 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.345 1.058 . . . . 0.0 112.999 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -157.42 -152.43 0.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.445 1.098 . . . . 0.0 109.031 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 164.63 37.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -126.24 168.41 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -136.66 147.88 47.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.828 0.74 . . . . 0.0 111.479 -172.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.82 174.84 13.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.185 1.794 . . . . 0.0 108.726 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.41 132.06 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -74.67 134.54 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.206 1.002 . . . . 0.0 110.107 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.99 166.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.032 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.18 26.54 43.31 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.54 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.66 37.51 9.59 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.83 1.652 . . . . 0.0 113.28 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.63 -14.72 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 O-C-N 121.336 -0.852 . . . . 0.0 114.637 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.7 172.18 8.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.269 1.034 . . . . 0.0 109.016 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.29 161.54 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.399 0.68 . . . . 0.0 110.093 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -114.31 135.56 53.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.33 168.98 25.04 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.165 0.586 . . . . 0.0 110.902 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.55 139.27 33.95 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.26 46.09 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.697 1.599 . . . . 0.0 109.233 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.87 158.92 40.26 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.078 1.852 . . . . 0.0 111.279 172.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 C-N-CA 123.143 2.562 . . . . 0.0 113.109 -177.408 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.32 173.09 12.57 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.996 1.718 . . . . 0.0 109.13 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -143.47 158.45 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -87.49 132.77 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.88 164.51 22.93 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 109.481 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -125.23 126.34 45.03 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.01 1.324 . . . . 0.0 108.301 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -68.38 135.56 51.97 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.593 -0.692 . . . . 0.0 109.275 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -43.67 75.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.872 0.76 . . . . 0.0 111.01 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -66.07 -19.37 65.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 -44.12 13.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.844 0.747 . . . . 0.0 110.228 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.32 -29.67 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.072 0.949 . . . . 0.0 111.281 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.97 -29.39 60.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.213 -0.899 . . . . 0.0 112.255 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.77 -109.49 0.64 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.86 1.219 . . . . 0.0 111.97 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -61.88 -0.49 0.48 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.645 1.978 . . . . 0.0 114.635 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t0 67.54 160.05 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 129.37 3.068 . . . . 0.0 114.152 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 96.98 129.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 131.63 3.972 . . . . 0.0 109.063 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -165.29 161.48 19.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.062 1.345 . . . . 0.0 108.959 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.1 156.75 42.97 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.332 1.453 . . . . 0.0 108.381 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.31 134.65 28.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -153.61 75.4 1.04 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.727 -0.608 . . . . 0.0 110.24 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.93 85.58 0.23 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.767 0.827 . . . . 0.0 108.883 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -62.25 125.09 22.67 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -171.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.49 44.37 13.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 126.474 1.91 . . . . 0.0 112.525 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.12 -18.87 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.18 -30.56 25.7 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.253 1.021 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -91.19 -34.42 15.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.781 0.832 . . . . 0.0 110.559 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.41 ' HB3' ' CD1' ' A' ' 122' ' ' TYR . 7.8 m-85 -80.48 175.7 10.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.965 0.888 . . . . 0.0 112.723 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -56.27 160.08 5.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.85 2.86 . . . . 0.0 113.786 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.77 -0.6 3.22 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.815 3.01 . . . . 0.0 115.68 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 mt -36.61 119.58 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.391 2.276 . . . . 0.0 112.638 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.94 151.01 35.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.057 2.504 . . . . 0.0 111.841 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.5 m -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.633 0.773 . . . . 0.0 111.104 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -51.34 66.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.854 1.261 . . . . 0.0 111.677 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.68 -34.95 76.64 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.979 0.912 . . . . 0.0 110.992 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.3 mt -65.13 -43.35 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.573 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.6 -48.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 120.017 1.28 . . . . 0.0 108.946 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -53.18 -47.39 68.89 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.627 1.171 . . . . 0.0 110.066 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -62.18 -50.56 71.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.945 0.498 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.44 78.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.834 0.454 . . . . 0.0 111.359 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -82.55 -11.18 58.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.24 0.616 . . . . 0.0 112.343 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.53 -21.89 35.23 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 109.783 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.08 -11.7 13.78 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.19 147.61 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.181 0.9 . . . . 0.0 109.832 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.01 -2.63 80.19 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.081 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -71.15 154.91 41.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.991 1.396 . . . . 0.0 109.174 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.92 148.9 29.02 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.01 178.27 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.397 1.079 . . . . 0.0 108.62 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.35 21.77 5.64 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.27 1.028 . . . . 0.0 111.167 -170.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -123.05 160.41 26.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.553 1.541 . . . . 0.0 109.735 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -75.2 169.01 18.88 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.54 43.59 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.343 1.857 . . . . 0.0 110.282 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 p -70.46 152.71 43.74 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.542 -1.349 . . . . 0.0 107.558 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -51.76 11.6 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 109.926 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.26 -37.59 83.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.712 1.605 . . . . 0.0 112.401 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -68.69 -39.13 80.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.346 1.43 . . . . 0.0 110.543 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.1 m -67.21 -44.81 78.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.73 -44.24 90.4 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.773 1.229 . . . . 0.0 110.573 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -58.79 -53.62 56.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.099 0.96 . . . . 0.0 109.486 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -46.96 87.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.06 -33.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.315 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.8 -33.52 74.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.184 0.902 . . . . 0.0 110.968 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -58.71 -33.74 70.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.202 1.001 . . . . 0.0 111.695 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.82 -52.98 7.57 Favored 'General case' 0 N--CA 1.458 -0.072 0 O-C-N 121.292 -0.88 . . . . 0.0 110.529 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -30.81 70.94 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.522 0.729 . . . . 0.0 111.395 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 84' ' ' TYR . 48.0 m-85 -135.03 9.2 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.66 -43.42 2.75 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.886 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.87 139.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.433 171.056 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -61.93 149.45 40.52 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.715 -0.615 . . . . 0.0 109.976 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.87 156.78 30.97 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 126.096 1.758 . . . . 0.0 108.221 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.87 175.34 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.381 2.054 . . . . 0.0 110.683 171.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.15 76.88 67.74 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.78 -23.89 5.34 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.719 2.946 . . . . 0.0 113.058 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.88 -53.91 10.92 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.432 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.15 160.93 28.36 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.801 2.334 . . . . 0.0 112.978 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -134.72 146.76 60.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.162 1.385 . . . . 0.0 107.636 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.17 133.55 15.17 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.538 2.159 . . . . 0.0 110.327 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.93 -8.76 50.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.239 1.399 . . . . 0.0 112.397 -169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.01 147.92 24.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.064 1.932 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.07 139.52 42.86 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.3 mm -118.12 146.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.32 153.09 35.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -129.17 103.15 8.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -168.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.575 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.33 169.38 7.52 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.819 1.648 . . . . 0.0 107.533 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.16 -28.18 50.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.947 2.432 . . . . 0.0 115.843 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -142.05 4.4 1.65 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.703 0.801 . . . . 0.0 112.92 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.4 -155.89 0.49 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.912 1.285 . . . . 0.0 108.465 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.66 170.02 19.66 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.51 1.05 . . . . 0.0 110.746 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -144.32 172.46 12.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.333 1.853 . . . . 0.0 109.352 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -137.42 146.92 44.97 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.73 173.72 15.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.401 1.48 . . . . 0.0 108.892 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 117' ' ' VAL . 17.7 tt -139.2 133.86 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -77.09 132.05 38.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.07 -3.81 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.9 177.22 42.27 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.14 53.39 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.525 1.13 . . . . 0.0 111.484 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.87 -13.17 0.39 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.225 -1.32 . . . . 0.0 114.083 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -119.21 155.49 31.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.121 1.961 . . . . 0.0 111.834 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -134.39 156.01 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.85 1.26 . . . . 0.0 110.874 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.46 142.71 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.53 171.27 16.07 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.326 0.651 . . . . 0.0 110.284 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.37 148.62 28.16 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.44 158.99 65.03 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 125.426 1.49 . . . . 0.0 108.571 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.65 156.58 22.09 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.006 1.804 . . . . 0.0 110.419 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.67 103.83 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.882 2.388 . . . . 0.0 110.958 169.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -135.21 3.32 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.784 0.834 . . . . 0.0 112.907 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -131.7 27.57 4.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.608 1.163 . . . . 0.0 109.871 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.62 -21.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 112.915 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.18 147.15 28.1 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.63 41.07 2.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.358 0.98 . . . . 0.0 111.834 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 49.68 27.78 2.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.548 1.939 . . . . 0.0 113.436 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.67 23.33 0.41 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.228 0.918 . . . . 0.0 112.658 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.68 17.36 2.0 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.528 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.71 169.03 23.74 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.976 1.711 . . . . 0.0 107.632 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 -8.71 2.37 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.922 1.289 . . . . 0.0 113.412 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.17 -30.53 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.524 -0.735 . . . . 0.0 110.73 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.4 ttt -62.45 -38.23 88.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.231 1.012 . . . . 0.0 110.443 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -79.35 -1.34 36.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.418 1.487 . . . . 0.0 112.136 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.2 36.36 6.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.412 1.885 . . . . 0.0 112.475 -170.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.7 tp -147.52 101.05 3.32 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -145.3 163.02 35.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -131.85 46.66 2.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.643 1.211 . . . . 0.0 108.79 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.47 163.17 29.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.677 1.591 . . . . 0.0 109.22 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.21 177.23 10.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.506 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 mt -134.83 147.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 t -88.58 125.94 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -135.17 165.57 25.09 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.246 1.018 . . . . 0.0 109.701 -168.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -125.69 139.11 53.82 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -151.95 160.85 43.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.859 1.264 . . . . 0.0 108.598 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.39 132.89 50.13 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -53.31 -43.91 67.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.531 0.732 . . . . 0.0 110.748 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -67.06 -19.19 65.63 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.6 -46.21 33.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.141 0.882 . . . . 0.0 109.906 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.95 -39.21 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.489 0.715 . . . . 0.0 110.197 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.76 -20.15 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.315 1.446 . . . . 0.0 112.861 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.5 -11.92 37.2 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.176 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -51.46 -57.94 7.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.531 1.132 . . . . 0.0 111.009 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -165.79 -50.8 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.968 1.707 . . . . 0.0 110.132 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -159.41 173.0 16.9 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.022 1.729 . . . . 0.0 107.977 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -157.96 164.1 37.16 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.475 -0.766 . . . . 0.0 109.75 173.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -147.83 160.19 43.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.403 1.481 . . . . 0.0 108.367 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.67 135.22 26.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -154.09 75.06 1.0 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.65 0.659 . . . . 0.0 110.779 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.45 94.89 0.42 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -57.53 -23.29 49.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -136.95 21.97 3.05 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.738 1.154 . . . . 0.0 112.251 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.62 -4.72 1.0 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.481 1.491 . . . . 0.0 112.08 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.28 -9.89 53.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.669 1.187 . . . . 0.0 110.729 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -132.3 -41.14 0.99 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.011 1.324 . . . . 0.0 111.213 -169.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -153.05 162.19 41.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.179 . . . . 0.0 111.898 -169.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -178.78 72.16 0.2 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 129.286 3.035 . . . . 0.0 105.275 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -13.64 40.45 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.535 2.823 . . . . 0.0 113.986 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.86 138.64 24.14 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 108.641 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.39 159.14 50.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.313 2.008 . . . . 0.0 109.823 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.24 -42.46 61.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.757 0.823 . . . . 0.0 111.502 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -53.66 -56.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.624 0.77 . . . . 0.0 111.194 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.7 -38.38 90.2 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.354 1.061 . . . . 0.0 111.718 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.84 -49.31 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.431 1.014 . . . . 0.0 108.692 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.29 -46.09 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.91 89.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.877 -0.582 . . . . 0.0 109.957 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -63.3 -48.0 79.92 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.925 0.784 . . . . 0.0 109.851 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.26 60.2 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.321 0.509 . . . . 0.0 110.005 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.68 -19.93 58.79 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.78 -26.51 61.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.864 1.266 . . . . 0.0 109.048 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.76 -10.65 19.75 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.88 -169.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.47 144.52 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.399 0.999 . . . . 0.0 109.784 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.14 60.77 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.66 1.124 . . . . 0.0 112.979 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -86.46 158.42 19.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.798 1.299 . . . . 0.0 109.536 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -100.68 154.04 18.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.53 147.06 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.968 1.307 . . . . 0.0 107.89 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.33 42.09 1.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.788 1.28 . . . . 0.0 110.16 -168.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -139.87 147.79 41.16 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.692 1.597 . . . . 0.0 108.406 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.33 150.5 34.85 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.116 0.967 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -77.23 56.28 1.29 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.177 1.391 . . . . 0.0 112.282 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -64.58 159.07 22.62 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.076 -1.015 . . . . 0.0 109.26 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.3 t -50.07 -45.03 52.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.42 -43.57 97.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.211 0.604 . . . . 0.0 111.476 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -71.71 -37.0 70.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.112 0.869 . . . . 0.0 111.142 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.3 m -67.87 -42.85 80.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.257 0.48 . . . . 0.0 110.159 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.45 -46.73 83.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.071 0.948 . . . . 0.0 109.643 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -58.06 -55.27 37.15 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.722 1.209 . . . . 0.0 109.771 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.39 -49.6 76.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.643 0.202 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 1.4 p -70.55 -30.59 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.819 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -67.34 -33.28 74.91 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.472 -0.768 . . . . 0.0 110.398 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -55.99 -29.86 60.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.541 0.736 . . . . 0.0 112.194 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.15 -50.17 9.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.534 0.606 . . . . 0.0 110.354 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -71.17 -33.34 69.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.558 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.25 6.72 6.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.669 0.668 . . . . 0.0 112.601 -170.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.56 7.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.113 0.869 . . . . 0.0 112.691 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.48 141.4 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.406 1.882 . . . . 0.0 107.914 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.793 168.871 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -66.99 -41.99 85.81 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.611 -0.68 . . . . 0.0 111.13 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.36 143.07 97.86 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.347 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.06 -20.49 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.3 2.0 . . . . 0.0 113.177 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.1 pt 37.02 55.63 3.37 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.395 1.878 . . . . 0.0 111.808 -172.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -80.44 175.62 10.0 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 123.725 2.95 . . . . 0.0 109.747 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.05 67.94 73.98 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.43 159.03 46.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.077 2.518 . . . . 0.0 112.182 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.35 148.43 67.91 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.32 1.448 . . . . 0.0 107.594 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -47.51 129.15 16.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.582 2.188 . . . . 0.0 110.088 170.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.64 -6.16 35.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.933 1.254 . . . . 0.0 112.297 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.35 150.8 22.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.385 2.092 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.66 142.53 38.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.13 146.08 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -129.05 146.78 50.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 167.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.83 93.78 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.8 135.04 51.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -128.21 172.41 6.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.055 1.342 . . . . 0.0 110.074 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.33 -34.88 26.21 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.454 2.77 . . . . 0.0 116.733 -169.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -139.75 7.98 2.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.699 0.8 . . . . 0.0 112.721 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.58 -169.0 1.97 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 109.121 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.17 156.82 45.88 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.166 -0.959 . . . . 0.0 109.216 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -119.76 169.08 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.471 1.508 . . . . 0.0 107.609 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -132.87 146.0 51.43 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.491 1.041 . . . . 0.0 111.146 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.89 174.88 12.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.647 1.979 . . . . 0.0 108.383 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 tt -135.72 135.51 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.35 131.52 37.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.82 -3.77 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.45 174.57 41.93 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.93 53.75 0.96 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.205 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.2 -13.08 0.29 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.289 -1.284 . . . . 0.0 113.781 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -120.3 155.76 32.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.095 1.948 . . . . 0.0 111.934 -171.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 m -133.98 160.33 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.971 1.308 . . . . 0.0 110.957 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -114.53 140.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 167.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.75 173.51 15.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.898 0.479 . . . . 0.0 110.937 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.32 141.22 34.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.94 160.93 58.63 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.425 1.89 . . . . 0.0 108.142 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -61.58 150.69 84.35 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.548 1.498 . . . . 0.0 109.727 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.83 148.62 21.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.395 2.73 . . . . 0.0 114.296 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -56.12 151.2 12.66 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.867 1.267 . . . . 0.0 111.426 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.86 73.56 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 168.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.287 26.2 m 42.39 -130.13 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.602 1.961 . . . . 0.0 110.931 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.79 -6.52 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.291 1.437 . . . . 0.0 114.01 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -19.71 64.44 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 112.139 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.98 17.9 3.63 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.577 1.951 . . . . 0.0 114.248 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.6 175.64 37.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.41 -178.41 6.97 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.579 1.152 . . . . 0.0 109.484 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.01 166.7 23.8 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.723 1.609 . . . . 0.0 108.177 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 m -64.7 -16.14 62.45 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.834 0.853 . . . . 0.0 112.946 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -52.81 107.79 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.669 1.588 . . . . 0.0 109.95 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.3 tpp 49.69 22.07 0.74 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.563 1.945 . . . . 0.0 113.557 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 m -146.2 13.44 1.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.456 1.103 . . . . 0.0 111.945 -169.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.02 -18.0 55.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.218 1.007 . . . . 0.0 113.621 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.0 tp -147.23 142.98 27.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.198 1.799 . . . . 0.0 106.712 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 p -144.8 152.49 40.4 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.349 1.459 . . . . 0.0 107.164 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.6 8.36 8.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -146.22 163.81 34.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.802 3.241 . . . . 0.0 106.912 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.56 12.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 112.058 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.42 148.5 25.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 125.761 1.624 . . . . 0.0 107.132 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.69 128.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -137.72 161.0 37.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.685 1.194 . . . . 0.0 109.145 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -121.67 134.08 54.97 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.62 160.9 43.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.755 1.222 . . . . 0.0 109.002 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.08 128.18 35.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.887 0.875 . . . . 0.0 108.877 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.33 -45.11 68.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.83 0.852 . . . . 0.0 110.626 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -64.3 -24.42 67.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.919 -172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.59 -43.22 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.706 0.685 . . . . 0.0 110.481 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.93 -46.8 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.452 0.701 . . . . 0.0 109.744 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.25 65.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.845 1.258 . . . . 0.0 112.117 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 -12.16 15.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.723 1.154 . . . . 0.0 113.363 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.9 m -52.42 -50.55 62.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.959 1.38 . . . . 0.0 111.133 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -165.04 -56.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.041 1.336 . . . . 0.0 110.631 171.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.95 -176.93 5.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.078 1.351 . . . . 0.0 109.855 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.79 169.53 24.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.894 0.878 . . . . 0.0 110.218 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -152.88 156.53 39.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.521 1.129 . . . . 0.0 110.065 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.64 138.43 20.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 169.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -150.63 67.96 0.95 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.171 0.51 . . . . 0.0 109.714 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.36 114.7 3.34 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -56.75 -42.33 79.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.458 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -163.11 43.47 0.12 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.331 0.652 . . . . 0.0 110.729 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.09 -14.25 6.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.818 . . . . 0.0 111.812 168.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.99 -16.74 37.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.0 1.32 . . . . 0.0 110.908 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -116.56 -27.11 6.82 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.454 1.102 . . . . 0.0 110.928 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -144.97 146.51 31.97 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.316 0.647 . . . . 0.0 111.643 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 p -164.82 66.28 1.23 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.541 1.536 . . . . 0.0 108.96 169.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.46 -13.82 41.49 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.452 2.101 . . . . 0.0 113.025 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.58 119.39 21.59 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.239 1.416 . . . . 0.0 108.764 -171.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.44 153.67 22.11 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.734 2.289 . . . . 0.0 110.146 167.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.1 m -52.71 -43.46 65.66 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.713 0.405 . . . . 0.0 111.87 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -56.71 -41.17 76.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.689 0.795 . . . . 0.0 112.269 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -64.94 -31.89 73.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.573 0.749 . . . . 0.0 111.133 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -64.74 -46.07 93.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.58 -48.81 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -55.64 -46.19 77.48 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.744 1.218 . . . . 0.0 110.724 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -61.03 -51.41 69.31 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.49 67.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.395 0.278 . . . . 0.0 110.712 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.76 -20.55 61.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.93 -27.49 61.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 119.254 0.934 . . . . 0.0 108.877 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.68 -16.19 15.54 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.711 -1.137 . . . . 0.0 113.529 -168.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.0 t -53.2 134.78 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.622 1.556 . . . . 0.0 108.578 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.78 -7.17 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.524 1.059 . . . . 0.0 113.335 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 159.36 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.184 1.492 . . . . 0.0 108.918 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -127.51 142.87 51.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.71 146.79 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.876 0.87 . . . . 0.0 109.01 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.36 -1.21 48.2 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.757 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -80.14 149.68 30.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.813 0.733 . . . . 0.0 109.209 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -74.65 154.45 38.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.498 1.919 . . . . 0.0 109.443 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.91 121.81 16.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.7 p -140.92 158.26 44.2 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 m -51.97 -42.38 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.852 0.461 . . . . 0.0 110.184 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.46 -48.33 70.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 110.841 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.67 -38.04 83.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.57 0.623 . . . . 0.0 110.853 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.2 m -67.91 -44.62 76.51 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.932 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -58.01 -44.69 87.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.489 0.715 . . . . 0.0 110.209 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -56.86 -52.41 65.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.163 1.385 . . . . 0.0 109.414 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -62.33 -49.97 73.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.757 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.0 -33.17 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.693 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.16 -34.7 78.62 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 121.639 -0.663 . . . . 0.0 110.682 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.55 -34.44 71.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.354 0.662 . . . . 0.0 112.203 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -76.88 -45.5 27.95 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.53 -0.731 . . . . 0.0 110.253 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -34.87 61.31 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.301 0.64 . . . . 0.0 111.265 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.08 8.35 6.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 111.999 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.77 -21.04 12.03 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.057 -1.027 . . . . 0.0 112.906 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.26 143.57 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.605 1.562 . . . . 0.0 106.891 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.483 0.713 . . . . 0.0 111.256 172.81 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -70.03 -33.15 71.61 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.4 -0.812 . . . . 0.0 111.755 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.44 47.26 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.944 1.698 . . . . 0.0 107.877 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.12 -166.81 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.209 2.606 . . . . 0.0 110.977 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -115.09 54.8 0.87 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.496 1.118 . . . . 0.0 112.231 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.58 -38.9 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.739 1.626 . . . . 0.0 110.335 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.27 64.21 7.18 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.462 1.905 . . . . 0.0 110.234 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.85 151.91 10.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.423 2.082 . . . . 0.0 111.824 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -125.35 141.52 39.02 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.98 134.84 18.2 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.772 2.315 . . . . 0.0 110.504 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.65 -10.0 58.96 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.154 1.359 . . . . 0.0 112.402 -169.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -78.04 140.5 39.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.119 1.959 . . . . 0.0 111.033 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.57 136.28 52.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.89 140.87 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.31 145.63 45.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 110.95 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -75.76 134.48 40.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -132.86 168.89 15.65 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.053 0.941 . . . . 0.0 110.687 -170.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.53 -30.41 35.61 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.37 2.713 . . . . 0.0 116.588 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 4.93 1.5 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.474 0.71 . . . . 0.0 112.763 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.68 -165.86 1.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.699 1.2 . . . . 0.0 109.029 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.09 149.46 44.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -120.69 171.77 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.746 1.618 . . . . 0.0 108.362 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -138.18 146.13 42.33 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.471 0.709 . . . . 0.0 111.012 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 174.43 12.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.459 1.904 . . . . 0.0 108.065 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.94 131.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.34 134.42 41.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.86 -3.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.58 175.18 42.63 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.88 55.38 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.163 0.985 . . . . 0.0 111.394 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.12 -15.3 0.33 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.956 1.265 . . . . 0.0 113.694 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -119.6 154.06 34.54 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.714 1.757 . . . . 0.0 111.738 -169.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.16 159.61 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.655 1.182 . . . . 0.0 110.673 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -111.47 138.68 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 167.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.67 168.03 27.95 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 111.009 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.39 139.95 33.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 165.34 21.07 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.534 1.533 . . . . 0.0 109.184 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.42 150.51 41.62 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.736 2.291 . . . . 0.0 112.458 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.11 145.92 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.324 2.016 . . . . 0.0 109.938 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -68.52 168.53 12.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.051 0.94 . . . . 0.0 110.949 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.27 61.76 2.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.036 1.335 . . . . 0.0 110.011 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.37 171.48 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.697 1.199 . . . . 0.0 111.268 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.53 142.98 25.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 111.092 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.27 32.6 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.005 0.812 . . . . 0.0 111.682 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.94 -14.23 59.44 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.114 0.966 . . . . 0.0 113.505 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.33 35.22 2.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.343 1.449 . . . . 0.0 110.901 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.76 163.24 32.7 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.182 1.393 . . . . 0.0 109.622 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.44 169.07 24.62 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.74 1.616 . . . . 0.0 108.692 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 m -132.97 10.67 4.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.039 0.936 . . . . 0.0 112.209 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 t 69.46 -39.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.707 2.403 . . . . 0.0 112.387 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.6 mtp -141.52 142.37 33.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.186 1.795 . . . . 0.0 106.707 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 m -60.6 -33.72 73.15 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.29 60.99 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.422 0.689 . . . . 0.0 112.554 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.82 122.91 19.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -151.98 150.08 29.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -144.11 20.28 1.76 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.687 1.232 . . . . 0.0 112.036 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.17 168.69 19.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.48 2.312 . . . . 0.0 108.727 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.22 176.83 10.83 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.222 1.009 . . . . 0.0 110.481 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -138.03 148.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.73 126.58 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -130.64 166.14 21.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.348 1.059 . . . . 0.0 109.772 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.06 127.46 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -151.8 163.16 39.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.462 1.105 . . . . 0.0 108.84 -169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.64 131.07 45.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.69 -45.64 70.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.693 0.797 . . . . 0.0 110.576 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -66.37 -19.81 65.9 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.94 -45.27 16.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.851 0.751 . . . . 0.0 110.065 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.6 t -59.43 -40.79 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.796 0.838 . . . . 0.0 110.638 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.02 -2.0 54.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 0.0 113.115 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.29 -15.88 46.88 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.917 0.77 . . . . 0.0 113.14 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 p -55.95 -47.13 78.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.139 1.376 . . . . 0.0 111.976 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -162.76 -67.9 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.707 1.203 . . . . 0.0 111.706 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -155.54 172.57 18.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.167 0.987 . . . . 0.0 109.926 -167.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.33 165.56 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.848 0.859 . . . . 0.0 110.75 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.56 163.08 40.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.07 0.948 . . . . 0.0 110.414 167.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.1 139.38 20.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 168.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -147.3 55.42 1.09 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.39 0.614 . . . . 0.0 110.39 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -54.61 113.03 1.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -61.84 -33.3 73.92 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -138.06 23.22 2.81 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.68 0.792 . . . . 0.0 112.13 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.4 -2.71 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.348 0.976 . . . . 0.0 112.491 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.69 -26.33 59.77 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.169 -0.957 . . . . 0.0 110.945 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -143.2 -25.02 0.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -128.92 164.81 22.32 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.494 1.518 . . . . 0.0 112.233 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 m 165.64 72.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 131.52 3.928 . . . . 0.0 106.077 168.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.33 -13.86 36.48 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.287 2.658 . . . . 0.0 113.512 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.6 120.06 34.99 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 108.218 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.23 158.33 12.26 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 111.884 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -48.56 -44.46 36.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 111.786 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.2 p -56.02 -51.91 66.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.575 0.75 . . . . 0.0 110.926 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -65.46 -37.02 85.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.7 0.8 . . . . 0.0 111.373 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.87 -48.7 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.79 -39.36 83.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -55.74 -45.68 77.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.485 0.714 . . . . 0.0 110.213 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -60.85 -53.93 51.26 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 119.008 -0.52 . . . . 0.0 109.678 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.99 -48.84 61.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.283 0.492 . . . . 0.0 111.21 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -66.31 -34.22 77.5 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.681 1.592 . . . . 0.0 112.244 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -72.88 -24.09 60.81 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.232 1.013 . . . . 0.0 109.979 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.17 -12.02 17.64 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.965 . . . . 0.0 112.669 -168.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.87 142.19 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.375 1.443 . . . . 0.0 109.598 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.02 -8.39 79.91 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.807 1.194 . . . . 0.0 113.172 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -81.68 153.62 26.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.0 1.4 . . . . 0.0 109.186 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -101.52 154.16 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.321 1.048 . . . . 0.0 109.238 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.57 147.99 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 107.797 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.18 34.92 2.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.17 0.985 . . . . 0.0 110.665 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -125.54 146.77 49.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 108.393 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -73.38 164.12 27.12 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 127.099 2.16 . . . . 0.0 110.383 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.36 126.71 30.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.5 p -145.01 159.0 43.64 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -44.43 64.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.035 0.534 . . . . 0.0 109.623 174.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.11 -43.5 70.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.798 0.839 . . . . 0.0 111.447 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -66.68 -41.85 87.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.102 0.865 . . . . 0.0 110.369 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.23 -43.97 80.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.878 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.48 -45.22 89.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.4 0.68 . . . . 0.0 110.311 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -57.13 -52.02 66.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.041 0.936 . . . . 0.0 109.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -61.54 -49.42 76.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.019 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.21 -32.45 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.603 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -67.9 -31.75 71.75 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.219 -0.925 . . . . 0.0 111.151 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.2 -19.76 55.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.651 1.18 . . . . 0.0 112.414 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.5 -43.87 6.37 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.783 0.833 . . . . 0.0 110.339 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.65 -43.23 76.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.577 1.08 . . . . 0.0 111.438 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.4 2.41 13.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.45 -30.62 5.18 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.346 -0.846 . . . . 0.0 112.138 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -156.1 141.36 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 169.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 118.282 0.492 . . . . 0.0 110.64 170.006 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mmm . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.55 -32.15 71.88 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.594 -0.691 . . . . 0.0 110.059 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.6 121.05 8.14 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.18 -179.88 3.43 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.278 1.986 . . . . 0.0 110.638 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 pt -124.46 59.73 21.43 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.229 1.412 . . . . 0.0 108.936 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.6 -40.62 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.185 1.924 . . . . 0.0 112.506 -168.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -146.54 30.7 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.845 1.258 . . . . 0.0 113.85 -170.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -61.85 158.13 39.61 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.657 1.985 . . . . 0.0 112.037 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -138.48 151.42 69.08 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.148 0.979 . . . . 0.0 110.036 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -46.33 135.33 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.879 2.386 . . . . 0.0 110.837 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -14.59 54.49 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.254 1.407 . . . . 0.0 111.797 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -83.77 151.03 25.42 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.098 1.949 . . . . 0.0 111.43 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.9 139.54 41.69 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.42 125.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -96.86 152.08 19.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.4 mm -126.35 109.84 22.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.91 132.51 46.83 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.41 166.43 17.33 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.32 -35.88 28.65 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.47 2.78 . . . . 0.0 116.235 -168.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.97 13.05 2.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.285 1.034 . . . . 0.0 111.801 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.09 -164.78 1.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.058 0.943 . . . . 0.0 109.954 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 156.66 47.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 172.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -124.16 170.71 10.44 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.748 2.019 . . . . 0.0 106.292 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -136.8 148.3 47.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.715 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 173.71 12.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 107.962 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.7 tt -136.58 134.21 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.22 131.73 37.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.286 1.035 . . . . 0.0 108.309 -171.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.41 -5.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.45 -178.88 38.23 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.35 41.77 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.255 1.022 . . . . 0.0 111.671 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.41 -29.75 0.28 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.905 1.24 . . . . 0.0 112.627 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -88.77 149.65 23.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.784 1.292 . . . . 0.0 111.445 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -131.59 155.48 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.561 1.545 . . . . 0.0 109.112 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -102.42 143.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 166.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.2 165.07 35.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.571 -0.705 . . . . 0.0 111.131 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 136.91 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.27 34.53 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.804 0.842 . . . . 0.0 110.71 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.7 164.25 36.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.416 2.077 . . . . 0.0 110.112 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.05 -41.46 52.26 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.058 1.839 . . . . 0.0 110.675 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -160.93 145.98 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.939 1.696 . . . . 0.0 106.852 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -93.51 10.7 31.37 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.565 1.174 . . . . 0.0 111.698 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -147.23 156.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 128.798 2.839 . . . . 0.0 105.854 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.99 39.75 1.92 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.684 1.194 . . . . 0.0 111.89 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.7 -121.62 0.6 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -168.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.87 61.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.515 0.726 . . . . 0.0 112.845 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.74 -169.38 11.08 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.557 1.075 . . . . 0.0 112.905 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.15 -17.94 13.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.019 1.328 . . . . 0.0 114.228 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.21 -29.18 21.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.765 0.826 . . . . 0.0 112.199 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m 54.76 34.24 21.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.837 1.255 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -76.99 -170.92 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.725 0.81 . . . . 0.0 109.846 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -49.52 -35.58 20.54 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.331 1.452 . . . . 0.0 113.218 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -60.82 -38.26 84.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.729 0.812 . . . . 0.0 112.388 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -27.84 37.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.42 0.94 17.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.043 1.337 . . . . 0.0 111.892 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -134.18 176.83 8.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.873 1.669 . . . . 0.0 107.112 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.85 30.09 4.36 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.686 0.795 . . . . 0.0 111.901 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -92.5 172.94 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.103 1.361 . . . . 0.0 110.453 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.28 -172.69 4.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 109.728 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 mt -141.8 156.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.867 1.267 . . . . 0.0 109.252 -170.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -98.82 127.88 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -129.92 168.7 16.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.456 1.102 . . . . 0.0 110.411 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -125.72 134.34 51.81 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -150.69 160.83 43.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.74 1.216 . . . . 0.0 108.686 -175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.44 138.01 56.31 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 167.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.85 -33.4 68.62 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.687 0.795 . . . . 0.0 110.623 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -36.97 74.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.954 0.797 . . . . 0.0 110.954 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.07 -46.04 65.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.831 0.287 . . . . 0.0 110.471 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.67 -41.24 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.091 0.557 . . . . 0.0 110.397 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.22 40.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.383 1.473 . . . . 0.0 113.45 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.48 -16.0 34.44 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.044 0.831 . . . . 0.0 113.689 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 p -61.64 -44.1 97.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.553 1.176 . . . . 0.0 112.014 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -162.26 -59.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.861 0.865 . . . . 0.0 112.377 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -164.32 -170.73 2.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.673 1.589 . . . . 0.0 108.986 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -148.1 166.88 26.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.889 0.875 . . . . 0.0 109.956 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -145.44 153.21 40.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.197 1.399 . . . . 0.0 107.482 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -83.77 137.31 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.37 70.78 0.87 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.228 0.537 . . . . 0.0 109.92 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.51 112.9 2.66 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -65.69 -11.43 45.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.869 . . . . 0.0 113.184 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.8 m-70 -129.85 26.24 5.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.639 1.175 . . . . 0.0 111.591 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.11 23.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.895 -1.128 . . . . 0.0 112.605 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.8 t70 -132.91 -3.38 3.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 111.607 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -132.82 -31.59 1.31 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.26 1.424 . . . . 0.0 111.579 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 67.81 136.11 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 128.569 2.748 . . . . 0.0 116.211 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -63.93 139.97 97.76 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.382 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -16.75 32.37 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.894 2.396 . . . . 0.0 112.211 168.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.04 128.39 26.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.669 1.588 . . . . 0.0 108.802 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.93 155.03 24.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.165 2.577 . . . . 0.0 111.832 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.0 p -54.3 -40.45 67.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.86 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -56.52 -53.56 56.12 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.595 0.758 . . . . 0.0 110.569 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -62.92 -36.89 84.89 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.298 0.639 . . . . 0.0 111.472 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.03 -51.55 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.158 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -56.03 -49.1 74.64 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.188 0.995 . . . . 0.0 110.036 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -65.16 -45.65 84.08 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.729 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.95 -52.07 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.632 0.651 . . . . 0.0 110.793 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.93 -23.18 60.66 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -72.73 -27.5 62.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.66 -4.58 30.58 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.703 0.801 . . . . 0.0 113.051 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.28 150.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 109.828 169.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.5 23.53 56.15 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.439 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -126.85 161.98 26.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.703 1.201 . . . . 0.0 107.927 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.08 156.86 16.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.941 1.296 . . . . 0.0 109.754 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.8 m -130.56 148.84 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.827 2.051 . . . . 0.0 106.664 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.44 19.78 11.6 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.62 -0.675 . . . . 0.0 112.223 -169.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -121.41 155.92 33.79 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.293 1.437 . . . . 0.0 109.179 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -88.44 169.93 11.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.431 1.093 . . . . 0.0 112.542 -170.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.19 121.45 14.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 p -147.05 152.86 39.24 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 165.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -53.57 -40.84 65.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.102 0.41 . . . . 0.0 110.571 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.79 -44.74 84.81 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.376 0.67 . . . . 0.0 111.047 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -67.94 -38.57 83.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 0.786 . . . . 0.0 110.534 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.62 -44.62 81.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.646 0.657 . . . . 0.0 110.039 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -60.11 -45.3 93.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.101 0.56 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -57.82 -54.48 46.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.251 1.02 . . . . 0.0 109.587 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.49 -48.62 80.18 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.919 0.488 . . . . 0.0 111.729 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.47 -31.25 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.165 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -72.38 -27.61 62.49 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.897 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -61.61 -39.61 91.86 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.811 1.187 . . . . 0.0 109.644 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.42 -47.32 50.04 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.288 -0.883 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -17.35 59.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.284 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -142.76 7.39 1.66 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.81 1.186 . . . . 0.0 113.585 -169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.97 -48.55 3.68 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 120.806 -1.184 . . . . 0.0 110.637 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.66 141.23 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.582 1.953 . . . . 0.0 106.931 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.938 168.362 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? 65.51 -39.15 0.28 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.494 2.318 . . . . 0.0 113.336 -169.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.76 147.69 20.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.662 1.585 . . . . 0.0 107.504 169.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.19 177.52 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.554 2.169 . . . . 0.0 111.045 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.435 HG22 HG23 ' A' ' 76' ' ' VAL . 29.8 pt -128.49 63.6 64.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.39 1.476 . . . . 0.0 107.61 171.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.32 -45.3 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.785 2.324 . . . . 0.0 113.436 -166.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.46 52.07 0.42 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.336 1.454 . . . . 0.0 110.914 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.5 Cg_endo -66.37 160.24 46.38 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.213 1.942 . . . . 0.0 111.799 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -135.81 151.79 74.74 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.726 1.211 . . . . 0.0 108.95 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HB2' HD11 ' A' ' 93' ' ' ILE . 94.8 Cg_exo -47.01 143.53 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.889 2.393 . . . . 0.0 111.495 169.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.56 73.99 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.038 1.304 . . . . 0.0 112.227 -170.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -76.76 147.81 37.07 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.509 1.654 . . . . 0.0 111.056 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.87 140.86 46.0 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.098 0.959 . . . . 0.0 108.829 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -125.21 138.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.39 148.9 41.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -121.87 106.37 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 -169.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -75.42 133.01 41.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -129.3 167.85 18.42 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 0.0 110.531 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.12 -25.54 29.65 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.252 2.635 . . . . 0.0 116.433 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -141.48 0.25 1.46 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.02 -165.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.67 1.188 . . . . 0.0 109.271 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -134.01 152.22 51.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -126.78 171.95 10.77 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.144 1.777 . . . . 0.0 107.998 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 66.6 m95 -139.2 150.0 45.05 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.073 0.851 . . . . 0.0 110.869 -172.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.33 173.24 16.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.421 1.488 . . . . 0.0 108.667 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.77 128.94 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.39 130.14 42.21 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.68 1.592 . . . . 0.0 109.433 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.53 168.6 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.075 1.35 . . . . 0.0 109.416 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.84 -135.31 49.23 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -120.71 8.99 10.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.397 1.079 . . . . 0.0 111.392 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.11 16.67 0.02 OUTLIER Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.437 -0.789 . . . . 0.0 113.686 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -107.6 169.2 8.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.847 1.324 . . . . 0.0 109.013 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.85 151.98 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.936 0.494 . . . . 0.0 110.649 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.28 141.37 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 166.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.84 171.54 17.59 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.92 143.2 30.88 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.6 159.33 71.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.286 1.834 . . . . 0.0 108.561 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.49 159.55 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.156 1.904 . . . . 0.0 110.921 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.02 -24.69 32.78 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.509 2.139 . . . . 0.0 113.008 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m 53.13 -164.21 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.247 1.419 . . . . 0.0 112.151 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -137.95 33.33 2.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.481 1.113 . . . . 0.0 109.368 -174.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t 69.77 -41.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.287 2.635 . . . . 0.0 112.357 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.82 168.82 23.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.853 1.661 . . . . 0.0 109.519 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.95 177.45 47.54 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 -21.13 64.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.333 0.653 . . . . 0.0 112.5 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.04 -27.68 0.34 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.625 1.107 . . . . 0.0 111.733 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.36 173.08 12.94 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.935 1.694 . . . . 0.0 108.703 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.86 176.36 10.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.782 1.633 . . . . 0.0 108.301 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.0 m -58.28 -11.77 3.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.374 1.07 . . . . 0.0 113.331 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.4 -34.66 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.211 -0.93 . . . . 0.0 110.856 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -69.33 -33.21 72.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.492 0.717 . . . . 0.0 109.975 173.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -72.69 5.58 3.04 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.981 1.312 . . . . 0.0 112.402 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 57.21 28.78 15.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.671 1.989 . . . . 0.0 113.161 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.16 -16.11 62.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.495 0.718 . . . . 0.0 111.993 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 152.74 19.9 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -120.39 22.94 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.937 0.875 . . . . 0.0 112.724 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -130.82 -179.12 5.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.108 2.163 . . . . 0.0 109.862 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.55 173.9 13.57 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.397 . . . . 0.0 108.21 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -142.13 154.52 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.65 138.52 19.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -142.92 168.59 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.953 1.301 . . . . 0.0 108.814 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -128.54 140.79 51.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -151.24 161.14 43.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.41 1.484 . . . . 0.0 107.929 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.82 137.25 57.09 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.61 -44.74 73.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.714 0.688 . . . . 0.0 110.82 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.04 -19.79 65.74 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.92 -47.58 28.99 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.129 0.877 . . . . 0.0 109.737 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.4 t -62.19 -43.35 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.563 0.745 . . . . 0.0 110.243 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.43 -7.97 56.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.992 1.317 . . . . 0.0 113.182 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.32 -20.41 58.56 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.714 0.673 . . . . 0.0 113.22 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 -47.49 84.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.77 1.228 . . . . 0.0 111.976 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -159.08 -61.42 0.07 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.733 0.813 . . . . 0.0 112.884 172.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -155.73 171.34 20.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -158.94 163.25 36.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.71 0.804 . . . . 0.0 110.111 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -151.15 154.14 36.33 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.605 0.762 . . . . 0.0 110.78 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 5' ' ' ILE . 92.2 t -79.81 137.56 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.74 68.55 0.46 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.528 0.68 . . . . 0.0 110.587 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.91 101.58 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -68.14 129.53 40.2 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 44.67 44.89 7.78 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.866 1.667 . . . . 0.0 112.1 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.78 -12.43 4.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.623 0.769 . . . . 0.0 112.967 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.95 -20.24 33.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.657 1.583 . . . . 0.0 111.029 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 -14.25 8.94 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.987 1.315 . . . . 0.0 111.026 -173.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -136.37 -156.09 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.973 1.709 . . . . 0.0 109.452 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m 57.79 59.93 6.57 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.361 1.864 . . . . 0.0 112.359 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -61.8 -14.74 38.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.363 2.042 . . . . 0.0 114.197 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.46 141.69 23.04 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.683 0.793 . . . . 0.0 110.51 -167.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 159.48 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.202 . . . . 0.0 110.137 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.7 m -48.05 -47.63 33.59 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.464 1.106 . . . . 0.0 111.57 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.68 -49.99 69.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.538 0.735 . . . . 0.0 111.683 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.38 -35.25 77.42 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.774 -0.579 . . . . 0.0 111.433 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.8 -49.01 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 10' ' ' PRO . 54.7 mt -63.69 -45.05 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.181 0.993 . . . . 0.0 109.166 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.07 -52.27 52.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.052 0.941 . . . . 0.0 108.963 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -66.86 -45.99 76.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.305 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.27 -47.88 62.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.617 0.644 . . . . 0.0 111.434 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.6 -10.72 57.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.351 0.661 . . . . 0.0 112.594 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.68 -22.49 40.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.38 0.991 . . . . 0.0 110.185 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.5 mt -111.7 -4.64 14.63 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.602 0.761 . . . . 0.0 112.372 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.25 142.79 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 118.869 0.759 . . . . 0.0 110.066 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.64 -3.2 80.04 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.297 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -74.07 152.74 39.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.321 1.561 . . . . 0.0 109.268 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.46 149.97 22.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.13 176.63 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.585 1.154 . . . . 0.0 107.944 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.42 6.12 6.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.564 -0.71 . . . . 0.0 112.519 -169.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -99.0 146.43 26.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.123 0.969 . . . . 0.0 109.062 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -61.83 153.46 28.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.323 1.449 . . . . 0.0 111.149 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.65 127.08 31.02 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.4 p -141.86 159.51 42.07 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 m -49.31 -42.09 40.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.21 0.604 . . . . 0.0 111.127 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.2 -23.75 18.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.318 -168.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -68.16 -39.93 82.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.633 1.106 . . . . 0.0 109.442 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.2 m -69.79 -40.6 75.91 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.079 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -53.64 -49.09 68.64 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.446 0.698 . . . . 0.0 109.883 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -60.2 -46.2 90.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.181 0.992 . . . . 0.0 110.11 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.31 -53.19 59.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.373 0.533 . . . . 0.0 111.77 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.86 -33.71 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 119.881 -0.727 . . . . 0.0 111.216 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -68.75 -32.12 71.65 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.596 -0.69 . . . . 0.0 111.148 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.17 -41.7 98.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.207 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.59 -44.79 81.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.865 1.212 . . . . 0.0 111.017 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -66.07 -42.43 89.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.343 0.657 . . . . 0.0 111.463 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -95.33 -43.98 7.78 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.001 0.364 . . . . 0.0 111.909 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.33 -53.52 0.69 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.53 138.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.127 -0.463 . . . . 0.0 109.82 -179.293 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -143.7 168.09 20.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.127 1.371 . . . . 0.0 108.869 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.1 79.62 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -72.2 -21.89 22.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.367 2.044 . . . . 0.0 113.815 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.1 mt 44.34 60.29 12.34 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.568 1.547 . . . . 0.0 109.64 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.18 -50.86 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.237 1.958 . . . . 0.0 112.133 -167.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -168.87 75.14 0.77 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.061 1.744 . . . . 0.0 108.863 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.44 129.43 26.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.492 2.128 . . . . 0.0 110.716 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.05 151.02 69.7 Favored Pre-proline 0 C--O 1.236 0.351 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.86 131.53 38.62 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.018 1.812 . . . . 0.0 109.3 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.9 -1.48 65.49 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.749 1.166 . . . . 0.0 113.015 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -73.61 147.71 43.55 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.963 1.881 . . . . 0.0 111.06 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.08 136.11 44.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.89 124.31 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.96 150.29 20.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -125.89 113.56 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -171.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 131.74 44.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -119.49 169.0 8.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.528 1.531 . . . . 0.0 107.888 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.26 96.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.733 2.288 . . . . 0.0 112.625 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 57.88 28.02 15.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.407 2.283 . . . . 0.0 113.508 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -149.21 -164.57 2.06 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.938 0.895 . . . . 0.0 109.436 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.9 158.84 43.43 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.065 -1.022 . . . . 0.0 109.591 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -127.77 168.53 15.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -135.62 150.65 49.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.864 0.757 . . . . 0.0 111.345 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.69 173.07 14.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.092 1.757 . . . . 0.0 108.181 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.77 132.97 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -70.93 134.83 47.54 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.624 1.17 . . . . 0.0 109.856 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.46 165.94 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.39 1.076 . . . . 0.0 109.879 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.54 -123.17 31.86 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -142.95 37.48 1.42 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.317 1.047 . . . . 0.0 109.021 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.2 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.382 -0.824 . . . . 0.0 115.016 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.39 171.03 7.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.938 1.369 . . . . 0.0 109.168 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.57 159.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.794 0.838 . . . . 0.0 110.194 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.8 137.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.73 173.3 14.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.545 0.738 . . . . 0.0 110.781 -172.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.26 143.37 30.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 161.9 46.7 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.862 1.665 . . . . 0.0 109.791 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 154.96 27.32 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.235 2.624 . . . . 0.0 112.533 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -68.66 -24.25 35.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.85 2.367 . . . . 0.0 112.373 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.1 m -141.62 62.93 1.44 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.667 1.587 . . . . 0.0 107.502 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.01 20.6 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.272 1.429 . . . . 0.0 112.7 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.61 160.36 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.882 2.073 . . . . 0.0 108.027 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.14 119.44 3.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.603 1.161 . . . . 0.0 110.245 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.21 -13.04 0.04 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.948 -0.918 . . . . 0.0 114.159 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.06 19.31 2.99 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.746 1.273 . . . . 0.0 111.064 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.4 176.89 48.26 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.696 1.617 . . . . 0.0 109.367 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.74 55.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.13 165.96 31.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.739 1.615 . . . . 0.0 108.206 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -57.44 -39.15 75.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.094 0.558 . . . . 0.0 111.194 169.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -65.88 -38.81 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.691 0.678 . . . . 0.0 111.516 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.2 ttm -71.77 -38.04 70.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.03 -0.419 . . . . 0.0 109.943 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -64.98 -41.21 95.63 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.381 0.672 . . . . 0.0 110.975 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.59 68.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.553 0.741 . . . . 0.0 111.792 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.3 103.15 0.6 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.038 0.935 . . . . 0.0 108.559 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 p -150.46 -177.95 6.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.454 1.901 . . . . 0.0 107.356 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -115.57 18.33 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.384 1.074 . . . . 0.0 112.589 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.05 -179.93 5.93 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 110.438 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.18 175.0 14.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.003 1.321 . . . . 0.0 108.467 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.78 157.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.0 139.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -142.74 169.65 17.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.572 1.549 . . . . 0.0 108.739 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.55 142.65 51.47 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -151.28 159.38 44.37 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.728 1.211 . . . . 0.0 108.443 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.9 135.6 52.73 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.87 -44.12 70.14 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.485 0.584 . . . . 0.0 111.679 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -66.51 -22.25 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.21 -44.4 59.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.789 0.722 . . . . 0.0 109.935 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.72 -41.49 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.414 0.686 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -3.78 22.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.657 1.183 . . . . 0.0 113.526 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.87 42.92 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.853 1.216 . . . . 0.0 114.831 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -58.88 -44.3 91.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.73 1.265 . . . . 0.0 112.365 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.2 -67.45 0.06 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 123.605 0.762 . . . . 0.0 112.439 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -157.76 177.03 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.638 1.175 . . . . 0.0 108.726 -166.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -151.93 169.59 21.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.05 1.34 . . . . 0.0 108.527 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.68 152.67 25.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.809 0.844 . . . . 0.0 110.296 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.69 133.24 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -149.68 70.86 1.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.729 0.776 . . . . 0.0 109.163 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.02 119.13 10.82 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -62.74 -28.27 69.85 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.326 -0.234 . . . . 0.0 110.761 169.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -97.16 17.52 16.99 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.041 -168.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.73 21.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.776 1.626 . . . . 0.0 113.048 176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.9 t70 -136.3 2.19 2.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 111.469 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -138.08 -30.44 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.737 1.615 . . . . 0.0 111.866 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 67.54 149.6 0.06 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 128.986 2.914 . . . . 0.0 115.968 169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -50.73 113.41 3.67 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.17 1.388 . . . . 0.0 111.261 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.82 -18.85 16.69 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.941 2.427 . . . . 0.0 111.793 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.49 136.42 20.83 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 126.029 1.731 . . . . 0.0 107.273 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.61 145.78 57.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.083 1.855 . . . . 0.0 109.284 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.1 m -54.42 -42.34 70.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.45 0.3 . . . . 0.0 111.433 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -56.66 -42.51 79.11 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.703 0.801 . . . . 0.0 112.055 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -66.42 -33.19 75.15 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 117.764 -1.112 . . . . 0.0 111.441 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.4 mt -58.22 -49.04 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.135 1.334 . . . . 0.0 108.045 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.2 mm -61.89 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.862 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -45.2 91.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.23 -51.98 65.57 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.47 49.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.839 0.856 . . . . 0.0 110.721 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -76.76 -18.01 58.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.958 -0.544 . . . . 0.0 112.324 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.86 -27.16 62.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.684 1.129 . . . . 0.0 110.265 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.86 -27.69 16.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 110.644 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.12 125.62 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.581 1.082 . . . . 0.0 108.956 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.93 82.6 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.098 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -82.22 153.82 25.74 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.851 1.826 . . . . 0.0 108.885 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.85 151.42 23.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.228 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.52 172.24 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.668 1.187 . . . . 0.0 108.429 169.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.25 14.27 10.46 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.474 -0.766 . . . . 0.0 111.667 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -112.04 149.48 31.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 109.288 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -68.19 161.3 27.39 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 112.359 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.19 124.16 20.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.5 p -144.57 157.53 44.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.5 m -53.26 -45.41 68.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.653 0.381 . . . . 0.0 110.144 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.48 -37.98 80.61 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.086 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -69.24 -37.82 78.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.329 0.968 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.2 m -65.3 -47.37 76.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.12 -44.31 87.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.236 1.014 . . . . 0.0 110.144 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -58.04 -56.26 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 109.309 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.81 -47.37 85.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.722 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.6 -32.64 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.611 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -70.96 -40.96 71.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 110.528 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.6 -43.77 68.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.452 1.101 . . . . 0.0 110.618 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -72.08 -44.72 62.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.356 1.062 . . . . 0.0 112.007 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -74.43 -35.11 63.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.415 1.007 . . . . 0.0 112.658 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -120.96 -2.41 9.73 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -167.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.06 -26.24 24.29 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.831 -1.168 . . . . 0.0 111.983 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.65 139.91 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.049 -0.501 . . . . 0.0 111.128 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.287 0.089 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -127.21 -20.36 4.13 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.48 113.7 3.51 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -72.3 -7.08 20.31 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.63 2.22 . . . . 0.0 113.763 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.279 44.7 pt 44.46 56.61 13.93 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 127.131 2.172 . . . . 0.0 113.331 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.2 -33.1 2.11 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.826 2.35 . . . . 0.0 113.126 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.15 -42.59 2.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.063 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -50.79 163.66 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.195 3.263 . . . . 0.0 113.046 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -128.91 147.13 63.37 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.497 0.719 . . . . 0.0 109.863 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -47.96 139.06 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.55 -3.1 68.16 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.662 1.125 . . . . 0.0 112.438 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -80.52 139.26 36.44 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.056 1.428 . . . . 0.0 109.661 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mt -67.73 135.33 52.55 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.69 126.9 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -97.49 148.6 23.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 mm -126.18 123.03 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -75.0 112.39 11.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -84.64 171.27 11.4 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.88 -34.19 74.9 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.549 2.166 . . . . 0.0 114.904 -171.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -141.21 13.06 2.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.437 1.095 . . . . 0.0 111.967 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -157.68 -157.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.759 1.224 . . . . 0.0 109.272 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.24 155.07 45.23 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.085 -1.009 . . . . 0.0 109.809 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.61 168.49 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.009 1.724 . . . . 0.0 106.565 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -136.4 147.12 47.13 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.782 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.68 11.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.214 1.805 . . . . 0.0 107.48 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 tt -134.07 132.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.88 129.08 38.41 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.228 1.411 . . . . 0.0 108.879 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.2 m -136.38 169.14 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.07 0.948 . . . . 0.0 109.326 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.12 -117.32 8.76 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -141.7 25.33 1.99 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.26 1.024 . . . . 0.0 110.685 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.79 -17.29 0.14 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.159 -0.963 . . . . 0.0 113.853 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -70.79 163.65 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.012 0.906 . . . . 0.0 109.723 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.76 154.65 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.17 137.44 33.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.76 168.9 25.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 111.501 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -89.81 133.14 34.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.119 1.368 . . . . 0.0 107.441 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.84 153.89 58.15 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.275 1.03 . . . . 0.0 111.171 -171.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 152.53 44.02 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.329 2.686 . . . . 0.0 112.934 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.65 -40.62 83.15 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.876 2.384 . . . . 0.0 112.94 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -85.26 11.22 10.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.049 0.939 . . . . 0.0 112.498 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.85 69.39 1.85 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.228 0.922 . . . . 0.0 109.409 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.07 -20.48 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.202 1.401 . . . . 0.0 112.421 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 19.35 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.97 0.508 . . . . 0.0 111.814 -168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.65 -145.71 35.69 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.07 -14.52 24.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.47 76.52 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.9 -0.944 . . . . 0.0 112.704 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.66 108.35 2.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.943 1.372 . . . . 0.0 108.795 173.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 38.79 -106.35 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.617 1.967 . . . . 0.0 111.98 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -124.86 27.29 6.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.28 1.432 . . . . 0.0 110.648 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.327 4.2 p 55.43 -47.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 1 C-N-CA 132.027 4.131 . . . . 0.0 116.11 -177.953 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -60.18 -25.22 65.39 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.321 0.964 . . . . 0.0 110.52 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -52.31 -26.68 12.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.625 1.97 . . . . 0.0 113.365 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -19.52 65.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.525 0.73 . . . . 0.0 112.42 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.05 114.28 3.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -147.38 153.89 40.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.96 11.12 2.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.545 1.164 . . . . 0.0 113.679 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -134.93 161.39 35.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.386 2.674 . . . . 0.0 107.994 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 -170.84 3.69 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.235 1.414 . . . . 0.0 109.734 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -149.76 173.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.73 141.11 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.83 166.96 21.78 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.785 1.234 . . . . 0.0 110.048 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -126.59 125.92 42.75 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.19 161.69 40.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.629 1.172 . . . . 0.0 108.415 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 132.12 44.94 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -49.11 -48.35 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.47 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.46 -25.99 68.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.049 0.386 . . . . 0.0 111.914 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.59 -43.59 31.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.482 0.583 . . . . 0.0 110.367 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.79 -35.87 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 110.224 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.18 10.59 31.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.762 1.225 . . . . 0.0 113.508 -176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.62 -22.17 38.46 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.817 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -57.5 -50.12 74.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 1.271 . . . . 0.0 113.254 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.86 -69.07 0.06 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -157.74 172.0 19.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.497 1.119 . . . . 0.0 109.294 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -163.99 157.55 18.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.402 1.081 . . . . 0.0 109.328 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.48 166.14 34.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.404 0.681 . . . . 0.0 110.115 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.76 139.98 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -150.58 71.54 1.05 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -66.98 93.53 0.28 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -60.99 122.13 14.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 48.56 44.44 20.88 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 113.017 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.12 -19.05 2.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.134 0.974 . . . . 0.0 113.307 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.17 -22.68 30.89 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.228 1.011 . . . . 0.0 110.892 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -112.49 -26.47 8.67 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.986 0.914 . . . . 0.0 111.279 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.92 159.99 42.03 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m 128.69 76.75 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 1 C-N-CA 131.801 4.041 . . . . 0.0 108.708 174.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.38 -19.48 43.44 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.804 2.336 . . . . 0.0 114.017 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.42 132.9 29.25 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.534 0.734 . . . . 0.0 109.818 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.46 162.83 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.11 1.873 . . . . 0.0 109.115 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.2 m -50.94 -43.12 60.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.82 0.848 . . . . 0.0 112.587 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 p -55.59 -47.68 76.09 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.847 0.859 . . . . 0.0 111.996 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -32.07 73.48 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.54 0.736 . . . . 0.0 111.228 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.8 mt -65.13 -47.56 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.05 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 118.603 0.638 . . . . 0.0 109.915 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -54.86 -49.74 70.38 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.865 0.866 . . . . 0.0 109.793 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.05 -52.29 66.02 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.088 0.555 . . . . 0.0 110.144 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.8 -15.71 55.69 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.229 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.89 -32.05 68.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.784 1.174 . . . . 0.0 109.165 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.0 -18.12 22.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.055 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -50.34 130.67 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.93 1.241 . . . . 0.0 109.445 171.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.3 -2.61 81.14 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.277 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.34 162.81 19.91 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.472 1.636 . . . . 0.0 109.193 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -103.77 153.19 20.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.887 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG21 HD21 ' A' ' 36' ' ' LEU . 16.1 m -129.2 146.6 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 109.682 171.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -97.56 23.11 8.07 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.003 -1.061 . . . . 0.0 112.336 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -125.04 151.42 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.048 1.339 . . . . 0.0 110.508 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -65.85 162.6 18.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.44 2.296 . . . . 0.0 112.167 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.53 125.89 28.07 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.0 p -146.69 156.54 43.25 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -53.76 -42.52 68.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.64 0.776 . . . . 0.0 110.408 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.24 -39.92 82.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.05 0.94 . . . . 0.0 110.987 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -68.26 -34.45 76.23 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.36 0.982 . . . . 0.0 110.93 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.58 -45.3 83.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.406 1.003 . . . . 0.0 110.145 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -60.61 -45.33 94.42 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.256 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -57.87 -55.39 35.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.136 1.374 . . . . 0.0 109.021 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -55.09 -50.5 69.01 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.893 0.477 . . . . 0.0 111.52 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.45 -31.28 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.701 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -70.62 -27.88 64.42 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 121.52 -0.738 . . . . 0.0 111.656 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 59.9 mt-10 -60.23 -30.33 69.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.416 1.007 . . . . 0.0 110.643 170.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 mt -81.94 -47.6 12.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.657 0.662 . . . . 0.0 110.018 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -26.43 67.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.311 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -119.84 -33.63 3.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.764 0.711 . . . . 0.0 112.776 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.09 -40.09 2.08 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 p -157.27 140.41 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 118.649 0.659 . . . . 0.0 110.606 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.596 0.236 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.8 mmt-85 -146.53 164.62 31.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 107.198 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.09 150.47 78.67 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.24 178.21 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.247 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 pt -127.54 61.32 49.19 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.865 1.666 . . . . 0.0 107.464 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.22 -41.59 1.81 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 -167.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -159.91 67.62 2.85 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.846 1.258 . . . . 0.0 110.981 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -51.35 139.74 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.074 1.85 . . . . 0.0 110.229 168.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.29 139.82 29.0 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.47 137.54 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.171 2.581 . . . . 0.0 111.931 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.84 -16.64 60.85 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.02 -1.434 . . . . 0.0 112.44 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -71.12 153.99 42.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.505 2.153 . . . . 0.0 109.803 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.29 138.79 39.58 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.36 145.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -123.54 151.18 43.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 166.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -126.58 108.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.7 140.71 48.02 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.989 171.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -115.2 169.39 6.8 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.626 1.57 . . . . 0.0 107.45 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.63 -24.74 55.81 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.784 2.323 . . . . 0.0 115.316 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -141.71 3.99 1.69 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.108 0.963 . . . . 0.0 113.323 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -157.92 -160.89 0.96 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.633 1.173 . . . . 0.0 109.076 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -150.2 154.09 37.39 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -140.22 169.13 18.26 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.335 1.854 . . . . 0.0 107.283 -173.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -135.85 149.86 49.18 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.712 0.687 . . . . 0.0 110.42 -173.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.83 173.3 13.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.667 1.987 . . . . 0.0 108.11 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.57 133.69 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.6 136.98 38.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.57 0.57 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.87 -175.09 39.23 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.88 42.83 0.32 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 111.377 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 -33.27 0.25 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.87 -0.961 . . . . 0.0 113.109 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -89.57 153.26 20.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.464 1.632 . . . . 0.0 111.713 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.55 155.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.31 1.444 . . . . 0.0 109.665 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.46 136.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.29 173.05 16.26 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.724 -0.61 . . . . 0.0 110.645 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.23 147.21 28.14 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.97 165.86 22.14 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.491 1.917 . . . . 0.0 108.202 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.45 154.13 12.25 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.628 2.219 . . . . 0.0 112.174 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 163.88 32.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.296 1.998 . . . . 0.0 110.923 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m 53.51 -159.11 0.15 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.891 0.877 . . . . 0.0 109.192 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -153.49 150.82 29.14 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.373 -1.455 . . . . 0.0 110.462 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.42 177.15 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 129.192 2.997 . . . . 0.0 105.841 172.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.12 17.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.93 1.292 . . . . 0.0 114.174 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.59 11.41 35.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.242 0.925 . . . . 0.0 113.722 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.73 62.2 3.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.026 1.413 . . . . 0.0 109.487 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.86 -136.6 2.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -173.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.47 31.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.39 -18.43 62.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.388 -0.815 . . . . 0.0 113.104 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.4 m 42.23 48.18 4.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.751 1.62 . . . . 0.0 112.087 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.31 152.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.281 0.633 . . . . 0.0 111.414 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -63.79 -21.67 66.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.614 1.165 . . . . 0.0 112.802 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -56.49 119.88 6.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.135 0.974 . . . . 0.0 110.1 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.93 14.91 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.309 1.843 . . . . 0.0 114.859 -173.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.41 119.08 8.42 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 p -150.39 -176.51 5.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.582 1.953 . . . . 0.0 105.82 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.14 28.91 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.938 -1.101 . . . . 0.0 113.346 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -130.6 165.76 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.008 2.123 . . . . 0.0 110.002 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 172.85 14.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.983 0.913 . . . . 0.0 110.109 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.42 149.09 28.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 125.401 1.481 . . . . 0.0 107.101 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.17 129.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -128.22 167.98 16.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.564 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -124.72 129.61 50.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.87 160.52 43.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.46 130.37 40.52 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.25 -40.69 64.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.202 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -36.02 67.92 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.443 0.565 . . . . 0.0 111.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.67 -42.82 67.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.113 0.415 . . . . 0.0 110.038 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 t -66.13 -45.73 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.569 0.748 . . . . 0.0 109.522 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.92 -22.79 65.89 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.411 1.084 . . . . 0.0 112.015 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.67 -11.63 8.2 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.23 1.395 . . . . 0.0 113.483 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -49.36 -51.44 34.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.658 1.229 . . . . 0.0 110.722 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.79 -52.34 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.918 1.687 . . . . 0.0 110.184 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -159.69 173.76 15.57 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.458 1.903 . . . . 0.0 107.973 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -153.21 167.74 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.347 -0.846 . . . . 0.0 110.787 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.3 165.71 27.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.919 1.687 . . . . 0.0 108.327 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.84 128.8 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -158.1 63.94 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -55.94 128.55 35.74 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -69.19 -56.08 8.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.62 -166.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.49 45.59 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.645 1.178 . . . . 0.0 109.812 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.89 -10.55 4.11 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.294 -0.879 . . . . 0.0 112.89 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -86.61 -21.71 26.64 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.223 1.009 . . . . 0.0 111.037 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -113.15 -25.91 8.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.295 1.038 . . . . 0.0 111.162 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -143.03 -165.16 2.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.178 1.791 . . . . 0.0 109.435 -169.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m 57.64 62.69 5.21 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.408 1.483 . . . . 0.0 113.569 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -11.66 31.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.354 2.036 . . . . 0.0 113.934 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.99 132.64 94.68 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.954 1.301 . . . . 0.0 110.429 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.6 151.67 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.632 2.221 . . . . 0.0 110.978 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.39 -41.11 65.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.302 0.641 . . . . 0.0 111.102 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -52.31 -50.51 62.06 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 111.335 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -68.33 -38.52 81.6 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.29 0.636 . . . . 0.0 110.7 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.64 -49.58 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.47 -41.4 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.874 0.87 . . . . 0.0 109.375 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -55.32 -51.23 67.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.764 0.826 . . . . 0.0 109.185 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -62.31 -43.1 99.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.271 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.88 83.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.265 0.939 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.57 -15.27 55.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.178 0.591 . . . . 0.0 112.308 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -79.99 -21.31 43.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.106 0.962 . . . . 0.0 110.737 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -115.65 -5.08 12.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.492 0.717 . . . . 0.0 112.813 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.75 146.0 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.054 0.843 . . . . 0.0 109.835 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 -6.34 79.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.621 1.105 . . . . 0.0 112.967 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -79.26 155.23 28.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.114 1.457 . . . . 0.0 109.519 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.97 151.71 24.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.638 1.175 . . . . 0.0 108.966 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.59 147.04 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.141 1.376 . . . . 0.0 107.996 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.53 33.73 3.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.543 1.163 . . . . 0.0 110.492 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -130.91 158.17 40.95 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.514 1.926 . . . . 0.0 108.182 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.36 156.22 39.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.36 48.54 0.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.475 1.51 . . . . 0.0 111.454 168.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 p -65.71 158.86 26.38 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.831 -1.168 . . . . 0.0 108.597 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.2 m -51.48 -41.31 60.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.117 0.967 . . . . 0.0 111.095 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.32 -41.62 80.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.663 0.785 . . . . 0.0 111.374 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -72.08 -34.91 69.04 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.168 0.894 . . . . 0.0 111.102 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 68.9 m -66.82 -45.46 78.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.74 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.1 -44.12 87.51 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.125 0.57 . . . . 0.0 110.013 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -56.66 -55.13 37.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.788 1.235 . . . . 0.0 108.898 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.82 -48.19 82.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.07 -32.5 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.233 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -69.71 -32.49 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.138 -0.976 . . . . 0.0 110.37 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.98 -8.42 1.01 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 113.026 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.13 -48.47 3.04 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.237 1.415 . . . . 0.0 110.261 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -58.2 -36.07 72.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.386 0.674 . . . . 0.0 111.265 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -121.23 -7.47 9.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.354 1.062 . . . . 0.0 111.53 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.84 -10.03 63.9 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.821 -1.174 . . . . 0.0 112.243 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.27 139.44 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.155 175.006 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -148.93 164.42 34.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 108.069 172.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.63 -53.62 42.94 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.083 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.73 177.34 8.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.989 1.793 . . . . 0.0 111.453 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.8 mt -127.92 70.13 77.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.66 -21.83 5.84 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.697 2.265 . . . . 0.0 113.257 -169.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 16.9 pt-20 -139.53 -25.85 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 51.7 Cg_exo -56.72 146.47 77.06 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 122.909 2.075 . . . . 0.0 111.613 170.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -153.1 147.11 18.55 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.024 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.76 139.35 19.1 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.497 2.131 . . . . 0.0 111.284 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.98 60.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.915 1.245 . . . . 0.0 112.287 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.64 153.85 20.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.425 1.612 . . . . 0.0 110.987 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.77 143.43 36.12 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.92 124.82 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.72 152.96 18.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.82 116.03 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -171.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 111.71 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 -89.62 170.51 10.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.333 1.053 . . . . 0.0 108.244 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.22 -31.32 55.12 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.02 2.48 . . . . 0.0 115.841 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.79 16.15 1.24 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.291 1.037 . . . . 0.0 111.814 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -154.48 -158.78 0.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 108.999 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.29 157.35 44.92 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.99 -1.069 . . . . 0.0 109.879 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -128.82 169.08 14.99 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.964 1.705 . . . . 0.0 106.749 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -135.37 146.0 47.93 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.569 0.622 . . . . 0.0 111.7 -173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.54 171.97 15.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.168 1.787 . . . . 0.0 108.422 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.36 134.72 63.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.08 130.04 35.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.77 -14.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.81 168.64 34.99 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 -32.17 8.15 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -168.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.6 12.89 4.85 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.159 -1.356 . . . . 0.0 113.671 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -124.05 149.71 45.78 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.103 1.952 . . . . 0.0 112.175 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.86 159.46 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.181 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.43 140.33 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 167.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.25 171.92 18.97 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.771 0.429 . . . . 0.0 111.281 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.05 143.91 33.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 169.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 161.68 51.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.224 1.81 . . . . 0.0 109.149 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.01 148.39 58.36 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.661 2.24 . . . . 0.0 111.768 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.07 -15.28 25.96 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.965 2.443 . . . . 0.0 111.678 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -58.67 159.58 6.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.815 2.446 . . . . 0.0 112.508 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.72 24.08 3.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 111.276 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -70.66 170.22 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.383 1.073 . . . . 0.0 110.681 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.51 77.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.172 0.989 . . . . 0.0 111.799 170.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.6 -174.35 42.66 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.7 69.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.216 0.607 . . . . 0.0 112.027 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.6 -157.68 33.4 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.594 0.616 . . . . 0.0 111.994 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -14.69 38.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.26 1.024 . . . . 0.0 113.703 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.25 68.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.937 0.789 . . . . 0.0 111.78 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m 54.79 22.91 4.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.934 1.294 . . . . 0.0 112.768 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.03 152.26 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 125.285 1.434 . . . . 0.0 107.248 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.3 tpp -78.84 73.2 5.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.643 0.777 . . . . 0.0 108.95 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.1 m -56.43 -27.08 55.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.851 0.86 . . . . 0.0 113.247 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.07 -8.98 57.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.129 0.972 . . . . 0.0 113.18 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.23 146.3 44.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.963 0.887 . . . . 0.0 109.603 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -141.01 173.92 11.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.646 2.779 . . . . 0.0 104.276 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -74.21 48.55 0.32 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.54 1.518 . . . . 0.0 112.476 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -134.64 163.51 29.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.252 2.621 . . . . 0.0 107.721 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.92 13.32 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.628 1.171 . . . . 0.0 108.758 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.0 159.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.26 134.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.43 166.9 22.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.377 1.071 . . . . 0.0 109.622 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -118.29 132.7 56.28 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -150.44 160.99 43.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.448 1.099 . . . . 0.0 108.617 -173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.09 126.8 30.33 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.62 -46.13 66.89 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.428 1.091 . . . . 0.0 110.632 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -65.2 -21.73 66.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.12 -41.6 20.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.686 0.676 . . . . 0.0 110.375 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.34 -41.17 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.367 0.667 . . . . 0.0 110.061 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.14 1.83 12.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.304 1.441 . . . . 0.0 113.756 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.01 -25.44 31.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.024 1.297 . . . . 0.0 115.175 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -57.72 -45.88 85.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.855 1.327 . . . . 0.0 112.338 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -164.04 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.669 0.788 . . . . 0.0 112.4 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -156.76 176.96 12.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.635 1.174 . . . . 0.0 109.292 -165.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -152.62 168.26 26.21 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.943 1.297 . . . . 0.0 108.417 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.41 157.8 37.61 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.254 0.622 . . . . 0.0 110.056 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.0 135.26 28.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -149.44 62.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -63.31 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.529 1.131 . . . . 0.0 110.655 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.41 114.06 0.63 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.001 1.721 . . . . 0.0 110.17 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m80 52.82 40.19 30.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.469 1.508 . . . . 0.0 113.255 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.88 -15.3 1.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 167.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -82.9 -20.19 35.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.206 1.802 . . . . 0.0 111.468 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -131.27 -18.78 2.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.047 0.939 . . . . 0.0 112.448 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -140.99 -167.92 2.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.418 1.487 . . . . 0.0 109.7 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m 57.3 68.82 1.85 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.228 1.411 . . . . 0.0 112.31 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.77 -16.47 37.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.429 2.086 . . . . 0.0 113.386 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -73.67 142.32 80.45 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.619 1.168 . . . . 0.0 110.005 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.93 154.07 53.04 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.29 1.993 . . . . 0.0 109.641 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.0 m -55.62 -34.85 65.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.846 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 p -52.91 -60.3 3.45 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.081 0.952 . . . . 0.0 110.82 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -61.32 -38.43 86.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.611 1.164 . . . . 0.0 111.503 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.06 -51.67 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.28 -44.22 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 109.231 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -42.8 89.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.051 0.541 . . . . 0.0 110.131 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -68.09 -45.79 72.78 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.569 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.3 -50.38 59.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.447 0.567 . . . . 0.0 110.855 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.16 -19.94 59.61 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -71.68 -28.35 63.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.984 1.266 . . . . 0.0 108.904 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 mt -88.54 -16.38 32.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.06 0.944 . . . . 0.0 111.869 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.92 129.43 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 119.65 1.114 . . . . 0.0 108.895 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.15 -3.37 86.85 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -84.2 164.1 19.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.604 1.702 . . . . 0.0 109.344 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -123.92 148.48 46.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.781 -168.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.56 161.13 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.234 1.014 . . . . 0.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.05 32.28 5.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.437 1.113 . . . . 0.0 111.561 -168.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -132.86 147.23 52.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.218 1.407 . . . . 0.0 109.265 170.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -67.92 166.02 16.51 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.787 2.035 . . . . 0.0 111.587 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 mt -69.51 127.55 33.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 167.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 73.1 p -144.22 151.58 39.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 166.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -36.33 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 122.168 -0.332 . . . . 0.0 110.915 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -71.76 -40.18 69.49 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.728 0.411 . . . . 0.0 110.567 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.6 -40.73 92.97 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.865 0.757 . . . . 0.0 110.239 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.4 m -64.82 -45.27 86.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.099 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.69 -45.02 93.36 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.182 0.447 . . . . 0.0 110.143 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -59.39 -50.21 74.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.586 1.154 . . . . 0.0 109.718 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -59.69 -52.41 65.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.102 0.41 . . . . 0.0 111.392 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -64.65 -32.5 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.895 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.24 -36.37 81.51 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.698 -0.626 . . . . 0.0 111.077 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.19 -46.5 62.17 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.242 1.017 . . . . 0.0 109.661 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.26 -46.26 70.93 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.158 0.583 . . . . 0.0 111.346 -177.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -76.98 -33.85 57.59 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.89 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -94.13 -48.26 6.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.028 0.376 . . . . 0.0 110.881 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.86 -51.41 0.6 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.17 128.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -147.25 160.19 42.78 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.747 1.219 . . . . 0.0 108.364 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.31 150.68 84.19 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 122.688 0.395 . . . . 0.0 110.678 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.36 -175.5 2.45 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.022 2.481 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 pt -130.95 59.49 46.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.407 1.883 . . . . 0.0 108.312 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.66 -49.32 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.415 2.076 . . . . 0.0 112.605 -167.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -166.17 71.26 1.2 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.637 1.575 . . . . 0.0 109.842 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.89 143.5 59.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.338 2.025 . . . . 0.0 111.259 170.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -133.49 155.76 80.33 Favored Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 124.979 1.312 . . . . 0.0 108.973 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.31 131.74 18.62 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.363 2.708 . . . . 0.0 112.529 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.68 84.09 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.899 1.238 . . . . 0.0 113.036 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.37 143.74 48.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 120.288 2.044 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -71.84 131.27 42.79 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -114.96 145.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.91 143.7 49.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 117.04 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.07 138.27 43.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -117.19 167.21 11.28 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.379 1.472 . . . . 0.0 107.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.92 -24.9 33.47 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.018 2.479 . . . . 0.0 115.754 -174.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -141.4 4.85 1.81 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.191 0.996 . . . . 0.0 113.209 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -158.22 -158.25 0.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.976 0.91 . . . . 0.0 110.199 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -153.09 141.27 20.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -127.46 165.31 20.06 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.416 1.486 . . . . 0.0 107.607 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -128.95 145.94 51.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.352 0.524 . . . . 0.0 110.008 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 169.86 22.23 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.951 1.7 . . . . 0.0 108.531 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt -140.46 126.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 121.368 -0.832 . . . . 0.0 109.534 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -72.24 132.11 43.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.062 1.345 . . . . 0.0 110.015 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.55 166.55 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.24 1.416 . . . . 0.0 108.873 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.04 21.5 38.63 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.531 -0.731 . . . . 0.0 114.255 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t0 39.26 50.66 1.97 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.869 2.068 . . . . 0.0 113.514 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.1 -11.55 0.1 OUTLIER Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.925 -0.484 . . . . 0.0 113.546 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.17 170.62 7.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.696 1.198 . . . . 0.0 108.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.84 148.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.402 0.681 . . . . 0.0 109.639 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.56 136.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 171.67 18.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.413 0.551 . . . . 0.0 111.019 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 151.12 36.76 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 158.1 64.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.501 2.32 . . . . 0.0 107.676 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.47 153.95 71.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 110.938 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.69 -21.81 18.64 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.906 2.404 . . . . 0.0 111.703 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.08 164.54 15.22 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.998 2.119 . . . . 0.0 112.768 -172.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -150.87 162.88 39.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 t -50.56 -29.65 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.266 1.426 . . . . 0.0 112.646 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.39 162.01 41.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.649 1.18 . . . . 0.0 108.975 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.96 -71.16 1.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.088 1.328 . . . . 0.0 111.876 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.67 -5.87 56.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.804 0.842 . . . . 0.0 112.259 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.8 -161.69 28.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.42 7.13 8.98 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 111.17 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 152.71 19.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.304 2.241 . . . . 0.0 106.057 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 m -82.3 33.25 0.4 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 111.637 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.25 172.29 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.441 1.496 . . . . 0.0 109.387 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.3 mmt -66.57 16.07 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -58.96 -36.68 75.23 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.433 -1.417 . . . . 0.0 109.55 167.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.97 51.17 1.98 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.795 1.238 . . . . 0.0 109.725 169.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.8 tp -48.34 118.29 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.495 1.518 . . . . 0.0 110.59 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -147.79 153.42 39.18 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.31 55.98 3.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.582 1.182 . . . . 0.0 109.528 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.39 164.49 29.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.171 1.788 . . . . 0.0 108.724 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.79 13.1 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.823 0.849 . . . . 0.0 109.35 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -134.01 158.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.29 132.22 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -136.67 169.05 18.36 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.059 0.944 . . . . 0.0 109.79 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.59 133.02 54.56 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -148.55 161.19 42.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.209 1.403 . . . . 0.0 107.753 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.15 133.26 47.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.13 -43.83 74.49 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.684 0.674 . . . . 0.0 110.678 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -65.07 -21.58 66.84 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.81 -46.06 19.55 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.897 0.771 . . . . 0.0 110.238 171.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.03 -40.11 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 110.294 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.1 -20.73 59.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.964 1.305 . . . . 0.0 112.512 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.35 -12.5 25.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.59 1.091 . . . . 0.0 113.226 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.7 m -50.34 -48.93 55.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.119 . . . . 0.0 110.915 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -167.84 -61.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.264 1.826 . . . . 0.0 109.239 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -160.92 171.31 18.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.149 2.179 . . . . 0.0 107.126 -167.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -153.36 164.01 38.9 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.571 -0.706 . . . . 0.0 110.607 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -138.77 158.01 45.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.881 1.672 . . . . 0.0 109.851 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 130.93 40.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -148.8 70.86 1.12 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -69.12 88.3 0.42 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -64.93 119.84 11.45 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.21 53.06 9.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.794 1.638 . . . . 0.0 111.786 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -51.86 -20.66 2.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.987 1.315 . . . . 0.0 113.248 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.71 -27.12 31.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -100.64 -20.32 15.7 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.024 0.929 . . . . 0.0 111.339 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -129.93 -174.09 3.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.765 0.793 . . . . 0.0 112.7 -168.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 52.51 62.71 9.9 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.531 1.932 . . . . 0.0 113.919 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 -12.14 28.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.462 2.108 . . . . 0.0 113.732 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.97 142.74 97.56 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.424 1.089 . . . . 0.0 110.594 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.92 142.48 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.165 1.91 . . . . 0.0 108.944 167.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -54.21 -43.2 70.57 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.443 0.297 . . . . 0.0 111.401 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.71 -44.73 73.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.138 0.975 . . . . 0.0 112.1 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -63.32 -34.37 77.55 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 124.203 1.001 . . . . 0.0 111.591 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.5 -48.36 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.69 -47.22 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -44.61 81.87 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.412 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -60.71 -52.98 62.79 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.294 0.952 . . . . 0.0 109.367 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.36 60.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.664 0.386 . . . . 0.0 111.189 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.82 -16.69 50.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.6 -29.02 56.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 119.904 1.229 . . . . 0.0 109.073 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.57 -11.71 44.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.972 0.909 . . . . 0.0 111.852 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -56.13 129.88 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.592 1.087 . . . . 0.0 108.925 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.29 -0.04 89.89 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.403 -1.221 . . . . 0.0 112.984 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -86.57 166.01 15.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.292 1.546 . . . . 0.0 109.4 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -120.55 149.51 42.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.319 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.17 147.16 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.706 1.202 . . . . 0.0 108.221 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.72 39.8 1.62 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.731 1.253 . . . . 0.0 111.153 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -141.08 149.72 41.99 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.469 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -60.28 148.54 36.37 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.947 1.299 . . . . 0.0 110.187 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 54.24 0.28 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.758 1.623 . . . . 0.0 113.266 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.8 p -64.26 161.69 16.12 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.655 -1.278 . . . . 0.0 109.206 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.56 -44.67 62.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.128 0.971 . . . . 0.0 110.309 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.67 -41.33 75.63 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.84 0.856 . . . . 0.0 110.893 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.42 -29.02 65.51 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.143 0.883 . . . . 0.0 111.294 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.7 m -69.87 -42.52 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.223 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.16 -43.98 95.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.346 0.521 . . . . 0.0 110.021 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -57.15 -58.23 9.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.032 1.733 . . . . 0.0 109.493 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.39 -54.88 30.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.754 0.421 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.02 -27.37 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.405 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -70.24 -29.4 66.19 Favored 'General case' 0 C--N 1.338 0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 111.144 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.0 -23.47 63.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.445 1.02 . . . . 0.0 112.094 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.88 -47.78 7.66 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.62 1.1 . . . . 0.0 110.115 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -86.54 -45.59 10.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.451 0.568 . . . . 0.0 112.221 -172.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -83.46 -48.32 10.44 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.54 -25.14 3.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.033 0.825 . . . . 0.0 111.634 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.42 149.91 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.38 169.937 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 40.67 45.24 1.99 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.455 1.902 . . . . 0.0 113.804 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.52 147.5 76.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 0.0 110.334 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.75 177.47 6.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.433 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 pt -121.67 74.19 33.83 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.343 1.457 . . . . 0.0 107.725 170.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -21.13 26.83 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.735 2.29 . . . . 0.0 112.63 -171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 44.8 mt-10 -131.57 -39.74 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.184 -1.389 . . . . 0.0 113.303 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 39.9 Cg_exo -57.43 137.35 81.11 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.396 2.064 . . . . 0.0 111.259 172.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.29 146.88 34.89 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.98 140.12 24.53 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.693 2.262 . . . . 0.0 110.983 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.36 -10.83 71.04 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.1 1.333 . . . . 0.0 112.313 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.89 156.09 23.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.31 2.055 . . . . 0.0 110.652 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.1 139.02 41.15 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.06 141.85 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.53 151.54 39.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -122.79 110.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.86 100.69 2.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -80.33 166.47 39.8 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.273 1.029 . . . . 0.0 108.919 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -51.01 -30.81 32.32 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.478 2.785 . . . . 0.0 116.379 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -145.55 14.71 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.094 0.957 . . . . 0.0 112.213 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -155.81 -159.2 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.892 1.277 . . . . 0.0 108.717 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.4 159.5 43.62 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.773 -1.204 . . . . 0.0 109.938 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -132.37 168.0 18.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.929 1.291 . . . . 0.0 107.612 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -137.37 147.27 45.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.804 0.729 . . . . 0.0 110.694 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.37 174.83 14.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.988 1.715 . . . . 0.0 108.569 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.18 131.64 58.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.66 130.09 41.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.098 1.359 . . . . 0.0 108.795 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.84 165.3 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 109.065 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.51 -158.36 18.25 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.91 -29.53 55.74 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.942 -0.74 . . . . 0.0 112.221 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.99 26.97 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.896 0.76 . . . . 0.0 113.359 -173.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -100.58 170.55 8.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.141 0.97 . . . . 0.0 109.394 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.72 153.28 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.229 0.612 . . . . 0.0 109.635 168.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.88 137.72 29.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.12 169.03 25.12 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.983 -0.448 . . . . 0.0 110.932 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.57 138.7 34.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.13 160.07 56.45 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 125.076 1.351 . . . . 0.0 109.536 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.88 145.16 24.98 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.328 2.685 . . . . 0.0 111.757 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.47 -46.46 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.857 1.705 . . . . 0.0 111.554 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -139.5 25.96 2.38 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.225 1.01 . . . . 0.0 111.084 -170.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 51.71 40.84 28.34 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.481 1.512 . . . . 0.0 111.584 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -49.76 -19.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 128.239 2.616 . . . . 0.0 115.664 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.94 27.53 2.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.265 1.026 . . . . 0.0 110.361 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.07 -27.5 0.06 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.112 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.99 -25.5 67.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.01 1.405 . . . . 0.0 112.561 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.46 -36.98 1.24 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.538 1.542 . . . . 0.0 109.311 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.02 164.01 11.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.179 0.991 . . . . 0.0 110.194 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.21 165.78 35.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.923 1.289 . . . . 0.0 108.556 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.1 m -62.88 3.77 0.21 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.73 1.612 . . . . 0.0 114.111 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -62.21 -19.89 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.842 0.857 . . . . 0.0 111.131 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.43 -168.66 2.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.014 1.726 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -52.78 -12.52 0.31 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.459 2.304 . . . . 0.0 116.662 -169.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.38 60.14 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.616 1.098 . . . . 0.0 111.948 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 tp -49.05 116.26 1.6 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.043 1.337 . . . . 0.0 108.818 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -148.26 162.8 38.76 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.037 1.735 . . . . 0.0 106.709 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -133.35 21.41 4.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.751 0.82 . . . . 0.0 112.405 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -97.13 173.8 7.06 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.907 1.683 . . . . 0.0 110.71 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.41 169.09 18.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.185 1.394 . . . . 0.0 108.128 166.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.78 146.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 t -85.51 122.25 38.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -127.25 165.82 18.93 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.309 1.044 . . . . 0.0 109.715 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -125.69 131.29 52.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -148.38 163.57 36.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.014 1.326 . . . . 0.0 107.787 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.69 140.18 58.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.14 -42.7 73.4 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -60.46 -29.77 69.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.964 0.906 . . . . 0.0 112.062 -173.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.43 -40.07 27.02 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.21 0.459 . . . . 0.0 110.838 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.68 -37.59 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.335 0.654 . . . . 0.0 109.826 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.54 30.7 0.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.026 1.731 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.81 -23.58 30.5 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.072 0.844 . . . . 0.0 112.918 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 -4.54 5.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.887 1.675 . . . . 0.0 113.654 171.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.4 t70 61.49 16.46 7.59 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 114.576 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -149.46 124.62 10.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.888 1.675 . . . . 0.0 108.739 -169.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -164.8 164.31 21.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -155.77 161.56 40.65 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.599 0.76 . . . . 0.0 110.865 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.61 138.17 22.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -145.85 66.18 1.21 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.31 0.576 . . . . 0.0 109.935 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.38 131.78 38.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 122.896 0.478 . . . . 0.0 110.469 169.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -103.77 3.02 33.61 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' ASP . 75.7 m-70 -132.2 23.5 4.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.847 0.859 . . . . 0.0 112.088 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.07 21.31 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.044 -1.035 . . . . 0.0 112.593 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' HIS . 37.9 t70 -127.36 -9.33 5.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 111.611 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -127.6 -31.85 2.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.084 1.354 . . . . 0.0 111.609 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 66.21 134.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 128.605 2.762 . . . . 0.0 115.728 173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -61.0 136.76 93.79 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.914 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.43 -16.76 34.78 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.599 2.199 . . . . 0.0 111.862 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.08 125.38 35.4 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 108.235 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.17 154.63 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.812 2.341 . . . . 0.0 111.374 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.26 -38.86 69.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.327 0.651 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -54.96 -53.15 59.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.905 0.882 . . . . 0.0 110.498 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.81 -34.78 78.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.161 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.8 -50.83 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.061 0.846 . . . . 0.0 108.889 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.29 -45.6 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 123.536 0.734 . . . . 0.0 109.112 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -64.37 -46.56 82.84 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.85 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.29 -51.92 55.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.692 0.678 . . . . 0.0 110.405 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.82 -21.72 59.13 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.7 mt -99.14 -4.13 32.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 112.476 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.75 150.71 8.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.341 1.056 . . . . 0.0 109.344 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.67 53.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.313 -0.715 . . . . 0.0 112.269 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -124.06 159.98 28.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.585 1.154 . . . . 0.0 108.071 171.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -109.6 153.45 24.17 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.312 1.445 . . . . 0.0 109.53 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.07 152.29 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.374 1.47 . . . . 0.0 107.353 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.58 8.22 44.62 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.835 0.454 . . . . 0.0 112.224 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -95.42 147.11 23.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -74.12 162.87 28.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.446 1.098 . . . . 0.0 111.799 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.08 125.33 23.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.6 p -145.75 154.53 42.15 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 167.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.1 m -55.94 -34.37 65.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.817 0.447 . . . . 0.0 111.206 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.97 -38.61 44.72 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.451 0.701 . . . . 0.0 111.174 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -68.24 -35.77 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.528 1.058 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -66.34 -47.7 72.64 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -56.27 -44.63 79.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.319 1.048 . . . . 0.0 110.377 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -57.73 -56.79 17.43 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.018 1.327 . . . . 0.0 109.135 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.416 ' CE2' HD11 ' A' ' 120' ' ' LEU . 24.2 t80 -58.68 -48.1 82.24 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.1 -29.35 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.543 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -73.36 -30.53 63.37 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.712 0.687 . . . . 0.0 111.64 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.88 -37.9 80.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.305 0.957 . . . . 0.0 110.09 170.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 116' ' ' PHE . 73.0 mt -73.16 -50.14 24.27 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.683 0.674 . . . . 0.0 110.243 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -64.8 -26.37 68.31 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.066 0.946 . . . . 0.0 112.349 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.77 3.28 1.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -168.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.38 -32.52 5.44 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.853 -1.154 . . . . 0.0 111.876 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -155.39 146.63 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.023 1.329 . . . . 0.0 107.576 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.277 0.631 . . . . 0.0 110.727 172.306 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 64.23 -38.41 0.21 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.199 2.6 . . . . 0.0 115.355 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.73 72.51 77.35 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 109.54 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.12 -12.38 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.08 2.52 . . . . 0.0 113.943 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mm 57.05 68.58 2.01 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.769 1.628 . . . . 0.0 109.197 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.73 -23.96 16.19 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.312 2.008 . . . . 0.0 112.584 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.597 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 44.1 mt-10 -142.3 -36.8 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.824 -171.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 27.9 Cg_exo -59.49 155.39 41.95 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.135 1.89 . . . . 0.0 113.421 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.04 55.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 109.026 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.62 135.74 27.24 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.769 2.313 . . . . 0.0 111.646 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.18 -13.61 57.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.321 1.439 . . . . 0.0 111.714 -169.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.21 142.86 32.78 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.144 1.472 . . . . 0.0 111.312 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.18 140.55 45.2 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.31 129.19 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.08 147.65 25.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.49 103.68 12.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -168.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.45 141.64 57.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.06 168.61 13.01 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.503 1.521 . . . . 0.0 107.935 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.86 -27.96 17.06 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.512 2.808 . . . . 0.0 117.059 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -145.8 13.78 1.34 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.609 0.764 . . . . 0.0 112.021 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.32 -163.86 1.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.511 1.124 . . . . 0.0 109.475 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -144.11 159.72 42.15 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.214 -0.929 . . . . 0.0 109.931 173.241 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -131.2 170.69 14.23 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.613 2.365 . . . . 0.0 107.046 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.42 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 77.9 m95 -136.49 146.27 46.09 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.935 0.789 . . . . 0.0 111.448 -174.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.19 172.42 14.35 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.127 2.171 . . . . 0.0 108.046 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.8 tt -137.4 133.36 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.65 127.71 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.16 -3.96 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.03 -175.19 34.67 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.09 -28.09 66.18 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.87 0.835 . . . . 0.0 113.072 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.9 13.22 1.13 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.216 -1.324 . . . . 0.0 114.136 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -117.31 153.19 33.4 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.963 1.881 . . . . 0.0 111.516 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 m -132.16 155.05 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.061 1.345 . . . . 0.0 110.073 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.1 142.3 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 167.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.4 173.62 14.66 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.276 0.631 . . . . 0.0 110.73 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.6 141.72 33.45 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.62 157.95 66.85 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.54 1.936 . . . . 0.0 107.427 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 151.49 69.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.181 1.457 . . . . 0.0 110.51 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.68 -25.97 68.8 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.211 1.941 . . . . 0.0 111.367 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -52.25 -24.2 6.94 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.282 2.233 . . . . 0.0 113.859 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -82.93 2.71 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 t -141.84 -54.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.587 1.155 . . . . 0.0 111.205 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.38 16.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.56 0.744 . . . . 0.0 111.836 -168.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.94 171.09 43.69 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.62 -22.95 66.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.004 0.521 . . . . 0.0 112.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 -173.85 46.47 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 126.273 1.892 . . . . 0.0 108.545 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.13 111.81 2.37 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 153.24 42.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.289 0.636 . . . . 0.0 110.38 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -62.43 -45.75 91.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.051 0.94 . . . . 0.0 110.119 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -144.38 152.6 15.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.289 2.236 . . . . 0.0 106.169 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -57.86 -25.66 61.01 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 m -56.16 -30.48 62.25 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.433 1.093 . . . . 0.0 112.504 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.07 -6.72 47.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 112.806 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.1 tp -128.62 -18.55 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.907 1.283 . . . . 0.0 111.605 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 m -105.74 5.49 31.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.777 1.275 . . . . 0.0 110.08 -172.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.8 19.37 4.8 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.858 2.063 . . . . 0.0 111.561 169.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -136.31 171.24 14.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 129.336 3.054 . . . . 0.0 107.871 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.9 168.91 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.594 0.712 . . . . 0.0 111.304 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 pt -147.11 154.97 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.918 1.687 . . . . 0.0 106.692 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.42 129.7 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -135.44 159.0 42.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.279 1.432 . . . . 0.0 107.954 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -127.38 131.25 50.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -151.54 163.36 39.21 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.784 1.233 . . . . 0.0 108.893 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.21 131.78 45.99 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.61 -40.87 66.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 110.963 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -61.92 -27.92 69.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.873 0.469 . . . . 0.0 111.638 -171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.71 -45.15 46.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.469 0.577 . . . . 0.0 110.402 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 t -64.17 -39.48 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.615 0.766 . . . . 0.0 109.757 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.64 -11.77 19.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.267 1.427 . . . . 0.0 113.169 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.16 -10.43 65.54 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.655 1.116 . . . . 0.0 113.071 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 -54.22 47.77 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.646 1.223 . . . . 0.0 112.339 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.23 -49.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.661 1.584 . . . . 0.0 110.145 169.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -166.73 -176.12 3.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.863 2.065 . . . . 0.0 107.673 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -152.02 165.45 34.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.54 1.064 . . . . 0.0 110.282 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -148.38 147.32 29.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.243 1.417 . . . . 0.0 109.089 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.03 132.01 33.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -149.83 73.04 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.5 101.96 1.07 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -59.23 124.52 20.24 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 m80 46.31 42.26 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 113.206 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -59.4 -10.82 3.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.562 0.745 . . . . 0.0 112.499 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.17 -17.87 26.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.971 2.109 . . . . 0.0 111.427 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -131.09 -16.83 3.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.074 0.95 . . . . 0.0 112.357 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.35 -161.07 1.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.186 1.794 . . . . 0.0 108.372 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 66.39 2.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.859 1.664 . . . . 0.0 112.953 -170.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.55 -22.18 58.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.571 2.181 . . . . 0.0 114.441 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.14 141.17 39.98 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 111.264 -168.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.15 161.85 39.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.64 2.227 . . . . 0.0 109.762 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 65.1 m -52.4 -40.96 62.74 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.634 0.774 . . . . 0.0 111.682 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.44 -54.23 43.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.293 0.637 . . . . 0.0 111.103 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.37 -37.98 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.337 1.055 . . . . 0.0 111.695 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.29 -49.26 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.39 -46.21 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.683 0.793 . . . . 0.0 108.861 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -43.89 86.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.085 0.554 . . . . 0.0 110.113 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.95 -50.73 69.66 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.23 67.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.562 0.345 . . . . 0.0 111.107 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.94 -20.84 55.65 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.213 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -69.0 -35.5 76.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.74 1.155 . . . . 0.0 109.486 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.38 -10.15 52.86 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.4 133.73 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.516 1.053 . . . . 0.0 109.063 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.0 -8.07 76.3 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.484 -1.176 . . . . 0.0 112.88 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -71.89 157.58 37.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.453 1.626 . . . . 0.0 109.264 171.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -126.58 144.23 50.96 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.44 146.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.055 0.942 . . . . 0.0 110.35 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.46 -9.87 42.97 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.228 -0.92 . . . . 0.0 112.924 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -75.67 154.61 36.41 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.556 0.616 . . . . 0.0 110.498 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -81.37 158.38 24.69 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.871 1.668 . . . . 0.0 110.022 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 108' ' ' LEU . 3.0 mm? -59.72 121.35 11.43 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.5 p -143.68 159.02 43.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -52.49 -45.33 66.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.799 0.44 . . . . 0.0 109.904 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.79 -46.34 79.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.939 0.896 . . . . 0.0 110.827 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -67.33 -41.41 85.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.65 0.659 . . . . 0.0 110.722 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.17 -41.62 81.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.265 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -61.1 -40.6 94.38 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.199 0.6 . . . . 0.0 110.394 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -63.82 -55.76 20.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 110.138 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 120' ' ' LEU . 7.0 t80 -57.59 -48.41 79.46 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.327 0.512 . . . . 0.0 110.883 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.4 -30.95 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.48 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -72.45 -25.55 61.49 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.422 -0.799 . . . . 0.0 111.817 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.35 -38.92 69.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.184 0.902 . . . . 0.0 110.319 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.403 HD11 ' CE2' ' A' ' 116' ' ' PHE . 11.4 mt -74.39 -43.42 56.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.355 0.662 . . . . 0.0 110.2 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 tpt85 -72.58 -31.98 65.65 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.527 -172.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -104.02 -36.46 7.73 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.037 0.535 . . . . 0.0 112.125 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.73 -37.17 3.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.972 1.273 . . . . 0.0 110.599 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.18 135.28 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 123.078 0.551 . . . . 0.0 110.71 -179.698 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -149.92 171.4 16.86 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.673 1.189 . . . . 0.0 109.343 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.68 140.27 80.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.412 0.685 . . . . 0.0 111.764 -170.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.97 -179.67 5.42 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.626 2.884 . . . . 0.0 111.746 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.31 73.64 72.9 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.804 1.642 . . . . 0.0 107.653 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.08 -40.1 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.361 2.041 . . . . 0.0 112.366 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.06 45.22 0.19 Allowed Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.513 1.125 . . . . 0.0 113.084 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -59.97 130.49 34.88 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.385 1.53 . . . . 0.0 109.823 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -83.91 144.09 44.24 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.07 129.33 24.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 109.745 169.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.83 3.86 67.93 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.308 0.956 . . . . 0.0 113.205 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.1 136.19 48.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.663 1.732 . . . . 0.0 110.216 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.48 138.04 54.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.92 133.5 66.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -104.65 146.37 29.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -127.48 115.35 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 -169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.35 140.21 46.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -128.66 167.72 18.31 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.982 0.913 . . . . 0.0 109.718 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.33 -26.79 36.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.19 2.593 . . . . 0.0 116.576 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -143.24 6.73 1.53 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.293 1.037 . . . . 0.0 112.942 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -160.97 -168.66 2.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.949 -169.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 7.1 ppt_? -136.24 161.03 36.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 121.65 -0.656 . . . . 0.0 109.44 169.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -137.09 169.09 18.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.343 1.857 . . . . 0.0 107.986 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.402 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 67.2 m95 -138.7 148.35 43.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.624 0.769 . . . . 0.0 110.591 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 174.97 11.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.321 1.848 . . . . 0.0 107.934 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.13 134.0 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.43 133.23 48.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.075 1.35 . . . . 0.0 109.009 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 m -139.0 165.8 23.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.123 0.969 . . . . 0.0 109.967 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.44 -121.07 18.72 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.354 -2.299 . . . . 0.0 107.354 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -146.06 51.24 1.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.52 -12.16 0.11 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.164 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.77 171.68 8.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.531 1.166 . . . . 0.0 109.101 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.23 157.35 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.194 0.998 . . . . 0.0 110.052 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.98 138.19 48.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 168.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 169.47 22.79 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.082 0.953 . . . . 0.0 110.396 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.85 140.46 32.89 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.52 163.66 23.31 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.672 1.189 . . . . 0.0 109.326 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.28 156.31 30.94 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.567 2.178 . . . . 0.0 112.134 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -55.25 132.89 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.034 2.489 . . . . 0.0 110.247 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -64.2 -19.27 65.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.53 12.63 10.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.612 0.765 . . . . 0.0 111.756 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.257 15.4 m 47.24 -39.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.61 1 C-N-CA 131.765 4.026 . . . . 0.0 118.633 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 166.68 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.592 1.542 . . . . 0.0 110.21 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.23 21.48 0.15 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.044 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.78 158.33 39.32 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.17 1.388 . . . . 0.0 108.615 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.32 -13.78 58.65 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.077 0.846 . . . . 0.0 113.425 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -8.69 23.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.576 1.151 . . . . 0.0 113.078 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.19 166.58 23.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.085 1.354 . . . . 0.0 109.746 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.3 m -138.18 40.86 2.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.866 1.267 . . . . 0.0 110.286 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.265 28.6 m 51.05 18.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 127.439 2.296 . . . . 0.0 114.79 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -10.73 59.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.882 1.273 . . . . 0.0 112.515 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.07 17.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.735 2.014 . . . . 0.0 115.964 -168.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.26 -27.88 64.42 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.093 -1.005 . . . . 0.0 109.877 168.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 tp -149.52 131.0 14.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.31 172.16 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -174.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.33 26.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -136.7 161.9 34.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.878 2.471 . . . . 0.0 108.628 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.11 172.96 13.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.752 1.221 . . . . 0.0 109.108 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.12 150.26 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -83.21 132.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -137.23 164.9 27.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.291 1.436 . . . . 0.0 109.525 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -125.62 141.31 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -149.92 156.46 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.779 1.232 . . . . 0.0 107.923 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.57 137.47 52.4 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -52.06 -37.74 54.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -36.27 61.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.217 0.607 . . . . 0.0 112.147 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.92 -35.26 80.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.689 0.396 . . . . 0.0 111.315 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -86.67 -41.58 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.878 0.871 . . . . 0.0 109.017 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.42 -21.83 65.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.359 1.064 . . . . 0.0 112.725 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.14 -11.12 24.56 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.545 -1.142 . . . . 0.0 113.728 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.9 m -56.05 -55.49 32.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.956 1.378 . . . . 0.0 111.787 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -166.57 -60.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.323 1.449 . . . . 0.0 110.398 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -159.36 173.74 15.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.275 1.43 . . . . 0.0 108.765 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -162.63 160.53 25.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -154.56 162.58 41.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.622 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.62 138.75 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -152.39 73.75 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.436 0.694 . . . . 0.0 109.587 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.24 92.32 0.41 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.96 131.97 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 49.28 34.93 6.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.842 1.657 . . . . 0.0 113.336 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.98 -9.29 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.081 0.952 . . . . 0.0 112.773 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.98 -27.82 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.483 1.113 . . . . 0.0 110.628 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -127.87 -21.78 3.64 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -108.47 -160.07 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.504 1.522 . . . . 0.0 110.023 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 59.35 59.61 4.94 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.22 1.808 . . . . 0.0 112.517 -169.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.29 -13.2 38.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.0 1.8 . . . . 0.0 113.528 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.2 130.54 33.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.169 0.988 . . . . 0.0 110.673 -169.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 156.91 17.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.119 2.546 . . . . 0.0 111.302 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.06 -48.55 52.95 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.154 0.982 . . . . 0.0 111.28 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -57.34 -45.65 84.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.335 1.054 . . . . 0.0 111.966 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.5 -33.31 75.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.314 0.646 . . . . 0.0 111.313 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.79 -44.22 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.17 -45.19 99.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.644 0.656 . . . . 0.0 109.702 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -54.67 -44.39 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.517 0.727 . . . . 0.0 110.372 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -61.9 -52.01 65.82 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.095 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.98 78.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.654 0.661 . . . . 0.0 111.442 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -71.83 -25.64 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.907 1.283 . . . . 0.0 112.255 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.94 -20.2 42.54 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.436 1.095 . . . . 0.0 109.948 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.9 -13.98 12.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -167.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.37 146.11 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 120.089 1.313 . . . . 0.0 110.27 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 -4.17 84.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.964 1.269 . . . . 0.0 113.605 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.67 154.05 38.63 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.172 1.486 . . . . 0.0 108.779 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.43 147.59 27.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.62 151.49 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.764 1.225 . . . . 0.0 109.586 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.25 32.66 4.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.989 0.899 . . . . 0.0 111.462 -168.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -123.09 146.71 47.48 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.152 1.381 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -62.59 159.17 16.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.37 1.868 . . . . 0.0 112.316 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.9 121.85 16.01 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 165.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.7 p -142.62 156.34 45.06 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.5 m -51.37 -41.82 60.93 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.681 0.793 . . . . 0.0 110.814 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -72.46 -41.79 65.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.443 1.097 . . . . 0.0 111.368 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -40.3 85.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.2 0.909 . . . . 0.0 110.343 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.53 -45.52 79.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.016 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -56.75 -46.6 81.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.629 0.772 . . . . 0.0 110.111 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -59.14 -53.73 54.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.82 0.848 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.17 -48.62 80.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -64.35 -30.61 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.469 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -70.75 -29.12 65.27 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.663 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 72.3 mt-10 -61.33 -34.6 75.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.829 1.195 . . . . 0.0 110.489 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.5 mt -75.5 -46.64 31.14 Favored 'General case' 0 C--O 1.228 -0.036 0 CA-C-N 118.693 0.679 . . . . 0.0 110.23 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -64.33 -40.63 96.27 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 122.981 0.512 . . . . 0.0 110.96 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.22 -33.06 10.58 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.55 -42.12 1.92 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -168.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.93 135.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.21 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -151.07 168.26 25.17 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.719 1.207 . . . . 0.0 108.009 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.89 150.15 61.46 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.5 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -67.69 176.37 5.17 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.971 2.447 . . . . 0.0 110.248 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mm -81.19 116.69 64.31 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.01 -38.39 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.769 1.646 . . . . 0.0 114.481 -166.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.12 -48.27 3.45 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.72 173.22 13.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.655 2.236 . . . . 0.0 111.898 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.43 144.78 50.6 Favored Pre-proline 0 N--CA 1.464 0.235 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.67 131.47 19.93 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.513 2.142 . . . . 0.0 110.718 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.04 27.43 7.82 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.678 1.132 . . . . 0.0 111.28 -168.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -123.19 148.0 46.26 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.701 1.751 . . . . 0.0 110.387 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.29 137.1 35.81 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.15 131.11 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.88 151.12 22.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mm -126.65 106.43 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.57 138.5 48.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.14 166.89 20.95 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.873 0.869 . . . . 0.0 109.169 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.51 -35.65 29.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.401 2.734 . . . . 0.0 116.174 -169.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -140.29 12.59 2.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.448 1.099 . . . . 0.0 112.065 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -160.18 -168.82 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.249 1.02 . . . . 0.0 110.179 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -138.07 153.91 49.29 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.156 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -135.28 170.55 15.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.4 1.88 . . . . 0.0 107.461 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.437 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 81.8 m95 -137.64 148.62 45.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.451 0.7 . . . . 0.0 111.515 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.28 171.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.142 1.777 . . . . 0.0 108.42 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.4 127.59 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -76.13 127.42 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.3 1.84 . . . . 0.0 108.306 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 34' ' ' VAL . 21.2 m -139.08 1.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 -172.29 22.18 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.94 -29.01 70.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.243 1.022 . . . . 0.0 112.479 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.14 11.2 1.03 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.555 1.074 . . . . 0.0 113.268 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.92 153.11 23.01 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.037 1.419 . . . . 0.0 110.733 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.53 154.34 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 109.831 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 28' ' ' VAL . 4.9 t -105.31 141.78 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 167.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.38 169.78 22.39 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.866 -0.521 . . . . 0.0 110.724 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.52 138.51 34.28 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.95 164.84 31.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 108.104 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.58 155.7 51.7 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.781 1.654 . . . . 0.0 110.824 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.46 139.07 62.97 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.27 1.98 . . . . 0.0 110.806 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -73.43 -14.49 61.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.854 0.861 . . . . 0.0 112.424 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.06 134.98 57.56 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.43 1.092 . . . . 0.0 110.049 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.26 169.12 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 110.371 174.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.78 -38.96 36.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.077 1.351 . . . . 0.0 112.042 175.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.78 -16.69 18.23 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.274 0.94 . . . . 0.0 114.45 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.0 18.38 3.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.198 1.399 . . . . 0.0 111.476 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.24 26.95 0.07 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.671 -171.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 155.4 20.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.85 1.325 . . . . 0.0 111.041 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.24 -24.26 63.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.49 0.716 . . . . 0.0 112.594 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m 59.32 13.99 3.44 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.428 1.491 . . . . 0.0 113.55 -170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -143.21 169.63 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.574 1.949 . . . . 0.0 107.588 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -66.32 -36.55 83.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.878 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.5 m -64.59 158.48 24.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.768 1.227 . . . . 0.0 111.091 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.21 36.29 0.15 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.695 1.198 . . . . 0.0 111.961 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.1 tp -58.91 121.07 10.26 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.847 1.259 . . . . 0.0 109.546 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -144.53 152.89 41.23 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -147.12 25.6 1.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.864 0.84 . . . . 0.0 112.721 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -136.19 160.24 39.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.799 1.24 . . . . 0.0 109.052 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.75 169.18 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.17 1.388 . . . . 0.0 109.123 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mt -135.82 144.12 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.94 121.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 163.03 19.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.467 1.507 . . . . 0.0 108.109 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.43 128.73 44.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -149.89 160.09 43.86 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.408 1.083 . . . . 0.0 108.642 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.56 133.9 49.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -54.69 -40.91 69.61 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.58 0.752 . . . . 0.0 111.902 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -61.03 -29.9 70.0 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.663 0.385 . . . . 0.0 111.898 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.55 -46.02 41.71 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.209 0.459 . . . . 0.0 110.277 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.14 -42.33 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.753 0.821 . . . . 0.0 109.908 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 -6.56 52.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.236 1.415 . . . . 0.0 113.28 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.27 -10.46 52.76 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.414 -0.659 . . . . 0.0 113.395 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 p -60.94 -43.75 98.21 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.76 1.224 . . . . 0.0 112.181 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -159.3 -58.56 0.07 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.296 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -166.05 -174.42 2.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.578 1.551 . . . . 0.0 108.853 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -154.64 167.87 28.68 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.201 1.001 . . . . 0.0 109.383 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -155.54 156.8 35.79 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.805 0.842 . . . . 0.0 109.958 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.04 138.77 21.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -148.22 71.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -68.58 81.7 0.27 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.22 1.008 . . . . 0.0 108.547 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -56.81 125.65 23.38 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 47.04 44.88 15.46 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.675 1.59 . . . . 0.0 112.528 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.76 -13.96 1.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 170.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.59 -15.61 25.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.159 1.383 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -123.6 -19.92 5.68 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.194 0.998 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -140.48 -167.65 2.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.111 1.364 . . . . 0.0 109.643 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m 52.15 60.38 13.51 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.91 1.284 . . . . 0.0 112.247 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.9 -12.54 34.7 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.395 2.064 . . . . 0.0 113.9 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.07 133.57 83.68 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 124.175 0.99 . . . . 0.0 110.72 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.55 145.46 69.36 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.201 1.934 . . . . 0.0 108.881 166.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.4 m -55.0 -39.38 69.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -170.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 p -54.88 -44.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.502 1.121 . . . . 0.0 112.14 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -63.5 -32.09 73.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.646 0.778 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.53 -46.09 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.0 -49.03 84.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -55.66 -43.24 76.12 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.866 0.867 . . . . 0.0 110.857 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -60.17 -55.65 31.2 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.83 -41.38 67.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -74.29 -24.89 59.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.369 1.068 . . . . 0.0 112.027 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -81.13 -23.05 38.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.704 0.683 . . . . 0.0 110.505 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.16 -22.79 13.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.43 -167.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.16 144.6 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.998 1.272 . . . . 0.0 109.066 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.63 34.86 62.79 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -132.06 160.54 35.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.84 150.94 42.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.071 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.88 142.01 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 108.304 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.2 mt -99.78 52.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.022 1.391 . . . . 0.0 110.446 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.71 150.96 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.256 -1.793 . . . . 0.0 108.347 169.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -70.18 164.12 24.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.032 0.933 . . . . 0.0 112.057 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.16 119.45 11.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.2 p -140.44 154.41 46.64 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 m -54.71 -40.22 69.0 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.944 0.498 . . . . 0.0 110.402 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.95 -41.78 77.56 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.749 0.82 . . . . 0.0 111.229 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.99 -39.15 87.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.082 0.856 . . . . 0.0 110.237 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.3 m -68.9 -44.23 73.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.907 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.45 -47.11 79.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.986 0.914 . . . . 0.0 109.91 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -58.38 -53.08 62.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.973 0.909 . . . . 0.0 109.363 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.23 -49.83 75.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.18 0.446 . . . . 0.0 111.678 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 -34.2 65.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.392 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -66.64 -38.47 86.98 Favored 'General case' 0 C--O 1.225 -0.209 0 O-C-N 121.889 -0.507 . . . . 0.0 110.361 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -56.24 -35.86 67.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.375 1.07 . . . . 0.0 111.86 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.15 -45.72 32.17 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.968 0.803 . . . . 0.0 110.922 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -78.09 -43.28 29.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.823 0.738 . . . . 0.0 111.937 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -75.77 -40.75 54.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.911 0.484 . . . . 0.0 110.838 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 116.02 -37.42 3.43 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 128.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 105.049 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.893 174.577 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -60.57 149.63 34.17 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.727 -0.608 . . . . 0.0 109.597 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 42.96 62.88 8.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.321 1.449 . . . . 0.0 112.026 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.97 -13.82 39.4 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.733 2.289 . . . . 0.0 114.094 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.272 44.0 pt 41.89 59.28 9.68 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.435 1.894 . . . . 0.0 111.735 -173.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.46 178.57 6.89 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.766 2.977 . . . . 0.0 109.096 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.09 67.36 77.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 150.22 83.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.599 2.866 . . . . 0.0 111.212 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -76.6 146.19 76.46 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.45 130.66 21.98 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.722 2.282 . . . . 0.0 110.163 168.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.99 -14.99 63.31 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 117.743 -1.587 . . . . 0.0 113.875 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -69.04 152.98 44.54 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.899 2.349 . . . . 0.0 111.82 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.07 139.28 38.15 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -119.92 145.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.87 149.93 41.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 mm -126.42 97.26 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 -168.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.4 143.43 57.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 174.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.48 168.25 18.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.356 1.062 . . . . 0.0 108.911 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.25 -32.88 52.57 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 115.904 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.64 3.34 2.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.94 -161.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.14 1.376 . . . . 0.0 108.504 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 147.79 36.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -117.68 167.47 11.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.466 1.906 . . . . 0.0 108.399 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.17 148.05 49.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.556 0.742 . . . . 0.0 110.304 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.54 172.94 14.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.237 1.415 . . . . 0.0 109.221 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 tt -132.62 128.61 57.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.14 133.07 45.93 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 109.278 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.01 165.68 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.637 1.175 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.66 -126.88 41.02 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -169.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -144.87 53.28 1.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 -8.53 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.783 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -103.72 168.06 9.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.694 1.247 . . . . 0.0 109.278 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.45 151.93 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.063 0.945 . . . . 0.0 109.546 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.86 141.38 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 168.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -163.6 171.59 15.53 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.271 0.629 . . . . 0.0 111.123 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.91 150.06 36.0 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.98 159.21 40.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.76 1.624 . . . . 0.0 108.408 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.0 159.78 40.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 121.474 1.449 . . . . 0.0 109.921 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.18 -0.72 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.549 2.833 . . . . 0.0 113.605 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -49.4 136.53 15.97 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 111.501 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -146.75 34.06 0.93 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.617 1.167 . . . . 0.0 108.796 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.26 165.57 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 126.005 1.722 . . . . 0.0 108.91 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.56 19.18 4.02 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.38 1.872 . . . . 0.0 114.621 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.4 -163.55 35.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.08 0.848 . . . . 0.0 113.063 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.18 171.06 17.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.095 1.758 . . . . 0.0 108.257 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.3 -176.96 44.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.9 -5.42 2.86 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.176 1.39 . . . . 0.0 114.584 -173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.37 -25.81 67.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.142 0.883 . . . . 0.0 111.057 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 m 55.69 22.65 5.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.795 1.638 . . . . 0.0 113.264 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.05 146.38 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.2 1.0 . . . . 0.0 110.14 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.0 mtt -142.17 71.05 1.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.412 1.485 . . . . 0.0 107.574 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -55.83 150.41 13.09 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.736 1.214 . . . . 0.0 111.577 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.03 61.63 2.02 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 110.394 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.4 -32.27 66.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.255 1.022 . . . . 0.0 111.362 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 p -148.89 174.75 11.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.791 2.036 . . . . 0.0 107.33 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.37 18.09 18.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.943 0.897 . . . . 0.0 112.723 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -119.99 179.12 4.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.534 1.933 . . . . 0.0 109.928 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.5 178.84 9.14 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 108.879 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 pt -145.88 166.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.143 1.777 . . . . 0.0 107.167 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.67 139.79 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -133.69 172.41 12.8 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.566 1.546 . . . . 0.0 109.378 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.38 142.1 50.53 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 125.204 1.402 . . . . 0.0 107.415 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -151.04 159.61 44.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.292 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.86 137.74 55.52 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.86 -41.64 67.7 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.217 0.917 . . . . 0.0 111.669 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -64.86 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.88 -25.84 61.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.858 0.753 . . . . 0.0 111.437 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.66 -36.48 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.873 1.269 . . . . 0.0 109.918 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.5 62.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.536 1.534 . . . . 0.0 113.28 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.42 37.42 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.762 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -53.04 -48.09 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.696 1.248 . . . . 0.0 111.799 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -166.33 -54.29 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 125.881 1.672 . . . . 0.0 109.27 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -166.92 178.79 5.6 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.498 1.919 . . . . 0.0 107.732 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -154.14 165.86 34.9 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.386 -0.821 . . . . 0.0 109.314 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -155.67 158.63 38.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.919 0.888 . . . . 0.0 110.377 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.17 136.65 25.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -149.68 66.94 1.0 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.186 0.517 . . . . 0.0 110.498 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.64 119.14 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -67.8 -11.68 59.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' ASP . 92.5 m-70 -129.27 29.14 5.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 111.621 -169.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.54 21.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.887 -1.133 . . . . 0.0 112.685 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' HIS . 34.8 t70 -130.49 -5.81 4.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.948 2.099 . . . . 0.0 111.351 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.88 -31.2 1.32 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.965 1.306 . . . . 0.0 111.905 -169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 66.65 150.68 0.06 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 128.292 2.637 . . . . 0.0 117.848 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -40.11 109.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.876 2.87 . . . . 0.0 113.94 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 -15.9 18.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.505 2.803 . . . . 0.0 111.812 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.22 138.24 24.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 126.671 1.988 . . . . 0.0 106.698 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 157.28 62.21 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.527 1.485 . . . . 0.0 109.391 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.76 -39.93 62.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.323 0.649 . . . . 0.0 111.557 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 m -54.07 -48.43 70.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 111.393 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.7 -35.89 77.76 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.563 -0.71 . . . . 0.0 111.526 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.29 -49.08 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.186 0.903 . . . . 0.0 108.618 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.09 -38.62 78.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.124 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -55.83 -45.11 78.42 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.387 0.675 . . . . 0.0 110.067 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.3 -48.81 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.477 0.581 . . . . 0.0 109.859 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.31 -42.15 66.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.705 0.684 . . . . 0.0 111.813 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -78.52 -19.17 53.55 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.312 -175.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.96 -29.79 26.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.193 0.906 . . . . 0.0 110.021 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.5 mt -96.68 -24.26 16.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.312 -168.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.45 132.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.785 1.175 . . . . 0.0 109.637 171.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.09 -4.87 82.07 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.55 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.45 159.79 25.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.779 1.789 . . . . 0.0 109.3 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -104.1 154.33 19.85 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.488 0.715 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.97 -175.98 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.993 1.317 . . . . 0.0 108.31 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.09 11.04 6.46 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.712 0.805 . . . . 0.0 112.842 -169.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.8 153.16 45.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 109.538 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -71.75 161.21 31.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 111.863 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.27 131.28 46.87 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.5 p -145.81 159.06 43.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 m -55.34 -39.3 69.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.126 0.421 . . . . 0.0 110.213 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.7 -47.48 66.32 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.126 0.571 . . . . 0.0 111.184 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.86 -40.39 87.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.679 0.672 . . . . 0.0 110.82 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.05 -42.46 76.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.774 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -58.97 -44.34 91.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.695 0.679 . . . . 0.0 110.395 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -56.6 -53.72 54.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.879 1.271 . . . . 0.0 109.06 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -60.18 -54.04 50.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.185 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -62.34 -28.22 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.921 0.782 . . . . 0.0 111.081 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -70.28 -32.77 70.72 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.411 -0.806 . . . . 0.0 111.718 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.3 -25.16 63.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.814 0.734 . . . . 0.0 111.321 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.22 -52.95 4.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -60.1 -37.56 80.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.556 1.142 . . . . 0.0 112.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -136.88 9.95 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.231 0.957 . . . . 0.0 111.676 -167.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.0 -29.92 5.72 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.772 -1.205 . . . . 0.0 112.55 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.0 145.58 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.01 1.724 . . . . 0.0 108.336 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.014 0.926 . . . . 0.0 111.064 169.041 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -151.15 167.52 27.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.446 1.098 . . . . 0.0 109.708 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.92 154.73 80.54 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.69 174.31 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.266 1.978 . . . . 0.0 111.151 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 pt -125.45 68.94 60.78 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.682 1.593 . . . . 0.0 106.791 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.17 -23.18 21.51 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 114.384 -167.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 13.1 pt-20 -145.95 -21.78 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 92.0 Cg_endo -74.65 158.38 43.54 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 123.697 2.356 . . . . 0.0 111.245 -174.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -131.7 145.93 59.64 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.15 0.98 . . . . 0.0 108.424 168.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.23 128.19 19.38 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.465 2.11 . . . . 0.0 111.037 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.99 -10.26 27.24 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.976 1.75 . . . . 0.0 112.141 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.9 135.86 34.32 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.006 1.403 . . . . 0.0 111.408 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.13 137.46 54.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -121.8 121.23 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.13 151.49 21.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.28 112.46 29.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 127.02 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.45 168.96 6.84 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 108.336 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -47.56 -33.19 17.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.052 3.168 . . . . 0.0 116.541 -170.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -146.87 17.35 1.25 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.897 0.879 . . . . 0.0 111.433 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -158.43 -160.64 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.408 1.083 . . . . 0.0 109.586 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 155.43 45.66 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -116.36 168.51 10.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -132.39 147.21 52.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.596 0.635 . . . . 0.0 111.159 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.29 174.7 11.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.237 1.815 . . . . 0.0 107.719 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.18 129.95 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -73.86 125.92 29.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 m -136.31 -10.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.59 167.11 28.67 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -55.37 -22.2 18.54 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -168.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -140.8 16.56 2.83 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.239 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -120.48 154.36 35.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.569 1.684 . . . . 0.0 111.976 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.47 158.17 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.553 1.141 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.87 143.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.0 174.45 13.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.154 0.982 . . . . 0.0 109.932 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.42 143.9 29.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 170.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.93 160.46 62.76 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.779 1.231 . . . . 0.0 108.994 171.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.42 156.86 20.11 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.274 1.982 . . . . 0.0 110.975 168.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.08 144.84 27.32 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 112.379 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 m -59.75 155.03 16.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.874 0.87 . . . . 0.0 111.505 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.56 166.31 31.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.12 -44.15 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.351 1.061 . . . . 0.0 108.888 174.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.87 159.2 39.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.971 1.709 . . . . 0.0 108.204 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.13 170.52 35.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.31 -31.6 70.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.795 0.438 . . . . 0.0 111.736 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.84 -169.4 34.61 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.206 1.384 . . . . 0.0 109.971 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.86 167.67 5.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.392 0.677 . . . . 0.0 110.453 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.8 22.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.995 0.518 . . . . 0.0 111.345 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -37.79 83.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.085 0.954 . . . . 0.0 110.841 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -67.5 157.65 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.355 0.662 . . . . 0.0 110.82 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.3 -17.85 55.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 112.91 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 m -57.5 -23.8 52.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.865 1.266 . . . . 0.0 112.68 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.48 35.4 1.33 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.531 1.933 . . . . 0.0 114.046 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.8 tp 55.35 11.26 0.55 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.437 1.895 . . . . 0.0 114.197 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -134.18 12.27 3.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.569 1.176 . . . . 0.0 112.119 -169.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -0.39 13.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 169.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -134.43 166.98 21.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.333 3.053 . . . . 0.0 106.891 171.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.34 -179.82 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.09 153.73 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.33 139.08 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -139.87 159.64 41.73 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.221 1.409 . . . . 0.0 107.997 -169.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.03 136.52 49.48 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -152.5 159.91 43.28 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 108.63 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.38 132.88 49.31 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.8 -46.61 71.13 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.385 0.674 . . . . 0.0 111.261 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -67.26 -24.46 65.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.86 0.464 . . . . 0.0 111.33 -170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.32 -37.39 60.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.363 0.528 . . . . 0.0 111.011 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.53 -45.33 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.095 0.558 . . . . 0.0 109.56 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.97 64.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.073 0.549 . . . . 0.0 110.381 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.09 -128.83 31.09 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 m -72.26 -8.45 54.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.57 1.148 . . . . 0.0 113.874 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.21 -170.6 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.524 1.056 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -140.12 158.48 43.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.499 2.32 . . . . 0.0 106.084 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -156.61 163.26 39.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.845 -0.534 . . . . 0.0 110.31 -168.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.85 158.92 40.11 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.661 0.784 . . . . 0.0 110.432 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.37 134.31 30.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -149.74 66.57 0.99 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -61.42 118.88 7.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -55.26 -43.99 75.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.94 36.41 1.4 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.396 0.678 . . . . 0.0 111.337 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -58.79 -9.86 2.04 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.355 0.98 . . . . 0.0 112.686 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.61 -20.62 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.918 0.887 . . . . 0.0 110.336 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -114.15 -44.77 3.1 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.022 1.329 . . . . 0.0 110.23 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -155.48 159.0 39.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.719 0.808 . . . . 0.0 112.82 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -171.2 76.87 0.53 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 128.482 2.713 . . . . 0.0 105.096 167.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.55 -16.21 52.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.686 2.924 . . . . 0.0 113.885 -171.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.85 120.82 47.85 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 157.52 61.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.842 1.695 . . . . 0.0 108.904 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.9 m -47.48 -47.83 27.2 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.889 0.876 . . . . 0.0 112.505 -169.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -54.84 -43.94 73.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.637 0.775 . . . . 0.0 112.445 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.48 -33.61 76.07 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.596 -0.69 . . . . 0.0 111.187 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.2 mt -60.84 -48.95 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.29 -50.62 79.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -52.79 -47.05 67.84 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.424 1.089 . . . . 0.0 110.534 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -66.35 -49.72 65.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.57 -45.07 73.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.494 0.588 . . . . 0.0 110.805 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.76 -30.57 71.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.467 1.507 . . . . 0.0 112.188 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -72.45 -28.83 63.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.598 0.759 . . . . 0.0 109.052 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.4 mt -91.95 -16.99 25.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.906 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 t -54.74 128.92 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.363 1.438 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.11 87.66 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.261 -1.3 . . . . 0.0 113.229 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -76.88 143.99 39.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.72 1.76 . . . . 0.0 108.491 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.01 151.4 23.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.756 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.22 146.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 109.18 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.08 1.92 52.87 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.588 -0.695 . . . . 0.0 112.769 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -92.76 155.03 17.94 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.592 0.757 . . . . 0.0 109.261 169.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -70.22 142.58 52.37 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -69.11 131.88 45.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.1 p -145.17 165.3 28.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.096 1.758 . . . . 0.0 106.38 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 m -50.53 -46.94 57.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.795 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.45 -40.22 73.86 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.133 -0.461 . . . . 0.0 111.618 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -71.55 -31.01 66.53 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.231 0.923 . . . . 0.0 110.959 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.1 m -69.87 -43.6 71.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.124 0.874 . . . . 0.0 109.926 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -59.91 -41.12 91.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.637 0.775 . . . . 0.0 110.149 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -59.84 -58.89 6.6 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 110.286 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.64 -49.84 73.8 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.09 -31.05 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 121.096 -0.241 . . . . 0.0 110.557 -170.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -70.14 -28.12 65.1 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.177 -0.952 . . . . 0.0 111.527 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -53.98 -31.5 51.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.764 0.711 . . . . 0.0 111.368 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.1 mt -80.78 -45.8 16.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.239 0.616 . . . . 0.0 110.408 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -74.79 -29.38 61.09 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.203 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -130.22 -5.18 4.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.04 -14.7 62.79 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.81 -1.181 . . . . 0.0 112.737 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -154.8 151.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.644 1.577 . . . . 0.0 106.984 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.198 170.593 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -143.97 151.14 39.35 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 33.89 58.91 1.93 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.918 2.087 . . . . 0.0 114.418 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.42 174.9 10.84 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.996 2.464 . . . . 0.0 111.145 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.5 73.6 80.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.25 176.29 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.41 2.74 . . . . 0.0 109.279 -174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.49 75.89 56.73 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 169.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -53.49 149.99 28.83 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.275 2.65 . . . . 0.0 112.536 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -113.64 138.38 22.6 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.32 132.36 23.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.29 -21.16 35.97 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.138 1.352 . . . . 0.0 112.014 -170.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -67.44 144.26 55.83 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.448 1.624 . . . . 0.0 111.674 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.11 139.92 43.08 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.61 128.21 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.51 150.83 22.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 165.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.05 114.1 40.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 102.355 -3.202 . . . . 0.0 102.355 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.45 131.08 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -108.87 167.26 9.42 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -50.39 -28.58 21.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 115.901 -173.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.62 14.5 1.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.819 0.848 . . . . 0.0 112.102 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -156.78 -155.81 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.488 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 157.87 44.13 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.865 1.211 . . . . 0.0 109.331 174.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -127.75 168.84 14.54 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.236 1.814 . . . . 0.0 106.113 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -135.09 147.45 49.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.848 0.749 . . . . 0.0 111.673 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.67 173.0 14.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.37 1.868 . . . . 0.0 108.879 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.78 133.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -80.48 135.23 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.56 -2.68 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -170.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.37 -175.41 38.56 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -77.04 44.28 0.39 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.195 0.998 . . . . 0.0 111.743 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.35 -32.31 0.35 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.861 1.22 . . . . 0.0 112.532 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.9 152.94 23.19 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.793 1.296 . . . . 0.0 111.651 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.82 156.31 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.33 1.452 . . . . 0.0 109.273 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 140.05 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.47 170.77 21.0 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.044 0.538 . . . . 0.0 110.798 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.02 138.43 33.74 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.04 8.59 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.671 . . . . 0.0 108.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.0 152.6 36.01 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.537 2.158 . . . . 0.0 112.425 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -69.94 -28.89 23.81 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.965 1.777 . . . . 0.0 111.213 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -68.53 165.12 19.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.381 1.873 . . . . 0.0 111.481 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -144.17 154.26 42.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.249 1.419 . . . . 0.0 107.337 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.11 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.704 0.801 . . . . 0.0 110.868 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.3 114.19 0.82 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.017 1.327 . . . . 0.0 109.908 172.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.18 -38.3 1.79 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.83 1.205 . . . . 0.0 110.355 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.81 -0.7 1.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.564 1.146 . . . . 0.0 112.437 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.94 -144.84 4.22 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.3 -0.09 0.88 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.23 145.62 16.63 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.495 1.498 . . . . 0.0 110.751 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -61.84 -32.95 73.33 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 112.263 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 m -147.09 153.93 12.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.7 1.6 . . . . 0.0 108.373 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 161.07 27.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.863 0.865 . . . . 0.0 109.467 168.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -76.61 45.48 0.4 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.75 1.62 . . . . 0.0 111.943 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 51.04 29.05 4.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.426 1.891 . . . . 0.0 112.527 -169.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.65 -27.96 69.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.231 1.012 . . . . 0.0 111.356 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 p -143.89 173.37 11.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.544 1.938 . . . . 0.0 106.934 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -133.07 29.69 4.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.698 1.199 . . . . 0.0 110.97 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.49 176.66 7.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.588 1.555 . . . . 0.0 110.564 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 174.02 12.39 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.318 1.447 . . . . 0.0 109.765 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.35 146.13 29.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.0 t -82.57 130.95 34.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 163.94 28.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.176 1.39 . . . . 0.0 108.019 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -131.09 130.32 43.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.25 160.8 43.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 108.895 -173.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -73.01 130.46 40.38 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.94 -40.23 63.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.11 0.964 . . . . 0.0 112.627 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -35.98 67.81 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.832 0.453 . . . . 0.0 111.832 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.35 -38.14 71.63 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.299 0.5 . . . . 0.0 110.605 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.09 -46.86 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.819 0.848 . . . . 0.0 108.834 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -24.6 66.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.536 1.135 . . . . 0.0 112.102 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.69 -14.3 3.66 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.503 1.525 . . . . 0.0 113.835 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.5 m -48.81 -48.2 41.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.595 1.197 . . . . 0.0 111.51 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -168.58 -55.92 0.02 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.927 1.691 . . . . 0.0 109.636 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.18 -174.95 3.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.947 2.099 . . . . 0.0 107.695 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -149.06 168.14 23.95 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.43 -0.794 . . . . 0.0 109.563 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -146.11 153.69 40.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.116 0.967 . . . . 0.0 108.88 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -78.14 135.09 26.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 166.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -147.19 69.66 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -63.47 104.72 0.66 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -54.0 -51.13 64.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.726 1.211 . . . . 0.0 113.848 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -148.2 38.95 0.9 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.383 1.073 . . . . 0.0 111.264 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.32 -14.26 1.14 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.09 1.356 . . . . 0.0 113.214 169.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.97 -28.27 27.89 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.476 -0.765 . . . . 0.0 110.596 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -97.44 -34.26 11.08 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.583 -177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -148.51 156.85 42.99 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.305 0.642 . . . . 0.0 111.756 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -178.4 72.86 0.21 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 128.475 2.71 . . . . 0.0 107.491 168.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.9 -14.45 41.36 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.643 2.229 . . . . 0.0 113.372 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.66 121.08 30.13 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 124.911 1.284 . . . . 0.0 108.491 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.62 159.67 10.74 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.294 2.662 . . . . 0.0 111.492 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -50.09 -46.57 53.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.655 0.782 . . . . 0.0 111.269 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.62 -44.7 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.32 0.648 . . . . 0.0 111.754 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.42 -35.72 68.42 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.293 0.637 . . . . 0.0 111.237 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.418 HD13 ' HD2' ' A' ' 121' ' ' ARG . 55.6 mt -59.81 -49.87 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.5 -46.08 96.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -53.99 -43.29 69.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.369 0.668 . . . . 0.0 110.338 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -51.05 64.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.79 -45.11 67.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.38 0.536 . . . . 0.0 111.213 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.01 -29.82 68.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.234 1.413 . . . . 0.0 112.127 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.38 -28.51 62.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.154 0.982 . . . . 0.0 109.192 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.78 -14.7 27.49 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.857 -1.068 . . . . 0.0 112.8 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.66 126.52 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 109.137 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.82 -1.22 88.04 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.453 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.21 159.93 21.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.629 1.715 . . . . 0.0 109.34 174.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -110.63 154.37 23.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.76 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.98 145.27 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.79 1.236 . . . . 0.0 107.755 169.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 tp -87.86 14.3 9.07 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.749 -0.595 . . . . 0.0 112.18 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -121.84 159.67 26.28 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.128 1.371 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -87.42 172.97 9.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.989 1.715 . . . . 0.0 113.501 -167.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.21 43.25 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.888 2.075 . . . . 0.0 112.477 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 p -70.18 148.19 48.95 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -55.21 -37.72 67.49 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.09 -0.381 . . . . 0.0 110.252 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -65.83 -40.44 91.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.445 1.098 . . . . 0.0 111.473 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -68.67 -36.98 79.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.054 1.297 . . . . 0.0 110.55 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.42 -45.43 79.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.2 -46.08 86.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.087 0.955 . . . . 0.0 110.086 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -56.47 -54.68 42.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.501 1.121 . . . . 0.0 109.052 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.59 -51.03 71.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.336 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.93 -33.47 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.22 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -68.45 -36.6 79.26 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.001 0.819 . . . . 0.0 110.713 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.72 -36.11 69.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.262 1.025 . . . . 0.0 111.421 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.0 mp -79.12 -45.05 20.78 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.066 0.848 . . . . 0.0 110.587 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.418 ' HD2' HD13 ' A' ' 92' ' ' ILE . 45.4 tpt85 -65.93 -33.61 76.23 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.915 0.886 . . . . 0.0 112.083 -175.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.51 5.51 4.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.871 0.868 . . . . 0.0 113.125 -170.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.18 4.0 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 120.793 -1.192 . . . . 0.0 112.124 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.32 138.49 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.122 0.569 . . . . 0.0 111.648 175.045 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -71.12 -37.64 72.33 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 0.0 111.098 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.01 147.29 86.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.027 0.531 . . . . 0.0 110.443 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.21 174.41 11.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.698 2.265 . . . . 0.0 111.194 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 pt -125.41 72.28 66.34 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 106.824 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.08 -19.87 15.3 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.113 2.542 . . . . 0.0 114.221 -168.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 13.0 pt-20 -127.93 -18.74 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 -169.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 53.6 Cg_exo -56.51 155.22 26.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.598 2.199 . . . . 0.0 112.427 169.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -138.22 148.28 59.13 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 109.941 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.18 131.9 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.904 2.403 . . . . 0.0 110.352 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.51 -20.82 31.66 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.011 1.767 . . . . 0.0 111.708 -172.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.45 145.51 52.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.687 1.743 . . . . 0.0 111.394 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.19 138.62 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.35 145.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -123.6 149.43 45.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 mm -125.57 124.15 66.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -168.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -73.76 134.53 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -132.16 163.99 46.37 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.437 0.695 . . . . 0.0 109.681 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.3 -21.19 61.79 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.696 1.597 . . . . 0.0 115.214 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -135.37 1.14 2.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.038 0.836 . . . . 0.0 113.01 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -166.49 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.525 1.53 . . . . 0.0 108.769 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.73 152.37 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -131.31 168.77 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 109.279 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -137.98 144.8 41.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.165 0.986 . . . . 0.0 110.279 -169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.7 14.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.791 1.636 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.23 131.54 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.15 131.39 39.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.085 1.354 . . . . 0.0 108.152 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.26 -20.65 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.52 43.97 0.94 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 119.265 0.938 . . . . 0.0 112.07 -168.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.68 38.21 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.16 1.784 . . . . 0.0 112.744 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.05 0.94 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.997 1.284 . . . . 0.0 110.536 -172.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -91.72 152.48 20.17 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.62 1.21 . . . . 0.0 110.766 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.19 160.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 126.1 1.76 . . . . 0.0 109.836 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.71 140.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.29 169.41 22.18 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.865 -0.522 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 143.02 31.32 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.52 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 108.122 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.99 155.3 65.23 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 N-CA-C 109.334 -1.064 . . . . 0.0 109.334 168.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.08 -37.54 57.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.175 2.583 . . . . 0.0 113.76 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 m -138.57 168.51 19.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.524 1.93 . . . . 0.0 106.956 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.11 34.14 0.07 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.546 1.538 . . . . 0.0 114.623 -172.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -49.59 -30.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.592 1.957 . . . . 0.0 114.396 -174.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.86 12.68 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.227 1.011 . . . . 0.0 111.138 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.69 156.56 6.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.545 1.545 . . . . 0.0 110.021 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.3 100.62 0.83 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.52 34.49 76.02 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -173.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 169.74 20.84 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.77 0.785 . . . . 0.0 111.478 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.22 176.14 9.75 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.213 1.805 . . . . 0.0 107.827 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m -131.46 27.53 4.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 110.813 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.38 38.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -152.65 43.31 0.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.013 1.725 . . . . 0.0 108.005 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -59.42 162.54 4.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 0.0 111.795 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.82 43.2 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.671 1.589 . . . . 0.0 112.722 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.9 tp 47.04 76.63 0.1 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.156 2.182 . . . . 0.0 110.725 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -143.48 158.07 43.95 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.58 1.952 . . . . 0.0 106.618 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -142.15 30.57 1.59 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.954 0.883 . . . . 0.0 112.039 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -137.85 164.6 28.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.365 1.466 . . . . 0.0 109.819 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 173.4 11.87 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.414 1.486 . . . . 0.0 109.333 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -135.88 147.68 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.65 125.97 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -122.59 166.4 14.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.324 1.05 . . . . 0.0 109.282 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.2 124.48 39.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -150.32 163.83 37.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 108.938 -169.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -69.77 128.88 37.97 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.69 -45.34 70.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.344 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.66 -18.19 64.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -88.13 -43.88 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.746 0.703 . . . . 0.0 110.5 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.78 -40.43 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.066 0.946 . . . . 0.0 110.824 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.72 -2.08 57.1 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.255 1.422 . . . . 0.0 113.088 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.45 -18.49 37.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.934 0.778 . . . . 0.0 113.125 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -53.7 -43.47 68.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.473 1.509 . . . . 0.0 112.424 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -161.12 -69.03 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.058 0.943 . . . . 0.0 111.411 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -167.28 -176.39 3.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.374 1.87 . . . . 0.0 108.811 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -156.18 168.47 27.19 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.795 0.838 . . . . 0.0 110.684 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -151.52 159.82 43.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.941 0.896 . . . . 0.0 110.284 168.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.7 t -70.76 139.26 20.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -148.05 67.4 1.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.321 0.582 . . . . 0.0 109.582 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -57.78 117.33 4.14 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.3 -38.47 71.76 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.415 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -144.9 25.62 1.42 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 112.23 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.27 -1.55 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.872 1.215 . . . . 0.0 112.055 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -99.99 -6.78 25.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.392 1.477 . . . . 0.0 110.868 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -128.81 -32.08 2.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.749 1.22 . . . . 0.0 111.343 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -146.47 149.13 33.07 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.492 1.117 . . . . 0.0 110.97 -170.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.9 p -162.56 65.8 1.72 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.061 1.344 . . . . 0.0 109.255 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.93 -14.78 46.15 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.362 2.042 . . . . 0.0 113.02 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.4 125.66 22.59 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.992 1.317 . . . . 0.0 108.376 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.31 167.17 27.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.444 2.096 . . . . 0.0 109.951 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -47.05 -49.14 21.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.486 1.114 . . . . 0.0 111.904 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -54.08 -54.21 42.56 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.812 1.245 . . . . 0.0 111.811 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.55 -35.02 79.11 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.229 1.012 . . . . 0.0 111.608 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.2 mt -61.99 -44.98 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.721 1.146 . . . . 0.0 108.618 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -63.41 -49.07 84.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.02 -40.37 73.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.088 0.555 . . . . 0.0 110.427 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -63.48 -54.44 36.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.401 0.68 . . . . 0.0 109.447 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.48 -43.8 55.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.736 0.414 . . . . 0.0 111.262 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.16 -32.11 72.14 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.201 1.401 . . . . 0.0 111.768 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.94 -25.57 62.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.13 0.572 . . . . 0.0 110.806 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.21 -10.74 17.69 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.895 -1.05 . . . . 0.0 113.315 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 t -59.0 139.88 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 121.026 1.739 . . . . 0.0 109.509 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.25 -5.88 84.33 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.377 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -80.94 154.46 26.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.25 1.525 . . . . 0.0 109.087 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.491 1.116 . . . . 0.0 109.104 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.19 146.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.139 1.376 . . . . 0.0 107.898 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.29 49.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 123.089 1.423 . . . . 0.0 109.812 -171.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -135.24 148.23 49.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.671 168.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -70.03 165.2 22.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.61 118.95 11.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -140.28 155.48 46.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 m -54.61 -40.25 68.71 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.721 0.408 . . . . 0.0 110.315 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.47 -42.85 74.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.466 0.706 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -67.42 -39.37 85.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.824 0.738 . . . . 0.0 110.385 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.8 m -69.93 -44.04 70.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.35 -46.65 79.87 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.498 0.719 . . . . 0.0 109.887 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -57.69 -54.49 46.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.872 0.869 . . . . 0.0 109.196 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -57.81 -52.3 66.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.374 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.94 -31.42 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.487 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.12 -28.26 67.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.624 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.26 -42.88 96.28 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 119.465 1.03 . . . . 0.0 109.728 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.93 -40.31 75.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.014 0.825 . . . . 0.0 110.405 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -76.66 -40.64 48.39 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.199 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -122.7 15.48 10.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.06 -52.51 3.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.4 142.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.144 -0.455 . . . . 0.0 110.502 172.811 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 121.051 0.453 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -144.44 -177.28 5.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.134 1.773 . . . . 0.0 106.813 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.64 89.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.15 -161.45 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.393 2.062 . . . . 0.0 110.772 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 pt -118.57 64.97 6.19 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.742 1.217 . . . . 0.0 110.832 -174.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.54 -21.55 16.86 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.518 2.146 . . . . 0.0 113.365 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 13.9 pt-20 -141.36 -16.48 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 118.062 2.616 . . . . 0.0 118.062 -170.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.506 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 88.4 Cg_endo -73.43 162.75 39.4 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 123.933 2.44 . . . . 0.0 111.417 -174.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -138.84 142.15 32.83 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 124.401 1.08 . . . . 0.0 109.093 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.97 133.15 14.48 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.183 2.589 . . . . 0.0 111.5 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.48 -25.34 12.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.051 1.786 . . . . 0.0 110.622 -169.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.75 136.64 56.5 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.183 0.991 . . . . 0.0 111.046 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.26 140.95 52.47 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.36 129.88 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.23 151.43 23.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.88 98.96 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 102.758 -3.053 . . . . 0.0 102.758 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.38 136.2 56.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -133.84 169.44 13.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.673 . . . . 0.0 110.526 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.95 -30.68 24.83 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.428 2.752 . . . . 0.0 117.134 -169.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -145.76 10.49 1.21 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.691 0.796 . . . . 0.0 112.635 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -163.78 -169.55 1.92 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.27 1.428 . . . . 0.0 108.618 -172.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 158.05 45.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -127.01 169.49 13.29 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -138.83 145.43 40.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.592 0.633 . . . . 0.0 110.681 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.13 174.46 12.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.924 2.09 . . . . 0.0 107.782 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.08 136.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -75.96 128.86 35.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.31 -15.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.19 168.5 33.06 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -50.21 -29.77 10.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -167.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.93 13.06 4.45 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.449 -1.195 . . . . 0.0 113.622 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -123.05 152.38 41.05 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.77 1.785 . . . . 0.0 111.928 -170.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -133.36 159.67 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.947 1.299 . . . . 0.0 110.594 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.52 136.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.23 168.71 26.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.351 0.661 . . . . 0.0 110.47 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.85 141.06 32.55 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 165.12 28.34 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 125.223 1.409 . . . . 0.0 108.812 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.4 151.76 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.977 2.451 . . . . 0.0 112.205 170.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.32 132.3 31.05 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.195 1.93 . . . . 0.0 110.364 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -68.9 -38.83 79.87 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.635 0.374 . . . . 0.0 110.686 173.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.93 144.24 49.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.514 0.725 . . . . 0.0 109.567 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.09 169.7 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 111.227 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.07 -38.04 64.86 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.489 1.515 . . . . 0.0 112.718 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.12 -143.56 29.67 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.08 -7.21 50.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.576 0.75 . . . . 0.0 112.934 174.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.63 -31.06 0.68 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.48 1.038 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 46.02 35.41 2.45 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.675 1.99 . . . . 0.0 113.793 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.14 7.43 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.998 1.719 . . . . 0.0 108.452 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -58.63 -35.42 72.48 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.023 0.929 . . . . 0.0 111.346 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.3 143.55 17.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -58.14 -21.48 46.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -57.93 -24.38 57.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.363 1.065 . . . . 0.0 113.122 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.54 -11.69 60.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.65 0.659 . . . . 0.0 112.362 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 127.62 32.16 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m 86.03 4.15 0.5 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.352 2.261 . . . . 0.0 111.299 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.33 41.89 2.22 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.268 2.227 . . . . 0.0 109.986 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -136.72 163.59 30.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.065 1.346 . . . . 0.0 109.882 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.44 172.19 13.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.582 1.553 . . . . 0.0 109.121 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.1 147.27 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.81 128.02 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 160.6 31.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.236 1.415 . . . . 0.0 108.481 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.55 124.67 41.78 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.6 165.03 35.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.389 1.076 . . . . 0.0 108.982 -169.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.16 132.86 49.45 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.763 0.825 . . . . 0.0 109.208 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.89 -45.38 71.08 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.609 0.764 . . . . 0.0 110.899 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -66.45 -19.6 65.83 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.032 -0.509 . . . . 0.0 112.25 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.84 -42.26 27.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.005 0.82 . . . . 0.0 110.167 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.38 -44.83 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.267 0.627 . . . . 0.0 110.099 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.47 18.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.359 1.064 . . . . 0.0 112.454 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.22 51.97 3.31 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.689 1.614 . . . . 0.0 110.649 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 p -140.51 -55.03 0.52 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.132 1.773 . . . . 0.0 107.692 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.41 -67.6 0.2 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 123.954 0.902 . . . . 0.0 111.486 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -155.25 176.12 12.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.195 0.598 . . . . 0.0 110.158 -168.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.65 164.68 37.88 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.724 0.81 . . . . 0.0 111.04 171.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -156.89 162.13 39.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.63 1.172 . . . . 0.0 110.227 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -71.17 142.52 15.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -153.58 76.61 1.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.173 0.589 . . . . 0.0 109.599 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -70.8 81.34 0.63 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -56.12 129.23 39.16 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.939 -0.475 . . . . 0.0 110.34 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 m80 62.45 19.46 11.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.878 2.071 . . . . 0.0 115.213 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.58 -6.2 1.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.997 0.817 . . . . 0.0 111.848 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.95 -25.25 48.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.249 1.02 . . . . 0.0 110.703 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.18 -27.56 1.8 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -140.87 141.94 34.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.816 0.735 . . . . 0.0 112.101 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -162.03 69.03 2.22 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.251 2.621 . . . . 0.0 107.554 171.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.22 -14.44 40.53 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.665 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.9 mt -122.58 126.08 26.25 Favored Pre-proline 0 C--O 1.235 0.307 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.12 162.3 42.78 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.3 2.0 . . . . 0.0 109.307 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.2 p -49.02 -45.99 43.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.892 0.877 . . . . 0.0 112.573 -171.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -53.11 -45.79 68.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.031 0.932 . . . . 0.0 112.352 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -66.51 -31.75 72.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.622 0.769 . . . . 0.0 111.549 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -64.49 -46.93 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.096 0.862 . . . . 0.0 108.815 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.36 -47.68 87.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -56.09 -43.16 77.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.802 0.841 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.7 -47.93 81.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.046 0.384 . . . . 0.0 110.168 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.23 92.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.841 -0.537 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -70.38 -20.59 62.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.264 1.425 . . . . 0.0 112.351 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.26 -28.95 38.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.34 1.056 . . . . 0.0 109.052 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.49 -20.98 13.31 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.611 -169.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 p -52.24 133.18 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 120.498 1.499 . . . . 0.0 109.779 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.78 -5.22 84.42 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.271 -1.294 . . . . 0.0 113.446 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -84.28 164.56 18.95 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.762 1.781 . . . . 0.0 109.593 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -117.49 150.85 38.25 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.238 1.015 . . . . 0.0 109.208 -172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.3 144.32 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.185 0.994 . . . . 0.0 108.37 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.45 53.0 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 123.303 1.525 . . . . 0.0 109.479 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.92 147.9 37.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.434 -2.166 . . . . 0.0 107.908 168.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -65.06 166.15 9.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.109 1.364 . . . . 0.0 113.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.32 125.4 25.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p -145.18 159.03 43.63 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -51.68 -44.63 63.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.675 0.39 . . . . 0.0 110.658 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.11 -48.74 69.9 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.558 0.743 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -64.97 -39.86 94.12 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.267 0.94 . . . . 0.0 110.955 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.57 -43.31 73.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.402 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.32 -44.85 92.54 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.545 0.611 . . . . 0.0 110.105 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.42 -47.55 85.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.517 1.127 . . . . 0.0 109.684 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -58.41 -50.55 73.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.557 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.04 -30.76 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.923 0.783 . . . . 0.0 111.148 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -68.17 -30.88 70.1 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.244 -0.91 . . . . 0.0 111.237 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.2 -11.35 2.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.353 1.061 . . . . 0.0 113.267 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.05 -41.61 5.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.597 1.159 . . . . 0.0 110.174 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.806 0.73 . . . . 0.0 111.893 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.25 -11.45 10.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.013 0.925 . . . . 0.0 111.248 -173.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.09 -9.96 76.28 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.326 -0.859 . . . . 0.0 112.742 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -145.08 143.73 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.555 169.425 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -156.17 151.27 26.43 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.707 1.203 . . . . 0.0 107.963 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.02 161.45 34.59 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.694 1.998 . . . . 0.0 106.297 168.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.4 -107.07 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.883 2.389 . . . . 0.0 108.522 169.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.0 pt -139.34 57.49 10.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.374 1.47 . . . . 0.0 109.167 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.64 -36.91 5.89 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.986 1.791 . . . . 0.0 112.2 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -159.88 60.24 1.44 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.862 1.265 . . . . 0.0 111.88 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -53.49 127.68 26.28 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.796 1.32 . . . . 0.0 110.376 169.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -115.31 153.83 47.49 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.22 1.408 . . . . 0.0 107.905 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.44 134.07 20.55 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.548 2.165 . . . . 0.0 110.484 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.22 7.32 88.57 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.789 -1.562 . . . . 0.0 113.055 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -81.19 149.38 29.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.339 2.57 . . . . 0.0 110.368 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.94 136.55 46.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -120.15 135.94 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.62 153.67 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -128.05 98.64 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 133.46 52.71 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.707 -0.62 . . . . 0.0 109.875 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.26 167.51 10.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.461 1.105 . . . . 0.0 109.11 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.28 -26.79 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.87 2.38 . . . . 0.0 115.175 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -140.59 2.8 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.345 1.058 . . . . 0.0 112.999 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -157.42 -152.43 0.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.445 1.098 . . . . 0.0 109.031 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 164.63 37.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -126.24 168.41 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -136.66 147.88 47.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.828 0.74 . . . . 0.0 111.479 -172.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.82 174.84 13.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.185 1.794 . . . . 0.0 108.726 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.41 132.06 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -74.67 134.54 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.206 1.002 . . . . 0.0 110.107 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.99 166.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.032 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.18 26.54 43.31 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.54 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.66 37.51 9.59 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.83 1.652 . . . . 0.0 113.28 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.63 -14.72 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 O-C-N 121.336 -0.852 . . . . 0.0 114.637 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.7 172.18 8.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.269 1.034 . . . . 0.0 109.016 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.29 161.54 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.399 0.68 . . . . 0.0 110.093 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -114.31 135.56 53.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.33 168.98 25.04 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.165 0.586 . . . . 0.0 110.902 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.55 139.27 33.95 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.26 46.09 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.697 1.599 . . . . 0.0 109.233 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.87 158.92 40.26 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.078 1.852 . . . . 0.0 111.279 172.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.69 -23.46 36.13 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.143 2.562 . . . . 0.0 113.109 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m 55.06 34.59 22.84 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.667 1.187 . . . . 0.0 112.389 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -139.29 31.48 2.14 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.895 1.278 . . . . 0.0 109.21 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.98 -27.07 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 113.832 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.96 2.98 2.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -169.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.59 172.55 28.02 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.301 1.429 . . . . 0.0 109.701 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -25.19 67.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 112.818 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.81 35.78 0.5 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.978 1.275 . . . . 0.0 110.557 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 163.82 16.95 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.592 0.757 . . . . 0.0 110.722 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.38 -26.23 52.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 112.719 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 m 50.58 50.22 19.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.938 1.295 . . . . 0.0 111.534 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.16 -37.09 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 123.345 0.658 . . . . 0.0 109.362 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.0 tpp -63.07 141.71 58.66 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 m -52.82 137.48 31.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.537 1.135 . . . . 0.0 110.823 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.26 -19.13 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.36 142.93 46.76 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.313 . . . . 0.0 110.003 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 p -145.84 -174.25 4.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 127.147 2.179 . . . . 0.0 107.517 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -95.18 12.23 29.54 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.79 0.805 . . . . 0.0 112.874 169.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.8 168.75 16.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.529 2.332 . . . . 0.0 109.433 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.32 173.09 12.57 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.996 1.718 . . . . 0.0 109.13 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -143.47 158.45 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -87.49 132.77 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.88 164.51 22.93 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 109.481 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -125.23 126.34 45.03 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.01 1.324 . . . . 0.0 108.301 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -68.38 135.56 51.97 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.593 -0.692 . . . . 0.0 109.275 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -43.67 75.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.872 0.76 . . . . 0.0 111.01 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -66.07 -19.37 65.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 -44.12 13.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.844 0.747 . . . . 0.0 110.228 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.32 -29.67 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.072 0.949 . . . . 0.0 111.281 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.97 -29.39 60.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.213 -0.899 . . . . 0.0 112.255 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.77 -109.49 0.64 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.86 1.219 . . . . 0.0 111.97 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -61.88 -0.49 0.48 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.645 1.978 . . . . 0.0 114.635 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t0 67.54 160.05 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 129.37 3.068 . . . . 0.0 114.152 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 96.98 129.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 131.63 3.972 . . . . 0.0 109.063 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -165.29 161.48 19.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.062 1.345 . . . . 0.0 108.959 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.1 156.75 42.97 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.332 1.453 . . . . 0.0 108.381 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.31 134.65 28.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -153.61 75.4 1.04 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.727 -0.608 . . . . 0.0 110.24 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.93 85.58 0.23 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.767 0.827 . . . . 0.0 108.883 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -62.25 125.09 22.67 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -171.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.49 44.37 13.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 126.474 1.91 . . . . 0.0 112.525 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.12 -18.87 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.18 -30.56 25.7 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.253 1.021 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -91.19 -34.42 15.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.781 0.832 . . . . 0.0 110.559 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.41 ' HB3' ' CD1' ' A' ' 122' ' ' TYR . 7.8 m-85 -80.48 175.7 10.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.965 0.888 . . . . 0.0 112.723 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -56.27 160.08 5.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.85 2.86 . . . . 0.0 113.786 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.77 -0.6 3.22 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.815 3.01 . . . . 0.0 115.68 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 mt -36.61 119.58 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.391 2.276 . . . . 0.0 112.638 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.94 151.01 35.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.057 2.504 . . . . 0.0 111.841 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.5 m -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.633 0.773 . . . . 0.0 111.104 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -51.34 66.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.854 1.261 . . . . 0.0 111.677 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.68 -34.95 76.64 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.979 0.912 . . . . 0.0 110.992 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.3 mt -65.13 -43.35 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.573 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.6 -48.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 120.017 1.28 . . . . 0.0 108.946 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -53.18 -47.39 68.89 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.627 1.171 . . . . 0.0 110.066 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -62.18 -50.56 71.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.945 0.498 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.44 78.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.834 0.454 . . . . 0.0 111.359 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -82.55 -11.18 58.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.24 0.616 . . . . 0.0 112.343 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.53 -21.89 35.23 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 109.783 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.08 -11.7 13.78 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.19 147.61 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.181 0.9 . . . . 0.0 109.832 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.01 -2.63 80.19 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.081 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -71.15 154.91 41.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.991 1.396 . . . . 0.0 109.174 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.92 148.9 29.02 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.01 178.27 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.397 1.079 . . . . 0.0 108.62 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.35 21.77 5.64 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.27 1.028 . . . . 0.0 111.167 -170.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -123.05 160.41 26.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.553 1.541 . . . . 0.0 109.735 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -75.2 169.01 18.88 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.54 43.59 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.343 1.857 . . . . 0.0 110.282 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 p -70.46 152.71 43.74 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.542 -1.349 . . . . 0.0 107.558 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -51.76 11.6 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 109.926 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.26 -37.59 83.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.712 1.605 . . . . 0.0 112.401 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -68.69 -39.13 80.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.346 1.43 . . . . 0.0 110.543 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.1 m -67.21 -44.81 78.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.73 -44.24 90.4 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.773 1.229 . . . . 0.0 110.573 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -58.79 -53.62 56.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.099 0.96 . . . . 0.0 109.486 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -46.96 87.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.06 -33.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.315 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.8 -33.52 74.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.184 0.902 . . . . 0.0 110.968 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -58.71 -33.74 70.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.202 1.001 . . . . 0.0 111.695 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.82 -52.98 7.57 Favored 'General case' 0 N--CA 1.458 -0.072 0 O-C-N 121.292 -0.88 . . . . 0.0 110.529 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -30.81 70.94 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.522 0.729 . . . . 0.0 111.395 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 84' ' ' TYR . 48.0 m-85 -135.03 9.2 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.66 -43.42 2.75 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.886 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.87 139.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.433 171.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--O 1.236 0.424 0 CA-C-O 121.688 0.62 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -134.72 146.76 60.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.162 1.385 . . . . 0.0 107.636 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.17 133.55 15.17 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.538 2.159 . . . . 0.0 110.327 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.93 -8.76 50.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.239 1.399 . . . . 0.0 112.397 -169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.01 147.92 24.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.064 1.932 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.07 139.52 42.86 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.3 mm -118.12 146.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.32 153.09 35.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -129.17 103.15 8.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -168.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.575 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.33 169.38 7.52 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.819 1.648 . . . . 0.0 107.533 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.16 -28.18 50.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.947 2.432 . . . . 0.0 115.843 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -142.05 4.4 1.65 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.703 0.801 . . . . 0.0 112.92 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.4 -155.89 0.49 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.912 1.285 . . . . 0.0 108.465 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.66 170.02 19.66 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.51 1.05 . . . . 0.0 110.746 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -144.32 172.46 12.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.333 1.853 . . . . 0.0 109.352 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -137.42 146.92 44.97 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.73 173.72 15.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.401 1.48 . . . . 0.0 108.892 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 117' ' ' VAL . 17.7 tt -139.2 133.86 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -77.09 132.05 38.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.07 -3.81 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.9 177.22 42.27 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.14 53.39 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.525 1.13 . . . . 0.0 111.484 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.87 -13.17 0.39 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.225 -1.32 . . . . 0.0 114.083 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -119.21 155.49 31.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.121 1.961 . . . . 0.0 111.834 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -134.39 156.01 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.85 1.26 . . . . 0.0 110.874 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.46 142.71 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.53 171.27 16.07 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.326 0.651 . . . . 0.0 110.284 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.37 148.62 28.16 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.44 158.99 65.03 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 125.426 1.49 . . . . 0.0 108.571 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.65 156.58 22.09 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.006 1.804 . . . . 0.0 110.419 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 CA--C 1.542 0.889 0 C-N-CA 122.882 2.388 . . . . 0.0 110.958 169.81 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.21 177.23 10.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.506 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 mt -134.83 147.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 t -88.58 125.94 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -135.17 165.57 25.09 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.246 1.018 . . . . 0.0 109.701 -168.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -125.69 139.11 53.82 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -151.95 160.85 43.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.859 1.264 . . . . 0.0 108.598 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.39 132.89 50.13 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -53.31 -43.91 67.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.531 0.732 . . . . 0.0 110.748 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -67.06 -19.19 65.63 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.6 -46.21 33.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.141 0.882 . . . . 0.0 109.906 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.95 -39.21 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.489 0.715 . . . . 0.0 110.197 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.76 -20.15 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.315 1.446 . . . . 0.0 112.861 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.5 -11.92 37.2 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.176 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -51.46 -57.94 7.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.531 1.132 . . . . 0.0 111.009 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -165.79 -50.8 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.968 1.707 . . . . 0.0 110.132 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -159.41 173.0 16.9 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.022 1.729 . . . . 0.0 107.977 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -157.96 164.1 37.16 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.475 -0.766 . . . . 0.0 109.75 173.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -147.83 160.19 43.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.403 1.481 . . . . 0.0 108.367 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.67 135.22 26.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -154.09 75.06 1.0 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.65 0.659 . . . . 0.0 110.779 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.45 94.89 0.42 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -57.53 -23.29 49.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -136.95 21.97 3.05 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.738 1.154 . . . . 0.0 112.251 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.62 -4.72 1.0 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.481 1.491 . . . . 0.0 112.08 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.28 -9.89 53.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.669 1.187 . . . . 0.0 110.729 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -132.3 -41.14 0.99 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.011 1.324 . . . . 0.0 111.213 -169.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -153.05 162.19 41.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.179 . . . . 0.0 111.898 -169.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -178.78 72.16 0.2 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 129.286 3.035 . . . . 0.0 105.275 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -13.64 40.45 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.535 2.823 . . . . 0.0 113.986 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.86 138.64 24.14 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 108.641 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.39 159.14 50.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.313 2.008 . . . . 0.0 109.823 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.24 -42.46 61.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.757 0.823 . . . . 0.0 111.502 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -53.66 -56.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.624 0.77 . . . . 0.0 111.194 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.7 -38.38 90.2 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.354 1.061 . . . . 0.0 111.718 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.84 -49.31 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.431 1.014 . . . . 0.0 108.692 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.29 -46.09 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.91 89.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.877 -0.582 . . . . 0.0 109.957 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -63.3 -48.0 79.92 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.925 0.784 . . . . 0.0 109.851 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.26 60.2 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.321 0.509 . . . . 0.0 110.005 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.68 -19.93 58.79 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.78 -26.51 61.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.864 1.266 . . . . 0.0 109.048 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.76 -10.65 19.75 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.88 -169.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.47 144.52 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.399 0.999 . . . . 0.0 109.784 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.14 60.77 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.66 1.124 . . . . 0.0 112.979 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -86.46 158.42 19.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.798 1.299 . . . . 0.0 109.536 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -100.68 154.04 18.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.53 147.06 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.968 1.307 . . . . 0.0 107.89 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.33 42.09 1.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.788 1.28 . . . . 0.0 110.16 -168.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -139.87 147.79 41.16 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.692 1.597 . . . . 0.0 108.406 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.33 150.5 34.85 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.116 0.967 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -77.23 56.28 1.29 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.177 1.391 . . . . 0.0 112.282 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -64.58 159.07 22.62 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.076 -1.015 . . . . 0.0 109.26 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.3 t -50.07 -45.03 52.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.42 -43.57 97.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.211 0.604 . . . . 0.0 111.476 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -71.71 -37.0 70.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.112 0.869 . . . . 0.0 111.142 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.3 m -67.87 -42.85 80.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.257 0.48 . . . . 0.0 110.159 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.45 -46.73 83.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.071 0.948 . . . . 0.0 109.643 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -58.06 -55.27 37.15 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.722 1.209 . . . . 0.0 109.771 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.39 -49.6 76.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.643 0.202 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 1.4 p -70.55 -30.59 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.819 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -67.34 -33.28 74.91 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.472 -0.768 . . . . 0.0 110.398 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -55.99 -29.86 60.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.541 0.736 . . . . 0.0 112.194 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.15 -50.17 9.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.534 0.606 . . . . 0.0 110.354 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -71.17 -33.34 69.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.558 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.25 6.72 6.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.669 0.668 . . . . 0.0 112.601 -170.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.56 7.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.113 0.869 . . . . 0.0 112.691 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.48 141.4 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.406 1.882 . . . . 0.0 107.914 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.793 168.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.457 -0.666 0 CA-C-O 121.667 0.611 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.35 148.43 67.91 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.32 1.448 . . . . 0.0 107.594 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -47.51 129.15 16.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.582 2.188 . . . . 0.0 110.088 170.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.64 -6.16 35.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.933 1.254 . . . . 0.0 112.297 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.35 150.8 22.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.385 2.092 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.66 142.53 38.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.13 146.08 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -129.05 146.78 50.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 167.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.83 93.78 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.8 135.04 51.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -128.21 172.41 6.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.055 1.342 . . . . 0.0 110.074 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.33 -34.88 26.21 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.454 2.77 . . . . 0.0 116.733 -169.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -139.75 7.98 2.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.699 0.8 . . . . 0.0 112.721 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.58 -169.0 1.97 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 109.121 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.17 156.82 45.88 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.166 -0.959 . . . . 0.0 109.216 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -119.76 169.08 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.471 1.508 . . . . 0.0 107.609 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -132.87 146.0 51.43 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.491 1.041 . . . . 0.0 111.146 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.89 174.88 12.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.647 1.979 . . . . 0.0 108.383 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 tt -135.72 135.51 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.35 131.52 37.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.82 -3.77 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.45 174.57 41.93 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.93 53.75 0.96 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.205 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.2 -13.08 0.29 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.289 -1.284 . . . . 0.0 113.781 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -120.3 155.76 32.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.095 1.948 . . . . 0.0 111.934 -171.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 m -133.98 160.33 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.971 1.308 . . . . 0.0 110.957 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -114.53 140.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 167.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.75 173.51 15.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.898 0.479 . . . . 0.0 110.937 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.32 141.22 34.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.94 160.93 58.63 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.425 1.89 . . . . 0.0 108.142 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -61.58 150.69 84.35 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.548 1.498 . . . . 0.0 109.727 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 N--CA 1.456 -0.678 0 C-N-CA 123.395 2.73 . . . . 0.0 114.296 -179.336 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.56 12.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 112.058 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.42 148.5 25.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 125.761 1.624 . . . . 0.0 107.132 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.69 128.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -137.72 161.0 37.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.685 1.194 . . . . 0.0 109.145 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -121.67 134.08 54.97 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.62 160.9 43.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.755 1.222 . . . . 0.0 109.002 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.08 128.18 35.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.887 0.875 . . . . 0.0 108.877 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.33 -45.11 68.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.83 0.852 . . . . 0.0 110.626 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -64.3 -24.42 67.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.919 -172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.59 -43.22 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.706 0.685 . . . . 0.0 110.481 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.93 -46.8 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.452 0.701 . . . . 0.0 109.744 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.25 65.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.845 1.258 . . . . 0.0 112.117 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 -12.16 15.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.723 1.154 . . . . 0.0 113.363 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.9 m -52.42 -50.55 62.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.959 1.38 . . . . 0.0 111.133 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -165.04 -56.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.041 1.336 . . . . 0.0 110.631 171.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.95 -176.93 5.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.078 1.351 . . . . 0.0 109.855 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.79 169.53 24.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.894 0.878 . . . . 0.0 110.218 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -152.88 156.53 39.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.521 1.129 . . . . 0.0 110.065 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.64 138.43 20.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 169.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -150.63 67.96 0.95 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.171 0.51 . . . . 0.0 109.714 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.36 114.7 3.34 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -56.75 -42.33 79.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.458 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -163.11 43.47 0.12 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.331 0.652 . . . . 0.0 110.729 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.09 -14.25 6.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.818 . . . . 0.0 111.812 168.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.99 -16.74 37.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.0 1.32 . . . . 0.0 110.908 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -116.56 -27.11 6.82 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.454 1.102 . . . . 0.0 110.928 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -144.97 146.51 31.97 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.316 0.647 . . . . 0.0 111.643 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 p -164.82 66.28 1.23 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.541 1.536 . . . . 0.0 108.96 169.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.46 -13.82 41.49 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.452 2.101 . . . . 0.0 113.025 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.58 119.39 21.59 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.239 1.416 . . . . 0.0 108.764 -171.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.44 153.67 22.11 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.734 2.289 . . . . 0.0 110.146 167.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.1 m -52.71 -43.46 65.66 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.713 0.405 . . . . 0.0 111.87 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -56.71 -41.17 76.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.689 0.795 . . . . 0.0 112.269 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -64.94 -31.89 73.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.573 0.749 . . . . 0.0 111.133 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -64.74 -46.07 93.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.58 -48.81 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -55.64 -46.19 77.48 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.744 1.218 . . . . 0.0 110.724 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -61.03 -51.41 69.31 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.49 67.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.395 0.278 . . . . 0.0 110.712 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.76 -20.55 61.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.93 -27.49 61.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 119.254 0.934 . . . . 0.0 108.877 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.68 -16.19 15.54 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.711 -1.137 . . . . 0.0 113.529 -168.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.0 t -53.2 134.78 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.622 1.556 . . . . 0.0 108.578 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.78 -7.17 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.524 1.059 . . . . 0.0 113.335 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 159.36 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.184 1.492 . . . . 0.0 108.918 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -127.51 142.87 51.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.71 146.79 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.876 0.87 . . . . 0.0 109.01 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.36 -1.21 48.2 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.757 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -80.14 149.68 30.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.813 0.733 . . . . 0.0 109.209 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -74.65 154.45 38.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.498 1.919 . . . . 0.0 109.443 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.91 121.81 16.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.7 p -140.92 158.26 44.2 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 m -51.97 -42.38 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.852 0.461 . . . . 0.0 110.184 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.46 -48.33 70.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 110.841 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.67 -38.04 83.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.57 0.623 . . . . 0.0 110.853 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.2 m -67.91 -44.62 76.51 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.932 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -58.01 -44.69 87.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.489 0.715 . . . . 0.0 110.209 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -56.86 -52.41 65.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.163 1.385 . . . . 0.0 109.414 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -62.33 -49.97 73.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.757 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.0 -33.17 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.693 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.16 -34.7 78.62 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 121.639 -0.663 . . . . 0.0 110.682 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.55 -34.44 71.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.354 0.662 . . . . 0.0 112.203 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -76.88 -45.5 27.95 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.53 -0.731 . . . . 0.0 110.253 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -34.87 61.31 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.301 0.64 . . . . 0.0 111.265 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.08 8.35 6.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 111.999 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.77 -21.04 12.03 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.057 -1.027 . . . . 0.0 112.906 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.26 143.57 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.605 1.562 . . . . 0.0 106.891 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.483 0.713 . . . . 0.0 111.256 172.81 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 N-CA-C 111.824 -0.106 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -125.35 141.52 39.02 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.98 134.84 18.2 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.772 2.315 . . . . 0.0 110.504 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.65 -10.0 58.96 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.154 1.359 . . . . 0.0 112.402 -169.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -78.04 140.5 39.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.119 1.959 . . . . 0.0 111.033 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.57 136.28 52.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.89 140.87 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.31 145.63 45.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 110.95 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -75.76 134.48 40.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -132.86 168.89 15.65 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.053 0.941 . . . . 0.0 110.687 -170.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.53 -30.41 35.61 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.37 2.713 . . . . 0.0 116.588 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 4.93 1.5 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.474 0.71 . . . . 0.0 112.763 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.68 -165.86 1.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.699 1.2 . . . . 0.0 109.029 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.09 149.46 44.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -120.69 171.77 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.746 1.618 . . . . 0.0 108.362 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -138.18 146.13 42.33 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.471 0.709 . . . . 0.0 111.012 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 174.43 12.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.459 1.904 . . . . 0.0 108.065 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.94 131.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.34 134.42 41.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.86 -3.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.58 175.18 42.63 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.88 55.38 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.163 0.985 . . . . 0.0 111.394 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.12 -15.3 0.33 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.956 1.265 . . . . 0.0 113.694 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -119.6 154.06 34.54 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.714 1.757 . . . . 0.0 111.738 -169.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.16 159.61 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.655 1.182 . . . . 0.0 110.673 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -111.47 138.68 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 167.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.67 168.03 27.95 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 111.009 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.39 139.95 33.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 165.34 21.07 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.534 1.533 . . . . 0.0 109.184 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.42 150.51 41.62 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.736 2.291 . . . . 0.0 112.458 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 C-N-CA 122.324 2.016 . . . . 0.0 109.938 174.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.22 176.83 10.83 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.222 1.009 . . . . 0.0 110.481 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -138.03 148.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.73 126.58 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -130.64 166.14 21.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.348 1.059 . . . . 0.0 109.772 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.06 127.46 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -151.8 163.16 39.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.462 1.105 . . . . 0.0 108.84 -169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.64 131.07 45.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.69 -45.64 70.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.693 0.797 . . . . 0.0 110.576 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -66.37 -19.81 65.9 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.94 -45.27 16.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.851 0.751 . . . . 0.0 110.065 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.6 t -59.43 -40.79 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.796 0.838 . . . . 0.0 110.638 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.02 -2.0 54.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 0.0 113.115 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.29 -15.88 46.88 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.917 0.77 . . . . 0.0 113.14 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 p -55.95 -47.13 78.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.139 1.376 . . . . 0.0 111.976 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -162.76 -67.9 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.707 1.203 . . . . 0.0 111.706 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -155.54 172.57 18.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.167 0.987 . . . . 0.0 109.926 -167.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.33 165.56 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.848 0.859 . . . . 0.0 110.75 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.56 163.08 40.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.07 0.948 . . . . 0.0 110.414 167.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.1 139.38 20.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 168.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -147.3 55.42 1.09 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.39 0.614 . . . . 0.0 110.39 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -54.61 113.03 1.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -61.84 -33.3 73.92 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -138.06 23.22 2.81 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.68 0.792 . . . . 0.0 112.13 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.4 -2.71 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.348 0.976 . . . . 0.0 112.491 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.69 -26.33 59.77 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.169 -0.957 . . . . 0.0 110.945 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -143.2 -25.02 0.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -128.92 164.81 22.32 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.494 1.518 . . . . 0.0 112.233 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 m 165.64 72.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 131.52 3.928 . . . . 0.0 106.077 168.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.33 -13.86 36.48 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.287 2.658 . . . . 0.0 113.512 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.6 120.06 34.99 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 108.218 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.23 158.33 12.26 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 111.884 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -48.56 -44.46 36.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 111.786 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.2 p -56.02 -51.91 66.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.575 0.75 . . . . 0.0 110.926 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -65.46 -37.02 85.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.7 0.8 . . . . 0.0 111.373 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.87 -48.7 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.79 -39.36 83.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -55.74 -45.68 77.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.485 0.714 . . . . 0.0 110.213 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -60.85 -53.93 51.26 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 119.008 -0.52 . . . . 0.0 109.678 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.99 -48.84 61.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.283 0.492 . . . . 0.0 111.21 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -66.31 -34.22 77.5 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.681 1.592 . . . . 0.0 112.244 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -72.88 -24.09 60.81 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.232 1.013 . . . . 0.0 109.979 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.17 -12.02 17.64 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.965 . . . . 0.0 112.669 -168.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.87 142.19 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.375 1.443 . . . . 0.0 109.598 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.02 -8.39 79.91 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.807 1.194 . . . . 0.0 113.172 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -81.68 153.62 26.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.0 1.4 . . . . 0.0 109.186 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -101.52 154.16 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.321 1.048 . . . . 0.0 109.238 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.57 147.99 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 107.797 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.18 34.92 2.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.17 0.985 . . . . 0.0 110.665 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -125.54 146.77 49.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 108.393 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -73.38 164.12 27.12 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 127.099 2.16 . . . . 0.0 110.383 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.36 126.71 30.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.5 p -145.01 159.0 43.64 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -44.43 64.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.035 0.534 . . . . 0.0 109.623 174.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.11 -43.5 70.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.798 0.839 . . . . 0.0 111.447 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -66.68 -41.85 87.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.102 0.865 . . . . 0.0 110.369 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.23 -43.97 80.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.878 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.48 -45.22 89.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.4 0.68 . . . . 0.0 110.311 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -57.13 -52.02 66.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.041 0.936 . . . . 0.0 109.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -61.54 -49.42 76.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.019 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.21 -32.45 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.603 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -67.9 -31.75 71.75 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.219 -0.925 . . . . 0.0 111.151 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.2 -19.76 55.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.651 1.18 . . . . 0.0 112.414 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.5 -43.87 6.37 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.783 0.833 . . . . 0.0 110.339 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.65 -43.23 76.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.577 1.08 . . . . 0.0 111.438 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.4 2.41 13.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.45 -30.62 5.18 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.346 -0.846 . . . . 0.0 112.138 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -156.1 141.36 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 169.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 118.282 0.492 . . . . 0.0 110.64 170.006 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 CA--C 1.536 0.617 0 CA-C-O 120.853 0.272 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -138.48 151.42 69.08 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.148 0.979 . . . . 0.0 110.036 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -46.33 135.33 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.879 2.386 . . . . 0.0 110.837 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -14.59 54.49 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.254 1.407 . . . . 0.0 111.797 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -83.77 151.03 25.42 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.098 1.949 . . . . 0.0 111.43 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.9 139.54 41.69 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.42 125.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -96.86 152.08 19.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.4 mm -126.35 109.84 22.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.91 132.51 46.83 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.41 166.43 17.33 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.32 -35.88 28.65 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.47 2.78 . . . . 0.0 116.235 -168.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.97 13.05 2.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.285 1.034 . . . . 0.0 111.801 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.09 -164.78 1.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.058 0.943 . . . . 0.0 109.954 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 156.66 47.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 172.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -124.16 170.71 10.44 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.748 2.019 . . . . 0.0 106.292 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -136.8 148.3 47.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.715 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 173.71 12.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 107.962 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.7 tt -136.58 134.21 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.22 131.73 37.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.286 1.035 . . . . 0.0 108.309 -171.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.41 -5.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.45 -178.88 38.23 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.35 41.77 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.255 1.022 . . . . 0.0 111.671 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.41 -29.75 0.28 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.905 1.24 . . . . 0.0 112.627 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -88.77 149.65 23.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.784 1.292 . . . . 0.0 111.445 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -131.59 155.48 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.561 1.545 . . . . 0.0 109.112 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -102.42 143.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 166.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.2 165.07 35.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.571 -0.705 . . . . 0.0 111.131 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 136.91 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.27 34.53 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.804 0.842 . . . . 0.0 110.71 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.7 164.25 36.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.416 2.077 . . . . 0.0 110.112 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 C--N 1.348 0.54 0 C-N-CA 122.058 1.839 . . . . 0.0 110.675 173.047 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.28 -172.69 4.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 109.728 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 mt -141.8 156.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.867 1.267 . . . . 0.0 109.252 -170.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -98.82 127.88 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -129.92 168.7 16.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.456 1.102 . . . . 0.0 110.411 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -125.72 134.34 51.81 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -150.69 160.83 43.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.74 1.216 . . . . 0.0 108.686 -175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.44 138.01 56.31 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 167.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.85 -33.4 68.62 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.687 0.795 . . . . 0.0 110.623 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -36.97 74.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.954 0.797 . . . . 0.0 110.954 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.07 -46.04 65.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.831 0.287 . . . . 0.0 110.471 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.67 -41.24 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.091 0.557 . . . . 0.0 110.397 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.22 40.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.383 1.473 . . . . 0.0 113.45 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.48 -16.0 34.44 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.044 0.831 . . . . 0.0 113.689 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 p -61.64 -44.1 97.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.553 1.176 . . . . 0.0 112.014 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -162.26 -59.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.861 0.865 . . . . 0.0 112.377 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -164.32 -170.73 2.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.673 1.589 . . . . 0.0 108.986 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -148.1 166.88 26.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.889 0.875 . . . . 0.0 109.956 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -145.44 153.21 40.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.197 1.399 . . . . 0.0 107.482 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -83.77 137.31 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.37 70.78 0.87 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.228 0.537 . . . . 0.0 109.92 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.51 112.9 2.66 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -65.69 -11.43 45.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.869 . . . . 0.0 113.184 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.8 m-70 -129.85 26.24 5.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.639 1.175 . . . . 0.0 111.591 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.11 23.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.895 -1.128 . . . . 0.0 112.605 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.8 t70 -132.91 -3.38 3.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 111.607 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -132.82 -31.59 1.31 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.26 1.424 . . . . 0.0 111.579 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 67.81 136.11 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 128.569 2.748 . . . . 0.0 116.211 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -63.93 139.97 97.76 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.382 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -16.75 32.37 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.894 2.396 . . . . 0.0 112.211 168.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.04 128.39 26.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.669 1.588 . . . . 0.0 108.802 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.93 155.03 24.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.165 2.577 . . . . 0.0 111.832 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.0 p -54.3 -40.45 67.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.86 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -56.52 -53.56 56.12 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.595 0.758 . . . . 0.0 110.569 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -62.92 -36.89 84.89 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.298 0.639 . . . . 0.0 111.472 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.03 -51.55 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.158 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -56.03 -49.1 74.64 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.188 0.995 . . . . 0.0 110.036 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -65.16 -45.65 84.08 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.729 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.95 -52.07 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.632 0.651 . . . . 0.0 110.793 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.93 -23.18 60.66 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -72.73 -27.5 62.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.66 -4.58 30.58 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.703 0.801 . . . . 0.0 113.051 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.28 150.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 109.828 169.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.5 23.53 56.15 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.439 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -126.85 161.98 26.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.703 1.201 . . . . 0.0 107.927 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.08 156.86 16.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.941 1.296 . . . . 0.0 109.754 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.8 m -130.56 148.84 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.827 2.051 . . . . 0.0 106.664 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.44 19.78 11.6 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.62 -0.675 . . . . 0.0 112.223 -169.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -121.41 155.92 33.79 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.293 1.437 . . . . 0.0 109.179 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -88.44 169.93 11.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.431 1.093 . . . . 0.0 112.542 -170.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.19 121.45 14.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 p -147.05 152.86 39.24 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 165.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -53.57 -40.84 65.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.102 0.41 . . . . 0.0 110.571 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.79 -44.74 84.81 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.376 0.67 . . . . 0.0 111.047 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -67.94 -38.57 83.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 0.786 . . . . 0.0 110.534 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.62 -44.62 81.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.646 0.657 . . . . 0.0 110.039 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -60.11 -45.3 93.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.101 0.56 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -57.82 -54.48 46.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.251 1.02 . . . . 0.0 109.587 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.49 -48.62 80.18 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.919 0.488 . . . . 0.0 111.729 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.47 -31.25 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.165 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -72.38 -27.61 62.49 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.897 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -61.61 -39.61 91.86 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.811 1.187 . . . . 0.0 109.644 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.42 -47.32 50.04 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.288 -0.883 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -17.35 59.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.284 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -142.76 7.39 1.66 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.81 1.186 . . . . 0.0 113.585 -169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.97 -48.55 3.68 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 120.806 -1.184 . . . . 0.0 110.637 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.66 141.23 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.582 1.953 . . . . 0.0 106.931 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.938 168.362 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.5 Cg_endo . . . . . 0 N--CA 1.46 -0.452 0 CA-C-O 121.179 0.408 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -135.81 151.79 74.74 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.726 1.211 . . . . 0.0 108.95 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HB2' HD11 ' A' ' 93' ' ' ILE . 94.8 Cg_exo -47.01 143.53 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.889 2.393 . . . . 0.0 111.495 169.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.56 73.99 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.038 1.304 . . . . 0.0 112.227 -170.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -76.76 147.81 37.07 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.509 1.654 . . . . 0.0 111.056 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.87 140.86 46.0 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.098 0.959 . . . . 0.0 108.829 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -125.21 138.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.39 148.9 41.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -121.87 106.37 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 -169.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -75.42 133.01 41.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -129.3 167.85 18.42 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 0.0 110.531 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.12 -25.54 29.65 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.252 2.635 . . . . 0.0 116.433 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -141.48 0.25 1.46 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.02 -165.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.67 1.188 . . . . 0.0 109.271 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -134.01 152.22 51.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -126.78 171.95 10.77 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.144 1.777 . . . . 0.0 107.998 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 66.6 m95 -139.2 150.0 45.05 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.073 0.851 . . . . 0.0 110.869 -172.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.33 173.24 16.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.421 1.488 . . . . 0.0 108.667 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.77 128.94 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.39 130.14 42.21 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.68 1.592 . . . . 0.0 109.433 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.53 168.6 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.075 1.35 . . . . 0.0 109.416 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.84 -135.31 49.23 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -120.71 8.99 10.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.397 1.079 . . . . 0.0 111.392 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.11 16.67 0.02 OUTLIER Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.437 -0.789 . . . . 0.0 113.686 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -107.6 169.2 8.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.847 1.324 . . . . 0.0 109.013 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.85 151.98 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.936 0.494 . . . . 0.0 110.649 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.28 141.37 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 166.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.84 171.54 17.59 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.92 143.2 30.88 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.6 159.33 71.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.286 1.834 . . . . 0.0 108.561 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.49 159.55 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.156 1.904 . . . . 0.0 110.921 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.538 0.676 0 C-N-CA 122.509 2.139 . . . . 0.0 113.008 -177.283 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.55 173.9 13.57 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.397 . . . . 0.0 108.21 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -142.13 154.52 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.65 138.52 19.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -142.92 168.59 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.953 1.301 . . . . 0.0 108.814 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -128.54 140.79 51.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -151.24 161.14 43.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.41 1.484 . . . . 0.0 107.929 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.82 137.25 57.09 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.61 -44.74 73.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.714 0.688 . . . . 0.0 110.82 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.04 -19.79 65.74 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.92 -47.58 28.99 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.129 0.877 . . . . 0.0 109.737 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.4 t -62.19 -43.35 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.563 0.745 . . . . 0.0 110.243 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.43 -7.97 56.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.992 1.317 . . . . 0.0 113.182 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.32 -20.41 58.56 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.714 0.673 . . . . 0.0 113.22 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 -47.49 84.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.77 1.228 . . . . 0.0 111.976 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -159.08 -61.42 0.07 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.733 0.813 . . . . 0.0 112.884 172.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -155.73 171.34 20.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -158.94 163.25 36.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.71 0.804 . . . . 0.0 110.111 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -151.15 154.14 36.33 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.605 0.762 . . . . 0.0 110.78 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 8' ' ' PRO . 92.2 t -79.81 137.56 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.74 68.55 0.46 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.528 0.68 . . . . 0.0 110.587 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.91 101.58 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -68.14 129.53 40.2 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 44.67 44.89 7.78 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.866 1.667 . . . . 0.0 112.1 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.78 -12.43 4.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.623 0.769 . . . . 0.0 112.967 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.95 -20.24 33.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.657 1.583 . . . . 0.0 111.029 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 -14.25 8.94 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.987 1.315 . . . . 0.0 111.026 -173.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -136.37 -156.09 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.973 1.709 . . . . 0.0 109.452 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m 57.79 59.93 6.57 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.361 1.864 . . . . 0.0 112.359 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -61.8 -14.74 38.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.363 2.042 . . . . 0.0 114.197 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.46 141.69 23.04 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.683 0.793 . . . . 0.0 110.51 -167.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 159.48 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.202 . . . . 0.0 110.137 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.7 m -48.05 -47.63 33.59 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.464 1.106 . . . . 0.0 111.57 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.68 -49.99 69.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.538 0.735 . . . . 0.0 111.683 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.38 -35.25 77.42 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.774 -0.579 . . . . 0.0 111.433 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.8 -49.01 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 10' ' ' PRO . 54.7 mt -63.69 -45.05 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.181 0.993 . . . . 0.0 109.166 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.07 -52.27 52.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.052 0.941 . . . . 0.0 108.963 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -66.86 -45.99 76.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.305 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.27 -47.88 62.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.617 0.644 . . . . 0.0 111.434 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.6 -10.72 57.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.351 0.661 . . . . 0.0 112.594 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.68 -22.49 40.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.38 0.991 . . . . 0.0 110.185 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.5 mt -111.7 -4.64 14.63 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.602 0.761 . . . . 0.0 112.372 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.25 142.79 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 118.869 0.759 . . . . 0.0 110.066 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.64 -3.2 80.04 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.297 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -74.07 152.74 39.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.321 1.561 . . . . 0.0 109.268 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.46 149.97 22.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.13 176.63 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.585 1.154 . . . . 0.0 107.944 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.42 6.12 6.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.564 -0.71 . . . . 0.0 112.519 -169.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -99.0 146.43 26.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.123 0.969 . . . . 0.0 109.062 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -61.83 153.46 28.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.323 1.449 . . . . 0.0 111.149 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.65 127.08 31.02 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.4 p -141.86 159.51 42.07 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 m -49.31 -42.09 40.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.21 0.604 . . . . 0.0 111.127 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.2 -23.75 18.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.318 -168.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -68.16 -39.93 82.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.633 1.106 . . . . 0.0 109.442 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.2 m -69.79 -40.6 75.91 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.079 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -53.64 -49.09 68.64 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.446 0.698 . . . . 0.0 109.883 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -60.2 -46.2 90.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.181 0.992 . . . . 0.0 110.11 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.31 -53.19 59.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.373 0.533 . . . . 0.0 111.77 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.86 -33.71 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 119.881 -0.727 . . . . 0.0 111.216 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -68.75 -32.12 71.65 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.596 -0.69 . . . . 0.0 111.148 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.17 -41.7 98.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.207 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.59 -44.79 81.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.865 1.212 . . . . 0.0 111.017 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -66.07 -42.43 89.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.343 0.657 . . . . 0.0 111.463 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -95.33 -43.98 7.78 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.001 0.364 . . . . 0.0 111.909 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.33 -53.52 0.69 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.53 138.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.127 -0.463 . . . . 0.0 109.82 -179.293 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 CA--C 1.536 0.576 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.05 151.02 69.7 Favored Pre-proline 0 C--O 1.236 0.351 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.86 131.53 38.62 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.018 1.812 . . . . 0.0 109.3 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.9 -1.48 65.49 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.749 1.166 . . . . 0.0 113.015 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -73.61 147.71 43.55 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.963 1.881 . . . . 0.0 111.06 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.08 136.11 44.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.89 124.31 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.96 150.29 20.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -125.89 113.56 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -171.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 131.74 44.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -119.49 169.0 8.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.528 1.531 . . . . 0.0 107.888 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.26 96.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.733 2.288 . . . . 0.0 112.625 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 57.88 28.02 15.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.407 2.283 . . . . 0.0 113.508 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -149.21 -164.57 2.06 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.938 0.895 . . . . 0.0 109.436 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.9 158.84 43.43 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.065 -1.022 . . . . 0.0 109.591 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -127.77 168.53 15.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -135.62 150.65 49.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.864 0.757 . . . . 0.0 111.345 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.69 173.07 14.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.092 1.757 . . . . 0.0 108.181 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.77 132.97 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -70.93 134.83 47.54 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.624 1.17 . . . . 0.0 109.856 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.46 165.94 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.39 1.076 . . . . 0.0 109.879 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.54 -123.17 31.86 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -142.95 37.48 1.42 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.317 1.047 . . . . 0.0 109.021 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.2 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.382 -0.824 . . . . 0.0 115.016 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.39 171.03 7.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.938 1.369 . . . . 0.0 109.168 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.57 159.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.794 0.838 . . . . 0.0 110.194 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.8 137.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.73 173.3 14.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.545 0.738 . . . . 0.0 110.781 -172.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.26 143.37 30.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 161.9 46.7 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.862 1.665 . . . . 0.0 109.791 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 154.96 27.32 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.235 2.624 . . . . 0.0 112.533 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 CA--C 1.54 0.787 0 C-N-CA 122.85 2.367 . . . . 0.0 112.373 175.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.18 175.0 14.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.003 1.321 . . . . 0.0 108.467 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.78 157.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.0 139.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -142.74 169.65 17.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.572 1.549 . . . . 0.0 108.739 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.55 142.65 51.47 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -151.28 159.38 44.37 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.728 1.211 . . . . 0.0 108.443 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.9 135.6 52.73 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.87 -44.12 70.14 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.485 0.584 . . . . 0.0 111.679 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -66.51 -22.25 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.21 -44.4 59.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.789 0.722 . . . . 0.0 109.935 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.72 -41.49 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.414 0.686 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -3.78 22.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.657 1.183 . . . . 0.0 113.526 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.87 42.92 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.853 1.216 . . . . 0.0 114.831 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -58.88 -44.3 91.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.73 1.265 . . . . 0.0 112.365 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.2 -67.45 0.06 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 123.605 0.762 . . . . 0.0 112.439 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -157.76 177.03 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.638 1.175 . . . . 0.0 108.726 -166.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -151.93 169.59 21.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.05 1.34 . . . . 0.0 108.527 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.68 152.67 25.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.809 0.844 . . . . 0.0 110.296 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.69 133.24 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -149.68 70.86 1.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.729 0.776 . . . . 0.0 109.163 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.02 119.13 10.82 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -62.74 -28.27 69.85 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.326 -0.234 . . . . 0.0 110.761 169.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -97.16 17.52 16.99 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.041 -168.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.73 21.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.776 1.626 . . . . 0.0 113.048 176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.9 t70 -136.3 2.19 2.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 111.469 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -138.08 -30.44 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.737 1.615 . . . . 0.0 111.866 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 67.54 149.6 0.06 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 128.986 2.914 . . . . 0.0 115.968 169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -50.73 113.41 3.67 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.17 1.388 . . . . 0.0 111.261 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.82 -18.85 16.69 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.941 2.427 . . . . 0.0 111.793 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.49 136.42 20.83 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 126.029 1.731 . . . . 0.0 107.273 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.61 145.78 57.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.083 1.855 . . . . 0.0 109.284 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.1 m -54.42 -42.34 70.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.45 0.3 . . . . 0.0 111.433 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -56.66 -42.51 79.11 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.703 0.801 . . . . 0.0 112.055 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -66.42 -33.19 75.15 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 117.764 -1.112 . . . . 0.0 111.441 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.4 mt -58.22 -49.04 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.135 1.334 . . . . 0.0 108.045 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.2 mm -61.89 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.862 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -45.2 91.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.23 -51.98 65.57 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.47 49.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.839 0.856 . . . . 0.0 110.721 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -76.76 -18.01 58.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.958 -0.544 . . . . 0.0 112.324 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.86 -27.16 62.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.684 1.129 . . . . 0.0 110.265 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.86 -27.69 16.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 110.644 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.12 125.62 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.581 1.082 . . . . 0.0 108.956 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.93 82.6 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.098 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -82.22 153.82 25.74 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.851 1.826 . . . . 0.0 108.885 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.85 151.42 23.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.228 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.52 172.24 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.668 1.187 . . . . 0.0 108.429 169.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.25 14.27 10.46 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.474 -0.766 . . . . 0.0 111.667 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -112.04 149.48 31.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 109.288 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -68.19 161.3 27.39 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 112.359 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.19 124.16 20.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.5 p -144.57 157.53 44.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.5 m -53.26 -45.41 68.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.653 0.381 . . . . 0.0 110.144 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.48 -37.98 80.61 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.086 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -69.24 -37.82 78.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.329 0.968 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.2 m -65.3 -47.37 76.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.12 -44.31 87.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.236 1.014 . . . . 0.0 110.144 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -58.04 -56.26 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 109.309 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.81 -47.37 85.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.722 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.6 -32.64 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.611 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -70.96 -40.96 71.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 110.528 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.6 -43.77 68.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.452 1.101 . . . . 0.0 110.618 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -72.08 -44.72 62.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.356 1.062 . . . . 0.0 112.007 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -74.43 -35.11 63.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.415 1.007 . . . . 0.0 112.658 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -120.96 -2.41 9.73 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -167.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.06 -26.24 24.29 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.831 -1.168 . . . . 0.0 111.983 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.65 139.91 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.049 -0.501 . . . . 0.0 111.128 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 121.131 0.388 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -128.91 147.13 63.37 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.497 0.719 . . . . 0.0 109.863 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -47.96 139.06 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.55 -3.1 68.16 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.662 1.125 . . . . 0.0 112.438 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -80.52 139.26 36.44 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.056 1.428 . . . . 0.0 109.661 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mt -67.73 135.33 52.55 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.69 126.9 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -97.49 148.6 23.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 mm -126.18 123.03 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -75.0 112.39 11.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -84.64 171.27 11.4 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.88 -34.19 74.9 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.549 2.166 . . . . 0.0 114.904 -171.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -141.21 13.06 2.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.437 1.095 . . . . 0.0 111.967 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -157.68 -157.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.759 1.224 . . . . 0.0 109.272 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.24 155.07 45.23 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.085 -1.009 . . . . 0.0 109.809 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.61 168.49 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.009 1.724 . . . . 0.0 106.565 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -136.4 147.12 47.13 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.782 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.68 11.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.214 1.805 . . . . 0.0 107.48 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 tt -134.07 132.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.88 129.08 38.41 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.228 1.411 . . . . 0.0 108.879 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.2 m -136.38 169.14 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.07 0.948 . . . . 0.0 109.326 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.12 -117.32 8.76 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -141.7 25.33 1.99 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.26 1.024 . . . . 0.0 110.685 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.79 -17.29 0.14 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.159 -0.963 . . . . 0.0 113.853 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -70.79 163.65 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.012 0.906 . . . . 0.0 109.723 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.76 154.65 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.17 137.44 33.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.76 168.9 25.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 111.501 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -89.81 133.14 34.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.119 1.368 . . . . 0.0 107.441 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.84 153.89 58.15 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.275 1.03 . . . . 0.0 111.171 -171.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 152.53 44.02 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.329 2.686 . . . . 0.0 112.934 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 C--N 1.35 0.625 0 C-N-CA 122.876 2.384 . . . . 0.0 112.94 179.151 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 -170.84 3.69 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.235 1.414 . . . . 0.0 109.734 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -149.76 173.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.73 141.11 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.83 166.96 21.78 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.785 1.234 . . . . 0.0 110.048 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -126.59 125.92 42.75 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.19 161.69 40.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.629 1.172 . . . . 0.0 108.415 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 132.12 44.94 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -49.11 -48.35 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.47 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.46 -25.99 68.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.049 0.386 . . . . 0.0 111.914 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.59 -43.59 31.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.482 0.583 . . . . 0.0 110.367 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.79 -35.87 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 110.224 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.18 10.59 31.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.762 1.225 . . . . 0.0 113.508 -176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.62 -22.17 38.46 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.817 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -57.5 -50.12 74.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 1.271 . . . . 0.0 113.254 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.86 -69.07 0.06 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -157.74 172.0 19.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.497 1.119 . . . . 0.0 109.294 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -163.99 157.55 18.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.402 1.081 . . . . 0.0 109.328 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.48 166.14 34.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.404 0.681 . . . . 0.0 110.115 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.76 139.98 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -150.58 71.54 1.05 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -66.98 93.53 0.28 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -60.99 122.13 14.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 48.56 44.44 20.88 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 113.017 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.12 -19.05 2.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.134 0.974 . . . . 0.0 113.307 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.17 -22.68 30.89 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.228 1.011 . . . . 0.0 110.892 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -112.49 -26.47 8.67 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.986 0.914 . . . . 0.0 111.279 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.92 159.99 42.03 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m 128.69 76.75 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 1 C-N-CA 131.801 4.041 . . . . 0.0 108.708 174.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.38 -19.48 43.44 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.804 2.336 . . . . 0.0 114.017 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.42 132.9 29.25 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.534 0.734 . . . . 0.0 109.818 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.46 162.83 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.11 1.873 . . . . 0.0 109.115 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.2 m -50.94 -43.12 60.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.82 0.848 . . . . 0.0 112.587 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 p -55.59 -47.68 76.09 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.847 0.859 . . . . 0.0 111.996 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -32.07 73.48 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.54 0.736 . . . . 0.0 111.228 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.8 mt -65.13 -47.56 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.05 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 118.603 0.638 . . . . 0.0 109.915 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -54.86 -49.74 70.38 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.865 0.866 . . . . 0.0 109.793 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.05 -52.29 66.02 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.088 0.555 . . . . 0.0 110.144 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.8 -15.71 55.69 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.229 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.89 -32.05 68.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.784 1.174 . . . . 0.0 109.165 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.0 -18.12 22.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.055 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -50.34 130.67 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.93 1.241 . . . . 0.0 109.445 171.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.3 -2.61 81.14 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.277 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.34 162.81 19.91 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.472 1.636 . . . . 0.0 109.193 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -103.77 153.19 20.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.887 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG21 HD21 ' A' ' 36' ' ' LEU . 16.1 m -129.2 146.6 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 109.682 171.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -97.56 23.11 8.07 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.003 -1.061 . . . . 0.0 112.336 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -125.04 151.42 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.048 1.339 . . . . 0.0 110.508 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -65.85 162.6 18.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.44 2.296 . . . . 0.0 112.167 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.53 125.89 28.07 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.0 p -146.69 156.54 43.25 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -53.76 -42.52 68.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.64 0.776 . . . . 0.0 110.408 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.24 -39.92 82.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.05 0.94 . . . . 0.0 110.987 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -68.26 -34.45 76.23 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.36 0.982 . . . . 0.0 110.93 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.58 -45.3 83.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.406 1.003 . . . . 0.0 110.145 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -60.61 -45.33 94.42 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.256 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -57.87 -55.39 35.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.136 1.374 . . . . 0.0 109.021 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -55.09 -50.5 69.01 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.893 0.477 . . . . 0.0 111.52 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.45 -31.28 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.701 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -70.62 -27.88 64.42 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 121.52 -0.738 . . . . 0.0 111.656 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 59.9 mt-10 -60.23 -30.33 69.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.416 1.007 . . . . 0.0 110.643 170.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 mt -81.94 -47.6 12.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.657 0.662 . . . . 0.0 110.018 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -26.43 67.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.311 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -119.84 -33.63 3.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.764 0.711 . . . . 0.0 112.776 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.09 -40.09 2.08 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 p -157.27 140.41 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 118.649 0.659 . . . . 0.0 110.606 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 110.229 -0.719 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.29 139.82 29.0 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.47 137.54 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.171 2.581 . . . . 0.0 111.931 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.84 -16.64 60.85 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.02 -1.434 . . . . 0.0 112.44 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -71.12 153.99 42.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.505 2.153 . . . . 0.0 109.803 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.29 138.79 39.58 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.36 145.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -123.54 151.18 43.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 166.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -126.58 108.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.7 140.71 48.02 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.989 171.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -115.2 169.39 6.8 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.626 1.57 . . . . 0.0 107.45 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.63 -24.74 55.81 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.784 2.323 . . . . 0.0 115.316 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -141.71 3.99 1.69 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.108 0.963 . . . . 0.0 113.323 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -157.92 -160.89 0.96 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.633 1.173 . . . . 0.0 109.076 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -150.2 154.09 37.39 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -140.22 169.13 18.26 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.335 1.854 . . . . 0.0 107.283 -173.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -135.85 149.86 49.18 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.712 0.687 . . . . 0.0 110.42 -173.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.83 173.3 13.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.667 1.987 . . . . 0.0 108.11 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.57 133.69 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.6 136.98 38.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.57 0.57 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.87 -175.09 39.23 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.88 42.83 0.32 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 111.377 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 -33.27 0.25 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.87 -0.961 . . . . 0.0 113.109 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -89.57 153.26 20.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.464 1.632 . . . . 0.0 111.713 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.55 155.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.31 1.444 . . . . 0.0 109.665 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.46 136.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.29 173.05 16.26 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.724 -0.61 . . . . 0.0 110.645 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.23 147.21 28.14 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.97 165.86 22.14 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.491 1.917 . . . . 0.0 108.202 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.45 154.13 12.25 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.628 2.219 . . . . 0.0 112.174 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.538 0.697 0 C-N-CA 122.296 1.998 . . . . 0.0 110.923 174.772 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.025 0.44 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 172.85 14.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.983 0.913 . . . . 0.0 110.109 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.42 149.09 28.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 125.401 1.481 . . . . 0.0 107.101 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.17 129.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -128.22 167.98 16.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.564 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -124.72 129.61 50.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.87 160.52 43.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.46 130.37 40.52 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.25 -40.69 64.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.202 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -36.02 67.92 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.443 0.565 . . . . 0.0 111.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.67 -42.82 67.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.113 0.415 . . . . 0.0 110.038 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 t -66.13 -45.73 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.569 0.748 . . . . 0.0 109.522 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.92 -22.79 65.89 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.411 1.084 . . . . 0.0 112.015 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.67 -11.63 8.2 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.23 1.395 . . . . 0.0 113.483 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -49.36 -51.44 34.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.658 1.229 . . . . 0.0 110.722 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.79 -52.34 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.918 1.687 . . . . 0.0 110.184 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -159.69 173.76 15.57 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.458 1.903 . . . . 0.0 107.973 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -153.21 167.74 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.347 -0.846 . . . . 0.0 110.787 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.3 165.71 27.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.919 1.687 . . . . 0.0 108.327 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.84 128.8 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -158.1 63.94 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -55.94 128.55 35.74 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -69.19 -56.08 8.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.62 -166.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.49 45.59 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.645 1.178 . . . . 0.0 109.812 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.89 -10.55 4.11 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.294 -0.879 . . . . 0.0 112.89 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -86.61 -21.71 26.64 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.223 1.009 . . . . 0.0 111.037 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -113.15 -25.91 8.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.295 1.038 . . . . 0.0 111.162 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -143.03 -165.16 2.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.178 1.791 . . . . 0.0 109.435 -169.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m 57.64 62.69 5.21 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.408 1.483 . . . . 0.0 113.569 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -11.66 31.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.354 2.036 . . . . 0.0 113.934 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.99 132.64 94.68 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.954 1.301 . . . . 0.0 110.429 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.6 151.67 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.632 2.221 . . . . 0.0 110.978 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.39 -41.11 65.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.302 0.641 . . . . 0.0 111.102 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -52.31 -50.51 62.06 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 111.335 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -68.33 -38.52 81.6 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.29 0.636 . . . . 0.0 110.7 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.64 -49.58 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.47 -41.4 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.874 0.87 . . . . 0.0 109.375 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -55.32 -51.23 67.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.764 0.826 . . . . 0.0 109.185 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -62.31 -43.1 99.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.271 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.88 83.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.265 0.939 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.57 -15.27 55.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.178 0.591 . . . . 0.0 112.308 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -79.99 -21.31 43.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.106 0.962 . . . . 0.0 110.737 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -115.65 -5.08 12.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.492 0.717 . . . . 0.0 112.813 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.75 146.0 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.054 0.843 . . . . 0.0 109.835 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 -6.34 79.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.621 1.105 . . . . 0.0 112.967 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -79.26 155.23 28.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.114 1.457 . . . . 0.0 109.519 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.97 151.71 24.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.638 1.175 . . . . 0.0 108.966 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.59 147.04 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.141 1.376 . . . . 0.0 107.996 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.53 33.73 3.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.543 1.163 . . . . 0.0 110.492 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -130.91 158.17 40.95 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.514 1.926 . . . . 0.0 108.182 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.36 156.22 39.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.36 48.54 0.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.475 1.51 . . . . 0.0 111.454 168.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 p -65.71 158.86 26.38 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.831 -1.168 . . . . 0.0 108.597 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.2 m -51.48 -41.31 60.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.117 0.967 . . . . 0.0 111.095 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.32 -41.62 80.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.663 0.785 . . . . 0.0 111.374 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -72.08 -34.91 69.04 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.168 0.894 . . . . 0.0 111.102 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 68.9 m -66.82 -45.46 78.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.74 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.1 -44.12 87.51 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.125 0.57 . . . . 0.0 110.013 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -56.66 -55.13 37.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.788 1.235 . . . . 0.0 108.898 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.82 -48.19 82.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.07 -32.5 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.233 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -69.71 -32.49 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.138 -0.976 . . . . 0.0 110.37 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.98 -8.42 1.01 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 113.026 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.13 -48.47 3.04 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.237 1.415 . . . . 0.0 110.261 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -58.2 -36.07 72.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.386 0.674 . . . . 0.0 111.265 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -121.23 -7.47 9.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.354 1.062 . . . . 0.0 111.53 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.84 -10.03 63.9 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.821 -1.174 . . . . 0.0 112.243 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.27 139.44 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.155 175.006 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 CA--C 1.537 0.629 0 N-CA-C 111.613 -0.187 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -153.1 147.11 18.55 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.024 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.76 139.35 19.1 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.497 2.131 . . . . 0.0 111.284 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.98 60.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.915 1.245 . . . . 0.0 112.287 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.64 153.85 20.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.425 1.612 . . . . 0.0 110.987 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.77 143.43 36.12 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.92 124.82 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.72 152.96 18.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.82 116.03 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -171.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 111.71 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 -89.62 170.51 10.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.333 1.053 . . . . 0.0 108.244 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.22 -31.32 55.12 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.02 2.48 . . . . 0.0 115.841 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.79 16.15 1.24 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.291 1.037 . . . . 0.0 111.814 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -154.48 -158.78 0.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 108.999 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.29 157.35 44.92 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.99 -1.069 . . . . 0.0 109.879 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -128.82 169.08 14.99 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.964 1.705 . . . . 0.0 106.749 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -135.37 146.0 47.93 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.569 0.622 . . . . 0.0 111.7 -173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.54 171.97 15.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.168 1.787 . . . . 0.0 108.422 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.36 134.72 63.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.08 130.04 35.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.77 -14.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.81 168.64 34.99 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 -32.17 8.15 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -168.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.6 12.89 4.85 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.159 -1.356 . . . . 0.0 113.671 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -124.05 149.71 45.78 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.103 1.952 . . . . 0.0 112.175 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.86 159.46 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.181 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.43 140.33 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 167.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.25 171.92 18.97 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.771 0.429 . . . . 0.0 111.281 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.05 143.91 33.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 169.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 161.68 51.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.224 1.81 . . . . 0.0 109.149 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.01 148.39 58.36 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.661 2.24 . . . . 0.0 111.768 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.541 0.846 0 C-N-CA 122.965 2.443 . . . . 0.0 111.678 176.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.8 mttt . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.92 13.32 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.628 1.171 . . . . 0.0 108.758 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.0 159.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.26 134.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.43 166.9 22.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.377 1.071 . . . . 0.0 109.622 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -118.29 132.7 56.28 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -150.44 160.99 43.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.448 1.099 . . . . 0.0 108.617 -173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.09 126.8 30.33 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.62 -46.13 66.89 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.428 1.091 . . . . 0.0 110.632 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -65.2 -21.73 66.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.12 -41.6 20.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.686 0.676 . . . . 0.0 110.375 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.34 -41.17 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.367 0.667 . . . . 0.0 110.061 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.14 1.83 12.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.304 1.441 . . . . 0.0 113.756 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.01 -25.44 31.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.024 1.297 . . . . 0.0 115.175 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -57.72 -45.88 85.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.855 1.327 . . . . 0.0 112.338 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -164.04 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.669 0.788 . . . . 0.0 112.4 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -156.76 176.96 12.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.635 1.174 . . . . 0.0 109.292 -165.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -152.62 168.26 26.21 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.943 1.297 . . . . 0.0 108.417 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.41 157.8 37.61 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.254 0.622 . . . . 0.0 110.056 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.0 135.26 28.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -149.44 62.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -63.31 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.529 1.131 . . . . 0.0 110.655 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.41 114.06 0.63 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.001 1.721 . . . . 0.0 110.17 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m80 52.82 40.19 30.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.469 1.508 . . . . 0.0 113.255 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.88 -15.3 1.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 167.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -82.9 -20.19 35.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.206 1.802 . . . . 0.0 111.468 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -131.27 -18.78 2.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.047 0.939 . . . . 0.0 112.448 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -140.99 -167.92 2.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.418 1.487 . . . . 0.0 109.7 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m 57.3 68.82 1.85 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.228 1.411 . . . . 0.0 112.31 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.77 -16.47 37.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.429 2.086 . . . . 0.0 113.386 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -73.67 142.32 80.45 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.619 1.168 . . . . 0.0 110.005 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.93 154.07 53.04 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.29 1.993 . . . . 0.0 109.641 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.0 m -55.62 -34.85 65.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.846 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 p -52.91 -60.3 3.45 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.081 0.952 . . . . 0.0 110.82 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -61.32 -38.43 86.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.611 1.164 . . . . 0.0 111.503 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.06 -51.67 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.28 -44.22 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 109.231 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -42.8 89.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.051 0.541 . . . . 0.0 110.131 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -68.09 -45.79 72.78 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.569 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.3 -50.38 59.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.447 0.567 . . . . 0.0 110.855 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.16 -19.94 59.61 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -71.68 -28.35 63.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.984 1.266 . . . . 0.0 108.904 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 mt -88.54 -16.38 32.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.06 0.944 . . . . 0.0 111.869 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.92 129.43 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 119.65 1.114 . . . . 0.0 108.895 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.15 -3.37 86.85 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -84.2 164.1 19.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.604 1.702 . . . . 0.0 109.344 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -123.92 148.48 46.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.781 -168.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.56 161.13 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.234 1.014 . . . . 0.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.05 32.28 5.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.437 1.113 . . . . 0.0 111.561 -168.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -132.86 147.23 52.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.218 1.407 . . . . 0.0 109.265 170.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -67.92 166.02 16.51 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.787 2.035 . . . . 0.0 111.587 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 mt -69.51 127.55 33.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 167.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 73.1 p -144.22 151.58 39.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 166.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -36.33 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 122.168 -0.332 . . . . 0.0 110.915 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -71.76 -40.18 69.49 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.728 0.411 . . . . 0.0 110.567 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.6 -40.73 92.97 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.865 0.757 . . . . 0.0 110.239 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.4 m -64.82 -45.27 86.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.099 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.69 -45.02 93.36 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.182 0.447 . . . . 0.0 110.143 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -59.39 -50.21 74.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.586 1.154 . . . . 0.0 109.718 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -59.69 -52.41 65.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.102 0.41 . . . . 0.0 111.392 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -64.65 -32.5 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.895 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.24 -36.37 81.51 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.698 -0.626 . . . . 0.0 111.077 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.19 -46.5 62.17 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.242 1.017 . . . . 0.0 109.661 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.26 -46.26 70.93 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.158 0.583 . . . . 0.0 111.346 -177.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -76.98 -33.85 57.59 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.89 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -94.13 -48.26 6.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.028 0.376 . . . . 0.0 110.881 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.86 -51.41 0.6 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.17 128.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 CA--C 1.537 0.672 0 N-CA-C 111.259 -0.324 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -133.49 155.76 80.33 Favored Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 124.979 1.312 . . . . 0.0 108.973 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.31 131.74 18.62 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.363 2.708 . . . . 0.0 112.529 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.68 84.09 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.899 1.238 . . . . 0.0 113.036 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.37 143.74 48.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 120.288 2.044 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -71.84 131.27 42.79 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -114.96 145.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.91 143.7 49.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 117.04 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.07 138.27 43.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -117.19 167.21 11.28 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.379 1.472 . . . . 0.0 107.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.92 -24.9 33.47 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.018 2.479 . . . . 0.0 115.754 -174.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -141.4 4.85 1.81 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.191 0.996 . . . . 0.0 113.209 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -158.22 -158.25 0.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.976 0.91 . . . . 0.0 110.199 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -153.09 141.27 20.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -127.46 165.31 20.06 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.416 1.486 . . . . 0.0 107.607 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -128.95 145.94 51.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.352 0.524 . . . . 0.0 110.008 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 169.86 22.23 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.951 1.7 . . . . 0.0 108.531 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt -140.46 126.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 121.368 -0.832 . . . . 0.0 109.534 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -72.24 132.11 43.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.062 1.345 . . . . 0.0 110.015 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.55 166.55 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.24 1.416 . . . . 0.0 108.873 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.04 21.5 38.63 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.531 -0.731 . . . . 0.0 114.255 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t0 39.26 50.66 1.97 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.869 2.068 . . . . 0.0 113.514 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.1 -11.55 0.1 OUTLIER Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.925 -0.484 . . . . 0.0 113.546 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.17 170.62 7.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.696 1.198 . . . . 0.0 108.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.84 148.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.402 0.681 . . . . 0.0 109.639 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.56 136.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 171.67 18.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.413 0.551 . . . . 0.0 111.019 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 151.12 36.76 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 158.1 64.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.501 2.32 . . . . 0.0 107.676 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.47 153.95 71.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 110.938 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.539 0.752 0 C-N-CA 122.906 2.404 . . . . 0.0 111.703 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 CA--C 1.517 -0.327 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.79 13.1 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.823 0.849 . . . . 0.0 109.35 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -134.01 158.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.29 132.22 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -136.67 169.05 18.36 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.059 0.944 . . . . 0.0 109.79 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.59 133.02 54.56 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -148.55 161.19 42.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.209 1.403 . . . . 0.0 107.753 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.15 133.26 47.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.13 -43.83 74.49 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.684 0.674 . . . . 0.0 110.678 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -65.07 -21.58 66.84 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.81 -46.06 19.55 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.897 0.771 . . . . 0.0 110.238 171.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.03 -40.11 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 110.294 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.1 -20.73 59.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.964 1.305 . . . . 0.0 112.512 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.35 -12.5 25.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.59 1.091 . . . . 0.0 113.226 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.7 m -50.34 -48.93 55.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.119 . . . . 0.0 110.915 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -167.84 -61.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.264 1.826 . . . . 0.0 109.239 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -160.92 171.31 18.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.149 2.179 . . . . 0.0 107.126 -167.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -153.36 164.01 38.9 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.571 -0.706 . . . . 0.0 110.607 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -138.77 158.01 45.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.881 1.672 . . . . 0.0 109.851 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 130.93 40.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -148.8 70.86 1.12 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -69.12 88.3 0.42 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -64.93 119.84 11.45 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.21 53.06 9.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.794 1.638 . . . . 0.0 111.786 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -51.86 -20.66 2.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.987 1.315 . . . . 0.0 113.248 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.71 -27.12 31.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -100.64 -20.32 15.7 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.024 0.929 . . . . 0.0 111.339 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -129.93 -174.09 3.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.765 0.793 . . . . 0.0 112.7 -168.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 52.51 62.71 9.9 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.531 1.932 . . . . 0.0 113.919 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 -12.14 28.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.462 2.108 . . . . 0.0 113.732 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.97 142.74 97.56 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.424 1.089 . . . . 0.0 110.594 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.92 142.48 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.165 1.91 . . . . 0.0 108.944 167.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -54.21 -43.2 70.57 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.443 0.297 . . . . 0.0 111.401 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.71 -44.73 73.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.138 0.975 . . . . 0.0 112.1 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -63.32 -34.37 77.55 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 124.203 1.001 . . . . 0.0 111.591 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.5 -48.36 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.69 -47.22 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -44.61 81.87 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.412 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -60.71 -52.98 62.79 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.294 0.952 . . . . 0.0 109.367 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.36 60.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.664 0.386 . . . . 0.0 111.189 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.82 -16.69 50.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.6 -29.02 56.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 119.904 1.229 . . . . 0.0 109.073 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.57 -11.71 44.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.972 0.909 . . . . 0.0 111.852 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -56.13 129.88 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.592 1.087 . . . . 0.0 108.925 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.29 -0.04 89.89 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.403 -1.221 . . . . 0.0 112.984 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -86.57 166.01 15.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.292 1.546 . . . . 0.0 109.4 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -120.55 149.51 42.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.319 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.17 147.16 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.706 1.202 . . . . 0.0 108.221 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.72 39.8 1.62 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.731 1.253 . . . . 0.0 111.153 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -141.08 149.72 41.99 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.469 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -60.28 148.54 36.37 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.947 1.299 . . . . 0.0 110.187 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 54.24 0.28 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.758 1.623 . . . . 0.0 113.266 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.8 p -64.26 161.69 16.12 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.655 -1.278 . . . . 0.0 109.206 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.56 -44.67 62.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.128 0.971 . . . . 0.0 110.309 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.67 -41.33 75.63 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.84 0.856 . . . . 0.0 110.893 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.42 -29.02 65.51 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.143 0.883 . . . . 0.0 111.294 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.7 m -69.87 -42.52 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.223 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.16 -43.98 95.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.346 0.521 . . . . 0.0 110.021 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -57.15 -58.23 9.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.032 1.733 . . . . 0.0 109.493 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.39 -54.88 30.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.754 0.421 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.02 -27.37 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.405 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -70.24 -29.4 66.19 Favored 'General case' 0 C--N 1.338 0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 111.144 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.0 -23.47 63.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.445 1.02 . . . . 0.0 112.094 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.88 -47.78 7.66 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.62 1.1 . . . . 0.0 110.115 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -86.54 -45.59 10.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.451 0.568 . . . . 0.0 112.221 -172.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -83.46 -48.32 10.44 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.54 -25.14 3.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.033 0.825 . . . . 0.0 111.634 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.42 149.91 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.38 169.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo . . . . . 0 CA--C 1.533 0.475 0 N-CA-C 111.259 -0.324 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.29 146.88 34.89 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.98 140.12 24.53 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.693 2.262 . . . . 0.0 110.983 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.36 -10.83 71.04 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.1 1.333 . . . . 0.0 112.313 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.89 156.09 23.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.31 2.055 . . . . 0.0 110.652 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.1 139.02 41.15 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.06 141.85 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.53 151.54 39.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -122.79 110.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.86 100.69 2.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -80.33 166.47 39.8 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.273 1.029 . . . . 0.0 108.919 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -51.01 -30.81 32.32 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.478 2.785 . . . . 0.0 116.379 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -145.55 14.71 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.094 0.957 . . . . 0.0 112.213 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -155.81 -159.2 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.892 1.277 . . . . 0.0 108.717 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.4 159.5 43.62 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.773 -1.204 . . . . 0.0 109.938 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -132.37 168.0 18.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.929 1.291 . . . . 0.0 107.612 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -137.37 147.27 45.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.804 0.729 . . . . 0.0 110.694 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.37 174.83 14.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.988 1.715 . . . . 0.0 108.569 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.18 131.64 58.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.66 130.09 41.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.098 1.359 . . . . 0.0 108.795 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.84 165.3 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 109.065 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.51 -158.36 18.25 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.91 -29.53 55.74 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.942 -0.74 . . . . 0.0 112.221 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.99 26.97 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.896 0.76 . . . . 0.0 113.359 -173.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -100.58 170.55 8.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.141 0.97 . . . . 0.0 109.394 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.72 153.28 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.229 0.612 . . . . 0.0 109.635 168.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.88 137.72 29.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.12 169.03 25.12 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.983 -0.448 . . . . 0.0 110.932 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.57 138.7 34.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.13 160.07 56.45 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 125.076 1.351 . . . . 0.0 109.536 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.88 145.16 24.98 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.328 2.685 . . . . 0.0 111.757 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 121.857 1.705 . . . . 0.0 111.554 -176.188 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 C--O 1.235 0.326 0 CA-C-O 121.199 0.523 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.41 169.09 18.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.185 1.394 . . . . 0.0 108.128 166.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.78 146.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 t -85.51 122.25 38.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -127.25 165.82 18.93 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.309 1.044 . . . . 0.0 109.715 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -125.69 131.29 52.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -148.38 163.57 36.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.014 1.326 . . . . 0.0 107.787 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.69 140.18 58.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.14 -42.7 73.4 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -60.46 -29.77 69.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.964 0.906 . . . . 0.0 112.062 -173.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.43 -40.07 27.02 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.21 0.459 . . . . 0.0 110.838 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.68 -37.59 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.335 0.654 . . . . 0.0 109.826 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.54 30.7 0.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.026 1.731 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.81 -23.58 30.5 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.072 0.844 . . . . 0.0 112.918 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 -4.54 5.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.887 1.675 . . . . 0.0 113.654 171.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.4 t70 61.49 16.46 7.59 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 114.576 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -149.46 124.62 10.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.888 1.675 . . . . 0.0 108.739 -169.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -164.8 164.31 21.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -155.77 161.56 40.65 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.599 0.76 . . . . 0.0 110.865 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.61 138.17 22.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -145.85 66.18 1.21 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.31 0.576 . . . . 0.0 109.935 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.38 131.78 38.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 122.896 0.478 . . . . 0.0 110.469 169.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -103.77 3.02 33.61 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' ASP . 75.7 m-70 -132.2 23.5 4.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.847 0.859 . . . . 0.0 112.088 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.07 21.31 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.044 -1.035 . . . . 0.0 112.593 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' HIS . 37.9 t70 -127.36 -9.33 5.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 111.611 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -127.6 -31.85 2.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.084 1.354 . . . . 0.0 111.609 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 66.21 134.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 128.605 2.762 . . . . 0.0 115.728 173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -61.0 136.76 93.79 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.914 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.43 -16.76 34.78 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.599 2.199 . . . . 0.0 111.862 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.08 125.38 35.4 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 108.235 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.17 154.63 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.812 2.341 . . . . 0.0 111.374 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.26 -38.86 69.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.327 0.651 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -54.96 -53.15 59.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.905 0.882 . . . . 0.0 110.498 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.81 -34.78 78.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.161 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.8 -50.83 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.061 0.846 . . . . 0.0 108.889 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.29 -45.6 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 123.536 0.734 . . . . 0.0 109.112 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -64.37 -46.56 82.84 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.85 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.29 -51.92 55.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.692 0.678 . . . . 0.0 110.405 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.82 -21.72 59.13 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.7 mt -99.14 -4.13 32.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 112.476 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.75 150.71 8.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.341 1.056 . . . . 0.0 109.344 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.67 53.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.313 -0.715 . . . . 0.0 112.269 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -124.06 159.98 28.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.585 1.154 . . . . 0.0 108.071 171.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -109.6 153.45 24.17 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.312 1.445 . . . . 0.0 109.53 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.07 152.29 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.374 1.47 . . . . 0.0 107.353 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.58 8.22 44.62 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.835 0.454 . . . . 0.0 112.224 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -95.42 147.11 23.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -74.12 162.87 28.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.446 1.098 . . . . 0.0 111.799 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.08 125.33 23.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.6 p -145.75 154.53 42.15 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 167.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.1 m -55.94 -34.37 65.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.817 0.447 . . . . 0.0 111.206 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.97 -38.61 44.72 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.451 0.701 . . . . 0.0 111.174 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -68.24 -35.77 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.528 1.058 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -66.34 -47.7 72.64 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -56.27 -44.63 79.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.319 1.048 . . . . 0.0 110.377 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -57.73 -56.79 17.43 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.018 1.327 . . . . 0.0 109.135 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.416 ' CE2' HD11 ' A' ' 120' ' ' LEU . 24.2 t80 -58.68 -48.1 82.24 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.1 -29.35 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.543 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -73.36 -30.53 63.37 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.712 0.687 . . . . 0.0 111.64 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.88 -37.9 80.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.305 0.957 . . . . 0.0 110.09 170.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 116' ' ' PHE . 73.0 mt -73.16 -50.14 24.27 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.683 0.674 . . . . 0.0 110.243 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -64.8 -26.37 68.31 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.066 0.946 . . . . 0.0 112.349 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.77 3.28 1.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -168.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.38 -32.52 5.44 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.853 -1.154 . . . . 0.0 111.876 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -155.39 146.63 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.023 1.329 . . . . 0.0 107.576 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.277 0.631 . . . . 0.0 110.727 172.306 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 CA--C 1.537 0.665 0 N-CA-C 113.421 0.508 . . . . 0.0 113.421 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.04 55.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 109.026 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.62 135.74 27.24 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.769 2.313 . . . . 0.0 111.646 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.18 -13.61 57.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.321 1.439 . . . . 0.0 111.714 -169.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.21 142.86 32.78 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.144 1.472 . . . . 0.0 111.312 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.18 140.55 45.2 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.31 129.19 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.08 147.65 25.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.49 103.68 12.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -168.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.45 141.64 57.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.06 168.61 13.01 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.503 1.521 . . . . 0.0 107.935 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.86 -27.96 17.06 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.512 2.808 . . . . 0.0 117.059 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -145.8 13.78 1.34 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.609 0.764 . . . . 0.0 112.021 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.32 -163.86 1.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.511 1.124 . . . . 0.0 109.475 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -144.11 159.72 42.15 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.214 -0.929 . . . . 0.0 109.931 173.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -131.2 170.69 14.23 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.613 2.365 . . . . 0.0 107.046 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.42 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 77.9 m95 -136.49 146.27 46.09 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.935 0.789 . . . . 0.0 111.448 -174.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.19 172.42 14.35 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.127 2.171 . . . . 0.0 108.046 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.8 tt -137.4 133.36 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.65 127.71 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.16 -3.96 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.03 -175.19 34.67 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.09 -28.09 66.18 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.87 0.835 . . . . 0.0 113.072 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.9 13.22 1.13 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.216 -1.324 . . . . 0.0 114.136 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -117.31 153.19 33.4 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.963 1.881 . . . . 0.0 111.516 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 m -132.16 155.05 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.061 1.345 . . . . 0.0 110.073 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.1 142.3 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 167.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.4 173.62 14.66 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.276 0.631 . . . . 0.0 110.73 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.6 141.72 33.45 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.62 157.95 66.85 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.54 1.936 . . . . 0.0 107.427 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 151.49 69.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.181 1.457 . . . . 0.0 110.51 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--N 1.349 0.553 0 C-N-CA 122.211 1.941 . . . . 0.0 111.367 175.133 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.9 168.91 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.594 0.712 . . . . 0.0 111.304 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 pt -147.11 154.97 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.918 1.687 . . . . 0.0 106.692 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.42 129.7 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -135.44 159.0 42.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.279 1.432 . . . . 0.0 107.954 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -127.38 131.25 50.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -151.54 163.36 39.21 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.784 1.233 . . . . 0.0 108.893 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.21 131.78 45.99 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.61 -40.87 66.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 110.963 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -61.92 -27.92 69.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.873 0.469 . . . . 0.0 111.638 -171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.71 -45.15 46.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.469 0.577 . . . . 0.0 110.402 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 t -64.17 -39.48 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.615 0.766 . . . . 0.0 109.757 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.64 -11.77 19.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.267 1.427 . . . . 0.0 113.169 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.16 -10.43 65.54 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.655 1.116 . . . . 0.0 113.071 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 -54.22 47.77 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.646 1.223 . . . . 0.0 112.339 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.23 -49.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.661 1.584 . . . . 0.0 110.145 169.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -166.73 -176.12 3.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.863 2.065 . . . . 0.0 107.673 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -152.02 165.45 34.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.54 1.064 . . . . 0.0 110.282 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -148.38 147.32 29.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.243 1.417 . . . . 0.0 109.089 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.03 132.01 33.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -149.83 73.04 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.5 101.96 1.07 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -59.23 124.52 20.24 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 m80 46.31 42.26 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 113.206 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -59.4 -10.82 3.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.562 0.745 . . . . 0.0 112.499 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.17 -17.87 26.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.971 2.109 . . . . 0.0 111.427 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -131.09 -16.83 3.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.074 0.95 . . . . 0.0 112.357 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.35 -161.07 1.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.186 1.794 . . . . 0.0 108.372 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 66.39 2.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.859 1.664 . . . . 0.0 112.953 -170.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.55 -22.18 58.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.571 2.181 . . . . 0.0 114.441 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.14 141.17 39.98 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 111.264 -168.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.15 161.85 39.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.64 2.227 . . . . 0.0 109.762 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 65.1 m -52.4 -40.96 62.74 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.634 0.774 . . . . 0.0 111.682 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.44 -54.23 43.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.293 0.637 . . . . 0.0 111.103 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.37 -37.98 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.337 1.055 . . . . 0.0 111.695 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.29 -49.26 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.39 -46.21 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.683 0.793 . . . . 0.0 108.861 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -43.89 86.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.085 0.554 . . . . 0.0 110.113 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.95 -50.73 69.66 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.23 67.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.562 0.345 . . . . 0.0 111.107 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.94 -20.84 55.65 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.213 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -69.0 -35.5 76.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.74 1.155 . . . . 0.0 109.486 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.38 -10.15 52.86 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.4 133.73 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.516 1.053 . . . . 0.0 109.063 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.0 -8.07 76.3 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.484 -1.176 . . . . 0.0 112.88 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -71.89 157.58 37.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.453 1.626 . . . . 0.0 109.264 171.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -126.58 144.23 50.96 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.44 146.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.055 0.942 . . . . 0.0 110.35 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.46 -9.87 42.97 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.228 -0.92 . . . . 0.0 112.924 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -75.67 154.61 36.41 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.556 0.616 . . . . 0.0 110.498 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -81.37 158.38 24.69 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.871 1.668 . . . . 0.0 110.022 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 108' ' ' LEU . 3.0 mm? -59.72 121.35 11.43 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.5 p -143.68 159.02 43.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -52.49 -45.33 66.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.799 0.44 . . . . 0.0 109.904 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.79 -46.34 79.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.939 0.896 . . . . 0.0 110.827 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -67.33 -41.41 85.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.65 0.659 . . . . 0.0 110.722 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.17 -41.62 81.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.265 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -61.1 -40.6 94.38 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.199 0.6 . . . . 0.0 110.394 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -63.82 -55.76 20.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 110.138 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 120' ' ' LEU . 7.0 t80 -57.59 -48.41 79.46 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.327 0.512 . . . . 0.0 110.883 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.4 -30.95 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.48 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -72.45 -25.55 61.49 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.422 -0.799 . . . . 0.0 111.817 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.35 -38.92 69.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.184 0.902 . . . . 0.0 110.319 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.403 HD11 ' CE2' ' A' ' 116' ' ' PHE . 11.4 mt -74.39 -43.42 56.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.355 0.662 . . . . 0.0 110.2 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 tpt85 -72.58 -31.98 65.65 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.527 -172.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -104.02 -36.46 7.73 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.037 0.535 . . . . 0.0 112.125 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.73 -37.17 3.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.972 1.273 . . . . 0.0 110.599 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.18 135.28 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 123.078 0.551 . . . . 0.0 110.71 -179.698 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 CA--C 1.534 0.483 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -83.91 144.09 44.24 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.07 129.33 24.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 109.745 169.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.83 3.86 67.93 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.308 0.956 . . . . 0.0 113.205 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.1 136.19 48.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.663 1.732 . . . . 0.0 110.216 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.48 138.04 54.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.92 133.5 66.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -104.65 146.37 29.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -127.48 115.35 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 -169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.35 140.21 46.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -128.66 167.72 18.31 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.982 0.913 . . . . 0.0 109.718 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.33 -26.79 36.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.19 2.593 . . . . 0.0 116.576 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -143.24 6.73 1.53 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.293 1.037 . . . . 0.0 112.942 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -160.97 -168.66 2.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.949 -169.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 7.1 ppt_? -136.24 161.03 36.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 121.65 -0.656 . . . . 0.0 109.44 169.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -137.09 169.09 18.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.343 1.857 . . . . 0.0 107.986 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.402 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 67.2 m95 -138.7 148.35 43.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.624 0.769 . . . . 0.0 110.591 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 174.97 11.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.321 1.848 . . . . 0.0 107.934 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.13 134.0 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.43 133.23 48.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.075 1.35 . . . . 0.0 109.009 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 m -139.0 165.8 23.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.123 0.969 . . . . 0.0 109.967 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.44 -121.07 18.72 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.354 -2.299 . . . . 0.0 107.354 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -146.06 51.24 1.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.52 -12.16 0.11 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.164 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.77 171.68 8.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.531 1.166 . . . . 0.0 109.101 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.23 157.35 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.194 0.998 . . . . 0.0 110.052 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.98 138.19 48.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 168.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 169.47 22.79 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.082 0.953 . . . . 0.0 110.396 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.85 140.46 32.89 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.52 163.66 23.31 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.672 1.189 . . . . 0.0 109.326 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.28 156.31 30.94 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.567 2.178 . . . . 0.0 112.134 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 123.034 2.489 . . . . 0.0 110.247 170.665 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.11 172.96 13.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.752 1.221 . . . . 0.0 109.108 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.12 150.26 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -83.21 132.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -137.23 164.9 27.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.291 1.436 . . . . 0.0 109.525 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -125.62 141.31 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -149.92 156.46 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.779 1.232 . . . . 0.0 107.923 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.57 137.47 52.4 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -52.06 -37.74 54.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -36.27 61.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.217 0.607 . . . . 0.0 112.147 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.92 -35.26 80.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.689 0.396 . . . . 0.0 111.315 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -86.67 -41.58 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.878 0.871 . . . . 0.0 109.017 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.42 -21.83 65.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.359 1.064 . . . . 0.0 112.725 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.14 -11.12 24.56 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.545 -1.142 . . . . 0.0 113.728 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.9 m -56.05 -55.49 32.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.956 1.378 . . . . 0.0 111.787 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -166.57 -60.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.323 1.449 . . . . 0.0 110.398 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -159.36 173.74 15.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.275 1.43 . . . . 0.0 108.765 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -162.63 160.53 25.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -154.56 162.58 41.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.622 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.62 138.75 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -152.39 73.75 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.436 0.694 . . . . 0.0 109.587 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.24 92.32 0.41 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.96 131.97 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 49.28 34.93 6.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.842 1.657 . . . . 0.0 113.336 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.98 -9.29 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.081 0.952 . . . . 0.0 112.773 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.98 -27.82 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.483 1.113 . . . . 0.0 110.628 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -127.87 -21.78 3.64 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -108.47 -160.07 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.504 1.522 . . . . 0.0 110.023 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 59.35 59.61 4.94 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.22 1.808 . . . . 0.0 112.517 -169.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.29 -13.2 38.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.0 1.8 . . . . 0.0 113.528 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.2 130.54 33.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.169 0.988 . . . . 0.0 110.673 -169.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 156.91 17.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.119 2.546 . . . . 0.0 111.302 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.06 -48.55 52.95 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.154 0.982 . . . . 0.0 111.28 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -57.34 -45.65 84.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.335 1.054 . . . . 0.0 111.966 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.5 -33.31 75.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.314 0.646 . . . . 0.0 111.313 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.79 -44.22 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.17 -45.19 99.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.644 0.656 . . . . 0.0 109.702 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -54.67 -44.39 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.517 0.727 . . . . 0.0 110.372 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -61.9 -52.01 65.82 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.095 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.98 78.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.654 0.661 . . . . 0.0 111.442 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -71.83 -25.64 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.907 1.283 . . . . 0.0 112.255 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.94 -20.2 42.54 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.436 1.095 . . . . 0.0 109.948 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.9 -13.98 12.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -167.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.37 146.11 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 120.089 1.313 . . . . 0.0 110.27 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 -4.17 84.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.964 1.269 . . . . 0.0 113.605 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.67 154.05 38.63 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.172 1.486 . . . . 0.0 108.779 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.43 147.59 27.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.62 151.49 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.764 1.225 . . . . 0.0 109.586 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.25 32.66 4.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.989 0.899 . . . . 0.0 111.462 -168.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -123.09 146.71 47.48 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.152 1.381 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -62.59 159.17 16.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.37 1.868 . . . . 0.0 112.316 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.9 121.85 16.01 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 165.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.7 p -142.62 156.34 45.06 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.5 m -51.37 -41.82 60.93 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.681 0.793 . . . . 0.0 110.814 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -72.46 -41.79 65.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.443 1.097 . . . . 0.0 111.368 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -40.3 85.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.2 0.909 . . . . 0.0 110.343 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.53 -45.52 79.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.016 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -56.75 -46.6 81.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.629 0.772 . . . . 0.0 110.111 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -59.14 -53.73 54.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.82 0.848 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.17 -48.62 80.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -64.35 -30.61 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.469 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -70.75 -29.12 65.27 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.663 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 72.3 mt-10 -61.33 -34.6 75.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.829 1.195 . . . . 0.0 110.489 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.5 mt -75.5 -46.64 31.14 Favored 'General case' 0 C--O 1.228 -0.036 0 CA-C-N 118.693 0.679 . . . . 0.0 110.23 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -64.33 -40.63 96.27 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 122.981 0.512 . . . . 0.0 110.96 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.22 -33.06 10.58 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.55 -42.12 1.92 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -168.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.93 135.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.21 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.458 -0.583 0 CA-C-O 121.804 0.668 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.43 144.78 50.6 Favored Pre-proline 0 N--CA 1.464 0.235 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.67 131.47 19.93 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.513 2.142 . . . . 0.0 110.718 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.04 27.43 7.82 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.678 1.132 . . . . 0.0 111.28 -168.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -123.19 148.0 46.26 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.701 1.751 . . . . 0.0 110.387 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.29 137.1 35.81 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.15 131.11 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.88 151.12 22.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mm -126.65 106.43 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.57 138.5 48.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.14 166.89 20.95 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.873 0.869 . . . . 0.0 109.169 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.51 -35.65 29.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.401 2.734 . . . . 0.0 116.174 -169.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -140.29 12.59 2.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.448 1.099 . . . . 0.0 112.065 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -160.18 -168.82 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.249 1.02 . . . . 0.0 110.179 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -138.07 153.91 49.29 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -135.28 170.55 15.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.4 1.88 . . . . 0.0 107.461 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.437 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 81.8 m95 -137.64 148.62 45.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.451 0.7 . . . . 0.0 111.515 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.28 171.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.142 1.777 . . . . 0.0 108.42 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.4 127.59 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -76.13 127.42 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.3 1.84 . . . . 0.0 108.306 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 34' ' ' VAL . 21.2 m -139.08 1.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 -172.29 22.18 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.94 -29.01 70.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.243 1.022 . . . . 0.0 112.479 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.14 11.2 1.03 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.555 1.074 . . . . 0.0 113.268 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.92 153.11 23.01 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.037 1.419 . . . . 0.0 110.733 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.53 154.34 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 109.831 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 28' ' ' VAL . 4.9 t -105.31 141.78 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 167.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.38 169.78 22.39 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.866 -0.521 . . . . 0.0 110.724 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.52 138.51 34.28 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.95 164.84 31.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 108.104 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.58 155.7 51.7 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.781 1.654 . . . . 0.0 110.824 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 N--CA 1.454 -0.832 0 C-N-CA 122.27 1.98 . . . . 0.0 110.806 -178.361 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 pttt . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.75 169.18 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.17 1.388 . . . . 0.0 109.123 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mt -135.82 144.12 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.94 121.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 163.03 19.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.467 1.507 . . . . 0.0 108.109 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.43 128.73 44.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -149.89 160.09 43.86 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.408 1.083 . . . . 0.0 108.642 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.56 133.9 49.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -54.69 -40.91 69.61 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.58 0.752 . . . . 0.0 111.902 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -61.03 -29.9 70.0 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.663 0.385 . . . . 0.0 111.898 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.55 -46.02 41.71 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.209 0.459 . . . . 0.0 110.277 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.14 -42.33 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.753 0.821 . . . . 0.0 109.908 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 -6.56 52.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.236 1.415 . . . . 0.0 113.28 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.27 -10.46 52.76 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.414 -0.659 . . . . 0.0 113.395 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 p -60.94 -43.75 98.21 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.76 1.224 . . . . 0.0 112.181 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -159.3 -58.56 0.07 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.296 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -166.05 -174.42 2.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.578 1.551 . . . . 0.0 108.853 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -154.64 167.87 28.68 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.201 1.001 . . . . 0.0 109.383 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -155.54 156.8 35.79 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.805 0.842 . . . . 0.0 109.958 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.04 138.77 21.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -148.22 71.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -68.58 81.7 0.27 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.22 1.008 . . . . 0.0 108.547 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -56.81 125.65 23.38 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 47.04 44.88 15.46 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.675 1.59 . . . . 0.0 112.528 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.76 -13.96 1.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 170.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.59 -15.61 25.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.159 1.383 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -123.6 -19.92 5.68 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.194 0.998 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -140.48 -167.65 2.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.111 1.364 . . . . 0.0 109.643 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m 52.15 60.38 13.51 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.91 1.284 . . . . 0.0 112.247 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.9 -12.54 34.7 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.395 2.064 . . . . 0.0 113.9 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.07 133.57 83.68 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 124.175 0.99 . . . . 0.0 110.72 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.55 145.46 69.36 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.201 1.934 . . . . 0.0 108.881 166.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.4 m -55.0 -39.38 69.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -170.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 p -54.88 -44.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.502 1.121 . . . . 0.0 112.14 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -63.5 -32.09 73.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.646 0.778 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.53 -46.09 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.0 -49.03 84.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -55.66 -43.24 76.12 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.866 0.867 . . . . 0.0 110.857 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -60.17 -55.65 31.2 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.83 -41.38 67.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -74.29 -24.89 59.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.369 1.068 . . . . 0.0 112.027 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -81.13 -23.05 38.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.704 0.683 . . . . 0.0 110.505 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.16 -22.79 13.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.43 -167.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.16 144.6 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.998 1.272 . . . . 0.0 109.066 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.63 34.86 62.79 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -132.06 160.54 35.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.84 150.94 42.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.071 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.88 142.01 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 108.304 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.2 mt -99.78 52.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.022 1.391 . . . . 0.0 110.446 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.71 150.96 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.256 -1.793 . . . . 0.0 108.347 169.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -70.18 164.12 24.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.032 0.933 . . . . 0.0 112.057 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.16 119.45 11.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.2 p -140.44 154.41 46.64 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 m -54.71 -40.22 69.0 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.944 0.498 . . . . 0.0 110.402 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.95 -41.78 77.56 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.749 0.82 . . . . 0.0 111.229 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.99 -39.15 87.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.082 0.856 . . . . 0.0 110.237 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.3 m -68.9 -44.23 73.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.907 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.45 -47.11 79.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.986 0.914 . . . . 0.0 109.91 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -58.38 -53.08 62.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.973 0.909 . . . . 0.0 109.363 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.23 -49.83 75.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.18 0.446 . . . . 0.0 111.678 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 -34.2 65.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.392 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -66.64 -38.47 86.98 Favored 'General case' 0 C--O 1.225 -0.209 0 O-C-N 121.889 -0.507 . . . . 0.0 110.361 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -56.24 -35.86 67.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.375 1.07 . . . . 0.0 111.86 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.15 -45.72 32.17 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.968 0.803 . . . . 0.0 110.922 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -78.09 -43.28 29.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.823 0.738 . . . . 0.0 111.937 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -75.77 -40.75 54.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.911 0.484 . . . . 0.0 110.838 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 116.02 -37.42 3.43 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 128.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 105.049 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.893 174.577 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.46 -0.479 0 CA-C-O 121.181 0.409 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -76.6 146.19 76.46 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.45 130.66 21.98 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.722 2.282 . . . . 0.0 110.163 168.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.99 -14.99 63.31 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 117.743 -1.587 . . . . 0.0 113.875 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -69.04 152.98 44.54 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.899 2.349 . . . . 0.0 111.82 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.07 139.28 38.15 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -119.92 145.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.87 149.93 41.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 mm -126.42 97.26 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 -168.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.4 143.43 57.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 174.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.48 168.25 18.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.356 1.062 . . . . 0.0 108.911 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.25 -32.88 52.57 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 115.904 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.64 3.34 2.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.94 -161.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.14 1.376 . . . . 0.0 108.504 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 147.79 36.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -117.68 167.47 11.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.466 1.906 . . . . 0.0 108.399 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.17 148.05 49.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.556 0.742 . . . . 0.0 110.304 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.54 172.94 14.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.237 1.415 . . . . 0.0 109.221 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 tt -132.62 128.61 57.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.14 133.07 45.93 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 109.278 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.01 165.68 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.637 1.175 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.66 -126.88 41.02 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -169.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -144.87 53.28 1.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 -8.53 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.783 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -103.72 168.06 9.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.694 1.247 . . . . 0.0 109.278 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.45 151.93 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.063 0.945 . . . . 0.0 109.546 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.86 141.38 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 168.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -163.6 171.59 15.53 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.271 0.629 . . . . 0.0 111.123 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.91 150.06 36.0 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.98 159.21 40.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.76 1.624 . . . . 0.0 108.408 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.0 159.78 40.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 121.474 1.449 . . . . 0.0 109.921 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 C-N-CA 123.549 2.833 . . . . 0.0 113.605 -178.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.5 178.84 9.14 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 108.879 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 pt -145.88 166.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.143 1.777 . . . . 0.0 107.167 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.67 139.79 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -133.69 172.41 12.8 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.566 1.546 . . . . 0.0 109.378 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.38 142.1 50.53 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 125.204 1.402 . . . . 0.0 107.415 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -151.04 159.61 44.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.292 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.86 137.74 55.52 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.86 -41.64 67.7 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.217 0.917 . . . . 0.0 111.669 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -64.86 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.88 -25.84 61.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.858 0.753 . . . . 0.0 111.437 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.66 -36.48 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.873 1.269 . . . . 0.0 109.918 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.5 62.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.536 1.534 . . . . 0.0 113.28 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.42 37.42 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.762 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -53.04 -48.09 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.696 1.248 . . . . 0.0 111.799 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -166.33 -54.29 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 125.881 1.672 . . . . 0.0 109.27 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -166.92 178.79 5.6 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.498 1.919 . . . . 0.0 107.732 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -154.14 165.86 34.9 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.386 -0.821 . . . . 0.0 109.314 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -155.67 158.63 38.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.919 0.888 . . . . 0.0 110.377 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.17 136.65 25.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -149.68 66.94 1.0 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.186 0.517 . . . . 0.0 110.498 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.64 119.14 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -67.8 -11.68 59.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' ASP . 92.5 m-70 -129.27 29.14 5.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 111.621 -169.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.54 21.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.887 -1.133 . . . . 0.0 112.685 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' HIS . 34.8 t70 -130.49 -5.81 4.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.948 2.099 . . . . 0.0 111.351 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.88 -31.2 1.32 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.965 1.306 . . . . 0.0 111.905 -169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 66.65 150.68 0.06 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 128.292 2.637 . . . . 0.0 117.848 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -40.11 109.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.876 2.87 . . . . 0.0 113.94 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 -15.9 18.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.505 2.803 . . . . 0.0 111.812 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.22 138.24 24.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 126.671 1.988 . . . . 0.0 106.698 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 157.28 62.21 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.527 1.485 . . . . 0.0 109.391 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.76 -39.93 62.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.323 0.649 . . . . 0.0 111.557 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 m -54.07 -48.43 70.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 111.393 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.7 -35.89 77.76 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.563 -0.71 . . . . 0.0 111.526 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.29 -49.08 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.186 0.903 . . . . 0.0 108.618 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.09 -38.62 78.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.124 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -55.83 -45.11 78.42 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.387 0.675 . . . . 0.0 110.067 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.3 -48.81 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.477 0.581 . . . . 0.0 109.859 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.31 -42.15 66.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.705 0.684 . . . . 0.0 111.813 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -78.52 -19.17 53.55 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.312 -175.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.96 -29.79 26.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.193 0.906 . . . . 0.0 110.021 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.5 mt -96.68 -24.26 16.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.312 -168.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.45 132.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.785 1.175 . . . . 0.0 109.637 171.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.09 -4.87 82.07 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.55 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.45 159.79 25.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.779 1.789 . . . . 0.0 109.3 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -104.1 154.33 19.85 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.488 0.715 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.97 -175.98 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.993 1.317 . . . . 0.0 108.31 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.09 11.04 6.46 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.712 0.805 . . . . 0.0 112.842 -169.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.8 153.16 45.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 109.538 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -71.75 161.21 31.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 111.863 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.27 131.28 46.87 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.5 p -145.81 159.06 43.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 m -55.34 -39.3 69.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.126 0.421 . . . . 0.0 110.213 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.7 -47.48 66.32 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.126 0.571 . . . . 0.0 111.184 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.86 -40.39 87.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.679 0.672 . . . . 0.0 110.82 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.05 -42.46 76.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.774 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -58.97 -44.34 91.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.695 0.679 . . . . 0.0 110.395 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -56.6 -53.72 54.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.879 1.271 . . . . 0.0 109.06 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -60.18 -54.04 50.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.185 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -62.34 -28.22 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.921 0.782 . . . . 0.0 111.081 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -70.28 -32.77 70.72 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.411 -0.806 . . . . 0.0 111.718 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.3 -25.16 63.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.814 0.734 . . . . 0.0 111.321 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.22 -52.95 4.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -60.1 -37.56 80.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.556 1.142 . . . . 0.0 112.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -136.88 9.95 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.231 0.957 . . . . 0.0 111.676 -167.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.0 -29.92 5.72 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.772 -1.205 . . . . 0.0 112.55 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.0 145.58 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.01 1.724 . . . . 0.0 108.336 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.014 0.926 . . . . 0.0 111.064 169.041 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 CA--C 1.536 0.579 0 N-CA-C 111.245 -0.329 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -131.7 145.93 59.64 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.15 0.98 . . . . 0.0 108.424 168.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.23 128.19 19.38 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.465 2.11 . . . . 0.0 111.037 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.99 -10.26 27.24 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.976 1.75 . . . . 0.0 112.141 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.9 135.86 34.32 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.006 1.403 . . . . 0.0 111.408 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.13 137.46 54.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -121.8 121.23 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.13 151.49 21.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.28 112.46 29.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 127.02 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.45 168.96 6.84 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 108.336 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -47.56 -33.19 17.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.052 3.168 . . . . 0.0 116.541 -170.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -146.87 17.35 1.25 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.897 0.879 . . . . 0.0 111.433 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -158.43 -160.64 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.408 1.083 . . . . 0.0 109.586 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 155.43 45.66 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -116.36 168.51 10.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -132.39 147.21 52.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.596 0.635 . . . . 0.0 111.159 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.29 174.7 11.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.237 1.815 . . . . 0.0 107.719 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.18 129.95 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -73.86 125.92 29.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 m -136.31 -10.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.59 167.11 28.67 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -55.37 -22.2 18.54 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -168.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -140.8 16.56 2.83 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.239 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -120.48 154.36 35.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.569 1.684 . . . . 0.0 111.976 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.47 158.17 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.553 1.141 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.87 143.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.0 174.45 13.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.154 0.982 . . . . 0.0 109.932 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.42 143.9 29.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 170.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.93 160.46 62.76 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.779 1.231 . . . . 0.0 108.994 171.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.42 156.86 20.11 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.274 1.982 . . . . 0.0 110.975 168.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 112.379 173.508 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.3 pttt . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.34 -179.82 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.09 153.73 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.33 139.08 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -139.87 159.64 41.73 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.221 1.409 . . . . 0.0 107.997 -169.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.03 136.52 49.48 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -152.5 159.91 43.28 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 108.63 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.38 132.88 49.31 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.8 -46.61 71.13 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.385 0.674 . . . . 0.0 111.261 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -67.26 -24.46 65.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.86 0.464 . . . . 0.0 111.33 -170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.32 -37.39 60.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.363 0.528 . . . . 0.0 111.011 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.53 -45.33 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.095 0.558 . . . . 0.0 109.56 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.97 64.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.073 0.549 . . . . 0.0 110.381 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.09 -128.83 31.09 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 m -72.26 -8.45 54.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.57 1.148 . . . . 0.0 113.874 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.21 -170.6 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.524 1.056 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -140.12 158.48 43.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.499 2.32 . . . . 0.0 106.084 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -156.61 163.26 39.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.845 -0.534 . . . . 0.0 110.31 -168.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.85 158.92 40.11 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.661 0.784 . . . . 0.0 110.432 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.37 134.31 30.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -149.74 66.57 0.99 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -61.42 118.88 7.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -55.26 -43.99 75.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.94 36.41 1.4 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.396 0.678 . . . . 0.0 111.337 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -58.79 -9.86 2.04 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.355 0.98 . . . . 0.0 112.686 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.61 -20.62 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.918 0.887 . . . . 0.0 110.336 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -114.15 -44.77 3.1 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.022 1.329 . . . . 0.0 110.23 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -155.48 159.0 39.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.719 0.808 . . . . 0.0 112.82 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -171.2 76.87 0.53 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 128.482 2.713 . . . . 0.0 105.096 167.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.55 -16.21 52.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.686 2.924 . . . . 0.0 113.885 -171.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.85 120.82 47.85 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 157.52 61.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.842 1.695 . . . . 0.0 108.904 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.9 m -47.48 -47.83 27.2 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.889 0.876 . . . . 0.0 112.505 -169.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -54.84 -43.94 73.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.637 0.775 . . . . 0.0 112.445 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.48 -33.61 76.07 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.596 -0.69 . . . . 0.0 111.187 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.2 mt -60.84 -48.95 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.29 -50.62 79.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -52.79 -47.05 67.84 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.424 1.089 . . . . 0.0 110.534 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -66.35 -49.72 65.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.57 -45.07 73.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.494 0.588 . . . . 0.0 110.805 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.76 -30.57 71.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.467 1.507 . . . . 0.0 112.188 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -72.45 -28.83 63.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.598 0.759 . . . . 0.0 109.052 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.4 mt -91.95 -16.99 25.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.906 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 t -54.74 128.92 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.363 1.438 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.11 87.66 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.261 -1.3 . . . . 0.0 113.229 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -76.88 143.99 39.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.72 1.76 . . . . 0.0 108.491 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.01 151.4 23.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.756 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.22 146.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 109.18 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.08 1.92 52.87 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.588 -0.695 . . . . 0.0 112.769 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -92.76 155.03 17.94 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.592 0.757 . . . . 0.0 109.261 169.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -70.22 142.58 52.37 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -69.11 131.88 45.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.1 p -145.17 165.3 28.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.096 1.758 . . . . 0.0 106.38 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 m -50.53 -46.94 57.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.795 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.45 -40.22 73.86 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.133 -0.461 . . . . 0.0 111.618 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -71.55 -31.01 66.53 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.231 0.923 . . . . 0.0 110.959 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.1 m -69.87 -43.6 71.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.124 0.874 . . . . 0.0 109.926 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -59.91 -41.12 91.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.637 0.775 . . . . 0.0 110.149 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -59.84 -58.89 6.6 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 110.286 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.64 -49.84 73.8 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.09 -31.05 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 121.096 -0.241 . . . . 0.0 110.557 -170.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -70.14 -28.12 65.1 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.177 -0.952 . . . . 0.0 111.527 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -53.98 -31.5 51.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.764 0.711 . . . . 0.0 111.368 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.1 mt -80.78 -45.8 16.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.239 0.616 . . . . 0.0 110.408 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -74.79 -29.38 61.09 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.203 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -130.22 -5.18 4.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.04 -14.7 62.79 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.81 -1.181 . . . . 0.0 112.737 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -154.8 151.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.644 1.577 . . . . 0.0 106.984 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.198 170.593 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo . . . . . 0 CA--C 1.534 0.509 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -113.64 138.38 22.6 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.32 132.36 23.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.29 -21.16 35.97 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.138 1.352 . . . . 0.0 112.014 -170.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -67.44 144.26 55.83 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.448 1.624 . . . . 0.0 111.674 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.11 139.92 43.08 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.61 128.21 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.51 150.83 22.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 165.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.05 114.1 40.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 102.355 -3.202 . . . . 0.0 102.355 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.45 131.08 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -108.87 167.26 9.42 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -50.39 -28.58 21.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 115.901 -173.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.62 14.5 1.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.819 0.848 . . . . 0.0 112.102 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -156.78 -155.81 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.488 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 157.87 44.13 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.865 1.211 . . . . 0.0 109.331 174.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -127.75 168.84 14.54 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.236 1.814 . . . . 0.0 106.113 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -135.09 147.45 49.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.848 0.749 . . . . 0.0 111.673 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.67 173.0 14.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.37 1.868 . . . . 0.0 108.879 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.78 133.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -80.48 135.23 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.56 -2.68 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -170.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.37 -175.41 38.56 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -77.04 44.28 0.39 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.195 0.998 . . . . 0.0 111.743 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.35 -32.31 0.35 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.861 1.22 . . . . 0.0 112.532 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.9 152.94 23.19 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.793 1.296 . . . . 0.0 111.651 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.82 156.31 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.33 1.452 . . . . 0.0 109.273 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 140.05 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.47 170.77 21.0 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.044 0.538 . . . . 0.0 110.798 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.02 138.43 33.74 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.04 8.59 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.671 . . . . 0.0 108.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.0 152.6 36.01 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.537 2.158 . . . . 0.0 112.425 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 121.965 1.777 . . . . 0.0 111.213 170.348 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt . . . . . 0 C--O 1.235 0.308 0 CA-C-O 120.735 0.302 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 174.02 12.39 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.318 1.447 . . . . 0.0 109.765 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.35 146.13 29.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.0 t -82.57 130.95 34.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 163.94 28.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.176 1.39 . . . . 0.0 108.019 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -131.09 130.32 43.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.25 160.8 43.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 108.895 -173.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -73.01 130.46 40.38 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.94 -40.23 63.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.11 0.964 . . . . 0.0 112.627 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -35.98 67.81 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.832 0.453 . . . . 0.0 111.832 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.35 -38.14 71.63 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.299 0.5 . . . . 0.0 110.605 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.09 -46.86 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.819 0.848 . . . . 0.0 108.834 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -24.6 66.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.536 1.135 . . . . 0.0 112.102 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.69 -14.3 3.66 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.503 1.525 . . . . 0.0 113.835 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.5 m -48.81 -48.2 41.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.595 1.197 . . . . 0.0 111.51 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -168.58 -55.92 0.02 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.927 1.691 . . . . 0.0 109.636 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.18 -174.95 3.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.947 2.099 . . . . 0.0 107.695 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -149.06 168.14 23.95 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.43 -0.794 . . . . 0.0 109.563 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -146.11 153.69 40.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.116 0.967 . . . . 0.0 108.88 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -78.14 135.09 26.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 166.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -147.19 69.66 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -63.47 104.72 0.66 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -54.0 -51.13 64.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.726 1.211 . . . . 0.0 113.848 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -148.2 38.95 0.9 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.383 1.073 . . . . 0.0 111.264 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.32 -14.26 1.14 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.09 1.356 . . . . 0.0 113.214 169.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.97 -28.27 27.89 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.476 -0.765 . . . . 0.0 110.596 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -97.44 -34.26 11.08 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.583 -177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -148.51 156.85 42.99 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.305 0.642 . . . . 0.0 111.756 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -178.4 72.86 0.21 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 128.475 2.71 . . . . 0.0 107.491 168.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.9 -14.45 41.36 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.643 2.229 . . . . 0.0 113.372 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.66 121.08 30.13 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 124.911 1.284 . . . . 0.0 108.491 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.62 159.67 10.74 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.294 2.662 . . . . 0.0 111.492 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -50.09 -46.57 53.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.655 0.782 . . . . 0.0 111.269 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.62 -44.7 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.32 0.648 . . . . 0.0 111.754 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.42 -35.72 68.42 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.293 0.637 . . . . 0.0 111.237 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.418 HD13 ' HD2' ' A' ' 121' ' ' ARG . 55.6 mt -59.81 -49.87 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.5 -46.08 96.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -43.29 69.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.369 0.668 . . . . 0.0 110.338 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -51.05 64.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.79 -45.11 67.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.38 0.536 . . . . 0.0 111.213 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.01 -29.82 68.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.234 1.413 . . . . 0.0 112.127 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.38 -28.51 62.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.154 0.982 . . . . 0.0 109.192 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.78 -14.7 27.49 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.857 -1.068 . . . . 0.0 112.8 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.66 126.52 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 109.137 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.82 -1.22 88.04 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.453 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.21 159.93 21.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.629 1.715 . . . . 0.0 109.34 174.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -110.63 154.37 23.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.76 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.98 145.27 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.79 1.236 . . . . 0.0 107.755 169.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 tp -87.86 14.3 9.07 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.749 -0.595 . . . . 0.0 112.18 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -121.84 159.67 26.28 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.128 1.371 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -87.42 172.97 9.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.989 1.715 . . . . 0.0 113.501 -167.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.21 43.25 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.888 2.075 . . . . 0.0 112.477 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 p -70.18 148.19 48.95 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -55.21 -37.72 67.49 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.09 -0.381 . . . . 0.0 110.252 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -65.83 -40.44 91.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.445 1.098 . . . . 0.0 111.473 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -68.67 -36.98 79.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.054 1.297 . . . . 0.0 110.55 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.42 -45.43 79.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.2 -46.08 86.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.087 0.955 . . . . 0.0 110.086 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -56.47 -54.68 42.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.501 1.121 . . . . 0.0 109.052 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.59 -51.03 71.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.336 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.93 -33.47 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.22 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -68.45 -36.6 79.26 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.001 0.819 . . . . 0.0 110.713 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.72 -36.11 69.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.262 1.025 . . . . 0.0 111.421 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.0 mp -79.12 -45.05 20.78 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.066 0.848 . . . . 0.0 110.587 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.418 ' HD2' HD13 ' A' ' 92' ' ' ILE . 45.4 tpt85 -65.93 -33.61 76.23 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.915 0.886 . . . . 0.0 112.083 -175.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.51 5.51 4.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.871 0.868 . . . . 0.0 113.125 -170.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.18 4.0 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 120.793 -1.192 . . . . 0.0 112.124 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.32 138.49 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.122 0.569 . . . . 0.0 111.648 175.045 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 C--O 1.237 0.466 0 CA-C-O 120.664 0.193 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -138.22 148.28 59.13 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 109.941 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.18 131.9 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.904 2.403 . . . . 0.0 110.352 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.51 -20.82 31.66 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.011 1.767 . . . . 0.0 111.708 -172.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.45 145.51 52.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.687 1.743 . . . . 0.0 111.394 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.19 138.62 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.35 145.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -123.6 149.43 45.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 mm -125.57 124.15 66.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -168.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -73.76 134.53 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -132.16 163.99 46.37 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.437 0.695 . . . . 0.0 109.681 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.3 -21.19 61.79 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.696 1.597 . . . . 0.0 115.214 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -135.37 1.14 2.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.038 0.836 . . . . 0.0 113.01 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -166.49 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.525 1.53 . . . . 0.0 108.769 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.73 152.37 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -131.31 168.77 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 109.279 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -137.98 144.8 41.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.165 0.986 . . . . 0.0 110.279 -169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.7 14.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.791 1.636 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.23 131.54 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.15 131.39 39.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.085 1.354 . . . . 0.0 108.152 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.26 -20.65 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.52 43.97 0.94 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 119.265 0.938 . . . . 0.0 112.07 -168.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.68 38.21 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.16 1.784 . . . . 0.0 112.744 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.05 0.94 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.997 1.284 . . . . 0.0 110.536 -172.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -91.72 152.48 20.17 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.62 1.21 . . . . 0.0 110.766 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.19 160.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 126.1 1.76 . . . . 0.0 109.836 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.71 140.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.29 169.41 22.18 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.865 -0.522 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 143.02 31.32 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.52 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 108.122 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.99 155.3 65.23 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 N-CA-C 109.334 -1.064 . . . . 0.0 109.334 168.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo . . . . . 0 C--N 1.349 0.59 0 C-N-CA 123.175 2.583 . . . . 0.0 113.76 -178.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 173.4 11.87 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.414 1.486 . . . . 0.0 109.333 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -135.88 147.68 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.65 125.97 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -122.59 166.4 14.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.324 1.05 . . . . 0.0 109.282 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.2 124.48 39.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -150.32 163.83 37.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 108.938 -169.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -69.77 128.88 37.97 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.69 -45.34 70.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.344 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.66 -18.19 64.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -88.13 -43.88 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.746 0.703 . . . . 0.0 110.5 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.78 -40.43 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.066 0.946 . . . . 0.0 110.824 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.72 -2.08 57.1 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.255 1.422 . . . . 0.0 113.088 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.45 -18.49 37.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.934 0.778 . . . . 0.0 113.125 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -53.7 -43.47 68.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.473 1.509 . . . . 0.0 112.424 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -161.12 -69.03 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.058 0.943 . . . . 0.0 111.411 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -167.28 -176.39 3.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.374 1.87 . . . . 0.0 108.811 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -156.18 168.47 27.19 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.795 0.838 . . . . 0.0 110.684 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -151.52 159.82 43.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.941 0.896 . . . . 0.0 110.284 168.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.7 t -70.76 139.26 20.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -148.05 67.4 1.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.321 0.582 . . . . 0.0 109.582 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -57.78 117.33 4.14 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.3 -38.47 71.76 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.415 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -144.9 25.62 1.42 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 112.23 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.27 -1.55 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.872 1.215 . . . . 0.0 112.055 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -99.99 -6.78 25.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.392 1.477 . . . . 0.0 110.868 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -128.81 -32.08 2.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.749 1.22 . . . . 0.0 111.343 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -146.47 149.13 33.07 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.492 1.117 . . . . 0.0 110.97 -170.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.9 p -162.56 65.8 1.72 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.061 1.344 . . . . 0.0 109.255 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.93 -14.78 46.15 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.362 2.042 . . . . 0.0 113.02 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.4 125.66 22.59 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.992 1.317 . . . . 0.0 108.376 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.31 167.17 27.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.444 2.096 . . . . 0.0 109.951 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -47.05 -49.14 21.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.486 1.114 . . . . 0.0 111.904 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -54.08 -54.21 42.56 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.812 1.245 . . . . 0.0 111.811 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.55 -35.02 79.11 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.229 1.012 . . . . 0.0 111.608 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.2 mt -61.99 -44.98 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.721 1.146 . . . . 0.0 108.618 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -63.41 -49.07 84.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.02 -40.37 73.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.088 0.555 . . . . 0.0 110.427 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -63.48 -54.44 36.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.401 0.68 . . . . 0.0 109.447 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.48 -43.8 55.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.736 0.414 . . . . 0.0 111.262 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.16 -32.11 72.14 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.201 1.401 . . . . 0.0 111.768 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.94 -25.57 62.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.13 0.572 . . . . 0.0 110.806 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.21 -10.74 17.69 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.895 -1.05 . . . . 0.0 113.315 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 t -59.0 139.88 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 121.026 1.739 . . . . 0.0 109.509 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.25 -5.88 84.33 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.377 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -80.94 154.46 26.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.25 1.525 . . . . 0.0 109.087 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.491 1.116 . . . . 0.0 109.104 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.19 146.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.139 1.376 . . . . 0.0 107.898 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.29 49.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 123.089 1.423 . . . . 0.0 109.812 -171.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -135.24 148.23 49.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.671 168.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -70.03 165.2 22.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.61 118.95 11.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -140.28 155.48 46.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 m -54.61 -40.25 68.71 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.721 0.408 . . . . 0.0 110.315 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.47 -42.85 74.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.466 0.706 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -67.42 -39.37 85.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.824 0.738 . . . . 0.0 110.385 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.8 m -69.93 -44.04 70.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.35 -46.65 79.87 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.498 0.719 . . . . 0.0 109.887 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -57.69 -54.49 46.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.872 0.869 . . . . 0.0 109.196 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -57.81 -52.3 66.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.374 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.94 -31.42 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.487 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.12 -28.26 67.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.624 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.26 -42.88 96.28 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 119.465 1.03 . . . . 0.0 109.728 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.93 -40.31 75.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.014 0.825 . . . . 0.0 110.405 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -76.66 -40.64 48.39 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.199 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -122.7 15.48 10.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.06 -52.51 3.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.4 142.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.144 -0.455 . . . . 0.0 110.502 172.811 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 N-CA-C 111.417 -0.263 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -138.84 142.15 32.83 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 124.401 1.08 . . . . 0.0 109.093 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.97 133.15 14.48 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.183 2.589 . . . . 0.0 111.5 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.48 -25.34 12.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.051 1.786 . . . . 0.0 110.622 -169.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.75 136.64 56.5 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.183 0.991 . . . . 0.0 111.046 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.26 140.95 52.47 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.36 129.88 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.23 151.43 23.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.88 98.96 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 102.758 -3.053 . . . . 0.0 102.758 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.38 136.2 56.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -133.84 169.44 13.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.673 . . . . 0.0 110.526 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.95 -30.68 24.83 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.428 2.752 . . . . 0.0 117.134 -169.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -145.76 10.49 1.21 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.691 0.796 . . . . 0.0 112.635 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -163.78 -169.55 1.92 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.27 1.428 . . . . 0.0 108.618 -172.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 158.05 45.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -127.01 169.49 13.29 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -138.83 145.43 40.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.592 0.633 . . . . 0.0 110.681 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.13 174.46 12.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.924 2.09 . . . . 0.0 107.782 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.08 136.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -75.96 128.86 35.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.31 -15.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.19 168.5 33.06 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -50.21 -29.77 10.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -167.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.93 13.06 4.45 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.449 -1.195 . . . . 0.0 113.622 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -123.05 152.38 41.05 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.77 1.785 . . . . 0.0 111.928 -170.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -133.36 159.67 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.947 1.299 . . . . 0.0 110.594 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.52 136.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.23 168.71 26.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.351 0.661 . . . . 0.0 110.47 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.85 141.06 32.55 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 165.12 28.34 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 125.223 1.409 . . . . 0.0 108.812 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.4 151.76 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.977 2.451 . . . . 0.0 112.205 170.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 122.195 1.93 . . . . 0.0 110.364 179.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.44 172.19 13.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.582 1.553 . . . . 0.0 109.121 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.1 147.27 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.81 128.02 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 160.6 31.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.236 1.415 . . . . 0.0 108.481 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.55 124.67 41.78 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.6 165.03 35.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.389 1.076 . . . . 0.0 108.982 -169.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.16 132.86 49.45 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.763 0.825 . . . . 0.0 109.208 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.89 -45.38 71.08 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.609 0.764 . . . . 0.0 110.899 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -66.45 -19.6 65.83 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.032 -0.509 . . . . 0.0 112.25 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.84 -42.26 27.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.005 0.82 . . . . 0.0 110.167 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.38 -44.83 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.267 0.627 . . . . 0.0 110.099 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.47 18.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.359 1.064 . . . . 0.0 112.454 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.22 51.97 3.31 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.689 1.614 . . . . 0.0 110.649 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 p -140.51 -55.03 0.52 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.132 1.773 . . . . 0.0 107.692 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.41 -67.6 0.2 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 123.954 0.902 . . . . 0.0 111.486 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -155.25 176.12 12.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.195 0.598 . . . . 0.0 110.158 -168.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.65 164.68 37.88 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.724 0.81 . . . . 0.0 111.04 171.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -156.89 162.13 39.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.63 1.172 . . . . 0.0 110.227 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -71.17 142.52 15.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -153.58 76.61 1.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.173 0.589 . . . . 0.0 109.599 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -70.8 81.34 0.63 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -56.12 129.23 39.16 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.939 -0.475 . . . . 0.0 110.34 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 m80 62.45 19.46 11.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.878 2.071 . . . . 0.0 115.213 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.58 -6.2 1.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.997 0.817 . . . . 0.0 111.848 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.95 -25.25 48.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.249 1.02 . . . . 0.0 110.703 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.18 -27.56 1.8 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -140.87 141.94 34.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.816 0.735 . . . . 0.0 112.101 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -162.03 69.03 2.22 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.251 2.621 . . . . 0.0 107.554 171.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.22 -14.44 40.53 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.665 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.9 mt -122.58 126.08 26.25 Favored Pre-proline 0 C--O 1.235 0.307 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.12 162.3 42.78 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.3 2.0 . . . . 0.0 109.307 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.2 p -49.02 -45.99 43.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.892 0.877 . . . . 0.0 112.573 -171.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -53.11 -45.79 68.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.031 0.932 . . . . 0.0 112.352 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -66.51 -31.75 72.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.622 0.769 . . . . 0.0 111.549 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -64.49 -46.93 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.096 0.862 . . . . 0.0 108.815 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.36 -47.68 87.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -56.09 -43.16 77.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.802 0.841 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.7 -47.93 81.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.046 0.384 . . . . 0.0 110.168 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.23 92.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.841 -0.537 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -70.38 -20.59 62.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.264 1.425 . . . . 0.0 112.351 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.26 -28.95 38.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.34 1.056 . . . . 0.0 109.052 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.49 -20.98 13.31 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.611 -169.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 p -52.24 133.18 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 120.498 1.499 . . . . 0.0 109.779 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.78 -5.22 84.42 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.271 -1.294 . . . . 0.0 113.446 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -84.28 164.56 18.95 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.762 1.781 . . . . 0.0 109.593 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -117.49 150.85 38.25 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.238 1.015 . . . . 0.0 109.208 -172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.3 144.32 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.185 0.994 . . . . 0.0 108.37 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.45 53.0 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 123.303 1.525 . . . . 0.0 109.479 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.92 147.9 37.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.434 -2.166 . . . . 0.0 107.908 168.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -65.06 166.15 9.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.109 1.364 . . . . 0.0 113.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.32 125.4 25.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p -145.18 159.03 43.63 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -51.68 -44.63 63.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.675 0.39 . . . . 0.0 110.658 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.11 -48.74 69.9 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.558 0.743 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -64.97 -39.86 94.12 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.267 0.94 . . . . 0.0 110.955 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.57 -43.31 73.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.402 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.32 -44.85 92.54 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.545 0.611 . . . . 0.0 110.105 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.42 -47.55 85.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.517 1.127 . . . . 0.0 109.684 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -58.41 -50.55 73.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.557 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.04 -30.76 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.923 0.783 . . . . 0.0 111.148 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -68.17 -30.88 70.1 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.244 -0.91 . . . . 0.0 111.237 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.2 -11.35 2.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.353 1.061 . . . . 0.0 113.267 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.05 -41.61 5.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.597 1.159 . . . . 0.0 110.174 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.806 0.73 . . . . 0.0 111.893 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.25 -11.45 10.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.013 0.925 . . . . 0.0 111.248 -173.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.09 -9.96 76.28 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.326 -0.859 . . . . 0.0 112.742 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -145.08 143.73 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.555 169.425 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 CA--C 1.537 0.646 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -115.31 153.83 47.49 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.22 1.408 . . . . 0.0 107.905 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.44 134.07 20.55 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.548 2.165 . . . . 0.0 110.484 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.22 7.32 88.57 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.789 -1.562 . . . . 0.0 113.055 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -81.19 149.38 29.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.339 2.57 . . . . 0.0 110.368 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.94 136.55 46.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -120.15 135.94 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.62 153.67 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -128.05 98.64 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 133.46 52.71 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.707 -0.62 . . . . 0.0 109.875 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.26 167.51 10.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.461 1.105 . . . . 0.0 109.11 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.28 -26.79 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.87 2.38 . . . . 0.0 115.175 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -140.59 2.8 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.345 1.058 . . . . 0.0 112.999 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -157.42 -152.43 0.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.445 1.098 . . . . 0.0 109.031 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 164.63 37.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -126.24 168.41 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -136.66 147.88 47.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.828 0.74 . . . . 0.0 111.479 -172.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.82 174.84 13.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.185 1.794 . . . . 0.0 108.726 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.41 132.06 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -74.67 134.54 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.206 1.002 . . . . 0.0 110.107 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.99 166.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.032 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.18 26.54 43.31 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.54 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.66 37.51 9.59 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.83 1.652 . . . . 0.0 113.28 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.63 -14.72 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 O-C-N 121.336 -0.852 . . . . 0.0 114.637 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.7 172.18 8.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.269 1.034 . . . . 0.0 109.016 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.29 161.54 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.399 0.68 . . . . 0.0 110.093 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -114.31 135.56 53.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.33 168.98 25.04 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.165 0.586 . . . . 0.0 110.902 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.55 139.27 33.95 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.26 46.09 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.697 1.599 . . . . 0.0 109.233 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.87 158.92 40.26 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.078 1.852 . . . . 0.0 111.279 172.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 C-N-CA 123.143 2.562 . . . . 0.0 113.109 -177.408 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.32 173.09 12.57 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.996 1.718 . . . . 0.0 109.13 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -143.47 158.45 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -87.49 132.77 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.88 164.51 22.93 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 109.481 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -125.23 126.34 45.03 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.01 1.324 . . . . 0.0 108.301 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -68.38 135.56 51.97 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.593 -0.692 . . . . 0.0 109.275 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -43.67 75.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.872 0.76 . . . . 0.0 111.01 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -66.07 -19.37 65.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 -44.12 13.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.844 0.747 . . . . 0.0 110.228 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.32 -29.67 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.072 0.949 . . . . 0.0 111.281 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.97 -29.39 60.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.213 -0.899 . . . . 0.0 112.255 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.77 -109.49 0.64 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.86 1.219 . . . . 0.0 111.97 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -61.88 -0.49 0.48 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.645 1.978 . . . . 0.0 114.635 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t0 67.54 160.05 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 129.37 3.068 . . . . 0.0 114.152 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 96.98 129.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 131.63 3.972 . . . . 0.0 109.063 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -165.29 161.48 19.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.062 1.345 . . . . 0.0 108.959 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.1 156.75 42.97 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.332 1.453 . . . . 0.0 108.381 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.31 134.65 28.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -153.61 75.4 1.04 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.727 -0.608 . . . . 0.0 110.24 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.93 85.58 0.23 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.767 0.827 . . . . 0.0 108.883 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -62.25 125.09 22.67 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -171.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.49 44.37 13.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 126.474 1.91 . . . . 0.0 112.525 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.12 -18.87 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.18 -30.56 25.7 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.253 1.021 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -91.19 -34.42 15.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.781 0.832 . . . . 0.0 110.559 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.41 ' HB3' ' CD1' ' A' ' 122' ' ' TYR . 7.8 m-85 -80.48 175.7 10.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.965 0.888 . . . . 0.0 112.723 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -56.27 160.08 5.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.85 2.86 . . . . 0.0 113.786 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.77 -0.6 3.22 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.815 3.01 . . . . 0.0 115.68 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 mt -36.61 119.58 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.391 2.276 . . . . 0.0 112.638 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.94 151.01 35.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.057 2.504 . . . . 0.0 111.841 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.5 m -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.633 0.773 . . . . 0.0 111.104 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -51.34 66.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.854 1.261 . . . . 0.0 111.677 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.68 -34.95 76.64 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.979 0.912 . . . . 0.0 110.992 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.3 mt -65.13 -43.35 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.573 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.6 -48.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 120.017 1.28 . . . . 0.0 108.946 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -53.18 -47.39 68.89 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.627 1.171 . . . . 0.0 110.066 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -62.18 -50.56 71.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.945 0.498 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.44 78.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.834 0.454 . . . . 0.0 111.359 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -82.55 -11.18 58.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.24 0.616 . . . . 0.0 112.343 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.53 -21.89 35.23 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 109.783 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.08 -11.7 13.78 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.19 147.61 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.181 0.9 . . . . 0.0 109.832 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.01 -2.63 80.19 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.081 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -71.15 154.91 41.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.991 1.396 . . . . 0.0 109.174 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.92 148.9 29.02 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.01 178.27 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.397 1.079 . . . . 0.0 108.62 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.35 21.77 5.64 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.27 1.028 . . . . 0.0 111.167 -170.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -123.05 160.41 26.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.553 1.541 . . . . 0.0 109.735 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -75.2 169.01 18.88 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.54 43.59 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.343 1.857 . . . . 0.0 110.282 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 p -70.46 152.71 43.74 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.542 -1.349 . . . . 0.0 107.558 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -51.76 11.6 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 109.926 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.26 -37.59 83.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.712 1.605 . . . . 0.0 112.401 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -68.69 -39.13 80.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.346 1.43 . . . . 0.0 110.543 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.1 m -67.21 -44.81 78.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.73 -44.24 90.4 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.773 1.229 . . . . 0.0 110.573 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -58.79 -53.62 56.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.099 0.96 . . . . 0.0 109.486 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -46.96 87.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.06 -33.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.315 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.8 -33.52 74.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.184 0.902 . . . . 0.0 110.968 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -58.71 -33.74 70.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.202 1.001 . . . . 0.0 111.695 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.82 -52.98 7.57 Favored 'General case' 0 N--CA 1.458 -0.072 0 O-C-N 121.292 -0.88 . . . . 0.0 110.529 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -30.81 70.94 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.522 0.729 . . . . 0.0 111.395 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 84' ' ' TYR . 48.0 m-85 -135.03 9.2 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.66 -43.42 2.75 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.886 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.87 139.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.433 171.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -61.93 149.45 40.52 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.715 -0.615 . . . . 0.0 109.976 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.87 156.78 30.97 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 126.096 1.758 . . . . 0.0 108.221 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.87 175.34 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.381 2.054 . . . . 0.0 110.683 171.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 pt -125.15 76.88 67.74 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.78 -23.89 5.34 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.719 2.946 . . . . 0.0 113.058 -169.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.88 -53.91 10.92 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 117.617 -1.182 . . . . 0.0 112.432 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.15 160.93 28.36 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.801 2.334 . . . . 0.0 112.978 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -134.72 146.76 60.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 125.162 1.385 . . . . 0.0 107.636 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.17 133.55 15.17 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.538 2.159 . . . . 0.0 110.327 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.93 -8.76 50.52 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.239 1.399 . . . . 0.0 112.397 -169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.01 147.92 24.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.064 1.932 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.07 139.52 42.86 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.3 mm -118.12 146.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.32 153.09 35.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -129.17 103.15 8.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -168.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.575 171.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.33 169.38 7.52 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.819 1.648 . . . . 0.0 107.533 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -54.16 -28.18 50.28 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.947 2.432 . . . . 0.0 115.843 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -142.05 4.4 1.65 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.703 0.801 . . . . 0.0 112.92 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.4 -155.89 0.49 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.912 1.285 . . . . 0.0 108.465 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.66 170.02 19.66 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.51 1.05 . . . . 0.0 110.746 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -144.32 172.46 12.9 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.333 1.853 . . . . 0.0 109.352 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -137.42 146.92 44.97 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 -169.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.73 173.72 15.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.401 1.48 . . . . 0.0 108.892 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 117' ' ' VAL . 17.7 tt -139.2 133.86 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -77.09 132.05 38.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.07 -3.81 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.9 177.22 42.27 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.14 53.39 0.79 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.525 1.13 . . . . 0.0 111.484 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.87 -13.17 0.39 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.225 -1.32 . . . . 0.0 114.083 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -119.21 155.49 31.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.121 1.961 . . . . 0.0 111.834 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -134.39 156.01 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.85 1.26 . . . . 0.0 110.874 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.46 142.71 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.53 171.27 16.07 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.326 0.651 . . . . 0.0 110.284 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.37 148.62 28.16 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.44 158.99 65.03 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 125.426 1.49 . . . . 0.0 108.571 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.65 156.58 22.09 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.006 1.804 . . . . 0.0 110.419 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.67 103.83 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.882 2.388 . . . . 0.0 110.958 169.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -135.21 3.32 3.12 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.784 0.834 . . . . 0.0 112.907 -169.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -131.7 27.57 4.64 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.608 1.163 . . . . 0.0 109.871 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.62 -21.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.238 1.415 . . . . 0.0 112.915 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.18 147.15 28.1 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.63 41.07 2.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.358 0.98 . . . . 0.0 111.834 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 49.68 27.78 2.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.548 1.939 . . . . 0.0 113.436 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.67 23.33 0.41 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.228 0.918 . . . . 0.0 112.658 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.68 17.36 2.0 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.724 1.21 . . . . 0.0 111.528 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.71 169.03 23.74 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.976 1.711 . . . . 0.0 107.632 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 -8.71 2.37 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.922 1.289 . . . . 0.0 113.412 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.17 -30.53 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.524 -0.735 . . . . 0.0 110.73 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.4 ttt -62.45 -38.23 88.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.231 1.012 . . . . 0.0 110.443 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -79.35 -1.34 36.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.418 1.487 . . . . 0.0 112.136 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.2 36.36 6.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.412 1.885 . . . . 0.0 112.475 -170.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.7 tp -147.52 101.05 3.32 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -145.3 163.02 35.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -131.85 46.66 2.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 122.643 1.211 . . . . 0.0 108.79 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -132.47 163.17 29.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.677 1.591 . . . . 0.0 109.22 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.21 177.23 10.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.506 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 mt -134.83 147.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 t -88.58 125.94 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -135.17 165.57 25.09 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.246 1.018 . . . . 0.0 109.701 -168.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -125.69 139.11 53.82 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -151.95 160.85 43.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.859 1.264 . . . . 0.0 108.598 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.39 132.89 50.13 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -53.31 -43.91 67.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.531 0.732 . . . . 0.0 110.748 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -67.06 -19.19 65.63 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -75.6 -46.21 33.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.141 0.882 . . . . 0.0 109.906 169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.95 -39.21 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.489 0.715 . . . . 0.0 110.197 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.76 -20.15 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.315 1.446 . . . . 0.0 112.861 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.5 -11.92 37.2 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.176 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -51.46 -57.94 7.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.531 1.132 . . . . 0.0 111.009 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -165.79 -50.8 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.968 1.707 . . . . 0.0 110.132 169.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -159.41 173.0 16.9 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.022 1.729 . . . . 0.0 107.977 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -157.96 164.1 37.16 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.475 -0.766 . . . . 0.0 109.75 173.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -147.83 160.19 43.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.403 1.481 . . . . 0.0 108.367 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.67 135.22 26.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -154.09 75.06 1.0 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.65 0.659 . . . . 0.0 110.779 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.45 94.89 0.42 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -57.53 -23.29 49.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -136.95 21.97 3.05 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.738 1.154 . . . . 0.0 112.251 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.62 -4.72 1.0 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.481 1.491 . . . . 0.0 112.08 169.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.28 -9.89 53.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.669 1.187 . . . . 0.0 110.729 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -132.3 -41.14 0.99 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.011 1.324 . . . . 0.0 111.213 -169.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -153.05 162.19 41.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.179 . . . . 0.0 111.898 -169.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -178.78 72.16 0.2 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 129.286 3.035 . . . . 0.0 105.275 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -13.64 40.45 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.535 2.823 . . . . 0.0 113.986 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.86 138.64 24.14 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 124.572 1.149 . . . . 0.0 108.641 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.39 159.14 50.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.313 2.008 . . . . 0.0 109.823 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 63.2 m -51.24 -42.46 61.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.757 0.823 . . . . 0.0 111.502 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -53.66 -56.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.624 0.77 . . . . 0.0 111.194 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.7 -38.38 90.2 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.354 1.061 . . . . 0.0 111.718 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.84 -49.31 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.431 1.014 . . . . 0.0 108.692 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.29 -46.09 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.91 89.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.877 -0.582 . . . . 0.0 109.957 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -63.3 -48.0 79.92 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.925 0.784 . . . . 0.0 109.851 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.51 -52.26 60.2 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.321 0.509 . . . . 0.0 110.005 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.68 -19.93 58.79 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.78 -26.51 61.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.864 1.266 . . . . 0.0 109.048 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.76 -10.65 19.75 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.88 -169.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.47 144.52 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.399 0.999 . . . . 0.0 109.784 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.14 60.77 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.66 1.124 . . . . 0.0 112.979 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -86.46 158.42 19.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.798 1.299 . . . . 0.0 109.536 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -100.68 154.04 18.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -131.53 147.06 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.968 1.307 . . . . 0.0 107.89 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.33 42.09 1.2 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.788 1.28 . . . . 0.0 110.16 -168.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -139.87 147.79 41.16 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.692 1.597 . . . . 0.0 108.406 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.33 150.5 34.85 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.116 0.967 . . . . 0.0 110.917 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -77.23 56.28 1.29 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.177 1.391 . . . . 0.0 112.282 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -64.58 159.07 22.62 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.076 -1.015 . . . . 0.0 109.26 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.3 t -50.07 -45.03 52.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.42 -43.57 97.09 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.211 0.604 . . . . 0.0 111.476 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -71.71 -37.0 70.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.112 0.869 . . . . 0.0 111.142 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.3 m -67.87 -42.85 80.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.257 0.48 . . . . 0.0 110.159 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.45 -46.73 83.3 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.071 0.948 . . . . 0.0 109.643 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -58.06 -55.27 37.15 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.722 1.209 . . . . 0.0 109.771 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -58.39 -49.6 76.67 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.643 0.202 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 1.4 p -70.55 -30.59 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.819 -169.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -67.34 -33.28 74.91 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.472 -0.768 . . . . 0.0 110.398 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -55.99 -29.86 60.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.541 0.736 . . . . 0.0 112.194 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.15 -50.17 9.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.534 0.606 . . . . 0.0 110.354 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -71.17 -33.34 69.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.558 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.25 6.72 6.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.669 0.668 . . . . 0.0 112.601 -170.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.27 -24.56 7.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 119.113 0.869 . . . . 0.0 112.691 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.48 141.4 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 126.406 1.882 . . . . 0.0 107.914 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.793 168.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -66.99 -41.99 85.81 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.611 -0.68 . . . . 0.0 111.13 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.36 143.07 97.86 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.347 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.06 -20.49 25.17 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.3 2.0 . . . . 0.0 113.177 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.1 pt 37.02 55.63 3.37 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 126.395 1.878 . . . . 0.0 111.808 -172.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -80.44 175.62 10.0 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 123.725 2.95 . . . . 0.0 109.747 -169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.05 67.94 73.98 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.43 159.03 46.1 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.077 2.518 . . . . 0.0 112.182 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.35 148.43 67.91 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.32 1.448 . . . . 0.0 107.594 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -47.51 129.15 16.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.582 2.188 . . . . 0.0 110.088 170.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.64 -6.16 35.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.933 1.254 . . . . 0.0 112.297 -171.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.35 150.8 22.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.385 2.092 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.3 mt -77.66 142.53 38.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.13 146.08 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -129.05 146.78 50.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 167.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.6 mm -115.83 93.78 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 102.967 -2.975 . . . . 0.0 102.967 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.8 135.04 51.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -128.21 172.41 6.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.055 1.342 . . . . 0.0 110.074 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -48.33 -34.88 26.21 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.454 2.77 . . . . 0.0 116.733 -169.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -139.75 7.98 2.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.699 0.8 . . . . 0.0 112.721 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -162.58 -169.0 1.97 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 109.121 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.17 156.82 45.88 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.166 -0.959 . . . . 0.0 109.216 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -119.76 169.08 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.471 1.508 . . . . 0.0 107.609 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -132.87 146.0 51.43 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.491 1.041 . . . . 0.0 111.146 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.89 174.88 12.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.647 1.979 . . . . 0.0 108.383 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 tt -135.72 135.51 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.35 131.52 37.03 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.82 -3.77 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.45 174.57 41.93 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.93 53.75 0.96 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.205 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.2 -13.08 0.29 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.289 -1.284 . . . . 0.0 113.781 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -120.3 155.76 32.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.095 1.948 . . . . 0.0 111.934 -171.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 m -133.98 160.33 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.971 1.308 . . . . 0.0 110.957 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -114.53 140.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 167.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.75 173.51 15.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.898 0.479 . . . . 0.0 110.937 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.32 141.22 34.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.94 160.93 58.63 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.425 1.89 . . . . 0.0 108.142 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -61.58 150.69 84.35 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.548 1.498 . . . . 0.0 109.727 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.83 148.62 21.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.395 2.73 . . . . 0.0 114.296 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -56.12 151.2 12.66 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.867 1.267 . . . . 0.0 111.426 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.86 73.56 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 168.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.287 26.2 m 42.39 -130.13 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.602 1.961 . . . . 0.0 110.931 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.79 -6.52 3.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.291 1.437 . . . . 0.0 114.01 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.28 -19.71 64.44 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 112.139 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.98 17.9 3.63 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.577 1.951 . . . . 0.0 114.248 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.6 175.64 37.3 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.41 -178.41 6.97 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.579 1.152 . . . . 0.0 109.484 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.01 166.7 23.8 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.723 1.609 . . . . 0.0 108.177 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 m -64.7 -16.14 62.45 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.834 0.853 . . . . 0.0 112.946 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -52.81 107.79 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.669 1.588 . . . . 0.0 109.95 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.3 tpp 49.69 22.07 0.74 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.563 1.945 . . . . 0.0 113.557 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 m -146.2 13.44 1.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.456 1.103 . . . . 0.0 111.945 -169.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.02 -18.0 55.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.218 1.007 . . . . 0.0 113.621 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.0 tp -147.23 142.98 27.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.198 1.799 . . . . 0.0 106.712 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 p -144.8 152.49 40.4 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.349 1.459 . . . . 0.0 107.164 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.6 8.36 8.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -146.22 163.81 34.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.802 3.241 . . . . 0.0 106.912 175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.56 12.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.894 0.77 . . . . 0.0 112.058 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.42 148.5 25.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 125.761 1.624 . . . . 0.0 107.132 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.69 128.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -137.72 161.0 37.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.685 1.194 . . . . 0.0 109.145 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -121.67 134.08 54.97 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -151.62 160.9 43.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.755 1.222 . . . . 0.0 109.002 -173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -67.08 128.18 35.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.887 0.875 . . . . 0.0 108.877 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.33 -45.11 68.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.83 0.852 . . . . 0.0 110.626 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -64.3 -24.42 67.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.919 -172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.59 -43.22 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.706 0.685 . . . . 0.0 110.481 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.93 -46.8 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.452 0.701 . . . . 0.0 109.744 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.25 65.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.845 1.258 . . . . 0.0 112.117 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.11 -12.16 15.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.723 1.154 . . . . 0.0 113.363 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.9 m -52.42 -50.55 62.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.959 1.38 . . . . 0.0 111.133 170.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -165.04 -56.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.041 1.336 . . . . 0.0 110.631 171.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.95 -176.93 5.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.078 1.351 . . . . 0.0 109.855 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.79 169.53 24.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.894 0.878 . . . . 0.0 110.218 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -152.88 156.53 39.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.521 1.129 . . . . 0.0 110.065 168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.64 138.43 20.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 169.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -150.63 67.96 0.95 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.171 0.51 . . . . 0.0 109.714 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.36 114.7 3.34 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -56.75 -42.33 79.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 118.87 -0.586 . . . . 0.0 112.458 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -163.11 43.47 0.12 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.331 0.652 . . . . 0.0 110.729 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.09 -14.25 6.4 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.744 0.818 . . . . 0.0 111.812 168.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.99 -16.74 37.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.0 1.32 . . . . 0.0 110.908 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -116.56 -27.11 6.82 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.454 1.102 . . . . 0.0 110.928 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -144.97 146.51 31.97 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.316 0.647 . . . . 0.0 111.643 -171.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 p -164.82 66.28 1.23 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.541 1.536 . . . . 0.0 108.96 169.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.46 -13.82 41.49 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.452 2.101 . . . . 0.0 113.025 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.58 119.39 21.59 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.239 1.416 . . . . 0.0 108.764 -171.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.44 153.67 22.11 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.734 2.289 . . . . 0.0 110.146 167.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.1 m -52.71 -43.46 65.66 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.713 0.405 . . . . 0.0 111.87 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -56.71 -41.17 76.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.689 0.795 . . . . 0.0 112.269 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -64.94 -31.89 73.34 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.573 0.749 . . . . 0.0 111.133 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.6 mt -64.74 -46.07 93.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.58 -48.81 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -55.64 -46.19 77.48 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.744 1.218 . . . . 0.0 110.724 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -61.03 -51.41 69.31 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.49 67.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.395 0.278 . . . . 0.0 110.712 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.76 -20.55 61.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.93 -27.49 61.05 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 119.254 0.934 . . . . 0.0 108.877 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.68 -16.19 15.54 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.711 -1.137 . . . . 0.0 113.529 -168.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.0 t -53.2 134.78 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 120.622 1.556 . . . . 0.0 108.578 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.78 -7.17 67.73 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.524 1.059 . . . . 0.0 113.335 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 159.36 33.96 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.184 1.492 . . . . 0.0 108.918 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -127.51 142.87 51.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.71 146.79 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.876 0.87 . . . . 0.0 109.01 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.36 -1.21 48.2 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.757 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -80.14 149.68 30.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.813 0.733 . . . . 0.0 109.209 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -74.65 154.45 38.49 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 126.498 1.919 . . . . 0.0 109.443 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.91 121.81 16.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.7 p -140.92 158.26 44.2 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 m -51.97 -42.38 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.852 0.461 . . . . 0.0 110.184 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -66.46 -48.33 70.28 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 110.841 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.67 -38.04 83.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.57 0.623 . . . . 0.0 110.853 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 85.2 m -67.91 -44.62 76.51 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.897 -0.573 . . . . 0.0 109.932 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -58.01 -44.69 87.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.489 0.715 . . . . 0.0 110.209 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -56.86 -52.41 65.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.163 1.385 . . . . 0.0 109.414 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -62.33 -49.97 73.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.757 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.0 -33.17 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.693 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.16 -34.7 78.62 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 121.639 -0.663 . . . . 0.0 110.682 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.55 -34.44 71.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.354 0.662 . . . . 0.0 112.203 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -76.88 -45.5 27.95 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.53 -0.731 . . . . 0.0 110.253 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -34.87 61.31 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.301 0.64 . . . . 0.0 111.265 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -127.08 8.35 6.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 111.999 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.77 -21.04 12.03 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.057 -1.027 . . . . 0.0 112.906 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.26 143.57 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.605 1.562 . . . . 0.0 106.891 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.483 0.713 . . . . 0.0 111.256 172.81 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 ttp . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 -70.03 -33.15 71.61 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.4 -0.812 . . . . 0.0 111.755 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.44 47.26 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.944 1.698 . . . . 0.0 107.877 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.12 -166.81 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.209 2.606 . . . . 0.0 110.977 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -115.09 54.8 0.87 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.496 1.118 . . . . 0.0 112.231 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.58 -38.9 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.739 1.626 . . . . 0.0 110.335 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.27 64.21 7.18 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.462 1.905 . . . . 0.0 110.234 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.85 151.91 10.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.423 2.082 . . . . 0.0 111.824 169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -125.35 141.52 39.02 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.98 134.84 18.2 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.772 2.315 . . . . 0.0 110.504 169.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.65 -10.0 58.96 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.154 1.359 . . . . 0.0 112.402 -169.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -78.04 140.5 39.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.119 1.959 . . . . 0.0 111.033 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.57 136.28 52.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.89 140.87 37.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.31 145.63 45.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 110.95 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 -172.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -75.76 134.48 40.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -132.86 168.89 15.65 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.053 0.941 . . . . 0.0 110.687 -170.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.53 -30.41 35.61 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.37 2.713 . . . . 0.0 116.588 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -142.93 4.93 1.5 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.474 0.71 . . . . 0.0 112.763 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -161.68 -165.86 1.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.699 1.2 . . . . 0.0 109.029 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.09 149.46 44.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -120.69 171.77 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.746 1.618 . . . . 0.0 108.362 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -138.18 146.13 42.33 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.471 0.709 . . . . 0.0 111.012 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 174.43 12.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.459 1.904 . . . . 0.0 108.065 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.94 131.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.34 134.42 41.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.86 -3.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.58 175.18 42.63 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.88 55.38 1.09 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.163 0.985 . . . . 0.0 111.394 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.12 -15.3 0.33 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.956 1.265 . . . . 0.0 113.694 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -119.6 154.06 34.54 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.714 1.757 . . . . 0.0 111.738 -169.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.16 159.61 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.655 1.182 . . . . 0.0 110.673 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -111.47 138.68 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 167.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.67 168.03 27.95 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 111.009 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.39 139.95 33.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 165.34 21.07 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.534 1.533 . . . . 0.0 109.184 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.42 150.51 41.62 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.736 2.291 . . . . 0.0 112.458 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.11 145.92 90.03 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.324 2.016 . . . . 0.0 109.938 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -68.52 168.53 12.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.051 0.94 . . . . 0.0 110.949 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -77.27 61.76 2.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.036 1.335 . . . . 0.0 110.011 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.37 171.48 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.697 1.199 . . . . 0.0 111.268 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.53 142.98 25.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 111.092 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.27 32.6 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.005 0.812 . . . . 0.0 111.682 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.94 -14.23 59.44 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.114 0.966 . . . . 0.0 113.505 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.33 35.22 2.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.343 1.449 . . . . 0.0 110.901 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.76 163.24 32.7 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.182 1.393 . . . . 0.0 109.622 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.44 169.07 24.62 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.74 1.616 . . . . 0.0 108.692 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 m -132.97 10.67 4.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.039 0.936 . . . . 0.0 112.209 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 t 69.46 -39.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.707 2.403 . . . . 0.0 112.387 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.6 mtp -141.52 142.37 33.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.186 1.795 . . . . 0.0 106.707 170.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 m -60.6 -33.72 73.15 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.29 60.99 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.422 0.689 . . . . 0.0 112.554 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.82 122.91 19.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 m -151.98 150.08 29.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -144.11 20.28 1.76 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.687 1.232 . . . . 0.0 112.036 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.17 168.69 19.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.48 2.312 . . . . 0.0 108.727 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -151.22 176.83 10.83 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.222 1.009 . . . . 0.0 110.481 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -138.03 148.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.73 126.58 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -130.64 166.14 21.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.348 1.059 . . . . 0.0 109.772 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.06 127.46 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -151.8 163.16 39.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.462 1.105 . . . . 0.0 108.84 -169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.64 131.07 45.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.69 -45.64 70.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.693 0.797 . . . . 0.0 110.576 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -66.37 -19.81 65.9 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.94 -45.27 16.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.851 0.751 . . . . 0.0 110.065 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.6 t -59.43 -40.79 82.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.796 0.838 . . . . 0.0 110.638 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.02 -2.0 54.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 0.0 113.115 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.29 -15.88 46.88 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.917 0.77 . . . . 0.0 113.14 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 p -55.95 -47.13 78.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.139 1.376 . . . . 0.0 111.976 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -162.76 -67.9 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.707 1.203 . . . . 0.0 111.706 173.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -155.54 172.57 18.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.167 0.987 . . . . 0.0 109.926 -167.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.33 165.56 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.848 0.859 . . . . 0.0 110.75 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.56 163.08 40.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.07 0.948 . . . . 0.0 110.414 167.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.1 139.38 20.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 168.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -147.3 55.42 1.09 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.39 0.614 . . . . 0.0 110.39 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -54.61 113.03 1.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -61.84 -33.3 73.92 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -138.06 23.22 2.81 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.68 0.792 . . . . 0.0 112.13 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.4 -2.71 0.52 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.348 0.976 . . . . 0.0 112.491 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.69 -26.33 59.77 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.169 -0.957 . . . . 0.0 110.945 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -143.2 -25.02 0.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -128.92 164.81 22.32 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.494 1.518 . . . . 0.0 112.233 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 m 165.64 72.52 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 131.52 3.928 . . . . 0.0 106.077 168.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.33 -13.86 36.48 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.287 2.658 . . . . 0.0 113.512 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.6 120.06 34.99 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 108.218 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.23 158.33 12.26 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 111.884 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.9 m -48.56 -44.46 36.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 111.786 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.2 p -56.02 -51.91 66.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.575 0.75 . . . . 0.0 110.926 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -65.46 -37.02 85.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.7 0.8 . . . . 0.0 111.373 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.8 mt -60.87 -48.7 87.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.79 -39.36 83.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -55.74 -45.68 77.95 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.485 0.714 . . . . 0.0 110.213 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -60.85 -53.93 51.26 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 119.008 -0.52 . . . . 0.0 109.678 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.99 -48.84 61.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.283 0.492 . . . . 0.0 111.21 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -66.31 -34.22 77.5 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.681 1.592 . . . . 0.0 112.244 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -72.88 -24.09 60.81 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.232 1.013 . . . . 0.0 109.979 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.17 -12.02 17.64 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.965 . . . . 0.0 112.669 -168.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.87 142.19 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.375 1.443 . . . . 0.0 109.598 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.02 -8.39 79.91 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.807 1.194 . . . . 0.0 113.172 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -81.68 153.62 26.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.0 1.4 . . . . 0.0 109.186 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -101.52 154.16 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.321 1.048 . . . . 0.0 109.238 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.57 147.99 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.342 1.457 . . . . 0.0 107.797 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.18 34.92 2.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.17 0.985 . . . . 0.0 110.665 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -125.54 146.77 49.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.495 1.518 . . . . 0.0 108.393 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -73.38 164.12 27.12 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 127.099 2.16 . . . . 0.0 110.383 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.36 126.71 30.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 168.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.5 p -145.01 159.0 43.64 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -44.43 64.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.035 0.534 . . . . 0.0 109.623 174.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.11 -43.5 70.9 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.798 0.839 . . . . 0.0 111.447 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -66.68 -41.85 87.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.102 0.865 . . . . 0.0 110.369 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.23 -43.97 80.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.878 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -58.48 -45.22 89.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.4 0.68 . . . . 0.0 110.311 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -57.13 -52.02 66.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.041 0.936 . . . . 0.0 109.156 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -61.54 -49.42 76.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.019 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.21 -32.45 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.603 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -67.9 -31.75 71.75 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.219 -0.925 . . . . 0.0 111.151 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.2 -19.76 55.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.651 1.18 . . . . 0.0 112.414 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 mp -99.5 -43.87 6.37 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.783 0.833 . . . . 0.0 110.339 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.65 -43.23 76.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.577 1.08 . . . . 0.0 111.438 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.4 2.41 13.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.45 -30.62 5.18 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.346 -0.846 . . . . 0.0 112.138 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -156.1 141.36 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 169.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-N 118.282 0.492 . . . . 0.0 110.64 170.006 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mmm . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.55 -32.15 71.88 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.594 -0.691 . . . . 0.0 110.059 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.6 121.05 8.14 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.18 -179.88 3.43 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.278 1.986 . . . . 0.0 110.638 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 pt -124.46 59.73 21.43 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.229 1.412 . . . . 0.0 108.936 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.6 -40.62 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.185 1.924 . . . . 0.0 112.506 -168.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -146.54 30.7 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.845 1.258 . . . . 0.0 113.85 -170.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -61.85 158.13 39.61 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.657 1.985 . . . . 0.0 112.037 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -138.48 151.42 69.08 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.148 0.979 . . . . 0.0 110.036 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -46.33 135.33 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.879 2.386 . . . . 0.0 110.837 169.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -14.59 54.49 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.254 1.407 . . . . 0.0 111.797 -170.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -83.77 151.03 25.42 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 120.098 1.949 . . . . 0.0 111.43 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.0 mt -75.9 139.54 41.69 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 170.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.42 125.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -96.86 152.08 19.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.4 mm -126.35 109.84 22.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 -170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.91 132.51 46.83 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.41 166.43 17.33 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.32 -35.88 28.65 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.47 2.78 . . . . 0.0 116.235 -168.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.97 13.05 2.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.285 1.034 . . . . 0.0 111.801 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.09 -164.78 1.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.058 0.943 . . . . 0.0 109.954 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 156.66 47.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 172.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -124.16 170.71 10.44 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.748 2.019 . . . . 0.0 106.292 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -136.8 148.3 47.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.826 0.739 . . . . 0.0 111.715 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 173.71 12.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 107.962 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.7 tt -136.58 134.21 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.22 131.73 37.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.286 1.035 . . . . 0.0 108.309 -171.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.41 -5.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.45 -178.88 38.23 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 107.937 -2.065 . . . . 0.0 107.937 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.35 41.77 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.255 1.022 . . . . 0.0 111.671 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.41 -29.75 0.28 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.905 1.24 . . . . 0.0 112.627 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -88.77 149.65 23.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.784 1.292 . . . . 0.0 111.445 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -131.59 155.48 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.561 1.545 . . . . 0.0 109.112 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -102.42 143.49 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 166.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.2 165.07 35.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.571 -0.705 . . . . 0.0 111.131 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 136.91 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.27 34.53 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 123.804 0.842 . . . . 0.0 110.71 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.7 164.25 36.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.416 2.077 . . . . 0.0 110.112 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.05 -41.46 52.26 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.058 1.839 . . . . 0.0 110.675 173.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -160.93 145.98 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.939 1.696 . . . . 0.0 106.852 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -93.51 10.7 31.37 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.565 1.174 . . . . 0.0 111.698 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -147.23 156.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 128.798 2.839 . . . . 0.0 105.854 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 42.99 39.75 1.92 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.684 1.194 . . . . 0.0 111.89 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.7 -121.62 0.6 Allowed Glycine 0 C--N 1.337 0.615 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -168.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.09 -11.87 61.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.515 0.726 . . . . 0.0 112.845 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.74 -169.38 11.08 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.557 1.075 . . . . 0.0 112.905 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.15 -17.94 13.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.019 1.328 . . . . 0.0 114.228 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.21 -29.18 21.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.765 0.826 . . . . 0.0 112.199 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m 54.76 34.24 21.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.837 1.255 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -76.99 -170.92 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.725 0.81 . . . . 0.0 109.846 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -49.52 -35.58 20.54 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.331 1.452 . . . . 0.0 113.218 -172.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -60.82 -38.26 84.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.729 0.812 . . . . 0.0 112.388 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.57 -27.84 37.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.1 tp -76.42 0.94 17.82 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.043 1.337 . . . . 0.0 111.892 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -134.18 176.83 8.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.873 1.669 . . . . 0.0 107.112 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.85 30.09 4.36 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.686 0.795 . . . . 0.0 111.901 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -92.5 172.94 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.103 1.361 . . . . 0.0 110.453 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -156.28 -172.69 4.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.731 1.612 . . . . 0.0 109.728 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 mt -141.8 156.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.867 1.267 . . . . 0.0 109.252 -170.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.9 t -98.82 127.88 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -129.92 168.7 16.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.456 1.102 . . . . 0.0 110.411 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -125.72 134.34 51.81 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -150.69 160.83 43.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.74 1.216 . . . . 0.0 108.686 -175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.44 138.01 56.31 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 167.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.85 -33.4 68.62 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.687 0.795 . . . . 0.0 110.623 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -36.97 74.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.954 0.797 . . . . 0.0 110.954 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -70.07 -46.04 65.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.831 0.287 . . . . 0.0 110.471 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -63.67 -41.24 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.091 0.557 . . . . 0.0 110.397 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.82 -6.22 40.0 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.383 1.473 . . . . 0.0 113.45 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.48 -16.0 34.44 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.044 0.831 . . . . 0.0 113.689 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 p -61.64 -44.1 97.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.553 1.176 . . . . 0.0 112.014 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -162.26 -59.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.861 0.865 . . . . 0.0 112.377 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -164.32 -170.73 2.15 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.673 1.589 . . . . 0.0 108.986 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -148.1 166.88 26.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.889 0.875 . . . . 0.0 109.956 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -145.44 153.21 40.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.197 1.399 . . . . 0.0 107.482 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -83.77 137.31 21.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 168.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -153.37 70.78 0.87 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.228 0.537 . . . . 0.0 109.92 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.51 112.9 2.66 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -65.69 -11.43 45.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.869 . . . . 0.0 113.184 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 82' ' ' ASP . 88.8 m-70 -129.85 26.24 5.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.639 1.175 . . . . 0.0 111.591 -170.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.11 23.92 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.895 -1.128 . . . . 0.0 112.605 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.8 t70 -132.91 -3.38 3.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 111.607 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -132.82 -31.59 1.31 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.26 1.424 . . . . 0.0 111.579 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 67.81 136.11 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 128.569 2.748 . . . . 0.0 116.211 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -63.93 139.97 97.76 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.382 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -16.75 32.37 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.894 2.396 . . . . 0.0 112.211 168.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.04 128.39 26.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.669 1.588 . . . . 0.0 108.802 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.93 155.03 24.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.165 2.577 . . . . 0.0 111.832 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.0 p -54.3 -40.45 67.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.86 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -56.52 -53.56 56.12 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.595 0.758 . . . . 0.0 110.569 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -62.92 -36.89 84.89 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.298 0.639 . . . . 0.0 111.472 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.03 -51.55 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.47 0.708 . . . . 0.0 109.158 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -56.03 -49.1 74.64 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.188 0.995 . . . . 0.0 110.036 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -65.16 -45.65 84.08 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.729 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.95 -52.07 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.632 0.651 . . . . 0.0 110.793 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.93 -23.18 60.66 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -72.73 -27.5 62.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.66 -4.58 30.58 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.703 0.801 . . . . 0.0 113.051 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.28 150.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 109.828 169.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.5 23.53 56.15 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.439 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -126.85 161.98 26.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.703 1.201 . . . . 0.0 107.927 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.08 156.86 16.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.941 1.296 . . . . 0.0 109.754 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.8 m -130.56 148.84 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.827 2.051 . . . . 0.0 106.664 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.44 19.78 11.6 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.62 -0.675 . . . . 0.0 112.223 -169.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -121.41 155.92 33.79 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.293 1.437 . . . . 0.0 109.179 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -88.44 169.93 11.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.431 1.093 . . . . 0.0 112.542 -170.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.19 121.45 14.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.0 p -147.05 152.86 39.24 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 165.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -53.57 -40.84 65.93 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.102 0.41 . . . . 0.0 110.571 174.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.79 -44.74 84.81 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.376 0.67 . . . . 0.0 111.047 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -67.94 -38.57 83.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 0.786 . . . . 0.0 110.534 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.62 -44.62 81.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.646 0.657 . . . . 0.0 110.039 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -60.11 -45.3 93.44 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.101 0.56 . . . . 0.0 109.892 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -57.82 -54.48 46.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.251 1.02 . . . . 0.0 109.587 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.49 -48.62 80.18 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.919 0.488 . . . . 0.0 111.729 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.47 -31.25 52.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.165 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -72.38 -27.61 62.49 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.897 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -61.61 -39.61 91.86 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.811 1.187 . . . . 0.0 109.644 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.42 -47.32 50.04 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.288 -0.883 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -17.35 59.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.284 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -142.76 7.39 1.66 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.81 1.186 . . . . 0.0 113.585 -169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.97 -48.55 3.68 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 120.806 -1.184 . . . . 0.0 110.637 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.66 141.23 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.582 1.953 . . . . 0.0 106.931 174.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.938 168.362 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? 65.51 -39.15 0.28 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.494 2.318 . . . . 0.0 113.336 -169.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.76 147.69 20.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.662 1.585 . . . . 0.0 107.504 169.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.19 177.52 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.554 2.169 . . . . 0.0 111.045 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.435 HG22 HG23 ' A' ' 76' ' ' VAL . 29.8 pt -128.49 63.6 64.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.39 1.476 . . . . 0.0 107.61 171.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.32 -45.3 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.785 2.324 . . . . 0.0 113.436 -166.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.46 52.07 0.42 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.336 1.454 . . . . 0.0 110.914 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.5 Cg_endo -66.37 160.24 46.38 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.213 1.942 . . . . 0.0 111.799 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -135.81 151.79 74.74 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 124.726 1.211 . . . . 0.0 108.95 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HB2' HD11 ' A' ' 93' ' ' ILE . 94.8 Cg_exo -47.01 143.53 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.889 2.393 . . . . 0.0 111.495 169.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.56 73.99 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.038 1.304 . . . . 0.0 112.227 -170.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -76.76 147.81 37.07 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.509 1.654 . . . . 0.0 111.056 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.87 140.86 46.0 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.098 0.959 . . . . 0.0 108.829 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -125.21 138.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.39 148.9 41.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -121.87 106.37 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 -169.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -75.42 133.01 41.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -129.3 167.85 18.42 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.88 0.872 . . . . 0.0 110.531 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.12 -25.54 29.65 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.252 2.635 . . . . 0.0 116.433 -171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -141.48 0.25 1.46 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.02 -165.83 1.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.67 1.188 . . . . 0.0 109.271 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -134.01 152.22 51.76 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -126.78 171.95 10.77 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.144 1.777 . . . . 0.0 107.998 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 66.6 m95 -139.2 150.0 45.05 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.073 0.851 . . . . 0.0 110.869 -172.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.33 173.24 16.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.421 1.488 . . . . 0.0 108.667 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 tt -136.77 128.94 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.39 130.14 42.21 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.68 1.592 . . . . 0.0 109.433 -172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.53 168.6 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.075 1.35 . . . . 0.0 109.416 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.84 -135.31 49.23 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -120.71 8.99 10.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.397 1.079 . . . . 0.0 111.392 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.11 16.67 0.02 OUTLIER Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.437 -0.789 . . . . 0.0 113.686 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -107.6 169.2 8.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.847 1.324 . . . . 0.0 109.013 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.85 151.98 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 122.936 0.494 . . . . 0.0 110.649 172.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -100.28 141.37 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 166.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.84 171.54 17.59 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.92 143.2 30.88 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.6 159.33 71.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.286 1.834 . . . . 0.0 108.561 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.49 159.55 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.156 1.904 . . . . 0.0 110.921 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.02 -24.69 32.78 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.509 2.139 . . . . 0.0 113.008 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m 53.13 -164.21 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.247 1.419 . . . . 0.0 112.151 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -137.95 33.33 2.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.481 1.113 . . . . 0.0 109.368 -174.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t 69.77 -41.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 128.287 2.635 . . . . 0.0 112.357 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.82 168.82 23.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.853 1.661 . . . . 0.0 109.519 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.95 177.45 47.54 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.33 -21.13 64.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.333 0.653 . . . . 0.0 112.5 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.04 -27.68 0.34 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.625 1.107 . . . . 0.0 111.733 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.36 173.08 12.94 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.935 1.694 . . . . 0.0 108.703 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.86 176.36 10.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.782 1.633 . . . . 0.0 108.301 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.0 m -58.28 -11.77 3.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.374 1.07 . . . . 0.0 113.331 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.4 -34.66 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.211 -0.93 . . . . 0.0 110.856 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -69.33 -33.21 72.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.492 0.717 . . . . 0.0 109.975 173.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -72.69 5.58 3.04 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.981 1.312 . . . . 0.0 112.402 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 57.21 28.78 15.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.671 1.989 . . . . 0.0 113.161 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -71.16 -16.11 62.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.495 0.718 . . . . 0.0 111.993 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 152.74 19.9 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -120.39 22.94 11.12 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.937 0.875 . . . . 0.0 112.724 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -130.82 -179.12 5.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.108 2.163 . . . . 0.0 109.862 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.55 173.9 13.57 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.397 . . . . 0.0 108.21 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -142.13 154.52 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.65 138.52 19.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -142.92 168.59 19.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.953 1.301 . . . . 0.0 108.814 -176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -128.54 140.79 51.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -151.24 161.14 43.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.41 1.484 . . . . 0.0 107.929 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.82 137.25 57.09 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.61 -44.74 73.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.714 0.688 . . . . 0.0 110.82 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -67.04 -19.79 65.74 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.92 -47.58 28.99 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.129 0.877 . . . . 0.0 109.737 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.4 t -62.19 -43.35 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.563 0.745 . . . . 0.0 110.243 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.43 -7.97 56.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.992 1.317 . . . . 0.0 113.182 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.32 -20.41 58.56 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.714 0.673 . . . . 0.0 113.22 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 -47.49 84.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.77 1.228 . . . . 0.0 111.976 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -159.08 -61.42 0.07 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.733 0.813 . . . . 0.0 112.884 172.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -155.73 171.34 20.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -158.94 163.25 36.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.71 0.804 . . . . 0.0 110.111 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -151.15 154.14 36.33 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.605 0.762 . . . . 0.0 110.78 168.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 5' ' ' ILE . 92.2 t -79.81 137.56 21.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -158.74 68.55 0.46 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.528 0.68 . . . . 0.0 110.587 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.91 101.58 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -68.14 129.53 40.2 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 44.67 44.89 7.78 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.866 1.667 . . . . 0.0 112.1 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.78 -12.43 4.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.623 0.769 . . . . 0.0 112.967 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.95 -20.24 33.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.657 1.583 . . . . 0.0 111.029 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 -14.25 8.94 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.987 1.315 . . . . 0.0 111.026 -173.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -136.37 -156.09 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.973 1.709 . . . . 0.0 109.452 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 m 57.79 59.93 6.57 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.361 1.864 . . . . 0.0 112.359 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -61.8 -14.74 38.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.363 2.042 . . . . 0.0 114.197 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.6 mt -102.46 141.69 23.04 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.683 0.793 . . . . 0.0 110.51 -167.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.1 159.48 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.202 . . . . 0.0 110.137 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.7 m -48.05 -47.63 33.59 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.464 1.106 . . . . 0.0 111.57 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.68 -49.99 69.32 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.538 0.735 . . . . 0.0 111.683 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.38 -35.25 77.42 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.774 -0.579 . . . . 0.0 111.433 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.8 -49.01 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 10' ' ' PRO . 54.7 mt -63.69 -45.05 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.181 0.993 . . . . 0.0 109.166 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.07 -52.27 52.24 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.052 0.941 . . . . 0.0 108.963 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -66.86 -45.99 76.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.305 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.27 -47.88 62.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.617 0.644 . . . . 0.0 111.434 176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.6 -10.72 57.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.351 0.661 . . . . 0.0 112.594 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.68 -22.49 40.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.38 0.991 . . . . 0.0 110.185 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.5 mt -111.7 -4.64 14.63 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.602 0.761 . . . . 0.0 112.372 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.25 142.79 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 118.869 0.759 . . . . 0.0 110.066 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.64 -3.2 80.04 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.653 -1.082 . . . . 0.0 113.297 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -74.07 152.74 39.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.321 1.561 . . . . 0.0 109.268 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -98.46 149.97 22.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.13 176.63 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.585 1.154 . . . . 0.0 107.944 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.42 6.12 6.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.564 -0.71 . . . . 0.0 112.519 -169.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -99.0 146.43 26.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.123 0.969 . . . . 0.0 109.062 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -61.83 153.46 28.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.323 1.449 . . . . 0.0 111.149 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 mp -66.65 127.08 31.02 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.4 p -141.86 159.51 42.07 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 167.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 m -49.31 -42.09 40.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.21 0.604 . . . . 0.0 111.127 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.2 -23.75 18.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.318 -168.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -68.16 -39.93 82.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.633 1.106 . . . . 0.0 109.442 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.2 m -69.79 -40.6 75.91 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.079 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -53.64 -49.09 68.64 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.446 0.698 . . . . 0.0 109.883 172.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -60.2 -46.2 90.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.181 0.992 . . . . 0.0 110.11 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.31 -53.19 59.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.373 0.533 . . . . 0.0 111.77 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.86 -33.71 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 119.881 -0.727 . . . . 0.0 111.216 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -68.75 -32.12 71.65 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 121.596 -0.69 . . . . 0.0 111.148 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.17 -41.7 98.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.207 172.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.59 -44.79 81.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.865 1.212 . . . . 0.0 111.017 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -66.07 -42.43 89.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.343 0.657 . . . . 0.0 111.463 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -95.33 -43.98 7.78 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.001 0.364 . . . . 0.0 111.909 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.33 -53.52 0.69 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.53 138.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.127 -0.463 . . . . 0.0 109.82 -179.293 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -143.7 168.09 20.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.127 1.371 . . . . 0.0 108.869 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.8 145.1 79.62 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -72.2 -21.89 22.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.367 2.044 . . . . 0.0 113.815 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.1 mt 44.34 60.29 12.34 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.568 1.547 . . . . 0.0 109.64 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.18 -50.86 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.237 1.958 . . . . 0.0 112.133 -167.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -168.87 75.14 0.77 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.061 1.744 . . . . 0.0 108.863 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.44 129.43 26.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.492 2.128 . . . . 0.0 110.716 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.05 151.02 69.7 Favored Pre-proline 0 C--O 1.236 0.351 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.86 131.53 38.62 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.018 1.812 . . . . 0.0 109.3 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.9 -1.48 65.49 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.749 1.166 . . . . 0.0 113.015 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -73.61 147.71 43.55 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.963 1.881 . . . . 0.0 111.06 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.08 136.11 44.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -121.89 124.31 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.96 150.29 20.32 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 166.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -125.89 113.56 34.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 -171.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 131.74 44.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 mmt-85 -119.49 169.0 8.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.528 1.531 . . . . 0.0 107.888 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.26 96.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.733 2.288 . . . . 0.0 112.625 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 57.88 28.02 15.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.407 2.283 . . . . 0.0 113.508 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -149.21 -164.57 2.06 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.938 0.895 . . . . 0.0 109.436 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.9 158.84 43.43 Favored 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 121.065 -1.022 . . . . 0.0 109.591 174.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -127.77 168.53 15.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -135.62 150.65 49.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.864 0.757 . . . . 0.0 111.345 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.69 173.07 14.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.092 1.757 . . . . 0.0 108.181 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 tt -128.77 132.97 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -70.93 134.83 47.54 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.624 1.17 . . . . 0.0 109.856 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.46 165.94 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.39 1.076 . . . . 0.0 109.879 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.54 -123.17 31.86 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -142.95 37.48 1.42 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.317 1.047 . . . . 0.0 109.021 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.2 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.382 -0.824 . . . . 0.0 115.016 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -101.39 171.03 7.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.938 1.369 . . . . 0.0 109.168 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.57 159.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 123.794 0.838 . . . . 0.0 110.194 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.8 137.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.73 173.3 14.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.545 0.738 . . . . 0.0 110.781 -172.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.26 143.37 30.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 161.9 46.7 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.862 1.665 . . . . 0.0 109.791 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.42 154.96 27.32 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.235 2.624 . . . . 0.0 112.533 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -68.66 -24.25 35.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.85 2.367 . . . . 0.0 112.373 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.1 m -141.62 62.93 1.44 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.667 1.587 . . . . 0.0 107.502 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.01 20.6 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.272 1.429 . . . . 0.0 112.7 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.61 160.36 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.882 2.073 . . . . 0.0 108.027 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.14 119.44 3.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.603 1.161 . . . . 0.0 110.245 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.21 -13.04 0.04 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.948 -0.918 . . . . 0.0 114.159 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.06 19.31 2.99 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.746 1.273 . . . . 0.0 111.064 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.4 176.89 48.26 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.696 1.617 . . . . 0.0 109.367 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.89 -9.74 55.98 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.13 165.96 31.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.739 1.615 . . . . 0.0 108.206 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -57.44 -39.15 75.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.094 0.558 . . . . 0.0 111.194 169.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -65.88 -38.81 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 118.691 0.678 . . . . 0.0 111.516 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.2 ttm -71.77 -38.04 70.4 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.03 -0.419 . . . . 0.0 109.943 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -64.98 -41.21 95.63 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.381 0.672 . . . . 0.0 110.975 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.59 68.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.553 0.741 . . . . 0.0 111.792 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.3 103.15 0.6 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.038 0.935 . . . . 0.0 108.559 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 p -150.46 -177.95 6.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.454 1.901 . . . . 0.0 107.356 -174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -115.57 18.33 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.384 1.074 . . . . 0.0 112.589 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.05 -179.93 5.93 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 110.438 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.18 175.0 14.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.003 1.321 . . . . 0.0 108.467 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 pt -142.78 157.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.0 139.68 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -142.74 169.65 17.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.572 1.549 . . . . 0.0 108.739 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.55 142.65 51.47 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -151.28 159.38 44.37 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.728 1.211 . . . . 0.0 108.443 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.9 135.6 52.73 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 168.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.87 -44.12 70.14 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.485 0.584 . . . . 0.0 111.679 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -66.51 -22.25 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.21 -44.4 59.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.789 0.722 . . . . 0.0 109.935 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 t -63.72 -41.49 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.414 0.686 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -3.78 22.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.657 1.183 . . . . 0.0 113.526 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.87 42.92 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.853 1.216 . . . . 0.0 114.831 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -58.88 -44.3 91.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.73 1.265 . . . . 0.0 112.365 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.2 -67.45 0.06 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 123.605 0.762 . . . . 0.0 112.439 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -157.76 177.03 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.638 1.175 . . . . 0.0 108.726 -166.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -151.93 169.59 21.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.05 1.34 . . . . 0.0 108.527 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.68 152.67 25.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.809 0.844 . . . . 0.0 110.296 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.69 133.24 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -149.68 70.86 1.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.729 0.776 . . . . 0.0 109.163 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -66.02 119.13 10.82 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -62.74 -28.27 69.85 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.326 -0.234 . . . . 0.0 110.761 169.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -97.16 17.52 16.99 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.672 1.189 . . . . 0.0 112.041 -168.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.73 21.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.776 1.626 . . . . 0.0 113.048 176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 80' ' ' HIS . 38.9 t70 -136.3 2.19 2.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 111.469 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -138.08 -30.44 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.737 1.615 . . . . 0.0 111.866 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 67.54 149.6 0.06 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 128.986 2.914 . . . . 0.0 115.968 169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -50.73 113.41 3.67 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.17 1.388 . . . . 0.0 111.261 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.82 -18.85 16.69 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.941 2.427 . . . . 0.0 111.793 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.49 136.42 20.83 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 126.029 1.731 . . . . 0.0 107.273 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.61 145.78 57.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.083 1.855 . . . . 0.0 109.284 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.1 m -54.42 -42.34 70.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.45 0.3 . . . . 0.0 111.433 -173.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -56.66 -42.51 79.11 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.703 0.801 . . . . 0.0 112.055 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -66.42 -33.19 75.15 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 117.764 -1.112 . . . . 0.0 111.441 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.4 mt -58.22 -49.04 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.135 1.334 . . . . 0.0 108.045 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.2 mm -61.89 -47.01 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.862 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -45.2 91.35 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.23 -51.98 65.57 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.47 49.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.839 0.856 . . . . 0.0 110.721 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -76.76 -18.01 58.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.958 -0.544 . . . . 0.0 112.324 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.86 -27.16 62.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.684 1.129 . . . . 0.0 110.265 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.86 -27.69 16.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 110.644 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.12 125.62 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.581 1.082 . . . . 0.0 108.956 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.93 82.6 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.098 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -82.22 153.82 25.74 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.851 1.826 . . . . 0.0 108.885 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -104.85 151.42 23.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.228 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.52 172.24 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.668 1.187 . . . . 0.0 108.429 169.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.25 14.27 10.46 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.474 -0.766 . . . . 0.0 111.667 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -112.04 149.48 31.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 109.288 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -68.19 161.3 27.39 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 112.359 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.19 124.16 20.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.5 p -144.57 157.53 44.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.5 m -53.26 -45.41 68.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.653 0.381 . . . . 0.0 110.144 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.48 -37.98 80.61 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.086 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -69.24 -37.82 78.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.329 0.968 . . . . 0.0 110.593 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.2 m -65.3 -47.37 76.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.12 -44.31 87.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.236 1.014 . . . . 0.0 110.144 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -58.04 -56.26 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 109.309 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.81 -47.37 85.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.722 -172.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.6 -32.64 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.611 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -70.96 -40.96 71.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 110.528 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.6 -43.77 68.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.452 1.101 . . . . 0.0 110.618 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -72.08 -44.72 62.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.356 1.062 . . . . 0.0 112.007 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -74.43 -35.11 63.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.415 1.007 . . . . 0.0 112.658 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -120.96 -2.41 9.73 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -167.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.06 -26.24 24.29 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.831 -1.168 . . . . 0.0 111.983 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.65 139.91 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.049 -0.501 . . . . 0.0 111.128 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.287 0.089 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -127.21 -20.36 4.13 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.48 113.7 3.51 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -72.3 -7.08 20.31 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.63 2.22 . . . . 0.0 113.763 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.279 44.7 pt 44.46 56.61 13.93 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 127.131 2.172 . . . . 0.0 113.331 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.2 -33.1 2.11 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.826 2.35 . . . . 0.0 113.126 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.15 -42.59 2.63 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.868 -1.063 . . . . 0.0 112.063 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -50.79 163.66 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.195 3.263 . . . . 0.0 113.046 167.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -128.91 147.13 63.37 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.497 0.719 . . . . 0.0 109.863 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -47.96 139.06 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.638 2.225 . . . . 0.0 110.239 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.55 -3.1 68.16 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.662 1.125 . . . . 0.0 112.438 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -80.52 139.26 36.44 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.056 1.428 . . . . 0.0 109.661 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mt -67.73 135.33 52.55 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.69 126.9 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -97.49 148.6 23.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 167.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 mm -126.18 123.03 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -75.0 112.39 11.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -84.64 171.27 11.4 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.88 -34.19 74.9 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.549 2.166 . . . . 0.0 114.904 -171.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -141.21 13.06 2.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.437 1.095 . . . . 0.0 111.967 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -157.68 -157.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.759 1.224 . . . . 0.0 109.272 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.24 155.07 45.23 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 121.085 -1.009 . . . . 0.0 109.809 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -135.61 168.49 19.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.009 1.724 . . . . 0.0 106.565 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -136.4 147.12 47.13 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.782 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 174.68 11.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.214 1.805 . . . . 0.0 107.48 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 tt -134.07 132.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -64.88 129.08 38.41 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.228 1.411 . . . . 0.0 108.879 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.2 m -136.38 169.14 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.07 0.948 . . . . 0.0 109.326 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.12 -117.32 8.76 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -141.7 25.33 1.99 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.26 1.024 . . . . 0.0 110.685 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.79 -17.29 0.14 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.159 -0.963 . . . . 0.0 113.853 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -70.79 163.65 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.012 0.906 . . . . 0.0 109.723 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.76 154.65 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.17 137.44 33.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.76 168.9 25.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 111.501 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -89.81 133.14 34.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.119 1.368 . . . . 0.0 107.441 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.84 153.89 58.15 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.275 1.03 . . . . 0.0 111.171 -171.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 152.53 44.02 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.329 2.686 . . . . 0.0 112.934 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.65 -40.62 83.15 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.876 2.384 . . . . 0.0 112.94 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -85.26 11.22 10.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.049 0.939 . . . . 0.0 112.498 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.85 69.39 1.85 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.228 0.922 . . . . 0.0 109.409 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.07 -20.48 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.202 1.401 . . . . 0.0 112.421 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 19.35 2.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.97 0.508 . . . . 0.0 111.814 -168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.65 -145.71 35.69 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.07 -14.52 24.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.47 76.52 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.9 -0.944 . . . . 0.0 112.704 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.66 108.35 2.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.943 1.372 . . . . 0.0 108.795 173.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 38.79 -106.35 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.617 1.967 . . . . 0.0 111.98 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -124.86 27.29 6.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.28 1.432 . . . . 0.0 110.648 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.327 4.2 p 55.43 -47.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 1 C-N-CA 132.027 4.131 . . . . 0.0 116.11 -177.953 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.1 mmt -60.18 -25.22 65.39 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.321 0.964 . . . . 0.0 110.52 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -52.31 -26.68 12.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.625 1.97 . . . . 0.0 113.365 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.08 -19.52 65.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.525 0.73 . . . . 0.0 112.42 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.05 114.28 3.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -147.38 153.89 40.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.96 11.12 2.86 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.545 1.164 . . . . 0.0 113.679 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -134.93 161.39 35.39 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.386 2.674 . . . . 0.0 107.994 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 -170.84 3.69 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.235 1.414 . . . . 0.0 109.734 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -149.76 173.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.73 141.11 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.83 166.96 21.78 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.785 1.234 . . . . 0.0 110.048 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -126.59 125.92 42.75 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.19 161.69 40.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.629 1.172 . . . . 0.0 108.415 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 132.12 44.94 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -49.11 -48.35 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.47 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -63.46 -25.99 68.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.049 0.386 . . . . 0.0 111.914 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.59 -43.59 31.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.482 0.583 . . . . 0.0 110.367 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.8 t -57.79 -35.87 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 110.224 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.18 10.59 31.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.762 1.225 . . . . 0.0 113.508 -176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.62 -22.17 38.46 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.817 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.2 m -57.5 -50.12 74.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.741 1.271 . . . . 0.0 113.254 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.86 -69.07 0.06 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -157.74 172.0 19.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.497 1.119 . . . . 0.0 109.294 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -163.99 157.55 18.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.402 1.081 . . . . 0.0 109.328 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -156.48 166.14 34.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.404 0.681 . . . . 0.0 110.115 171.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.76 139.98 19.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -150.58 71.54 1.05 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -66.98 93.53 0.28 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -60.99 122.13 14.15 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 48.56 44.44 20.88 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 113.017 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.12 -19.05 2.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.134 0.974 . . . . 0.0 113.307 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.17 -22.68 30.89 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.228 1.011 . . . . 0.0 110.892 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -112.49 -26.47 8.67 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.986 0.914 . . . . 0.0 111.279 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -144.92 159.99 42.03 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m 128.69 76.75 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 1 C-N-CA 131.801 4.041 . . . . 0.0 108.708 174.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.38 -19.48 43.44 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.804 2.336 . . . . 0.0 114.017 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.4 mt -93.42 132.9 29.25 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.534 0.734 . . . . 0.0 109.818 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.46 162.83 41.04 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.11 1.873 . . . . 0.0 109.115 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.2 m -50.94 -43.12 60.14 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.82 0.848 . . . . 0.0 112.587 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 p -55.59 -47.68 76.09 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.847 0.859 . . . . 0.0 111.996 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -32.07 73.48 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.54 0.736 . . . . 0.0 111.228 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.8 mt -65.13 -47.56 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.05 -45.66 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 118.603 0.638 . . . . 0.0 109.915 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -54.86 -49.74 70.38 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.865 0.866 . . . . 0.0 109.793 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.05 -52.29 66.02 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.088 0.555 . . . . 0.0 110.144 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.8 -15.71 55.69 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 118.67 -0.681 . . . . 0.0 112.229 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.89 -32.05 68.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.784 1.174 . . . . 0.0 109.165 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt -94.0 -18.12 22.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.055 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -50.34 130.67 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.93 1.241 . . . . 0.0 109.445 171.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.3 -2.61 81.14 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.277 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.34 162.81 19.91 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.472 1.636 . . . . 0.0 109.193 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -103.77 153.19 20.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.887 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG21 HD21 ' A' ' 36' ' ' LEU . 16.1 m -129.2 146.6 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 109.682 171.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -97.56 23.11 8.07 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.003 -1.061 . . . . 0.0 112.336 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -125.04 151.42 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.048 1.339 . . . . 0.0 110.508 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -65.85 162.6 18.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.44 2.296 . . . . 0.0 112.167 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.53 125.89 28.07 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.0 p -146.69 156.54 43.25 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -53.76 -42.52 68.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.64 0.776 . . . . 0.0 110.408 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.24 -39.92 82.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.05 0.94 . . . . 0.0 110.987 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -68.26 -34.45 76.23 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.36 0.982 . . . . 0.0 110.93 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.58 -45.3 83.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.406 1.003 . . . . 0.0 110.145 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -60.61 -45.33 94.42 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.256 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -57.87 -55.39 35.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.136 1.374 . . . . 0.0 109.021 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -55.09 -50.5 69.01 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.893 0.477 . . . . 0.0 111.52 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.45 -31.28 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.701 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -70.62 -27.88 64.42 Favored 'General case' 0 C--N 1.34 0.152 0 O-C-N 121.52 -0.738 . . . . 0.0 111.656 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 59.9 mt-10 -60.23 -30.33 69.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.416 1.007 . . . . 0.0 110.643 170.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 mt -81.94 -47.6 12.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.657 0.662 . . . . 0.0 110.018 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -26.43 67.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.311 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -119.84 -33.63 3.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.764 0.711 . . . . 0.0 112.776 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.09 -40.09 2.08 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.0 p -157.27 140.41 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 118.649 0.659 . . . . 0.0 110.606 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.596 0.236 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 82.8 mmt-85 -146.53 164.62 31.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.878 1.671 . . . . 0.0 107.198 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.09 150.47 78.67 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.24 178.21 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.247 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 pt -127.54 61.32 49.19 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.865 1.666 . . . . 0.0 107.464 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.22 -41.59 1.81 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 -167.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -159.91 67.62 2.85 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.846 1.258 . . . . 0.0 110.981 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -51.35 139.74 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.074 1.85 . . . . 0.0 110.229 168.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.29 139.82 29.0 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.47 137.54 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.171 2.581 . . . . 0.0 111.931 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.84 -16.64 60.85 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.02 -1.434 . . . . 0.0 112.44 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -71.12 153.99 42.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.505 2.153 . . . . 0.0 109.803 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.29 138.79 39.58 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.36 145.03 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -123.54 151.18 43.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 166.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -126.58 108.21 18.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.7 140.71 48.02 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.989 171.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -115.2 169.39 6.8 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.626 1.57 . . . . 0.0 107.45 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.63 -24.74 55.81 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.784 2.323 . . . . 0.0 115.316 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -141.71 3.99 1.69 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.108 0.963 . . . . 0.0 113.323 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -157.92 -160.89 0.96 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.633 1.173 . . . . 0.0 109.076 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -150.2 154.09 37.39 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -140.22 169.13 18.26 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.335 1.854 . . . . 0.0 107.283 -173.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -135.85 149.86 49.18 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.712 0.687 . . . . 0.0 110.42 -173.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.83 173.3 13.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.667 1.987 . . . . 0.0 108.11 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.57 133.69 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.6 136.98 38.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -131.57 0.57 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.87 -175.09 39.23 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.88 42.83 0.32 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.367 1.067 . . . . 0.0 111.377 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 -33.27 0.25 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.87 -0.961 . . . . 0.0 113.109 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -89.57 153.26 20.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.464 1.632 . . . . 0.0 111.713 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.55 155.46 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.31 1.444 . . . . 0.0 109.665 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.46 136.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.29 173.05 16.26 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.724 -0.61 . . . . 0.0 110.645 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.23 147.21 28.14 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.97 165.86 22.14 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.491 1.917 . . . . 0.0 108.202 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -52.45 154.13 12.25 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.628 2.219 . . . . 0.0 112.174 171.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 163.88 32.24 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.296 1.998 . . . . 0.0 110.923 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m 53.51 -159.11 0.15 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.891 0.877 . . . . 0.0 109.192 -168.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -153.49 150.82 29.14 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.373 -1.455 . . . . 0.0 110.462 168.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.42 177.15 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 129.192 2.997 . . . . 0.0 105.841 172.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.12 17.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.93 1.292 . . . . 0.0 114.174 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.59 11.41 35.73 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.242 0.925 . . . . 0.0 113.722 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.73 62.2 3.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.026 1.413 . . . . 0.0 109.487 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.86 -136.6 2.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -173.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.47 31.64 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.39 -18.43 62.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.388 -0.815 . . . . 0.0 113.104 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.4 m 42.23 48.18 4.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.751 1.62 . . . . 0.0 112.087 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.31 152.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.281 0.633 . . . . 0.0 111.414 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -63.79 -21.67 66.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.614 1.165 . . . . 0.0 112.802 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 m -56.49 119.88 6.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.135 0.974 . . . . 0.0 110.1 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.93 14.91 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.309 1.843 . . . . 0.0 114.859 -173.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.41 119.08 8.42 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 p -150.39 -176.51 5.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.582 1.953 . . . . 0.0 105.82 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.14 28.91 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.938 -1.101 . . . . 0.0 113.346 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -130.6 165.76 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.008 2.123 . . . . 0.0 110.002 -174.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.24 172.85 14.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.983 0.913 . . . . 0.0 110.109 168.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -135.42 149.09 28.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 125.401 1.481 . . . . 0.0 107.101 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.17 129.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -128.22 167.98 16.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.779 1.232 . . . . 0.0 109.564 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -124.72 129.61 50.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.87 160.52 43.17 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.46 130.37 40.52 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.25 -40.69 64.79 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.219 1.007 . . . . 0.0 112.202 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.19 -36.02 67.92 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.443 0.565 . . . . 0.0 111.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.67 -42.82 67.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.113 0.415 . . . . 0.0 110.038 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 t -66.13 -45.73 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.569 0.748 . . . . 0.0 109.522 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.92 -22.79 65.89 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.411 1.084 . . . . 0.0 112.015 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.67 -11.63 8.2 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.23 1.395 . . . . 0.0 113.483 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -49.36 -51.44 34.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.658 1.229 . . . . 0.0 110.722 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.79 -52.34 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.918 1.687 . . . . 0.0 110.184 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -159.69 173.76 15.57 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.458 1.903 . . . . 0.0 107.973 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -153.21 167.74 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.347 -0.846 . . . . 0.0 110.787 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -144.3 165.71 27.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.919 1.687 . . . . 0.0 108.327 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.84 128.8 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -158.1 63.94 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -55.94 128.55 35.74 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -69.19 -56.08 8.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.62 -166.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -144.49 45.59 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.645 1.178 . . . . 0.0 109.812 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.89 -10.55 4.11 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.294 -0.879 . . . . 0.0 112.89 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -86.61 -21.71 26.64 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.223 1.009 . . . . 0.0 111.037 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -113.15 -25.91 8.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.295 1.038 . . . . 0.0 111.162 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -143.03 -165.16 2.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.178 1.791 . . . . 0.0 109.435 -169.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m 57.64 62.69 5.21 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.408 1.483 . . . . 0.0 113.569 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -11.66 31.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.354 2.036 . . . . 0.0 113.934 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.99 132.64 94.68 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.954 1.301 . . . . 0.0 110.429 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.6 151.67 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.632 2.221 . . . . 0.0 110.978 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -53.39 -41.11 65.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.302 0.641 . . . . 0.0 111.102 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -52.31 -50.51 62.06 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 111.335 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -68.33 -38.52 81.6 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.29 0.636 . . . . 0.0 110.7 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.64 -49.58 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.47 -41.4 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.874 0.87 . . . . 0.0 109.375 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -55.32 -51.23 67.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.764 0.826 . . . . 0.0 109.185 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -62.31 -43.1 99.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.271 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.88 83.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.265 0.939 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.57 -15.27 55.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.178 0.591 . . . . 0.0 112.308 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -79.99 -21.31 43.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.106 0.962 . . . . 0.0 110.737 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -115.65 -5.08 12.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.492 0.717 . . . . 0.0 112.813 -168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.75 146.0 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.054 0.843 . . . . 0.0 109.835 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.15 -6.34 79.8 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.621 1.105 . . . . 0.0 112.967 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -79.26 155.23 28.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.114 1.457 . . . . 0.0 109.519 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.97 151.71 24.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.638 1.175 . . . . 0.0 108.966 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.59 147.04 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.141 1.376 . . . . 0.0 107.996 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.53 33.73 3.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.543 1.163 . . . . 0.0 110.492 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -130.91 158.17 40.95 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.514 1.926 . . . . 0.0 108.182 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.36 156.22 39.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.36 48.54 0.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.475 1.51 . . . . 0.0 111.454 168.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 p -65.71 158.86 26.38 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.831 -1.168 . . . . 0.0 108.597 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.2 m -51.48 -41.31 60.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.117 0.967 . . . . 0.0 111.095 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.32 -41.62 80.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.663 0.785 . . . . 0.0 111.374 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -72.08 -34.91 69.04 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.168 0.894 . . . . 0.0 111.102 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 68.9 m -66.82 -45.46 78.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.74 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.1 -44.12 87.51 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.125 0.57 . . . . 0.0 110.013 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -56.66 -55.13 37.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.788 1.235 . . . . 0.0 108.898 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -60.82 -48.19 82.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.07 -32.5 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.233 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -69.71 -32.49 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.138 -0.976 . . . . 0.0 110.37 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.98 -8.42 1.01 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 113.026 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.2 mt -112.13 -48.47 3.04 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.237 1.415 . . . . 0.0 110.261 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -58.2 -36.07 72.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.386 0.674 . . . . 0.0 111.265 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -121.23 -7.47 9.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.354 1.062 . . . . 0.0 111.53 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.84 -10.03 63.9 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.821 -1.174 . . . . 0.0 112.243 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -153.27 139.44 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.155 175.006 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -148.93 164.42 34.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 108.069 172.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.63 -53.62 42.94 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.083 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.73 177.34 8.61 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.989 1.793 . . . . 0.0 111.453 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.8 mt -127.92 70.13 77.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.66 -21.83 5.84 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.697 2.265 . . . . 0.0 113.257 -169.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 16.9 pt-20 -139.53 -25.85 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 51.7 Cg_exo -56.72 146.47 77.06 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 122.909 2.075 . . . . 0.0 111.613 170.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -153.1 147.11 18.55 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.024 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.76 139.35 19.1 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.497 2.131 . . . . 0.0 111.284 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.98 60.16 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.915 1.245 . . . . 0.0 112.287 -173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -88.64 153.85 20.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.425 1.612 . . . . 0.0 110.987 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.77 143.43 36.12 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mm -121.92 124.82 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.72 152.96 18.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.82 116.03 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -171.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 111.71 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 -89.62 170.51 10.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.333 1.053 . . . . 0.0 108.244 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.22 -31.32 55.12 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.02 2.48 . . . . 0.0 115.841 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.79 16.15 1.24 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.291 1.037 . . . . 0.0 111.814 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -154.48 -158.78 0.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.016 1.326 . . . . 0.0 108.999 -171.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.29 157.35 44.92 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.99 -1.069 . . . . 0.0 109.879 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -128.82 169.08 14.99 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.964 1.705 . . . . 0.0 106.749 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -135.37 146.0 47.93 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.569 0.622 . . . . 0.0 111.7 -173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.54 171.97 15.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.168 1.787 . . . . 0.0 108.422 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.36 134.72 63.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.08 130.04 35.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.77 -14.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.81 168.64 34.99 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 -32.17 8.15 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -168.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -133.6 12.89 4.85 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.159 -1.356 . . . . 0.0 113.671 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -124.05 149.71 45.78 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.103 1.952 . . . . 0.0 112.175 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.86 159.46 43.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.181 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.43 140.33 27.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 167.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -159.25 171.92 18.97 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.771 0.429 . . . . 0.0 111.281 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.05 143.91 33.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 169.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 161.68 51.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.224 1.81 . . . . 0.0 109.149 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.01 148.39 58.36 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.661 2.24 . . . . 0.0 111.768 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.07 -15.28 25.96 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.965 2.443 . . . . 0.0 111.678 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -58.67 159.58 6.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.815 2.446 . . . . 0.0 112.508 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.72 24.08 3.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 111.276 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -70.66 170.22 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.383 1.073 . . . . 0.0 110.681 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.51 77.42 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.172 0.989 . . . . 0.0 111.799 170.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.6 -174.35 42.66 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.7 69.33 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.216 0.607 . . . . 0.0 112.027 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.6 -157.68 33.4 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.594 0.616 . . . . 0.0 111.994 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -14.69 38.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.26 1.024 . . . . 0.0 113.703 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.6 -26.25 68.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.937 0.789 . . . . 0.0 111.78 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m 54.79 22.91 4.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.934 1.294 . . . . 0.0 112.768 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.03 152.26 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 125.285 1.434 . . . . 0.0 107.248 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.3 tpp -78.84 73.2 5.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.643 0.777 . . . . 0.0 108.95 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.1 m -56.43 -27.08 55.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.851 0.86 . . . . 0.0 113.247 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.07 -8.98 57.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.129 0.972 . . . . 0.0 113.18 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.23 146.3 44.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.963 0.887 . . . . 0.0 109.603 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -141.01 173.92 11.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.646 2.779 . . . . 0.0 104.276 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -74.21 48.55 0.32 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.54 1.518 . . . . 0.0 112.476 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -134.64 163.51 29.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.252 2.621 . . . . 0.0 107.721 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -155.95 175.92 13.32 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.628 1.171 . . . . 0.0 108.758 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.0 159.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.26 134.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.43 166.9 22.73 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.377 1.071 . . . . 0.0 109.622 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -118.29 132.7 56.28 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -150.44 160.99 43.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.448 1.099 . . . . 0.0 108.617 -173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.09 126.8 30.33 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.62 -46.13 66.89 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.428 1.091 . . . . 0.0 110.632 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -65.2 -21.73 66.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.12 -41.6 20.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.686 0.676 . . . . 0.0 110.375 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.34 -41.17 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.367 0.667 . . . . 0.0 110.061 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.14 1.83 12.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.304 1.441 . . . . 0.0 113.756 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.01 -25.44 31.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.024 1.297 . . . . 0.0 115.175 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -57.72 -45.88 85.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.855 1.327 . . . . 0.0 112.338 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -164.04 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 123.669 0.788 . . . . 0.0 112.4 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -156.76 176.96 12.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.635 1.174 . . . . 0.0 109.292 -165.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -152.62 168.26 26.21 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.943 1.297 . . . . 0.0 108.417 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -155.41 157.8 37.61 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.254 0.622 . . . . 0.0 110.056 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.0 135.26 28.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -149.44 62.0 1.02 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -63.31 85.29 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.529 1.131 . . . . 0.0 110.655 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.41 114.06 0.63 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.001 1.721 . . . . 0.0 110.17 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.6 m80 52.82 40.19 30.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.469 1.508 . . . . 0.0 113.255 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.88 -15.3 1.27 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 167.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -82.9 -20.19 35.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.206 1.802 . . . . 0.0 111.468 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -131.27 -18.78 2.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.047 0.939 . . . . 0.0 112.448 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -140.99 -167.92 2.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.418 1.487 . . . . 0.0 109.7 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m 57.3 68.82 1.85 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.228 1.411 . . . . 0.0 112.31 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.77 -16.47 37.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.429 2.086 . . . . 0.0 113.386 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -73.67 142.32 80.45 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.619 1.168 . . . . 0.0 110.005 -172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.93 154.07 53.04 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.29 1.993 . . . . 0.0 109.641 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.0 m -55.62 -34.85 65.25 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.846 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 p -52.91 -60.3 3.45 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.081 0.952 . . . . 0.0 110.82 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -61.32 -38.43 86.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.611 1.164 . . . . 0.0 111.503 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.06 -51.67 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.28 -44.22 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.628 0.771 . . . . 0.0 109.231 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -42.8 89.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.051 0.541 . . . . 0.0 110.131 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -68.09 -45.79 72.78 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.776 -0.63 . . . . 0.0 109.569 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.3 -50.38 59.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.447 0.567 . . . . 0.0 110.855 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.16 -19.94 59.61 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -71.68 -28.35 63.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.984 1.266 . . . . 0.0 108.904 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 mt -88.54 -16.38 32.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.06 0.944 . . . . 0.0 111.869 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.92 129.43 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 119.65 1.114 . . . . 0.0 108.895 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.15 -3.37 86.85 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.285 -1.286 . . . . 0.0 112.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -84.2 164.1 19.32 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.604 1.702 . . . . 0.0 109.344 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -123.92 148.48 46.83 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.781 -168.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.56 161.13 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.234 1.014 . . . . 0.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.05 32.28 5.83 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.437 1.113 . . . . 0.0 111.561 -168.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -132.86 147.23 52.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.218 1.407 . . . . 0.0 109.265 170.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -67.92 166.02 16.51 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.787 2.035 . . . . 0.0 111.587 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 mt -69.51 127.55 33.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 167.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 73.1 p -144.22 151.58 39.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 166.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.0 m -55.0 -36.33 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 122.168 -0.332 . . . . 0.0 110.915 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -71.76 -40.18 69.49 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.728 0.411 . . . . 0.0 110.567 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.6 -40.73 92.97 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.865 0.757 . . . . 0.0 110.239 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.4 m -64.82 -45.27 86.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.099 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.69 -45.02 93.36 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.182 0.447 . . . . 0.0 110.143 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -59.39 -50.21 74.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.586 1.154 . . . . 0.0 109.718 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -59.69 -52.41 65.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.102 0.41 . . . . 0.0 111.392 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.9 m -64.65 -32.5 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.895 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -67.24 -36.37 81.51 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.698 -0.626 . . . . 0.0 111.077 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.19 -46.5 62.17 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.242 1.017 . . . . 0.0 109.661 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.26 -46.26 70.93 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.158 0.583 . . . . 0.0 111.346 -177.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -76.98 -33.85 57.59 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.89 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -94.13 -48.26 6.29 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.028 0.376 . . . . 0.0 110.881 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.86 -51.41 0.6 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.17 128.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -147.25 160.19 42.78 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.747 1.219 . . . . 0.0 108.364 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.31 150.68 84.19 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 122.688 0.395 . . . . 0.0 110.678 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.36 -175.5 2.45 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.022 2.481 . . . . 0.0 112.177 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.3 pt -130.95 59.49 46.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 126.407 1.883 . . . . 0.0 108.312 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.66 -49.32 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.415 2.076 . . . . 0.0 112.605 -167.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -166.17 71.26 1.2 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.637 1.575 . . . . 0.0 109.842 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.89 143.5 59.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.338 2.025 . . . . 0.0 111.259 170.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -133.49 155.76 80.33 Favored Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 124.979 1.312 . . . . 0.0 108.973 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.31 131.74 18.62 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.363 2.708 . . . . 0.0 112.529 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 -0.68 84.09 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.899 1.238 . . . . 0.0 113.036 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -72.37 143.74 48.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 120.288 2.044 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -71.84 131.27 42.79 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 171.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.8 mm -114.96 145.12 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.91 143.7 49.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 117.04 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.07 138.27 43.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -117.19 167.21 11.28 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.379 1.472 . . . . 0.0 107.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.92 -24.9 33.47 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.018 2.479 . . . . 0.0 115.754 -174.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -141.4 4.85 1.81 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.191 0.996 . . . . 0.0 113.209 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -158.22 -158.25 0.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.976 0.91 . . . . 0.0 110.199 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -153.09 141.27 20.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -127.46 165.31 20.06 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.416 1.486 . . . . 0.0 107.607 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -128.95 145.94 51.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.352 0.524 . . . . 0.0 110.008 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 169.86 22.23 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.951 1.7 . . . . 0.0 108.531 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.1 tt -140.46 126.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 121.368 -0.832 . . . . 0.0 109.534 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -72.24 132.11 43.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.062 1.345 . . . . 0.0 110.015 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.55 166.55 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.24 1.416 . . . . 0.0 108.873 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.04 21.5 38.63 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.531 -0.731 . . . . 0.0 114.255 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t0 39.26 50.66 1.97 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.869 2.068 . . . . 0.0 113.514 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.1 -11.55 0.1 OUTLIER Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.925 -0.484 . . . . 0.0 113.546 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.17 170.62 7.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.696 1.198 . . . . 0.0 108.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.84 148.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.402 0.681 . . . . 0.0 109.639 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 t -97.56 136.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 171.67 18.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.413 0.551 . . . . 0.0 111.019 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 151.12 36.76 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 158.1 64.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.501 2.32 . . . . 0.0 107.676 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.47 153.95 71.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 110.938 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.69 -21.81 18.64 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.906 2.404 . . . . 0.0 111.703 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.08 164.54 15.22 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.998 2.119 . . . . 0.0 112.768 -172.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -150.87 162.88 39.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.9 t -50.56 -29.65 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.266 1.426 . . . . 0.0 112.646 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.39 162.01 41.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.649 1.18 . . . . 0.0 108.975 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.96 -71.16 1.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.088 1.328 . . . . 0.0 111.876 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.67 -5.87 56.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.804 0.842 . . . . 0.0 112.259 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.8 -161.69 28.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.42 7.13 8.98 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 111.17 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 152.71 19.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.304 2.241 . . . . 0.0 106.057 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 m -82.3 33.25 0.4 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 111.637 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 m -140.25 172.29 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.441 1.496 . . . . 0.0 109.387 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.3 mmt -66.57 16.07 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -58.96 -36.68 75.23 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.433 -1.417 . . . . 0.0 109.55 167.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.97 51.17 1.98 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.795 1.238 . . . . 0.0 109.725 169.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.8 tp -48.34 118.29 2.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.495 1.518 . . . . 0.0 110.59 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -147.79 153.42 39.18 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.31 55.98 3.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.582 1.182 . . . . 0.0 109.528 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.39 164.49 29.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.171 1.788 . . . . 0.0 108.724 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.79 13.1 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.823 0.849 . . . . 0.0 109.35 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -134.01 158.85 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.29 132.22 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -136.67 169.05 18.36 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.059 0.944 . . . . 0.0 109.79 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.59 133.02 54.56 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -148.55 161.19 42.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.209 1.403 . . . . 0.0 107.753 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.15 133.26 47.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.13 -43.83 74.49 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.684 0.674 . . . . 0.0 110.678 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -65.07 -21.58 66.84 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.81 -46.06 19.55 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.897 0.771 . . . . 0.0 110.238 171.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.03 -40.11 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 110.294 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.1 -20.73 59.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.964 1.305 . . . . 0.0 112.512 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.35 -12.5 25.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.59 1.091 . . . . 0.0 113.226 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.7 m -50.34 -48.93 55.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.437 1.119 . . . . 0.0 110.915 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -167.84 -61.11 0.03 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.264 1.826 . . . . 0.0 109.239 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -160.92 171.31 18.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.149 2.179 . . . . 0.0 107.126 -167.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -153.36 164.01 38.9 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.571 -0.706 . . . . 0.0 110.607 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -138.77 158.01 45.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.881 1.672 . . . . 0.0 109.851 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 130.93 40.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -148.8 70.86 1.12 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -69.12 88.3 0.42 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -64.93 119.84 11.45 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.21 53.06 9.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.794 1.638 . . . . 0.0 111.786 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -51.86 -20.66 2.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.987 1.315 . . . . 0.0 113.248 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.71 -27.12 31.41 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -100.64 -20.32 15.7 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.024 0.929 . . . . 0.0 111.339 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -129.93 -174.09 3.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.765 0.793 . . . . 0.0 112.7 -168.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m 52.51 62.71 9.9 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.531 1.932 . . . . 0.0 113.919 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 -12.14 28.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.462 2.108 . . . . 0.0 113.732 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.97 142.74 97.56 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.424 1.089 . . . . 0.0 110.594 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.92 142.48 84.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.165 1.91 . . . . 0.0 108.944 167.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p -54.21 -43.2 70.57 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.443 0.297 . . . . 0.0 111.401 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.71 -44.73 73.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.138 0.975 . . . . 0.0 112.1 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -63.32 -34.37 77.55 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 124.203 1.001 . . . . 0.0 111.591 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.5 -48.36 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.69 -47.22 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -44.61 81.87 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.412 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -60.71 -52.98 62.79 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.294 0.952 . . . . 0.0 109.367 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.36 60.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.664 0.386 . . . . 0.0 111.189 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.82 -16.69 50.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.6 -29.02 56.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 119.904 1.229 . . . . 0.0 109.073 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.3 mt -88.57 -11.71 44.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.972 0.909 . . . . 0.0 111.852 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.6 t -56.13 129.88 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 119.592 1.087 . . . . 0.0 108.925 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.29 -0.04 89.89 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.403 -1.221 . . . . 0.0 112.984 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -86.57 166.01 15.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.292 1.546 . . . . 0.0 109.4 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -120.55 149.51 42.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.319 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.17 147.16 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.706 1.202 . . . . 0.0 108.221 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -104.72 39.8 1.62 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.731 1.253 . . . . 0.0 111.153 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -141.08 149.72 41.99 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.469 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -60.28 148.54 36.37 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.947 1.299 . . . . 0.0 110.187 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 54.24 0.28 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.758 1.623 . . . . 0.0 113.266 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.8 p -64.26 161.69 16.12 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.655 -1.278 . . . . 0.0 109.206 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.56 -44.67 62.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.128 0.971 . . . . 0.0 110.309 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.67 -41.33 75.63 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.84 0.856 . . . . 0.0 110.893 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.42 -29.02 65.51 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.143 0.883 . . . . 0.0 111.294 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.7 m -69.87 -42.52 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.223 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.16 -43.98 95.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.346 0.521 . . . . 0.0 110.021 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -57.15 -58.23 9.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.032 1.733 . . . . 0.0 109.493 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -53.39 -54.88 30.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.754 0.421 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.8 p -66.02 -27.37 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.405 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -70.24 -29.4 66.19 Favored 'General case' 0 C--N 1.338 0.075 0 O-C-N 121.348 -0.845 . . . . 0.0 111.144 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.0 -23.47 63.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.445 1.02 . . . . 0.0 112.094 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.88 -47.78 7.66 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.62 1.1 . . . . 0.0 110.115 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 -86.54 -45.59 10.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.451 0.568 . . . . 0.0 112.221 -172.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -83.46 -48.32 10.44 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.54 -25.14 3.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.033 0.825 . . . . 0.0 111.634 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.4 t -144.42 149.91 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.38 169.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 40.67 45.24 1.99 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.455 1.902 . . . . 0.0 113.804 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.52 147.5 76.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 0.0 110.334 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.75 177.47 6.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.433 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 pt -121.67 74.19 33.83 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.343 1.457 . . . . 0.0 107.725 170.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -21.13 26.83 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.735 2.29 . . . . 0.0 112.63 -171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 44.8 mt-10 -131.57 -39.74 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.184 -1.389 . . . . 0.0 113.303 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 39.9 Cg_exo -57.43 137.35 81.11 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.396 2.064 . . . . 0.0 111.259 172.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.29 146.88 34.89 Favored Pre-proline 0 C--O 1.235 0.325 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.98 140.12 24.53 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.693 2.262 . . . . 0.0 110.983 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.36 -10.83 71.04 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.1 1.333 . . . . 0.0 112.313 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.89 156.09 23.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.31 2.055 . . . . 0.0 110.652 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.1 139.02 41.15 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.06 141.85 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -120.53 151.54 39.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -122.79 110.97 28.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.86 100.69 2.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -80.33 166.47 39.8 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.273 1.029 . . . . 0.0 108.919 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -51.01 -30.81 32.32 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.478 2.785 . . . . 0.0 116.379 -171.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -145.55 14.71 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.094 0.957 . . . . 0.0 112.213 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -155.81 -159.2 0.88 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.892 1.277 . . . . 0.0 108.717 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.4 159.5 43.62 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.773 -1.204 . . . . 0.0 109.938 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -132.37 168.0 18.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.929 1.291 . . . . 0.0 107.612 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -137.37 147.27 45.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.804 0.729 . . . . 0.0 110.694 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.37 174.83 14.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.988 1.715 . . . . 0.0 108.569 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 tt -133.18 131.64 58.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.66 130.09 41.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.098 1.359 . . . . 0.0 108.795 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.84 165.3 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 109.065 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.51 -158.36 18.25 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.91 -29.53 55.74 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.942 -0.74 . . . . 0.0 112.221 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.99 26.97 0.19 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.896 0.76 . . . . 0.0 113.359 -173.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -100.58 170.55 8.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.141 0.97 . . . . 0.0 109.394 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.72 153.28 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 123.229 0.612 . . . . 0.0 109.635 168.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.88 137.72 29.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.12 169.03 25.12 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 121.983 -0.448 . . . . 0.0 110.932 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.57 138.7 34.17 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.13 160.07 56.45 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 125.076 1.351 . . . . 0.0 109.536 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.88 145.16 24.98 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.328 2.685 . . . . 0.0 111.757 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.47 -46.46 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.857 1.705 . . . . 0.0 111.554 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.6 m -139.5 25.96 2.38 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.225 1.01 . . . . 0.0 111.084 -170.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 51.71 40.84 28.34 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.481 1.512 . . . . 0.0 111.584 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -49.76 -19.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 128.239 2.616 . . . . 0.0 115.664 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.94 27.53 2.94 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.265 1.026 . . . . 0.0 110.361 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.07 -27.5 0.06 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.112 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.99 -25.5 67.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.01 1.405 . . . . 0.0 112.561 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.46 -36.98 1.24 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.538 1.542 . . . . 0.0 109.311 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.02 164.01 11.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.179 0.991 . . . . 0.0 110.194 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.21 165.78 35.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.923 1.289 . . . . 0.0 108.556 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.1 m -62.88 3.77 0.21 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.73 1.612 . . . . 0.0 114.111 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -62.21 -19.89 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.842 0.857 . . . . 0.0 111.131 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.43 -168.66 2.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.014 1.726 . . . . 0.0 108.885 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -52.78 -12.52 0.31 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.459 2.304 . . . . 0.0 116.662 -169.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -16.38 60.14 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.616 1.098 . . . . 0.0 111.948 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 tp -49.05 116.26 1.6 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.043 1.337 . . . . 0.0 108.818 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -148.26 162.8 38.76 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.037 1.735 . . . . 0.0 106.709 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -133.35 21.41 4.01 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.751 0.82 . . . . 0.0 112.405 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -97.13 173.8 7.06 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.907 1.683 . . . . 0.0 110.71 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.41 169.09 18.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.185 1.394 . . . . 0.0 108.128 166.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.78 146.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 t -85.51 122.25 38.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -127.25 165.82 18.93 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.309 1.044 . . . . 0.0 109.715 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -125.69 131.29 52.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -148.38 163.57 36.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.014 1.326 . . . . 0.0 107.787 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.69 140.18 58.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.14 -42.7 73.4 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -60.46 -29.77 69.25 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.964 0.906 . . . . 0.0 112.062 -173.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.43 -40.07 27.02 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.21 0.459 . . . . 0.0 110.838 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.68 -37.59 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.335 0.654 . . . . 0.0 109.826 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.54 30.7 0.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.026 1.731 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.81 -23.58 30.5 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.072 0.844 . . . . 0.0 112.918 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 -4.54 5.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.887 1.675 . . . . 0.0 113.654 171.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.4 t70 61.49 16.46 7.59 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.897 2.479 . . . . 0.0 114.576 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -149.46 124.62 10.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.888 1.675 . . . . 0.0 108.739 -169.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -164.8 164.31 21.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -155.77 161.56 40.65 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.599 0.76 . . . . 0.0 110.865 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.61 138.17 22.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -145.85 66.18 1.21 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.31 0.576 . . . . 0.0 109.935 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.38 131.78 38.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 122.896 0.478 . . . . 0.0 110.469 169.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -103.77 3.02 33.61 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' ASP . 75.7 m-70 -132.2 23.5 4.49 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.847 0.859 . . . . 0.0 112.088 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.07 21.31 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.044 -1.035 . . . . 0.0 112.593 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' HIS . 37.9 t70 -127.36 -9.33 5.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 111.611 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -127.6 -31.85 2.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.084 1.354 . . . . 0.0 111.609 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 66.21 134.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 128.605 2.762 . . . . 0.0 115.728 173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -61.0 136.76 93.79 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.914 -172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.43 -16.76 34.78 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.599 2.199 . . . . 0.0 111.862 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.08 125.38 35.4 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 108.235 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.17 154.63 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.812 2.341 . . . . 0.0 111.374 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.26 -38.86 69.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.327 0.651 . . . . 0.0 112.181 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -54.96 -53.15 59.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.905 0.882 . . . . 0.0 110.498 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.81 -34.78 78.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.161 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.8 -50.83 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.061 0.846 . . . . 0.0 108.889 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.29 -45.6 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 123.536 0.734 . . . . 0.0 109.112 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -64.37 -46.56 82.84 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.85 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.29 -51.92 55.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.692 0.678 . . . . 0.0 110.405 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.82 -21.72 59.13 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.7 mt -99.14 -4.13 32.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 112.476 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.75 150.71 8.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.341 1.056 . . . . 0.0 109.344 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.28 24.67 53.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.313 -0.715 . . . . 0.0 112.269 171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -124.06 159.98 28.71 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.585 1.154 . . . . 0.0 108.071 171.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -109.6 153.45 24.17 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.312 1.445 . . . . 0.0 109.53 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.07 152.29 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.374 1.47 . . . . 0.0 107.353 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -99.58 8.22 44.62 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.835 0.454 . . . . 0.0 112.224 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -95.42 147.11 23.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 167.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -74.12 162.87 28.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.446 1.098 . . . . 0.0 111.799 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.08 125.33 23.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.6 p -145.75 154.53 42.15 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 104.918 -2.252 . . . . 0.0 104.918 167.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.1 m -55.94 -34.37 65.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.817 0.447 . . . . 0.0 111.206 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.97 -38.61 44.72 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.451 0.701 . . . . 0.0 111.174 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -68.24 -35.77 78.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.528 1.058 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -66.34 -47.7 72.64 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -56.27 -44.63 79.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.319 1.048 . . . . 0.0 110.377 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -57.73 -56.79 17.43 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.018 1.327 . . . . 0.0 109.135 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.416 ' CE2' HD11 ' A' ' 120' ' ' LEU . 24.2 t80 -58.68 -48.1 82.24 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.1 -29.35 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.543 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -73.36 -30.53 63.37 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.712 0.687 . . . . 0.0 111.64 175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.88 -37.9 80.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.305 0.957 . . . . 0.0 110.09 170.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 116' ' ' PHE . 73.0 mt -73.16 -50.14 24.27 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.683 0.674 . . . . 0.0 110.243 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -64.8 -26.37 68.31 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.066 0.946 . . . . 0.0 112.349 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -140.77 3.28 1.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -168.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.38 -32.52 5.44 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.853 -1.154 . . . . 0.0 111.876 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -155.39 146.63 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.023 1.329 . . . . 0.0 107.576 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.277 0.631 . . . . 0.0 110.727 172.306 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 64.23 -38.41 0.21 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.199 2.6 . . . . 0.0 115.355 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.73 72.51 77.35 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.702 1.201 . . . . 0.0 109.54 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.12 -12.38 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.08 2.52 . . . . 0.0 113.943 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mm 57.05 68.58 2.01 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.769 1.628 . . . . 0.0 109.197 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.73 -23.96 16.19 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.312 2.008 . . . . 0.0 112.584 -174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.597 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 44.1 mt-10 -142.3 -36.8 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.824 -171.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 27.9 Cg_exo -59.49 155.39 41.95 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.135 1.89 . . . . 0.0 113.421 -176.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.04 55.07 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.245 1.418 . . . . 0.0 109.026 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.62 135.74 27.24 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.769 2.313 . . . . 0.0 111.646 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.18 -13.61 57.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.321 1.439 . . . . 0.0 111.714 -169.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.21 142.86 32.78 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.144 1.472 . . . . 0.0 111.312 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.18 140.55 45.2 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 mm -123.31 129.19 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.08 147.65 25.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.7 mm -124.49 103.68 12.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 -168.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.45 141.64 57.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.06 168.61 13.01 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.503 1.521 . . . . 0.0 107.935 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.86 -27.96 17.06 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.512 2.808 . . . . 0.0 117.059 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -145.8 13.78 1.34 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.609 0.764 . . . . 0.0 112.021 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.32 -163.86 1.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.511 1.124 . . . . 0.0 109.475 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' NE ' ' HE1' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -144.11 159.72 42.15 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.214 -0.929 . . . . 0.0 109.931 173.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -131.2 170.69 14.23 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.613 2.365 . . . . 0.0 107.046 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.42 ' HE1' ' NE ' ' A' ' 22' ' ' ARG . 77.9 m95 -136.49 146.27 46.09 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.935 0.789 . . . . 0.0 111.448 -174.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.19 172.42 14.35 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.127 2.171 . . . . 0.0 108.046 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.8 tt -137.4 133.36 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.65 127.71 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.16 -3.96 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -169.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.03 -175.19 34.67 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.09 -28.09 66.18 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.87 0.835 . . . . 0.0 113.072 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.9 13.22 1.13 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.216 -1.324 . . . . 0.0 114.136 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -117.31 153.19 33.4 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.963 1.881 . . . . 0.0 111.516 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.7 m -132.16 155.05 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.061 1.345 . . . . 0.0 110.073 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.1 142.3 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 167.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.4 173.62 14.66 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.276 0.631 . . . . 0.0 110.73 176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.6 141.72 33.45 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.62 157.95 66.85 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.54 1.936 . . . . 0.0 107.427 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.77 151.49 69.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.181 1.457 . . . . 0.0 110.51 176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.68 -25.97 68.8 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.211 1.941 . . . . 0.0 111.367 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -52.25 -24.2 6.94 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.282 2.233 . . . . 0.0 113.859 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -82.93 2.71 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 t -141.84 -54.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.587 1.155 . . . . 0.0 111.205 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.38 16.94 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.56 0.744 . . . . 0.0 111.836 -168.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.94 171.09 43.69 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.62 -22.95 66.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.004 0.521 . . . . 0.0 112.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.36 -173.85 46.47 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 126.273 1.892 . . . . 0.0 108.545 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.13 111.81 2.37 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 153.24 42.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.289 0.636 . . . . 0.0 110.38 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -62.43 -45.75 91.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.051 0.94 . . . . 0.0 110.119 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -144.38 152.6 15.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 127.289 2.236 . . . . 0.0 106.169 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -57.86 -25.66 61.01 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 m -56.16 -30.48 62.25 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.433 1.093 . . . . 0.0 112.504 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.07 -6.72 47.47 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.464 0.706 . . . . 0.0 112.806 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.1 tp -128.62 -18.55 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.907 1.283 . . . . 0.0 111.605 -175.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 m -105.74 5.49 31.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.777 1.275 . . . . 0.0 110.08 -172.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.8 19.37 4.8 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.858 2.063 . . . . 0.0 111.561 169.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -136.31 171.24 14.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 129.336 3.054 . . . . 0.0 107.871 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.9 168.91 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.594 0.712 . . . . 0.0 111.304 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 pt -147.11 154.97 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.918 1.687 . . . . 0.0 106.692 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 t -83.42 129.7 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -135.44 159.0 42.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.279 1.432 . . . . 0.0 107.954 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -127.38 131.25 50.36 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -151.54 163.36 39.21 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.784 1.233 . . . . 0.0 108.893 -171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.21 131.78 45.99 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -53.61 -40.87 66.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.395 1.078 . . . . 0.0 110.963 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -61.92 -27.92 69.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.873 0.469 . . . . 0.0 111.638 -171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.71 -45.15 46.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.469 0.577 . . . . 0.0 110.402 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 t -64.17 -39.48 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.615 0.766 . . . . 0.0 109.757 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.64 -11.77 19.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.267 1.427 . . . . 0.0 113.169 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.16 -10.43 65.54 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.655 1.116 . . . . 0.0 113.071 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.1 m -56.14 -54.22 47.77 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.646 1.223 . . . . 0.0 112.339 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.23 -49.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.661 1.584 . . . . 0.0 110.145 169.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -166.73 -176.12 3.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.863 2.065 . . . . 0.0 107.673 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -152.02 165.45 34.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.54 1.064 . . . . 0.0 110.282 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -148.38 147.32 29.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.243 1.417 . . . . 0.0 109.089 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.03 132.01 33.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -149.83 73.04 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -67.5 101.96 1.07 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -59.23 124.52 20.24 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 m80 46.31 42.26 10.15 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 113.206 169.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -59.4 -10.82 3.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.562 0.745 . . . . 0.0 112.499 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -90.17 -17.87 26.82 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.971 2.109 . . . . 0.0 111.427 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -131.09 -16.83 3.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.074 0.95 . . . . 0.0 112.357 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -141.35 -161.07 1.16 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.186 1.794 . . . . 0.0 108.372 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 66.39 2.17 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.859 1.664 . . . . 0.0 112.953 -170.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.55 -22.18 58.49 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.571 2.181 . . . . 0.0 114.441 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.14 141.17 39.98 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 111.264 -168.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.15 161.85 39.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.64 2.227 . . . . 0.0 109.762 169.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 65.1 m -52.4 -40.96 62.74 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.634 0.774 . . . . 0.0 111.682 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -54.44 -54.23 43.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.293 0.637 . . . . 0.0 111.103 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.37 -37.98 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.337 1.055 . . . . 0.0 111.695 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.0 mt -59.29 -49.26 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.39 -46.21 93.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.683 0.793 . . . . 0.0 108.861 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.97 -43.89 86.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.085 0.554 . . . . 0.0 110.113 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -62.95 -50.73 69.66 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.23 67.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.562 0.345 . . . . 0.0 111.107 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.94 -20.84 55.65 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.213 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -69.0 -35.5 76.77 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.74 1.155 . . . . 0.0 109.486 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.38 -10.15 52.86 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.4 133.73 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.516 1.053 . . . . 0.0 109.063 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.0 -8.07 76.3 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.484 -1.176 . . . . 0.0 112.88 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -71.89 157.58 37.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.453 1.626 . . . . 0.0 109.264 171.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -126.58 144.23 50.96 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.44 146.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.055 0.942 . . . . 0.0 110.35 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.46 -9.87 42.97 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.228 -0.92 . . . . 0.0 112.924 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -75.67 154.61 36.41 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.556 0.616 . . . . 0.0 110.498 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -81.37 158.38 24.69 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.871 1.668 . . . . 0.0 110.022 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 108' ' ' LEU . 3.0 mm? -59.72 121.35 11.43 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.5 p -143.68 159.02 43.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -52.49 -45.33 66.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.799 0.44 . . . . 0.0 109.904 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.79 -46.34 79.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.939 0.896 . . . . 0.0 110.827 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -67.33 -41.41 85.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.65 0.659 . . . . 0.0 110.722 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.17 -41.62 81.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.265 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -61.1 -40.6 94.38 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.199 0.6 . . . . 0.0 110.394 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -63.82 -55.76 20.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.415 1.086 . . . . 0.0 110.138 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 120' ' ' LEU . 7.0 t80 -57.59 -48.41 79.46 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.327 0.512 . . . . 0.0 110.883 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.4 -30.95 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.48 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -72.45 -25.55 61.49 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.422 -0.799 . . . . 0.0 111.817 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.35 -38.92 69.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.184 0.902 . . . . 0.0 110.319 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.403 HD11 ' CE2' ' A' ' 116' ' ' PHE . 11.4 mt -74.39 -43.42 56.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.355 0.662 . . . . 0.0 110.2 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 tpt85 -72.58 -31.98 65.65 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.527 -172.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -104.02 -36.46 7.73 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.037 0.535 . . . . 0.0 112.125 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.73 -37.17 3.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.972 1.273 . . . . 0.0 110.599 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -147.18 135.28 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 123.078 0.551 . . . . 0.0 110.71 -179.698 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -149.92 171.4 16.86 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.673 1.189 . . . . 0.0 109.343 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.68 140.27 80.87 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.412 0.685 . . . . 0.0 111.764 -170.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.97 -179.67 5.42 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.626 2.884 . . . . 0.0 111.746 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.31 73.64 72.9 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.804 1.642 . . . . 0.0 107.653 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.08 -40.1 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.361 2.041 . . . . 0.0 112.366 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.06 45.22 0.19 Allowed Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.513 1.125 . . . . 0.0 113.084 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -59.97 130.49 34.88 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.385 1.53 . . . . 0.0 109.823 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -83.91 144.09 44.24 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.07 129.33 24.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 109.745 169.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.83 3.86 67.93 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.308 0.956 . . . . 0.0 113.205 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -71.1 136.19 48.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.663 1.732 . . . . 0.0 110.216 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.48 138.04 54.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.92 133.5 66.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -104.65 146.37 29.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.2 mm -127.48 115.35 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 104.513 -2.402 . . . . 0.0 104.513 -169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -73.35 140.21 46.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 170.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -128.66 167.72 18.31 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.982 0.913 . . . . 0.0 109.718 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.33 -26.79 36.28 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.19 2.593 . . . . 0.0 116.576 -169.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -143.24 6.73 1.53 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.293 1.037 . . . . 0.0 112.942 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -160.97 -168.66 2.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.889 1.276 . . . . 0.0 108.949 -169.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 7.1 ppt_? -136.24 161.03 36.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 121.65 -0.656 . . . . 0.0 109.44 169.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -137.09 169.09 18.37 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.343 1.857 . . . . 0.0 107.986 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.402 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 67.2 m95 -138.7 148.35 43.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.624 0.769 . . . . 0.0 110.591 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 174.97 11.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.321 1.848 . . . . 0.0 107.934 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tt -133.13 134.0 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.43 133.23 48.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.075 1.35 . . . . 0.0 109.009 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 m -139.0 165.8 23.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.123 0.969 . . . . 0.0 109.967 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.44 -121.07 18.72 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.354 -2.299 . . . . 0.0 107.354 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -146.06 51.24 1.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.52 -12.16 0.11 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.522 -0.599 . . . . 0.0 114.164 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -92.77 171.68 8.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.531 1.166 . . . . 0.0 109.101 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.23 157.35 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.194 0.998 . . . . 0.0 110.052 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.98 138.19 48.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 168.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 169.47 22.79 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.082 0.953 . . . . 0.0 110.396 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.85 140.46 32.89 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.52 163.66 23.31 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.672 1.189 . . . . 0.0 109.326 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.28 156.31 30.94 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.567 2.178 . . . . 0.0 112.134 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -55.25 132.89 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.034 2.489 . . . . 0.0 110.247 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -64.2 -19.27 65.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.53 12.63 10.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.612 0.765 . . . . 0.0 111.756 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.257 15.4 m 47.24 -39.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.61 1 C-N-CA 131.765 4.026 . . . . 0.0 118.633 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 166.68 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.592 1.542 . . . . 0.0 110.21 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.23 21.48 0.15 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.044 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.78 158.33 39.32 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.17 1.388 . . . . 0.0 108.615 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.32 -13.78 58.65 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.077 0.846 . . . . 0.0 113.425 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -8.69 23.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.576 1.151 . . . . 0.0 113.078 172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.19 166.58 23.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.085 1.354 . . . . 0.0 109.746 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.3 m -138.18 40.86 2.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.866 1.267 . . . . 0.0 110.286 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.265 28.6 m 51.05 18.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 127.439 2.296 . . . . 0.0 114.79 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -10.73 59.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.882 1.273 . . . . 0.0 112.515 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.07 17.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.735 2.014 . . . . 0.0 115.964 -168.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.26 -27.88 64.42 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.093 -1.005 . . . . 0.0 109.877 168.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 tp -149.52 131.0 14.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.31 172.16 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -174.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -76.33 26.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -136.7 161.9 34.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.878 2.471 . . . . 0.0 108.628 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.11 172.96 13.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.752 1.221 . . . . 0.0 109.108 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.12 150.26 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -83.21 132.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -137.23 164.9 27.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.291 1.436 . . . . 0.0 109.525 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -125.62 141.31 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -149.92 156.46 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.779 1.232 . . . . 0.0 107.923 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.57 137.47 52.4 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -52.06 -37.74 54.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -53.51 -36.27 61.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.217 0.607 . . . . 0.0 112.147 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.92 -35.26 80.6 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.689 0.396 . . . . 0.0 111.315 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -86.67 -41.58 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.878 0.871 . . . . 0.0 109.017 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.42 -21.83 65.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.359 1.064 . . . . 0.0 112.725 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -61.14 -11.12 24.56 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.545 -1.142 . . . . 0.0 113.728 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.9 m -56.05 -55.49 32.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.956 1.378 . . . . 0.0 111.787 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -166.57 -60.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.323 1.449 . . . . 0.0 110.398 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -159.36 173.74 15.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.275 1.43 . . . . 0.0 108.765 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -162.63 160.53 25.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -154.56 162.58 41.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.622 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.62 138.75 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -152.39 73.75 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.436 0.694 . . . . 0.0 109.587 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.24 92.32 0.41 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.96 131.97 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 49.28 34.93 6.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.842 1.657 . . . . 0.0 113.336 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.98 -9.29 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.081 0.952 . . . . 0.0 112.773 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.98 -27.82 60.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.483 1.113 . . . . 0.0 110.628 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -127.87 -21.78 3.64 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -108.47 -160.07 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.504 1.522 . . . . 0.0 110.023 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 59.35 59.61 4.94 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.22 1.808 . . . . 0.0 112.517 -169.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.29 -13.2 38.61 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.0 1.8 . . . . 0.0 113.528 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.2 130.54 33.83 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.169 0.988 . . . . 0.0 110.673 -169.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 156.91 17.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.119 2.546 . . . . 0.0 111.302 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 62.7 m -50.06 -48.55 52.95 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.154 0.982 . . . . 0.0 111.28 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -57.34 -45.65 84.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.335 1.054 . . . . 0.0 111.966 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.5 -33.31 75.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.314 0.646 . . . . 0.0 111.313 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.79 -44.22 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.17 -45.19 99.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 CA-C-N 118.644 0.656 . . . . 0.0 109.702 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -54.67 -44.39 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.517 0.727 . . . . 0.0 110.372 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -61.9 -52.01 65.82 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.095 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.98 78.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.654 0.661 . . . . 0.0 111.442 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -71.83 -25.64 62.06 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.907 1.283 . . . . 0.0 112.255 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.94 -20.2 42.54 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.436 1.095 . . . . 0.0 109.948 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.3 mt -113.9 -13.98 12.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -167.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.37 146.11 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 120.089 1.313 . . . . 0.0 110.27 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 -4.17 84.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.964 1.269 . . . . 0.0 113.605 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.67 154.05 38.63 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.172 1.486 . . . . 0.0 108.779 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.43 147.59 27.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.62 151.49 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.764 1.225 . . . . 0.0 109.586 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.25 32.66 4.29 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.989 0.899 . . . . 0.0 111.462 -168.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -123.09 146.71 47.48 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.152 1.381 . . . . 0.0 108.835 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -62.59 159.17 16.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.37 1.868 . . . . 0.0 112.316 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.9 121.85 16.01 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 165.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 64.7 p -142.62 156.34 45.06 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.5 m -51.37 -41.82 60.93 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.681 0.793 . . . . 0.0 110.814 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -72.46 -41.79 65.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.443 1.097 . . . . 0.0 111.368 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -40.3 85.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.2 0.909 . . . . 0.0 110.343 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.53 -45.52 79.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.016 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -56.75 -46.6 81.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.629 0.772 . . . . 0.0 110.111 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -59.14 -53.73 54.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.82 0.848 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.17 -48.62 80.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.9 m -64.35 -30.61 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.469 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -70.75 -29.12 65.27 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.663 175.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 72.3 mt-10 -61.33 -34.6 75.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.829 1.195 . . . . 0.0 110.489 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.5 mt -75.5 -46.64 31.14 Favored 'General case' 0 C--O 1.228 -0.036 0 CA-C-N 118.693 0.679 . . . . 0.0 110.23 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -64.33 -40.63 96.27 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 122.981 0.512 . . . . 0.0 110.96 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.22 -33.06 10.58 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.55 -42.12 1.92 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -168.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.93 135.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' A' ' 119' ' ' GLU . . . . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.21 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -151.07 168.26 25.17 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.719 1.207 . . . . 0.0 108.009 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.89 150.15 61.46 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.5 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -67.69 176.37 5.17 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.971 2.447 . . . . 0.0 110.248 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mm -81.19 116.69 64.31 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.01 -38.39 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.769 1.646 . . . . 0.0 114.481 -166.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.12 -48.27 3.45 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.72 173.22 13.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.655 2.236 . . . . 0.0 111.898 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.43 144.78 50.6 Favored Pre-proline 0 N--CA 1.464 0.235 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 168.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.67 131.47 19.93 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.513 2.142 . . . . 0.0 110.718 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.04 27.43 7.82 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.678 1.132 . . . . 0.0 111.28 -168.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -123.19 148.0 46.26 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.701 1.751 . . . . 0.0 110.387 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.29 137.1 35.81 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.1 mm -124.15 131.11 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.88 151.12 22.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.4 mm -126.65 106.43 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.57 138.5 48.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.14 166.89 20.95 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.873 0.869 . . . . 0.0 109.169 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.51 -35.65 29.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.401 2.734 . . . . 0.0 116.174 -169.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -140.29 12.59 2.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.448 1.099 . . . . 0.0 112.065 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -160.18 -168.82 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.249 1.02 . . . . 0.0 110.179 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' NH1' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -138.07 153.91 49.29 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 175.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -135.28 170.55 15.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 126.4 1.88 . . . . 0.0 107.461 -176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.437 ' HE1' ' NH1' ' A' ' 22' ' ' ARG . 81.8 m95 -137.64 148.62 45.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.451 0.7 . . . . 0.0 111.515 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.28 171.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.142 1.777 . . . . 0.0 108.42 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.4 127.59 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -76.13 127.42 32.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.3 1.84 . . . . 0.0 108.306 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 34' ' ' VAL . 21.2 m -139.08 1.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.46 -172.29 22.18 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.94 -29.01 70.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.243 1.022 . . . . 0.0 112.479 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.14 11.2 1.03 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.555 1.074 . . . . 0.0 113.268 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.92 153.11 23.01 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.037 1.419 . . . . 0.0 110.733 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.53 154.34 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.442 1.097 . . . . 0.0 109.831 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.438 HG23 HG21 ' A' ' 28' ' ' VAL . 4.9 t -105.31 141.78 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 167.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.38 169.78 22.39 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.866 -0.521 . . . . 0.0 110.724 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.52 138.51 34.28 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.95 164.84 31.58 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 108.104 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.58 155.7 51.7 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.781 1.654 . . . . 0.0 110.824 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.46 139.07 62.97 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.27 1.98 . . . . 0.0 110.806 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m -73.43 -14.49 61.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.854 0.861 . . . . 0.0 112.424 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -60.06 134.98 57.56 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.43 1.092 . . . . 0.0 110.049 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.26 169.12 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.837 0.855 . . . . 0.0 110.371 174.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.78 -38.96 36.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.077 1.351 . . . . 0.0 112.042 175.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.78 -16.69 18.23 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.274 0.94 . . . . 0.0 114.45 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.0 18.38 3.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.198 1.399 . . . . 0.0 111.476 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.24 26.95 0.07 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.671 -171.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.08 155.4 20.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.85 1.325 . . . . 0.0 111.041 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.24 -24.26 63.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.49 0.716 . . . . 0.0 112.594 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m 59.32 13.99 3.44 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.428 1.491 . . . . 0.0 113.55 -170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -143.21 169.63 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.574 1.949 . . . . 0.0 107.588 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -66.32 -36.55 83.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.909 0.484 . . . . 0.0 110.878 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.5 m -64.59 158.48 24.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.768 1.227 . . . . 0.0 111.091 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.21 36.29 0.15 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.695 1.198 . . . . 0.0 111.961 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.1 tp -58.91 121.07 10.26 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.847 1.259 . . . . 0.0 109.546 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 m -144.53 152.89 41.23 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -147.12 25.6 1.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.864 0.84 . . . . 0.0 112.721 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -136.19 160.24 39.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.799 1.24 . . . . 0.0 109.052 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.75 169.18 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.17 1.388 . . . . 0.0 109.123 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mt -135.82 144.12 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 t -79.94 121.12 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 163.03 19.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.467 1.507 . . . . 0.0 108.109 -177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.43 128.73 44.99 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -149.89 160.09 43.86 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.408 1.083 . . . . 0.0 108.642 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.56 133.9 49.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.3 tt -54.69 -40.91 69.61 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.58 0.752 . . . . 0.0 111.902 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -61.03 -29.9 70.0 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.663 0.385 . . . . 0.0 111.898 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -74.55 -46.02 41.71 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.209 0.459 . . . . 0.0 110.277 175.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.14 -42.33 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.753 0.821 . . . . 0.0 109.908 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 -6.56 52.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.236 1.415 . . . . 0.0 113.28 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.27 -10.46 52.76 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.414 -0.659 . . . . 0.0 113.395 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 p -60.94 -43.75 98.21 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.76 1.224 . . . . 0.0 112.181 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -159.3 -58.56 0.07 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.296 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -166.05 -174.42 2.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.578 1.551 . . . . 0.0 108.853 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -154.64 167.87 28.68 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.201 1.001 . . . . 0.0 109.383 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -155.54 156.8 35.79 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.805 0.842 . . . . 0.0 109.958 169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.04 138.77 21.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -148.22 71.69 1.18 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -68.58 81.7 0.27 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.22 1.008 . . . . 0.0 108.547 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -56.81 125.65 23.38 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 47.04 44.88 15.46 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.675 1.59 . . . . 0.0 112.528 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.76 -13.96 1.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 170.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.59 -15.61 25.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.159 1.383 . . . . 0.0 111.552 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -123.6 -19.92 5.68 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.194 0.998 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -140.48 -167.65 2.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.111 1.364 . . . . 0.0 109.643 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m 52.15 60.38 13.51 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.91 1.284 . . . . 0.0 112.247 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.9 -12.54 34.7 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.395 2.064 . . . . 0.0 113.9 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.07 133.57 83.68 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 124.175 0.99 . . . . 0.0 110.72 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.55 145.46 69.36 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.201 1.934 . . . . 0.0 108.881 166.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.4 m -55.0 -39.38 69.01 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -170.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 p -54.88 -44.38 74.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.502 1.121 . . . . 0.0 112.14 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -63.5 -32.09 73.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.646 0.778 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.53 -46.09 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.9 mm -59.0 -49.03 84.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -55.66 -43.24 76.12 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.866 0.867 . . . . 0.0 110.857 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -60.17 -55.65 31.2 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.83 -41.38 67.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -74.29 -24.89 59.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.369 1.068 . . . . 0.0 112.027 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -81.13 -23.05 38.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.704 0.683 . . . . 0.0 110.505 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.16 -22.79 13.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.43 -167.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.16 144.6 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.998 1.272 . . . . 0.0 109.066 168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.63 34.86 62.79 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -132.06 160.54 35.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.84 150.94 42.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.071 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.88 142.01 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 108.304 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.2 mt -99.78 52.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 123.022 1.391 . . . . 0.0 110.446 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.71 150.96 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.256 -1.793 . . . . 0.0 108.347 169.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -70.18 164.12 24.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.032 0.933 . . . . 0.0 112.057 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.16 119.45 11.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.2 p -140.44 154.41 46.64 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 m -54.71 -40.22 69.0 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.944 0.498 . . . . 0.0 110.402 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.95 -41.78 77.56 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.749 0.82 . . . . 0.0 111.229 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.99 -39.15 87.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.082 0.856 . . . . 0.0 110.237 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.3 m -68.9 -44.23 73.6 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.907 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.45 -47.11 79.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.986 0.914 . . . . 0.0 109.91 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -58.38 -53.08 62.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.973 0.909 . . . . 0.0 109.363 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -61.23 -49.83 75.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.18 0.446 . . . . 0.0 111.678 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 -34.2 65.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.392 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -66.64 -38.47 86.98 Favored 'General case' 0 C--O 1.225 -0.209 0 O-C-N 121.889 -0.507 . . . . 0.0 110.361 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -56.24 -35.86 67.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.375 1.07 . . . . 0.0 111.86 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.15 -45.72 32.17 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.968 0.803 . . . . 0.0 110.922 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -78.09 -43.28 29.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.823 0.738 . . . . 0.0 111.937 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -75.77 -40.75 54.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.911 0.484 . . . . 0.0 110.838 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 116.02 -37.42 3.43 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 128.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 105.049 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.893 174.577 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -60.57 149.63 34.17 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.727 -0.608 . . . . 0.0 109.597 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 42.96 62.88 8.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.321 1.449 . . . . 0.0 112.026 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.97 -13.82 39.4 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.733 2.289 . . . . 0.0 114.094 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . 0.272 44.0 pt 41.89 59.28 9.68 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.435 1.894 . . . . 0.0 111.735 -173.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.46 178.57 6.89 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.766 2.977 . . . . 0.0 109.096 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.09 67.36 77.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 150.22 83.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.599 2.866 . . . . 0.0 111.212 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -76.6 146.19 76.46 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 169.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.45 130.66 21.98 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.722 2.282 . . . . 0.0 110.163 168.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.99 -14.99 63.31 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 117.743 -1.587 . . . . 0.0 113.875 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -69.04 152.98 44.54 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.899 2.349 . . . . 0.0 111.82 -174.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.07 139.28 38.15 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -119.92 145.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.87 149.93 41.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 mm -126.42 97.26 4.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 -168.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.4 143.43 57.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 174.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.48 168.25 18.65 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.356 1.062 . . . . 0.0 108.911 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.25 -32.88 52.57 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 115.904 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.64 3.34 2.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.94 -161.42 0.76 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.14 1.376 . . . . 0.0 108.504 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.79 147.79 36.09 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -117.68 167.47 11.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.466 1.906 . . . . 0.0 108.399 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.17 148.05 49.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 123.556 0.742 . . . . 0.0 110.304 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.54 172.94 14.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.237 1.415 . . . . 0.0 109.221 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 tt -132.62 128.61 57.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -71.14 133.07 45.93 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 109.278 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.01 165.68 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.637 1.175 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.66 -126.88 41.02 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -169.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -144.87 53.28 1.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 -8.53 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.783 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -103.72 168.06 9.39 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.694 1.247 . . . . 0.0 109.278 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.45 151.93 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.063 0.945 . . . . 0.0 109.546 174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.86 141.38 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 168.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -163.6 171.59 15.53 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.271 0.629 . . . . 0.0 111.123 -175.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.91 150.06 36.0 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.98 159.21 40.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.76 1.624 . . . . 0.0 108.408 172.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.0 159.78 40.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 121.474 1.449 . . . . 0.0 109.921 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.18 -0.72 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.549 2.833 . . . . 0.0 113.605 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -49.4 136.53 15.97 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 111.501 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -146.75 34.06 0.93 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.617 1.167 . . . . 0.0 108.796 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.26 165.57 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 126.005 1.722 . . . . 0.0 108.91 -173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 56.56 19.18 4.02 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.38 1.872 . . . . 0.0 114.621 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.4 -163.55 35.12 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.08 0.848 . . . . 0.0 113.063 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.18 171.06 17.53 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.095 1.758 . . . . 0.0 108.257 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.3 -176.96 44.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.9 -5.42 2.86 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.176 1.39 . . . . 0.0 114.584 -173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.37 -25.81 67.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.142 0.883 . . . . 0.0 111.057 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 m 55.69 22.65 5.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.795 1.638 . . . . 0.0 113.264 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.05 146.38 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.2 1.0 . . . . 0.0 110.14 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.0 mtt -142.17 71.05 1.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.412 1.485 . . . . 0.0 107.574 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -55.83 150.41 13.09 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.736 1.214 . . . . 0.0 111.577 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.03 61.63 2.02 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 110.394 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.4 -32.27 66.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.255 1.022 . . . . 0.0 111.362 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 p -148.89 174.75 11.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.791 2.036 . . . . 0.0 107.33 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -99.37 18.09 18.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.943 0.897 . . . . 0.0 112.723 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -119.99 179.12 4.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.534 1.933 . . . . 0.0 109.928 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -152.5 178.84 9.14 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 108.879 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.5 pt -145.88 166.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.143 1.777 . . . . 0.0 107.167 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.67 139.79 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -133.69 172.41 12.8 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.566 1.546 . . . . 0.0 109.378 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.38 142.1 50.53 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 125.204 1.402 . . . . 0.0 107.415 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -151.04 159.61 44.43 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.292 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 tp -67.86 137.74 55.52 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.86 -41.64 67.7 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.217 0.917 . . . . 0.0 111.669 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -64.86 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.88 -25.84 61.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.858 0.753 . . . . 0.0 111.437 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 t -93.66 -36.48 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.873 1.269 . . . . 0.0 109.918 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.57 -25.5 62.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.536 1.534 . . . . 0.0 113.28 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.66 -10.42 37.42 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.762 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.5 m -53.04 -48.09 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.696 1.248 . . . . 0.0 111.799 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -166.33 -54.29 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 125.881 1.672 . . . . 0.0 109.27 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -166.92 178.79 5.6 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.498 1.919 . . . . 0.0 107.732 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -154.14 165.86 34.9 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.386 -0.821 . . . . 0.0 109.314 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -155.67 158.63 38.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.919 0.888 . . . . 0.0 110.377 170.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.17 136.65 25.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -149.68 66.94 1.0 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.186 0.517 . . . . 0.0 110.498 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.64 119.14 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -67.8 -11.68 59.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' ASP . 92.5 m-70 -129.27 29.14 5.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 111.621 -169.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.54 21.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.887 -1.133 . . . . 0.0 112.685 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' HIS . 34.8 t70 -130.49 -5.81 4.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.948 2.099 . . . . 0.0 111.351 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.88 -31.2 1.32 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.965 1.306 . . . . 0.0 111.905 -169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 66.65 150.68 0.06 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 128.292 2.637 . . . . 0.0 117.848 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -40.11 109.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.876 2.87 . . . . 0.0 113.94 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 -15.9 18.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.505 2.803 . . . . 0.0 111.812 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.22 138.24 24.09 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 126.671 1.988 . . . . 0.0 106.698 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 157.28 62.21 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.527 1.485 . . . . 0.0 109.391 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.76 -39.93 62.67 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.323 0.649 . . . . 0.0 111.557 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 m -54.07 -48.43 70.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 0.0 111.393 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.7 -35.89 77.76 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.563 -0.71 . . . . 0.0 111.526 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.29 -49.08 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.186 0.903 . . . . 0.0 108.618 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.09 -38.62 78.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.124 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -55.83 -45.11 78.42 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.387 0.675 . . . . 0.0 110.067 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -60.3 -48.81 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.477 0.581 . . . . 0.0 109.859 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.31 -42.15 66.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.705 0.684 . . . . 0.0 111.813 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -78.52 -19.17 53.55 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.312 -175.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.96 -29.79 26.77 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.193 0.906 . . . . 0.0 110.021 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.5 mt -96.68 -24.26 16.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.312 -168.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.45 132.76 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.785 1.175 . . . . 0.0 109.637 171.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.09 -4.87 82.07 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.55 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.45 159.79 25.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.779 1.789 . . . . 0.0 109.3 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -104.1 154.33 19.85 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.488 0.715 . . . . 0.0 109.996 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.97 -175.98 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.993 1.317 . . . . 0.0 108.31 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.09 11.04 6.46 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.712 0.805 . . . . 0.0 112.842 -169.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.8 153.16 45.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 109.538 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -71.75 161.21 31.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 111.863 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.27 131.28 46.87 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.5 p -145.81 159.06 43.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 m -55.34 -39.3 69.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.126 0.421 . . . . 0.0 110.213 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -68.7 -47.48 66.32 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.126 0.571 . . . . 0.0 111.184 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -66.86 -40.39 87.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.679 0.672 . . . . 0.0 110.82 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.05 -42.46 76.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.774 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -58.97 -44.34 91.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.695 0.679 . . . . 0.0 110.395 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -56.6 -53.72 54.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.879 1.271 . . . . 0.0 109.06 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -60.18 -54.04 50.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.185 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.4 m -62.34 -28.22 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 118.921 0.782 . . . . 0.0 111.081 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -70.28 -32.77 70.72 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.411 -0.806 . . . . 0.0 111.718 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.3 -25.16 63.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.814 0.734 . . . . 0.0 111.321 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.22 -52.95 4.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.8 tpt85 -60.1 -37.56 80.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.556 1.142 . . . . 0.0 112.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -136.88 9.95 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.231 0.957 . . . . 0.0 111.676 -167.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.0 -29.92 5.72 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.772 -1.205 . . . . 0.0 112.55 169.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.0 145.58 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.01 1.724 . . . . 0.0 108.336 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.014 0.926 . . . . 0.0 111.064 169.041 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -151.15 167.52 27.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.446 1.098 . . . . 0.0 109.708 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.92 154.73 80.54 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.69 174.31 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.266 1.978 . . . . 0.0 111.151 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 pt -125.45 68.94 60.78 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.682 1.593 . . . . 0.0 106.791 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.17 -23.18 21.51 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 114.384 -167.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 13.1 pt-20 -145.95 -21.78 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 92.0 Cg_endo -74.65 158.38 43.54 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 123.697 2.356 . . . . 0.0 111.245 -174.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -131.7 145.93 59.64 Favored Pre-proline 0 C--O 1.236 0.368 0 C-N-CA 124.15 0.98 . . . . 0.0 108.424 168.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.23 128.19 19.38 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.465 2.11 . . . . 0.0 111.037 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.99 -10.26 27.24 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.976 1.75 . . . . 0.0 112.141 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.9 135.86 34.32 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.006 1.403 . . . . 0.0 111.408 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.8 mt -68.13 137.46 54.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -121.8 121.23 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.13 151.49 21.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.28 112.46 29.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 127.02 30.24 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -111.45 168.96 6.84 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.067 1.347 . . . . 0.0 108.336 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -47.56 -33.19 17.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.052 3.168 . . . . 0.0 116.541 -170.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -146.87 17.35 1.25 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.897 0.879 . . . . 0.0 111.433 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -158.43 -160.64 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.408 1.083 . . . . 0.0 109.586 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 155.43 45.66 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -116.36 168.51 10.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -132.39 147.21 52.38 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.596 0.635 . . . . 0.0 111.159 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.29 174.7 11.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.237 1.815 . . . . 0.0 107.719 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.18 129.95 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -73.86 125.92 29.25 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 m -136.31 -10.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -171.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.59 167.11 28.67 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -55.37 -22.2 18.54 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -168.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -140.8 16.56 2.83 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.239 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -120.48 154.36 35.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.569 1.684 . . . . 0.0 111.976 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.47 158.17 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.553 1.141 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.87 143.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.0 174.45 13.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.154 0.982 . . . . 0.0 109.932 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.42 143.9 29.97 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 170.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.93 160.46 62.76 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.779 1.231 . . . . 0.0 108.994 171.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.42 156.86 20.11 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.274 1.982 . . . . 0.0 110.975 168.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.08 144.84 27.32 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 112.379 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.2 m -59.75 155.03 16.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.874 0.87 . . . . 0.0 111.505 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.56 166.31 31.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.12 -44.15 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.351 1.061 . . . . 0.0 108.888 174.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.87 159.2 39.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.971 1.709 . . . . 0.0 108.204 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.13 170.52 35.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.31 -31.6 70.17 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.795 0.438 . . . . 0.0 111.736 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.84 -169.4 34.61 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.206 1.384 . . . . 0.0 109.971 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.86 167.67 5.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.392 0.677 . . . . 0.0 110.453 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 149.8 22.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.995 0.518 . . . . 0.0 111.345 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -37.79 83.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.085 0.954 . . . . 0.0 110.841 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -67.5 157.65 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.355 0.662 . . . . 0.0 110.82 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.3 mtt -61.3 -17.85 55.66 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 112.91 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 m -57.5 -23.8 52.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.865 1.266 . . . . 0.0 112.68 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.48 35.4 1.33 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.531 1.933 . . . . 0.0 114.046 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.8 tp 55.35 11.26 0.55 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.437 1.895 . . . . 0.0 114.197 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -134.18 12.27 3.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.569 1.176 . . . . 0.0 112.119 -169.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -0.39 13.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 169.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -134.43 166.98 21.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.333 3.053 . . . . 0.0 106.891 171.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.34 -179.82 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 pt -142.09 153.73 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -81.33 139.08 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -139.87 159.64 41.73 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.221 1.409 . . . . 0.0 107.997 -169.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.03 136.52 49.48 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -152.5 159.91 43.28 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 108.63 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.38 132.88 49.31 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.8 -46.61 71.13 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.385 0.674 . . . . 0.0 111.261 -173.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -67.26 -24.46 65.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.86 0.464 . . . . 0.0 111.33 -170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.32 -37.39 60.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.363 0.528 . . . . 0.0 111.011 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.53 -45.33 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.095 0.558 . . . . 0.0 109.56 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.97 64.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.073 0.549 . . . . 0.0 110.381 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.09 -128.83 31.09 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -171.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 m -72.26 -8.45 54.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.57 1.148 . . . . 0.0 113.874 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -75.21 -170.6 1.2 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.524 1.056 . . . . 0.0 110.895 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -140.12 158.48 43.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.499 2.32 . . . . 0.0 106.084 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -156.61 163.26 39.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.845 -0.534 . . . . 0.0 110.31 -168.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.85 158.92 40.11 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.661 0.784 . . . . 0.0 110.432 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.6 t -67.37 134.31 30.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 169.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -149.74 66.57 0.99 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -61.42 118.88 7.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -55.26 -43.99 75.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -142.94 36.41 1.4 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.396 0.678 . . . . 0.0 111.337 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -58.79 -9.86 2.04 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.355 0.98 . . . . 0.0 112.686 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.61 -20.62 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.918 0.887 . . . . 0.0 110.336 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -114.15 -44.77 3.1 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.022 1.329 . . . . 0.0 110.23 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -155.48 159.0 39.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.719 0.808 . . . . 0.0 112.82 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -171.2 76.87 0.53 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 128.482 2.713 . . . . 0.0 105.096 167.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.55 -16.21 52.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.686 2.924 . . . . 0.0 113.885 -171.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.85 120.82 47.85 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 157.52 61.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.842 1.695 . . . . 0.0 108.904 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.9 m -47.48 -47.83 27.2 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.889 0.876 . . . . 0.0 112.505 -169.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 m -54.84 -43.94 73.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.637 0.775 . . . . 0.0 112.445 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.48 -33.61 76.07 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.596 -0.69 . . . . 0.0 111.187 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.2 mt -60.84 -48.95 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.29 -50.62 79.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -52.79 -47.05 67.84 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.424 1.089 . . . . 0.0 110.534 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -66.35 -49.72 65.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.57 -45.07 73.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.494 0.588 . . . . 0.0 110.805 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.76 -30.57 71.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.467 1.507 . . . . 0.0 112.188 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -72.45 -28.83 63.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.598 0.759 . . . . 0.0 109.052 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.4 mt -91.95 -16.99 25.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.906 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 t -54.74 128.92 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.363 1.438 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.11 87.66 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.261 -1.3 . . . . 0.0 113.229 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -76.88 143.99 39.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.72 1.76 . . . . 0.0 108.491 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.01 151.4 23.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.756 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.22 146.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.71 1.204 . . . . 0.0 109.18 170.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.08 1.92 52.87 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.588 -0.695 . . . . 0.0 112.769 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -92.76 155.03 17.94 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.592 0.757 . . . . 0.0 109.261 169.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -70.22 142.58 52.37 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -69.11 131.88 45.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.1 p -145.17 165.3 28.72 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.096 1.758 . . . . 0.0 106.38 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 m -50.53 -46.94 57.71 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.795 172.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.45 -40.22 73.86 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.133 -0.461 . . . . 0.0 111.618 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -71.55 -31.01 66.53 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.231 0.923 . . . . 0.0 110.959 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 69.1 m -69.87 -43.6 71.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.124 0.874 . . . . 0.0 109.926 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -59.91 -41.12 91.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.637 0.775 . . . . 0.0 110.149 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -59.84 -58.89 6.6 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.092 1.757 . . . . 0.0 110.286 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -56.64 -49.84 73.8 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.09 -31.05 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 121.096 -0.241 . . . . 0.0 110.557 -170.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -70.14 -28.12 65.1 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 121.177 -0.952 . . . . 0.0 111.527 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -53.98 -31.5 51.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.764 0.711 . . . . 0.0 111.368 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.1 mt -80.78 -45.8 16.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.239 0.616 . . . . 0.0 110.408 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -74.79 -29.38 61.09 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.203 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -130.22 -5.18 4.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.04 -14.7 62.79 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.81 -1.181 . . . . 0.0 112.737 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -154.8 151.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.644 1.577 . . . . 0.0 106.984 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.198 170.593 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 88.6 mmt-85 -143.97 151.14 39.35 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 33.89 58.91 1.93 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.918 2.087 . . . . 0.0 114.418 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.42 174.9 10.84 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.996 2.464 . . . . 0.0 111.145 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.9 mt -128.5 73.6 80.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.25 176.29 8.9 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.41 2.74 . . . . 0.0 109.279 -174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -135.49 75.89 56.73 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 169.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -53.49 149.99 28.83 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.275 2.65 . . . . 0.0 112.536 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -113.64 138.38 22.6 Favored Pre-proline 0 N--CA 1.464 0.255 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.32 132.36 23.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.29 -21.16 35.97 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.138 1.352 . . . . 0.0 112.014 -170.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -67.44 144.26 55.83 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.448 1.624 . . . . 0.0 111.674 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.11 139.92 43.08 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.61 128.21 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.51 150.83 22.65 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 165.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.05 114.1 40.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 102.355 -3.202 . . . . 0.0 102.355 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.45 131.08 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -108.87 167.26 9.42 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -50.39 -28.58 21.39 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.259 2.639 . . . . 0.0 115.901 -173.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.62 14.5 1.22 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.819 0.848 . . . . 0.0 112.102 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -156.78 -155.81 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.488 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 157.87 44.13 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.865 1.211 . . . . 0.0 109.331 174.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -127.75 168.84 14.54 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.236 1.814 . . . . 0.0 106.113 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -135.09 147.45 49.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.848 0.749 . . . . 0.0 111.673 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.67 173.0 14.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.37 1.868 . . . . 0.0 108.879 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.78 133.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -80.48 135.23 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.56 -2.68 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -170.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.37 -175.41 38.56 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -77.04 44.28 0.39 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.195 0.998 . . . . 0.0 111.743 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.35 -32.31 0.35 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.861 1.22 . . . . 0.0 112.532 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.9 152.94 23.19 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.793 1.296 . . . . 0.0 111.651 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.82 156.31 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.33 1.452 . . . . 0.0 109.273 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 140.05 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.47 170.77 21.0 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.044 0.538 . . . . 0.0 110.798 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.02 138.43 33.74 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.16 170.04 8.59 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.671 . . . . 0.0 108.808 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -56.0 152.6 36.01 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.537 2.158 . . . . 0.0 112.425 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -69.94 -28.89 23.81 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.965 1.777 . . . . 0.0 111.213 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -68.53 165.12 19.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.381 1.873 . . . . 0.0 111.481 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -144.17 154.26 42.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.249 1.419 . . . . 0.0 107.337 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.11 173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.704 0.801 . . . . 0.0 110.868 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.3 114.19 0.82 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.017 1.327 . . . . 0.0 109.908 172.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.18 -38.3 1.79 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.83 1.205 . . . . 0.0 110.355 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.81 -0.7 1.49 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.564 1.146 . . . . 0.0 112.437 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.94 -144.84 4.22 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 107.534 -2.226 . . . . 0.0 107.534 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.3 -0.09 0.88 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.23 145.62 16.63 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.495 1.498 . . . . 0.0 110.751 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -61.84 -32.95 73.33 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.566 0.746 . . . . 0.0 112.263 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.8 m -147.09 153.93 12.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.7 1.6 . . . . 0.0 108.373 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 161.07 27.26 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.863 0.865 . . . . 0.0 109.467 168.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -76.61 45.48 0.4 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.75 1.62 . . . . 0.0 111.943 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 51.04 29.05 4.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.426 1.891 . . . . 0.0 112.527 -169.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.65 -27.96 69.29 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.231 1.012 . . . . 0.0 111.356 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.5 p -143.89 173.37 11.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.544 1.938 . . . . 0.0 106.934 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -133.07 29.69 4.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.698 1.199 . . . . 0.0 110.97 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.49 176.66 7.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.588 1.555 . . . . 0.0 110.564 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -148.17 174.02 12.39 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.318 1.447 . . . . 0.0 109.765 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.35 146.13 29.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.0 t -82.57 130.95 34.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 163.94 28.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.176 1.39 . . . . 0.0 108.019 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -131.09 130.32 43.04 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.25 160.8 43.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.537 1.135 . . . . 0.0 108.895 -173.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -73.01 130.46 40.38 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.94 -40.23 63.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.11 0.964 . . . . 0.0 112.627 -170.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.17 -35.98 67.81 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.832 0.453 . . . . 0.0 111.832 -172.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -71.35 -38.14 71.63 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.299 0.5 . . . . 0.0 110.605 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.09 -46.86 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.819 0.848 . . . . 0.0 108.834 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -24.6 66.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.536 1.135 . . . . 0.0 112.102 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.69 -14.3 3.66 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.503 1.525 . . . . 0.0 113.835 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.5 m -48.81 -48.2 41.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.595 1.197 . . . . 0.0 111.51 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -168.58 -55.92 0.02 OUTLIER 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.927 1.691 . . . . 0.0 109.636 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -166.18 -174.95 3.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.947 2.099 . . . . 0.0 107.695 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -149.06 168.14 23.95 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.43 -0.794 . . . . 0.0 109.563 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -146.11 153.69 40.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.116 0.967 . . . . 0.0 108.88 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -78.14 135.09 26.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 166.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -147.19 69.66 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -63.47 104.72 0.66 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 169.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -54.0 -51.13 64.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.726 1.211 . . . . 0.0 113.848 -167.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -148.2 38.95 0.9 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.383 1.073 . . . . 0.0 111.264 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.32 -14.26 1.14 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.09 1.356 . . . . 0.0 113.214 169.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.97 -28.27 27.89 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.476 -0.765 . . . . 0.0 110.596 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -97.44 -34.26 11.08 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.583 -177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -148.51 156.85 42.99 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.305 0.642 . . . . 0.0 111.756 -169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -178.4 72.86 0.21 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 128.475 2.71 . . . . 0.0 107.491 168.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.9 -14.45 41.36 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.643 2.229 . . . . 0.0 113.372 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.66 121.08 30.13 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 124.911 1.284 . . . . 0.0 108.491 -174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.62 159.67 10.74 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.294 2.662 . . . . 0.0 111.492 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -50.09 -46.57 53.64 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.655 0.782 . . . . 0.0 111.269 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -54.62 -44.7 73.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.32 0.648 . . . . 0.0 111.754 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.42 -35.72 68.42 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.293 0.637 . . . . 0.0 111.237 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.418 HD13 ' HD2' ' A' ' 121' ' ' ARG . 55.6 mt -59.81 -49.87 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.5 -46.08 96.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -43.29 69.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.369 0.668 . . . . 0.0 110.338 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -51.05 64.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.79 -45.11 67.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.38 0.536 . . . . 0.0 111.213 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.01 -29.82 68.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.234 1.413 . . . . 0.0 112.127 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -73.38 -28.51 62.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.154 0.982 . . . . 0.0 109.192 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.78 -14.7 27.49 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.857 -1.068 . . . . 0.0 112.8 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.66 126.52 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 109.137 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.82 -1.22 88.04 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.304 -1.276 . . . . 0.0 113.453 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -83.21 159.93 21.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.629 1.715 . . . . 0.0 109.34 174.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -110.63 154.37 23.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.76 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.98 145.27 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.79 1.236 . . . . 0.0 107.755 169.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 tp -87.86 14.3 9.07 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.749 -0.595 . . . . 0.0 112.18 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -121.84 159.67 26.28 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.128 1.371 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -87.42 172.97 9.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.989 1.715 . . . . 0.0 113.501 -167.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.21 43.25 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.888 2.075 . . . . 0.0 112.477 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 p -70.18 148.19 48.95 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -55.21 -37.72 67.49 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.09 -0.381 . . . . 0.0 110.252 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -65.83 -40.44 91.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.445 1.098 . . . . 0.0 111.473 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -68.67 -36.98 79.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.054 1.297 . . . . 0.0 110.55 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.42 -45.43 79.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.2 -46.08 86.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.087 0.955 . . . . 0.0 110.086 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -56.47 -54.68 42.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.501 1.121 . . . . 0.0 109.052 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.59 -51.03 71.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.336 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.93 -33.47 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.22 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -68.45 -36.6 79.26 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.001 0.819 . . . . 0.0 110.713 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -56.72 -36.11 69.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.262 1.025 . . . . 0.0 111.421 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.0 mp -79.12 -45.05 20.78 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.066 0.848 . . . . 0.0 110.587 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.418 ' HD2' HD13 ' A' ' 92' ' ' ILE . 45.4 tpt85 -65.93 -33.61 76.23 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.915 0.886 . . . . 0.0 112.083 -175.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.51 5.51 4.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.871 0.868 . . . . 0.0 113.125 -170.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.18 4.0 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 120.793 -1.192 . . . . 0.0 112.124 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.32 138.49 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.122 0.569 . . . . 0.0 111.648 175.045 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -71.12 -37.64 72.33 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 0.0 111.098 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.01 147.29 86.3 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.027 0.531 . . . . 0.0 110.443 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.21 174.41 11.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.698 2.265 . . . . 0.0 111.194 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 pt -125.41 72.28 66.34 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 106.824 169.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.08 -19.87 15.3 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.113 2.542 . . . . 0.0 114.221 -168.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 13.0 pt-20 -127.93 -18.74 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 -169.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 53.6 Cg_exo -56.51 155.22 26.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.598 2.199 . . . . 0.0 112.427 169.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -138.22 148.28 59.13 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 109.941 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -48.18 131.9 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.904 2.403 . . . . 0.0 110.352 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.51 -20.82 31.66 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.011 1.767 . . . . 0.0 111.708 -172.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -69.45 145.51 52.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.687 1.743 . . . . 0.0 111.394 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.19 138.62 39.56 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.35 145.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -123.6 149.43 45.34 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 mm -125.57 124.15 66.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -168.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -73.76 134.53 43.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -132.16 163.99 46.37 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 123.437 0.695 . . . . 0.0 109.681 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.3 -21.19 61.79 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.696 1.597 . . . . 0.0 115.214 -168.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -135.37 1.14 2.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.038 0.836 . . . . 0.0 113.01 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.34 -166.49 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.525 1.53 . . . . 0.0 108.769 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.73 152.37 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -131.31 168.77 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.475 0.71 . . . . 0.0 109.279 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -137.98 144.8 41.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.165 0.986 . . . . 0.0 110.279 -169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.32 172.7 14.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.791 1.636 . . . . 0.0 108.574 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 tt -131.23 131.54 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -76.15 131.39 39.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.085 1.354 . . . . 0.0 108.152 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.3 m -137.26 -20.65 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.52 43.97 0.94 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 119.265 0.938 . . . . 0.0 112.07 -168.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 45.68 38.21 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.16 1.784 . . . . 0.0 112.744 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.05 0.94 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.997 1.284 . . . . 0.0 110.536 -172.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -91.72 152.48 20.17 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.62 1.21 . . . . 0.0 110.766 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.19 160.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 126.1 1.76 . . . . 0.0 109.836 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.71 140.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 167.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.29 169.41 22.18 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.865 -0.522 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 143.02 31.32 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.67 161.52 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 108.122 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.99 155.3 65.23 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 N-CA-C 109.334 -1.064 . . . . 0.0 109.334 168.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.08 -37.54 57.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.175 2.583 . . . . 0.0 113.76 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 m -138.57 168.51 19.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.524 1.93 . . . . 0.0 106.956 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.11 34.14 0.07 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.546 1.538 . . . . 0.0 114.623 -172.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -49.59 -30.18 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.592 1.957 . . . . 0.0 114.396 -174.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.86 12.68 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.227 1.011 . . . . 0.0 111.138 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.69 156.56 6.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.545 1.545 . . . . 0.0 110.021 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.3 100.62 0.83 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.52 34.49 76.02 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -173.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 169.74 20.84 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.77 0.785 . . . . 0.0 111.478 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.22 176.14 9.75 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.213 1.805 . . . . 0.0 107.827 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m -131.46 27.53 4.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.527 1.131 . . . . 0.0 110.813 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.38 38.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.9 tpp -152.65 43.31 0.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.013 1.725 . . . . 0.0 108.005 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -59.42 162.54 4.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 0.0 111.795 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.82 43.2 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.671 1.589 . . . . 0.0 112.722 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.9 tp 47.04 76.63 0.1 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.156 2.182 . . . . 0.0 110.725 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 p -143.48 158.07 43.95 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.58 1.952 . . . . 0.0 106.618 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -142.15 30.57 1.59 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.954 0.883 . . . . 0.0 112.039 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -137.85 164.6 28.56 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.365 1.466 . . . . 0.0 109.819 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.72 173.4 11.87 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.414 1.486 . . . . 0.0 109.333 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -135.88 147.68 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.65 125.97 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -122.59 166.4 14.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.324 1.05 . . . . 0.0 109.282 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.2 124.48 39.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -150.32 163.83 37.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 108.938 -169.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.6 tp -69.77 128.88 37.97 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.69 -45.34 70.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.344 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.66 -18.19 64.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -88.13 -43.88 11.33 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.746 0.703 . . . . 0.0 110.5 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.78 -40.43 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.066 0.946 . . . . 0.0 110.824 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.72 -2.08 57.1 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.255 1.422 . . . . 0.0 113.088 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.45 -18.49 37.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.934 0.778 . . . . 0.0 113.125 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -53.7 -43.47 68.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.473 1.509 . . . . 0.0 112.424 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -161.12 -69.03 0.06 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.058 0.943 . . . . 0.0 111.411 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -167.28 -176.39 3.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.374 1.87 . . . . 0.0 108.811 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -156.18 168.47 27.19 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.795 0.838 . . . . 0.0 110.684 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -151.52 159.82 43.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.941 0.896 . . . . 0.0 110.284 168.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.7 t -70.76 139.26 20.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -148.05 67.4 1.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.321 0.582 . . . . 0.0 109.582 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -57.78 117.33 4.14 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.3 -38.47 71.76 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.415 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -144.9 25.62 1.42 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 112.23 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.27 -1.55 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.872 1.215 . . . . 0.0 112.055 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -99.99 -6.78 25.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.392 1.477 . . . . 0.0 110.868 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -128.81 -32.08 2.13 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.749 1.22 . . . . 0.0 111.343 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -146.47 149.13 33.07 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.492 1.117 . . . . 0.0 110.97 -170.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.9 p -162.56 65.8 1.72 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.061 1.344 . . . . 0.0 109.255 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.93 -14.78 46.15 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.362 2.042 . . . . 0.0 113.02 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.4 125.66 22.59 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 124.992 1.317 . . . . 0.0 108.376 -171.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.31 167.17 27.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.444 2.096 . . . . 0.0 109.951 169.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -47.05 -49.14 21.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.486 1.114 . . . . 0.0 111.904 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.6 p -54.08 -54.21 42.56 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.812 1.245 . . . . 0.0 111.811 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.55 -35.02 79.11 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.229 1.012 . . . . 0.0 111.608 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.2 mt -61.99 -44.98 99.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 119.721 1.146 . . . . 0.0 108.618 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -63.41 -49.07 84.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.02 -40.37 73.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.088 0.555 . . . . 0.0 110.427 -177.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -63.48 -54.44 36.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.401 0.68 . . . . 0.0 109.447 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.48 -43.8 55.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.736 0.414 . . . . 0.0 111.262 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.16 -32.11 72.14 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.201 1.401 . . . . 0.0 111.768 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.94 -25.57 62.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.13 0.572 . . . . 0.0 110.806 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.2 mt -104.21 -10.74 17.69 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 117.895 -1.05 . . . . 0.0 113.315 -168.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 t -59.0 139.88 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 121.026 1.739 . . . . 0.0 109.509 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.25 -5.88 84.33 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.377 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -80.94 154.46 26.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.25 1.525 . . . . 0.0 109.087 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.491 1.116 . . . . 0.0 109.104 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.19 146.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 125.139 1.376 . . . . 0.0 107.898 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.29 49.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 123.089 1.423 . . . . 0.0 109.812 -171.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -135.24 148.23 49.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.671 168.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -70.03 165.2 22.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.819 0.848 . . . . 0.0 112.075 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.61 118.95 11.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -140.28 155.48 46.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.2 m -54.61 -40.25 68.71 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.721 0.408 . . . . 0.0 110.315 175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.47 -42.85 74.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.466 0.706 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -67.42 -39.37 85.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.824 0.738 . . . . 0.0 110.385 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.8 m -69.93 -44.04 70.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.35 -46.65 79.87 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.498 0.719 . . . . 0.0 109.887 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -57.69 -54.49 46.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.872 0.869 . . . . 0.0 109.196 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -57.81 -52.3 66.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.374 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.94 -31.42 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.487 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.12 -28.26 67.18 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.624 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.26 -42.88 96.28 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 119.465 1.03 . . . . 0.0 109.728 170.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -69.93 -40.31 75.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.014 0.825 . . . . 0.0 110.405 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -76.66 -40.64 48.39 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.199 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -122.7 15.48 10.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.06 -52.51 3.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.4 142.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.144 -0.455 . . . . 0.0 110.502 172.811 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 121.051 0.453 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -144.44 -177.28 5.4 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.134 1.773 . . . . 0.0 106.813 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.64 89.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.15 -161.45 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.393 2.062 . . . . 0.0 110.772 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 pt -118.57 64.97 6.19 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.742 1.217 . . . . 0.0 110.832 -174.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.54 -21.55 16.86 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.518 2.146 . . . . 0.0 113.365 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 13.9 pt-20 -141.36 -16.48 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 118.062 2.616 . . . . 0.0 118.062 -170.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.506 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 88.4 Cg_endo -73.43 162.75 39.4 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 123.933 2.44 . . . . 0.0 111.417 -174.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -138.84 142.15 32.83 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 124.401 1.08 . . . . 0.0 109.093 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.97 133.15 14.48 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.183 2.589 . . . . 0.0 111.5 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.48 -25.34 12.33 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.051 1.786 . . . . 0.0 110.622 -169.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -65.75 136.64 56.5 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.183 0.991 . . . . 0.0 111.046 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.26 140.95 52.47 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 166.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.36 129.88 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.23 151.43 23.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 166.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.8 mm -125.88 98.96 5.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 102.758 -3.053 . . . . 0.0 102.758 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.38 136.2 56.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -133.84 169.44 13.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.673 . . . . 0.0 110.526 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.95 -30.68 24.83 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.428 2.752 . . . . 0.0 117.134 -169.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -145.76 10.49 1.21 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.691 0.796 . . . . 0.0 112.635 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -163.78 -169.55 1.92 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.27 1.428 . . . . 0.0 108.618 -172.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 158.05 45.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -127.01 169.49 13.29 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 125.008 1.323 . . . . 0.0 107.626 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -138.83 145.43 40.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.592 0.633 . . . . 0.0 110.681 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.13 174.46 12.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.924 2.09 . . . . 0.0 107.782 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.08 136.24 51.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -75.96 128.86 35.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.31 -15.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -174.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.19 168.5 33.06 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -50.21 -29.77 10.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -167.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.93 13.06 4.45 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.449 -1.195 . . . . 0.0 113.622 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -123.05 152.38 41.05 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.77 1.785 . . . . 0.0 111.928 -170.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 m -133.36 159.67 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.947 1.299 . . . . 0.0 110.594 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.52 136.92 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 167.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.23 168.71 26.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.351 0.661 . . . . 0.0 110.47 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.85 141.06 32.55 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.79 165.12 28.34 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 125.223 1.409 . . . . 0.0 108.812 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.4 151.76 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.977 2.451 . . . . 0.0 112.205 170.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.32 132.3 31.05 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.195 1.93 . . . . 0.0 110.364 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -68.9 -38.83 79.87 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.635 0.374 . . . . 0.0 110.686 173.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.93 144.24 49.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.514 0.725 . . . . 0.0 109.567 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.09 169.7 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 111.227 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.07 -38.04 64.86 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.489 1.515 . . . . 0.0 112.718 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.12 -143.56 29.67 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.08 -7.21 50.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.576 0.75 . . . . 0.0 112.934 174.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.63 -31.06 0.68 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.48 1.038 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 46.02 35.41 2.45 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.675 1.99 . . . . 0.0 113.793 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.14 7.43 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.998 1.719 . . . . 0.0 108.452 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -58.63 -35.42 72.48 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.023 0.929 . . . . 0.0 111.346 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.3 143.55 17.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -58.14 -21.48 46.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -57.93 -24.38 57.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.363 1.065 . . . . 0.0 113.122 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.54 -11.69 60.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.65 0.659 . . . . 0.0 112.362 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 127.62 32.16 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m 86.03 4.15 0.5 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.352 2.261 . . . . 0.0 111.299 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.33 41.89 2.22 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.268 2.227 . . . . 0.0 109.986 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -136.72 163.59 30.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.065 1.346 . . . . 0.0 109.882 172.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.44 172.19 13.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.582 1.553 . . . . 0.0 109.121 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.1 147.27 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -81.81 128.02 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 160.6 31.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.236 1.415 . . . . 0.0 108.481 -175.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.55 124.67 41.78 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -151.6 165.03 35.55 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.389 1.076 . . . . 0.0 108.982 -169.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.16 132.86 49.45 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.763 0.825 . . . . 0.0 109.208 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 tt -53.89 -45.38 71.08 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.609 0.764 . . . . 0.0 110.899 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -66.45 -19.6 65.83 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.032 -0.509 . . . . 0.0 112.25 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.84 -42.26 27.96 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.005 0.82 . . . . 0.0 110.167 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.38 -44.83 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.267 0.627 . . . . 0.0 110.099 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.47 18.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.359 1.064 . . . . 0.0 112.454 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.22 51.97 3.31 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.689 1.614 . . . . 0.0 110.649 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 p -140.51 -55.03 0.52 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.132 1.773 . . . . 0.0 107.692 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.41 -67.6 0.2 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 123.954 0.902 . . . . 0.0 111.486 166.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -155.25 176.12 12.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.195 0.598 . . . . 0.0 110.158 -168.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.65 164.68 37.88 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.724 0.81 . . . . 0.0 111.04 171.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -156.89 162.13 39.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.63 1.172 . . . . 0.0 110.227 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -71.17 142.52 15.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -153.58 76.61 1.09 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.173 0.589 . . . . 0.0 109.599 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -70.8 81.34 0.63 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.673 0.789 . . . . 0.0 109.766 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -56.12 129.23 39.16 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.939 -0.475 . . . . 0.0 110.34 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 m80 62.45 19.46 11.18 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.878 2.071 . . . . 0.0 115.213 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.58 -6.2 1.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.997 0.817 . . . . 0.0 111.848 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -77.95 -25.25 48.15 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.249 1.02 . . . . 0.0 110.703 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.18 -27.56 1.8 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -140.87 141.94 34.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.816 0.735 . . . . 0.0 112.101 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -162.03 69.03 2.22 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.251 2.621 . . . . 0.0 107.554 171.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.22 -14.44 40.53 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.665 -173.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.9 mt -122.58 126.08 26.25 Favored Pre-proline 0 C--O 1.235 0.307 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.12 162.3 42.78 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.3 2.0 . . . . 0.0 109.307 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.2 p -49.02 -45.99 43.44 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.892 0.877 . . . . 0.0 112.573 -171.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 m -53.11 -45.79 68.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.031 0.932 . . . . 0.0 112.352 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -66.51 -31.75 72.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.622 0.769 . . . . 0.0 111.549 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -64.49 -46.93 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.096 0.862 . . . . 0.0 108.815 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.2 mm -58.36 -47.68 87.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -56.09 -43.16 77.78 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.802 0.841 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -62.7 -47.93 81.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.046 0.384 . . . . 0.0 110.168 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.23 92.92 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.841 -0.537 . . . . 0.0 110.688 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -70.38 -20.59 62.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.264 1.425 . . . . 0.0 112.351 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.26 -28.95 38.31 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.34 1.056 . . . . 0.0 109.052 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.49 -20.98 13.31 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 117.808 -1.092 . . . . 0.0 113.611 -169.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 p -52.24 133.18 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 120.498 1.499 . . . . 0.0 109.779 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.78 -5.22 84.42 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.271 -1.294 . . . . 0.0 113.446 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -84.28 164.56 18.95 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.762 1.781 . . . . 0.0 109.593 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -117.49 150.85 38.25 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.238 1.015 . . . . 0.0 109.208 -172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.3 144.32 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 124.185 0.994 . . . . 0.0 108.37 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.45 53.0 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 123.303 1.525 . . . . 0.0 109.479 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.92 147.9 37.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 112.434 -2.166 . . . . 0.0 107.908 168.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -65.06 166.15 9.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.109 1.364 . . . . 0.0 113.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.32 125.4 25.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p -145.18 159.03 43.63 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -51.68 -44.63 63.16 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.675 0.39 . . . . 0.0 110.658 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.11 -48.74 69.9 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.558 0.743 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -64.97 -39.86 94.12 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.267 0.94 . . . . 0.0 110.955 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.57 -43.31 73.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.402 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -59.32 -44.85 92.54 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.545 0.611 . . . . 0.0 110.105 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.42 -47.55 85.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.517 1.127 . . . . 0.0 109.684 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -58.41 -50.55 73.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.557 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.04 -30.76 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 118.923 0.783 . . . . 0.0 111.148 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -68.17 -30.88 70.1 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.244 -0.91 . . . . 0.0 111.237 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.2 -11.35 2.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.353 1.061 . . . . 0.0 113.267 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.05 -41.61 5.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.597 1.159 . . . . 0.0 110.174 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.806 0.73 . . . . 0.0 111.893 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.25 -11.45 10.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.013 0.925 . . . . 0.0 111.248 -173.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.09 -9.96 76.28 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 121.326 -0.859 . . . . 0.0 112.742 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -145.08 143.73 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.555 169.425 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -156.17 151.27 26.43 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.707 1.203 . . . . 0.0 107.963 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.02 161.45 34.59 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.694 1.998 . . . . 0.0 106.297 168.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.4 -107.07 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.883 2.389 . . . . 0.0 108.522 169.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.0 pt -139.34 57.49 10.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.374 1.47 . . . . 0.0 109.167 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.64 -36.91 5.89 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.986 1.791 . . . . 0.0 112.2 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -159.88 60.24 1.44 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.862 1.265 . . . . 0.0 111.88 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -53.49 127.68 26.28 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.796 1.32 . . . . 0.0 110.376 169.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -115.31 153.83 47.49 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.22 1.408 . . . . 0.0 107.905 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.44 134.07 20.55 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.548 2.165 . . . . 0.0 110.484 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.22 7.32 88.57 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.789 -1.562 . . . . 0.0 113.055 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -81.19 149.38 29.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.339 2.57 . . . . 0.0 110.368 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 mt -71.94 136.55 46.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -120.15 135.94 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.62 153.67 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -128.05 98.64 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 133.46 52.71 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.707 -0.62 . . . . 0.0 109.875 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.26 167.51 10.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.461 1.105 . . . . 0.0 109.11 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.28 -26.79 53.94 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.87 2.38 . . . . 0.0 115.175 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -140.59 2.8 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.345 1.058 . . . . 0.0 112.999 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -157.42 -152.43 0.36 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.445 1.098 . . . . 0.0 109.031 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 164.63 37.16 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -126.24 168.41 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -136.66 147.88 47.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.828 0.74 . . . . 0.0 111.479 -172.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.82 174.84 13.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.185 1.794 . . . . 0.0 108.726 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.41 132.06 64.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -74.67 134.54 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.206 1.002 . . . . 0.0 110.107 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.99 166.25 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.911 1.284 . . . . 0.0 109.032 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.18 26.54 43.31 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.54 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.66 37.51 9.59 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.83 1.652 . . . . 0.0 113.28 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.63 -14.72 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 O-C-N 121.336 -0.852 . . . . 0.0 114.637 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.7 172.18 8.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.269 1.034 . . . . 0.0 109.016 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.29 161.54 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.399 0.68 . . . . 0.0 110.093 170.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 t -114.31 135.56 53.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.33 168.98 25.04 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.165 0.586 . . . . 0.0 110.902 -173.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.55 139.27 33.95 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.3 162.26 46.09 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.697 1.599 . . . . 0.0 109.233 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.87 158.92 40.26 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.078 1.852 . . . . 0.0 111.279 172.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.69 -23.46 36.13 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.143 2.562 . . . . 0.0 113.109 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.8 m 55.06 34.59 22.84 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.667 1.187 . . . . 0.0 112.389 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -139.29 31.48 2.14 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.895 1.278 . . . . 0.0 109.21 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.98 -27.07 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 113.832 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.96 2.98 2.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -169.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.59 172.55 28.02 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.301 1.429 . . . . 0.0 109.701 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.95 -25.19 67.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 112.818 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.81 35.78 0.5 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.978 1.275 . . . . 0.0 110.557 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 163.82 16.95 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.592 0.757 . . . . 0.0 110.722 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.38 -26.23 52.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 112.719 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 m 50.58 50.22 19.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.938 1.295 . . . . 0.0 111.534 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.16 -37.09 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 123.345 0.658 . . . . 0.0 109.362 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.0 tpp -63.07 141.71 58.66 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 m -52.82 137.48 31.76 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.537 1.135 . . . . 0.0 110.823 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.26 -19.13 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.36 142.93 46.76 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.313 . . . . 0.0 110.003 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 p -145.84 -174.25 4.37 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 127.147 2.179 . . . . 0.0 107.517 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -95.18 12.23 29.54 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.79 0.805 . . . . 0.0 112.874 169.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -129.8 168.75 16.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.529 2.332 . . . . 0.0 109.433 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.32 173.09 12.57 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.996 1.718 . . . . 0.0 109.13 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -143.47 158.45 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 t -87.49 132.77 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -128.88 164.51 22.93 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.994 1.318 . . . . 0.0 109.481 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -125.23 126.34 45.03 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.01 1.324 . . . . 0.0 108.301 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -68.38 135.56 51.97 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.593 -0.692 . . . . 0.0 109.275 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tt -55.37 -43.67 75.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.872 0.76 . . . . 0.0 111.01 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -66.07 -19.37 65.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 -44.12 13.09 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.844 0.747 . . . . 0.0 110.228 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.32 -29.67 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.072 0.949 . . . . 0.0 111.281 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.97 -29.39 60.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.213 -0.899 . . . . 0.0 112.255 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.77 -109.49 0.64 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.86 1.219 . . . . 0.0 111.97 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -61.88 -0.49 0.48 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.645 1.978 . . . . 0.0 114.635 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.3 t0 67.54 160.05 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 129.37 3.068 . . . . 0.0 114.152 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 96.98 129.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 131.63 3.972 . . . . 0.0 109.063 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -165.29 161.48 19.18 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.062 1.345 . . . . 0.0 108.959 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.1 156.75 42.97 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.332 1.453 . . . . 0.0 108.381 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.31 134.65 28.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -153.61 75.4 1.04 Allowed 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.727 -0.608 . . . . 0.0 110.24 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.93 85.58 0.23 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.767 0.827 . . . . 0.0 108.883 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -62.25 125.09 22.67 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -171.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 46.49 44.37 13.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 126.474 1.91 . . . . 0.0 112.525 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -52.12 -18.87 1.63 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.18 -30.56 25.7 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.253 1.021 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -91.19 -34.42 15.01 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.781 0.832 . . . . 0.0 110.559 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.41 ' HB3' ' CD1' ' A' ' 122' ' ' TYR . 7.8 m-85 -80.48 175.7 10.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.965 0.888 . . . . 0.0 112.723 -170.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 m -56.27 160.08 5.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 128.85 2.86 . . . . 0.0 113.786 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.77 -0.6 3.22 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.815 3.01 . . . . 0.0 115.68 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 mt -36.61 119.58 0.75 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.391 2.276 . . . . 0.0 112.638 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.94 151.01 35.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.057 2.504 . . . . 0.0 111.841 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.5 m -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.633 0.773 . . . . 0.0 111.104 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 p -55.17 -51.34 66.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.854 1.261 . . . . 0.0 111.677 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.68 -34.95 76.64 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.979 0.912 . . . . 0.0 110.992 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.3 mt -65.13 -43.35 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.573 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.6 -48.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 120.017 1.28 . . . . 0.0 108.946 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -53.18 -47.39 68.89 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.627 1.171 . . . . 0.0 110.066 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -62.18 -50.56 71.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.945 0.498 . . . . 0.0 109.886 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.44 78.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.834 0.454 . . . . 0.0 111.359 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -82.55 -11.18 58.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.24 0.616 . . . . 0.0 112.343 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -82.53 -21.89 35.23 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.393 0.997 . . . . 0.0 109.783 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.08 -11.7 13.78 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.19 147.61 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.181 0.9 . . . . 0.0 109.832 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.01 -2.63 80.19 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.081 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -71.15 154.91 41.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.991 1.396 . . . . 0.0 109.174 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.92 148.9 29.02 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.01 178.27 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.397 1.079 . . . . 0.0 108.62 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.35 21.77 5.64 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.27 1.028 . . . . 0.0 111.167 -170.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -123.05 160.41 26.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.553 1.541 . . . . 0.0 109.735 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -75.2 169.01 18.88 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.54 43.59 0.25 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.343 1.857 . . . . 0.0 110.282 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 p -70.46 152.71 43.74 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.542 -1.349 . . . . 0.0 107.558 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.6 -51.76 11.6 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.083 1.353 . . . . 0.0 109.926 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.26 -37.59 83.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.712 1.605 . . . . 0.0 112.401 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -68.69 -39.13 80.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.346 1.43 . . . . 0.0 110.543 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 57.1 m -67.21 -44.81 78.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.73 -44.24 90.4 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.773 1.229 . . . . 0.0 110.573 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -58.79 -53.62 56.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.099 0.96 . . . . 0.0 109.486 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -46.96 87.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.06 -33.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.315 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.8 -33.52 74.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.184 0.902 . . . . 0.0 110.968 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -58.71 -33.74 70.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.202 1.001 . . . . 0.0 111.695 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.82 -52.98 7.57 Favored 'General case' 0 N--CA 1.458 -0.072 0 O-C-N 121.292 -0.88 . . . . 0.0 110.529 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -30.81 70.94 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.522 0.729 . . . . 0.0 111.395 -169.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 84' ' ' TYR . 48.0 m-85 -135.03 9.2 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.66 -43.42 2.75 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.886 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.87 139.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.433 171.056 . . . . . . . . 0 0 . 1 stop_ save_